Citrus Sinensis ID: 005210
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | no | no | 0.779 | 0.774 | 0.561 | 0.0 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.629 | 0.779 | 0.637 | 1e-173 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.472 | 0.653 | 0.536 | 1e-102 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.582 | 0.817 | 0.470 | 1e-101 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.458 | 0.626 | 0.545 | 1e-101 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.455 | 0.629 | 0.538 | 3e-98 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.458 | 0.217 | 0.445 | 4e-77 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.411 | 0.235 | 0.462 | 5e-77 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | no | no | 0.452 | 0.212 | 0.448 | 8e-77 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.411 | 0.196 | 0.462 | 1e-76 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/632 (56%), Positives = 433/632 (68%), Gaps = 79/632 (12%)
Query: 89 HHPGMGSIPKASEGE---QVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKIGQGTYSN 145
P M I S GE QV AGWP+WLA+VAGEAI GW+PR+ADSFEKL+KIGQGTYS+
Sbjct: 117 QQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSS 176
Query: 146 VYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205
VY+ARDL+ ++VALKKVRF N++P+SVRFMAREI ILRRLDH NV+KLEGL+TSR+S S
Sbjct: 177 VYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGS 236
Query: 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID 265
+YL+FEYMEHDLAGLAS PG+ FSEAQ+KCYM+QLL GL+HCHSRGVLHRDIKGSNLL+D
Sbjct: 237 MYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLD 296
Query: 266 NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 325
+N LKI DFGLA+FY Q QPLTSRVVTLWYRPPELLLG+T YG VDLWSTGCILAE
Sbjct: 297 HNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAE 356
Query: 326 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 385
L+ GKPIMPGRTEVEQLHKIFKLCGSPSE+YW+ SKLPHATIFKPQQPYKRCVAETFK
Sbjct: 357 LFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSL 416
Query: 386 PAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 445
P+ ALAL+E LL+++P RG+ ASAL SEFFT PL DPSSLPKY P KE D K ++EE
Sbjct: 417 PSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEE 476
Query: 446 ARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEE 505
A+R+ + ++ D ++ +RES+A+PAPD+NAE + S+QKRQ Q+N S S+KFNP E
Sbjct: 477 AKRKKDTSSKQND-SKQVSRESKAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPG--E 533
Query: 506 VASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGAD 565
A+ F I+P +S GH R + +N ++
Sbjct: 534 DAASFRIEP------LKSGTAKDGHT------------RYGVSSVNRNGENV-------- 567
Query: 566 LSTGLVAARRSLLSEDRRERS----GSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQ 621
++ + RS E R +RS G+AQ ++RF S S D H A
Sbjct: 568 ----MMGSSRSPRKELRTQRSFVQRGTAQ------LSRF-------SNSVAARDGSHFA- 609
Query: 622 GVAGSHQKEDGR-----------------------IGNKDPILLGYGSKGHKIHYSGPLI 658
+A ED +K+ I + G K ++H SGPL+
Sbjct: 610 -IANPRWFEDSYNNNNGRQNGGAWSQRLVVKHKEFTKHKESITVN-GEKKERMHCSGPLV 667
Query: 659 VPSGNVDQMLKDHDRQIQEAVRRARFDKAKVR 690
GN+D+MLK+H+RQIQ AVR+AR DK R
Sbjct: 668 SAGGNLDEMLKEHERQIQLAVRKARVDKKTNR 699
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 292/458 (63%), Positives = 361/458 (78%), Gaps = 12/458 (2%)
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+++ NG DR+R + +P + + K GEQVAAGWP+WL+ GEA
Sbjct: 53 NEEANGDKERKSSKGDRRRS------TKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEA 106
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
+ GWVPR+AD+FEK+DKIGQGTYSNVY+A+D+ KIVALKKVRFDNLEPESV+FMAREI
Sbjct: 107 LNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREI 166
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
+LRRLDH NV+KLEGLVTSRMSCSLYLVF+YM+HDLAGLAS P +KFSE++VKC M+QL
Sbjct: 167 LVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQL 226
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ GL+HCHSRGVLHRDIKGSNLLID+ G+LKIADFGLA+ +DP+ +P+TSRVVTLWYR
Sbjct: 227 ISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRA 286
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGAT YG +DLWS GCILAEL AG+PIMPGRTEVEQLHKI+KLCGSPSEDYW+K
Sbjct: 287 PELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKG 346
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
K H I+KP++PYKR + ETFKDFP +L L++ LLSI+P DR +A++AL+SEFFT +P
Sbjct: 347 KFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEP 406
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRG---TRESRAIPAPDANA 477
C+P+ LPKYPPSKE DAK RDEE RRQ + + D R+ R +RA+PAP+ANA
Sbjct: 407 YACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNRALPAPEANA 466
Query: 478 ELVLSMQKRQ--SQYNSKSRSEKF-NPHPEEVASGFPI 512
EL ++ +R+ + N+KS+SEKF PH + A G P+
Sbjct: 467 ELQSNVDRRRLITHANAKSKSEKFPPPHQDGGAMGVPL 504
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 190/354 (53%), Positives = 239/354 (67%), Gaps = 19/354 (5%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D FEKL++IG+GTY VY A++ + +IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHINVIKLEGLVTS---------------RMSCSLYLVFEYMEHDLAGLASHPGLK 227
L++L H NVI+L+ +VTS + S+Y+VFEYM+HDL GLA PG++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287
F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGLA + D N
Sbjct: 136 FTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YG AVD+WS GCI AEL GKPI+ G+ E EQL KIF+
Sbjct: 196 NLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFE 255
Query: 348 LCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406
LCG+P E W +K+P FKPQ+P KR V E+FK F AL L+E +L++DP+ R S
Sbjct: 256 LCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRIS 315
Query: 407 AASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLE 460
A AL +E+F PLPCDP SLPKY S EF K + + +RQ +R L+
Sbjct: 316 AKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTK-KKRQQQRQAEEAAKRQKLQ 368
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 203/431 (47%), Positives = 256/431 (59%), Gaps = 18/431 (4%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D FEKL++IG+GTY VY A+++ +IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHINVIKLEGLVTS--------------RMSCSLYLVFEYMEHDLAGLASHPGLKF 228
L++L H NVI+L+ +VTS + +Y+VFEYM+HDL GLA PGL+F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288
+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGLA Y D
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YG A+D+WS GCI AEL KPI+PG+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 349 CGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
CGSP E W SK+P FKP +P KR V E F+ F AL L+E +L +DPA R SA
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 408 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRES 467
AL +E+F PLPCDP SLP Y S EF K + + +RQ +R L+ + S
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTK-KKRQQQRQNEEAAKRQKLQHPPLQHS 375
Query: 468 RAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGP 527
R P + + + + P G P PP ++ S
Sbjct: 376 RLPPLQHGGQSHAAPHWPAGPNHPTNNAPPQVPAGPSHNFYGKPRGPPGPNRYPPSGNQS 435
Query: 528 QGHNHKRASHS 538
G+N R +S
Sbjct: 436 GGYNQSRGGYS 446
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (948), Expect = e-101, Method: Compositional matrix adjust.
Identities = 191/350 (54%), Positives = 235/350 (67%), Gaps = 25/350 (7%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D FEKL++IG+GTY VY AR+ + ++IVALKK+R DN E E A REI I
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN-EREGFPITAIREIKI 75
Query: 183 LRRLDHINVIKLEGLVTS---------------RMSCSLYLVFEYMEHDLAGLASHPGLK 227
L++L H NVI+L+ +VTS + S+Y+VFEYM+HDL GLA PG++
Sbjct: 76 LKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMR 135
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287
F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGLA + D N
Sbjct: 136 FTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNG 195
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
LT+RV+TLWYRPPELLLG+T YG AVD+WS GCI AEL GKPI+PG+ E EQL KIF
Sbjct: 196 NLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFD 255
Query: 348 LCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406
+CG+P E W +K+P FKP + KR V E FK F AL L+E +L++DPA R S
Sbjct: 256 VCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRIS 315
Query: 407 AASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIR-------DEEARRQ 449
A AL +E+F PLPCDP SLPKY S EF K + DE A+RQ
Sbjct: 316 AQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKRQ 365
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 183/340 (53%), Positives = 227/340 (66%), Gaps = 17/340 (5%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D FEKL++IG+GTY VY A+++ +IVALKK+R DN E E A REI I
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 183 LRRLDHINVIKLEGLVTS--------------RMSCSLYLVFEYMEHDLAGLASHPGLKF 228
L++L H NVI L+ +VTS + +Y+VFEYM+HDL GLA PGL+F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 229 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288
+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGLA Y D
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348
LT+RV+TLWYRPPELLLGAT YG A+D+WS GCI AEL GKPI+PG+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 349 CGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
CGSP E W SK+P K +P KR V E ++ F AL L+E +L +DP+ R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 408 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEAR 447
AL +E+F PLPCDP SLP Y S EF K + ++ R
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMR 356
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (741), Expect = 4e-77, Method: Compositional matrix adjust.
Identities = 151/339 (44%), Positives = 211/339 (62%), Gaps = 14/339 (4%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D F+ + IG+GTY VY+A+D D ++VALKKVR DN E E A REI I
Sbjct: 720 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 778
Query: 183 LRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVK 234
LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL + FSE +K
Sbjct: 779 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 838
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+M+QL+ GLD+CH + LHRDIK SN+L++N+G +K+ADFGLA Y+ ++++P T++V+
Sbjct: 839 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 898
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYRPPELLLG Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP
Sbjct: 899 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 958
Query: 355 DYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
W KLP+ KP++ Y+R + E F P+ AL L++ +L++DP+ R +A L+S
Sbjct: 959 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1018
Query: 414 EFFTMKPLP-CDPSSLPKYPPSKEFDAKIRDEEARRQGG 451
+F L DP LP + E +K R + RQ G
Sbjct: 1019 DFLKDVELSKMDPPDLPHWQDCHELWSKKRRRQ--RQSG 1055
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (740), Expect = 5e-77, Method: Compositional matrix adjust.
Identities = 140/303 (46%), Positives = 197/303 (65%), Gaps = 11/303 (3%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D F+ + IG+GTY VY+A+D D ++VALKKVR DN E E A REI I
Sbjct: 702 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 760
Query: 183 LRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVK 234
LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL ++FSE +K
Sbjct: 761 LRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIK 820
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+M+QL+ GL++CH + LHRDIK SN+L++N+G +K+ADFGLA Y ++++P T++V+
Sbjct: 821 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVI 880
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYRPPELLLG Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP
Sbjct: 881 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 940
Query: 355 DYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
W KLP+ KP++ Y+R + E F P PAL L++ +L++DP+ R +A L+S
Sbjct: 941 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQS 1000
Query: 414 EFF 416
+F
Sbjct: 1001 DFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 8e-77, Method: Compositional matrix adjust.
Identities = 151/337 (44%), Positives = 208/337 (61%), Gaps = 16/337 (4%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D F+ + IG+GTY VY+ARD D ++VALKKVR DN E E A REI I
Sbjct: 697 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKI 755
Query: 183 LRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVK 234
LR+L H ++I ++ +VT + + YLVFEYM+HDL GL + F+E +K
Sbjct: 756 LRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIK 815
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+M+QL+ GLD+CH + LHRDIK SN+L++N G +K+ADFGLA Y ++++P T++V+
Sbjct: 816 SFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVI 875
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYRPPELLLG Y A+D+WS GCIL EL+ KPI E+ QL I ++CGSP
Sbjct: 876 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCP 935
Query: 355 DYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
W KLP+ KP++ Y+R + E F PA AL L + +L++DP+ R +A AL+
Sbjct: 936 AVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQC 995
Query: 414 EFF-TMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
EF ++P P LP + E +K R RRQ
Sbjct: 996 EFLRDVEPSKMPPPDLPLWQDCHELWSKKR----RRQ 1028
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 140/303 (46%), Positives = 197/303 (65%), Gaps = 11/303 (3%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D F+ + IG+GTY VY+A+D D ++VALKKVR DN E E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 183 LRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVK 234
LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL + FSE +K
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 833
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+M+QL+ GLD+CH + LHRDIK SN+L++N+G +K+ADFGLA Y+ ++++P T++V+
Sbjct: 834 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 893
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYRPPELLLG Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP
Sbjct: 894 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 953
Query: 355 DYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
W KLP+ KP++ Y+R + E F P+ AL L++ +L++DP+ R +A L+S
Sbjct: 954 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1013
Query: 414 EFF 416
+F
Sbjct: 1014 DFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | ||||||
| 224114928 | 713 | predicted protein [Populus trichocarpa] | 0.998 | 0.992 | 0.883 | 0.0 | |
| 224128322 | 713 | predicted protein [Populus trichocarpa] | 0.998 | 0.992 | 0.873 | 0.0 | |
| 225461467 | 713 | PREDICTED: probable serine/threonine-pro | 0.998 | 0.992 | 0.865 | 0.0 | |
| 302143004 | 712 | unnamed protein product [Vitis vinifera] | 0.998 | 0.994 | 0.865 | 0.0 | |
| 356544039 | 708 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.992 | 0.845 | 0.0 | |
| 356549726 | 712 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.987 | 0.834 | 0.0 | |
| 357452947 | 712 | Serine/threonine protein kinase cdk9 [Me | 0.991 | 0.987 | 0.821 | 0.0 | |
| 356543323 | 710 | PREDICTED: probable serine/threonine-pro | 0.992 | 0.991 | 0.822 | 0.0 | |
| 449457023 | 707 | PREDICTED: probable serine/threonine-pro | 0.991 | 0.994 | 0.819 | 0.0 | |
| 356517145 | 710 | PREDICTED: probable serine/threonine-pro | 0.992 | 0.991 | 0.819 | 0.0 |
| >gi|224114928|ref|XP_002316895.1| predicted protein [Populus trichocarpa] gi|222859960|gb|EEE97507.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1293 bits (3345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/714 (88%), Positives = 659/714 (92%), Gaps = 6/714 (0%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSKASSDLR SRATSSRREE YR KDR D NDGR MLI
Sbjct: 1 MGCLCCKPSAIEDSKESPRERLSSKASSDLRVSRATSSRREEAYRAKDRCDGNDGRTMLI 60
Query: 61 DKQVNGSVRLHG-ENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGE 119
DKQVNGS+R+HG E+ +RKR+K EY V HHPGMGSIPKA+EGEQVAAGWP+WLAAVAGE
Sbjct: 61 DKQVNGSLRVHGGEHVERKRDKSEYAVV-HHPGMGSIPKATEGEQVAAGWPSWLAAVAGE 119
Query: 120 AIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
AI+GW+PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE
Sbjct: 120 AIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
IHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA+HPGLKF+EAQVKCYMQQ
Sbjct: 180 IHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAAHPGLKFTEAQVKCYMQQ 239
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
LL GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP QPLTSRVVTLWYR
Sbjct: 240 LLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPAHVQPLTSRVVTLWYR 299
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK
Sbjct: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
SKLPHATIFKPQQPY+RCVA+TFK+FP PALALMETLLSIDPADRGSAASALRSEFF K
Sbjct: 360 SKLPHATIFKPQQPYRRCVADTFKEFPPPALALMETLLSIDPADRGSAASALRSEFFITK 419
Query: 420 PLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDANA 477
PLPCDPSS PKYPPSKEFDAK+RDEEARRQG GSKGQ+ D+ERRG RESRA+PAPDANA
Sbjct: 420 PLPCDPSSFPKYPPSKEFDAKMRDEEARRQGAAGSKGQKSDMERRGRRESRAVPAPDANA 479
Query: 478 ELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASH 537
ELVLSMQKR Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ ES+ PQGH HKRASH
Sbjct: 480 ELVLSMQKRHGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAAESNMDPQGHQHKRASH 539
Query: 538 SGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVPK 595
SGPL+ RAAWAKA +N DDAPKISTGADLST LVAARRSLLSEDR ERSG AQPEVPK
Sbjct: 540 SGPLSHRAAWAKASRNPDDAPKISTGADLSTISSLVAARRSLLSEDRNERSGLAQPEVPK 599
Query: 596 LIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYSG 655
L+ARFPGSFKE SESF Q D +H +QGVAG HQKEDGR +KDP+LLGYGSKGHKIHYSG
Sbjct: 600 LMARFPGSFKETSESFTQQDPRHPSQGVAGFHQKEDGRNSSKDPVLLGYGSKGHKIHYSG 659
Query: 656 PLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
PLIVPSGNVDQMLKDHDRQIQEAVRRAR DK KVRKVQ E NQ+STNSLFVSGR
Sbjct: 660 PLIVPSGNVDQMLKDHDRQIQEAVRRARLDKEKVRKVQAESNQISTNSLFVSGR 713
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128322|ref|XP_002329133.1| predicted protein [Populus trichocarpa] gi|222869802|gb|EEF06933.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 624/714 (87%), Positives = 657/714 (92%), Gaps = 6/714 (0%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSK SSDLR SRATSSRREE YR KD++DSNDGR MLI
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKPSSDLRVSRATSSRREEAYRAKDQYDSNDGRTMLI 60
Query: 61 DKQVNGSVRLHG-ENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGE 119
DKQVNGS+R+HG E+ DRKR+K EY V HHPGMGSIPKA+EGEQVAAGWP+WLAAVAGE
Sbjct: 61 DKQVNGSLRVHGVEHVDRKRDKSEYAVL-HHPGMGSIPKATEGEQVAAGWPSWLAAVAGE 119
Query: 120 AIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
AI+GW+PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE
Sbjct: 120 AIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
IHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL F+EAQVKCYMQQ
Sbjct: 180 IHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLNFTEAQVKCYMQQ 239
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
LL GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP Q QPLTSRVVTLWYR
Sbjct: 240 LLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPAQVQPLTSRVVTLWYR 299
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PPELLLGATYYG AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK
Sbjct: 300 PPELLLGATYYGIAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
SKLPHATIFKPQQPY+RCVAETFK+FPAPALALMETLL+IDP DRGSAASALRSEFFT K
Sbjct: 360 SKLPHATIFKPQQPYRRCVAETFKEFPAPALALMETLLAIDPVDRGSAASALRSEFFTTK 419
Query: 420 PLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDANA 477
PLPCDPSSLP YPPSKEFDAK+RDEEARRQG GSKGQ+ D+ERRG RESRA+PAPDANA
Sbjct: 420 PLPCDPSSLPDYPPSKEFDAKMRDEEARRQGAAGSKGQKPDMERRGQRESRAVPAPDANA 479
Query: 478 ELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASH 537
ELVLSMQKR + NSKSRSEKFNPHPEEVASGFPIDPPR SQ ES+ PQGH HKRASH
Sbjct: 480 ELVLSMQKRHGRPNSKSRSEKFNPHPEEVASGFPIDPPRPSQAAESNMDPQGHQHKRASH 539
Query: 538 SGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVPK 595
SGPL+ R+ WAKAG+N DDAPKI TGADLST L AARRSLLSED RERSG +QPEVPK
Sbjct: 540 SGPLSHRSGWAKAGRNPDDAPKIYTGADLSTISSLEAARRSLLSEDHRERSGLSQPEVPK 599
Query: 596 LIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYSG 655
L+ARFPGSFKE SESF Q D + +QGVAGSHQKEDGR +KDP+LLGYGSK HKIHYSG
Sbjct: 600 LMARFPGSFKETSESFAQQDPQRLSQGVAGSHQKEDGRNNSKDPVLLGYGSKAHKIHYSG 659
Query: 656 PLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
PLIVPSGN+DQMLKDHDRQIQEAVRRARFDKA+VRKVQ E Q+S NSLFVSGR
Sbjct: 660 PLIVPSGNMDQMLKDHDRQIQEAVRRARFDKARVRKVQAESYQISANSLFVSGR 713
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461467|ref|XP_002285008.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1268 bits (3280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/713 (86%), Positives = 655/713 (91%), Gaps = 5/713 (0%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCIC KPSAIEDS+ESPRERLSSKASS+LR + SSRREE YRVKDRFDSNDGR MLI
Sbjct: 2 MGCICCKPSAIEDSRESPRERLSSKASSNLRVAGPASSRREEAYRVKDRFDSNDGRTMLI 61
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+KQ NGSVRLHGEN +RKRE+ EYVVAQH PG+GSIPKA EGEQVAAGWPAWL+AVAGEA
Sbjct: 62 EKQANGSVRLHGENVERKRERGEYVVAQH-PGLGSIPKAMEGEQVAAGWPAWLSAVAGEA 120
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
I+GW+PRRADSFEKLDKIGQGTYSNVYRARDLDQ+KIVALKKVRFDNLEPESVRFMAREI
Sbjct: 121 IRGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQRKIVALKKVRFDNLEPESVRFMAREI 180
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
H+LRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+E QVKCYMQQL
Sbjct: 181 HVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFTEPQVKCYMQQL 240
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L GLDHCHSRGVLHRDIKGSNLLIDN+GILKIADFGLASF+DP Q QPLTSRVVTLWYRP
Sbjct: 241 LRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPHQIQPLTSRVVTLWYRP 300
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS
Sbjct: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
KLPHATIFKPQQPY+RCVAETFKDFP PAL LMETLLSIDPADRGSAASAL+SEFFT+KP
Sbjct: 361 KLPHATIFKPQQPYRRCVAETFKDFPTPALGLMETLLSIDPADRGSAASALKSEFFTVKP 420
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS-KGQRMDLERRGTRESRAIPAPDANAEL 479
LPCDPSSLPKYPPSKEFDAK+RDEEARRQG + KGQR+D ER+G RESRA+PAPDANAEL
Sbjct: 421 LPCDPSSLPKYPPSKEFDAKVRDEEARRQGATGKGQRLDHERKGIRESRAVPAPDANAEL 480
Query: 480 VLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTE-SSAGPQGHNHKRASHS 538
VLSMQKRQ Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ E S QG HKRASHS
Sbjct: 481 VLSMQKRQGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAIEDGSIDTQGPLHKRASHS 540
Query: 539 GPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVPKL 596
GPLA RA WAKAGKN DDAPK+STGADLST LVAARRSLLSEDRRE+SGS+QP+V KL
Sbjct: 541 GPLAHRAVWAKAGKNLDDAPKVSTGADLSTMSSLVAARRSLLSEDRREKSGSSQPDVSKL 600
Query: 597 IARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYSGP 656
I RFPGSFKEASES IQ DQKH QG QKEDGR+ +KDP+LLGYGSKGHKIHYSGP
Sbjct: 601 IVRFPGSFKEASESTIQQDQKHQMQGAGRCTQKEDGRMTSKDPVLLGYGSKGHKIHYSGP 660
Query: 657 LIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
L+VPSG VDQMLKDHDRQIQ+A RRAR D+ K+RKVQ+EGN++S NSLFVSGR
Sbjct: 661 LLVPSGKVDQMLKDHDRQIQDAERRARLDREKLRKVQVEGNKISANSLFVSGR 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143004|emb|CBI20299.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1266 bits (3275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/713 (86%), Positives = 655/713 (91%), Gaps = 5/713 (0%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCIC KPSAIEDS+ESPRERLSSKASS+LR + SSRREE YRVKDRFDSNDGR MLI
Sbjct: 1 MGCICCKPSAIEDSRESPRERLSSKASSNLRVAGPASSRREEAYRVKDRFDSNDGRTMLI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+KQ NGSVRLHGEN +RKRE+ EYVVAQH PG+GSIPKA EGEQVAAGWPAWL+AVAGEA
Sbjct: 61 EKQANGSVRLHGENVERKRERGEYVVAQH-PGLGSIPKAMEGEQVAAGWPAWLSAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
I+GW+PRRADSFEKLDKIGQGTYSNVYRARDLDQ+KIVALKKVRFDNLEPESVRFMAREI
Sbjct: 120 IRGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQRKIVALKKVRFDNLEPESVRFMAREI 179
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
H+LRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+E QVKCYMQQL
Sbjct: 180 HVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFTEPQVKCYMQQL 239
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L GLDHCHSRGVLHRDIKGSNLLIDN+GILKIADFGLASF+DP Q QPLTSRVVTLWYRP
Sbjct: 240 LRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPHQIQPLTSRVVTLWYRP 299
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS
Sbjct: 300 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 359
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
KLPHATIFKPQQPY+RCVAETFKDFP PAL LMETLLSIDPADRGSAASAL+SEFFT+KP
Sbjct: 360 KLPHATIFKPQQPYRRCVAETFKDFPTPALGLMETLLSIDPADRGSAASALKSEFFTVKP 419
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS-KGQRMDLERRGTRESRAIPAPDANAEL 479
LPCDPSSLPKYPPSKEFDAK+RDEEARRQG + KGQR+D ER+G RESRA+PAPDANAEL
Sbjct: 420 LPCDPSSLPKYPPSKEFDAKVRDEEARRQGATGKGQRLDHERKGIRESRAVPAPDANAEL 479
Query: 480 VLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTE-SSAGPQGHNHKRASHS 538
VLSMQKRQ Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ E S QG HKRASHS
Sbjct: 480 VLSMQKRQGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAIEDGSIDTQGPLHKRASHS 539
Query: 539 GPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVPKL 596
GPLA RA WAKAGKN DDAPK+STGADLST LVAARRSLLSEDRRE+SGS+QP+V KL
Sbjct: 540 GPLAHRAVWAKAGKNLDDAPKVSTGADLSTMSSLVAARRSLLSEDRREKSGSSQPDVSKL 599
Query: 597 IARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYSGP 656
I RFPGSFKEASES IQ DQKH QG QKEDGR+ +KDP+LLGYGSKGHKIHYSGP
Sbjct: 600 IVRFPGSFKEASESTIQQDQKHQMQGAGRCTQKEDGRMTSKDPVLLGYGSKGHKIHYSGP 659
Query: 657 LIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
L+VPSG VDQMLKDHDRQIQ+A RRAR D+ K+RKVQ+EGN++S NSLFVSGR
Sbjct: 660 LLVPSGKVDQMLKDHDRQIQDAERRARLDREKLRKVQVEGNKISANSLFVSGR 712
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544039|ref|XP_003540463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1230 bits (3182), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/714 (84%), Positives = 646/714 (90%), Gaps = 11/714 (1%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSKA SDLR SR SSRREE +RVKDR+D+NDGR LI
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKAVSDLRVSRGASSRREEAFRVKDRYDNNDGRTALI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
DKQ NGSVR+ GE+F+RKREKMEY VAQH PG+GS+PKA EGEQVAAGWP+WLAAVAGEA
Sbjct: 61 DKQGNGSVRVQGESFERKREKMEYAVAQH-PGIGSVPKAMEGEQVAAGWPSWLAAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
I+GW+PRRADSFEKLDKIGQGTYSNVYRARDL+Q+K+VALKKVRFDNLEPESVRFMAREI
Sbjct: 120 IKGWLPRRADSFEKLDKIGQGTYSNVYRARDLEQRKVVALKKVRFDNLEPESVRFMAREI 179
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
HILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+EAQVKCYMQQL
Sbjct: 180 HILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFTEAQVKCYMQQL 239
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L GLDHCHS GVLHRDIKGSNLLIDNNGILKIADFGLASF+DP+Q QPLTSRVVTLWYRP
Sbjct: 240 LRGLDHCHSCGVLHRDIKGSNLLIDNNGILKIADFGLASFFDPNQAQPLTSRVVTLWYRP 299
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS
Sbjct: 300 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 359
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
KLPHATIFKPQQPY+RCV+ETFK+FPAPA+ L+ETLLSIDPADRG++ASAL SEFF+ KP
Sbjct: 360 KLPHATIFKPQQPYRRCVSETFKEFPAPAIELIETLLSIDPADRGTSASALNSEFFSTKP 419
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDANAE 478
LPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR DLERRG RESRAIPAPDANAE
Sbjct: 420 LPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDLERRGARESRAIPAPDANAE 479
Query: 479 LVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHS 538
LVLSMQKRQ Q NS+S+SEKFNPHPEEVASGFPIDPPR SQ A P H HKRASHS
Sbjct: 480 LVLSMQKRQGQANSQSKSEKFNPHPEEVASGFPIDPPRPSQAAGLIADPPVHQHKRASHS 539
Query: 539 GPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVPKL 596
GPL RAAWAKAGKN DDAPKIS DLST GLVAARRS+LS+DRRERSGS+Q PKL
Sbjct: 540 GPLTHRAAWAKAGKNQDDAPKISMVGDLSTVSGLVAARRSMLSDDRRERSGSSQTVAPKL 599
Query: 597 IARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGR-IGNKDPILLGYGSKGHKIHYSG 655
I RFPGSFKEASES +Q DQK+HA QKE+GR NKD L+GYGSKGHKIH+SG
Sbjct: 600 INRFPGSFKEASESMMQQDQKYHAH----VPQKEEGRGSSNKDSNLVGYGSKGHKIHHSG 655
Query: 656 PLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
PL+VPS N DQMLKDHDRQIQE VRRAR DKAK+R++Q EGNQ+ TNSLFVSGR
Sbjct: 656 PLLVPSSNHDQMLKDHDRQIQEVVRRARLDKAKMRRLQTEGNQI-TNSLFVSGR 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549726|ref|XP_003543242.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1204 bits (3115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/718 (83%), Positives = 648/718 (90%), Gaps = 15/718 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSD---LRGSRATSSRREEVYRVKDRFDSNDGRA 57
MGC+C KPSAIEDSKESPRERLSSK+ LR SR TSSRREE + +KDR+D+NDGRA
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKSDKSVSDLRVSRGTSSRREEAFWLKDRYDNNDGRA 60
Query: 58 MLIDKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVA 117
LIDKQ NGSVR+ GE+F+RKREKMEY VAQH PG+GS+PKA EGEQVAAGWP+WLAAVA
Sbjct: 61 ALIDKQGNGSVRVQGESFERKREKMEYTVAQH-PGIGSVPKAMEGEQVAAGWPSWLAAVA 119
Query: 118 GEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 177
GEAI+GW+PRRADSFEKLDKIGQGTYSNVYRARDL+Q+KIVALKKVRFDNLEPESVRFMA
Sbjct: 120 GEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLEQRKIVALKKVRFDNLEPESVRFMA 179
Query: 178 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 237
REIHILRRL+H NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+EAQVKCYM
Sbjct: 180 REIHILRRLNHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFTEAQVKCYM 239
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
QQLL GLDHCHS GVLHRDIKGSNLLIDN+GILKIADFGLASF+DP+Q QPLTSRVVTLW
Sbjct: 240 QQLLRGLDHCHSCGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPNQAQPLTSRVVTLW 299
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW
Sbjct: 300 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 359
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
RKSKLPHATIFKPQQPY+RCV+ETFK+FPAPA+ L+E LLSIDPADRG++ASAL SEFF+
Sbjct: 360 RKSKLPHATIFKPQQPYRRCVSETFKEFPAPAIELIEILLSIDPADRGTSASALNSEFFS 419
Query: 418 MKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDA 475
KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR D+ERRG RESRAIPAPDA
Sbjct: 420 TKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDIERRGARESRAIPAPDA 479
Query: 476 NAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRA 535
NAELVLS+QKRQ Q NS+SRSEKFNPHPEEVASGFPIDPPR SQ A P H HKR+
Sbjct: 480 NAELVLSIQKRQGQANSQSRSEKFNPHPEEVASGFPIDPPRPSQAAGLIADPPVHQHKRS 539
Query: 536 SHSGPLAQRAAWA-KAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPE 592
SHSGPL RAAWA KAGKN +DAPKIS G DLST GLVAARRS+LS+DRRE SGS+Q E
Sbjct: 540 SHSGPLTHRAAWANKAGKNQEDAPKISMGGDLSTVSGLVAARRSMLSDDRREWSGSSQAE 599
Query: 593 VPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIG-NKDPILLGYGSKGHKI 651
PKLI+RFPGSFKEASES +Q DQKHHA + QKE+GR NKD L+GYGSKGHKI
Sbjct: 600 APKLISRFPGSFKEASESMMQQDQKHHAH----APQKEEGRGSRNKDSNLVGYGSKGHKI 655
Query: 652 HYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
HYSGPL+VPS N DQMLKDHDRQIQEAVRRAR DKAK+R++Q EG+Q+S NSLFVSGR
Sbjct: 656 HYSGPLLVPSSNHDQMLKDHDRQIQEAVRRARLDKAKMRRLQAEGSQIS-NSLFVSGR 712
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452947|ref|XP_003596750.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] gi|355485798|gb|AES67001.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1203 bits (3113), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/718 (82%), Positives = 643/718 (89%), Gaps = 15/718 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSN-DGRAML 59
MGC+C KPSAIEDSK+SPRERLS+K D R SR SSRREE YRVKDR D+N D R L
Sbjct: 1 MGCMCCKPSAIEDSKDSPRERLSNKPVLDSRVSRGASSRREEAYRVKDRNDNNNDARMAL 60
Query: 60 IDK--QVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVA 117
IDK Q NGSVR+HG+NF+RKREKMEYV+A H PG+GS+PKA EGE VAAGWP+WLAAVA
Sbjct: 61 IDKHGQGNGSVRVHGDNFERKREKMEYVIAPH-PGIGSVPKAMEGEHVAAGWPSWLAAVA 119
Query: 118 GEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 177
G+AI+GW+PRRADSFEKLDKIGQGTYSNVYRARDL+Q+KIVALKKVRFDNLEPESVRFMA
Sbjct: 120 GDAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLEQRKIVALKKVRFDNLEPESVRFMA 179
Query: 178 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 237
REIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+E+QVKCYM
Sbjct: 180 REIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFTESQVKCYM 239
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
QQLL GLDHCHSRGVLHRDIKGSNLLIDNNG+LKIADFGLASF+DP+ NQPLTSRVVTLW
Sbjct: 240 QQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGVLKIADFGLASFFDPNLNQPLTSRVVTLW 299
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW
Sbjct: 300 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 359
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
RKSKLPHATIFKPQQPY+RCVAETFK+FPAPA+ L+ETLLSIDPADRG++ASAL SEFF+
Sbjct: 360 RKSKLPHATIFKPQQPYRRCVAETFKEFPAPAIELIETLLSIDPADRGTSASALISEFFS 419
Query: 418 MKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDA 475
KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR D ERRG RESRA+PAPDA
Sbjct: 420 TKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDPERRGVRESRAVPAPDA 479
Query: 476 NAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRA 535
NAELV+SMQKRQ Q S+SRSEKFNPHPE+ SGFPI+PPR SQ E++ PQ + HKRA
Sbjct: 480 NAELVVSMQKRQGQNYSQSRSEKFNPHPEDAGSGFPIEPPRPSQAAEANVDPQANQHKRA 539
Query: 536 SHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEV 593
SHSGPL RAAWAKAGKN DDAPKIS G DLST GLVAARRS+LS+DRRE SGS+Q E
Sbjct: 540 SHSGPLTHRAAWAKAGKNQDDAPKISVGGDLSTMSGLVAARRSMLSDDRRESSGSSQVEA 599
Query: 594 PKLIARFPGSFKEASESFIQ--HDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKI 651
PKLI RFPGSFKEASES +Q +QKHH + QKED + NKDP +GYGSKG+KI
Sbjct: 600 PKLITRFPGSFKEASESLMQQNQNQKHHVH----ASQKEDAKGSNKDPNNVGYGSKGYKI 655
Query: 652 HYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
HYSGPL+VPS N+DQMLKDHDRQIQEAVRRAR DKAK+R++Q EGNQ++ NSLFVSGR
Sbjct: 656 HYSGPLLVPSSNMDQMLKDHDRQIQEAVRRARLDKAKMRRLQAEGNQIN-NSLFVSGR 712
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543323|ref|XP_003540111.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1187 bits (3072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/715 (82%), Positives = 633/715 (88%), Gaps = 11/715 (1%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASS-DLRGSRATSSRREEVYRVKDRFDSNDGRAML 59
MG +C KPSAIEDSKESPRER+S+KA+S D R SR S RRE+ YR KDR+D ND R L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKAASLDSRVSRGASLRREDAYRGKDRYDGNDVRTAL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVA-QHHPGMGSIPKASEGEQVAAGWPAWLAAVAG 118
IDKQ NGSVRL EN +RKRE+ME VVA Q HPG GS+PKA EGEQVAAGWP+WLAAVAG
Sbjct: 61 IDKQGNGSVRLQDENIERKRERMECVVAAQQHPGAGSVPKAMEGEQVAAGWPSWLAAVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 178
EAI+GW+PRRADSFEKLDKIGQGTYSNVYRARDL+Q KIVALKKVRFDNLEPESVRFMAR
Sbjct: 121 EAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLEQNKIVALKKVRFDNLEPESVRFMAR 180
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
EIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP LKF+EAQVKCYMQ
Sbjct: 181 EIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPKLKFTEAQVKCYMQ 240
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
QLL GLDHCH+ GVLHRDIKGSNLLIDNNGILKIADFGLAS +DP+Q QPLTSRVVTLWY
Sbjct: 241 QLLQGLDHCHNCGVLHRDIKGSNLLIDNNGILKIADFGLASVFDPNQTQPLTSRVVTLWY 300
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR
Sbjct: 301 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 360
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
KSKLPHATIFKP+QPY RCVA+TFKDFPAPALALMETLLSIDPADRG+AASAL+S+FFT
Sbjct: 361 KSKLPHATIFKPRQPYWRCVADTFKDFPAPALALMETLLSIDPADRGTAASALKSDFFTT 420
Query: 419 KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDAN 476
KPLPCDPSSLPKYPPSKEFDAK+RDE+ARRQG GS+GQR DLERRG +ESRA+PAPDAN
Sbjct: 421 KPLPCDPSSLPKYPPSKEFDAKLRDEQARRQGATGSRGQRHDLERRGAKESRAVPAPDAN 480
Query: 477 AELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRAS 536
AEL LSMQKRQSQ SKSRSEKFNPHPEE ASGFPIDPPR SQ E Q HKRAS
Sbjct: 481 AELPLSMQKRQSQAQSKSRSEKFNPHPEE-ASGFPIDPPRSSQAVEVGIETQVPQHKRAS 539
Query: 537 HSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVP 594
HSGPLA R AWAK+GKN DDAPKIS G DLST GLVAA RS+LS+DRRERSGS+Q E
Sbjct: 540 HSGPLAHRTAWAKSGKNQDDAPKISVGGDLSTISGLVAA-RSMLSDDRRERSGSSQTEAS 598
Query: 595 KLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYS 654
KL RFPGSFK+ SES I+ DQ+HH QG G+ QKE+GR NKD +L+GYGS+GHKIHYS
Sbjct: 599 KLTNRFPGSFKDFSESSIKQDQRHHVQGQVGTSQKEEGRSSNKDLVLVGYGSEGHKIHYS 658
Query: 655 GPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
GPL S N+DQ+LKDHDRQIQEAVRRAR DKAK+R++Q EGNQ+ TNSLFVS R
Sbjct: 659 GPLT--SSNMDQVLKDHDRQIQEAVRRARLDKAKIRRLQAEGNQV-TNSLFVSKR 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457023|ref|XP_004146248.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449526203|ref|XP_004170103.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/713 (81%), Positives = 633/713 (88%), Gaps = 10/713 (1%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPR+R+SSK SSDLR +R TSS REE YR KD++D ND R LI
Sbjct: 1 MGCVCCKPSAIEDSKESPRDRVSSKTSSDLRVARLTSSSREEAYRAKDQYDGNDARVTLI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
DKQVNGS RL GEN +RKREKME++ AQH P MG IPKA+EG+ +AAGWP WLAAVAGEA
Sbjct: 61 DKQVNGSGRLPGENCERKREKMEHMTAQH-PSMGRIPKAAEGDHIAAGWPPWLAAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
I+GW+PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI
Sbjct: 120 IRGWLPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 179
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
HILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG+KF+EAQVKCYMQQL
Sbjct: 180 HILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGVKFTEAQVKCYMQQL 239
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L GLDHCHS GVLHRDIKGSNLLIDN+GILKIADFGLASF+D QNQPLTSRVVTLWYRP
Sbjct: 240 LRGLDHCHSHGVLHRDIKGSNLLIDNHGILKIADFGLASFFDIHQNQPLTSRVVTLWYRP 299
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS
Sbjct: 300 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 359
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
+LPHATIFKPQQPY+RCVA+TFKDFPAPALAL+ETLLSIDPADRGSAA AL+SEFF+ KP
Sbjct: 360 RLPHATIFKPQQPYRRCVADTFKDFPAPALALIETLLSIDPADRGSAALALKSEFFSAKP 419
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDANAE 478
LPCDPSSLPKYPPSKEFDAKIRDEEARRQG GSKG R+DL+R+ R+SRA+PAPDANAE
Sbjct: 420 LPCDPSSLPKYPPSKEFDAKIRDEEARRQGAVGSKGHRLDLQRK-DRDSRAVPAPDANAE 478
Query: 479 LVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHS 538
L SMQKRQ +SKSRSEKFNPHPEE ASGFPIDPPR SQ E Q + K+ASHS
Sbjct: 479 LASSMQKRQGLSSSKSRSEKFNPHPEE-ASGFPIDPPRPSQGAE-RMDSQVRHPKKASHS 536
Query: 539 GPLAQRAAWAKAGKNTDDAPKISTGADL--STGLVAARRSLLSEDRRERSGSAQPEVPKL 596
GPLAQRAAWAKA +N DD PKISTG + ++GLVAARRS+L+ED RE+S S+Q EV KL
Sbjct: 537 GPLAQRAAWAKASRNPDDPPKISTGTETFATSGLVAARRSMLAEDCREKSDSSQGEVQKL 596
Query: 597 IARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYSGP 656
I RFPGSFKE SES + DQK +AGSH KE R KDPI++GYGSKGHKIHYSGP
Sbjct: 597 IGRFPGSFKETSESSMLPDQKFSNHSIAGSHDKE--RSSTKDPIVVGYGSKGHKIHYSGP 654
Query: 657 LIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
L+VPSGN+DQMLKDHDR IQEAVRRAR DKAKVRK+Q +G Q+STNSLFVSGR
Sbjct: 655 LLVPSGNMDQMLKDHDRHIQEAVRRARLDKAKVRKIQADGKQISTNSLFVSGR 707
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517145|ref|XP_003527250.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/715 (81%), Positives = 631/715 (88%), Gaps = 11/715 (1%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASS-DLRGSRATSSRREEVYRVKDRFDSNDGRAML 59
MG +C KPSAIEDSKESPRER+S+K++S D R S RRE+ YRVKDR+D N+ R L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKSASLDSCVPRGASLRREDAYRVKDRYDGNNVRTAL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVA-QHHPGMGSIPKASEGEQVAAGWPAWLAAVAG 118
IDKQ NGSVRL EN +RKRE+ME VVA Q HPG GS+PKA EGEQVAAGWP+WLAAVAG
Sbjct: 61 IDKQGNGSVRLQSENVERKRERMECVVAAQQHPGAGSVPKALEGEQVAAGWPSWLAAVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 178
EAI+GW+PRRADSFEKLDKIGQGTYSNVYRARDL+QKKIVALKKVRFDNLEPESVRFMAR
Sbjct: 121 EAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLEQKKIVALKKVRFDNLEPESVRFMAR 180
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
EIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP LKF+EAQVKCYMQ
Sbjct: 181 EIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPKLKFTEAQVKCYMQ 240
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
QLL GL+HCH+ GVLHRDIKGSNLLIDNNGILKIADFGLAS +DP++ QPLTSRVVTLWY
Sbjct: 241 QLLRGLEHCHNCGVLHRDIKGSNLLIDNNGILKIADFGLASVFDPNRTQPLTSRVVTLWY 300
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR
Sbjct: 301 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 360
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
KSKLPHATIFKPQQPY+RCVA+TFKDF APALALMETLLSIDPADRG+AASAL+SEFFT
Sbjct: 361 KSKLPHATIFKPQQPYRRCVADTFKDFAAPALALMETLLSIDPADRGTAASALKSEFFTT 420
Query: 419 KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDAN 476
KPLPCDPSSLPKYPPSKE DAK+RDE+ARRQG GSKGQR DLERRG RESRA+PAPDAN
Sbjct: 421 KPLPCDPSSLPKYPPSKELDAKLRDEQARRQGATGSKGQRHDLERRGARESRAVPAPDAN 480
Query: 477 AELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRAS 536
AEL LSMQKRQSQ SKSRSEKFNPH EE ASGFPIDPPR SQ E PQ HKRAS
Sbjct: 481 AELPLSMQKRQSQAQSKSRSEKFNPHLEE-ASGFPIDPPRPSQAVEVGIEPQVPQHKRAS 539
Query: 537 HSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRERSGSAQPEVP 594
HSGPLA R AW KAGKN DDAPKIS G DLST GLVAA RS+LS+DRRERSGS+Q E
Sbjct: 540 HSGPLAHRTAWGKAGKNQDDAPKISVGGDLSTISGLVAA-RSMLSDDRRERSGSSQMEAS 598
Query: 595 KLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYGSKGHKIHYS 654
KL+ RFPGSFK+ SE I+ DQ+HH G G+ QKE+GR NKD +L+GYGSKGHKIHYS
Sbjct: 599 KLMNRFPGSFKDISELLIKQDQRHHVPGQVGTSQKEEGRSSNKDLVLVGYGSKGHKIHYS 658
Query: 655 GPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLFVSGR 709
GPL S N+DQ+LKDHDRQIQEAVRRAR DKAK+R++Q EGNQ+ TNSLFVSGR
Sbjct: 659 GPLT--SSNMDQVLKDHDRQIQEAVRRARLDKAKMRRLQAEGNQI-TNSLFVSGR 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | ||||||
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.853 | 0.871 | 0.710 | 3.9e-258 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.696 | 0.691 | 0.598 | 3.8e-168 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.706 | 0.677 | 0.558 | 1.3e-155 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.733 | 0.846 | 0.534 | 4.9e-155 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.575 | 0.703 | 0.693 | 4.1e-152 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.702 | 0.869 | 0.574 | 1.4e-151 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.660 | 0.726 | 0.575 | 8.9e-149 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.647 | 0.647 | 0.553 | 6.2e-142 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.840 | 0.852 | 0.475 | 2.1e-139 | |
| TAIR|locus:2140543 | 469 | AT4G10010 [Arabidopsis thalian | 0.485 | 0.733 | 0.656 | 1.7e-137 |
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2195 (777.7 bits), Expect = 3.9e-258, Sum P(2) = 3.9e-258
Identities = 441/621 (71%), Positives = 495/621 (79%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSR-ATSSRREEVYRVKDRFDSNDGRAML 59
MGC+C KPSAIEDSK+SPRER SSK+SS+ R SR SSRREE R+K+R D R +L
Sbjct: 1 MGCVCGKPSAIEDSKDSPRERFSSKSSSEFRVSRPVASSRREEPLRIKERSDVVSVRPVL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMG-SIPKASEGEQXXXXXXXXXXXXXX 118
+KQ N S+ L GEN R+ +++E V A M +I KA+EGE
Sbjct: 61 SNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 178
EAI+GWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR
Sbjct: 121 EAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 180
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
EI ILRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP +KFSE+QVKCY+Q
Sbjct: 181 EIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIKFSESQVKCYLQ 240
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
QLL GLDHCHSRGVLHRDIKGSNLLIDN+G+LKIADFGLASF+DP Q QPLTSRVVTLWY
Sbjct: 241 QLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQPLTSRVVTLWY 300
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
RPPELLLGAT YG AVDLWS GCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP+EDYW
Sbjct: 301 RPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYWV 360
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
KS+LPHATIFKP QPYKR V ETFK+FP PALAL+ETLLS++P DRG+A +AL+SEFF+
Sbjct: 361 KSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTATAALKSEFFST 420
Query: 419 KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ-GGSKGQRMDLERRGTRESRAIPAPDANA 477
+PLPCDPSSLPKYPPSKE DA++RDEE+RRQ GG++ QR ERRGT+ESRAIPAPDANA
Sbjct: 421 RPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQ-ERRGTKESRAIPAPDANA 479
Query: 478 ELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPR-QSQVTESSAGPQGH--NHKR 534
ELV SMQKRQSQ ++SRSEKFNPHPEEVASGFPIDPPR SQ E + QG+ HKR
Sbjct: 480 ELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPSSQAFEPNRESQGNIIPHKR 539
Query: 535 ASHSGPLAQRAAWAKAGKNTDDAPKISTGADLSTGLVAAXXXXXXXXXXXXXXXAQPEVP 594
ASHSGPL++R+A AK +N D+ K+S+ AD S Q E
Sbjct: 540 ASHSGPLSRRSASAKGRRNYQDSQKVSSIADYSA---------MPGFAATRTGAPQQETC 590
Query: 595 KLIARFPGSFKEASESFIQHD 615
+ + R PGSFKE SE Q +
Sbjct: 591 RGMTRLPGSFKETSEEANQEE 611
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1518 (539.4 bits), Expect = 3.8e-168, Sum P(2) = 3.8e-168
Identities = 307/513 (59%), Positives = 380/513 (74%)
Query: 15 KESPRERLSSKASSDLRGSRA-----TSSRREEVYRVKDRFDSN-DGRAMLIDKQVNGSV 68
K++P+++ SK++S + + ++ +E + D+ D + +K+VN
Sbjct: 36 KKTPKKKKKSKSASSSKDNNVGFEERSNDNKEASLTLLIPIDAKKDDES---EKKVNLER 92
Query: 69 RLHGENFDRKREKMEY----VVAQHHPGMGSIPKASEGE---QXXXXXXXXXXXXXXEAI 121
+ F R+ +E + P M I S GE Q EAI
Sbjct: 93 KSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAI 152
Query: 122 QGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH 181
GW+PR+ADSFEKL+KIGQGTYS+VY+ARDL+ ++VALKKVRF N++P+SVRFMAREI
Sbjct: 153 NGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREII 212
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
ILRRLDH NV+KLEGL+TSR+S S+YL+FEYMEHDLAGLAS PG+ FSEAQ+KCYM+QLL
Sbjct: 213 ILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLL 272
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
GL+HCHSRGVLHRDIKGSNLL+D+N LKI DFGLA+FY Q QPLTSRVVTLWYRPP
Sbjct: 273 HGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPP 332
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
ELLLG+T YG VDLWSTGCILAEL+ GKPIMPGRTEVEQLHKIFKLCGSPSE+YW+ SK
Sbjct: 333 ELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISK 392
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421
LPHATIFKPQQPYKRCVAETFK P+ ALAL+E LL+++P RG+ ASAL SEFFT PL
Sbjct: 393 LPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPL 452
Query: 422 PCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVL 481
DPSSLPKY P KE D K ++EEA+R+ + ++ D ++ +RES+A+PAPD+NAE +
Sbjct: 453 ASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQND-SKQVSRESKAVPAPDSNAESLT 511
Query: 482 SMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDP 514
S+QKRQ Q+N S S+KFNP E+ AS F I+P
Sbjct: 512 SIQKRQGQHNQVSNSDKFNPG-EDAAS-FRIEP 542
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1386 (493.0 bits), Expect = 1.3e-155, Sum P(3) = 1.3e-155
Identities = 291/521 (55%), Positives = 361/521 (69%)
Query: 42 EVYRVK-DRFDSNDGRAMLIDKQ-VNGSVRLHGENFDRKREKMEY-----VVAQHHPGMG 94
+V + K DR++S D + LI+ + ++ S+ ++ EK E VV +
Sbjct: 114 KVVKAKLDRWNSKDSKVRLIESEKLSSSMFSEHHQIEKGVEKPEVEASVRVVHRELKRGS 173
Query: 95 SI--PKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDL 152
SI PK +E +Q E++ W PRRA++FEKL+KIGQGTYS+VYRARDL
Sbjct: 174 SIVSPKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDL 233
Query: 153 DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212
KIVALKKVRFD + ESV+FMAREI ++RRLDH NV+KLEGL+T+ +S SLYLVFEY
Sbjct: 234 LHNKIVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEY 293
Query: 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 272
M+HDL GL+S PG+KF+E QVKCYM+QLL GL+HCHSRGVLHRDIKGSNLLID+ G+LKI
Sbjct: 294 MDHDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKI 353
Query: 273 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI 332
ADFGLA+F+DP ++ LTS VVTLWYRPPELLLGA++YG VDLWSTGCIL ELYAGKPI
Sbjct: 354 ADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPI 413
Query: 333 MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALAL 392
+PG+TEVEQLHKIFKLCGSP+E+YWRK KLP + FK PY+R V+E FKDFPA L+L
Sbjct: 414 LPGKTEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSL 473
Query: 393 METLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG-- 450
+ETLLSIDP R SA AL SE+F KP CDPS+LPKYPPSKE DAK+RDE R+Q
Sbjct: 474 LETLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMR 533
Query: 451 GSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNS-KSRSEKFNPHPEEVASG 509
K +R D R + E + +P AN L ++M+K QY +SR++ F EE
Sbjct: 534 AEKQERQDSMTRISHERKFVPPVKANNSLSMTMEK---QYKDLRSRNDSFKSFKEERTPH 590
Query: 510 FPIDPPRQSQVTESSAGPQGHNHKRASHSGPLAQRAAWAKA 550
P+ P + + G R SHSGPL AK+
Sbjct: 591 GPV--PDYQNMQHNRNNQTG---VRISHSGPLMSNRNMAKS 626
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1375 (489.1 bits), Expect = 4.9e-155, Sum P(2) = 4.9e-155
Identities = 284/531 (53%), Positives = 368/531 (69%)
Query: 1 MGCICFKPSAI-EDSKESPRERLS---SKASSDLRGSRATSSRREEVYRVKDRFDSNDGR 56
MGCIC K +A E+ RE+ + +K+SS + S++ + ++ D R
Sbjct: 1 MGCICSKGAAEDEEGVVYHREKANEYWNKSSSVQLIAPLPSNKDDFSHKAVDGSSGGGRR 60
Query: 57 AMLIDKQVNGSVRLHGENFDR-KREKMEYVVAQHHPGMG----SIPKASEGEQXXXXXXX 111
A + ++ S +R R + V+ + G G ++P+++E E
Sbjct: 61 ASGLIVPIDDSHDGKTVIVERPSRSQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPY 120
Query: 112 XXXXXXXEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE 171
EAI+GWVPRRADSFEKLDKIGQGTYS VY+ARDL+ KIVA+KKVRF N++PE
Sbjct: 121 WLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFANMDPE 180
Query: 172 SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEA 231
SVRFMAREI+ILR+LDH NV+KL+ LVTS++S SL+LVFEYMEHDL+GLA PG+KF+E
Sbjct: 181 SVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEP 240
Query: 232 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291
Q+KC+M+QLLCGL+HCHSRG+LHRDIKGSNLL++N+G+LKI DFGLASFY PDQ+QPLTS
Sbjct: 241 QIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTS 300
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
RVVTLWYR PELLLG+T YG A+DLWS GCILAEL+ KPIMPGRTEVEQ+HKIFKLCGS
Sbjct: 301 RVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGS 360
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411
PSE++W +K P AT +KPQ PYKR + ETFK+ + +L L++ LLS++P R SA+S L
Sbjct: 361 PSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTL 420
Query: 412 RSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS--KGQRMDLERRGTRESRA 469
SEFFT +PLPC SSLPKYPPSKE DAK+RDEEA+R+ K + + RRG R+S+
Sbjct: 421 LSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKRKKAEAVKWRGHESVRRGLRDSKV 480
Query: 470 IPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQV 520
P A+ +S+ + + HP ++ + P R + V
Sbjct: 481 TPEFIASGNSNVSLTTPSFKKEKRFTDTNSVIHPSSRSNVGEVKPSRSNNV 531
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1484 (527.5 bits), Expect = 4.1e-152, P = 4.1e-152
Identities = 292/421 (69%), Positives = 344/421 (81%)
Query: 119 EAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 178
++I+ PRRA ++EKL+KIGQGTYSNVY+A+DL KIVALKKVRFDNLE ESV+FMAR
Sbjct: 101 DSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDNLEAESVKFMAR 160
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
EI +LRRL+H NVIKL+GLVTSR+SCSLYLVFEYMEHDL+GLA+ GLKF QVKC+M+
Sbjct: 161 EILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMK 220
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
QLL GL+HCHSRGVLHRDIKGSNLLIDN+GILKIADFGLA+FYDP Q Q +TSRVVTLWY
Sbjct: 221 QLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQTMTSRVVTLWY 280
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
RPPELLLGAT YGT VDLWS GCI+AEL AGKP+MPGRTEVEQLHKIFKLCGSPS+ YW+
Sbjct: 281 RPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWK 340
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
K +LP+AT+FKPQ PYKRCVAE F F ++ L+ETLL+IDPADRG++ SAL SEFFT
Sbjct: 341 KYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTT 400
Query: 419 KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGG--SKGQRMDLERR----GTRESRAIPA 472
+PLPCDPSSLPKYPPSKE + K+RDEE RRQ G KG +D RR G R RAIPA
Sbjct: 401 EPLPCDPSSLPKYPPSKELNVKLRDEELRRQKGLAGKGSGIDGARRIRYRGDRTGRAIPA 460
Query: 473 PDANAELVLSMQKRQS--QYNSKSRSEKFNPHPEEVASGFPI-DPPRQSQV----TESSA 525
P+ANAE ++ + +S Q N KS+SEKF P ++ A G+P+ D +++ V TE+S
Sbjct: 461 PEANAESQANLDRWRSISQTNGKSKSEKFPPPHQDGAVGYPLEDLSKKTSVFGAKTETSF 520
Query: 526 G 526
G
Sbjct: 521 G 521
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1479 (525.7 bits), Expect = 1.4e-151, P = 1.4e-151
Identities = 298/519 (57%), Positives = 374/519 (72%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+ + +A + E+ + + SSKASS + +S + + D +
Sbjct: 1 MGCVFGREAATTTTAEAKQAK-SSKASSGVVVVGESSVTKSNGV-IADDVEKKK------ 52
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQXXXXXXXXXXXXXXEA 120
+++ NG DR+R + +P + + K GEQ EA
Sbjct: 53 NEEANGDKERKSSKGDRRRS------TKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEA 106
Query: 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
+ GWVPR+AD+FEK+DKIGQGTYSNVY+A+D+ KIVALKKVRFDNLEPESV+FMAREI
Sbjct: 107 LNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREI 166
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
+LRRLDH NV+KLEGLVTSRMSCSLYLVF+YM+HDLAGLAS P +KFSE++VKC M+QL
Sbjct: 167 LVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQL 226
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ GL+HCHSRGVLHRDIKGSNLLID+ G+LKIADFGLA+ +DP+ +P+TSRVVTLWYR
Sbjct: 227 ISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRA 286
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PELLLGAT YG +DLWS GCILAEL AG+PIMPGRTEVEQLHKI+KLCGSPSEDYW+K
Sbjct: 287 PELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKG 346
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
K H I+KP++PYKR + ETFKDFP +L L++ LLSI+P DR +A++AL+SEFFT +P
Sbjct: 347 KFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEP 406
Query: 421 LPCDPSSLPKYPPSKEFDAKIRDEEARRQ-GGSK--GQRMDLERRGTRESRAIPAPDANA 477
C+P+ LPKYPPSKE DAK RDEE RRQ SK G R R +RA+PAP+ANA
Sbjct: 407 YACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNRALPAPEANA 466
Query: 478 ELVLSMQKRQ---SQYNSKSRSEKFNP-HPEEVASGFPI 512
EL ++ +R+ + N+KS+SEKF P H + A G P+
Sbjct: 467 ELQSNVDQRRRLITHANAKSKSEKFPPPHQDGGAMGVPL 505
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 8.9e-149, Sum P(3) = 8.9e-149
Identities = 282/490 (57%), Positives = 338/490 (68%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCI K K+SP+ K + + R SR SSR ++ + K+ D ++ + LI
Sbjct: 1 MGCIISK-------KKSPKRNPPWKETLEKRSSRINSSRIDDSSQTKEEQDRSN-KVRLI 52
Query: 61 DKQVNGSVRLHGENFDRKR--EKMEYVVAQHHPGMGS-------IPKA----SEGEQXXX 107
+ + S R ++ + + E HHP IP + S+ +
Sbjct: 53 ESEKFSSSRFSEKHQEIAEIGDTDEDEDDDHHPPEELKREPSVVIPPSPETVSKEAELAA 112
Query: 108 XXXXXXXXXXXEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN 167
EA+ W PRRA +FEKL+KIGQGTYS+VY+ARDL KIVALK+VRFD
Sbjct: 113 GWPAWLVSVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRVRFDL 172
Query: 168 LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 227
+ ESV+FMAREI ++RRLDH NV+KLEGL+T+ +S SLYLVFEYM+HDL GLAS PG+K
Sbjct: 173 SDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASIPGIK 232
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287
FSE QVKCYMQQLL GL HCHSRGVLHRDIKGSNLLID+NG+LKIADFGLA+F+DP
Sbjct: 233 FSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCV 292
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
PLTSRVVTLWYRPPELLLGA +YG VDLWSTGCIL ELY+GKPI+ G+TEVEQLHKIFK
Sbjct: 293 PLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFK 352
Query: 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
LCGSP+EDYWRK KLP + F+P PY R VAE FKD P L+L+E LLSIDP RGSA
Sbjct: 353 LCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSA 412
Query: 408 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEAR-RQGGSKGQRMDLERRGTRE 466
A AL SE+F +P CDPSSLPKYPPSKE DAKIRD+ R R K +R D + R + E
Sbjct: 413 ARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQTRRSHE 472
Query: 467 SRAIPAPDAN 476
+ IP AN
Sbjct: 473 RKLIPPVKAN 482
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1284 (457.0 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 274/495 (55%), Positives = 333/495 (67%)
Query: 93 MGSIPKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDL 152
+G++ K E EQ EAI GWVP R+D+FEKL+KIGQGTYS+V+RAR+
Sbjct: 92 LGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARET 151
Query: 153 DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212
+ +IVALKKVRFDN EPESVRFMAREI ILR+L+H N+IKLEG+VTS++SCS++LVFEY
Sbjct: 152 ETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEY 211
Query: 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 272
MEHDL GL S P + F+ Q+KCYM+QLL GLDHCH+RGV+HRDIKGSNLL++N GILK+
Sbjct: 212 MEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKV 271
Query: 273 ADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
ADFGLA+F + N QPLTSRVVTLWYRPPELLLGAT YG +VDLWS GC+ AEL GKP
Sbjct: 272 ADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKP 331
Query: 332 IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFK--DFPAPA 389
++ GRTEVEQLHKIFKLCGSP EDYW+KSKLPHA +FKPQQ Y C+ ET K
Sbjct: 332 VLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDAD 391
Query: 390 LALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
+ L+ETLLSI P RG+A++AL S++FT KP CDPSSLP Y PSKE DAK R++ R++
Sbjct: 392 INLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKK 451
Query: 450 GGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASG 509
G RRGT + P A A+L + R ++S+ + +K N H V +
Sbjct: 452 ISGNG------RRGTESRKPTRKPPAFAKLAPAEDVR---HHSQ-KFQKRNGH--SVHNS 499
Query: 510 FPIDPPRQSQVTESSAGPQGHNHKRASH-----------SGPL----AQRAAWAKAGKNT 554
D S + E P H ASH SGPL + AWAK K
Sbjct: 500 IDSD----STLFEKMQKPSNHEKDEASHVKNASQGDVPFSGPLQVSVSSGFAWAKRRK-- 553
Query: 555 DDAPKISTGADLSTG 569
DD S LS G
Sbjct: 554 DDICVRSHNRSLSRG 568
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
Identities = 299/629 (47%), Positives = 396/629 (62%)
Query: 93 MGSIPKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDL 152
+G++ + E EQ EAI GWVP R+D+FEKL+KIGQGTYSNV+RA +
Sbjct: 82 LGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVET 141
Query: 153 DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212
+ +IVALKKVRFDN EPESV+FMAREI ILRRL+H N+IKLEGL+TS++SC++ LVFEY
Sbjct: 142 ETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFEY 201
Query: 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 272
MEHDL GL S P +KF+ Q+KCYM+QLL GLDHCHSRGV+HRDIKGSNLL+ N GILK+
Sbjct: 202 MEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKV 261
Query: 273 ADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330
ADFGLA+F + + +PLTSRVVTLWYRPPELLLGAT YG +VDLWS GC+ AEL GK
Sbjct: 262 ADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGK 321
Query: 331 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPAL 390
PI+ GRTEVEQLHKIFKLCGSP EDYW+KSKLPHA +FKPQQ Y C+ ET KD +
Sbjct: 322 PILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEI 381
Query: 391 ALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG 450
L+ETLLSIDP RG+A+SAL S++FT KP CDPSSLP YPPSKE D K RDE AR++
Sbjct: 382 NLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKI 441
Query: 451 GSKGQRMDLERRGTRESRAIP--APDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVAS 508
G+R R+ +R++ + APD + + QKR S E ++ +
Sbjct: 442 SGNGRRGIDPRKPSRKAHSFNRLAPDVRHQTE-TFQKRIGHLVHSS-IESDARLCGKLQN 499
Query: 509 GFPIDPPRQSQVTESSAGPQGHNHKRASHSGPL----AQRAAWAKAGKNTDDAPKISTGA 564
P+D ++ + + QG SGPL + AWAK K DD
Sbjct: 500 --PLDH-KKDEASHVKHASQGD----VPFSGPLQVSKSNSFAWAKREK--DDVCVRVHNR 550
Query: 565 DLSTGLVAAXXXXXXXXXXXXXXXAQ----PEVPKLIARFPGSFKEASESFIQHD---QK 617
LS G + + ++ + K +R S++ S ++ ++
Sbjct: 551 SLSRGYIPSLSGHSPAFNGKSDVESKINKDEKEDKTDSRGEESYEMVKRSMLKQWRQLER 610
Query: 618 HHAQGVAGSHQKEDGRIG--NKDPILLGYGSK---GHKIHYSGPLIVPSGNVDQMLKDHD 672
+ G + + ++ +G +D + G+ G KI +SGPL+ S VD++L+ H+
Sbjct: 611 PDSFGASDEYHSQELSLGLYQRDEMAKKMGNNLGDGDKIEFSGPLLSQSYGVDELLERHE 670
Query: 673 RQIQEAVRRARFDKA--KVRKVQMEGNQL 699
R I++ +R+ F K K +K+ + ++L
Sbjct: 671 RNIRKLIRKPWFQKVQDKQKKILLFSSEL 699
|
|
| TAIR|locus:2140543 AT4G10010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1219 (434.2 bits), Expect = 1.7e-137, Sum P(2) = 1.7e-137
Identities = 233/355 (65%), Positives = 289/355 (81%)
Query: 157 IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216
+VA+KKVRF N++PESVRFMAREI+ILR+LDH NV+KLE LVTS++S SLYLVFEYMEHD
Sbjct: 1 MVAMKKVRFVNMDPESVRFMAREINILRKLDHPNVMKLECLVTSKLSGSLYLVFEYMEHD 60
Query: 217 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276
L+GLA PG+KF+E+Q+KCYM+QLL GL+HCHSRG+LHRDIKG NLL++N+G+LKI DFG
Sbjct: 61 LSGLALRPGVKFTESQIKCYMKQLLSGLEHCHSRGILHRDIKGPNLLVNNDGVLKIGDFG 120
Query: 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 336
LA+ Y P+Q+QPLTSRVVTLWYR PELLLGAT YG +DLWS GCIL EL+ GKPIMPGR
Sbjct: 121 LANIYHPEQDQPLTSRVVTLWYRAPELLLGATEYGPGIDLWSVGCILTELFLGKPIMPGR 180
Query: 337 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETL 396
TEVEQ+HKIFK CGSPS+DYW+K+KLP AT FKPQQPYKR + ETFK+ P ALAL++ L
Sbjct: 181 TEVEQMHKIFKFCGSPSDDYWQKTKLPLATSFKPQQPYKRVLLETFKNLPPSALALVDKL 240
Query: 397 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS--KG 454
LS++PA RG+A+S L S+FFTM+PLPC+ SSLPKYPPSKE DAK+RDEEARR+ KG
Sbjct: 241 LSLEPAKRGTASSTLSSKFFTMEPLPCNVSSLPKYPPSKELDAKVRDEEARRKKSETVKG 300
Query: 455 QRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASG 509
+ + RRG+R+ ++ E V S Q + + +++FNP E+ +G
Sbjct: 301 RGPESVRRGSRDFKSTAT---TPEFVASGQSKDT-----ITTKRFNPQ-EDSRTG 346
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pm.C_LG_XI0294 | hypothetical protein (714 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 709 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-155 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-120 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-112 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-111 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-104 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-104 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-102 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-94 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-92 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-87 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-84 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-84 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-83 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-78 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-77 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-76 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-75 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-74 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-74 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-73 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-72 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-71 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-69 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-68 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-64 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-63 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-62 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-60 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-60 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-59 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-58 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-58 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-58 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-57 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-57 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-54 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-54 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-52 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-52 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-48 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-47 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-46 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-46 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-46 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-43 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-42 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-42 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-40 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-04 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 451 bits (1163), Expect = e-155
Identities = 157/287 (54%), Positives = 211/287 (73%), Gaps = 2/287 (0%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+EK+ +IG+GTY VY+AR+ ++VALKK+R +N + REI +L++L H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
++L+ +VTS+ S+Y+VFEYM+HDL GL P +KF+E+Q+KCYM+QLL GL + HS G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
+LHRDIKGSN+LI+N+G+LK+ADFGLA Y + T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 312 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKP 370
VD+WS GCILAEL+ GKPI G TE+EQL KIF+LCGSP+++ W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 371 QQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFF 416
++PYKR + E FK P AL L++ LL++DP R SA AL+ E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 360 bits (927), Expect = e-120
Identities = 125/290 (43%), Positives = 176/290 (60%), Gaps = 13/290 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFMAREIHILRRLD 187
+EKL+K+G+GTY VY+ARD +IVALKK+R DN E ++R EI +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
H N++KL ++ + LYLVFEY + DL S +K M QLL GL +C
Sbjct: 57 HPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS +LHRD+K N+LI+ +G+LK+ADFGLA + T VVTLWYR PE+LLG+
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGS 173
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
+Y TAVD+WS GCI AE+ GKP+ PG +E++QL KIF++ G+P+E+ W +KLP
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P+ P K + + + L+ +L +PA R SA AL+ +F
Sbjct: 234 PTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-112
Identities = 150/304 (49%), Positives = 195/304 (64%), Gaps = 6/304 (1%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHIN 190
FEKL++IG+GTY VYRARD +IVALKKVR DN E + + + REI +L L H N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPN 67
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+++L+ +V + S++LV EY E DLA L + FSE+QVKC M QLL GL + H
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
++HRD+K SNLL+ + G LKIADFGLA Y P+T +VVTLWYR PELLLG T Y
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTY 186
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFK 369
TA+D+W+ GCILAEL A KP++PG++E+EQL I +L G+P+E W S LP F
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 370 -PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 428
P+QPY + F L L+ LL DP R +A AL S +F KPLPC+P +
Sbjct: 247 LPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMM 305
Query: 429 PKYP 432
P +P
Sbjct: 306 PTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 338 bits (870), Expect = e-111
Identities = 127/303 (41%), Positives = 187/303 (61%), Gaps = 11/303 (3%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMA-REIHILRRLDH 188
+EK K+G+GTY+ VY+ARD + +IVA+KK++ + + + F A REI +L+ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+I L + + + + LVFE+ME DL + + + A +K YM L GL++ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
S +LHRD+K +NLLI ++G+LK+ADFGLA SF P++ +T +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGA 177
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
+YG VD+WS GCI AEL P +PG ++++QL KIF+ G+P+E+ W + LP
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
FKP P + + F AL L++ LL+++P R +A AL +F+ P P PS
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295
Query: 427 SLP 429
LP
Sbjct: 296 QLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 320 bits (823), Expect = e-104
Identities = 144/302 (47%), Positives = 198/302 (65%), Gaps = 11/302 (3%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
W R D F+ + +IG+GTY VY+ARD D ++VALKKVR DN E E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 183 LRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVK 234
LR+L+H N++ L+ +VT + + YLVFEYM+HDL GL + FSE +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+M+QLL GL++CH + LHRDIK SN+L++N G +K+ADFGLA Y+ ++++P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYRPPELLLG YG A+D+WS GCIL EL+ KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 355 DYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
W KLP+ KP++ Y+R + E F P PAL L++ +L++DP+ R +A AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 414 EF 415
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 319 bits (820), Expect = e-104
Identities = 142/299 (47%), Positives = 188/299 (62%), Gaps = 16/299 (5%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRR 185
R D +EKL++I +GTY VYRARD +IVALKK++ + E E + REI+IL +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 186 LDHINVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
L H N++ + E +V S + +Y+V EY+EHDL L F +++VKC M QLL G+
Sbjct: 61 LQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
H H +LHRD+K SNLL++N GILKI DFGLA Y +P T VVTLWYR PELL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELL 178
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLP 363
LGA Y TA+D+WS GCI AEL KP+ PG++E++QL+KIFKL G+P+E W S+LP
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238
Query: 364 HATIFKPQ-QPYKRCVAETFKDFPAPALA-----LMETLLSIDPADRGSAASALRSEFF 416
A PY + K FPA +L+ L+ LL+ DPA R SA AL+ +F
Sbjct: 239 GAKKKTFTKYPYNQ----LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 315 bits (808), Expect = e-102
Identities = 134/305 (43%), Positives = 185/305 (60%), Gaps = 19/305 (6%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+E L K+G+GT+ VY+AR + ++VALKK+ N E + A REI IL++L H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKH 66
Query: 189 INVIKLEGLV------TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
NV+ L + + R S+Y+V YM+HDL+GL +P +K +E+Q+KCYM QLL
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP----------LTSR 292
G+++ H +LHRDIK +N+LIDN GILKIADFGLA YD P T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352
VVT WYRPPELLLG Y TAVD+W GC+ AE++ +PI+ G+++++QLH IFKLCG+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 353 SEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411
+E+ W LP Y R + E F L L+ LLS+DP R +A+ AL
Sbjct: 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 412 RSEFF 416
+F
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 2e-94
Identities = 139/306 (45%), Positives = 183/306 (59%), Gaps = 14/306 (4%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
+EKL KIGQGT+ V++AR K+IVALKKV +N E E A REI I
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKI 64
Query: 183 LRRLDHINVIKL------EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 236
L+ L H NV+ L + +R S YLVFE+ EHDLAGL S+ +KF+ +++K
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP--LTSRV 293
M+ LL GL + H +LHRD+K +N+LI +GILK+ADFGLA +F ++P T+RV
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
VTLWYRPPELLLG YG +D+W GCI+AE++ PIM G TE QL I +LCGS +
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 354 EDYWRK-SKLPHATIFKPQQPYKRCVAETFKDF--PAPALALMETLLSIDPADRGSAASA 410
+ W KL + Q KR V E K + AL L++ LL +DPA R A +A
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 411 LRSEFF 416
L +FF
Sbjct: 305 LNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 2e-92
Identities = 121/286 (42%), Positives = 168/286 (58%), Gaps = 4/286 (1%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++KL KIG+GTY VY+ARD +IVA+KK++ + REI +L+ L+H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
IKL + + LYLVFE+M+ DL L E+ +K Y+ QLL GL CHS G
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
+LHRD+K NLLI+ G+LK+ADFGLA + +P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 312 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKP 370
T VD+WS GCI AEL + +P+ PG++E++QL KIF+ G+P + W K + L F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ + + F + AL L+ +L DP R +A AL +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 4e-87
Identities = 123/298 (41%), Positives = 176/298 (59%), Gaps = 24/298 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLD- 187
+E+L +IG+G Y VY+ARDL+ + VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 188 --HINVIKL----EGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQL 240
H N+++L G T R L LVFE+++ DLA L+ P +K M+QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L G+D HS ++HRD+K N+L+ ++G +KIADFGLA Y LTS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRA 174
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RK 359
PE+LL ++Y T VD+WS GCI AEL+ +P+ G +E +QL KIF + G PSE+ W R
Sbjct: 175 PEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 360 SKLPHATI-FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
LP ++ + +K V E ++ L L++ +L+ +P R SA AL+ +F
Sbjct: 234 VSLPRSSFPSYTPRSFKSFVPEICEE----GLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 6e-87
Identities = 107/287 (37%), Positives = 154/287 (53%), Gaps = 35/287 (12%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+E L+K+G+G++ VY ARD K+VA+K ++ ++ + R + REI IL++L H N+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 192 IKLEG-LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
++L LYLV EY E DL L G + SE + + Y++Q+L L++ HS
Sbjct: 60 VRLYDVFEDED---KLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHS 115
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+G++HRD+K N+L+D +G +K+ADFGLA DP + LT+ V T Y PE+LLG
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KG 172
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
YG AVD+WS G IL EL GKP PG +QL ++FK G P +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP---------- 219
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
D A L+ LL DP R +A AL+ FF
Sbjct: 220 ------------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 2e-84
Identities = 127/293 (43%), Positives = 180/293 (61%), Gaps = 18/293 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHIN 190
++K++KIG+GTY VY+ARD +IVALKK+R + E E V A REI +L+ L+H N
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+++L +V S LYLVFE+++ DL + S P +K Y+ QLL G+ +CHS
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL---TSRVVTLWYRPPELLLG 306
VLHRD+K NLLID G LK+ADFGLA + P+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLG 173
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHA 365
+ Y T VD+WS GCI AE+ +P+ PG +E++QL +IF+ G+P ED W + LP
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 366 TIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+KP P ++ +++ + L L+ +L DPA R SA +AL+ +F
Sbjct: 233 --YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 7e-84
Identities = 120/295 (40%), Positives = 166/295 (56%), Gaps = 19/295 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDH 188
++ L +IG+G + V++A+D + + VALKKV LE P REI L+ H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQH 58
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL---ASHPGLKFSEAQVKCYMQQLLCGLD 245
V+KL L LV EYM DL+ + P EAQVK YM+ LL G+
Sbjct: 59 PYVVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVA 113
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K +NLLI +G+LKIADFGLA + ++ + + +V T WYR PELL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPH 364
GA Y VDLW+ GCI AEL G P+ PG ++EQL +F+ G+P+E+ W + LP
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 365 AT--IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
F +P + E F D AL L++ LL DP+ R SAA ALR +FT
Sbjct: 234 YNKITFPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 1e-83
Identities = 125/325 (38%), Positives = 184/325 (56%), Gaps = 32/325 (9%)
Query: 132 FEKLDK-IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-----------VRFMA-R 178
+ + +G+GTY V +A D KIVA+KKV+ + + + F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
E+ I+ + H N++ L + + LV + M DL + ++ +E+QVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDRK-IRLTESQVKCILL 126
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY----------DPDQNQP 288
Q+L GL+ H +HRD+ +N+ I++ GI KIADFGLA Y + Q
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 289 ---LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
+TS+VVTLWYR PELL+GA Y AVD+WS GCI AEL GKP+ PG E++QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 346 FKLCGSPSEDYW-RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
F+L G+P+ED W + KLP T F P++P + + F + A+ L+++LL ++P +R
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 405 GSAASALRSEFFTMKPLPCDPSSLP 429
SA AL+ E+F PLPCDPS LP
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 9e-80
Identities = 115/321 (35%), Positives = 174/321 (54%), Gaps = 13/321 (4%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 195
IG G Y V A D + VA+KK+ FD+L + + REI +LR L H N+I L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGLL 65
Query: 196 GLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
++ +Y+V E ME DL + P ++ ++ ++ Q+L GL + HS V
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANV 124
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPELLLGATYY 310
+HRD+K SN+L+++N LKI DFGLA DPD+++ LT VVT WYR PELLL ++ Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
A+D+WS GCI AEL KP+ PGR ++QL+ I ++ G+PSE+ + A +
Sbjct: 185 TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244
Query: 371 QQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PSS 427
P K+ +++ F A+ L+E +L DP R +A AL + P D P +
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304
Query: 428 LPKYPPSKEFDAKIRDEEARR 448
P + D ++ +EE +
Sbjct: 305 KPPFDFDFFDDDELTEEELKE 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 2e-79
Identities = 104/287 (36%), Positives = 146/287 (50%), Gaps = 29/287 (10%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+E L K+G G++ VY+A+ KIVA+K ++ + + + + REI ILRRL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
++L LYLV EY E DL S G SE + K Q+L GL++ HS
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
G++HRD+K N+L+D NG++KIADFGLA + LT+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS-SSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK-LCGSPSEDYWRKSKLPHATIFK 369
G VD+WS G IL EL GKP G ++QL I + L D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE------------- 223
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P +E KD ++ L+ DP+ R +A L+ +F
Sbjct: 224 ---PKWSSGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 4e-78
Identities = 126/294 (42%), Positives = 174/294 (59%), Gaps = 18/294 (6%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+F+K++KIG+GTY VY+AR+ ++VALKK+R D E E V A REI +L+ L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++KL ++ + LYLVFE++ DL + + P +K Y+ QLL GL CH
Sbjct: 60 NIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
S VLHRD+K NLLI+ G +K+ADFGLA +F P + T VVTLWYR PE+LLG
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC 175
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
YY TAVD+WS GCI AE+ + + PG +E++QL +IF+ G+P E W + LP
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD-- 233
Query: 367 IFKPQQPYKRCVAETFKDFPAP----ALALMETLLSIDPADRGSAASALRSEFF 416
+KP P + + F P L+ +L DP R SA +AL FF
Sbjct: 234 -YKPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 1e-77
Identities = 125/290 (43%), Positives = 172/290 (59%), Gaps = 10/290 (3%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+EKL+KIG+GTY V++A++ + +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N+++L ++ S L LVFEY + DL VK +M QLL GL CHS
Sbjct: 60 NIVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
VLHRD+K NLLI+ NG LK+ADFGLA +F P + ++ VVTLWYRPP++L GA
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 175
Query: 309 YYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
Y T++D+WS GCI AEL AG+P+ PG +QL +IF+L G+P+E+ W SKLP
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ V K L++ LL +P R SA AL+ +F
Sbjct: 236 PYPMYPATTSLVNVVPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 7e-76
Identities = 117/299 (39%), Positives = 173/299 (57%), Gaps = 20/299 (6%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRL 186
+ ++++KLDK+G+G+Y+ VY+ R ++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLD 245
H N++ L ++ ++ + L LVFEY++ DL + G S V+ ++ QLL GL
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGG-LSMHNVRLFLFQLLRGLA 117
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD-PDQNQPLTSRVVTLWYRPPELL 304
+CH R VLHRD+K NLLI G LK+ADFGLA P + ++ VVTLWYRPP++L
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVL 175
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSEDYWRK-SKL 362
LG+T Y T++D+W GCI E+ G+P+ PG T+V +QLHKIF++ G+P+E+ W S
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235
Query: 363 PHATIFKPQQ-----PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P FKP P D L L +P R SAA A++ +F
Sbjct: 236 PE---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 4e-75
Identities = 109/291 (37%), Positives = 173/291 (59%), Gaps = 14/291 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRL-DH 188
++ + ++G GT+ +VY AR+ + ++VA+KK+ +F + E E + RE+ LR+L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N++KL+ + R + LY VFEYME +L L G FSE+ ++ + Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H G HRD+K NLL+ ++KIADFGLA + P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHAT 366
T Y + VD+W+ GCI+AELY +P+ PG +E++QL+KI + G+P++ W + KL
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 367 IFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
F+ PQ + + + A+ L++ +L DP R +A+ AL+ +F
Sbjct: 234 GFRFPQFAPTS-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 4e-74
Identities = 129/299 (43%), Positives = 179/299 (59%), Gaps = 17/299 (5%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
D++EKL+KIG+GTY VY+ARD + K+VALKK R + ++ E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 189 -INVIKL---EGLVTSRMSCSLYLVFEYMEHDLA----GLASHPGLKFSEAQVKCYMQQL 240
I +++L E + SLYLVFEY++ DL PG +K +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLA-SFYDPDQNQPLTSRVVTLWY 298
L G+ HCH GV+HRD+K NLL+D G+LKIAD GL +F P ++ T +VTLWY
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWY 177
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE+LLG+T+Y T VD+WS GCI AE+ +P+ PG +E++QL IFKL G+P+E W
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 359 K-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
SKL F +P ++ D L L++ +L DPA R SA +AL +F
Sbjct: 238 GVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 9e-74
Identities = 113/292 (38%), Positives = 170/292 (58%), Gaps = 14/292 (4%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLDH 188
+F++L+K+G+GTY+ VY+ R+ +IVALK++ D E P + REI +++ L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKH 57
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLA---GLASHPGLKFSEAQVKCYMQQLLCGLD 245
N+++L ++ + L LVFEYM+ DL G VK + QLL G+
Sbjct: 58 ENIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIA 114
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
CH VLHRD+K NLLI+ G LK+ADFGLA + N ++ VVTLWYR P++LL
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVVTLWYRAPDVLL 173
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPH 364
G+ Y T++D+WS GCI+AE+ G+P+ PG +QL KIF++ G+P+E W S+LP
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P+ P + + + F + L+ LL ++P R SA AL+ +F
Sbjct: 234 YKPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-73
Identities = 126/292 (43%), Positives = 180/292 (61%), Gaps = 15/292 (5%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHIN 190
+ K++KIG+GTY VY+ R+ +IVA+KK+R ++ E E V A REI +L+ L H N
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQ-VKCYMQQLLCGLDHCH 248
++ L+ ++ LYL+FE++ DL L S P ++ +A+ VK Y+ Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
SR VLHRD+K NLLIDN G++K+ADFGLA +F P + T VVTLWYR PE+LLG+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGS 176
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
Y T VD+WS G I AE+ KP+ G +E++QL +IF++ G+P+ED W + LP
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD-- 234
Query: 367 IFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+K P K + K+ L L+E +L DPA R SA AL +F
Sbjct: 235 -YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 2e-72
Identities = 125/292 (42%), Positives = 181/292 (61%), Gaps = 11/292 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
D +EK++KIG+GTY VY+ARD + +ALKK+R + E E V A REI +L+ + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N+++L+ +V S LYLVFEY++ DL + S P + +K Y+ Q+L G+ +C
Sbjct: 61 GNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 248 HSRGVLHRDIKGSNLLID-NNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS VLHRD+K NLLID LK+ADFGLA +F P + T VVTLWYR PE+LL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILL 176
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPH 364
G+ +Y T VD+WS GCI AE+ KP+ PG +E+++L KIF++ G+P+E+ W + LP
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P+ P K +A + L+ +L +DP+ R +A +AL E+F
Sbjct: 237 YKSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-71
Identities = 104/292 (35%), Positives = 155/292 (53%), Gaps = 9/292 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +E L +G+G Y V + R+ +IVA+KK + + + + RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N++ L R LYLVFEY+E L L AS GL V+ Y+ QLL + +C
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGL--PPDAVRSYIWQLLQAIAYC 116
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS ++HRDIK N+L+ +G+LK+ DFG A PLT V T WYR PELL+G
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYWRKSKLPHAT 366
T YG VD+W+ GCI+AEL G+P+ PG ++++QL+ I K G P S P
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 367 IFK-PQQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P+ + + +PAL ++ L +DP +R + L+ +F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 2e-69
Identities = 117/320 (36%), Positives = 169/320 (52%), Gaps = 36/320 (11%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD---NLEPESVRFMAREIHILRRL-D 187
+E L K+G+G Y V++A D K++VALKK+ FD N F REI L+ L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDL-----AGLASHPGLKFSEAQVKCYMQQLLC 242
H N++KL ++ + +YLVFEYME DL A + L+ + + M QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-----LE--DVHKRYIMYQLLK 118
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA----SFYDPDQNQPLTSRVVTLWY 298
L + HS V+HRD+K SN+L++++ +K+ADFGLA + +N LT V T WY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE+LLG+T Y VD+WS GCIL E+ GKP+ PG + + QL KI ++ G PS +
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 359 --KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR---- 412
KS + ++ + E AL L++ LL +P R +A AL
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
Query: 413 SEFFTMKPLPCDPSSLPKYP 432
++F +PS P P
Sbjct: 299 AQFH-------NPSDEPVLP 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 1e-68
Identities = 109/316 (34%), Positives = 157/316 (49%), Gaps = 32/316 (10%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+E IG+GTY VY+A+ + K K A+KK + D + + A REI +LR L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL----ASHPGLKFSEAQVKCYMQQLLCGL 244
NV+ L + S+YL+F+Y EHDL + + + VK + Q+L G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 245 DHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR--VVTLWY 298
+ HS VLHRD+K +N+L+ G++KI D GLA ++ VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLC 349
R PELLLGA +Y A+D+W+ GCI AEL +PI GR +QL +IF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 350 GSPSEDYWRK-SKLPH----ATIFKPQQPYKRCV----AETFKDFPAPALALMETLLSID 400
G+P+E W K+P FK + Y E K + L+ LL D
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 401 PADRGSAASALRSEFF 416
P R +A AL +F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 4e-64
Identities = 118/300 (39%), Positives = 173/300 (57%), Gaps = 25/300 (8%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ +++ KLDK+G+GTY+ V++ R + +VALK++R ++ E + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 188 HINVIKLEGLV-TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
H N++ L ++ T R L LVFEY++ DL + G S VK +M QLL GL +
Sbjct: 62 HANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
CH R +LHRD+K NLLI+ G LK+ADFGLA + ++ VVTLWYRPP++LLG
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
+T Y T +D+W GCIL E+ G+P+ PG T E+LH IF+L G+P+E+ W P T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGIT 232
Query: 367 IFK-------PQ---QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ PQ QP D + L+ +LL + R SA +ALR +F
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTD----GIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 7e-64
Identities = 100/298 (33%), Positives = 157/298 (52%), Gaps = 23/298 (7%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +EKL KIG+G+Y V++ R+ + +IVA+KK +P + REI +L++L H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHC 247
N++ L + R L+LVFEY +H L L +P G+ E +K + Q L ++ C
Sbjct: 61 NLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKKIIWQTLQAVNFC 116
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H +HRD+K N+LI G +K+ DFG A T V T WYR PELL+G
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGD 175
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS---------PSEDYWR 358
T YG VD+W+ GC+ AEL G+P+ PG+++V+QL+ I K G + +++
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+P +P + F + +PAL+ ++ L +DP +R S L +F
Sbjct: 236 GLSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 1e-63
Identities = 107/292 (36%), Positives = 155/292 (53%), Gaps = 23/292 (7%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALK--KVRFDNLEPESVRFMAREIHILRRL-DHINV 191
L KIG+GT+S V +A+ K A+K K F +LE + REI LRRL H N+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCH 248
++L ++ R + L LVFE M+ +L L P E +VK YM QLL LDH H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMH 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFG-LASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
G+ HRDIK N+LI ++ ILK+ADFG Y P T + T WYR PE LL
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIY---SKPPYTEYISTRWYRAPECLLTD 173
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
YYG +D+W+ GC+ E+ + P+ PG E++Q+ KI + G+P + +K +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHM 232
Query: 368 ---FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
F ++ + + + A L L++ LL+ DP +R +A ALR +F
Sbjct: 233 NYNFPSKKG--TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 8e-62
Identities = 119/295 (40%), Positives = 160/295 (54%), Gaps = 18/295 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DH 188
+E + +IG G Y VY+ARD VALK VR E RE+ +L+RL DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 189 INVIKLEGL-VTSRM--SCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLC 242
N+++L + TSR + LVFE+++ DL PGL +K M+Q L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE--TIKDLMRQFLR 119
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
GLD H+ ++HRD+K N+L+ + G +K+ADFGLA Y LT VVTLWYR PE
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPE 177
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSK 361
+LL +TY T VD+WS GCI AE++ KP+ G +E +QL KIF L G P ED W R
Sbjct: 178 VLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
LP F P+ P R V + L+ +L+ +P R SA AL+ FF
Sbjct: 237 LPRGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-60
Identities = 110/291 (37%), Positives = 167/291 (57%), Gaps = 7/291 (2%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ +++ KLDK+G+GTY+ VY+ R +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
H N++ L ++ + S L LVFEY++ DL G + VK ++ QLL GL++C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H R VLHRD+K NLLI+ G LK+ADFGLA + ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK--SKLPHA 365
T Y T +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+E+ W S
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ P+ C+ + L+ LL + R SA A++ +F
Sbjct: 240 SYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 7e-60
Identities = 111/326 (34%), Positives = 158/326 (48%), Gaps = 31/326 (9%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRLD 187
++ ++ IG G Y V A D K VA+KK+ FD P + RE+ ILR
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFK 62
Query: 188 HINVIKLEGLVTSRMS--CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
H N+I + ++ + +Y+V + ME DL + H +E ++ ++ QLL GL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLK 121
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP---DQNQPLTSRVVTLWYRPPE 302
+ HS V+HRD+K SNLL++ + L+I DFG+A + +T V T WYR PE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE-------- 354
LLL Y TA+D+WS GCI AE+ + + PG+ V QL I + GSPSE
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 355 DYWRKS--KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
D RK LP K P+ + F AL L+ +L DP +R + AL+
Sbjct: 242 DRVRKYIQNLPR----KQPVPWS----KIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293
Query: 413 SEFFTMKPLPCDPSSLPKYPPSKEFD 438
F DP P PP +FD
Sbjct: 294 HPFLAQYH---DPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 4e-59
Identities = 122/295 (41%), Positives = 170/295 (57%), Gaps = 14/295 (4%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLD 187
A S+ L+K+G+G+Y+ VY+ ++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDH 246
H N++ L ++ ++ + L VFEYM DLA + HPG V+ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAY 118
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H + +LHRD+K NLLI G LK+ADFGLA +Q +S VVTLWYRPP++LLG
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLG 177
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSEDYWRK-SKLPH 364
AT Y +A+D+W GCI E+ G+P PG ++V EQL KI+ + G P+ED W SKLP+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 365 --ATIFKPQQPYK-RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
F P +P + R V + P A L +L + P DR SA AL +F
Sbjct: 238 YKPEWFLPCKPQQLRVVWKRLSRPPK-AEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 7e-59
Identities = 76/191 (39%), Positives = 111/191 (58%), Gaps = 6/191 (3%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+G + VY ARD K VA+K ++ ++ + REI IL++L+H N++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 198 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 256
LYLV EY E L L K SE ++ + Q+L GL++ HS G++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 257 IKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
+K N+L+D+ NG +K+ADFGL+ D++ L + V T Y PE+LLG YY D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 316 LWSTGCILAEL 326
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 123/322 (38%), Positives = 178/322 (55%), Gaps = 18/322 (5%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 195
IG+G Y V A++ + + VA+KK+ FDN ++ R + REI +LR LDH NVI ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTL-REIKLLRHLDHENVIAIK 70
Query: 196 GLV--TSRMSCS-LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
++ R + + +Y+V+E M+ DL + S L S+ + ++ QLL GL + HS
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTL--SDDHCQYFLYQLLRGLKYIHSAN 128
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
VLHRD+K SNLL++ N LKI DFGLA ++ +T VVT WYR PELLL + Y
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAPELLLNCSEYT 187
Query: 312 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371
TA+D+WS GCI AEL KP+ PG+ V QL I +L GSPSE+ + A +
Sbjct: 188 TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247
Query: 372 QPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 429
PY ++ A F A+ L+E +L DP+ R + AL + L DPS P
Sbjct: 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA--SLH-DPSDEP 304
Query: 430 --KYPPSKEFDAKIRDEEARRQ 449
+ P S +F+ EE ++
Sbjct: 305 VCQTPFSFDFEEDALTEEDIKE 326
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 6e-58
Identities = 115/344 (33%), Positives = 167/344 (48%), Gaps = 41/344 (11%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILR 184
++ L IG+G Y V A VA+KK+ P + REI ILR
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILR 58
Query: 185 RLDHINVIKLEGLVTSRMSCSL---YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
R H N+I + ++ S Y+V E ME DL L L S ++ ++ Q+L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQIL 116
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP--DQNQPLTSRVVTLWYR 299
GL + HS VLHRD+K SNLL++ N LKI DFGLA DP D LT V T WYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYW- 357
PE++L + Y A+D+WS GCILAE+ + +P+ PG+ + QL+ I + G+PS ED
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 358 ---RKSK-----LPHATIFKPQQPYKRCVAETFKDFP---APALALMETLLSIDPADRGS 406
+++ LP FKP+ P+ + FP AL L++ +L+ +P R +
Sbjct: 237 IISLRARNYIKSLP----FKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRIT 285
Query: 407 AASALRSEFFTMKPLPCD-PSSLPKYPPSKEFDAKIRDEEARRQ 449
AL + P D P + +P E + E+ +
Sbjct: 286 VEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 7e-58
Identities = 112/329 (34%), Positives = 165/329 (50%), Gaps = 16/329 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKK--IVALKKVR--FDNLEPESVRFMAREIHILRRL- 186
+E + ++GQG Y V AR+ + + VA+KK+ F + RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 187 DHINVIKLEGL--VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
H N+ L + V LYL E ME DL + G ++A + ++ Q+LCGL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGL 118
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQP-LTSRVVTLWYRPP 301
+ HS VLHRD+K NLL++ + LKI DFGLA + + +N +T V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
E++L Y A+D+WS GCILAEL KP+ G+ V+QL++I ++ G+P E+ +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 362 LPHATIFKPQQPYKRCVA-ETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFTMK 419
P A + P E+ P AL L+E LL+ DP R S AL + +
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 420 PLPCDPSSLPKYPPSKEFDAKIRDEEARR 448
P D K P F+++ EE R
Sbjct: 299 HDPDDEPVCQK-PFDFSFESEDSMEELRD 326
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 107/298 (35%), Positives = 168/298 (56%), Gaps = 21/298 (7%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ +++ KL+K+G+GTY+ V++ R + +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
H N++ L +V + S L LVFEY++ DL G S VK ++ Q+L GL +C
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H R VLHRD+K NLLI+ G LK+ADFGLA + ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW---------R 358
+ Y T +D+W GCI E+ +G+P+ PG T ++LH IF+L G+P+E+ W +
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P +KPQ + + L+ L + R SA A++ +F
Sbjct: 240 NYNFPK---YKPQP-----LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 4e-57
Identities = 104/291 (35%), Positives = 169/291 (58%), Gaps = 13/291 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHIN 190
+E L +G+G+Y V + + + +IVA+KK ++ + + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCH 248
++ L + R LYLVFE+++H L L +P GL S +V+ Y+ Q+L G++ CH
Sbjct: 62 LVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDES--RVRKYLFQILRGIEFCH 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S ++HRDIK N+L+ +G++K+ DFG A + T V T WYR PELL+G T
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDT 176
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY---WRKSKLPHA 365
YG AVD+W+ GC++ E+ G+P+ PG ++++QL+ I K G+ + ++K+ L A
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FA 235
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ P+ + + F L L + L IDP DR S++ L EFF
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-57
Identities = 119/303 (39%), Positives = 174/303 (57%), Gaps = 20/303 (6%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRL 186
+ADS+EKL+K+G+G+Y+ VY+ + K+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLD 245
H N++ L ++ ++ + L LVFEY+ DL + HPG VK ++ QLL GL
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLS 117
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ H R +LHRD+K NLLI + G LK+ADFGLA + ++ VVTLWYRPP++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRK-SKLP 363
G+T Y T +D+W GCI E+ G PG +++ QL +IF + G+P+ED W LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236
Query: 364 HATIFKPQQPYKRCVAETFK------DFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
H FKP++ + + + + A L LL P +R SA +AL E+F+
Sbjct: 237 H---FKPER-FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 418 MKP 420
P
Sbjct: 293 DLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 87/298 (29%), Positives = 142/298 (47%), Gaps = 50/298 (16%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 190
+ + + +G+G++ +VY A D D +++A+K V E + + REI IL L H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASH--PGLKFSEAQVKCYMQQLLCGLDH 246
+++ G +L + EY+ +G L+S K E ++ Y +Q+L GL +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYV----SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS G++HRDIKG+N+L+D++G++K+ADFG A D + + S T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
G YG A D+WS GC + E+ GKP W + P A
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPP------------------------WSELGNPMA 211
Query: 366 TIFK-------PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
++K P+ P ++E KDF + L DP R +A L+ F
Sbjct: 212 ALYKIGSSGEPPEIP--EHLSEEAKDF-------LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 7e-54
Identities = 112/328 (34%), Positives = 162/328 (49%), Gaps = 19/328 (5%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
VP R ++ L +G G Y V A D + VA+KK+ F + + RE+ +
Sbjct: 13 VPDR---YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRL 67
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
L+ +DH NVI L + T S +YLV M DL + K S+ ++ +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVY 125
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+L GL + HS G++HRD+K SN+ ++ + LKI DFGLA D + +T V T WY
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 181
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++L +Y VD+WS GCI+AEL GK + PG ++QL +I L G+P E+ +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241
Query: 359 KSKLPHATIFKPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
K A + P K+ E F A+ L+E +L +DP R +AA AL +
Sbjct: 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
Query: 417 TMKPLPCDPSSLPKYPPSKEFDAKIRDE 444
P D P Y S E DE
Sbjct: 302 AEYHDPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 1e-52
Identities = 106/296 (35%), Positives = 149/296 (50%), Gaps = 11/296 (3%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ L +G G + V ARD + VA+KK+ P + RE+ +L+ L H N+
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQ-VKCYMQQLLCGLDHCHSR 250
I L + S + +Y V E + DL L + L E Q ++ ++ Q+L GL + HS
Sbjct: 72 ISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVHSA 127
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
GV+HRD+K SN+LI+ N LKI DFGLA DP +T V T +YR PE++L Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKY 183
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
VD+WS GCI AE+ GKP+ PG+ V Q I L G+P +D + F
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 371 QQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424
P +E FK+ A+ L+E +L DP R SAA AL + P D
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 5e-52
Identities = 114/325 (35%), Positives = 167/325 (51%), Gaps = 23/325 (7%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ L +G G+ V+ A D D K VA+KK+ +P+SV+ REI I+RRLDH N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 192 IKLEGLVTSRMS------------CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
+K+ ++ S S+Y+V EYME DLA + L SE + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQ 122
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQP--LTSRVVTL 296
LL GL + HS VLHRD+K +N+ I+ +LKI DFGLA DP + L+ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
WYR P LLL Y A+D+W+ GCI AE+ GKP+ G E+EQ+ I + E+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 357 WRK--SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414
+ + +P +P +R + + AL +E +L+ +P DR +A AL
Sbjct: 243 RNELLNVIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301
Query: 415 FFTMKPLPCD-PSSLPKYPPSKEFD 438
+ + P D P SL + E D
Sbjct: 302 YMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 5e-51
Identities = 121/295 (41%), Positives = 165/295 (55%), Gaps = 17/295 (5%)
Query: 132 FEKLDKIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--- 187
+E + +IG+G Y V++ARDL + + VALK+VR E RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 188 HINVIKLEGLVT-SRM--SCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
H NV++L + T SR L LVFE+++ DL L P +K M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
LD HS V+HRD+K N+L+ ++G +K+ADFGLA Y LTS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEV 180
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSKL 362
LL ++Y T VDLWS GCI AE++ KP+ G ++V+QL KI + G P E+ W R L
Sbjct: 181 LLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 363 PHATIF-KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P K QP ++ V D L+ L+ +PA R SA SAL +F
Sbjct: 240 PRQAFHSKSAQPIEKFVT----DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 5e-49
Identities = 112/284 (39%), Positives = 154/284 (54%), Gaps = 18/284 (6%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+ FE L +G+G Y V + R + K+IVA+KK + D+ E E V+ RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N+++L+ R LYLVFEY+E + L L P E +V+ Y+ QL+ + C
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWC 116
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H ++HRDIK NLLI +N +LK+ DFG A N T V T WYR PELLLGA
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYW------RKS 360
YG AVD+WS GCIL EL G+P+ PG +E++QL I K+ G P+E R
Sbjct: 177 P-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
L + PQ +R + L LM+ LL ++P DR
Sbjct: 236 GLRFPAVNHPQSLERRYLG----ILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 95/330 (28%), Positives = 141/330 (42%), Gaps = 40/330 (12%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDH- 188
S+ L K+G+G++ VY ARD +K+VALK + + + V REI IL L+H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPG--LKFSEAQVKCYMQQLLCGLD 245
N++KL SLYLV EY++ L L G SE++ + Q+L L+
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 246 HCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQ-----NQPLTSRVVTLWYR 299
+ HS+G++HRDIK N+L+D + ++K+ DFGLA ++ V T Y
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 300 PPELLLGAT--YYGTAVDLWSTGCILAELYAGKP---IMPGRTEVEQLHKIFKLCGSPSE 354
PE+LLG + Y ++ D+WS G L EL G P + Q KI +PS
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414
P A L++ LL+ DP +R S++S L +
Sbjct: 236 ASPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 415 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDE 444
L S P
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 110/335 (32%), Positives = 173/335 (51%), Gaps = 27/335 (8%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REI 180
+P R + L ++G G Y +V A D + VA+KK+ P A RE+
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYREL 65
Query: 181 HILRRLDHINVIKLEGLVTSRMSC----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 236
+L+ + H NVI L + TS +S YLV YM+ DL + HP SE +V+
Sbjct: 66 TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYL 122
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+ Q+LCGL + HS G++HRD+K NL ++ + LKI DFGLA D + +T VVT
Sbjct: 123 VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTR 178
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
WYR PE++L +Y VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P ++
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238
Query: 357 WRKSKLPHATIF---KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
+K + A + P+ P ++ + F A+ L+E +L +D R +A AL
Sbjct: 239 VQKLEDKAAKSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297
Query: 414 EFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARR 448
+F + + Y S E + K+ +E ++
Sbjct: 298 PYFDSFRDADEETEQQPYDDSLE-NEKLSVDEWKK 331
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-47
Identities = 105/285 (36%), Positives = 155/285 (54%), Gaps = 15/285 (5%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIK-L 194
IG G + V+ D K VALKK+ F NL S + + RE+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 195 EGLVTSRMSC--SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
+ L + +Y+V E M+ DL + P S VK ++ Q+L GL + HS G+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 312
LHRDIK NLL+++N +LKI DFGLA +PD+++ +T VVT +YR PE+L+G+ +Y +
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 313 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHATIFKPQ 371
AVD+WS GCI AEL + + ++ ++QL I L G+PS E +S A +
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM--RSACEGARAHILR 242
Query: 372 QPYK-RCVAETFK---DFPAPALALMETLLSIDPADRGSAASALR 412
P+K + + A+ L+ +L DP R SAA AL
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-46
Identities = 108/326 (33%), Positives = 167/326 (51%), Gaps = 15/326 (4%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
VP R ++ L +G G Y +V A D ++ VA+KK+ R RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 185 RLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
+ H NVI L + T S +YLV M DL + K S+ V+ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQL 127
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L GL + HS G++HRD+K SN+ ++ + L+I DFGLA D + +T V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRA 183
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PE++L +Y VD+WS GCI+AEL GK + PG ++QL +I ++ G+PS + +K
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 361 KLPHATIFKPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
HA + P+ ++ + + F+ A+ L+E +L +D R SA+ AL +F+
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 419 KPLPCDPSSLPKYPPSKEFDAKIRDE 444
P D Y S E + +E
Sbjct: 304 YHDPEDEPEAEPYDESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 106/315 (33%), Positives = 162/315 (51%), Gaps = 20/315 (6%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRR 185
D + L ++G G Y V A D VA+KK+ P A RE+ +L+
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKH 70
Query: 186 LDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
+ H NVI L + T +S YLV +M DL L H K SE +++ + Q+L
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQML 128
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
GL + H+ G++HRD+K NL ++ + LKI DFGLA D + +T VVT WYR P
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAP 184
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
E++L +Y VD+WS GCI+AE+ GKP+ G ++QL +I K+ G+PS+++ +K +
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244
Query: 362 LPHATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
A + + P K+ + A+ ++E +L +D R +AA AL +F
Sbjct: 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304
Query: 420 PLPCDPSSLPKYPPS 434
P D + P Y S
Sbjct: 305 HDPEDETEAPPYDDS 319
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 115/336 (34%), Positives = 177/336 (52%), Gaps = 31/336 (9%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHI 189
++ + IG+G+Y V A D + VA+KK+ F+++ ++ R + REI +LR L H
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 190 NVIKLEGLV---TSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLC 242
++++++ ++ + R +Y+VFE ME DL H +K + + ++ QLL
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEHHQFFLYQLLR 114
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVVTLWYRP 300
L + H+ V HRD+K N+L + + LKI DFGLA +F D T V T WYR
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 301 PELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
PEL G+ + Y A+D+WS GCI AE+ GKP+ PG+ V QL I L G+PS +
Sbjct: 175 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAP---ALALMETLLSIDPADRGSAASALRSEF 415
+ + A + K+ V + K FP AL L+E LL+ DP DR +A AL +
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 416 FTMKPLPC---DPSSLPKYPPSKEFDA-KIRDEEAR 447
F K L +PS+ P EF+ ++ E+ R
Sbjct: 293 F--KGLAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 81/290 (27%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+E + +IG+G++ VY R K+ LK++ N+ + E+ IL++L+H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 192 IKL-EGLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLLCGLDH 246
IK E L +V EY + DL+ G F E Q+ + QL L +
Sbjct: 62 IKYYESFEEK---GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
HSR +LHRDIK N+ + +NG++K+ DFG++ + + V T +Y PEL
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQN 177
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
Y D+WS GC+L EL K G +E KI
Sbjct: 178 KP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--------------------- 215
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ P + ++ L+ +LL DP +R S A L+S F
Sbjct: 216 LKGQYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 2e-44
Identities = 111/318 (34%), Positives = 166/318 (52%), Gaps = 46/318 (14%)
Query: 137 KIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
K+G+GTY +VY+A+ D K + ALK++ + + REI +LR L H NVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 195 EGLVTSRMSCSLYLVFEYMEHDL--------AGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ + S ++L+F+Y EHDL A A+ ++ VK + Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 247 CHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR------VVTL 296
H+ VLHRD+K +N+L+ G +KIAD G A + N PL VVT
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTF 179
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFK 347
WYR PELLLGA +Y A+D+W+ GCI AEL +PI R E +QL +IF
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 348 LCGSPSEDYWRK-SKLP-HATIFKP--QQPYKRC----VAETFKDFP-APALALMETLLS 398
+ G P++ W K+P H+T+ K + Y C E K P + A L++ LL+
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299
Query: 399 IDPADRGSAASALRSEFF 416
+DP R ++ A++ +F
Sbjct: 300 MDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
FE L+KIG+G + VY+AR K VA+K ++ + E + EI IL++ H N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+K G + L++V E+ L L +E+Q+ ++LL GL++ HS
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
G++HRDIK +N+L+ ++G +K+ DFGL++ + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
D+WS G EL GKP ++ L KI + + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGLRNP 220
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
++ ++ FKDF ++ L +P R +A L+ F
Sbjct: 221 EK-----WSDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 72/199 (36%), Positives = 121/199 (60%), Gaps = 10/199 (5%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
D IG+G + VY+ +L+ VA+K++ + ++ E+++ + +EI +L+ L H N++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 196 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 254
G + + S SLY++ EY E+ L + G F E+ V Y+ Q+L GL + H +GV+H
Sbjct: 66 GSIET--SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL--GATYYGT 312
RDIK +N+L +G++K+ADFG+A+ D ++ S V T ++ PE++ GA+ T
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMSGAS---T 178
Query: 313 AVDLWSTGCILAELYAGKP 331
A D+WS GC + EL G P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 109/320 (34%), Positives = 163/320 (50%), Gaps = 50/320 (15%)
Query: 137 KIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
K+G+GTY +VY+A+ D K K ALK++ + + REI +LR L H NVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 195 EGLVTSRMSCSLYLVFEYMEHDL--------AGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ + S ++L+F+Y EHDL A A+ ++ + VK + Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 247 CHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR------VVTL 296
H+ VLHRD+K +N+L+ G +KIAD G A + N PL VVT
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTF 179
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFK 347
WYR PELLLGA +Y A+D+W+ GCI AEL +PI R E +QL +IF
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 348 LCGSPSEDYWRK-SKLPHATIFKPQQPYKRCV---------AETFKDFP-APALALMETL 396
+ G P++ W K+P Q+ ++R E K P + L++ L
Sbjct: 240 VMGFPADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297
Query: 397 LSIDPADRGSAASALRSEFF 416
L++DP R ++ AL+ +F
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 102/328 (31%), Positives = 157/328 (47%), Gaps = 17/328 (5%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++ L +G G Y +V A D VA+KK+ + RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 190 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
NVI L + T S +YLV M DL + K ++ V+ + Q+L GL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL ++ + LKI DFGLA D + +T V T WYR PE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 190
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
+Y VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +K A
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 366 TIFKPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
+ K A F A+ L+E +L +D R +AA AL +F
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH--- 307
Query: 424 DPSSLPKYPP-SKEFDAKIRD-EEARRQ 449
DP P P + F+++ +E +
Sbjct: 308 DPDDEPVADPYDQSFESRDLLIDEWKSL 335
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 91/314 (28%), Positives = 134/314 (42%), Gaps = 61/314 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRLD 187
D F+ IG+G++S V A++ + K A+K + R E + V+++ E +L RL+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 188 -HINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
H +IKL T + +LY V EY + +L G E + Y ++L L+
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD---------------QNQPLT 290
+ HS+G++HRD+K N+L+D + +KI DFG A DP+ Q +
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 291 SR----VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 346
R V T Y PELL G + DLW+ GCI+ ++ GKP G E KI
Sbjct: 177 RRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 347 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-- 404
KL P +FP A L+E LL +DP DR
Sbjct: 236 KLE----------YSFPP-------------------NFPPDAKDLIEKLLVLDPQDRLG 266
Query: 405 --GSAASALRSEFF 416
FF
Sbjct: 267 VNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 85/291 (29%), Positives = 144/291 (49%), Gaps = 38/291 (13%)
Query: 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
++ +KIG GT+ VY A +LD +++A+K++R + +P++++ +A E+ +L L H N++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 193 KLEGLVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
K G+ R +Y+ EY L L H G E ++ Y QLL GL + HS G
Sbjct: 63 KYYGVEVHREK--VYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGA 307
++HRDIK +N+ +D+NG++K+ DFG + + + V +L Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 308 TY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI-FKLCGSPSEDYWRKSKLPH 364
+G A D+WS GC++ E+ GK E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH------------ 223
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
KP P ++ KDF ++ L DP R +A+ L+ F
Sbjct: 224 ----KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 94/294 (31%), Positives = 132/294 (44%), Gaps = 44/294 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
E++ +GQG+ VY+ R KI ALKK+ D + E + + RE+ LR +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
V+K G + +V EYM+ DL L K E + +Q+L GLD
Sbjct: 60 YVVKCYGAFYK--EGEISIVLEYMDGGSLADL--LKKVG--KIPEPVLAYIARQILKGLD 113
Query: 246 HCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
+ H+ R ++HRDIK SNLLI++ G +KIADFG++ + +Q T V T+ Y PE +
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERI 172
Query: 305 LGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSK 361
G Y A D+WS G L E GK P +P E + I C P
Sbjct: 173 QGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP-------- 220
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P P + E F+DF + L DP R SAA L+ F
Sbjct: 221 --------PSLPAEEFSPE-FRDF-------ISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 9e-39
Identities = 114/333 (34%), Positives = 164/333 (49%), Gaps = 27/333 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL--- 194
IG G++ VY A +D + VA+KKV D P+ + RE+ I++ L+HIN+I L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 195 ---EGLVTSRMSCSLYLVFEYME---HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
E + + L +V E++ H + VK Y QL L + H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 249 SRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
S+ + HRD+K NLLID N LK+ DFG A Q S + + +YR PEL+LGA
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPELMLGA 245
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
T Y T +DLWS GCI+AE+ G PI G++ V+QL +I ++ G+P+ED ++ +A I
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 427
P K K P A+ + L +P R + AL FF PC
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPC--IK 363
Query: 428 LPKY----PPSKEF-DAKIRD--EEARRQGGSK 453
LPKY P F DA+I++ + RR+ K
Sbjct: 364 LPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396
|
Length = 440 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 41/302 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++ L+KIG+G VY+A D K VA+KK+R E + EI I++ H N+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 192 IKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+ LV L++V EYM+ L + + ++ +E Q+ +++L GL++ H
Sbjct: 78 VDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S+ V+HRDIK N+L+ +G +K+ADFG A+ ++++ S V T ++ PE++
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-NSVVGTPYWMAPEVIKR-K 191
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
YG VD+WS G + E+ G+P P L +F + +K
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP--P-YLREPPLRALFLI----------TTKGI----- 233
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 428
P + FKDF + L DP R SA L+ F C
Sbjct: 234 -PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEEF 282
Query: 429 PK 430
Sbjct: 283 AP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 105/353 (29%), Positives = 171/353 (48%), Gaps = 59/353 (16%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
V +R ++ L IG G V A D + VA+KK+ F N + RE+ +
Sbjct: 14 VLKR---YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVL 68
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAS----HPGLKFSEAQVK 234
++ ++H N+I L + T + S +YLV E M+ +L + H + +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY------ 122
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-----SFYDPDQNQPL 289
+ Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA SF +
Sbjct: 123 -LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------M 174
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
T VVT +YR PE++LG Y VD+WS GCI+ E+ G + PG ++Q +KI +
Sbjct: 175 TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD------FPAP-----------ALAL 392
G+PS+++ + + P + +P + +F++ FP A L
Sbjct: 234 GTPSDEFMSRLQ-PTVRNYVENRP--KYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290
Query: 393 METLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 445
+ +L IDP R S AL+ + + DPS + + PP +D I + E
Sbjct: 291 LSKMLVIDPEKRISVDDALQHPYIN---VWYDPSEV-EAPPPAPYDHSIDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 2e-37
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 196
+G+G++ V R D K+ A+K ++ ++ + V E +IL R++H ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 197 LVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+ LYLV EY +L S G +FSE + + Y +++ L++ HS
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHS 111
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
G+++RD+K N+L+D +G +K+ DFGLA + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKG- 169
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
YG AVD WS G +L E+ GKP E KI
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 102/332 (30%), Positives = 165/332 (49%), Gaps = 29/332 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+++L IG G V A D VA+KK+ + RE+ +L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 192 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
I L + T + S +YLV E M+ +L + ++ ++ + Q+LCG+ H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHL 139
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN+++ ++ LKI DFGLA N +T VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK--SKLPHA 365
Y VD+WS GCI+ EL G I G ++Q +K+ + G+PS ++ + + +
Sbjct: 198 G-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 366 TIFKPQQPYKRCVAETFKDFPAP------------ALALMETLLSIDPADRGSAASALRS 413
+PQ P E F D+ P A L+ +L IDP R S ALR
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 414 EFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 445
+ T+ P + + PP + +DA++ + E
Sbjct: 316 PYITVWYDPAEAEA----PPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-36
Identities = 89/291 (30%), Positives = 144/291 (49%), Gaps = 41/291 (14%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKV--------RFDNLEPESVRFMAREIHILRRLDHI 189
IG+GTY VY A ++ +++A+K+V R D+ + + V+ + EI L+ LDH+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+++ G T+ S++L EY+ + G +F E V+ + +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH 125
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGL----ASFYDPDQNQPLTSRVVTLWYRPPELL 304
S+G+LHRD+K NLL+D +GI KI+DFG+ YD DQN + V W P +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV--FWMAPEVIH 183
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
+ Y VD+WS GC++ E++AG+ P E E + +FKL S
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKLGNKRS----------- 229
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P P + + AL + +I+P +R +A L+ F
Sbjct: 230 ----APPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 95/326 (29%), Positives = 162/326 (49%), Gaps = 23/326 (7%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++ L IG G V A D ++ VA+KK+ + RE+ +++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 192 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
I L + T + S +Y+V E M+ +L + ++ ++ + Q+LCG+ H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 142
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN+++ ++ LKI DFGLA + +T VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y VD+WS GCI+ E+ G + PG ++Q +K+ + G+P ++ +K + T
Sbjct: 201 G-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 368 FKPQQPYKRCVAET-FKD--FPA----------PALALMETLLSIDPADRGSAASALRSE 414
+ + Y E F D FPA A L+ +L ID + R S AL+
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 415 FFTMKPLPCDPSSLPKYPPSKEFDAK 440
+ + P + + P P K+ D +
Sbjct: 320 YINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 11/223 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+E L+ IG+G++ V + R KI+ K++ + N+ + + + E++ILR L H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHC 247
++ + R + +LY+V EY E DLA L E + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 248 HSRG-----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
H+R VLHRD+K +N+ +D N +K+ DFGLA + + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
L + Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 99/332 (29%), Positives = 169/332 (50%), Gaps = 29/332 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++ L IG G V A D + VA+KK+ + RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
I L + T + S +YLV E M+ +L + ++ ++ + Q+LCG+ H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN+++ ++ LKI DFGLA + +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K + P
Sbjct: 194 G-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRN 251
Query: 368 FKPQQPYKRCVA--ETFKD--FPA----------PALALMETLLSIDPADRGSAASALRS 413
+ +P + + F D FPA A L+ +L IDPA R S AL+
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311
Query: 414 EFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 445
+ + DP+ + + PP + +D ++ + E
Sbjct: 312 PYINVW---YDPAEV-EAPPPQIYDKQLDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 86/282 (30%), Positives = 141/282 (50%), Gaps = 36/282 (12%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKL 194
+G G++ +VY +LD A+K+V + E+V+ + +EI +L +L H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 195 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
G T R +LY+ E + LA L G F E ++ Y +Q+L GL++ H R +
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 313
HRDIKG+N+L+D NG++K+ADFG+A + S + ++ PE++ YG A
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
Query: 314 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373
D+WS GC + E+ GKP +++E + +FK+ S LP P
Sbjct: 183 ADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE--------LP---------P 222
Query: 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+++ KDF + L DP+ R +AA L F
Sbjct: 223 IPDHLSDEAKDF-------ILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDH 188
+F+ KIG+G +S VY+A L ++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 189 INVIK-LEGLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCG 243
NVIK L + + L +V E + DL+ + H E + Y QL
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
L+H HS+ ++HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 177
Query: 304 LLGATYYGTAVDLWSTGCILAELYA 328
+ Y D+WS GC+L E+ A
Sbjct: 178 IHENG-YNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 132 FEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
E K+G+G + VY+ + VA+K ++ E E F+ E I+++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
H N+++L G+ T LY+V EYM DL G K + + Q+ G+++
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRVVTL-WYRPPELL 304
S+ +HRD+ N L+ N ++KI+DFGL+ Y+ D + + + W PE L
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESL 176
Query: 305 LGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIFK 347
+ + D+WS G +L E+ +P PG + E L +
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 82/263 (31%), Positives = 124/263 (47%), Gaps = 16/263 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKK-VRFDNLEPESVRFMAREIHILRRLDHIN 190
FE L IG+G + V + D KK+ A+K + +E SVR + E IL+ L+H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPG--LKFSEAQVKCYMQQLLCGLDHC 247
++ L + + ++YLV + + L G L H +KFSE QVK ++ +++ L++
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS+G++HRDIK N+L+D G + I DF +A+ PD TS T Y PE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ 174
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPG--RTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y AVD WS G E GK G RT +Q+ + W +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 366 TIFKPQQPYKR--CVAETFKDFP 386
+ P KR + K+ P
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 71/237 (29%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHINVIKL- 194
I +G Y V+ A+ I A+K ++ ++ ++ + + E IL + V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 195 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
+ +LYLV EY+ DLA L + G E + Y+ +++ L++ HS G++
Sbjct: 60 YSFQGKK---NLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASF------YDPDQNQPLTSRVV-TLWYRPPELLLG 306
HRD+K N+LID+NG LK+ DFGL+ + + ++ R+V T Y PE++LG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI------FKLCGSPSEDYW 357
+ VD WS GCIL E G P G T E I + S++
Sbjct: 176 QG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAI 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 133 EKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
K+G+G + VY+ ++ VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDH 246
N++KL G+ T L +V EYM DL L + + S + + + Q+ G+++
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLL 305
S+ +HRD+ N L+ N ++KI+DFGL+ D + + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 306 GATYYGTAVDLWSTGCILAELY 327
+ + D+WS G +L E++
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 133 EKLDKIGQGTYSNVYRA--RDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRLDH 188
K+G+G + VY+ + KK VA+K ++ D E + F+ RE I+R+LDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDH 246
NV+KL G+ T LY+V EYME DL L + K S + + + Q+ G+++
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEY 117
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLL 305
S+ +HRD+ N L+ N ++KI+DFGL+ D + + W PE L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLK 176
Query: 306 GATYYGTAVDLWSTGCILAELY 327
+ + D+WS G +L E++
Sbjct: 177 EGKFT-SKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 47/293 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ F L+ IG+G++ VY+A D ++VA+K + + E E + + +EI L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDH 246
+ K G L+++ EY G PG K E + ++++L GL++
Sbjct: 60 YITKYYGSFLKG--SKLWIIMEYCG---GGSCLDLLKPG-KLDETYIAFILREVLLGLEY 113
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR----VVTLWYRPPE 302
H G +HRDIK +N+L+ G +K+ADFG++ Q S+ V T ++ PE
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG-----QLTSTMSKRNTFVGTPFWMAPE 168
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
++ + Y D+WS G EL G+P + + L I K PS L
Sbjct: 169 VIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPS--------L 218
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
KP FKDF + L+ DP +R SA L+ +F
Sbjct: 219 EGNKFSKP-----------FKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 136 DKIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
K+G+G + VY+ + + VA+K ++ D E E F+ +E ++++L H NV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 193 KLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLASHPGLKFSEAQVKCYMQQLLCG 243
+L G+ T LYLV EYME DL S S + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPP 301
+++ S+ +HRD+ N L+ + ++KI+DFGL+ D + ++ W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 302 ELLLGATYYGTAVDLWSTGCILAELY 327
E L + + D+WS G +L E++
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 79/303 (26%), Positives = 128/303 (42%), Gaps = 52/303 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLD 187
D +E ++ IG G + VY A L + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
H NV+K L+LV Y+ D+ +S+P EA + ++++L G
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKG 114
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL-ASFYDPDQNQPLTSRVV--TLWYRP 300
L++ HS G +HRDIK N+L+ +G +KIADFG+ AS D + T +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF-------KLCGSPS 353
PE++ Y D+WS G EL G P K L P
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYPPMKVLMLTLQNDPP 225
Query: 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
L +K +++F+ + L DP+ R +A L+
Sbjct: 226 -------SLETGADYKK-------YSKSFRKM-------ISLCLQKDPSKRPTAEELLKH 264
Query: 414 EFF 416
+FF
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 77/232 (33%), Positives = 124/232 (53%), Gaps = 24/232 (10%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLDHINVIK 193
+G G +S+ Y+ARD+ ++A+K+V + + + E V + +EI ++ RL+H ++I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 194 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
+ G +L++ E+M ++ L S G F EA + Y +QLL GL + H +
Sbjct: 68 MLGATCEDSHFNLFV--EWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 253 LHRDIKGSNLLIDNNG-ILKIADFGLASFYDPD-------QNQPLTSRVVTLWYRPPELL 304
+HRD+KG+NLLID+ G L+IADFG A+ Q Q L T+ + PE+L
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG----TIAFMAPEVL 180
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC---GSPS 353
G YG + D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 181 RGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 98/325 (30%), Positives = 131/325 (40%), Gaps = 75/325 (23%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDH 188
D FE + IG+G + V+ RD D ++ A+K +R D ++ + + E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 189 INVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
++KL S LYLV EYM DL L + F E + Y+ +L+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELV 111
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS---------FYDPDQNQPLTSR 292
LD H G +HRDIK N+LID +G +K+ADFGL +Y D + L
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 293 VVTLWYRP-------------------PELLLGATYYGTAVDLWSTGCILAE-LYAGKPI 332
V + R PE+L G T YG D WS G IL E LY P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 333 MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALAL 392
T E +KI W++S F P P A+ L
Sbjct: 231 Y-SDTLQETYNKIIN---------WKES-----LRFPPDPPV-----------SPEAIDL 264
Query: 393 METLLSIDPADR-GSAASALRSEFF 416
+ LL DP DR GS FF
Sbjct: 265 ICRLL-CDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 70/226 (30%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIKL 194
+GQG + VY D+D + +A+K+V FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 195 EGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
G + + S+++ EYM D L ++ L +E + Y +Q+L G+++ HS
Sbjct: 70 YGCLRDDETLSIFM--EYMPGGSVKDQ--LKAYGAL--TETVTRKYTRQILEGVEYLHSN 123
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGAT 308
++HRDIKG+N+L D+ G +K+ DFG + + + V T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
YG D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 73/231 (31%), Positives = 129/231 (55%), Gaps = 20/231 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-------VRFMAREIHILRRLDHIN 190
IG G++ +VY + +++A+K+V ++ S + +AREI +L+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+++ G +S + L + EY+ +A L ++ G F E V+ +++Q+L GL++ H+
Sbjct: 68 IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGL-----ASFYDPDQNQPLTSRVVTLWYRPPELL 304
RG++HRDIKG+N+L+DN G +KI+DFG+ A+ N S ++++ PE +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355
+ T Y D+WS GC++ E+ GK P + QL IFK+ + S +
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 10/218 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
F+ L K+G+G+Y +VY+ + L + ALK+V ++ + EI IL ++H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHC 247
I + L +V EY DL+ S K E ++ QLL GL
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H + +LHRD+K +N+L+ N ++KI D G++ + +++ T Y PE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGR 176
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
Y + D+WS GC+L E+ P R+ + +K+
Sbjct: 177 PYSYKS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +E + +IG GTY +VY+ARD+ ++VA+K ++ + + + +EI +L+ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHP 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
N++ G R L++V EY D+ + P SE Q+ ++ L GL
Sbjct: 61 NIVAYFGSYLRRDK--LWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLA 115
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPE 302
+ H G +HRDIKG+N+L+ +G +K+ADFG+++ + R + T ++ PE
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPYWMAPE 171
Query: 303 LLLGATY--YGTAVDLWSTGCILAELYAGKPIM 333
+ Y D+W+ G EL +P M
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 43/292 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ F+ L+K+G+G+Y +VY+A + ++VA+K V + E ++ + +EI IL++ D
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 190 NVIKLEGLVTSRMSCS-LYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
++K G S + L++V EY D+ + + +E ++ + Q L GL
Sbjct: 59 YIVKYYG---SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGL 112
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
++ HS +HRDIK N+L++ G K+ADFG+ S D + + T ++ PE++
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV-SGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
Y A D+WS G E+ GKP P +++ + IF + P
Sbjct: 172 QEIGYNNKA-DIWSLGITAIEMAEGKP--P-YSDIHPMRAIFMIPNKPPP---------- 217
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
T+ P++ + F DF L DP +R SA L+ F
Sbjct: 218 -TLSDPEK-----WSPEFNDFVK-------KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 91/299 (30%), Positives = 129/299 (43%), Gaps = 68/299 (22%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+GTY VY ARDL + +A+K++ + V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 198 VTSRMSCSLYLVFE-YMEHDLAG-----LASHPG-LKFSEAQVKCYMQQLLCGLDHCHSR 250
S S F+ +ME G L S G LK +E + Y +Q+L GL + H
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 251 GVLHRDIKGSNLLIDN-NGILKIADFG----LASFYDPDQNQPLTSRVV-TLWYRPPELL 304
++HRDIKG N+L++ +G++KI+DFG LA P T TL Y PE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYMAPEVI 181
Query: 305 -LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
G YG D+WS GC + E+ GKP P F G P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP--P-----------FIELGE-----------P 217
Query: 364 HATIFKPQQPYKRCVAETFKDFP-------APALALMETLLSIDPADRGSAASALRSEF 415
A +FK FK P A A + DP R SA L+ F
Sbjct: 218 QAAMFK---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 35/288 (12%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+E + KIG+G++ +Y A+ + +K++ + + +E+ +L ++ H N+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+ + + + L++V EY + DL + G+ FSE Q+ + Q+ GL H H
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 250 RGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
R +LHRDIK N+ + NG + K+ DFG+A + D + + V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRP 178
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
Y D+WS GC+L EL K G + QL + K+C F
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQG---------------YF 219
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P P +F +L+ L + P DR S S L+ F
Sbjct: 220 APISP----------NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
D FE + +G G++ V R K ALK + ++ + V + E IL+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLC 242
++ L G + + +LYLV EY + G L SH L +F E + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEY----VPGGELFSH--LRKSGRFPEPVARFYAAQVVL 112
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----Y 298
L++ HS +++RD+K NLL+D++G +KI DFG A + R TL Y
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEY 164
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
PE++L YG AVD W+ G ++ E+ AG P
Sbjct: 165 LAPEIILSKG-YGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 25/234 (10%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-D 187
FE ++ IG+GTY VY+AR ++VA+K + E E ++ E +ILR+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 188 HINVIKLEGLVTSRMSCS----LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQ 239
H N+ G + L+LV E DL G + E + +++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
L GL + H V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWM 180
Query: 300 PPELLLG----ATYYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKI 345
PE++ Y D+WS G EL GKP + P R L KI
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 80/253 (31%), Positives = 125/253 (49%), Gaps = 33/253 (13%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHI 189
+F+ KIG+G +S VYRA L +K VALKKV+ F+ ++ ++ + +EI +L++L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 190 NVIK-LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQVKCYMQQLLCGL 244
NVIK L+ + L +V E + DL+ + + + E V Y QL +
Sbjct: 63 NVIKYLDSFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
+H HSR V+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-R 177
Query: 305 LGATYYGTAVDLWSTGCILAEL-------YAGK---------------PIMPGRTEVEQL 342
+ Y D+WS GC+L E+ Y K P +P E+L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 343 HKIFKLCGSPSED 355
++ +C P D
Sbjct: 238 RELVSMCIYPDPD 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI-HILRRLDHIN 190
F+ L ++GQG Y V+ A+ D +IVALK+++ +S+ F E+ H+L D +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILT 56
Query: 191 VIKLEGLVTSRMSC----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
K E LV + LYL EY+ D L ++ G+ SE + YM ++ +D
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVD 115
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
H G +HRD+K N LID +G +K+ DFGL+ N S V + Y PE+L
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN----SVVGSPDYMAPEVLR 171
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
G Y VD WS GC+L E G P G T E + YW++
Sbjct: 172 G-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
FE L+KIG+G++ V++ K++ A+K++ + E +L +LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 192 IK-LEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
I+ E + L +V EY E H L L G E QV + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
HS+ +LHRDIK NL +D +KI D G+A + N T V T +Y PEL
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCED 175
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
Y + D+W+ G +L E GK + + KI +
Sbjct: 176 KPYNEKS-DVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 72/225 (32%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIKL 194
+GQG + VY D+D + +A K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLCGLDHCHSR 250
G + R +L + EYM G + LK +E+ + Y +Q+L G+ + HS
Sbjct: 70 YGCLRDRAEKTLTIFMEYM----PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGAT 308
++HRDIKG+N+L D+ G +K+ DFG + R V T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
YG D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 186 -YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 77/222 (34%), Positives = 111/222 (50%), Gaps = 10/222 (4%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLE 195
KIG+G +S VYRA L VALKKV+ FD ++ ++ +EI +L++L+H NVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 196 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRG 251
L +V E + DL+ + H + E V Y QL L+H HSR
Sbjct: 69 ASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
V+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 312 TAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 352
D+WS GC+L E+ A P + + L K + C P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 39/289 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI-- 189
+++L+ IG+G Y VYR + + ++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 190 -NVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
N+ K G L R L+++ EY E G +E + ++++L L +
Sbjct: 62 PNITKYYGSYLKGPR----LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H GV+HRDIK +N+L+ N G +K+ DFG+A+ + + ++ T V T ++ PE++
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITE 175
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
YY T D+WS G + E+ G P + L +P +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMML-------------IPKS- 217
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
KP + ++ ++F + L +P +R SA L+S++
Sbjct: 218 --KPPRLEDNGYSKLLREF-------VAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 42/300 (14%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILR 184
P++ + + +KIGQG VY A D+ + VA+K++ NL+ + + + EI ++R
Sbjct: 17 PKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMR 71
Query: 185 RLDHINVIKLEGLVTSRMSC-SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLC 242
H N++ + S + L++V EY+ L + + + E Q+ ++ L
Sbjct: 72 ENKHPNIVNY---LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQ 126
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
L+ HS V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPE 185
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
++ YG VD+WS G + E+ G+P + L+ I
Sbjct: 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------------- 227
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 421
AT P+ ++ F+DF + L +D RGSA L+ F + KPL
Sbjct: 228 --ATNGTPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 134 KLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++G+G + V R + + VA+K + E + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHE 66
Query: 190 NVIKLEGLVTSRMSCSLYLVFEY-----MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
N++K +G+ SL L+ EY + L LK ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK----RLLLFSSQICKGM 122
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-----NQPLTSRVVTLWYR 299
D+ S+ +HRD+ N+L+++ ++KI+DFGLA D+ +P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELY 327
PE L + + +A D+WS G L EL+
Sbjct: 180 APECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 13/223 (5%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIKL 194
+GQG + VY D D + +A+K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
G + M +L + E+M L S+ L +E + Y +Q+L G+ + HS +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSYLHSNMI 127
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGATYY 310
+HRDIKG+N+L D+ G +K+ DFG + + S T ++ PE++ G Y
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-Y 186
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
G D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 81/306 (26%), Positives = 142/306 (46%), Gaps = 47/306 (15%)
Query: 130 DSFEKLD---KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRR 185
D LD KIG+G+ V A D + VA+KK+ +L + R + E+ I+R
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRD 72
Query: 186 LDHINVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLC 242
H N++++ LV L++V E++E L + +H + +E Q+ +L
Sbjct: 73 YQHPNIVEMYSSYLVGDE----LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLK 126
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
L H++GV+HRDIK ++L+ ++G +K++DFG + + + S V T ++ PE
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPE 185
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
++ YGT VD+WS G ++ E+ G+P ++ + +I R +
Sbjct: 186 -VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDNLP 232
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
P + +K V+ + F ++ +L DPA R +AA L F
Sbjct: 233 PKL-----KNLHK--VSPRLRSF-------LDRMLVRDPAQRATAAELLNHPFLA---KA 275
Query: 423 CDPSSL 428
PSS+
Sbjct: 276 GPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 8e-23
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHIN 190
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 191 VIKLEGLVTSRMSCSLYLVFEYM---EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
I+ +G + +LV EY D+ + P E ++ L GL +
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS +HRDIK N+L+ G +K+ADFG AS P S V T ++ PE++L
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAM 186
Query: 308 T--YYGTAVDLWSTGCILAELYAGKP 331
Y VD+WS G EL KP
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 28/227 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH------IL 183
D E++ +G GT+ V+ RD + ALK + PE +R + +E H +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIR-LKQEQHVHNEKRVL 55
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLC 242
+ + H +I+L T LY++ EY+ +L + G +FS + Y +++C
Sbjct: 56 KEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVC 112
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----Y 298
L++ HS+ +++RD+K N+L+D G +K+ DFG A + L R TL Y
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEY 164
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
PE ++ + + AVD W+ G ++ E+ G P KI
Sbjct: 165 LAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
F KL++IG+G++ V++ D +++VA+K + + E E + + +EI +L + D V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 192 IKLEGLVTSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
K G + L+++ EY+ L L + P F E Q+ ++++L GLD+ HS
Sbjct: 65 TKYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHS 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+HRDIK +N+L+ G +K+ADFG+A Q + T W P ++ +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQSA 177
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
Y + D+WS G EL G+P P+ D P +F
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PNSDMH-----PMRVLFL 212
Query: 370 -PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P+ E K F ++ L+ DP+ R +A L+ +F
Sbjct: 213 IPKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 132 FEKLDKIGQGTY--SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + +G+G + + +YR + D +V K+V L + R EI IL L H
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDS--LVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHC 247
N+I +L + EY L G F E V Y+ Q++ + +
Sbjct: 60 NIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H G+LHRDIK N+ + G++K+ DFG++ + + T V T +Y PEL G
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGV 176
Query: 308 TYYGTAVDLWSTGCILAEL 326
Y + D+W+ GC+L EL
Sbjct: 177 KYNFKS-DIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 44/288 (15%)
Query: 137 KIGQGTYSNVYRARD---LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
++G+G++ VY +D + ++++ LK++ L P +E +L +LDH ++K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 194 LEGLVTSRMSCSLYLVFEYME-HDL---AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
R + ++ EY E DL H G SE QV + QLL G+ + H
Sbjct: 67 FHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFY--DPDQNQPLTSRVVTLWYRPPELLLGA 307
R +LHRD+K N+ + NN +LKI DFG++ D T T +Y PE L
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKH 179
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y + D+WS GCIL E+ G+ + + +I + +PS LP
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPS--------LPET-- 228
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+ ++M+++L+ DP+ R SAA LR+ F
Sbjct: 229 -----------------YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-22
Identities = 78/233 (33%), Positives = 113/233 (48%), Gaps = 26/233 (11%)
Query: 117 AGEAIQGWVPRRADSFEKLDK---IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV 173
+ + G P A S +L++ IG G VY+ ++ ALK V + N E
Sbjct: 58 SSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVR 116
Query: 174 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQ 232
R + REI ILR ++H NV+K + + + ++ E+M+ L G +H E
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDGGSLEG--THIA---DEQF 169
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG----LASFYDPDQNQP 288
+ +Q+L G+ + H R ++HRDIK SNLLI++ +KIADFG LA D P
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----P 224
Query: 289 LTSRVVTLWYRPPEL----LLGATYYGTAVDLWSTGCILAELYAGK-PIMPGR 336
S V T+ Y PE L Y G A D+WS G + E Y G+ P GR
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ K+ KIG+G++ + + K +K++ + P+ +E+ +L + H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
++ + + + +LY+V +Y E DL + + G+ F E Q+ + Q+ L H H
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
R +LHRDIK N+ + +G +K+ DFG+A + T + T +Y PE+ Y
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRPY 178
Query: 310 YGTAVDLWSTGCILAEL 326
+ D+W+ GC+L E+
Sbjct: 179 NNKS-DIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
F KL+KIG+G++ V++ D +K+VA+K + + E E + + +EI +L + D V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
K G + L+++ EY+ A PG E Q+ ++++L GLD+ HS
Sbjct: 65 TKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEK 121
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
+HRDIK +N+L+ +G +K+ADFG+A D + V T ++ PE++ + Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 312 TAVDLWSTGCILAELYAGKP 331
A D+WS G EL G+P
Sbjct: 181 KA-DIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 78/276 (28%), Positives = 117/276 (42%), Gaps = 43/276 (15%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHIN 190
L I +G + +VY A+ A+K ++ ++ + +V+ + I +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG--ESPY 58
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
V KL S+ LYLV EY+ D A L G E K Y+ +++ G++ H
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGAT 308
RG++HRDIK NLLID G LK+ DFGL+ +N + V T Y PE +LG
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVG 169
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
D WS GC++ E G P E +F + I
Sbjct: 170 -DDKMSDWWSLGCVIFEFLFGYPPF----HAETPDAVFD-------------NILSRRIN 211
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
P++ + C E A+ L+ LL +DPA R
Sbjct: 212 WPEEVKEFCSPE--------AVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
F KL++IG+G++ VY+ D K++VA+K + + E E + + +EI +L + D +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+ G + L+++ EY+ A PG E + ++++L GLD+ HS
Sbjct: 65 TRYYG--SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSER 121
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
+HRDIK +N+L+ G +K+ADFG+A Q + T W P ++ + Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIKQSAYD 179
Query: 312 TAVDLWSTGCILAELYAGKP 331
D+WS G EL G+P
Sbjct: 180 FKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 6e-21
Identities = 71/235 (30%), Positives = 112/235 (47%), Gaps = 15/235 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHIN 190
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L+R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
I+ +G + +LV EY + L E ++ L GL + HS
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT-- 308
++HRDIK N+L+ G +K+ADFG AS P S V T ++ PE++L
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVILAMDEG 199
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK-----LCGSPSEDYWR 358
Y VD+WS G EL KP + + L+ I + L + DY+R
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVR----FDNLEPESVRFMAREIHILRRLDHINVIK 193
+G G + V + + + ALK V+ + + E + E IL +H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 194 LEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
L T + +Y++ EY +L + GL F E + Y+ ++ ++ H+RG+
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGI 114
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYG 311
++RD+K NLL+D+NG +K+ DFG A ++ T T Y PE++L Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG-YD 170
Query: 312 TAVDLWSTGCILAELYAGKP 331
+VD WS G +L EL G+P
Sbjct: 171 FSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +L ++G+G +V + R + I ALK + D P+ + + RE+ I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
++K G S S+ + EY E + G + E + + +L GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ HSR ++HRDIK SN+L+ G +K+ DFG++ T T +Y PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQ 176
Query: 306 GATYYGTAVDLWSTGCILAELYAGK-PIMP 334
G Y T+ D+WS G L E+ + P P
Sbjct: 177 GKPYSITS-DVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHIN 190
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
I+ G + +LV EY + L E ++ L GL + HS
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT-- 308
++HRD+K N+L+ G++K+ DFG AS P V T ++ PE++L
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEG 189
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
Y VD+WS G EL KP + + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 73/259 (28%), Positives = 126/259 (48%), Gaps = 19/259 (7%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHIN 190
+E + ++G GTY +VY+AR+L ++ A+K ++ LEP + + +EI +++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
++ G SR L++ EY H SE Q+ ++ L GL + HS+
Sbjct: 68 IVAYFGSYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY- 309
G +HRDIKG+N+L+ +NG +K+ADFG+A+ + S + T ++ PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNG 184
Query: 310 -YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
Y D+W+ G EL +P M ++ + +F + S + K K ++ F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM---FDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241
Query: 369 K-------PQQPYKRCVAE 380
+ P KR AE
Sbjct: 242 HNFVKISLTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRL 186
+A+ F+ + IG+G + V R K++ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-- 98
Query: 187 DHINVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
H N E +V ++ + LY+V EYM DL L S+ E + Y +
Sbjct: 99 -HANS---EWIV--QLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAE 150
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ LD HS G +HRD+K N+L+D +G LK+ADFG D + + V T Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 300 PPELLL---GATYYGTAVDLWSTGCILAELYAGKP 331
PE+L G YYG D WS G L E+ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 36/292 (12%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ + +KIGQG VY A D+ + VA+K++ +P+ + EI ++R + N+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNI 78
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+ L + + L++V EY+ L + + + E Q+ ++ L LD HS
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHSN 134
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-Y 192
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
G VD+WS G + E+ G+P + L+ I AT P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNGTP 233
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 421
+ ++ F+DF + L +D RGSA L+ F + KPL
Sbjct: 234 ELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 38/293 (12%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRRLDHIN 190
+ + +KIGQG V+ A D+ + VA+K++ NL+ + + + EI +++ L + N
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
++ L + + L++V EY+ L + + + EAQ+ ++ L L+ H+
Sbjct: 78 IVNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHA 133
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA- 191
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
YG VD+WS G + E+ G+P + L+ I G+P +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP----------------E 234
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 421
Q P K ++ F+DF + L +D RGSA L+ F + KPL
Sbjct: 235 LQNPEK--LSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-20
Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 5/195 (2%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLEG 196
IG+GT+ VY+ R D ++I A+K + + + + + V E +IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 197 LVTSRMSCS-LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 254
L S + S LYLV +YM +L G +FSE + K Y+ +L+ L+H H +++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 314
RD+K N+L+D G + + DFGL S + N+ + T Y PE+LL Y V
Sbjct: 120 RDLKPENILLDATGHIALCDFGL-SKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 315 DLWSTGCILAELYAG 329
D WS G ++ E+ G
Sbjct: 179 DFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIKL 194
+G+G + VY D D + +A+K+V FD E+ V + EI +L+ L H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLCGLDHCHSR 250
G + L + EYM G + LK +E + Y +Q+L G+ + HS
Sbjct: 70 YGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDP--DQNQPLTSRVVTLWYRPPELLLGAT 308
++HRDIKG+N+L D+ G +K+ DFG + + S T ++ PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
YG D+WS C + E+ KP E E + IFK+ P++
Sbjct: 186 -YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 6e-20
Identities = 78/292 (26%), Positives = 139/292 (47%), Gaps = 36/292 (12%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ + +KIGQG VY A D+ + VA++++ +P+ + EI ++R + N+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNI 79
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+ L + + L++V EY+ L + + + E Q+ ++ L L+ HS
Sbjct: 80 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-Y 193
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
G VD+WS G + E+ G+P + L+ I G+P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP----------------EL 236
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 421
Q P K ++ F+DF + L +D RGSA L+ +F + KPL
Sbjct: 237 QNPEK--LSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDH 188
+ FE + +IG GTY +VY+AR+++ ++ A+K ++ LEP E + +EI +++ H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ G R L++ E+ H SE+Q+ ++ L GL + H
Sbjct: 66 SNIVAYFGSYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL--LLG 306
S+G +HRDIKG+N+L+ +NG +K+ADFG+++ + S + T ++ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR-KSFIGTPYWMAPEVAAVER 182
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIM 333
Y D+W+ G EL +P M
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 58/223 (26%), Positives = 107/223 (47%), Gaps = 34/223 (15%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLE--------PESVRFMAREIH 181
+ L+ +G G + VY+ R + + ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 182 ILR-RLDHINVIK-----LEGLVTSRMSCSLYLVFEYMEHDLAGLASH------PGLKFS 229
I++ +L H N+++ LE LY+V + +E A L H +F+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEG--APLGEHFNSLKEKKQRFT 111
Query: 230 EAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288
E ++ Q++ L + H + ++HRD+ +N+++ + + I DFGLA P
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESK 169
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
LTS V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 170 LTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 74/270 (27%), Positives = 103/270 (38%), Gaps = 73/270 (27%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDH 188
D FE + IG+G + V + D I A+KK+R + LE E V + E IL D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 189 INVIKLEGLVTSRMSCS------LYLVFEYMEHDLAGLASHPG-------LK---FSEAQ 232
V+K + S LYL+ EY+ PG +K F+E +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYL----------PGGDMMTLLMKKDTFTEEE 102
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL---------ASFY-D 282
+ Y+ + + +D H G +HRDIK NLL+D G +K++DFGL FY
Sbjct: 103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 283 PDQNQPLTSRVVTL-----------W----------------YRPPELLLGATYYGTAVD 315
P W Y PE+ L T Y D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECD 221
Query: 316 LWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
WS G I+ E+ G P E KI
Sbjct: 222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
F+ +G+G + V R+ I A+K ++ L E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ +L + +LYLV EY DL L + +F E + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 305
H G +HRDIK N+LID G +K+ADFG A+ ++ V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 306 ---GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
G YG D WS G I E+ G+ T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+G + V + K+ A KK+ L+ MA +N K+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA-----------LNEKKILEK 49
Query: 198 VTSRMSCSLYLVFEYMEH-----------DLAGLASHPGLK-FSEAQVKCYMQQLLCGLD 245
V+SR SL FE + DL + G F EA+ Y Q++CGL+
Sbjct: 50 VSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
H H R +++RD+K N+L+D++G ++I+D GLA + + + R T Y PE+L
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV--ELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 306 GATYYGTAVDLWSTGCILAELYAGK 330
G Y +VD ++ GC L E+ AG+
Sbjct: 168 GEV-YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHIN 190
F L +IG G++ VY A + ++VA+KK+ + + E + + +E+ L++L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
I+ +G + +LV EY + L E ++ L GL + HS
Sbjct: 83 TIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT-- 308
++HRDIK N+L+ G +K+ADFG AS ++ P S V T ++ PE++L
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
Y VD+WS G EL KP + + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 35/292 (11%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
E KIG+G+ V AR+ + VA+K + + + F E+ I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+++ + + L+++ E+++ L + S + +E Q+ + +L L + HS+
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ 136
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
GV+HRDIK ++L+ +G +K++DFG + D + S V T ++ PE ++ T Y
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPE-VISRTPY 194
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
GT VD+WS G ++ E+ G+P + V+ + ++ R S P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPPKLKNAHK 242
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
P +DF +E +L+ +P +R +A L F LP
Sbjct: 243 ISP-------VLRDF-------LERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 36/294 (12%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
D +E + ++G G + VY+A+ + A K ++ ++ E E FM EI IL H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKH 61
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N++ L L+++ E+ + L + +E Q++ +Q+L L+
Sbjct: 62 PNIVGL--YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS V+HRD+K N+L+ +G +K+ADFG+ S + Q + + T ++ PE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 308 TY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
T+ Y D+WS G L EL +P P E+ + + K+ S + SK
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTLDQPSKW- 234
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+ +F DF L DP DR +AA L+ F +
Sbjct: 235 ---------------SSSFNDFLKSCLVK-------DPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPESVRFMAREIH 181
+ D++E ++ IG+GTY VY+ +D + L + + E E+ E +
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA------EYN 70
Query: 182 ILRRL-DHINVIKLEGLVTSRMSCS---LYLVFEY-----MEHDLAGLASHPGLKFSEAQ 232
IL+ L +H NV+K G+ L+LV E + + GL G + EA
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAM 129
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292
+ + L GL H H+ ++HRD+KG+N+L+ G +K+ DFG+++ + + TS
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 293 VVTLWYRPPELLLGATY---YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
W P + Y Y D+WS G EL G P + V+ L KI
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 132 FEKLDKIGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+K+ +G+G + V Y + ++VA+K ++ + ++ +EI+IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDH 246
H N++K +G + + L L+ EY+ L L + P K + AQ+ + QQ+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS-------FY--DPDQNQPLTSRVVTLW 297
HS+ +HRD+ N+L+DN+ ++KI DFGLA +Y D + P+ W
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV------FW 176
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAEL 326
Y L Y A D+WS G L EL
Sbjct: 177 YAVECLKENKFSY--ASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 132 FEKLDKIGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPES----VRFMAREIHIL 183
+++ +G+G + V Y + + VA+K +L+PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYM-----EHDLAGLASHPGLKFSEAQVKCYMQ 238
R L H N++K +G+ T + L+ E++ + L + LK Q Y
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAV 116
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-----NQPLTSRV 293
Q+ G+D+ SR +HRD+ N+L+++ +KI DFGL + D+ L S V
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326
WY PE L+ + +Y A D+WS G L EL
Sbjct: 177 --FWY-APECLIQSKFY-IASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 74/258 (28%), Positives = 108/258 (41%), Gaps = 48/258 (18%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHIN 190
F K+ IG G + V R +D + A+K +R D L + E IL D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
V+KL + + +LY V +Y+ D+ L G+ F E + Y+ +L C ++ H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS---------FYDPDQN-------------- 286
G +HRDIK N+LID +G +K+ DFGL + +Y +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 287 ------QPLTSR-------------VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327
+PL R V T Y PE+LL T Y D WS G IL E+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 328 AGKPIMPGRTEVEQLHKI 345
G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRL 186
+A+ ++ + IG+G + V R +K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
+ V++L + LY+V EYM DL L S+ E K Y +++ LD
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALD 156
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS G++HRD+K N+L+D +G LK+ADFG D + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 306 ---GATYYGTAVDLWSTGCILAELYAG 329
G YYG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 25/224 (11%)
Query: 128 RADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
+ D+ ++G+G + V+ + K++VA+K ++ + ++ + RE +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAEL 61
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-PGLKF----------- 228
L H N++K G+ T +VFEYMEH DL L SH P F
Sbjct: 62 LTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 229 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQ 287
+ +Q+ Q+ G+ + S+ +HRD+ N L+ + ++KI DFG++ Y D +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GK 330
++ + + PPE ++ + T D+WS G +L E++ GK
Sbjct: 180 VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDHINVIKLEG 196
IG+G++ V + R D ++I ALK +R ++ S V E +L +++ ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 197 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
S LYLV ++ +L G +F ++ + Y +LLC L++ H V++R
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
D+K N+L+D G + + DFGL D ++ T T Y PELLLG Y AVD
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTPEYLAPELLLGHG-YTKAVD 175
Query: 316 LWSTGCILAELYAGKP 331
W+ G +L E+ G P
Sbjct: 176 WWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRL 186
+A+ +E + IG+G + V R +K+ A+K + +F+ ++ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
+ V++L + LY+V EYM DL L S+ E + Y +++ LD
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALD 156
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS G +HRD+K N+L+D +G LK+ADFG + + + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 306 ---GATYYGTAVDLWSTGCILAELYAG 329
G YYG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 14/223 (6%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D E L ++G G V + KI+A+K +R + + + + RE+ IL + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
++ G + + + + EYM+ L + + E + +L GL + H
Sbjct: 60 YIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 249 S-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
++HRD+K SN+L+++ G +K+ DFG++ N + V T Y PE + G
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGN 174
Query: 308 TYYGTAVDLWSTGCILAELYAGK-----PIMPGRTEVEQLHKI 345
Y D+WS G L EL G+ P E L I
Sbjct: 175 D-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV----RFMAREIHILRRLDHINVIK 193
+G+G Y VY +Q +++A+K+V D + + E+ +L+ L H+N+++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 194 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
G T ++ + E++ + E Y +Q+L G+ + H+ V+
Sbjct: 67 YLG--TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASFY-----DPDQNQPLTSRVVTLWYRPPELLLGAT 308
HRDIKG+N+++ NGI+K+ DFG A + L S T ++ PE ++ +
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINES 183
Query: 309 YYGTAVDLWSTGCILAELYAGKP 331
YG D+WS GC + E+ GKP
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 18/224 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDH 188
+ L +G+G++ + ++ + A+K++R P+S V +E +L ++ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
N++ + + LY+V EY + + + G F E + + Q+ G+ H
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H + VLHRDIK N+ + NG +K+ DFG A T V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWEN 174
Query: 307 ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLC 349
Y + D+WS GCIL EL K P + + I K+C
Sbjct: 175 MPYNNKS-DIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 77/264 (29%), Positives = 115/264 (43%), Gaps = 52/264 (19%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRF-DNLEPESVRFMAREIHILRRLDHIN 190
F K+ +G G + V AR +D K + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
V++L + + +LY V +Y+ D+ L G+ F E + Y+ +L C ++ H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFY---------------------------D 282
G +HRDIK N+LID +G +K+ DFGL + + D
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 283 P------DQNQPLTSR-------------VVTLWYRPPELLLGATYYGTAVDLWSTGCIL 323
P D+ +PL R V T Y PE+LL T Y D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL 238
Query: 324 AELYAGKPIMPGRTEVEQLHKIFK 347
E+ G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
+KIG+G + +VY+ L VA+K R L P+ R +E IL++ DH N++KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC-----GLDHCHSR 250
G+ + +Y+V E + L + L+ + ++ + G+++ S+
Sbjct: 59 GVCVQKQP--IYIVMELVPG--GSLLTF--LRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGAT 308
+HRD+ N L+ N +LKI+DFG++ + ++ W P L G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR- 171
Query: 309 YYGTAVDLWSTGCILAELYAG 329
Y + D+WS G +L E ++
Sbjct: 172 -YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 86/319 (26%), Positives = 129/319 (40%), Gaps = 70/319 (21%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
IG+G + VY R D K+ A+K K R + E++ R I L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------------IML 48
Query: 195 EGLVTSRMSCSLYLVFEYMEH---------------DLAGLASHPGLKFSEAQVKCYMQQ 239
+ S C + Y H DL S G+ FSEA+++ Y +
Sbjct: 49 S--LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAE 105
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ GL+H H+R V++RD+K +N+L+D +G ++I+D GLA D + +P S V T Y
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYM 162
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE+L Y ++ D +S GC+L +L G SP + K
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH--------------------SPFRQHKTK 202
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR----GSAASALR-SE 414
K + E F +L+E LL D R G A ++
Sbjct: 203 DKHEIDRMTLTMAV------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256
Query: 415 FFTMKPLPCDPSSLPKYPP 433
FF + L L KYPP
Sbjct: 257 FF--RSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +IG G + V+ L+++K VA+K +R + E E ++ +L H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCG--LDHC 247
+++L G+ T R + LVFE+MEH G S + AQ + Q+ L G LD C
Sbjct: 60 KLVQLYGVCTER--SPICLVFEFMEH---GCLS----DYLRAQRGKFSQETLLGMCLDVC 110
Query: 248 H------SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
S V+HRD+ N L+ N ++K++DFG+ F DQ T + + P
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTE---VEQLHKIFKLCGSPSEDYW 357
E + + Y + D+WS G ++ E+++ GK R+ VE ++ F+L
Sbjct: 171 E-VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--------- 220
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALME 394
K +L ++++ Q C E +D P+ +L L +
Sbjct: 221 YKPRLASQSVYELMQ---HCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDH 188
F+K+ +G+G V+ R K+ ALK + + + ++ V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEY-MEHDL-AGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ L + + L LV +Y +L L PG SE + Y ++L L++
Sbjct: 61 PFLPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLA----------------SFYDPDQNQPLT 290
H G+++RD+K N+L+ +G + ++DF L+ N +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 291 SRVV------------TLWYRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKP 331
T Y PE++ G +G+AVD W+ G +L E LY P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL 186
FE L +G G Y V+ R + D K+ A+K ++ + + ++ E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 187 DHINVIKLEGLVT----SRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
LVT + L+L+ +Y+ +L F+E++V+ Y+ +++
Sbjct: 62 RRCPF-----LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIV 115
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
LDH H G+++RDIK N+L+D+ G + + DFGL+ + ++ + S T+ Y P
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 302 ELLLGATY-YGTAVDLWSTGCILAELYAG 329
E++ G + + AVD WS G + EL G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
W +PR +S + K+G G + V+ K VA+K ++ + PE+ +E I
Sbjct: 1 WEIPR--ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQI 54
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQL 240
+++L H +++L + + +Y+V EYM L L S G K Q+ Q+
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
G+ + SR +HRD+ N+L+ N + KIADFGLA + D+ + +
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA 172
Query: 301 PELLLGATYYGT---AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
PE A YG D+WS G +L E+ G+ PG T E L ++
Sbjct: 173 PE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 12/234 (5%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+F +G+G + V + K+ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLD 245
V+ L ++ + L LV M DL + PG F E + Y ++ CGL+
Sbjct: 61 FVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLE 116
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
H +++RD+K N+L+D+ G ++I+D GLA + + + + RV T+ Y PE++
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAV--EIPEGETIRGRVGTVGYMAPEVVK 174
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
Y + D W GC++ E+ GK R E + ++ + E+Y K
Sbjct: 175 NER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 145 NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204
V+ A+ +VA+KK+ D+ E ++ + +EI R+L H N++ VTS +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVTSFIVD 71
Query: 205 S-LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259
S LY+V M + DL L +H E + ++ +L LD+ HS+G +HR +K
Sbjct: 72 SELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129
Query: 260 SNLLIDNNGILKIADFGLA-SFYDPDQNQ-----PLTSRVVTLWYRPPELL----LGATY 309
S++L+ +G + ++ + S + Q S V L + PE+L G
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--- 186
Query: 310 YGTAVDLWSTGCILAEL------YAGKPIMPGRTE-----VEQLHKIFKLCGSPSEDYWR 358
Y D++S G EL + P E V L
Sbjct: 187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246
Query: 359 KSKLPHATIFKPQQ-PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+S H PY R +E F F +E L DP R SA+ L FF
Sbjct: 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 86/329 (26%), Positives = 142/329 (43%), Gaps = 33/329 (10%)
Query: 131 SFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRR 185
+FE L +G G Y V+ R + D K+ A+K ++ L + ++V E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL-- 58
Query: 186 LDHINVIKLEGLVT----SRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
+H+ LVT + L+L+ +Y+ + FSE +V+ Y +++
Sbjct: 59 -EHVRQSPF--LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
L+H H G+++RDIK N+L+D+ G + + DFGL+ + ++ + S T+ Y P
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKP--IMPGR--TEVEQLHKIFKLCGS-PSEDY 356
E++ G +G AVD WS G ++ EL G + G T+ E +I K PS
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG 235
Query: 357 WRKSKLPHATIFKPQQPYKRCVAET-----------FKDFPAPALALMETLLSIDPADRG 405
L H + K P KR A FK ALAL + P+ R
Sbjct: 236 PEAQDLLHKLLRK--DPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRN 293
Query: 406 SA-ASALRSEFFTMKPLPCDPSSLPKYPP 433
EF ++P+ + P
Sbjct: 294 ELDVGNFAEEFTNLEPVYSPAGTPPSGAR 322
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+EK+ +G+G + V+ R +K+V +K++ + + + E +L+ L H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK-FSEAQVKCYMQQLLCGLDHCHS 249
I E +L +V EY LA E + + Q+L L H H+
Sbjct: 62 I--EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 250 RGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGA 307
+ +LHRD+K N+L+D + ++KI DFG++ ++ VV T Y PEL G
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGK 176
Query: 308 TYYGTAVDLWSTGCILAEL 326
Y + D+W+ GC+L EL
Sbjct: 177 PYNQKS-DIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 35/287 (12%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 196
KIG+G+ V A K+VA+KK+ + + F E+ I+R H NV+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 197 LVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
+ + L++V E++E L + +H + +E Q+ +L L H++GV+HR
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
DIK ++L+ ++G +K++DFG + + S V T ++ PE L+ YG VD
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPE-LISRLPYGPEVD 198
Query: 316 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 375
+WS G ++ E+ G+P ++ + I + LP P+
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP------PKLKNL 239
Query: 376 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
V+ + K F ++ LL DPA R +AA L+ F P
Sbjct: 240 HKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/240 (27%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILR 184
P +D++E ++ IG+GTY V++ + A+K + +++ E + E +IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 185 RL-DHINVIKLEGLVTSRMSCS---LYLVFEYME----HDLAGLASHPGLKFSEAQVKCY 236
L DH NV+K G+ + + L+LV E DL G + E +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+ + L GL H H +HRD+KG+N+L+ G +K+ DFG+++ + + TS
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 297 WYRPP----ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352
W P E L +T Y D+WS G EL G P + ++ + +FK+ +P
Sbjct: 190 WMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 52/220 (23%), Positives = 105/220 (47%), Gaps = 14/220 (6%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
L ++G G + V+ + + VA+K +R + + F+ E ++ +L H N+++L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDD--FI-EEAKVMMKLSHPNLVQL 64
Query: 195 EGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
G+ T + +++V EYM + L L G K + + +++ S G
Sbjct: 65 YGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 312
+HRD+ N L+ + ++K++DFGLA + DQ + + PPE+ + + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-YSRFSS 180
Query: 313 AVDLWSTGCILAELYA-GKPIMPGRTE---VEQLHKIFKL 348
D+WS G ++ E+++ GK + VE + ++L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 58/292 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDH 188
+ FE L IG+G + V + D + A+K +R D LE E V + E IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ V+K+ +++ LYL+ E++ D+ L +E + + Y+ + + +D
Sbjct: 61 LWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI 117
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGL------------------------------ 277
H G +HRDIK NLL+D+ G +K++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 278 ----ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 333
A + ++ Q S V T Y PE+ + T Y D WS G I+ E+ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 385
T E K+ W+++ IF P+ P ++E KD
Sbjct: 237 CSETPQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 18/231 (7%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR +S + + K+G G + V+ K VA+K ++ + PES E I++
Sbjct: 3 IPR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +V+ +Y+V EYM L L G + Q+
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPP 301
G+ + +HRD++ +N+L+ + + KIADFGLA D + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GK---PIMPGRTEVEQLHKIFKL 348
L G + D+WS G +L EL G+ P M R +EQ+ + +++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+G++ V+ A + A+K ++ D V M ++ + + E
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 198 VTSRMSCS------LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+ + C+ L+ V EY+ KF + Y +++CGL HS+G
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP----PELLLGA 307
+++RD+K N+L+D +G +KIADFG+ +N ++ T P PE+LLG
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
Y T+VD WS G +L E+ G+ G E E I
Sbjct: 172 K-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 79/292 (27%), Positives = 119/292 (40%), Gaps = 58/292 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDH 188
D FE L IG+G + V + D I A+K +R D LE E V + E IL D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
V+K+ + + +LYL+ E++ D+ L SE + Y+ + + +D
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI 117
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGL------------------------------ 277
H G +HRDIK NLL+D G +K++DFGL
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 278 ----ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 333
A + ++ Q S V T Y PE+ + T Y D WS G I+ E+ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 385
T E K+ W+++ +F P+ P ++E KD
Sbjct: 237 CSETPQETYRKVMN---------WKET-----LVFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 131 SFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRR 185
+FE L +G G Y V+ R + D K+ A+K ++ + + ++ E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL-- 58
Query: 186 LDHINVIKLEGLVT----SRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQ 239
+HI LVT + L+L+ +Y+ L +H +F E +V+ Y +
Sbjct: 59 -EHIRQSPF--LVTLHYAFQTDTKLHLILDYING--GELFTHLSQRERFKEQEVQIYSGE 113
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ L+H H G+++RDIK N+L+D+NG + + DFGL+ + D+ + S T+ Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 300 PPELLLGA-TYYGTAVDLWSTGCILAELYAG 329
P+++ G + AVD WS G ++ EL G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 12/177 (6%)
Query: 157 IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH- 215
+VA+KK++ E +R REI IL+ L H N++K +G+ S +L LV EY+ +
Sbjct: 35 VVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 216 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275
L + ++ Y Q+ G+++ S+ +HRD+ N+L+++ +KI DF
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDF 152
Query: 276 GLASFYDPDQN-----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327
GL D+ +P S + WY P L + + A D+WS G +L EL+
Sbjct: 153 GLTKVLPQDKEYYKVREPGESPI--FWYAPES--LTESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 86/311 (27%), Positives = 132/311 (42%), Gaps = 57/311 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRR 185
+ FE + I G Y VY R + ++ A+KK+ NL + + V F+ R+I L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDI--LTF 57
Query: 186 LDHINVIKLEG-LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
++ V+ + T R C +V EY+E D A L + G + + Y + +
Sbjct: 58 AENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLA 113
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS-------------FYDPDQNQPLT 290
L++ H+ G++HRD+K NLLI + G +K+ DFGL+ + D + L
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 291 SRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
+V T Y PE++L YG VD W+ G IL E G G T E ++
Sbjct: 174 KQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--- 229
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GS 406
S+D I P E + PA A L+ LL +P +R G
Sbjct: 230 ---SDD-----------IEWP---------EGDEALPADAQDLISRLLRQNPLERLGTGG 266
Query: 407 AASALRSEFFT 417
A + FF
Sbjct: 267 AFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A FE ++ +G GTY VY+ R + ++ A+K + E E ++ +EI++L++ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 189 -INVIKLEGLVTSR----MSCSLYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQ 239
N+ G + M L+LV E+ DL + + G E + ++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 119
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
+L GL H H V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 178
Query: 300 PPELLL-----GATYYGTAVDLWSTGCILAELYAGKP 331
PE++ ATY + DLWS G E+ G P
Sbjct: 179 APEVIACDENPDATYDFKS-DLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 71/287 (24%), Positives = 134/287 (46%), Gaps = 35/287 (12%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 196
KIG+G+ V A + K VA+KK+ + + F E+ I+R H NV+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 197 LVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
+ + L++V E++E L + +H + +E Q+ +L L + H++GV+HR
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
DIK ++L+ ++G +K++DFG + + + S V T ++ PE ++ YGT VD
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPE-VISRLPYGTEVD 200
Query: 316 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 375
+WS G ++ E+ G+P ++ + +I + LP P+
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------RDNLP------PRVKDS 241
Query: 376 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
V+ + F ++ +L +P+ R +A L+ F + P
Sbjct: 242 HKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 135 LDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAR---EIHILRRLDH 188
L +GQG++ V+ R + D ++ A+K ++ L+ VR R E IL ++H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNH 57
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++KL + LYL+ +++ DL S + F+E VK Y+ +L LDH
Sbjct: 58 PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHL 114
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS G+++RD+K N+L+D G +K+ DFGL S D + S T+ Y PE ++
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE-VVNR 172
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
+ + D WS G ++ E+ G G+ E + I K
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
VPR ++ + + K+G G + V+ K VA+K ++ ++ PE+ F+A E ++++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +VT +Y++ EYME+ + L + G+K + ++ Q+
Sbjct: 57 QLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G+ + +HRD++ +N+L+ KIADFGLA + ++ + + PE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 303 LLLGATYYGT---AVDLWSTGCILAELYA-GKPIMPGRTEVE 340
A YGT D+WS G +L E+ G+ PG T E
Sbjct: 174 ----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEG 196
+G+G++ V A + A+K ++ D LE + V E +L + E
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVL-------ALAWEH 55
Query: 197 LVTSRMSCS------LYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCH 248
+ + C+ L+ V EY+ L H +F EA+ + Y +++CGL H
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPELL 304
+G+++RD+K N+L+D +G +KIADFG+ +N + T Y PE+L
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKASTFCGTPDYIAPEIL 168
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
G Y +VD WS G +L E+ G+ G E E I
Sbjct: 169 KGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 131 SFEKLDK-IGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRL 186
S K+++ IG G + V R R L K+ VA+K ++ E + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
DH N+I LEG+VT S + ++ E+ME+ L +F+ Q+ ++ + G+
Sbjct: 63 DHPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-----LTSRVVTLWYRP 300
+ +HRD+ N+L+++N + K++DFGL+ F + D + P L ++ W P
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 301 PELLLGATYYGTAVDLWSTGCILAEL--YAGKP 331
+ + +A D+WS G ++ E+ Y +P
Sbjct: 181 EAIAY--RKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
IG+G + VY R D K+ A+K + ++ + +A I+ L
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL----------- 50
Query: 198 VTSRMSCSLYLVFEYMEH---------------DLAGLASHPGLKFSEAQVKCYMQQLLC 242
S C + Y H DL S G+ FSE +++ Y +++
Sbjct: 51 -VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIIL 108
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
GL+H H+R V++RD+K +N+L+D +G ++I+D GLA D + +P S V T Y PE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPE 165
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAG 329
+L T Y ++ D +S GC+L +L G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEG 196
+G+G++ V A ++ A+K ++ D L+ + V E +L L G
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL---------ALAG 53
Query: 197 ---LVTSRMSC-----SLYLVFEY------MEHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
+T SC L+ V EY M H +F E + + Y +++
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH------IQRSGRFDEPRARFYAAEIVL 107
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----- 297
GL H RG+++RD+K N+L+D+ G +KIADFG+ + + V T
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTP 160
Query: 298 -YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
Y PE+L YG AVD W+ G +L E+ AG+ G E E I
Sbjct: 161 DYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 10/217 (4%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
F K+G G + V+ ++ + VA+K ++ D+L + +E+ L+RL H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
I L + + +Y++ E ME LA L S G A + Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+ +HRD+ N+L+ + + K+ADFGLA D ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 310 YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
+ T D+WS G +L E++ G+ PG E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 40/293 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +E + ++G G + VY+A++ + + A K + + E E +M EI IL +H
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHP 69
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH---DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
++KL G L+++ E+ D L GL + QV C +Q+L L +
Sbjct: 70 YIVKLLGAFY--WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC--RQMLEALQY 125
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
HS ++HRD+K N+L+ +G +K+ADFG+ S + Q S + T ++ PE+++
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGV-SAKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 307 ATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
T Y D+WS G L E+ I P E+ + + K+ KS+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------KSEP 232
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P + QP K + F+DF ++T L P R SAA L F
Sbjct: 233 PTLS-----QPSKWSM--EFRDF-------LKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 30/259 (11%)
Query: 179 EIHILRRLDHINVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 237
E +L+ ++H +VI++ + LV+ ++C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF--YDPDQNQPLTSRVVT 295
+Q+L GL + H++ ++HRD+K N+ I++ + I D G A F P L V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET 222
Query: 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA----------GKPIMPGRTEVEQLHKI 345
PE+L Y + D+WS G +L E+ A P ++ L KI
Sbjct: 223 ---NAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 346 FKLCGSPSEDYWRK--SKLPHATIFKP---QQPYKR--CVAETFKDFPAPALALMETLLS 398
E++ R S+L I +QPY R C + P L+ +L+
Sbjct: 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLVHKMLT 336
Query: 399 IDPADRGSAASALRSEFFT 417
D A R SA L F
Sbjct: 337 FDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 81/271 (29%), Positives = 118/271 (43%), Gaps = 45/271 (16%)
Query: 154 QKKIVALKKVRFDNLEPESVRFMAR-EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212
++K+VA +F L E AR E+H L DH ++K S L L+ EY
Sbjct: 93 KEKVVA----KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIMEY 146
Query: 213 MEH-DLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266
DL L H L F E +V Q++ LD HSR ++HRD+K +N+ +
Sbjct: 147 GSGGDLNKQIKQRLKEH--LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204
Query: 267 NGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAE 325
GI+K+ DFG + Y + + S T +Y PEL Y A D+WS G IL E
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA-DMWSLGVILYE 263
Query: 326 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 385
L LH+ FK PS+ ++ ++ P+ V+ K
Sbjct: 264 LLT-------------LHRPFK---GPSQ-----REIMQQVLYGKYDPFPCPVSSGMK-- 300
Query: 386 PAPALALMETLLSIDPADRGSAASALRSEFF 416
AL++ LLS +PA R + L +EF
Sbjct: 301 -----ALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 34/214 (15%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHIN 190
FE + +G G++ V A+ + A+K ++ L+ + V+ +A+E IL L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 191 VIKLEGLVTSRMSCS------LYLVFEYMEHDLAG-LASH--PGLKFSEAQVKCYMQQLL 241
++ M CS +Y + E++ + G L +H +F K Y +L+
Sbjct: 80 IVN--------MMCSFQDENRVYFLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW---- 297
++ HS+ +++RD+K NLL+DN G +K+ DFG A + + R TL
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPE 180
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
Y PE ++ + +G AVD W+ G +L E AG P
Sbjct: 181 YLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 138 IGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
IG G + V R R L KK VA+K ++ + + + + F+ E I+ + DH N+I+L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 195 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
EG+VT + ++ EYME+ L KF+ Q+ ++ + G+ + +
Sbjct: 71 EGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPELLLGATYY 310
HRD+ N+L+++N + K++DFGL S D T++ + W P + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGL-SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--F 185
Query: 311 GTAVDLWSTGCILAEL--YAGKP 331
+A D+WS G ++ E+ Y +P
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMARE 179
PR ++ E + IGQG + V++AR + +VA+K ++ + F RE
Sbjct: 2 YPR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 58
Query: 180 IHILRRLDHINVIKLEGL-VTSRMSCSLYLVFEYMEH-DL-------------------- 217
++ DH N++KL G+ + C L+FEYM + DL
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 218 -AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276
A L S + C +Q+ G+ + R +HRD+ N L+ N ++KIADFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 277 L------ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
L A +Y +N + R + PPE + Y T D+W+ G +L E+++
Sbjct: 176 LSRNIYSADYYKASENDAIPIR-----WMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 72/285 (25%), Positives = 114/285 (40%), Gaps = 43/285 (15%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+G+Y V R K +KK+ N + +E +L +L H N+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 198 VTSRMS-----CSLYLVFEYMEH-DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
V R S LY+V + E DL L G E QV + Q+ L + H +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
+LHRD+K N+ + I+K+ D G+A + +Q ++ + T +Y PEL Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKP-Y 179
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
D+W+ GC + E+ K + +++I + KL P
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKL-------P 220
Query: 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P KD+ L+ T+LS P R S S LR +
Sbjct: 221 PMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 15/208 (7%)
Query: 134 KLDK-IGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
K++K IG G + V R L K+ VA+K ++ E + F++ E I+ + DH
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDL--AGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N+I LEG+VT S + +V EYME+ A L H G +F+ Q+ ++ + G+ +
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYL 122
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR--VVTLWYRPPELLL 305
G +HRD+ N+L+++N + K++DFGL+ + D T+R + + + PE +
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AI 181
Query: 306 GATYYGTAVDLWSTGCILAEL--YAGKP 331
+ +A D+WS G ++ E+ Y +P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 58/236 (24%), Positives = 109/236 (46%), Gaps = 16/236 (6%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+F + +G+G + V + K+ A K++ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 190 NVIKLEGLVTSRMSCSLYLV------FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
V+ L ++ + L L ++ +++ +PG F E + Y ++LCG
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG----NPG--FEEERALFYAAEILCG 114
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
L+ H ++RD+K N+L+D+ G ++I+D GLA + + + RV T+ Y PE
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE- 171
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
+L Y + D W GC++ E+ G+ GR E + ++ + E Y K
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+F + +G+G + V + K+ A KK+ ++ MA E IL +++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHC 247
V+ L ++ + L LV M DL H G F E + Y ++ CGL+
Sbjct: 61 FVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H +++RD+K N+L+D++G ++I+D GLA Q + RV T+ Y PE++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 176
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y + D W+ GC+L E+ AG+ R + + ++ +L E+Y K
Sbjct: 177 RYTFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK-------- 227
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
F P A +L + LL DP +R
Sbjct: 228 FSPD-----------------ARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 50/143 (34%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264
LY V EY+ DL G KF E Y ++ GL HS+G+++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 265 DNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGATYYGTAVDLWSTGCI 322
D G +KIADFG+ + T+R T Y PE++ YG +VD W+ G +
Sbjct: 135 DAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL 190
Query: 323 LAELYAGKPIMPGRTEVEQLHKI 345
L E+ AG+P G E E I
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL 183
W R D K K+G G Y VY VA+K ++ D +E E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYM-QQLL 241
+ + H N+++L G+ T Y++ E+M + +L + A V YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRP 300
+++ + +HRD+ N L+ N ++K+ADFGL+ D ++ W P
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
Query: 301 PELLLGATYYGTAVDLWSTGCILAEL 326
L + D+W+ G +L E+
Sbjct: 175 ESLAYNK--FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A FE ++ +G GTY VY+ R + ++ A+K + E E ++ EI++L++ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 189 -INVIKLEGLVTSRMSC----SLYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQ 239
N+ G + L+LV E+ DL + + G E + ++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKEDWIAYICRE 129
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
+L GL H H+ V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 188
Query: 300 PPELLL----GATYYGTAVDLWSTGCILAELYAGKP 331
PE++ Y D+WS G E+ G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR + E K+GQG + V+ + VA+K ++ + PE+ +E +++
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +V+ +Y+V EYM L L G Q+ Q+
Sbjct: 57 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPP 301
G+ + +HRD++ +N+L+ N + K+ADFGLA D + ++ W P
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/231 (27%), Positives = 113/231 (48%), Gaps = 21/231 (9%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +E + ++G G + VY+A++ + ++A KV E E +M EI IL DH
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQN-KETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHP 62
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL-----KFSEAQVKCYMQQLLCGL 244
N++KL L +L+++ E+ AG A + +E Q++ +Q L L
Sbjct: 63 NIVKL--LDAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
++ H ++HRD+K N+L +G +K+ADFG+++ + Q S + T ++ PE++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 305 LGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
+ T Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 17/228 (7%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
W + R S + L K+G G + V+ + VA+K ++ ++P+ F+ E I
Sbjct: 1 WEIDRT--SIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKD--FL-AEAQI 54
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQL 240
+++L H +I+L + T + +Y+V E M++ L L G Q+ Q+
Sbjct: 55 MKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
G+ + ++ +HRD+ N+L+ N I K+ADFGLA D + + +
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 301 PELLLGATY--YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
PE A Y + D+WS G +L E+ G+ PG T E L ++
Sbjct: 173 PE---AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+ +G G VY+A L ++I+A+K + D + E + + E+ IL + D +I
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 195 EG--LVTSRMS-CSLYLVFEYMEH---DLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHC 247
G V +R+S C+ E+M+ D+ L + + A VK GL +
Sbjct: 65 YGAFFVENRISICT-----EFMDGGSLDVYRKIPEHVLGRIAVAVVK--------GLTYL 111
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
S +LHRD+K SN+L++ G +K+ DFG+++ N + V T Y PE + G
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGE 168
Query: 308 TYYGTAVDLWSTGCILAELYAGK 330
YG D+WS G EL G+
Sbjct: 169 Q-YGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHI 189
F L +G+G++ V A ++ A+K ++ D ++ + V E +L D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 190 NVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
+T SC LY V EY+ DL G KF E Q Y ++ G
Sbjct: 60 -----PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVG 113
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPP 301
L H RG+++RD+K N+++D+ G +KIADFG+ +T+R T Y P
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAP 170
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
E ++ YG +VD W+ G +L E+ AG+P G E E I +
Sbjct: 171 E-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL 183
W + + IG+G + +V QK VA+K ++ D+ ++ F+A E ++
Sbjct: 1 WAINSKE-LKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQA--FLA-EASVM 54
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
L H N+++L G+V LY+V EYM L + L+ V QQL
Sbjct: 55 TTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAK--GSLVDY--LRSRGRAVITLAQQLGFA 108
Query: 244 LDHC------HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
LD C + +HRD+ N+L+ + + K++DFGLA + Q Q + ++ W
Sbjct: 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKW 165
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYA 328
P L + T D+WS G +L E+Y+
Sbjct: 166 TAPEALREKK--FSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 10/210 (4%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR-EIHILRRLDHINVIKLEG 196
+G+G + V + + K+ A KK+ L+ +S MA E IL +++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 197 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSE-AQVKCYMQQLLCGLDHCHSRGVLH 254
S+ L LV M DL + G + E +V Y Q+ CG+ H HS +++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 314
RD+K N+L+D+ G +++D GLA + + +T R T Y PE+L Y V
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 315 DLWSTGCILAELYAGKPIMPGRTEVEQLHK 344
D ++ GC + E+ AG+ P + E++ K
Sbjct: 176 DWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 19/218 (8%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR----FDNLEPESVRFMAREIHILRRLD 187
F L +G+G + V A ++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
H ++ L + + V EY DL + H + FSE + Y ++ GL +
Sbjct: 61 HPFLVNLFACFQT--EDHVCFVMEYAAGGDLM-MHIHTDV-FSEPRAVFYAACVVLGLQY 116
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP----PE 302
H +++RD+K NLL+D G +KIADFGL + R T P PE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAPE 171
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 340
+L + Y AVD W G ++ E+ G+ PG E E
Sbjct: 172 VLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 10/216 (4%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
+G+G + V++ L K VA+K + D + ++F++ E IL++ DH N++KL G+
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 198 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 256
T R +Y+V E + D + Q+ + G+ + S+ +HRD
Sbjct: 61 CTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 257 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 316
+ N L+ N +LKI+DFG++ D + + + + PE L Y + D+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESDV 177
Query: 317 WSTGCILAELYA----GKPIMPGRTEVEQLHKIFKL 348
WS G +L E ++ P M + EQ+ K +++
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 69/264 (26%), Positives = 106/264 (40%), Gaps = 51/264 (19%)
Query: 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264
L+ V E++ DL G +F + Y +++CGL HS+G+++RD+K N+++
Sbjct: 71 LFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 265 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP----PELLLGATYYGTAVDLWSTG 320
D +G +KIADFG+ +N +R T P PE+L G Y +VD WS G
Sbjct: 130 DRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFG 183
Query: 321 CILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 380
+L E+ G+ G E E I + PH Y R + +
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFESI-------------RVDTPH---------YPRWITK 221
Query: 381 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFF-------TMKPLPCDPSSLPKYPP 433
KD ++E L DP R +R F ++ DP PK
Sbjct: 222 ESKD-------ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKS 274
Query: 434 SKE---FDAKIRDEEARRQGGSKG 454
+ FD + E+ R K
Sbjct: 275 PSDYSNFDREFLSEKPRLSYSDKN 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
+ IG+G + V + QK VA+K ++ D + + E ++ +L H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK--VAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 196 GLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
G++ + LY+V E M +L L + S Q+ + + G+++ S+ ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 313
HRD+ N+L+ +G+ K++DFGLA + S++ W P L + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKK--FSSK 177
Query: 314 VDLWSTGCILAELY----AGKPIMPGRTEVEQLHKIFKL 348
D+WS G +L E++ A P M + E + K +++
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR + EK K+G G + V+ A ++ VA+K ++ ++ SV E ++++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
L H ++KL +VT +Y++ E+M L L S G K ++ + Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G+ R +HRD++ +N+L+ + + KIADFGLA + ++ + + PE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 303 LLLGATYYGTAV---DLWSTGCILAELYA-GKPIMPGRTEVE 340
A +G+ D+WS G +L E+ G+ PG + E
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE- 195
+G+GT+ V R+ K A+K ++ + + + V E +L+ H + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 196 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 254
T C V EY +L S + FSE + + Y +++ L + HS V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 314
RD+K NL++D +G +KI DFGL + + T Y PE+L YG AV
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAV 176
Query: 315 DLWSTGCILAELYAGK 330
D W G ++ E+ G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 8/222 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDH 188
D FE L IG+G + V + + ++ A+K + +++ L+ E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ L + LYLV +Y + DL L S + E + Y+ +++ +D
Sbjct: 61 RWITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 305
H G +HRDIK N+L+D NG +++ADFG D V T Y PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 306 --GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
G YG D WS G + E+ G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 138 IGQGTYSNVYRARDL---DQKKIVA---LKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+G+G Y V++ R + D KI A LKK + ++ A E +IL + H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASH---PGLKFSEAQVKCYMQQLLCGLDH 246
+ L + + LYL+ EY L+G L H G+ F E Y+ ++ L+H
Sbjct: 63 VDL--IYAFQTGGKLYLILEY----LSGGELFMHLEREGI-FMEDTACFYLSEISLALEH 115
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H +G+++RD+K N+L+D G +K+ DFGL + + T+ Y PE+L+
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
+ +G AVD WS G ++ ++ G P + + KI K
Sbjct: 175 SG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLE 195
IG+G+Y+ V R ++I A+K V+ + + + E + ++ E H+ + +H ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
+ L+ V EY+ K E + Y ++ L++ H RG+++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 256 DIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 313
D+K N+L+D+ G +K+ D+G+ D T Y PE+L G YG +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG---TPNYIAPEILRGED-YGFS 176
Query: 314 VDLWSTGCILAELYAGK 330
VD W+ G ++ E+ AG+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 136 DKIGQGTYSNVY--RARDL------------DQKKIVALKKVRFDNLEPESVRFMAREIH 181
+K+G+G + V+ A L Q +VA+K +R D + F+ +EI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGL--KFSEAQ-VKC-- 235
I+ RL + N+I+L G+ S L ++ EYME+ DL S + F+ A +
Sbjct: 70 IMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 236 -----YMQ-QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP 288
YM Q+ G+ + S +HRD+ N L+ N+ +KIADFG++ + Y D +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 289 LTSRVVTL-WYRPPELLLGATYYGTAVDLWSTGCILAELY 327
V+ + W +LLG + TA D+W+ G L E++
Sbjct: 188 QGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR +S + + K+G G + V+ + K VA+K ++ + SV+ E ++++
Sbjct: 3 IPR--ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
L H +++L +VT +Y++ EYM L L S G K ++ + Q+
Sbjct: 57 TLQHDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G+ + + +HRD++ +N+L+ + + KIADFGLA + ++ + + PE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 303 LLLGATYYGTAV---DLWSTGCILAELYA-GKPIMPGRTEVE 340
A +G+ D+WS G +L E+ GK PG + +
Sbjct: 175 ----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 136 DKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
K+G G++ V R K I VA+K ++ D L F+ +E I+ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 193 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAS------HPGLKFSEAQVKC-YMQQLLCGLD 245
+L G+V ++ L +V E LA L S L C Y Q+ G+
Sbjct: 60 RLYGVV---LTHPLMMVTE-----LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLT-SRVVTLWYRPPEL 303
+ S+ +HRD+ N+L+ ++ +KI DFGL + + + + V + PE
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 304 LLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
L T + A D+W G L E+ Y +P G + + L KI
Sbjct: 172 LRTRT-FSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 135 LDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
L+++G+G + VY+ + VA+K ++ +N EP+ + +E ++ L H
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 190 NVIKLEGLVT-SRMSCSLYLVFEYMEH-DLAG-LASH-----PGLKFSEAQVKCYMQ--- 238
N++ L G+ T + +C L FEY+ H DL L + G + + VK +
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 239 ------QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTS 291
Q+ G+++ S +HRD+ N L+ +KI+DFGL+ Y D + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 292 RVVTLWYRPPELLLGATYYG---TAVDLWSTGCILAELYA 328
++ + + PPE +L YG T D+WS G +L E+++
Sbjct: 186 SLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 137 KIGQGTYSNVYRARDL----DQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++G+G + V+ A +Q KI VA+K ++ + + + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHI 69
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-----------PGLKFSEAQVKCYMQ 238
+K G+ L +VFEYM+H DL L +H + +++Q+ Q
Sbjct: 70 VKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 297
Q+ G+ + S+ +HRD+ N L+ N ++KI DFG++ Y D + ++ +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELY 327
+ PPE ++ + T D+WS G +L E++
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 70/259 (27%), Positives = 104/259 (40%), Gaps = 54/259 (20%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRF-DNLEPESVRFMAREIHILRRLDHIN 190
F K+ +G G + V A +D + A+K +R D L V + E IL D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
V+KL + + LY V +Y+ D+ L + F E + Y+ +L ++ H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS--------------------------FYDP 283
G +HRDIK N+LID +G +K+ DFGL + +D
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 284 DQNQPLTSRVVTLWYR--------------------PPELLLGATYYGTAVDLWSTGCIL 323
N R+ TL R PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238
Query: 324 AELYAGKP--IMPGRTEVE 340
E+ G+P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 138 IGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
IG G + V+R + +K VA+K ++ E + F++ E I+ + H N+I+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
EG+VT ++ EYME+ L H G +FS Q+ ++ + G+ +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFY--DPDQNQPLTSRVVTLWYRPPELLLGATYY 310
+HRD+ N+L+++N K++DFGL+ DP+ + + + + PE + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKF 187
Query: 311 GTAVDLWSTGCILAELYA 328
+A D+WS G ++ E+ +
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 6/195 (3%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEG 196
IG+G+Y+ V R +I A+K V+ + + + E + ++ E H+ + L G
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF--LVG 60
Query: 197 LVTSRMSCS-LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
L + + S L+LV EY+ K E + Y ++ L+ H RG+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
D+K N+L+D +G +K+ D+G+ ++ T Y PE+L G YG +VD
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVD 178
Query: 316 LWSTGCILAELYAGK 330
W+ G ++ E+ AG+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
++IG+G + V+ R VA+K R + L P+ +E IL++ H N+++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 196 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 254
G+ T + +Y+V E ++ D G + ++ ++ G+++ S+ +H
Sbjct: 60 GVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS---RVVTLWYRPPELLLGATYYG 311
RD+ N L+ +LKI+DFG+ S + D T ++ W P L G Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGM-SREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YS 174
Query: 312 TAVDLWSTGCILAELYA 328
+ D+WS G +L E ++
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 8/223 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDH 188
+ FE L IG+G + V + + K+ A+K + +++ L+ E +L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ L + +LYLV +Y + DL L S + E + Y+ +++ +D
Sbjct: 61 QWITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 305
H +HRDIK N+L+D NG +++ADFG D + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 306 --GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 346
G YG D WS G + E+ G+ + VE KI
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 8/222 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDH 188
D FE + IG+G + V + ++I A+K + +++ L+ E ++L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFE-YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ L + LYLV + Y+ DL L S + E + Y+ +++ +
Sbjct: 61 QWITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 305
H +HRDIK N+L+D NG +++ADFG + D + V T Y PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 306 --GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
G YG D WS G + E+ G+ + VE KI
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-12
Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 12/181 (6%)
Query: 175 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEA--- 231
+ EI L RL+H N++K+E ++ R + Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 232 -QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290
Q + M+QLLC +++ H + ++HRDIK N+ ++ +G + + DFG A ++ ++
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP----GRTEVEQLHKIF 346
V T+ PE+L G Y D+WS G IL ++ + P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 347 K 347
Sbjct: 385 D 385
|
Length = 501 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 132 FEKLDKIGQGTYSNVYRAR---DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLD 187
EK+ +G G + VY+ + ++ KI VA+K +R + P++ + + E +++ +D
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEH---------DLAGLASHPGLKFSEAQVKCYMQ 238
H +V++L G+ +S + L+ + M + S L +
Sbjct: 68 HPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV-------- 116
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTL 296
Q+ G+ + + ++HRD+ N+L+ +KI DFGLA D D+ + +V
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAEL-------YAGKP 331
W +L Y D+WS G + EL Y G P
Sbjct: 177 WMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL-RRLDHINVIKLEG 196
IG+G++ V A+ K A+K L+ +++ + HI+ R + +K
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV-----LQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 197 LVTSRMSCS----LYLVFEYMEHDLAGLASHPGLK--FSEAQVKCYMQQLLCGLDHCHSR 250
LV S LY V +Y+ L H + F E + + Y ++ L + HS
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNG--GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
+++RD+K N+L+D+ G + + DFGL + ++ ++ T Y PE+L Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP-Y 173
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
VD W G +L E+ G P R E I
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR + + K+GQG + V+ K VA+K ++ + PE+ +E I++
Sbjct: 3 IPRESLRLDV--KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMK 56
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
+L H ++ L +V+ +Y+V E+M L L G Q+ Q+
Sbjct: 57 KLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPP 301
G+ + +HRD++ +N+L+ +N + KIADFGLA D + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 174 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264
LY V EY+ DL G +F E Y ++ GL HS+G+++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 265 DNNGILKIADFGLA--SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCI 322
D+ G +KIADFG+ + +D + T Y PE ++ YG +VD W+ G +
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIAPE-IIAYQPYGKSVDWWAFGVL 190
Query: 323 LAELYAGKPIMPGRTEVEQLHKIFK 347
L E+ AG+ G E E I +
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 49/162 (30%), Positives = 91/162 (56%), Gaps = 15/162 (9%)
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCY 236
E ++ +L H +++L G+ T + +Y+V EYM + L L H G +F +Q+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEM 105
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+ + G+ + S+ +HRD+ N L+D+ G +K++DFGL+ + D+ TS V +
Sbjct: 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSK 162
Query: 297 W---YRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMP 334
+ + PPE+LL + + + D+W+ G ++ E+Y+ GK MP
Sbjct: 163 FPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 6/122 (4%)
Query: 223 HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282
+PG F E + Y Q++ GL+H H R +++RD+K N+L+DN+G ++I+D GLA
Sbjct: 91 NPG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148
Query: 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 342
Q++ T + PELL G Y +VD ++ G L E+ A + P R E++
Sbjct: 149 DGQSKT-KGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARG--PFRARGEKV 204
Query: 343 HK 344
Sbjct: 205 EN 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 53/203 (26%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+ ++G G + V+ + Q K VA+K + + E F+ E ++ +L H +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 195 EGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
G+ T + LY+V E+ME+ L L G K S+ + Q + G+++
Sbjct: 65 YGVCTQQKP--LYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 312
+HRD+ N L+ + G++K++DFG+ + D+ + + + PPE+ + Y +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSS 180
Query: 313 AVDLWSTGCILAELYA-GKPIMP 334
D+WS G ++ E++ GK MP
Sbjct: 181 KSDVWSFGVLMWEVFTEGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 177 AREIHILRRLDHINVIKLEGLVT-SRMSCSLYLVFEYMEHDL-AGLASHPGLKFSEAQVK 234
A E HILR ++H ++I+L+G T ++ +C L+ + DL LA+ + + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAICD--IL 185
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRV 293
+ +L + + H ++HRDIK N+ I++ G + + DFG A F D + N+
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWA 244
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330
T+ PE LL YG AVD+WS G +L E+
Sbjct: 245 GTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 151 DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210
+ D +VA+K +R D + F+ +E+ IL RL N+ +L G+ T L ++
Sbjct: 42 NADAPVLVAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIM 98
Query: 211 EYMEH-DLAG-LASH--------PGLKFSEAQVKCYM-QQLLCGLDHCHSRGVLHRDIKG 259
EYME+ DL L H K YM Q+ G+ + S +HRD+
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 260 SNLLIDNNGILKIADFGLAS------FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 313
N L+ N +KIADFG++ +Y PL R W +LLG + T
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTK 212
Query: 314 VDLWSTGCILAELY 327
D+W+ G L E+
Sbjct: 213 SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 179 EIHILRRLDHINVIKLEGL-VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 237
E +LRRL H V+ L + V ++C LV DL AQV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TL 296
+QLL +D+ H G++HRDIK N+L++ + + DFG A F + P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAE 325
PE+L G Y +VD+WS G ++ E
Sbjct: 327 DTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 51/244 (20%)
Query: 138 IGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
+G G + +V Y + + + VA+K ++ + RE ++ +LDH +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 194 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF-------SEAQVKCYMQQLLCGLDH 246
L G+ LV E LA L P LK+ + +K Q+ G+ +
Sbjct: 61 LIGVCKGEPLM---LVME-----LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---------PLTSRVVTLW 297
S+ +HRD+ N+L+ N KI+DFG++ + PL W
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------W 164
Query: 298 YRPPELLLGATYYGT---AVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCG 350
Y P + YG D+WS G L E Y KP M G + L +L
Sbjct: 165 YAPECI-----NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P 218
Query: 351 SPSE 354
P E
Sbjct: 219 RPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 4/127 (3%)
Query: 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID 265
L+ V EY+ KF E + + Y ++ L H GV++RD+K N+L+D
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130
Query: 266 NNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILA 324
G K+ADFG+ + N T+ T Y PE +L YG +VD W+ G ++
Sbjct: 131 AEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMY 187
Query: 325 ELYAGKP 331
E+ AG+P
Sbjct: 188 EMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 35/238 (14%)
Query: 138 IGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HI 189
+G+G + V RA DQ VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 190 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEHDLAGLASHPGLKFSEAQ 232
N+I L G+ T LY++ EY ++ +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTS 291
V C Q+ G+++ SR +HRD+ N+L+ + ++KIADFGLA +D D + ++
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 347
+ + + PE L Y + D+WS G ++ E++ G P PG VE+L K+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGGSP-YPG-IPVEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287
F+E + + Y +++ L++ HSR V++RDIK NL++D +G +KI DFGL D
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 150
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330
+ + T Y PE+L YG AVD W G ++ E+ G+
Sbjct: 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 52/264 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
+ F + IG+G + V + D KI A+K + + + + + + E +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
V+ L + + + LYL+ E++ DL + FSE + YM + + ++
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLAS-FYDPDQN----QPLTSRVVT------- 295
H G +HRDIK N+LID G +K++DFGL++ F+ + + L +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 296 ------------------LW----------------YRPPELLLGATYYGTAVDLWSTGC 321
W Y PE+ L YG D WS G
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGA 236
Query: 322 ILAELYAGKPIMPGRTEVEQLHKI 345
I+ E G P E KI
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEG 196
IG+G+Y+ V ++I A+K ++ + + + E + ++ E H+ N L G
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS--NHPFLVG 60
Query: 197 LVTSRMSCS-LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
L + + S L+ V E++ K E + Y ++ L+ H RG+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAV 314
D+K N+L+D G +K+ D+G+ + + TS T Y PE+L G YG +V
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSV 177
Query: 315 DLWSTGCILAELYAGK 330
D W+ G ++ E+ AG+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ D FE++ ++G G V + + I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++ G S S+ + E+M+ + E + +L GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 248 HSR-GVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ ++HRD+K SN+L+++ G +K+ DFG++ D N S V T Y PE L
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQ 175
Query: 306 GATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
G T+Y D+WS G L EL G+ PI P + ++L IF G P D + PH
Sbjct: 176 G-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD--GEEGEPH 227
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETL 396
+ +P+ P R V+ D PA+A+ E L
Sbjct: 228 SISPRPRPP-GRPVSGHGMD-SRPAMAIFELL 257
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 2e-11
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 33/233 (14%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
R + +E + KIG G + V+ + ++ K + + L+ + E++++R L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEY-----MEHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
H N+++ ++ + LY++ E+ + ++ G K E + +QLL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLH 129
Query: 243 GLDHCHS-------RGVLHRDIKGSNLLIDN---------------NG--ILKIADFGLA 278
L +CH+ VLHRD+K N+ + NG I KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGK 330
+ S V T +Y PELLL T Y D+W+ GCI+ EL +GK
Sbjct: 190 K--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEG 196
+G+G++ V AR + ++ A+K ++ D L+ + V E IL ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRIL------SLARNHP 56
Query: 197 LVTSRMSC-----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+T C L+ V E++ +F EA+ + Y ++ L H +G
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYY 310
+++RD+K N+L+D+ G K+ADFG+ + N TS T Y PE +L Y
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEMLY 173
Query: 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
G +VD W+ G +L E+ G E + I
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 35/227 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D E LD++G+G Y +VY+ +A+K++R + L+ + E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYM----------EHDLAGLASHPGLKFSEAQVKCYMQQ 239
++ G + ++Y+ EYM L+ V ++
Sbjct: 60 YIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV---VKG 114
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT---- 295
L L H+ ++HRD+K +N+L++ NG +K+ DFG++ + S T
Sbjct: 115 LKF-LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSG-------NLVASLAKTNIGC 164
Query: 296 LWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRT 337
Y PE + Y D+WS G + E+ G+ P T
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 137 KIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++G+G + V+ A K +VA+K ++ L + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLA---------------GLASHPGLKFSEAQVKC 235
+K G+ L +VFEYM+H DL G + +Q+
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV 294
Q+ G+ + S+ +HRD+ N L+ N ++KI DFG++ Y D + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327
+ + PPE ++ + T D+WS G IL E++
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 5/194 (2%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEG 196
+G+GT+ V R+ K A+K ++ + + + V E +L+ H + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 197 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 256
+ + L V EY+ FSE + + Y +++ LD+ HS +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 257 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 316
+K NL++D +G +KI DFGL D + + T Y PE+L YG AVD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDND-YGRAVDW 178
Query: 317 WSTGCILAELYAGK 330
W G ++ E+ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 16/236 (6%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHI 189
+F +G+G + V + K+ A KK+ ++ MA E IL +++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH------PGLKFSEAQVKCYMQQLLCG 243
V+ L +L LV M L H PG F E + Y +L CG
Sbjct: 61 FVVSLA--YAYETKDALCLVLTIMNG--GDLKFHIYNMGNPG--FDEQRAIFYAAELCCG 114
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
L+ +++RD+K N+L+D+ G ++I+D GLA + + + RV T+ Y PE+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRVGTVGYMAPEV 172
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
+ Y + D W GC++ E+ G+ R E + ++ + E+Y K
Sbjct: 173 INNEKYTFSP-DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 41/240 (17%)
Query: 138 IGQGTYSNVYRA--RDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINV 191
+G+G + V +A LD + VA+K ++ D E + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHD-----------LAGLASHPGLKFSEAQVKCY---- 236
I L G+ T LY+V EY H AS + E +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 237 -MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQPL 289
Q+ G++ S+ +HRD+ N+L+ + ++KIADFGLA +Y N
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN--- 193
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 347
R+ W P L Y D+WS G +L E++ G P PG VE+L K+ K
Sbjct: 194 -GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 39/240 (16%)
Query: 138 IGQGTYSNVYRAR----DLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 189
+G+G + V A D D+ K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 190 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEH--DLAGLASHPGLKFSE 230
N+I L G T LY++ EY ME+ D+A + + F +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-MTFKD 138
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPL 289
V C Q+ G+++ S+ +HRD+ N+L+ N ++KIADFGLA + D +
Sbjct: 139 L-VSC-TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 347
T+ + + + PE L Y + D+WS G ++ E++ G P PG VE+L K+ K
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 6/211 (2%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLE 195
IG+G++ V AR ++K A+K ++ + + E M+ +L+ + H ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
+ + + LY V +Y+ F E + + Y ++ L + HS +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
D+K N+L+D+ G + + DFGL + + N ++ T Y PE+L Y T VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-VD 178
Query: 316 LWSTGCILAELYAGKPIMPGRTEVEQLHKIF 346
W G +L E+ G P R E I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-11
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 158 VALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKL--EGLVTSRMSCSLYLVFEYME 214
VA+K +R D E E R RE + RL H N++ L G + L+ VFEY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVFEYVP 62
Query: 215 -HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---L 270
L + + G + M Q+L L H++G++HRD+K N+++ G+
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 271 KIADFGLAS----FYDPDQNQ-PLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILA 324
K+ DFG+ + D D T+ V+ T Y PE L G + DL++ G I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLIFL 180
Query: 325 ELYAGKPIMPGRTEVEQLHK 344
E G+ ++ G + E L++
Sbjct: 181 ECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVY----RARDLDQKKI-VALKKVRFDNLEPESVRFMARE 179
VPR DS L +G G + VY R RD D ++ VA+K + E + F+ E
Sbjct: 3 VPR--DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-ME 59
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLA----SHPGLKFSEAQVK 234
I+ + +H N+++L G+ R+ +++ E M DL P S
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLT--- 114
Query: 235 CYMQQLL-CGLD---HCH---SRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDP 283
M+ LL C D C +HRDI N L+ G + KIADFG+A Y
Sbjct: 115 --MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342
+ ++ + + PPE L + + D+WS G +L E+++ G PGRT E +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 126 PRRADSFEKLDKIGQGTYSNV----------YRARDL------DQKKIVALKKVRFDNLE 169
PR+ +F+ +K+G+G + V + +D +Q +VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 170 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME----------HDLAG 219
F+ +EI I+ RL N+I+L L S L ++ EYME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 220 LASHPGLKFSEAQVKCYMQ-QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
A + +M Q+ G+ + S +HRD+ N L+ N +KIADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 279 -SFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAVDLWSTGCILAELY 327
+ Y D + V+ + W +LLG + TA D+W+ G L E+
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 138 IGQGTYSNVYRA------RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 190
+G+G + V A +D K + K+ D+ + + + E+ +++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 191 VIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC---- 242
+I L G T LY++ EY + PG+ +S K +QL
Sbjct: 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 243 --------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRV 293
G+++ S+ +HRD+ N+L+ + ++KIADFGLA ++ D + T+
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347
+ + + PE L Y + D+WS G +L E++ G PG VE+L K+ K
Sbjct: 198 LPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMA 177
W +PR + + ++GQG++ VY + + VA+K V + E + F+
Sbjct: 1 WELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN 58
Query: 178 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-------PGLKF 228
E +++ + +V++L G+V+ +V E M DL L S PGL
Sbjct: 59 -EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 229 SEAQVKCYMQ-QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQN 286
Q M ++ G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326
+ ++ + + PE L + T D+WS G +L E+
Sbjct: 176 RKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 14/224 (6%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLE 195
IG+G++ V A+ A+K ++ + + E MA +L+ L H ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255
+ + + LY V +Y+ F E + + Y ++ + + HS +++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAV 314
D+K N+L+D+ G + + DFGL + + + TS T Y PE+L Y V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTV 177
Query: 315 DLWSTGCILAELYAGKPIMPGRTEVEQ-----LHKIFKLCGSPS 353
D W G +L E+ G P R +V Q LHK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 71/275 (25%), Positives = 115/275 (41%), Gaps = 32/275 (11%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----ESVRFMAREI 180
PR SF K +G G + V A K A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 181 HILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQ-VKCYM 237
I+ L +H N++ L G T + + ++ EY + DL F + + +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL--TSRVVT 295
Q+ G+ S+ +HRD+ N+L+ + I+KI DFGLA D N + +R+
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 354
W P + Y D+WS G +L E+++ G PG + +K+ K
Sbjct: 208 KWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------- 258
Query: 355 DYWRKSKLPHATIFKPQQPY---KRCVAETFKDFP 386
+ +R ++ HA P + Y K C P
Sbjct: 259 EGYRMAQPEHA----PAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQK-KIVALKKVRFDN---LEPESVRFMAREIHIL 183
+ + F + +G G++ V A ++ VA+K RF+ ++ + V + E IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIK--RFEKSKIIKQKQVDHVFSERKIL 85
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKC-YMQQLLC 242
++H + L G + + LYLV E++ +F V C Y Q++
Sbjct: 86 NYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVL 142
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP-- 300
++ S +++RD+K NLL+D +G +K+ DFG A D +R TL P
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TRTYTLCGTPEY 194
Query: 301 --PELLLGATYYGTAVDLWSTGCILAELYAGKP 331
PE+LL +G A D W+ G + E+ G P
Sbjct: 195 IAPEILLNVG-HGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 292
CY Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347
+ W P + Y T D+WS G +L E+++ G PG E+ + K
Sbjct: 238 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 15/232 (6%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ D FEK+ ++G G V++ I+A K + + ++P + RE+ +L +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++ G S S+ + E+M+ + E + ++ GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 248 HSR-GVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ ++HRD+K SN+L+++ G +K+ DFG++ D N S V T Y PE L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQ 175
Query: 306 GATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIF--KLCGSPSE 354
G T+Y D+WS G L E+ G+ PI P + ++L +F + G P+E
Sbjct: 176 G-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAE 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 70/302 (23%), Positives = 125/302 (41%), Gaps = 51/302 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH- 188
D E ++++G+G Y V + R + I+A+K++R + + + + ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDC 59
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLD 245
+ G + +++ E M+ L GL E + ++ L+
Sbjct: 60 PYTVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 246 HCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-----WYR 299
+ HS+ V+HRD+K SN+LI+ NG +K+ DFG++ + S T+ Y
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG-------YLVDSVAKTIDAGCKPYM 170
Query: 300 PPELL---LGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSED 355
PE + L Y D+WS G + EL G+ P +T +QL ++ + PS
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPS-- 225
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+LP F P+ F+DF L + +R + L+ F
Sbjct: 226 ----PQLPAEK-FSPE----------FQDFVNKC-------LKKNYKERPNYPELLQHPF 263
Query: 416 FT 417
F
Sbjct: 264 FE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 48/181 (26%), Positives = 72/181 (39%), Gaps = 13/181 (7%)
Query: 151 DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210
D +KK++ REI IL+ + H +I L + R ++ +V
Sbjct: 116 DEQRKKVIVKAVTGGKTPG--------REIDILKTISHRAIINL--IHAYRWKSTVCMVM 165
Query: 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 270
+ DL G Q ++LL L + H RG++HRD+K N+ +D
Sbjct: 166 PKYKCDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA 224
Query: 271 KIADFGLASFYDPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG 329
+ DFG A D + P TL PELL Y D+WS G +L E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVK 283
Query: 330 K 330
Sbjct: 284 N 284
|
Length = 392 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 35/238 (14%)
Query: 138 IGQGTYSNVYRAR--DLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 189
+G+G + V A LD++K VA+K ++ D E + ++ E+ +++ + H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEMMKMIGKHK 84
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFS-------------EAQ 232
N+I L G T LY++ EY + PG+++ +
Sbjct: 85 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTS 291
V C Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA + D + T+
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 347
+ + + PE L Y + D+WS G +L E++ G P PG VE+L K+ K
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 137 KIGQGTYSNVYRARDLDQK--KI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
IG+G + +VY+ + + KI VA+K + +F+ E +I+R+ DH +++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 194 LEGLVTSRMSCSLYLVFE---------YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
L G++T +++V E Y++ + L + + Y QL L
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTAL 120
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284
+ S+ +HRDI N+L+ + +K+ DFGL+ + + +
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 137 KIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHIN 190
++G+G + V+ A K +VA+K ++ + ES R RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQH 68
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-PGLKFSE------------AQVKC 235
+++ G+ T L +VFEYM H DL L SH P K Q+
Sbjct: 69 IVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV 294
Q+ G+ + S +HRD+ N L+ ++KI DFG++ Y D + ++
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327
+ + PPE +L + T D+WS G +L E++
Sbjct: 187 PIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL-EG 196
+G G V A+ + + A+K V + + E+ L D +++K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 197 LVTS-----RMSCSLYLVFEYMEHDLAG-------LASHPGLKFSEAQVKCYMQQLLCGL 244
+ LV +Y AG + F E + Q+L +
Sbjct: 100 FAKKDPRNPENVLMIALVLDYAN---AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPEL 303
H HS+ ++HRDIK +N+L+ +NG++K+ DFG + Y + + T +Y PE+
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344
Y A D++S G +L EL K G E +HK
Sbjct: 217 WRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 138 IGQGTYSNVYRA-RDLD---------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
IG+G++ V A R LD QKKIV +K E MA +L+ +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK--------EQKHIMAERNVLLKNVK 54
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
H ++ L + + + LY V +++ F E + + Y ++ L +
Sbjct: 55 HPFLVGLH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS +++RD+K N+L+D+ G + + DFGL Q+ T+ T Y PE++
Sbjct: 113 HSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ----LHKIFKLCGSPSEDYW 357
Y T VD W G +L E+ G P R E LHK L S W
Sbjct: 172 PYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 292
CY Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 335
+ W P + Y D+WS G +L E+++ G PG
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 228 FSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286
FSE + + Y +++ LD+ HS + V++RD+K NL++D +G +KI DFGL D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 150
Query: 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330
+ + T Y PE+L YG AVD W G ++ E+ G+
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
IG+G + +V D K VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLG-DYRGNK-VAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 198 VTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLC-GLDHCHSRGVLHR 255
+ LY+V EYM + L G +C +++ + +HR
Sbjct: 68 IVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 315
D+ N+L+ + + K++DFGL Q+ T ++ W P L + T D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKSD 181
Query: 316 LWSTGCILAELYA-GK---PIMPGRTEVEQLHKIFKL 348
+WS G +L E+Y+ G+ P +P + V ++ K +K+
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 136 DKIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 193
D IG+G + V +AR D ++ A K + + R A E+ +L +L H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 194 LEGLVTSRMSCSLYLVFEYMEH---------------DLA-GLASHPGLKFSEAQVKCYM 237
L G R LYL EY H D A +A+ S Q+ +
Sbjct: 73 LLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
+ G+D+ + +HRD+ N+L+ N + KIADFGL+ + + + R+ W
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRW 189
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYA--GKP 331
L + Y T D+WS G +L E+ + G P
Sbjct: 190 MAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 40/183 (21%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 154 QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213
++ VA+ +R + + F+A E L + DH N+++LEG++T ++ +V EYM
Sbjct: 32 RELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYM 88
Query: 214 EHDL--AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILK 271
+ + L H G + Q+ + L G+ + G +H+ + +L++++ + K
Sbjct: 89 SNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK 147
Query: 272 IADFG------LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 325
I+ F + Y ++ + LW P + ++ +A D+WS G ++ E
Sbjct: 148 ISGFRRLQEDKSEAIY-----TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWE 200
Query: 326 LYA 328
+ +
Sbjct: 201 VMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 138 IGQGTYSNVYRARDLDQKKI------VALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+G G + VY D VA+K +R + E F+ E H++ +H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASH--PGLKFSEAQVKC------- 235
+KL G+ ++ Y++ E ME DL A + P L E C
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 236 -YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-----ILKIADFGLA-SFYDPDQNQP 288
Y++Q+ H +HRD+ N L+ G ++KI DFGLA Y D +
Sbjct: 120 VYLEQM-------H---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKI 345
++ + + PE LL + T D+WS G ++ E L G+ P E L +
Sbjct: 170 EGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 77/272 (28%), Positives = 121/272 (44%), Gaps = 56/272 (20%)
Query: 116 VAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 175
V GE I R F+ L +G+GT+ V A D +K+ A+K VR N+ P+ R
Sbjct: 119 VLGEDIDVSTQR----FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR--NV-PKYTRD 171
Query: 176 MAREIHILRRL------DHINVIKLEGLVTSRMSCSLYLVFEY--------MEHDLAGLA 221
EI + ++ D ++K++ + ++ +Y M+H G
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH---GPF 228
Query: 222 SHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGI----------- 269
SH L AQ+ + Q LD+ H+ ++H D+K N+L++ +
Sbjct: 229 SHRHL----AQI---IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281
Query: 270 -----LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCIL 323
++I D G D+ T+ V T YR PE++LG + Y T D+WS GCI+
Sbjct: 282 PDPCRVRICDLGGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCII 335
Query: 324 AELYAGKPIMPGRTEVEQLHKIFK-LCGSPSE 354
ELY GK + +E LH + K L PSE
Sbjct: 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A+ + L +IG+G + V + I+A+K++R E E R + ++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS----EAQVKCYMQQLLC-- 242
++K G + C ++ E M+ L KF E +++L
Sbjct: 63 PYIVKFYGALFREGDC--WICMELMDISLD--------KFYKYVYEVLKSVIPEEILGKI 112
Query: 243 ------GLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 295
L++ ++HRD+K SN+L+D NG +K+ DFG++ Q ++
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKTRD 167
Query: 296 LWYRP---PELLLGATYYGTAV--DLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLC 349
RP PE + + G V D+WS G L E+ GK P V +QL ++ K
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-- 225
Query: 350 GSP 352
G P
Sbjct: 226 GDP 228
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 292
Y Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 335
+ W P + Y T D+WS G +L E+++ G PG
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 44/209 (21%)
Query: 205 SLYLVFEYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNL 262
S++LV ++ E L SH L E VK + +++ LD H G++ RD+ +N+
Sbjct: 59 SVFLVLQHAEG--GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 263 LIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT-AVDLWSTGC 321
L+D+ G +++ F S + + + Y PE +G T A D WS G
Sbjct: 117 LLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE--VGGISEETEACDWWSLGA 170
Query: 322 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 381
IL EL GK ++ + H PS H T+ P+ V+E
Sbjct: 171 ILFELLTGKTLV-------ECH--------PS------GINTHTTLNIPE-----WVSE- 203
Query: 382 FKDFPAPALALMETLLSIDPADRGSAASA 410
A +L++ LL +P +R A A
Sbjct: 204 ------EARSLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 49/216 (22%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 135 LDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 190
++++G+ + +Y+ +D ++VA+K ++ D P+ +E ++ L H N
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 191 VIKLEGLVTSRMSCSLYLVFEYME----HDLAGLAS-HPGLKFS---EAQVKCYMQ---- 238
++ L G+VT + ++FEY+ H+ + S H + S + VK +
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 239 -----QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSR 292
Q+ G+++ S +H+D+ N+LI +KI+D GL+ Y D +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
++ + + PPE ++ + + D+WS G +L E+++
Sbjct: 187 LLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 135 LDK-IGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
L K +G+G + V +A K VA+K ++ +N +R + E ++L++++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNH 62
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-------------DLAGLAS----------HPG 225
+VIKL G + L L+ EY ++ + L S +P
Sbjct: 63 PHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 226 LK-FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDP 283
+ + + + Q+ G+ + ++HRD+ N+L+ +KI+DFGL+ Y+
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 284 DQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326
D + R+ W L Y T D+WS G +L E+
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 37/235 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKK-VRFDNLEPESVRFMAREIHILRRLDH 188
+ E L +IG GT VY+ R ++A+K+ R N E M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYME------HDLAGLASHP------GLKFSEAQVKC- 235
++K G + VF ME L P G K + A VK
Sbjct: 74 PYIVKCYGYFITDSD-----VFICMELMSTCLDKLLKRIQGPIPEDILG-KMTVAIVKAL 127
Query: 236 -YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
Y+++ GV+HRD+K SN+L+D +G +K+ DFG++ + + ++
Sbjct: 128 HYLKE---------KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCA 178
Query: 295 TLWYRPPELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKI 345
Y PE + Y D+WS G L EL G+ P +TE E L KI
Sbjct: 179 A--YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 138 IGQGTYSNVYRAR--DLDQKKI-VALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIK 193
IG+G + VY D D +KI A+K + R +LE V +E I++ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 194 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
L G+ L +V YM+H DL + + + Q+ G+++ S+
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL---WYRPPELLLGAT 308
+HRD+ N ++D + +K+ADFGLA YD + L W L T
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL---QT 176
Query: 309 Y-YGTAVDLWSTGCILAEL 326
+ T D+WS G +L EL
Sbjct: 177 QKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 138 IGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+G+G + +V A+ + + VA+K ++ D + RE ++ DH NVIKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 195 EGL-VTSRMSCSL---YLVFEYMEH-DLAG--LASHPG---LKFSEAQVKCYMQQLLCGL 244
G+ + SR L ++ +M+H DL L S G + +M + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTSRVVTLWYRPPE 302
++ S+ +HRD+ N +++ N + +ADFGL+ Y D Q S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 303 LLLGATYYGTAVDLWSTGCILAEL-------YAG 329
L Y T D+W+ G + E+ YAG
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 59/296 (19%)
Query: 134 KLDKI-GQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
KL KI G+G + +V + D Q K VA+K ++ D + E ++ DH
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 189 INVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAG--LASHPGLKFSEAQVKCYMQQL 240
NV+KL G V S ++ +M+H DL L S + K +Q L
Sbjct: 61 PNVMKLIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS----RLGGLPEKLPLQTL 115
Query: 241 L-------CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTS 291
L G+++ +R +HRD+ N ++ + + +ADFGL+ Y D Q +
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 350
++ W L Y + D+W+ G + E+ G+ PG VE H+I+
Sbjct: 176 KMPVKWIAIES--LADRVYTSKSDVWAFGVTMWEIATRGQTPYPG---VEN-HEIYDY-- 227
Query: 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406
L H K QP + C+ E + LM + DP DR +
Sbjct: 228 -----------LRHGNRLK--QP-EDCLDELY--------DLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 145 NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204
NV + R L +VA+K +R D + F+ +E+ IL RL N+I+L G+
Sbjct: 40 NVRKGRPL----LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 205 SLYLVFEYMEH-DL------------------AGLASHPGLKFSEAQVKCYMQQLLCGLD 245
L ++ EYME+ DL A +H S + + Q+ G+
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-WYRPPEL 303
+ S +HRD+ N L+ N +KIADFG++ + Y D + V+ + W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 304 LLGATYYGTAVDLWSTGCILAEL 326
L+G + TA D+W+ G L E+
Sbjct: 213 LMGK--FTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 137 KIGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
++G G + V + + +K VA+K ++ DN +P + RE +++++LD+ ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF-------SEAQVKCYMQQLLCGLDHC 247
G+ + S LV E LA L P KF +E + + Q+ G+ +
Sbjct: 62 IGICEAE---SWMLVME-----LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---QPLTSRVVTLWYRPPELL 304
+HRD+ N+L+ KI+DFGL+ D+N + WY P
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 305 LGATYYGTAVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 352
+ + + D+WS G ++ E Y KP M G EV Q+ + + P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 80/333 (24%), Positives = 128/333 (38%), Gaps = 45/333 (13%)
Query: 137 KIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+IG+G ++VY AR +V ++ +N E ++ + E+ + H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
+ T+ L+++ +M + A L ++ SEA + + L GL++ H G
Sbjct: 65 WTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---------PLTSRVVTLWYRPPEL 303
+HR+IK S++LI +G++ ++ GL+ Y +N P S V W PEL
Sbjct: 123 IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS-PEL 179
Query: 304 LLGATY-YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
L Y Y D++S G EL G+ P L K+ SP +
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP----LDITT 235
Query: 362 LPH---------------------ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSID 400
P A +R + K F L+E L D
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295
Query: 401 PADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 433
P R SA+S L FF S L PP
Sbjct: 296 PEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR 299
L L H ++HRD+K SN+L+++ G +K+ DFG++ D N S V T Y
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYM 165
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGK-PI-MPGRTEVEQLH 343
PE L G T+Y D+WS G L E+ G+ PI P E+E +
Sbjct: 166 SPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 197
I +G + VY R + K+ A+K V+ ++ ++ M ++ R D + + K +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN---MVHQVQAER--DALALSKSPFI 66
Query: 198 VT---SRMSCS-LYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
V S S + +YLV EY+ D+ L G F E Y+ ++ LD+ H G+
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGI 125
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLA 278
+HRD+K N+LI N G +K+ DFGL+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 46/268 (17%)
Query: 136 DKIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 193
D IG+G + V RA D K+ A K+ + R A E+ +L +L H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 194 LEGLVTSRMSCSLYLVFEY---------------MEHDLAGLASH-PGLKFSEAQVKCYM 237
L G +R LY+ EY +E D A H + Q+ +
Sbjct: 68 LLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
+ G+ + + +HRD+ N+L+ N KIADFGL+ + + + R+ W
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRLPVRW 184
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEVEQLHKIFKLCGSPSED 355
L + Y T D+WS G +L E+ + G P CG +
Sbjct: 185 MAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------------YCGMTCAE 226
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFK 383
+ KLP ++ ++P + C E ++
Sbjct: 227 LYE--KLPQG--YRMEKP-RNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 66/316 (20%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHI 189
++ + IG+G VY A D + VALKK+R D E + RF+ RE I L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLL--- 241
++ + + + +Y Y+E L + L E K + L
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIF 119
Query: 242 ----CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA----------SFYDPDQNQ 287
+++ HS+GVLHRD+K N+L+ G + I D+G A D D+
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 288 PLTSR-------VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 340
S V T Y PE LLG + D+++ G I
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVI------------------ 220
Query: 341 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ--PYKRCVAETFKDFPAPALALMETLLS 398
L+++ L RK I P + PY ++ P + L+
Sbjct: 221 -LYQMLTLSFPYRRKKGRKISYRD-VILSPIEVAPY--------REIPPFLSQIAMKALA 270
Query: 399 IDPADRGSAASALRSE 414
+DPA+R S+ L+ +
Sbjct: 271 VDPAERYSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 135 LDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
++++G+ + VY+ +Q + VA+K ++ D E E + RL H
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLA------SHPGLKFSEAQVKCYMQ---- 238
N++ L G+VT S+ +F Y H DL S G + VK ++
Sbjct: 69 NIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 239 -----QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL------ASFYDPDQNQ 287
Q+ G++ S V+H+D+ N+L+ + +KI+D GL A +Y N
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
L R W P ++ G + D+WS G +L E+++
Sbjct: 187 LLPIR----WMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 8/204 (3%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
R + E + +G G +V + + + ++A KKV + + + RE+ I+
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++ G + + + + E+M+ G + ++ GL +
Sbjct: 62 SPYIVSFYGAFLNENNICMCM--EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 248 HSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
++ ++HRDIK SN+L+++ G +K+ DFG++ N + V T Y PE + G
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYMSPERIQG 176
Query: 307 ATYYGTAVDLWSTGCILAELYAGK 330
Y D+WS G + EL GK
Sbjct: 177 GK-YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRA----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
D D + +GT+ ++ +++ V +K V+ D+ V + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYG 64
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH----------DLAGLASHPGLKFSEAQVKC 235
L H N++ + V ++++ YM L + L S Q+
Sbjct: 65 LSHQNILPI-LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVH 121
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--------QNQ 287
Q+ CG+ + H RGV+H+DI N +ID +KI D L+ P +N+
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326
P+ W L+ Y +A D+WS G +L EL
Sbjct: 182 PVK------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 15/213 (7%)
Query: 128 RADSFEKLDKIGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+ KL +G G + V++ + D KI K D ++ + + + +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
LDH +++L G+ SL LV + L + H ++ + Q+
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAK 120
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT--LWYRP 300
G+ + ++HR++ N+L+ ++ I++IADFG+A PD + S T W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 301 PELLLGATYYGTAVDLWSTGCILAEL--YAGKP 331
+L G Y D+WS G + E+ Y +P
Sbjct: 181 ESILFGR--YTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
+G+G + +V + I VA+K ++ + E ++ DH NV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 196 GLVTSRMSCSLY----LVFEYMEH-DL------AGLASHPGLKFSEAQVKCYMQQLLCGL 244
G+ + Y ++ +M+H DL + L P ++ VK +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTSRVVTLWYRPPE 302
++ S+ +HRD+ N +++ N + +ADFGL+ Y+ D Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 303 LLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 335
L Y T D+WS G + E+ G+ PG
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 30/200 (15%)
Query: 146 VYRARDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204
VY+ R +K+I VA+K ++ +N E M RE I+ +LD+ ++++ G+ +
Sbjct: 15 VYKMR---KKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--- 67
Query: 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQ--------VKCYMQQLLCGLDHCHSRGVLHRD 256
+L LV ME G P KF + V M Q+ G+ + + +HRD
Sbjct: 68 ALMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 257 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW---YRPPELLLGATYYGTA 313
+ N+L+ N KI+DFGL+ D + +R W + PE + + +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECIN-FRKFSSR 178
Query: 314 VDLWSTGCILAEL--YAGKP 331
D+WS G + E Y KP
Sbjct: 179 SDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 23/209 (11%)
Query: 136 DKIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 193
D IG+G + V +AR D ++ A K + + R A E+ +L +L H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 194 LEGLVTSRMSCSLYLVFEY---------------MEHDLAGLASH-PGLKFSEAQVKCYM 237
L G R LYL EY +E D A ++ S Q+ +
Sbjct: 61 LLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
+ G+D+ + +HRD+ N+L+ N + KIADFGL+ + + + R+ W
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRW 177
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAEL 326
L + Y T D+WS G +L E+
Sbjct: 178 MAIES--LNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 18/153 (11%)
Query: 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
KL K G + VY D+ ++ + + + RE+ IL+ L +
Sbjct: 4 KLLKGGLT--NRVYLLGTKDEDYVL-----KINPSREKGADR-EREVAILQLLARKGLPV 55
Query: 194 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS---R 250
+ L + YL+ E++E + SE + + +QL L H
Sbjct: 56 PKVLASGESDGWSYLLMEWIE-------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283
+ H D+ N+L+D+ IL I D+ A + P
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 132 FEKLDKIGQGTYSNVYRA---RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLD 187
F+K+ +G G + VY+ + ++ KI VA+K++R + P++ + + E +++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 188 HINVIKLEG--------LVTSRM--SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 237
+ +V +L G L+T M C L V E+ + + +
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD------------NIGSQYLLNWC 115
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTSRVVT 295
Q+ G+++ R ++HRD+ N+L+ +KI DFGLA D+ +V
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 296 LWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKP 331
W E +L Y + D+WS G + EL + KP
Sbjct: 176 KWM-ALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 25/182 (13%)
Query: 229 SEAQVKCYMQ------QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282
+E+ YM Q+ G++ S+ +HRD+ N+LI ++KI DFGLA
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 283 PDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEV 339
D N S + L + PE + Y T D+WS G +L E++ G P P
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMN 348
Query: 340 EQLHKIFKLCGSPSEDYWRKSKLPHAT--IFKPQQPYKRCVAETFKDFP--APALALMET 395
EQ + + + +R +K HA+ I++ Q +C E F+ P + + L+
Sbjct: 349 EQFY-------NAIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLVGD 398
Query: 396 LL 397
LL
Sbjct: 399 LL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 141 GTYSNVY--RARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
G + V + + QK KI+ K F+ +EP +H L + D+ N IKL
Sbjct: 27 GKFGKVSVLKHKP-TQKLFVQKIIKAKN--FNAIEPM--------VHQLMK-DNPNFIKL 74
Query: 195 EGLVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
VT+ L+ +Y+ + DL L G K SEA+VK ++QL+ L+ H ++
Sbjct: 75 YYSVTT--LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 254 HRDIKGSNLLID-NNGILKIADFGLA------SFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H DIK N+L D + + D+GL S YD TL Y PE + G
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-----------TLDYFSPEKIKG 180
Query: 307 ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTE---VEQLHK 344
Y + D W+ G + EL GK P E +E L K
Sbjct: 181 HN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 136 DKIGQGTYSNVY--RARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
D+IG G + V A K V +K++R E + F+ +E+ R L+H NV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 194 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQ---QLLCGLDHCH 248
G S LV E+ DL L S+ G+ AQ + ++ GL H
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPEL---- 303
+H D+ N + + +KI D+GLA Y D V L + PEL
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 304 ---LLGA--TYYGTAVDLWSTGCILAELY 327
LL T ++WS G + EL+
Sbjct: 178 GQDLLPKDQTKKS---NIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 5/112 (4%)
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL--TSRVVTL 296
Q+ G+D S+ +HRD+ N+L+ + + KI DFGLA D N + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347
W P + Y D+WS G +L E+++ GK PG + +K+ K
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 23/46 (50%), Positives = 31/46 (67%)
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+K M+Q+L GL H G++HRDIK NLL+ +G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 138 IGQGTYSNVYRAR-------DLDQKKIV-ALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+G+G + V+ A+ + +V AL+K + +NL+ E RE+ + R+L H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELDMFRKLSHK 68
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME-HDLAG--LASHPGLK------FSEAQVKCYMQQL 240
NV++L GL R + Y++ EY + DL A+ + S Q Q+
Sbjct: 69 NVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
G+DH + +HRD+ N L+ + +K++ L+ + L + ++ L +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 301 PELLLGATYYGTAVDLWSTGCILAELY 327
PE + + T D+WS G ++ E++
Sbjct: 187 PEAVQ-EDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 59/240 (24%), Positives = 110/240 (45%), Gaps = 25/240 (10%)
Query: 128 RADSFEKLDKIGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPES-VRFMAREIHIL 183
+ +++ +G G + VY+ + + KI K+ + P++ V FM E I+
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLL 241
+DH ++++L G+ +S ++ LV + M H L + H S+ + + Q+
Sbjct: 64 ASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIA 119
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSRVVTLWYR 299
G+ + R ++HRD+ N+L+ + +KI DFGLA + D+ + ++ W
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-- 177
Query: 300 PPELLLGATYYGTAV---DLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 352
+ L +Y D+WS G + EL + GKP +P R + L K +L P
Sbjct: 178 ---MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 13/140 (9%)
Query: 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 270
E +E D L + L FS Q+ G+ S+ +HRD+ N+L+ + I
Sbjct: 202 EILEEDELALDTEDLLSFS--------YQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 271 KIADFGLASFYDPDQNQPL--TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
KI DFGLA D N + +R+ W P + Y D+WS G +L E+++
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311
Query: 329 -GKPIMPGRTEVEQLHKIFK 347
G PG + +K+ K
Sbjct: 312 LGSSPYPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 80/341 (23%), Positives = 128/341 (37%), Gaps = 61/341 (17%)
Query: 133 EKLDKIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 190
E L IG+G V AR + V ++++ + E V F+ E+H+ + +H N
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
++ + L++V +M + A + +H SE + +Q +L LD+ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFY---DPDQNQ------PLTSRVVTLWYR 299
G +HR +K S++LI +G K+ GL S + Q P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGK-PI--MPG-RTEVEQLHKI---------- 345
P L Y D++S G EL G P MP + +E+L+
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236
Query: 346 ---------------FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPAL 390
L S + R S PY R + F F
Sbjct: 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGE-----SSSHPYNRTFSPHFHHF----- 286
Query: 391 ALMETLLSIDPADRGSAASALRSEFFT-MKPLPCDPSSLPK 430
+E L +P R SA++ L FF +K + +LP+
Sbjct: 287 --VEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 132 FEKLDKIGQGTYSNVYR---ARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+K+ +G G + VY+ D + KI KV +N P++ + + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
V +L G+ ++ ++ LV + M + L + + + + + Q+ G+ +
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSY 124
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELL 304
++HRD+ N+L+ + +KI DFGLA D D+ + +V W +L
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 305 LGATYYGTAVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 352
+ D+WS G + EL + KP +P R + L K +L P
Sbjct: 185 --HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSRV 293
+ Q+ G++ S+ +HRD+ N+L+ I+KI DFGLA +D + ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 335
W P + Y T D+WS G +L E+++ G PG
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 40/210 (19%)
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
R L H N+++ G + LVFEY E DL S +Q+ +Q++ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL-LLLQRMAC 106
Query: 243 ----GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 297
G+ H H LH D+ N + ++ +K+ D+G+ S Y D + + V L
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 298 YRPPEL-------LLGA--TYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIF 346
+ PEL L+ A T ++W+ G L EL+ A +P ++ E L+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVI 222
Query: 347 KLCGSPSEDYWRKSKLPHATIFKPQ--QPY 374
K ++ KL FKPQ PY
Sbjct: 223 KD---------QQVKL-----FKPQLELPY 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 32/168 (19%)
Query: 179 EIHILRRLDHINVIKLEGLVTSRMS--CSLYLVFEY-----------MEHDLAGLASHPG 225
EI LRR+D N++K+ G + + L L+ EY E DL
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDL-------- 119
Query: 226 LKFSEAQVKCYMQQLLC-GLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283
+ K M C GL + + ++++ + L+ N LKI
Sbjct: 120 ----SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI---ICHGLEKI 172
Query: 284 DQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGK 330
+ P V + Y ++L + Y D++S G +L E++ GK
Sbjct: 173 LSSPPF-KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 54/235 (22%)
Query: 134 KLDK-IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI---------- 182
K+DK IG G + VY + I + +NLE E+ + E +
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKI 71
Query: 183 -----LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY- 236
+ +DH+ + K G S C +Y F +E L + F ++KC
Sbjct: 72 ALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEK----LVENTKEIFK--RIKCKN 124
Query: 237 -------MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289
M+ +L L++ H G+ H DIK N+++D N I D+G+AS +
Sbjct: 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE 184
Query: 290 TSRVVTLWYRPPELLLGATYY-------GTAV----DLWSTG-CILAELYAGKPI 332
S+ +R G YY G V DL S G C+L +AG +
Sbjct: 185 YSKEQKDLHR------GTLYYAGLDAHNGACVTRRGDLESLGYCMLK--WAGIKL 231
|
Length = 294 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 3/74 (4%)
Query: 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266
Y V Y+ + L GL+ ++ M+Q+L LD HS G++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 267 -NGILKIADFGLAS 279
+G KI D G A+
Sbjct: 291 GSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYR--ARDL---DQKKIVALKKVRFDNLEPESVRFMARE 179
V R + L ++GQG++ VY ARD+ + + VA+K V E + F+ E
Sbjct: 3 VSR--EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NE 59
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL--------ASHPGLKFSE 230
+++ +V++L G+V S+ +L +V E M H DL ++PG
Sbjct: 60 ASVMKGFTCHHVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 231 AQVKCYMQ-QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP 288
Q M ++ G+ + +++ +HRD+ N ++ ++ +KI DFG+ Y+ D +
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326
++ + + PE L + T+ D+WS G +L E+
Sbjct: 178 GGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 137 KIGQGTYSNVYRA------RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 190
++GQG++ VY +D + + VA+K V E + F+ E +++ + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFL-NEASVMKEFNCHH 70
Query: 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLC--- 242
V++L G+V+ ++ E M L S+ P ++ + Q +++++
Sbjct: 71 VVRLLGVVSQGQPT--LVIMELMTR--GDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 243 ----GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 297
G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D + ++ +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAEL 326
+ PE L + T D+WS G +L E+
Sbjct: 187 WMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.26 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.06 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.46 | |
| PLN02236 | 344 | choline kinase | 96.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.2 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.95 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.03 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.98 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.97 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.53 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.3 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.94 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.6 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 92.77 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.16 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.62 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-90 Score=742.99 Aligned_cols=423 Identities=70% Similarity=1.147 Sum_probs=401.6
Q ss_pred CCCCCCCCCchhhhccCchhhHHhhhhhcccCccCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH
Q 005210 92 GMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE 171 (709)
Q Consensus 92 ~~~~~p~~~~~~~~~~g~p~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~ 171 (709)
+.+++++..++++.+++||.|+..++++++.+|.+++.+.|+.+++||+|+||.||+|++..||+.||+|+|++++.++.
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 45677788888999999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC
Q 005210 172 SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251 (709)
Q Consensus 172 ~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g 251 (709)
...++.|||.||++|+|||||+|.++.+++..+.+|||||||++||..++...+.+|++.++++||.||+.||+|||++|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 99999999999999999999999999999778899999999999999999999999999999999999999999999999
Q ss_pred eeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCC
Q 005210 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331 (709)
Q Consensus 252 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~ 331 (709)
|+|||||.+|||||++|.+||+|||||+++.......+|.+|.|.||+|||+|+|...|+.++|+||+||||.||+.|+|
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99999999999999999999999999999998888889999999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 005210 332 IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411 (709)
Q Consensus 332 pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L 411 (709)
+|+|.++++|+++||++||+|++++|...++|++..|++..+|++++.+.+..+++.+++|+..||.+||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCCCCCCCCCCCCChHHHHhhHHHHHHHcCCCCCCCccccccCCCCCCCCCCCcchhHHHHhHhhhhcccc
Q 005210 412 RSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYN 491 (709)
Q Consensus 412 ~hp~f~~~~~~~~p~~~p~~pp~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (709)
+|+||+..|++|+|+.+|+|+++.|++++.++++.+++.+...++... .++.+.++++++++++++.+.+.+++ +.+
T Consensus 399 ~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~~-~~~~~~~r~~p~~~~~~~~~~~~~~~--~~n 475 (560)
T KOG0600|consen 399 QSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRIR-ERGDRGSRAIPAQPANAESQASPQRR--KSN 475 (560)
T ss_pred cCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccccc-cccccccCCCCCCCCCHHHhcccccc--ccC
Confidence 999999999999999999999999999999999998877544444333 45577889999999999999999988 789
Q ss_pred ccccCCCCCCCccccCCCCcCCCCCCc
Q 005210 492 SKSRSEKFNPHPEEVASGFPIDPPRQS 518 (709)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (709)
..+.+++|.|+++++ .||++++.+..
T Consensus 476 ~~~~s~kf~p~~~~~-~~~~~~~~~~~ 501 (560)
T KOG0600|consen 476 SRSNSEKFPPPEQDG-VGFPIGPSRRS 501 (560)
T ss_pred CcCcccCCCCccccc-cCcccCCcccc
Confidence 999999999988776 89999887764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-62 Score=504.34 Aligned_cols=309 Identities=44% Similarity=0.766 Sum_probs=273.3
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.+.++.|+.++.|++|+||.||+|+++.|+++||+|+++.+.......=.-.|||.+|.+++|||||.+.++.....-+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 34478899999999999999999999999999999999876422211112458999999999999999999988777788
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|||||||++||..++..-..+|...++++++.|+|.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 152 iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC-CC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-PH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l-p~ 364 (709)
...+|..+.|.||+|||+|+|...|++++||||+|||++||++++|+|+|..+.+|+.+||+.+|+|++..|..... |.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 56688899999999999999999999999999999999999999999999999999999999999999999987544 44
Q ss_pred ccccC-CCCccccchhcccCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCCCCCChH
Q 005210 365 ATIFK-PQQPYKRCVAETFKD--FPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKE 436 (709)
Q Consensus 365 ~~~~~-~~~~~~~~~~~~~~~--~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~pp~~~ 436 (709)
...+. +..+|. .+...|.. +++...+|+..||.+||.+|.||+++|+|.||...|+|++|..+|.||...+
T Consensus 311 ~k~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 311 VKKMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred hhccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 43233 444443 34444443 5699999999999999999999999999999999999999999999987543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-60 Score=475.60 Aligned_cols=297 Identities=43% Similarity=0.747 Sum_probs=265.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|..+++||+|.||.||+|++..||+.||||+|+..+..........|||++|+.++|+||+.|+++|-. ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 57899999999999999999999999999999999876554444567799999999999999999999976 6679999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
+|||+.+|...+......|+..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.+... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999999876443 34
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh-cCCCCcccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~-~~lp~~~~~ 368 (709)
+..+.|.||+|||+|+|...|+..+||||+|||++||+-|.|.|+|.++.+|+..||..+|+|.++.|.. ..+|....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 5559999999999999999999999999999999999999999999999999999999999999999976 445555444
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 431 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~ 431 (709)
. ..|. ......|...++++.||+.+||.+||.+|+|+.|+|+|+||+..|.|+.|..+|..
T Consensus 239 ~-~~P~-~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 239 Q-QFPK-PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred h-cCCC-CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 3 1111 11233778899999999999999999999999999999999999999988887744
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-58 Score=466.40 Aligned_cols=285 Identities=34% Similarity=0.591 Sum_probs=251.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.|+.+.++|+|+||+||+|++++||+.||||++.....++...+-.+|||++|++|+|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 57999999999999999999999999999999997666566666667899999999999999999999966 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||++..+..+......+++..++.|+.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.. .+...
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999998888877666799999999999999999999999999999999999999999999999999998864 45567
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc-CCCCc-cc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHA-TI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~-~lp~~-~~ 367 (709)
|.++.|.||+|||++.|...|+..+||||+|||+.||++|.|+|+|.++.+|+..|.+.+|...++...-. ..+.. .+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 88999999999999999888999999999999999999999999999999999999999999887653321 11111 11
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
-.|.......+...++.++..+.||+.+||..||.+|++.+++|.|+||.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 12333334456677888999999999999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=493.05 Aligned_cols=287 Identities=38% Similarity=0.678 Sum_probs=259.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|.++++||.|+||.||+|+.+.++..||||+++.....-+.+-. +||+..|++|+ |||||+|.+++.+... .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 57899999999999999999999999999999999866544444333 48999999998 9999999999987433 899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+|||||+.+|..++..++..|+|..++.||.||+.||+|+|.+|+.|||||||||||..+..|||+|||+|+.+. ...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--Skp 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--SKP 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--cCC
Confidence 999999999999999999899999999999999999999999999999999999999989999999999999874 456
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh-cCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~-~~lp~~~ 366 (709)
+.|.++.|.||+|||+|+....|+.++|||++|||++|+++-+|+|+|.++.+++.+|+.++|+|..+.|.. ..+..+-
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 788999999999999999999999999999999999999999999999999999999999999999999976 5555555
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.|...+.....+...+++.+.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 66655555555677778899999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-57 Score=496.08 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=230.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..|+..+.||+|||+.||.+++..+|..||+|+|.+..+ .....+.+.+||+|.+.|+|||||+++++|++ .+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 569999999999999999999999999999999987644 45667789999999999999999999999988 788999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|+|+|..+.+..+......|+|.+++.|++||+.||.|||+++|||||||..||||+.+.+|||+|||||..+..+.. .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence 999999766655555677899999999999999999999999999999999999999999999999999998875433 3
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
..+.||||.|+|||++.... ++..+||||+|||||.||+|+|||...+..+.+.+|...-.
T Consensus 175 k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------ 235 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------ 235 (592)
T ss_pred cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------------
Confidence 35679999999999998655 79999999999999999999999999999999999965311
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
..+.+++.++++||.+||+.||.+|||++++|.|+||+...
T Consensus 236 -----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 236 -----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred -----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 11236899999999999999999999999999999996543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-56 Score=467.24 Aligned_cols=297 Identities=36% Similarity=0.569 Sum_probs=259.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee---cCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS---RMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~---~~~~~ 205 (709)
...|..++.||+|+||.|+.|.+..+|+.||||++.......-..++..||+.+|+.++|+||+.+++++.. ..-+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456777899999999999999999999999999998554456677888999999999999999999998865 23468
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD- 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~- 284 (709)
+|+|+|+|+.+|...+.... .|++.+++.++.|||.||+|+|+.+|+||||||+|||++.+..+||||||+|+..+..
T Consensus 101 vYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999999988877643 5999999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+|..+.|.||+|||+++....|+.++||||+||||+||++|+++|+|.+..+|+..|...+|+|+++.+.......
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 23456888999999999999999999999999999999999999999999999999999999999999999887655444
Q ss_pred ccccCCC--CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCC
Q 005210 365 ATIFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426 (709)
Q Consensus 365 ~~~~~~~--~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~ 426 (709)
+..+... ...+..+...++++++.+.+||++||.+||.+|+|++|+|+||||.....|.+.+
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 4333221 2223456788899999999999999999999999999999999999887776554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-55 Score=458.80 Aligned_cols=264 Identities=30% Similarity=0.436 Sum_probs=224.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-----HHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----ESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|++||++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4677999999999999999999999999999999998764322 223346799999999999999999999987
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---CcEEEeeccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLAS 279 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGla~ 279 (709)
..+.|||||||+|+-+....-..+.+.|..-+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 67789999999975444433344579999999999999999999999999999999999999876 689999999999
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDY 356 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e-~l~~I~k~~g~p~~~~ 356 (709)
... ....+.+.||||.|.|||++.+. ..|..++||||||||||-+|+|.+||.+..... ...+|.+.-...-+.+
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 875 44567889999999999999753 345669999999999999999999998876555 6677766544444444
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
| ..+++++++||..||.+||+.|||++|+|+||||+..+
T Consensus 406 w-------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 W-------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred h-------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 5 35899999999999999999999999999999999754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=445.41 Aligned_cols=293 Identities=41% Similarity=0.720 Sum_probs=249.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeecC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRM----S 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~----~ 203 (709)
...|+.+++||+|+||+||+|+++.+|+.||||+++....+........||+.+|+.|+|+| ||.|++++.... .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999876543223344579999999999999 999999987732 1
Q ss_pred CeEEEEEeeccccccccccCCC---CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 204 CSLYLVFEYMEHDLAGLASHPG---LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
..+||||||++.+|...+.... ..++...++.++.||+.||+|||+++|+||||||.||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3899999999998877766544 3578899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+.-. ....+..++|.||+|||+|+|...|+..+||||+|||++||++++++|+|..+.+++..|++++|+|+++.|...
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 6532 233677899999999999999989999999999999999999999999999999999999999999999999753
Q ss_pred C-CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 361 K-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 361 ~-lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
. +|.....-+...-.+.+....+..++.+.+|+.+||+++|.+|.||..+|.||||...+.+
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 2 3333221122222345666777778899999999999999999999999999999876443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=433.29 Aligned_cols=260 Identities=32% Similarity=0.474 Sum_probs=227.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||+||.++.++|++.||+|++++... ....++.+..|..||.+++||+||+++..|++ ...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeE
Confidence 37899999999999999999999999999999999987754 44567888999999999999999999877776 7899
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||+||+.|+.+...+...+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||||+..... .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-G 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-C
Confidence 999999998655544454558999999999999999999999999999999999999999999999999999864332 2
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
....+.|||+.|||||++.+.. |+.++|+|||||++|||++|.+||.+.+....+.+|.+.-
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----------------- 241 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----------------- 241 (357)
T ss_pred CccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------------
Confidence 2334579999999999999875 8999999999999999999999999999999999997631
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC----CHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG----SAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp----Ta~e~L~hp~f~~~ 419 (709)
+.....-++.++++||++||+.||++|. .+.++-+||||...
T Consensus 242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred -----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 0111223789999999999999999995 78999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=433.24 Aligned_cols=285 Identities=39% Similarity=0.623 Sum_probs=241.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC---e
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---S 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~---~ 205 (709)
.-.|...+.+|.|+||.||+|....+++.||||++-.+.. .-.+|++||+.++|||||+|.-+|....+. +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4468999999999999999999999999999999865432 123799999999999999998888665444 5
Q ss_pred EEEEEeeccccccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeeccccccc
Q 005210 206 LYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFY 281 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~~~ 281 (709)
+.||||||+.+|...+.. .+..++.-.++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 678999999988776653 45689999999999999999999999999999999999999965 99999999999988
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... ++..++..|..|+|||+++|...|+.++||||+|||++||+-|+|+|+|.+..+|+..|++.+|.|+.+......
T Consensus 177 ~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 543 445778899999999999999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccCCCCccccchhc-ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAE-TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.. ...++..+.-...+.+ ..+..++++.+|+.++|.++|.+|.++.++|.||||.....+
T Consensus 255 ~~-y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PN-YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cc-cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 22 1222222222223333 567899999999999999999999999999999999875443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=388.38 Aligned_cols=286 Identities=41% Similarity=0.740 Sum_probs=251.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
..|...++||+|+||+||+|++.++++.||+|.++.+.-+........|||.+|+.|+|.|||+++++..+ .+.+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35788899999999999999999999999999999876555445567799999999999999999999877 7789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||..+|......-++.+..+.++.+|.|++.||.|||+++++||||||.|+||+.+|.+||+|||+++.++-.- ...
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999888777777789999999999999999999999999999999999999999999999999999875432 234
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHH-hCCCCCCCCChHHHHHHHHHhhCCCChhhhhh-cCCCCccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELl-tG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~-~~lp~~~~ 367 (709)
...+.|.||++|.++.|...|++..|+||.|||++||. .|+|+|+|.+..+|+.+||+.+|+|+++.|.. .++|....
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 45688999999999999999999999999999999997 59999999999999999999999999999965 33332221
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.|.-+....|..+.+.+....+||+.++|.-+|.+|++|+++|+||||+.-
T Consensus 239 -yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 -YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 233333456788888999999999999999999999999999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=436.72 Aligned_cols=264 Identities=34% Similarity=0.516 Sum_probs=226.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|+.+.||.+||+|++++..+ ....++.+..|..||...++|+||+||..|.+ ..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCee
Confidence 47899999999999999999999999999999999998754 56778889999999999999999999988877 7899
Q ss_pred EEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC--
Q 005210 207 YLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-- 283 (709)
Q Consensus 207 yLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~-- 283 (709)
||||||++|+ +..++.. ...|+|.+++.|+.+++.|++.||+.|+|||||||+|+|||..|++||+||||+..+..
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999965 5555554 44899999999999999999999999999999999999999999999999999854311
Q ss_pred ---------------------CCC-----------------------CCccccccccCCCCchhhcCCccCCccccccch
Q 005210 284 ---------------------DQN-----------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWST 319 (709)
Q Consensus 284 ---------------------~~~-----------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSL 319 (709)
+.. ....+.+|||.|||||+|++.. |+..+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHH
Confidence 000 0112468999999999999977 8999999999
Q ss_pred hHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh-cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcc
Q 005210 320 GCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLS 398 (709)
Q Consensus 320 G~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~-~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~ 398 (709)
|||+||||.|.|||.+.+..+...+|.. |.. ...|. -..++++++|||.+||+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~-----------------~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPE-----------------EVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCC-----------------cCcccHHHHHHHHHHhc
Confidence 9999999999999999999999999975 432 11111 12467899999999999
Q ss_pred cCCCCCCC---HHHHHhcccCCCCCCC
Q 005210 399 IDPADRGS---AASALRSEFFTMKPLP 422 (709)
Q Consensus 399 ~DP~kRpT---a~e~L~hp~f~~~~~~ 422 (709)
||++|.- ++||.+||||+...+-
T Consensus 429 -d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred -CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999975 9999999999976543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=421.17 Aligned_cols=257 Identities=29% Similarity=0.411 Sum_probs=225.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+.+.++.||+|..|+||+|+++.|++.+|+|+|. -+.++...+++.+|++|++..+|||||.+|+.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 457888999999999999999999999999999994 45677788899999999999999999999999988433 6999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+++.++.+....++++|.....++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999988877777666789999999999999999999995 89999999999999999999999999999876443
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-----TEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~-----~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
...+.+||..|||||.+.+.. |+.++||||||++++||++|+.||... ...+++..|+. +.|+ .
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP-~------- 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPP-R------- 301 (364)
T ss_pred hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCC-C-------
Confidence 456789999999999999876 899999999999999999999999875 56667776643 2221 1
Q ss_pred CCccccCCCCccccchhcccC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
... .+++++++||..||++||.+|+|+.++|+|||++..
T Consensus 302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 112 389999999999999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=435.94 Aligned_cols=260 Identities=34% Similarity=0.512 Sum_probs=229.2
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (709)
+...+|...+.||+|+|++||+|+++.+++.||||++.+..+ ....++.+.+|-.+|.+| .||.|++|+-.|.+ ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 457899999999999999999999999999999999987654 334456678999999999 89999999887777 77
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+|+||+++ +|+.++..- +.|+|..++.|+.||+.||+|||++|||||||||+|||||.||++||+|||.|+.+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 89999999984 666666554 5899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC------------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 005210 284 DQNQ------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 284 ~~~~------------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
.... ...+.|||..|.+||+|.... .+..+|||+||||||.||.|.|||.+.++.-..++|+++-.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y- 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY- 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-
Confidence 2221 125689999999999988765 69999999999999999999999999999999999987532
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+..+++++.+.|||+++|..||.+|+|+.+|.+||||...
T Consensus 305 ----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 305 ----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 2335789999999999999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=418.88 Aligned_cols=267 Identities=30% Similarity=0.466 Sum_probs=231.5
Q ss_pred CccCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 123 GWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
+|.....++|.+.+.||.|+||+||+|+++.++..||||.|.+..+.+..++.+..||.||+.|+|||||.|++++..
T Consensus 3 ~~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-- 80 (429)
T KOG0595|consen 3 GGSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-- 80 (429)
T ss_pred CCcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--
Confidence 455667899999999999999999999999999999999999988888888999999999999999999999999987
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC------CcEEEeecc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN------GILKIADFG 276 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~------g~vKL~DFG 276 (709)
.+.+|||||||.|+-+..++...+.++|..++.++.||+.||++||+++||||||||.||||+.+ -.+||+|||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 67999999999965444444445589999999999999999999999999999999999999865 468999999
Q ss_pred cccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
+|+.+.+ .....+.||+|.|||||++.... |+.|+|+||+|+|||+|++|++||...+..|++..|-+....
T Consensus 161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~----- 232 (429)
T KOG0595|consen 161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI----- 232 (429)
T ss_pred hhhhCCc--hhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-----
Confidence 9999864 34456789999999999997554 899999999999999999999999999999988866442110
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+......++....+|+..+|+.+|..|.+..+-+.|+++...+
T Consensus 233 ---------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 ---------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ---------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1111123566788999999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=401.54 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=228.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|+.++.||.|+||.|.+++++.+|..||+|++.+... ....++....|..+|+.+.||++++|++.+.+ ...+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEE
Confidence 6789999999999999999999999999999999987643 45677888899999999999999999887766 78999
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||++|+.+.-+.+...+|++..++.|+.||+.||+|||+++|++|||||+|||||.+|++||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999877777777779999999999999999999999999999999999999999999999999999986432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
..+.||||.|+|||++.... |+.++|+|||||++|||++|.+||...+....+++|+..--
T Consensus 198 -T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v----------------- 258 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV----------------- 258 (355)
T ss_pred -EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------------
Confidence 45679999999999998765 89999999999999999999999999999999999986311
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
..+..+++++++||++||++|-.+|. ...++..||||...
T Consensus 259 ------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 259 ------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 12245889999999999999999993 46799999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=405.63 Aligned_cols=294 Identities=37% Similarity=0.629 Sum_probs=240.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
...|+++..||+|+||.||+|....++. .+|||+++.............||+.+++.|+||||+.|..+|... ..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 4569999999999999999997665543 789999876532222223345899999999999999999988764 67
Q ss_pred eEEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC----CcEEEeecc
Q 005210 205 SLYLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN----GILKIADFG 276 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~DFG 276 (709)
.+||+|||.+++|+..+.. ....++...++.++.||+.|+.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 8999999999999987653 23468999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 005210 277 LASFYDPDQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---------EVEQLHKI 345 (709)
Q Consensus 277 la~~~~~~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~---------~~e~l~~I 345 (709)
+++.+...-.. .....+.|.||+|||+|+|...|++++|||++|||++|||+-.|+|.+.+ ..+|+.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99988543222 23456889999999999999999999999999999999999999998864 46789999
Q ss_pred HHhhCCCChhhhhh-cCCCCcc-ccC--CCCccccc----hhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 346 FKLCGSPSEDYWRK-SKLPHAT-IFK--PQQPYKRC----VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 346 ~k~~g~p~~~~w~~-~~lp~~~-~~~--~~~~~~~~----~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
++++|.|+++.|.. .++|+.. ... +..-+..+ +-...+.-++.+.+||.+||++||.+|+|++++|+|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 99999999999976 3455541 111 11122222 2233344566799999999999999999999999999999
Q ss_pred CCCCCC
Q 005210 418 MKPLPC 423 (709)
Q Consensus 418 ~~~~~~ 423 (709)
..++|.
T Consensus 342 ~d~lpp 347 (438)
T KOG0666|consen 342 EDPLPP 347 (438)
T ss_pred cCCCCC
Confidence 887663
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=406.25 Aligned_cols=283 Identities=39% Similarity=0.708 Sum_probs=236.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||.|+||.||+|.+..++..||+|+++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 57899999999999999999999999999999998754322 223356689999999999999999999876 568999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.+++...+...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999998877776656578999999999999999999999999999999999999999999999999997653222 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc--c
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA--T 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~--~ 366 (709)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+++.++.|..+.|........ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34457899999999998766689999999999999999999999999999999999999999999998865321110 0
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...+.. ....+......++.++++||.+||++||.+|+|++|+|+||||
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111110 1111223345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=431.30 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=231.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.+-|++.+.||.|+.|.|-+|++..||+.+|||+|.+. .........+.+||-||+.|.||||++||++|+. ..++|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEE
Confidence 56789999999999999999999999999999999876 4445555678899999999999999999999987 78899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+|+||++++.++.+....++|+|.++..++.||+.|+.|||..+|+||||||+|+|||..+++||+|||+|..-. .+.
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--CCc
Confidence 999999976555555555689999999999999999999999999999999999999999999999999998643 334
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.+.+.||+|.|.|||++.|..+.+.++||||.|||||.||+|+.||.+++-..++.++.+..
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------------ 228 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------------ 228 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------------
Confidence 56677999999999999999989999999999999999999999999998888888886531
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.+....+|+++.+||.+||.+||.+|+|.+|+++|||+....-+.
T Consensus 229 -----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 229 -----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred -----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 122346999999999999999999999999999999998764433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=419.94 Aligned_cols=259 Identities=31% Similarity=0.477 Sum_probs=225.8
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC---hHHHHHHHHHHHHHHhcC-CCceeeeeceEeecC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLD-HINVIKLEGLVTSRM 202 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~ 202 (709)
...+.|++.+.||+|+||+|++|.+..++..||||++...... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-- 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-- 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence 3478999999999999999999999999999999987764221 133456779999999998 9999999999987
Q ss_pred CCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccccc
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASF 280 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~~ 280 (709)
...+|||||||.| +|++.+.. .+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 5669999999996 67777666 6689999999999999999999999999999999999999999 9999999999998
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCc-cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~-~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
.. .....+.+.|||+.|+|||++.+.. +-+.++||||+|||||.|++|+.||...+....+.+|.+.. .
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~--~------- 240 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE--F------- 240 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC--c-------
Confidence 74 2334567789999999999999877 55799999999999999999999999988888888875521 1
Q ss_pred cCCCCccccCCCCccccchhcccCCC-CHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDF-PAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~-s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 241 --------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 --------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 112234 899999999999999999999999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=398.00 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=229.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+.+.|++.+.||+|.|+.||++.+..||+.+|+|+|+...+.....+.+.+|+.|-+.|+|||||+|++.+.. ....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeE
Confidence 4688999999999999999999999999999999998777766678889999999999999999999998866 67899
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccccccCC
Q 005210 208 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~~~~~ 283 (709)
||||+|.|+ +...+.. ..-++|..+-.+++|||++|.|||.+||||||+||+|+|+-+ .-.+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999975 4443333 246899999999999999999999999999999999999964 3369999999999876
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.......++|||.|||||++.... |+..+|||+.|||||-||.|++||.+.+...++++|.+.-...+..+|
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w------ 236 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW------ 236 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc------
Confidence 444556789999999999987765 899999999999999999999999999999999999875444433344
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.++++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 237 -------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 237 -------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 5799999999999999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=397.44 Aligned_cols=284 Identities=36% Similarity=0.596 Sum_probs=232.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 47999999999999999999999999999999998664444455667899999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999887777665556799999999999999999999999999999999999999999999999999987644333333
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC-Cc--c
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HA--T 366 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp-~~--~ 366 (709)
....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+....+..+.+.+...... .. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 4567899999999998765 799999999999999999999999999988888888887777766555321110 00 0
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.+................++..+.+||.+||++||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=423.54 Aligned_cols=282 Identities=31% Similarity=0.544 Sum_probs=230.7
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-C-----CceeeeeceEeecCCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-H-----INVIKLEGLVTSRMSC 204 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-H-----pnIv~l~~~~~~~~~~ 204 (709)
+|++++.||+|+||.|.+|.+..|++.||||+|+.. +....+...|+.||..|+ | -|||+++++|.. .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999754 344555668999999996 4 489999999988 78
Q ss_pred eEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC--cEEEeeccccccc
Q 005210 205 SLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFY 281 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g--~vKL~DFGla~~~ 281 (709)
++|||+|.++.+|..++.... ..|+...++.|+.|||.||.+||+.||||+|||||||||.+-+ .|||+|||.++..
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999999999998876543 3599999999999999999999999999999999999998544 7999999999874
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.. ...+++-+..|+|||+++|.. |+.++||||||||++||++|.|+|+|.++.+|+..|..++|.|+.......+
T Consensus 342 ~q----~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQ----RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CC----cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 32 223678899999999999976 8999999999999999999999999999999999999999999987654322
Q ss_pred CCCccccCC-----C----------------------------Cc-cccchhcccC-CCCHHHHHHHHHhcccCCCCCCC
Q 005210 362 LPHATIFKP-----Q----------------------------QP-YKRCVAETFK-DFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 362 lp~~~~~~~-----~----------------------------~~-~~~~~~~~~~-~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
-... .|.. . .| ..+.+...+. .-...+.|||.+||.+||.+|+|
T Consensus 417 ~~~k-ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 417 KAHK-FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred ccce-ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 1110 0000 0 00 0000111111 12235799999999999999999
Q ss_pred HHHHHhcccCCCCCCCC
Q 005210 407 AASALRSEFFTMKPLPC 423 (709)
Q Consensus 407 a~e~L~hp~f~~~~~~~ 423 (709)
+.++|+||||+...+..
T Consensus 496 p~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSLER 512 (586)
T ss_pred HHHHhcCcccccccccc
Confidence 99999999999765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=411.44 Aligned_cols=266 Identities=30% Similarity=0.450 Sum_probs=226.9
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh------------HHHHHHHHHHHHHHhcCCCceeee
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------------ESVRFMAREIHILRRLDHINVIKL 194 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~------------~~~~~~~rEi~iL~~L~HpnIv~l 194 (709)
...+.|++++.||+|.||.|.+|++..+++.||||++.+..+.. ...+.+.+||.||++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35789999999999999999999999999999999997543211 123578899999999999999999
Q ss_pred eceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEee
Q 005210 195 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 274 (709)
Q Consensus 195 ~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 274 (709)
+++..+.....+|||+|||..+-....-.....|++.+++.|++.++.||+|||.+|||||||||+|+||+.+|++||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 99999888899999999999766655544443499999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----CCCCccccccccCCCCchhhcC---CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 005210 275 FGLASFYDPD----QNQPLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 275 FGla~~~~~~----~~~~~~~~~gT~~Y~APE~l~~---~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k 347 (709)
||.+..+... ....+...+|||.|+|||++.+ ....+.+.|||||||+||.|+.|+.||.+....++..+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998766221 1122334699999999999987 34457899999999999999999999999999999999975
Q ss_pred hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.- ......+++.+.++|||.+||++||++|+++.++..|||.+..
T Consensus 334 ~p---------------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DP---------------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred Cc---------------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 21 0111224578899999999999999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=396.45 Aligned_cols=295 Identities=45% Similarity=0.746 Sum_probs=247.2
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee------c
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS------R 201 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~------~ 201 (709)
..+.|+.+.+||+|.||.||+|+...+|+.||+|++-.++.....-....+|+.+|..|.|+|++.|+++|.. +
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3567999999999999999999999999999999876654333223345689999999999999999988743 2
Q ss_pred CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
....+||||.+|+++|..++.....+|+..+|+.+|.+++.||.|+|...|+|||+|++|+||+.+|.+||+|||+++.+
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 23469999999999999999998889999999999999999999999999999999999999999999999999999776
Q ss_pred CC---CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 282 DP---DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~---~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
.. ......+.++.|.||++||.++|...|+++.|||+.|||+.||+++.|+|.|.++..+++.|-.+||+.+.+.|.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 42 222346778999999999999999999999999999999999999999999999999999999999999999996
Q ss_pred hc-CCCCcccc--CC-CCccccchhcccC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 359 KS-KLPHATIF--KP-QQPYKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 359 ~~-~lp~~~~~--~~-~~~~~~~~~~~~~--~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.. ++|-...+ .| .+.-.+.+....+ .-++++.||++.||.+||.+|+++.++|.|.||...|.|
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 52 23332222 11 0111122222222 125689999999999999999999999999999977554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=398.48 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=217.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|+++++||.|+||.||++.+..+|..||+|.|.+..++....+.+..|+.+|+.|+|||||++++.-..+....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45799999999999999999999999999999999999999988999999999999999999999998443444556999
Q ss_pred EEeeccc-ccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhh--CC--eeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 209 VFEYMEH-DLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHS--RG--VLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 209 VmEy~~g-~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~--~g--IvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
|||||.+ ||...+. .....++|..++.++.|++.||.+||. .. |+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999984 5655543 355679999999999999999999999 44 99999999999999999999999999998
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+... .....+.+|||.||+||++.+.. |+.++|||||||++|||..-++||.|++-.++-.+|.+.-.+|.+.
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~----- 250 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD----- 250 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence 8654 34557889999999999998876 8999999999999999999999999999888888886642222110
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa 407 (709)
...|..+..||..|+..||+.||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 1357789999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=418.00 Aligned_cols=256 Identities=32% Similarity=0.499 Sum_probs=231.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+........+.+.+|++|++.|+|||||.++++|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 67899999999999999999999999999999998887777788889999999999999999999999987 7899999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
.||+.|+|..++... ..++|+.++.++.+++.||.|||+++|+|||+||.||||+..|++|+||||+|+.+.. +....
T Consensus 80 te~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred ehhhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 999999887777664 4899999999999999999999999999999999999999999999999999998764 44556
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
++.-|||.|||||++.+.. |+..+|+||||||||||++|+|||....-.+....|.+.-..|
T Consensus 158 tsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 7788999999999998655 8999999999999999999999999998888888886521111
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+..++..+.+||..+|.+||.+|+|..++|.|||++..
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 12578899999999999999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=399.24 Aligned_cols=285 Identities=38% Similarity=0.647 Sum_probs=231.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 688999999999999999999999999999999987543222 22345689999999999999999999876 568999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 99999998888776665679999999999999999999999999999999999999999999999999987543222 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..++...+.|....|....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--H 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc--c
Confidence 3456789999999999876668999999999999999999999998854 456778888888888888775422110 0
Q ss_pred cCCCC---ccccchhccc--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQ---PYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~---~~~~~~~~~~--~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+.+.. .....+...+ ..+++.+.+||.+||++||.+|+|+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 11100 0001111111 1356789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=420.49 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=229.6
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 203 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 203 (709)
....++|.++++||+|+||+|++|..+.+++.||||+++++.+ ..+.++.++.|..|+... +||.+++|+..|+. .
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--K 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--C
Confidence 3457899999999999999999999999999999999998754 667888899999999988 59999999999977 7
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.++|+||||+.|+.+.+++..+ .|+|..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++.--.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~-~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTD-VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecc-cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 8999999999987766665544 799999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. .....+.||||.|||||+|.+.. |+.++|+|||||+|||||.|.+||+|+++.+....|+..- +
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~----------- 585 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--V----------- 585 (694)
T ss_pred C-CCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--C-----------
Confidence 2 22456789999999999998866 8999999999999999999999999999999999996521 1
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
..+..++.++.+++++||.+||++|.- ++++..||||...
T Consensus 586 ----------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 586 ----------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ----------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 122458899999999999999999975 5889999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=396.82 Aligned_cols=303 Identities=49% Similarity=0.825 Sum_probs=252.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||.|+||.||+|.+..+|..||+|+++...........+.+|+.++++++|+||+++++++.......+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 36789999999999999999999999999999999976543333233456799999999999999999998765456789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+++++...+......+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 999999988777666545679999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~ 366 (709)
..+...+++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.+....|.... ++...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 23344568899999999876668999999999999999999999999999999999999999999888875432 22222
Q ss_pred ccC-CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCCCC
Q 005210 367 IFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 432 (709)
Q Consensus 367 ~~~-~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~p 432 (709)
.+. +..++ ..+...+..+++.+.+||.+||+.||.+|||+.++|+||||...++++.|..+|.+|
T Consensus 244 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 244 KFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred cccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 221 11121 223344555789999999999999999999999999999999999999999888775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=400.63 Aligned_cols=290 Identities=33% Similarity=0.506 Sum_probs=232.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ly 207 (709)
+|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333344456789999999999999999999875432 23589
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC--
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-- 285 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-- 285 (709)
+|||||+++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999998877766543 469999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.......+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+...++..+....|.|....+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122456899999999988652 457899999999999999999999999999999999999889988877654322111
Q ss_pred cccc-C-CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIF-K-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~-~-~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...+ . -.......+...++.+++.+.+||.+||+.||.+|||++++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 0 0000011233445678899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=388.95 Aligned_cols=282 Identities=40% Similarity=0.656 Sum_probs=227.6
Q ss_pred CCeeEEeeecccCceEEEEEEECC-CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEee---cC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTS---RM 202 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~---~~ 202 (709)
.+|++++.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.+ .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999864 578899999876544333334456788877766 69999999998753 12
Q ss_pred CCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+|+||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 456899999999887776643 2345899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+.+|+..++.|..+.|....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 432 2334557899999999987654 7899999999999999999999999999999999999999988887775422
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......+.+. ....+....++++..+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111111111 0112334456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=416.17 Aligned_cols=285 Identities=34% Similarity=0.503 Sum_probs=229.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec------C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR------M 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~------~ 202 (709)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 567999999999999999999999999999999986432 2234799999999999999998876432 1
Q ss_pred CCeEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccc
Q 005210 203 SCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLA 278 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla 278 (709)
...+|+||||+++++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999987755442 3455799999999999999999999999999999999999999665 7999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
+.+.... .....+||+.|+|||++.+...|+.++||||||||||||++|.+||.+.+..+++.+|.+.+|.|..+.+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8764322 23345789999999999887678999999999999999999999999999999999999999999887765
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...-.......+...............++++++||.+||++||.+|+|+.++|+||||.....
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 422111111011111111111122357889999999999999999999999999999986543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=392.96 Aligned_cols=288 Identities=36% Similarity=0.659 Sum_probs=237.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|.+.+.||+|+||.||+|++..++..||||+++...... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 678999999999999999999999999999999987553322 22346689999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+++++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 999999988877766666789999999999999999999999999999999999999999999999999976433222 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc-c
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT-I 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~-~ 367 (709)
.....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+++.++.|..+.|......... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 234477999999999887666899999999999999999999999999999999999999999999888653221110 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+.........+....+.+++++++||.+||+.||.+|+|+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000000112234456899999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=407.04 Aligned_cols=289 Identities=35% Similarity=0.523 Sum_probs=236.2
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ly 207 (709)
+|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++|+||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998654434445567889999999999999999999987532 12789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999998877766543 47999999999999999999999999999999999999999999999999999876544444
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc-
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT- 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~- 366 (709)
..+..++|+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|...+|.|+.+.+.........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 4455678999999999988777899999999999999999999999999999999999999999987665321100000
Q ss_pred cc-CCC-CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 367 IF-KPQ-QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 367 ~~-~~~-~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.. .+. .+............++.+.+||.+||++||.+|||+.++|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00 000 0000111123345788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=407.50 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=224.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|....+||+|+.|.||.|+...+++.||||.+....... .+.+..|+.+|+.++|+|||.+++.|.. ...+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence 456889999999999999999999999999999998765433 3557899999999999999999988866 578999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||||+|+.+..+.... .++|.+|.+++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+......
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 99999987666555433 5999999999999999999999999999999999999999999999999999988766543
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
..+.+|||+|||||++.... |++++||||||+|++||+-|.|||...+....+..|.. .|+|.-.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------------- 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------------- 490 (550)
T ss_pred cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------------
Confidence 45669999999999987655 89999999999999999999999999888888887764 4554321
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....+++.+++||.+||+.|+.+|++|.++|+||||+.
T Consensus 491 ------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 22458999999999999999999999999999999954
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=398.91 Aligned_cols=290 Identities=29% Similarity=0.514 Sum_probs=233.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 67899999999999999999999999999999999765444455566789999999999999999998875421 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 6899999999887776543 5889999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC--
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-- 362 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l-- 362 (709)
......++|+.|+|||++.+.. ++.++|||||||+||+|++|+.||.+.+..+.+.+++..++.|..+.+.....
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2234557899999999998755 79999999999999999999999999999999999999999988776554221
Q ss_pred -------CCccccCCCCccc----cchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 363 -------PHATIFKPQQPYK----RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 363 -------p~~~~~~~~~~~~----~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
+....+....... ..........+..+++||.+||+.||.+|||+.++|+||||.....+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 329 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence 1111100000000 0011112234678999999999999999999999999999986544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=394.53 Aligned_cols=262 Identities=30% Similarity=0.461 Sum_probs=213.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|...+.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|.+|+|||||+++|.........++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345778999999999999999999999999999988763222 667889999999999999999999754432237899
Q ss_pred EEeeccccc-cccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccccCC--C
Q 005210 209 VFEYMEHDL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDP--D 284 (709)
Q Consensus 209 VmEy~~g~L-~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~--~ 284 (709)
+|||+.++. ..++...+..|+|+.++.|.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... .
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999754 4455544448999999999999999999999999999999999999999 79999999999987763 2
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.........||+.|||||++........++|||||||++.||+||++||.. ....+.+..|....-
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~------------- 240 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS------------- 240 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC-------------
Confidence 222344678999999999998532234599999999999999999999987 344444444322110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......+|+++++||.+||.+||.+||||+++|.|||....
T Consensus 241 --------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 241 --------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 112345689999999999999999999999999999999764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=381.18 Aligned_cols=281 Identities=39% Similarity=0.658 Sum_probs=227.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeec---CCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSR---MSC 204 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~---~~~ 204 (709)
+|++++.||+|+||.||+|.+..+++.||||.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999876533322223445677777765 799999999987642 235
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+++||||+.+++...+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998776665442 33589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+++|.+....+.+.+++...+.+....|......
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 223457899999999997755 799999999999999999999999999999999999999888887777532111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
....+.+. ....+....+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1123445556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=396.64 Aligned_cols=288 Identities=32% Similarity=0.510 Sum_probs=231.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 67899999999999999999999999999999999765544555567789999999999999999999886432 13
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5899999999887766532 5899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC---
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK--- 361 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~--- 361 (709)
.......+|+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+++.++.|..+++....
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2234567899999999998755 7999999999999999999999999999999999999999998877654311
Q ss_pred ------CCCccccCCCCcccc----chhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 362 ------LPHATIFKPQQPYKR----CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 362 ------lp~~~~~~~~~~~~~----~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.+..........+.. .........++.+.+||.+||+.||.+|||+.|+|+||||.....+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 000000000000000 0011122356789999999999999999999999999999864333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=405.39 Aligned_cols=282 Identities=24% Similarity=0.336 Sum_probs=221.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|++++.||+|+||.||+|.+..+++.||||+... ..+.+|+.+|+.|+|||||++++++.. ....|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 5679999999999999999999999999999997532 235689999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||++.+++...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 161 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 9999998877666543 368999999999999999999999999999999999999999999999999997543322233
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-------TEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~-------~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
....+||+.|+|||++.+.. |+.++||||||||||||++|+.||.+. ....++..|++..|.++.+++....
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 34568999999999987754 899999999999999999999776543 2345777888888876554321100
Q ss_pred CCCcccc------CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 362 LPHATIF------KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 362 lp~~~~~------~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
......+ ....+..+........++.++.+||.+||++||.+|||+.|+|+||||+..+.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000000 000011111111223467789999999999999999999999999999876544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=392.89 Aligned_cols=288 Identities=34% Similarity=0.565 Sum_probs=234.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 57899999999999999999999999999999998765433344556778999999999999999998875421 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|++||++.+++...+. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999877765543 236999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.+..++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3455789999999999886668999999999999999999999999999999999999988888777654322111
Q ss_pred ccccCCC--CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 365 ATIFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 365 ~~~~~~~--~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
...+... ......+...+...++.+.+||.+||.+||.+|||+.++|.||||.....+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 1111000 001112334445678889999999999999999999999999999875433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=397.85 Aligned_cols=261 Identities=33% Similarity=0.487 Sum_probs=226.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ 205 (709)
....|++.+.||.|.||.||+|+++.||+.||+|++.+.... ......+.+|+.||+.|. |||||.++++|++ ...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 356799999999999999999999999999999999876542 234567889999999998 9999999999988 668
Q ss_pred EEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC----CcEEEeecccccc
Q 005210 206 LYLVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN----GILKIADFGLASF 280 (709)
Q Consensus 206 lyLVmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~DFGla~~ 280 (709)
+|+|||+|.|+.+ +.+... .++|..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++..
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999996544 444433 49999999999999999999999999999999999999743 4799999999998
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
... .......+||+.|+|||++.... |+..+||||+||++|.|++|.+||.+.+..+...+|...-.....
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~------ 259 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS------ 259 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC------
Confidence 765 44567789999999999987644 899999999999999999999999999999988888664333333
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+.+.+++..+++||+.||..||.+|+|+.++|+|||++...
T Consensus 260 -------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 260 -------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred -------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 34467899999999999999999999999999999998653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.46 Aligned_cols=282 Identities=41% Similarity=0.707 Sum_probs=234.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|+||.||+|.+..+|..||+|+++...........+.+|+.+++.++||||+++++++.+ ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4889999999999999999999999999999997654433334556789999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||+++++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcC
Confidence 9999988877665556799999999999999999999999999999999999999999999999999986543222 223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcccc
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIF 368 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~~~ 368 (709)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+++.++.+....|.... .+... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK-P 236 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc-c
Confidence 457789999999998876689999999999999999998755 67778888899999999988887775421 22211 1
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.+..+....+....+.+++.+.+||.+||+.||.+|||++++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 112222223345566789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=381.91 Aligned_cols=287 Identities=38% Similarity=0.689 Sum_probs=237.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.|+||||+++++++.. ...+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEE
Confidence 367899999999999999999999999999999998754322 223346689999999999999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.+++...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 999999988877776656679999999999999999999999999999999999999999999999999997643222 1
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC-cc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH-AT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~-~~ 366 (709)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|....... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22344678999999998877668899999999999999999999999999999999999999999888886421110 00
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+........++......+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0111111112233344578999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=385.00 Aligned_cols=278 Identities=35% Similarity=0.631 Sum_probs=218.5
Q ss_pred EeeecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 135 LDKIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
..+||+|+||.||+|.+. .+++.||||.+...... ..+.+|+.+|+.++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 458999999999999965 46789999998754322 235689999999999999999999876656789999999
Q ss_pred ccccccccccC--------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----cCCCcEEEeecccccc
Q 005210 213 MEHDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASF 280 (709)
Q Consensus 213 ~~g~L~~~~~~--------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGla~~ 280 (709)
+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99877655432 12358999999999999999999999999999999999999 4567999999999987
Q ss_pred cCCCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhh
Q 005210 281 YDPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLC 349 (709)
Q Consensus 281 ~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---------~e~l~~I~k~~ 349 (709)
+..... ......++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+... ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 1234568899999999998877789999999999999999999999976543 46788899999
Q ss_pred CCCChhhhhhcC-CCCccccC--------CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 350 GSPSEDYWRKSK-LPHATIFK--------PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 350 g~p~~~~w~~~~-lp~~~~~~--------~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
|.|....|.... .+...... ........+.......+..+.+||.+||++||.+|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999988886532 11111000 00000011111122356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=377.68 Aligned_cols=283 Identities=40% Similarity=0.696 Sum_probs=232.9
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|+||.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 5889999999999999999999999999999987654433344567789999999999999999999876 67899999
Q ss_pred eeccccccccccC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g~L~~~~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+++...+.. .+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 9999877665543 23579999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++...+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23456789999999988766678999999999999999999999999999999999998888888887754221111000
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.........+......+++++.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000111122334456689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=392.54 Aligned_cols=288 Identities=31% Similarity=0.520 Sum_probs=232.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 67899999999999999999999999999999999765545555667789999999999999999999886422 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5899999999887766543 5899999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC--
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-- 362 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l-- 362 (709)
......++|+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..++..++.+..+.+....-
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 2234567899999999997755 79999999999999999999999999999999999999999888776644211
Q ss_pred -------CCcccc-CCCC---ccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 363 -------PHATIF-KPQQ---PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 363 -------p~~~~~-~~~~---~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
+....+ .+.. .............+..+.+||.+||..||.+|||+.++|+||||.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 000000 0000 00000111223356788999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=389.68 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=216.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 6789999999999999999999999999999999975432 23345668899999999999999999999877 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999986544433334457999999999999999999999999999999999999999999999999999865432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..|... .+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~--------------- 232 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL--------------- 232 (329)
T ss_pred -cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc---------------
Confidence 12457999999999988765 789999999999999999999999998887777666431 10
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||+.||.+|++ +++++.||||..
T Consensus 233 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 233 ------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 011236788999999999999999997 799999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=367.54 Aligned_cols=255 Identities=31% Similarity=0.449 Sum_probs=224.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|-||.||+|+...++-.||+|++.+..+.. ....++.||++|...|+||||+++|++|.+ ...+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 789999999999999999999999999999999997665433 334568899999999999999999999988 78899
Q ss_pred EEEeecccc-cccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEHD-LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|++||...+ ++..+. ....+|++..+..|+.|++.||.|||..+||||||||+|+|++..|.+||+|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999854 444443 355679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....+.|||..|.+||++.+.. ++..+|+|++|++.||++.|.+||...+..+.+.+|.+.--.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-------------- 240 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-------------- 240 (281)
T ss_pred CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--------------
Confidence 23345679999999999998876 799999999999999999999999999999999999874211
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....++..+.|||.+||.++|.+|.+..|++.|||+..
T Consensus 241 ---------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ---------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 12468999999999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.05 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=215.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 479999999999999999999999999999999975432 22345567899999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999987544444444457999999999999999999999999999999999999999999999999999865332
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+... .+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~---------------- 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KL---------------- 215 (291)
T ss_pred cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--Cc----------------
Confidence 22457899999999987755 799999999999999999999999998887777776532 00
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||+.||.+|++ ++++++||||+..
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 112346788999999999999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=384.48 Aligned_cols=266 Identities=29% Similarity=0.404 Sum_probs=226.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||.|.-|+||+|....++..+|+|++.+..+. .....+...|.+||..++||.++.||..|+. ...+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 67899999999999999999999999999999999877653 4556677889999999999999999999987 78999
Q ss_pred EEEeecccc-cccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC--
Q 005210 208 LVFEYMEHD-LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-- 283 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~-- 283 (709)
||||||.|+ |..+.. +++..|++..++.|+.+++.||+|||-.|||+|||||+||||-++|+|-|+||.|+.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999875 444433 3556799999999999999999999999999999999999999999999999998643210
Q ss_pred -------------------------------C-C---------------------CCCccccccccCCCCchhhcCCccC
Q 005210 284 -------------------------------D-Q---------------------NQPLTSRVVTLWYRPPELLLGATYY 310 (709)
Q Consensus 284 -------------------------------~-~---------------------~~~~~~~~gT~~Y~APE~l~~~~~y 310 (709)
. . .....+.|||-.|+|||++.|.. .
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-H 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-H 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-C
Confidence 0 0 01223578999999999999987 5
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHH
Q 005210 311 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPAL 390 (709)
Q Consensus 311 ~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~ 390 (709)
+.++|+|+|||+|||||.|..||.|.+..+.+..|+.. +. .+| ..+.++..++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~---~l-------~Fp-----------------~~~~vs~~ak 365 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ---PL-------KFP-----------------EEPEVSSAAK 365 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC---CC-------cCC-----------------CCCcchhHHH
Confidence 99999999999999999999999999999999998642 10 000 1125778999
Q ss_pred HHHHHhcccCCCCCCC----HHHHHhcccCCCCCCCCC
Q 005210 391 ALMETLLSIDPADRGS----AASALRSEFFTMKPLPCD 424 (709)
Q Consensus 391 dLI~~lL~~DP~kRpT----a~e~L~hp~f~~~~~~~~ 424 (709)
|||++||.+||.+|.. |+||-+||||....++.-
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALI 403 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCChhhe
Confidence 9999999999999999 999999999998776643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=387.53 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=210.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999985432 33445667789999999999999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 7655544444557999999999999999999999999999999999999999999999999998753222 222345679
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
|+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+... .+
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~---------------------- 212 (323)
T cd05571 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EI---------------------- 212 (323)
T ss_pred CccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CC----------------------
Confidence 99999999987755 799999999999999999999999988776666555321 00
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||..||.+|| ++.++|+||||...
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 11235788999999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=392.80 Aligned_cols=261 Identities=29% Similarity=0.412 Sum_probs=214.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999975432 33445667889999999999999999999877 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 287 (709)
||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999986544433333457999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCC
Q 005210 288 ------------------------------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331 (709)
Q Consensus 288 ------------------------------------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~ 331 (709)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCC
Confidence 111347999999999987654 7999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HH
Q 005210 332 IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AA 408 (709)
Q Consensus 332 pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~ 408 (709)
||.+.+..+.+..+....... . + .....+++.+.+||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~--------~------~-----------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL--------Q------F-----------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc--------C------C-----------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999988877776665311000 0 0 0011478899999999997 9999998 99
Q ss_pred HHHhcccCCCC
Q 005210 409 SALRSEFFTMK 419 (709)
Q Consensus 409 e~L~hp~f~~~ 419 (709)
++|+||||...
T Consensus 292 ~ll~h~~~~~~ 302 (364)
T cd05599 292 EIKSHPFFKGV 302 (364)
T ss_pred HHhcCCCcCCC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=384.88 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=229.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
-.+|++.+.||+|+||+|-+|++...|+.||||.|+++.+ +...+-.+.|||+||..|+||||+.+|++|++ .+.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEE
Confidence 3569999999999999999999999999999999998876 45567788999999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||..++.+..++.....|+|.+++.|++||+.|+.|||.++|+|||||.+|||||.++++||+||||+..+.. ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 9999998766666666666899999999999999999999999999999999999999999999999999988753 45
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.++++||+|-|.+||++.|..+-++.+|-|||||+||.|+.|..||.|.+...++.+|-....
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY----------------- 270 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY----------------- 270 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-----------------
Confidence 678899999999999999998889999999999999999999999999999888888854211
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.-+.-|..+.-||+.||-+||++|.|++++..|=|.+-
T Consensus 271 -------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 271 -------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred -------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 11345677899999999999999999999999988864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=371.72 Aligned_cols=268 Identities=29% Similarity=0.402 Sum_probs=229.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC------ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRL-DHINVIKLEGLVTSR 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~------~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~ 201 (709)
-..|+-.+.||.|..++|-+|.+..+|..+|+|+|..... ..+-.+...+|+.||+++ .||||++|.++|+.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes- 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES- 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-
Confidence 3467778899999999999999999999999999874321 122344566899999998 79999999999987
Q ss_pred CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+++|||.|..+.+..++.....++|.+++.+|+||++|+.|||.++||||||||+|||++++.++||+|||+++.+
T Consensus 95 -~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 -DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred -cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 6789999999997766666777778999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCccccccccCCCCchhhc-----CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~-----~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
.+. ..+...||||.|+|||.+. +...|+..+|+|++|||||.||.|.|||--+...-.+..|...-.....+.
T Consensus 174 ~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 174 EPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred CCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 653 4567889999999999985 456689999999999999999999999988888878888876554444444
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 425 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p 425 (709)
| .+++..++|||.+||++||.+|+|++|+|.||||.+......+
T Consensus 252 W-------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 252 W-------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred h-------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 4 5789999999999999999999999999999999654333333
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=391.75 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=213.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..++|+||+++++.+.+ ...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 479999999999999999999999999999999975432 33445677889999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
|||||.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999998754444444455799999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCC
Q 005210 287 --------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 334 (709)
Q Consensus 287 --------------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~ 334 (709)
......+||+.|+|||++.+.. |+.++|||||||+||||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0112458999999999998755 7999999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCC---CCCCHHHHH
Q 005210 335 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA---DRGSAASAL 411 (709)
Q Consensus 335 g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~---kRpTa~e~L 411 (709)
+.+..+.+.+|....... .+. ....+++++++||.+||. +|. .||++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------------~~p-----------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETL--------------IFP-----------PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcc--------------cCC-----------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 998888877775421110 000 012478899999999876 454 458999999
Q ss_pred hcccCCCC
Q 005210 412 RSEFFTMK 419 (709)
Q Consensus 412 ~hp~f~~~ 419 (709)
+||||...
T Consensus 292 ~hp~f~~~ 299 (363)
T cd05628 292 TNPFFEGV 299 (363)
T ss_pred CCCCCCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=385.85 Aligned_cols=262 Identities=29% Similarity=0.401 Sum_probs=218.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 4699999999999999999999999999999999765322 2345667889999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999998765554444455799999999999999999999999999999999999999999999999999986533 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+.+..+........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------- 218 (333)
T ss_pred cCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------
Confidence 3455899999999999876 489999999999999999999999999888777766643211000
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+. .......+++++.+||.+||..+|.+|+|+.++++||||...
T Consensus 219 ~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 RPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 000113578999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=381.97 Aligned_cols=271 Identities=24% Similarity=0.385 Sum_probs=222.0
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
...++|++.+.||.|..++||+|+...++..||||++..+....+ +..+.+|+..|+.++||||++++..|.. ...+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--ccee
Confidence 347899999999999999999999999999999999998766544 7889999999999999999999999987 7789
Q ss_pred EEEEeecccccc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 207 YLVFEYMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 207 yLVmEy~~g~L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
|+||.||.++.. +++.. -...|.|..|..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999996544 43332 1124999999999999999999999999999999999999999999999999987655322
Q ss_pred C-C--CCccccccccCCCCchhh-cCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 285 Q-N--QPLTSRVVTLWYRPPELL-LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 285 ~-~--~~~~~~~gT~~Y~APE~l-~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
. . ....+.+||++|||||++ ..-..|+.|+||||||++..||.+|..||........+..-++ +.|+.-.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~---- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL---- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc----
Confidence 1 1 111456999999999994 4456699999999999999999999999988887776655433 3332100
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+... -.+..+.++..++++|..||.+||.+||||+++|+|+||+..
T Consensus 254 -----t~~~--------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 -----TSGL--------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred -----cccC--------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0000 112234567789999999999999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.52 Aligned_cols=285 Identities=40% Similarity=0.661 Sum_probs=238.2
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||.|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5899999999999999999999999999999998765544555678899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||+.++|...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966777666554567999999999999999999999999999999999999999999999999999876543322334
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC-CccccC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIFK 369 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp-~~~~~~ 369 (709)
...++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+....|...... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 5678999999999887666789999999999999999999999999999999999999999988777542211 111111
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
........+...+++++..+.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 111111113445567889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=374.93 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=211.9
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|+..+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++.. .+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 488999999999999999999999999999998765432 2233456789999999999999999998876 5689999
Q ss_pred Eeecccccc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g~L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+.++.+ ..+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 999986544 33322 2346899999999999999999999999999999999999999999999999999875322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.........+...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 234557899999999998754 79999999999999999999999998765444444333221110
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.||.+|++ ++++++||||...
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 1123457899999999999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=372.81 Aligned_cols=287 Identities=26% Similarity=0.373 Sum_probs=237.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|+.++.||+|.||+|.+|+.+.+++.||||++++..+ ..+.+.....|-.+|+..+||.+..|...|+. ..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceE
Confidence 57899999999999999999999999999999999988754 66778888899999999999999998766655 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||++|+.+...+....-|+|..++.|...|+.||.|||+++||+||||.+|+|+|.+|++||+||||++.--. ..
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-cc
Confidence 99999999765554444455799999999999999999999999999999999999999999999999999975322 23
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
....+.||||.|+|||+|.... |+.++|+|.+|||+|||+||+.||...+...+...|+-.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------------ 383 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------------ 383 (516)
T ss_pred ceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------------------
Confidence 3456789999999999998755 899999999999999999999999998877776666431
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCCCCCC--CCCCCCCCCC--ChHH
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKPLPC--DPSSLPKYPP--SKEF 437 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~~~~~--~p~~~p~~pp--~~~~ 437 (709)
-...+..++++++.||..+|.+||.+|. .|.|+.+|+||....+.. .....|.+.| ..+.
T Consensus 384 -----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSet 452 (516)
T KOG0690|consen 384 -----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSET 452 (516)
T ss_pred -----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccccc
Confidence 1122346899999999999999999996 488999999998754321 1222333433 3456
Q ss_pred HHhhHHHHHH
Q 005210 438 DAKIRDEEAR 447 (709)
Q Consensus 438 ~~~~~~~~~r 447 (709)
|.+.-|+|..
T Consensus 453 DTryFD~EFT 462 (516)
T KOG0690|consen 453 DTRYFDEEFT 462 (516)
T ss_pred chhhhhhhhh
Confidence 7777777663
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=391.28 Aligned_cols=260 Identities=28% Similarity=0.391 Sum_probs=211.1
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58999999999999999999999999999999976533 34456678899999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC---
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--- 286 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~--- 286 (709)
|||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++++||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99998754443333445799999999999999999999999999999999999999999999999999764311000
Q ss_pred -------------------------------------------CCccccccccCCCCchhhcCCccCCccccccchhHHH
Q 005210 287 -------------------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCIL 323 (709)
Q Consensus 287 -------------------------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL 323 (709)
......+||+.|+|||++.+.. |+.++||||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence 0112457999999999987755 79999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhccc--CC
Q 005210 324 AELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI--DP 401 (709)
Q Consensus 324 ~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~--DP 401 (709)
|||++|++||.+.+..+...++........ ......+++++.+||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998887766666543111000 001124789999999997655 44
Q ss_pred CCCCCHHHHHhcccCCC
Q 005210 402 ADRGSAASALRSEFFTM 418 (709)
Q Consensus 402 ~kRpTa~e~L~hp~f~~ 418 (709)
..|++++++|.||||+.
T Consensus 294 ~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 294 LGRNGADDIKAHPFFSE 310 (381)
T ss_pred cCCCCHHHHhcCcccCC
Confidence 55999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=391.66 Aligned_cols=259 Identities=30% Similarity=0.441 Sum_probs=212.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++.+.. ...+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999975432 33455678899999999999999999999877 6789999
Q ss_pred Eeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC---
Q 005210 210 FEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ--- 285 (709)
Q Consensus 210 mEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~--- 285 (709)
||||+++ |...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLI-RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999865 444443 34478999999999999999999999999999999999999999999999999975331000
Q ss_pred -------------------------------------------CCCccccccccCCCCchhhcCCccCCccccccchhHH
Q 005210 286 -------------------------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCI 322 (709)
Q Consensus 286 -------------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~i 322 (709)
.......+||+.|+|||++.+.. |+.++||||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHH
Confidence 00112357999999999988755 7999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCC
Q 005210 323 LAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 402 (709)
Q Consensus 323 L~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~ 402 (709)
||||++|++||.+.+..+...++........ ......+++++.+||.+|+ .||.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHh
Confidence 9999999999999888777766653211100 0012357899999999987 5999
Q ss_pred CCCC---HHHHHhcccCCCC
Q 005210 403 DRGS---AASALRSEFFTMK 419 (709)
Q Consensus 403 kRpT---a~e~L~hp~f~~~ 419 (709)
+|++ ++++++||||...
T Consensus 292 ~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 292 DRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HcCCCCCHHHHhcCCCcCCc
Confidence 9997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=386.32 Aligned_cols=260 Identities=33% Similarity=0.476 Sum_probs=216.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 479999999999999999999999999999999986533 22445667899999999999999999998876 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC--
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-- 285 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-- 285 (709)
||||+.++ |...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999864 4444443 3579999999999999999999999999999999999999999999999999998664332
Q ss_pred --------------------------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH
Q 005210 286 --------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV 339 (709)
Q Consensus 286 --------------------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~ 339 (709)
.......+||+.|+|||++.+.. ++.++||||||||||||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11234567899999999998764 799999999999999999999999998877
Q ss_pred HHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-HHHHHhcccCCC
Q 005210 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFTM 418 (709)
Q Consensus 340 e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-a~e~L~hp~f~~ 418 (709)
+...++....... . ......+++.+.+||..||. ||.+|++ ++++|+||||..
T Consensus 237 ~~~~~i~~~~~~~--------~-----------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESL--------R-----------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCcc--------c-----------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 7777665411100 0 00112378999999999998 9999999 999999999986
Q ss_pred C
Q 005210 419 K 419 (709)
Q Consensus 419 ~ 419 (709)
.
T Consensus 291 ~ 291 (350)
T cd05573 291 I 291 (350)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=400.85 Aligned_cols=282 Identities=24% Similarity=0.335 Sum_probs=220.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC------CceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH------INVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H------pnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.+.| .+|+++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 578999999999999999999999999999999996431 222344568888877755 4588888888653
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCC-------------
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNG------------- 268 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g------------- 268 (709)
...+|||||++.++|+..+... ..+++.+++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4679999999988888766554 479999999999999999999998 5999999999999998765
Q ss_pred ---cEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHH
Q 005210 269 ---ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 269 ---~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I 345 (709)
.+||+|||++.... ...+..+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++..|
T Consensus 283 ~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCc----cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999886432 2234568999999999998765 899999999999999999999999999999999999
Q ss_pred HHhhCCCChhhhhhcCCCCcc-------ccCCCCccccchhcc-----cC--CCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 005210 346 FKLCGSPSEDYWRKSKLPHAT-------IFKPQQPYKRCVAET-----FK--DFPAPALALMETLLSIDPADRGSAASAL 411 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~-------~~~~~~~~~~~~~~~-----~~--~~s~~~~dLI~~lL~~DP~kRpTa~e~L 411 (709)
.+.+|.++..++......... .+.+... ...+... +. ..++.+.|||.+||++||.+|||++|+|
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 999998876654332111110 0000000 0000000 00 1245688999999999999999999999
Q ss_pred hcccCCCCCC
Q 005210 412 RSEFFTMKPL 421 (709)
Q Consensus 412 ~hp~f~~~~~ 421 (709)
+||||.....
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987533
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=390.21 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=211.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|.+++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 479999999999999999999999999999999875432 33445677889999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999998654443333445799999999999999999999999999999999999999999999999999864311000
Q ss_pred --------------------------------------------CCccccccccCCCCchhhcCCccCCccccccchhHH
Q 005210 287 --------------------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCI 322 (709)
Q Consensus 287 --------------------------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~i 322 (709)
......+||+.|+|||++.+.. |+.++||||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchh
Confidence 0001347999999999987754 7999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCC
Q 005210 323 LAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 402 (709)
Q Consensus 323 L~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~ 402 (709)
||||++|.+||.+.+..+.+..|....... .+ .....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~-----------------p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETL--------YF-----------------PDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CC-----------------CCCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999988877777765311000 00 0112478899999999998 777
Q ss_pred CC---CCHHHHHhcccCCCC
Q 005210 403 DR---GSAASALRSEFFTMK 419 (709)
Q Consensus 403 kR---pTa~e~L~hp~f~~~ 419 (709)
+| +|+.++|.||||...
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCC
Confidence 65 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=384.22 Aligned_cols=262 Identities=27% Similarity=0.371 Sum_probs=218.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 469999999999999999999999999999999986533 33455677899999999999999999998876 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++ |...+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999764 55555444457999999999999999999999999999999999999999999999999999876543333
Q ss_pred CccccccccCCCCchhhcC-----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 288 PLTSRVVTLWYRPPELLLG-----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~-----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.....+||+.|+|||++.. ...++.++||||||||||||++|+.||.+.+....+.+|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---------- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 3344578999999999873 3447899999999999999999999999988877777765421000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......++..+.+||..||+ ||.+|+|+++++.||||...
T Consensus 229 ---------------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 229 ---------------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000113578899999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=388.99 Aligned_cols=264 Identities=26% Similarity=0.374 Sum_probs=219.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. .+.+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 46789999999999999999999999999999999975432 23344567789999999999999999988876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||||+.++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999986544444333 3689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCCchhhcCC---ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGA---TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~---~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+||+.|+|||++.+. ..++.++|||||||+||||++|++||.+.+....+.+|........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------- 267 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---------- 267 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC----------
Confidence 233456899999999998753 2478999999999999999999999999988777777754211100
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.+|.+ |+|++++|+||||+..
T Consensus 268 ---------------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 268 ---------------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0011347899999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.29 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=216.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCC-eEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQK-KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++.+.||+|+||.||+|.+..++ ..||||++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 3678999999999999999999876655 6899999875432 23445667899999999999999999999977 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999987554444444557999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+||+.|+|||++.+.. ++.++||||||||+|||++|.+||.+.+....+..+....
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------------- 244 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------------- 244 (340)
T ss_pred ---cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 23457999999999998754 7899999999999999999999999988877777665321
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|+ |++++++||||...
T Consensus 245 -------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 245 -------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011234788899999999999999995 89999999999864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=390.46 Aligned_cols=261 Identities=28% Similarity=0.386 Sum_probs=211.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++.+.. .+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999865322 22344567799999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC---
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ--- 285 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~--- 285 (709)
|||||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999865444443444578999999999999999999999999999999999999999999999999985331100
Q ss_pred ---------------------------------------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHH
Q 005210 286 ---------------------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326 (709)
Q Consensus 286 ---------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~EL 326 (709)
.......+||+.|||||++.+.. ++.++||||||||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeeh
Confidence 00112357999999999987755 79999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-
Q 005210 327 YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG- 405 (709)
Q Consensus 327 ltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp- 405 (709)
++|++||.+.+..+....+....... .......+++.+.+||.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTL-------------------------HIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccc-------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999988777666554211000 00012357889999999987 5999999
Q ss_pred --CHHHHHhcccCCCC
Q 005210 406 --SAASALRSEFFTMK 419 (709)
Q Consensus 406 --Ta~e~L~hp~f~~~ 419 (709)
|+.++|+||||...
T Consensus 292 ~~t~~ell~h~~~~~~ 307 (376)
T cd05598 292 KNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCHHHHhCCCCcCCC
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=373.47 Aligned_cols=277 Identities=36% Similarity=0.650 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEECC--CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
.+||+|+||.||+|.+.. ++..||+|.+...... ..+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 589999999999999654 6688999998754322 2456899999999999999999988765567899999999
Q ss_pred cccccccccC--------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----cCCCcEEEeeccccccc
Q 005210 214 EHDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFY 281 (709)
Q Consensus 214 ~g~L~~~~~~--------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~ 281 (709)
++++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9877655421 22358999999999999999999999999999999999999 46679999999999876
Q ss_pred CCCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhhC
Q 005210 282 DPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCG 350 (709)
Q Consensus 282 ~~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---------~e~l~~I~k~~g 350 (709)
..... ......++|+.|+|||++.+...++.++|||||||++|||++|++||....+ ..++..++..+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43222 1234557899999999998766689999999999999999999999976542 456788889999
Q ss_pred CCChhhhhhcCC-CCccc----cC----CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 351 SPSEDYWRKSKL-PHATI----FK----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 351 ~p~~~~w~~~~l-p~~~~----~~----~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.+..+.|..... +.... +. ................+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 998888865321 11000 00 00000011111122356679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=377.90 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=208.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 33445667889999999999999999998876 67899999999876
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccccc
Q 005210 217 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296 (709)
Q Consensus 217 L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~ 296 (709)
.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 554444445579999999999999999999999999999999999999999999999999997543222 2234457999
Q ss_pred CCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcccc
Q 005210 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 376 (709)
Q Consensus 297 ~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~ 376 (709)
.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 158 ~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------------------- 209 (312)
T cd05585 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------------------- 209 (312)
T ss_pred ccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------------
Confidence 999999998754 7999999999999999999999999888776666654310
Q ss_pred chhcccCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccCCC
Q 005210 377 CVAETFKDFPAPALALMETLLSIDPADRG---SAASALRSEFFTM 418 (709)
Q Consensus 377 ~~~~~~~~~s~~~~dLI~~lL~~DP~kRp---Ta~e~L~hp~f~~ 418 (709)
......+++.+.+||.+||..||.+|+ ++.++|.||||..
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 011235788999999999999999997 5899999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=368.23 Aligned_cols=289 Identities=40% Similarity=0.700 Sum_probs=237.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+|++.+.||+|+||.||+|.+..+++.||||+++..... ......+..|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488999999999999999999999999999999865443 2334456789999999999999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++|...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999666666655444479999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~ 366 (709)
......+++.|+|||.+.+...++.++|||||||++|||++|.++|.+.+..+.+.+++..++.|....|.... ++...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22344678899999998776668899999999999999999999999999999999999988888877775422 11111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
.. ...........+..++..+.+||.+||..||.+|||+.++|.|+||...+.+..
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cc--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 11 111111233445667889999999999999999999999999999998776653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=380.21 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=209.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986532 33445677889999999999999999988876 678999999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 7655544444557999999999999999999999999999999999999999999999999998754222 122334579
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
|+.|+|||++.+.. ++.++|||||||+||+|++|+.||.+.+..+....+... .
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~----------------------- 211 (328)
T cd05593 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--D----------------------- 211 (328)
T ss_pred CcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--C-----------------------
Confidence 99999999987654 799999999999999999999999888776665554321 0
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 418 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~ 418 (709)
......+++.+.+||.+||..||.+|+ ++.++|+|+||..
T Consensus 212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 212 ----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 011235788999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.46 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=208.6
Q ss_pred CeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (709)
+|++++.||+|+||.||+|++. .+++.||+|++..... .....+.+..|+.+|+.+ .|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 5899999999999999999864 5789999999975422 223345677899999999 59999999988876 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 89999999987544443334457999999999999999999999999999999999999999999999999999866443
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH----HHHHHHHHhhCCCChhhhhhc
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV----EQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~----e~l~~I~k~~g~p~~~~w~~~ 360 (709)
........+||+.|+|||++.+...++.++||||||||||||++|+.||...... +....+...
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC------------ 226 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC------------
Confidence 3333345689999999999987666789999999999999999999999754322 122222110
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......+++.+.+||.+||..||.+|+ +++++|+||||+..
T Consensus 227 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 227 -----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0011234788999999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=369.37 Aligned_cols=287 Identities=45% Similarity=0.753 Sum_probs=236.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++||||+++++++.......+||
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 56899999999999999999999999999999999865444333345668999999999999999999887744488999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++|...+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987777665545569999999999999999999999999999999999999999999999999998764322 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~~ 367 (709)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.|....|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3345678999999998876667899999999999999999999999999999999999999999988886432 222221
Q ss_pred cCCCCccccchhcccCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKD--FPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~--~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
..........+...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111222334444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=369.49 Aligned_cols=288 Identities=45% Similarity=0.816 Sum_probs=235.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC------
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM------ 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~------ 202 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 68999999999999999999999999999999998765433222334568999999999999999998875432
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
...+|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 24689999999998887776666689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCC----------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 005210 283 PDQN----------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352 (709)
Q Consensus 283 ~~~~----------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p 352 (709)
.... ...+...+++.|+|||++.+...++.++|||||||++|||++|++||.+.+.......++..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2211 122344678999999998776668999999999999999999999999999999999999999988
Q ss_pred ChhhhhhcC-CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 353 SEDYWRKSK-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 353 ~~~~w~~~~-lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.+..|.... ++..............+...+..+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877665432 2221111111112223444556677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=385.23 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=216.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEE
Confidence 36789999999999999999999999999999999975322 23344567789999999999999999999876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+|||||.++.+..+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999986544333332 3689999999999999999999999999999999999999999999999999987644333
Q ss_pred CCccccccccCCCCchhhcCCc---cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~---~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+||+.|+|||++.+.. .++.++|||||||+||||++|++||.+.+....+.+|......+. +
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------ 268 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F------ 268 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C------
Confidence 2334568999999999987542 378899999999999999999999999988877777754211110 0
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~ 419 (709)
.....++..+++||..||..++.+ |+|+.++|+||||+..
T Consensus 269 ----------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 269 ----------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ----------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 011247889999999999865543 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=368.81 Aligned_cols=291 Identities=48% Similarity=0.876 Sum_probs=240.2
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--- 202 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~--- 202 (709)
....++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34578999999999999999999999999999999999765433333445678999999999999999999886532
Q ss_pred -----CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccc
Q 005210 203 -----SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 277 (709)
Q Consensus 203 -----~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 277 (709)
...+|+||||+++++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 237999999999987777666555799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
+..+............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 98765433333334466888999999876655789999999999999999999999999999999999999998887777
Q ss_pred hhcC-CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 358 RKSK-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 358 ~~~~-lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.... .+......+.....+.+...+..+|..+.+||..||..||.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 5422 1111112222223334445566789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=376.95 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=215.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||++.+..+++.||||++.... ........+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 47999999999999999999999999999999997532 233345567889999999999999999998876 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999976 455555444557999999999999999999999999999999999999999999999999999766443332
Q ss_pred CccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------- 227 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 2334579999999999863 3457889999999999999999999999988777777664321100
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~ 419 (709)
. +......++..+++||.+||..++.+ |+++.++|+||||...
T Consensus 228 -----~--------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 228 -----Q--------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -----c--------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0 11122348899999999999765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.12 Aligned_cols=282 Identities=41% Similarity=0.720 Sum_probs=230.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++++.||.|+||.||+|.+..++..||||++............+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4899999999999999999999999999999987654444444567789999999999999999999876 67899999
Q ss_pred eeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||+.+++...+.. ....+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++..+.... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 9998776665433 34568999999999999999999999999999999999999999999999999987654322 222
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~~~ 368 (709)
....+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.++.+.+.++++..+.+....|.... ++.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 344678999999998876667889999999999999999999999999999999999999988777664311 1100000
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.+. .....+....+.+++.+++||.+||+.||.+|||++++|.||||
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 01112233345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=378.61 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=210.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
+.||+|+||.||++.+..+|..||+|+++.... .......+.+|+.+++.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 33445667789999999999999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 76555444445579999999999999999999999999999999999999999999999999987532221 22234579
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 99999999987654 79999999999999999999999998887766666542100
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||..||.+|+ ++.++|+|+||...
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 11235788999999999999999998 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=383.17 Aligned_cols=261 Identities=28% Similarity=0.394 Sum_probs=213.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++..++||||+++++.+.. ...+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 47999999999999999999999999999999997542 233455677889999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
|||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999998754444444445799999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCC
Q 005210 287 --------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 334 (709)
Q Consensus 287 --------------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~ 334 (709)
......+||+.|+|||++.+.. |+.++|||||||+||||++|++||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCC
Confidence 0112457999999999988755 7999999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC---CHHHHH
Q 005210 335 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG---SAASAL 411 (709)
Q Consensus 335 g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp---Ta~e~L 411 (709)
+.+..+.+.+|....... .+. ....+++.+.+||.+|+. ||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------------~~p-----------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETL--------------VFP-----------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCce--------------ecC-----------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 988877777665310000 000 012378899999999874 999998 489999
Q ss_pred hcccCCCC
Q 005210 412 RSEFFTMK 419 (709)
Q Consensus 412 ~hp~f~~~ 419 (709)
+||||...
T Consensus 292 ~hp~f~~~ 299 (360)
T cd05627 292 SHPFFEGV 299 (360)
T ss_pred cCCCCCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.50 Aligned_cols=285 Identities=54% Similarity=0.964 Sum_probs=241.1
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.......+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78899999999999999999999999999999876433344456778999999999999999999987632378999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
|+++++...+......+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99988877776655689999999999999999999999999999999999999999999999999998765443333445
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCccccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~~~~~ 370 (709)
..++..|+|||.+.+...++.++|||||||++|||++|++||.+.+....+..++..++.+....|.... +.....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 5778999999988776668999999999999999999999999999999999999999999888775432 222233333
Q ss_pred CCccccchhcccCCC-CHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 371 QQPYKRCVAETFKDF-PAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~-s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......+.+.+..+ +..+.++|.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 344444445555565 9999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=360.95 Aligned_cols=281 Identities=36% Similarity=0.597 Sum_probs=227.9
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
|++++.||+|+||.||+|.+..++..||+|+++......... ...+|+.++.++. |+||+++++++.+.....+|+||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678999999999999999999999999999987543333322 3347999999884 99999999998875447899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||++++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++. +.+||+|||++..+.... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 99999888777665557999999999999999999999999999999999999999 999999999998664322 223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
...++..|+|||++.....++.++|||||||++|||++|.+||.+.+..+.+..+....+.+....+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45679999999987665667899999999999999999999999999999999998888888775543322111111111
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......+......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111112233345679999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.94 Aligned_cols=284 Identities=38% Similarity=0.668 Sum_probs=228.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||.|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 678999999999999999999999999999999987543221 12335689999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 999999888776665555789999999999999999999999999999999999999999999999999875432211 1
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhcCCCC-cc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLPH-AT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~~lp~-~~ 366 (709)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+ ..+++..+.+..+.+..+.|....... ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2233568899999998876668899999999999999999999998776 677888888999999888875432111 11
Q ss_pred ccCCCCccccchhcccCCCC--HHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFP--APALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s--~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...........+......++ ..+.+||.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000111223333455 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=374.79 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=212.3
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCC-ceeeeeceEeecCCCeEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHI-NVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~Hp-nIv~l~~~~~~~~~~~lyL 208 (709)
+|++++.||+|+||.||+|.+..+++.||||++..... .....+.+..|+.++..+.|+ +|+++++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 58999999999999999999999999999999986432 334456677899999999765 57888888876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999875544444444579999999999999999999999999999999999999999999999999987532211 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (324)
T ss_pred eeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 33457999999999998755 79999999999999999999999999888777777653110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-----~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||.+||.+|++. .++++||||..
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1123578899999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=374.32 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=211.2
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHH---HhcCCCceeeeeceEeecCCCeEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHIL---RRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL---~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
|++++.||+|+||.||+|.+..+++.||||+++.... .....+.+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 7889999999999999999999999999999975432 233445666777665 45689999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++.+...... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 99999997655444433 36999999999999999999999999999999999999999999999999998754222 12
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.... +
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~--------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--V--------------- 218 (324)
T ss_pred cccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------
Confidence 234567999999999987754 7999999999999999999999999998887777665421 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||+.||.+|| ++.++++||||...
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 01235788999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=362.02 Aligned_cols=282 Identities=38% Similarity=0.693 Sum_probs=232.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||.|++|.||+|.+..+|..||||+++..... .....+.+|+.+++.++|+||+++++++.. .+.+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 589999999999999999999999999999999765432 223456689999999999999999999987 57899999
Q ss_pred eeccccccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+++...+.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+..... .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 999988777655433 4689999999999999999999999999999999999999999999999999976543222 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+|..|++||++.+...++.++|||||||++|+|++|++||.+.+..+.+.+++.....|....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23446789999999987766678999999999999999999999999999999999999999999888865432111110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
..............+.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000001112233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=376.92 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=208.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 369999999999999999999999999986432 23345567789999999999999999988876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
++.+.........+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 76555444445579999999999999999999997 79999999999999999999999999998754322 12233457
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||+||+|++|+.||.+.+..+....+.... .
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--I--------------------- 213 (325)
T ss_pred CCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--C---------------------
Confidence 999999999987754 7999999999999999999999999887766665553210 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~ 418 (709)
.....+++++.+||.+||+.||.+|+ ++.++|+||||..
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 01234788999999999999999997 9999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.98 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=234.6
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
+.++=|.+.+.||+|.|++|.+|++.-||..||||+|.+..++.-....+..|+..|+.++|||||+||+++.. ...+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceE
Confidence 34677999999999999999999999999999999999988887777889999999999999999999999866 5689
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeecccccccCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPD 284 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~ 284 (709)
|||+|+-++ +|.+.+......+.|.-++.|+.||+.|+.|||+..||||||||+|+.+- .-|-|||+|||++..+.+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999985 78888877777899999999999999999999999999999999998765 6789999999999888654
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
+.+++.||+..|-|||+|+|..+..+++||||||||||-|+||++||...++.|.+-+|+..-
T Consensus 173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--------------- 235 (864)
T KOG4717|consen 173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--------------- 235 (864)
T ss_pred --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc---------------
Confidence 456788999999999999999877899999999999999999999999999999999987521
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+..++.++++||..||..||.+|.|.+++..++|++..
T Consensus 236 --------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 236 --------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred --------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 12334688999999999999999999999999999999864
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=359.01 Aligned_cols=283 Identities=33% Similarity=0.612 Sum_probs=226.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 47999999999999999999999999999999987543333333456789999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||++++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999888777665555799999999999999999999999999999999999999999999999999987643321 22
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh---hhhcCCCCcc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY---WRKSKLPHAT 366 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~---w~~~~lp~~~ 366 (709)
....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++...... |.........
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3446789999999988766688999999999999999999999999988888777776665443321 1110000000
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
. .+.......+...+.+++..+.+||.+||+.||++|||+.++|.||||
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 S-IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred c-CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 011000111233456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=375.10 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=208.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999975432 233455667889998876 79999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 87544444444457999999999999999999999999999999999999999999999999998754322 12234457
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..|.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (320)
T cd05590 158 GTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--V--------------------- 213 (320)
T ss_pred cCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C---------------------
Confidence 999999999987654 7999999999999999999999999998888777775311 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa------~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||+.||.+|+++ +++++||||..
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 0112468889999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=371.64 Aligned_cols=284 Identities=23% Similarity=0.307 Sum_probs=215.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999987542 34455678899999999999999999999877 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999765554444445799999999999999999999986 6999999999999999999999999999765322
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh-cCCC--C
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLP--H 364 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~-~~lp--~ 364 (709)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+-..........+.. ...+ .
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223457899999999988755 79999999999999999999999988766554332211100000000000 0000 0
Q ss_pred cccc-------CCCCcccc----chhcc-----cCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIF-------KPQQPYKR----CVAET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~-------~~~~~~~~----~~~~~-----~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.... .+...... ..... ...+++++.+||.+||++||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 00000000 00000 12367899999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.09 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=209.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 369999999999999999999999999976432 234455677899999876 89999999999977 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 875554444444579999999999999999999999999999999999999999999999999987543222 2234557
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (321)
T cd05591 158 GTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--V--------------------- 213 (321)
T ss_pred cCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 899999999987654 7999999999999999999999999999888877775411 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCC-------CHHHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRG-------SAASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-------Ta~e~L~hp~f~~ 418 (709)
.....++.++.+||.+||+.||.+|+ ++.++++||||..
T Consensus 214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 01123678899999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=379.30 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=215.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 5789999999999999999999999999999999875322 23344567789999999999999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999986544433333 35899999999999999999999999999999999999999999999999999876543333
Q ss_pred CccccccccCCCCchhhcCCc---cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 288 PLTSRVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~---~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+||+.|+|||++.+.. .|+.++|||||||+||||++|++||.+.+......+|........
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------- 267 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------- 267 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-----------
Confidence 334568999999999987532 378999999999999999999999999988777777754211100
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||..||..++.+ |++++++++|+||+..
T Consensus 268 --------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 268 --------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred --------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0112368899999999999844433 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=363.20 Aligned_cols=289 Identities=45% Similarity=0.726 Sum_probs=228.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC-----
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----- 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----- 202 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 367899999999999999999999999999999998755433333334568999999999999999999876532
Q ss_pred -CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 -SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 -~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
....|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 2467999999999887777666667999999999999999999999999999999999999999999999999999766
Q ss_pred CCCCC---CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 282 DPDQN---QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~~~~---~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..... ......+++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.+.+|..+.+.|.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 43221 122345678999999998776667899999999999999999999999999888888888888887776654
Q ss_pred hcCCCC-ccccCCCCccccchhccc--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 359 KSKLPH-ATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 359 ~~~lp~-~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...... ...+.............. ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 321110 000010011111111111 1235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=375.60 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=208.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++.. .+.+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 567899999999999999999999999999999986543 33445678899999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999997654321 245788899999999999999999999999999999999999999999999998764322 22
Q ss_pred ccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 289 LTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+||..|+|||++.. ...++.++|||||||+||||++|+.||......+....+.......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------ 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------------
Confidence 345589999999998743 2334568999999999999999999997433222211111110000
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
.......++..+.+||.+||..||.+|||+.++|+||||.....
T Consensus 293 -------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 293 -------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred -------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 01122457889999999999999999999999999999987543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=372.16 Aligned_cols=286 Identities=30% Similarity=0.515 Sum_probs=230.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 57899999999999999999999999999999998755444455566778999999999999999999876422 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 6899999999887776543 3899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
. ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+.++.+.++.|..+++.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 223456889999999998755 7999999999999999999999999999999999999999999877654321110
Q ss_pred ccccC--------------CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 365 ATIFK--------------PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 365 ~~~~~--------------~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
..... +...+...........++.+++||.+||+.||.+|||+.++|.||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 00000 000000000111223567799999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=412.12 Aligned_cols=266 Identities=29% Similarity=0.386 Sum_probs=233.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.|.+++++.|+++||+|++++-. +.......|..|..||..-+.+-||+|+..|.+ ..++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~L 150 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYL 150 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccce
Confidence 3789999999999999999999999999999999997632 234455678899999999999999999888877 7899
Q ss_pred EEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||. |||+.++...+ +++|..++.|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.|..++.+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999997 57888888777 89999999999999999999999999999999999999999999999999999888777
Q ss_pred CCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 286 NQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.-.....||||.|++||+|.. ...|++.+|+|||||++||||.|..||...+.++.+.+|...-.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~----------- 298 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE----------- 298 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-----------
Confidence 666778899999999999862 35699999999999999999999999999999999999976410
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccCCCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMKPLP 422 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~e~L~hp~f~~~~~~ 422 (709)
.|. +. ...++|..+++||+++|+ +|+.|.. ++++-.||||....+.
T Consensus 299 -----~l~--------FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 299 -----SLS--------FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred -----hcC--------CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 000 00 113599999999999998 6999998 9999999999987664
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=371.01 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=212.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyL 208 (709)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+ .|++|+++++++.. ...+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 58899999999999999999999999999999986532 233345566788888877 58899999988876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999865444333344579999999999999999999999999999999999999999999999999997543221 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred cccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 33557899999999998755 79999999999999999999999999888777777654210
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....++.++.+||.+||++||.+|++ ..++++||||...
T Consensus 219 -----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 219 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 112357889999999999999999998 4899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=362.18 Aligned_cols=286 Identities=41% Similarity=0.739 Sum_probs=233.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|++|.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999999999999999987654433444567789999999999999999999876 6789999
Q ss_pred EeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+++++...+... ...+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 999998777665442 334688999999999999999999999999999999999985 5679999999997653321 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~ 366 (709)
..+...+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+.+++...+.|....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22345678999999998776667899999999999999999999999999999999999999999888886421 11111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+... ........+.+++.+.+||.+||+.||++||++.++|+||||...
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 1111100 112233346788999999999999999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=383.25 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=230.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|+.++.||+|+||.+++++++..++.|+||+|..........+....|+.+++++.|||||.+++.|... ++.++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 5789999999999999999999999999999999998877666666778999999999999999999999772 455999
Q ss_pred EEeeccccccc-cccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHDLAG-LASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~L~~-~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||+||+|+.+. .+.. ++..|+|..+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999976544 4433 34679999999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
....+.+||+.||+||++.+.. |+.++|||||||++|||++-++.|.+.+...++.+|++.+..|.+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------ 227 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------ 227 (426)
T ss_pred hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------------
Confidence 2446779999999999998766 899999999999999999999999999999999999987655532
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+.+++.||..||..+|..||++.++|.+|.+..
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 346788999999999999999999999999988763
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.56 Aligned_cols=264 Identities=26% Similarity=0.349 Sum_probs=214.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||++.+..+++.||+|++.... ........+..|+.++..++|+||+++++++.. ...+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 47999999999999999999999999999999986432 223334557789999999999999999998876 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999985 455555444557999999999999999999999999999999999999999999999999999765433332
Q ss_pred CccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+||+.|+|||++.+ ...|+.++|||||||+||||++|+.||.+.+..+.+.+|.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 3334579999999999863 3457899999999999999999999999988888777765321000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~ 419 (709)
.+......++..+.+||.+||..++.+ |++++++++||||...
T Consensus 228 -------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 228 -------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 011123457899999999999765554 6899999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=371.71 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=208.6
Q ss_pred EeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 135 LDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++.||+|+||.||+|.+. .+++.||||++..... .......+..|+.+|+.++||||+++++++.. .+.+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 368999999999999864 5788999999975432 12334456789999999999999999998876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999975554444445578999999999999999999999999999999999999999999999999987543222 223
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
...+||+.|+|||++.+.. ++.++|||||||+||||++|++||.+.+....+..+....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------------- 216 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------------- 216 (323)
T ss_pred cccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 3457999999999987755 7899999999999999999999999988777766664310
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|+ ++++++.||||...
T Consensus 217 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 ---------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 011234788899999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=361.36 Aligned_cols=286 Identities=42% Similarity=0.725 Sum_probs=229.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCC---Ce
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMS---CS 205 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~---~~ 205 (709)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765433333455778999999994 6999999998865321 23
Q ss_pred EEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccc
Q 005210 206 LYLVFEYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASF 280 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 280 (709)
+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999998876655432 346899999999999999999999999999999999999998 88999999999986
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+..... ..+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++++.++.|....|...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 533221 2233467899999999877666899999999999999999999999999999999999998888887776432
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
.........+.. .........+.++..+.+||.+||..||.+|||+.++|.||||+
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111000000100 01112334457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=370.38 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986432 233344556677777654 89999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
+++.+.........+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 876554444444579999999999999999999999999999999999999999999999999997643222 2334567
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P--------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 999999999998765 7999999999999999999999999988877766654310 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA-ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||..||.+|+++ .++++||||..
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 0113467889999999999999999986 47889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=357.25 Aligned_cols=285 Identities=34% Similarity=0.619 Sum_probs=233.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.++|+||+++++++.. .+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 46999999999999999999999999999999987654444455678899999999999999999999977 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||++++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999888776666556799999999999999999999999999999999999999999999999999987654433244
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC-cccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH-ATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~-~~~~ 368 (709)
...+++.+|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...++......+....... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 456789999999999887568999999999999999999999999998888888888877776665543321100 0000
Q ss_pred C-CCCccccchhcccC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 K-PQQPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~-~~~~~~~~~~~~~~-~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
. +.......+...+. .++..+.+||.+||..||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 00000111122222 358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=358.64 Aligned_cols=284 Identities=33% Similarity=0.616 Sum_probs=228.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46999999999999999999999999999999986544333344567789999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999987776665555568999999999999999999999999999999999999999999999999998764332 233
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCC-ccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPH-ATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~-~~~ 367 (709)
+...++.+|+|||++.+...++.++|||||||++|||++|+++|.+....+.+..+....+......-.... .+. ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445789999999998876667889999999999999999999999998888888887766654332111000 000 000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
..+...........++.++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0111111122333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.73 Aligned_cols=291 Identities=34% Similarity=0.537 Sum_probs=233.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 578999999999999999999999999999999986432 2233455678999999999999999998875422 246
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|+||||+.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999999887766543 369999999999999999999999999999999999999999999999999997653321
Q ss_pred C--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 N--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 ~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+...++.+..+.+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 12234578999999999877666899999999999999999999999999988889999988888887766532221
Q ss_pred CccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 364 HATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 364 ~~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
....+.. .......+....+.+++.+.+||.+||+.||.+|||+.++|+||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 1111100 0011112233345678899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=369.35 Aligned_cols=294 Identities=32% Similarity=0.532 Sum_probs=238.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--CCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~l 206 (709)
.++|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++... ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4689999999999999999999999999999999876543334456677899999999999999999887542 24578
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999998777766543 4699999999999999999999999999999999999999999999999999976543221
Q ss_pred ---CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 287 ---QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 287 ---~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+++.+|+|||++.+...++.++|||||||++|||++|++||.+.+...++..+....|.|....+....-.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 12234578999999999876555899999999999999999999999999999999999999999887765432111
Q ss_pred CccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 364 HATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 364 ~~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
...... ........+...++.++..+.+||.+||+.||.+|||++++|.||||...+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 000000 000001113344567899999999999999999999999999999998766554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=369.74 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=214.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||++++..+++.||||++.... ........+..|+.++..++|+||+++++++.. .+.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 57999999999999999999999999999999987532 223344557789999999999999999998876 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++ |...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999864 55555443457999999999999999999999999999999999999999999999999999876443322
Q ss_pred CccccccccCCCCchhhcCC----ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~----~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.+|......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------
Confidence 22345799999999998752 347889999999999999999999999988877777664311000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTM 418 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~ 418 (709)
.+...+.+++..+.+||.+||..++.+ |++++++++|+||..
T Consensus 228 -------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 228 -------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 011223457899999999999976654 569999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=361.32 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=211.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 488999999999999999999999999999999754332 2233456789999999999999999998876 5689999
Q ss_pred Eeeccccccc-cccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEHDLAG-LASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g~L~~-~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+.++.+. .+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999865443 3322 2346999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 220 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--------------- 220 (285)
T ss_pred ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc---------------
Confidence 223457899999999987654 7899999999999999999999999877655444443221100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||..||.+|| +++++++||||...
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 221 ----------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0011235788899999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=380.66 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=220.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|..++.||+|+||.||+|.+..+++.||||++..+.. ...++.+.+|+.+|..++++||.++|+.|.. +..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHH
Confidence 4568889999999999999999999999999999987654 3456778899999999999999999999887 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
+||||.|+....+...+..+.|.++..++++++.||.|||..+.+|||||+.||||..+|.+||+|||.+..+.......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999987766666667677999999999999999999999999999999999999999999999999998776544443
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.+.+|||.|||||++.+ ..|+.++||||||++.+||++|.||+........+..|-+
T Consensus 169 -~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------------------- 225 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------------------- 225 (467)
T ss_pred -ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---------------------
Confidence 56799999999999985 4589999999999999999999999987765333222211
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+. ..-.++++.+++||..||.+||+.||||.++|+|+|++.
T Consensus 226 ---~~PP----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 ---SAPP----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---CCCC----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1100 111268899999999999999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=357.49 Aligned_cols=281 Identities=42% Similarity=0.740 Sum_probs=230.4
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|++.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998664443344557789999999999999999999876 678999999
Q ss_pred eccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 212 YMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 212 y~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
|+++.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+..... ...
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 99877666554322 3689999999999999999999999999999999999999999999999999976543221 223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC-CCccccC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-PHATIFK 369 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l-p~~~~~~ 369 (709)
...++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+.++++..+.|....|..... +....-.
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 346789999999887766678899999999999999999999999999999999999999988887754221 1111100
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+... ..........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1111 112233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.96 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||++..... .......+..|+. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 2223334445554 5678999999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 97655444444557999999999999999999999999999999999999999999999999998753221 22234557
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 999999999987755 7999999999999999999999999988777766664310
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f~~ 418 (709)
......++..+.+||.+||+.||.+|+++ .+++.||||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 01123578899999999999999999997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.05 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=209.1
Q ss_pred EeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 135 LDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
++.||+|+||.||++.+. .+|+.||+|++............+.+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEc
Confidence 357999999999999863 578999999998654433344556789999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
|+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 99865443333444579999999999999999999999999999999999999999999999999997653321 22345
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.+...
T Consensus 158 ~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------------------- 215 (318)
T cd05582 158 FCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------------------- 215 (318)
T ss_pred ccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 67899999999987654 68999999999999999999999999888777776643210
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||+.||.+||| +.+++.||||...
T Consensus 216 --------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 216 --------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 112347889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=357.20 Aligned_cols=293 Identities=34% Similarity=0.533 Sum_probs=244.1
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS-- 203 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~-- 203 (709)
|...-+.+-.+.||.|+||.||.+.+..+|+.||+|++......-...+.+.+|+.+|..++|.|++..+++.....-
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 444566777889999999999999999999999999986443334455677899999999999999998887654322
Q ss_pred -CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 204 -CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 204 -~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
..+|+|.|+|..+|..++..+. .|+..+++-+++||++||+|||+.+|+||||||.|+||++|..+||||||+|+..+
T Consensus 129 FqEiYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 129 FQELYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence 3478999999999998887765 79999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.+....++..+.|.+|+|||++.|...|+.++||||+|||+.||+..+.+|...+..+++..|..++|+|+.+..+.-..
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 88888889999999999999999999999999999999999999999999999999999999999999999887653211
Q ss_pred C-CccccC--CCCccccchhc--ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 P-HATIFK--PQQPYKRCVAE--TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p-~~~~~~--~~~~~~~~~~~--~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
- ..-+++ +..|....+.. ...+-..++.+++..||.+||.+|++.+++|.|+|+...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 1 011111 11111111111 112344578999999999999999999999999998754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=360.48 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||+|+||.||+|.+..+++.||+|++...... ......+..|+.+++.++|+||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999998755332 2234566789999999999999999988876 57799999999875
Q ss_pred cccccc----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 005210 217 LAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292 (709)
Q Consensus 217 L~~~~~----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 292 (709)
.+.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 443222 2345699999999999999999999999999999999999999999999999999976543322 22345
Q ss_pred ccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCC
Q 005210 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 372 (709)
Q Consensus 293 ~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~ 372 (709)
.||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+....-..
T Consensus 158 ~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 216 (280)
T cd05608 158 AGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------------- 216 (280)
T ss_pred CCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------------------
Confidence 7899999999998765 7899999999999999999999998765432222222111000
Q ss_pred ccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 373 PYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 373 ~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||+.||.+|+ |++++|+||||+..
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 217 -----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred -----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0011235788999999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.22 Aligned_cols=293 Identities=36% Similarity=0.566 Sum_probs=235.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ 205 (709)
..+|.+.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999999999999999998754333334456678999999999999999999876432 245
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++|...+... ..+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 8999999998877666543 479999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....|.+..+.|........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2334557899999999987655589999999999999999999999999998888888998888887766532111111
Q ss_pred cccCCCCc--cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 366 TIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 366 ~~~~~~~~--~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
..+....+ .........+++++.+.+||.+||+.||.+|||+.++|+||||.....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 10000000 00112233467899999999999999999999999999999998755444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=368.63 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=204.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..++..||||+++.... .......+..|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 479999999999999999999999999976432 123345566788888765 89999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 87544434444457999999999999999999999999999999999999999999999999998753221 12234567
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+... .+
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~--------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP--------------------- 213 (316)
T ss_pred CCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------------------
Confidence 999999999998755 799999999999999999999999988877666655321 11
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA-ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-~e~L~hp~f~~ 418 (709)
.....++.++.+||.+||..||.+|+++ +++++||||..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 0112367889999999999999999998 57889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=368.39 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=202.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||+++++++.. ...+|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 369999999999999999999999999986533 234456678899999998 79999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 87554443334457999999999999999999999999999999999999999999999999998753211 12234468
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh--------HHHHHH-HHHhhCCCChhhhhhcCCCC
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--------VEQLHK-IFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--------~e~l~~-I~k~~g~p~~~~w~~~~lp~ 364 (709)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+.+ +...
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------- 220 (329)
T cd05588 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------------
Confidence 999999999998754 79999999999999999999999963211 111111 1110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC------HHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT------a~e~L~hp~f~~ 418 (709)
.......++..+.+||.+||+.||.+|+| ++++++||||..
T Consensus 221 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 221 -------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 00112357888999999999999999987 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=366.58 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=211.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyL 208 (709)
+|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+..|+.++..+. |++|+++++++.. ...+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47889999999999999999999999999999986432 2334556778999998885 5677888888876 568999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999865544444444579999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred ccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 23457899999999987654 79999999999999999999999999888777776654210
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||++||.+|++ ..++++||||...
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 112357888999999999999999997 5799999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=355.64 Aligned_cols=284 Identities=38% Similarity=0.604 Sum_probs=223.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|.+++.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 57899999999999999999999999999999998754322 222345689999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988877665555568899999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhcC-CCCcc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSK-LPHAT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~ 366 (709)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+.++....|.|....|.... ++...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2344679999999998776557889999999999999999999997654 456777888888888777664321 11100
Q ss_pred ccCCCCccccchhcccC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...........+..... ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000001111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.28 Aligned_cols=296 Identities=41% Similarity=0.746 Sum_probs=239.5
Q ss_pred CCCeeE-EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHH------------HHHHHHHHHHHHhcCCCceeeee
Q 005210 129 ADSFEK-LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES------------VRFMAREIHILRRLDHINVIKLE 195 (709)
Q Consensus 129 ~~~y~~-~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~------------~~~~~rEi~iL~~L~HpnIv~l~ 195 (709)
.++|.. .+.||.|+||.||+|.+..+++.||||++......... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 566765 46799999999999999999999999998754322100 11366899999999999999999
Q ss_pred ceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 196 ~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
+++.. ...+|+||||+.+++...+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99876 678999999999887776654 346999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-------------CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHH
Q 005210 276 GLASFYDPD-------------QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 342 (709)
Q Consensus 276 Gla~~~~~~-------------~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l 342 (709)
|++..+... .........+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+++
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 1112233456889999999987666799999999999999999999999999999999
Q ss_pred HHHHHhhCCCChhhhhhcC-CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 343 HKIFKLCGSPSEDYWRKSK-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~-lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
..++..++.|....|.... ++....+.... ...+...+...+..+.+||.+||..||.+|||++++|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCC--cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999999998887765321 11111111111 12233445677899999999999999999999999999999999888
Q ss_pred CCCCCCCC
Q 005210 422 PCDPSSLP 429 (709)
Q Consensus 422 ~~~p~~~p 429 (709)
++.+..+|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 88766554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=370.54 Aligned_cols=253 Identities=29% Similarity=0.403 Sum_probs=209.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
....+.+.||.|+||+||++.+..+. .||||++..........+.+.+|+.+|.+|+|||||+++|++.... ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEE
Confidence 34455667999999999999986543 2999999876665555778999999999999999999999998732 268999
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHHhhhhhCC-eeeccCCCccEEEcCCC-cEEEeecccccccCCCC
Q 005210 210 FEYMEHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRG-VLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQ 285 (709)
Q Consensus 210 mEy~~g~L~~~~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~g-IvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 285 (709)
||||+++.+..+... ...|+...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999997766655544 678999999999999999999999999 99999999999999998 99999999998764322
Q ss_pred CCCccccccccCCCCchhhcC-CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~-~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+....+....+....-.|
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------------ 265 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------------ 265 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence 34455789999999999985 3558999999999999999999999999998866555554321111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......++.+..||..|+..||.+||+..+++.
T Consensus 266 ---------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 ---------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 112237888999999999999999999998864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=352.15 Aligned_cols=259 Identities=32% Similarity=0.479 Sum_probs=212.2
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|++.+.||+|+||.||++.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 789999999999999999999999999999998776544444455679999999999999999999987 778999999
Q ss_pred eccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 212 YMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 212 y~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
|+.+ +|...+. ....+++.+++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||++..+. .......
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 9998 4544444 44578999999999999999999999999999999999999999999999999997642 2233445
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
...+|..|+|||++.....++.++|||||||++|+|++|..||...........+.+.........+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 224 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------------ 224 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------------
Confidence 56889999999998734457999999999999999999999999885444444443332221111110
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.....+..+.+||..||+.||.+|||+.++++||||
T Consensus 225 ----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ----------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=367.25 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=208.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..++..||||+++.... .......+.+|+.++..+ +||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999999999999999986532 233455677899999888 79999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccccee
Confidence 87655444444557999999999999999999999999999999999999999999999999998753221 12223457
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.... +
T Consensus 158 g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~--------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--V--------------------- 213 (318)
T ss_pred cCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 899999999998755 7999999999999999999999999888776666554210 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-----~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||..||.+|||+ .+++.||||..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0113478899999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=378.43 Aligned_cols=279 Identities=24% Similarity=0.323 Sum_probs=217.7
Q ss_pred CCCeeEEeeecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.|+|||||++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 457999999999999999999764 456789999876431 24579999999999999999998876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||+.+++...+. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 162 ~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999988877663 345799999999999999999999999999999999999999999999999999976643322
Q ss_pred C-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 287 Q-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 287 ~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~---~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
. .....+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.. ...++..|++.++....++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2 223457899999999987655 7999999999999999999999997754 4566777777776554433211100
Q ss_pred CC-------ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 363 PH-------ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 363 p~-------~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.. ....++.......+. -..++.++.+||.+||..||.+|||+.++|.||||...|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hHHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00 000001000000000 124677899999999999999999999999999998754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=373.05 Aligned_cols=277 Identities=24% Similarity=0.315 Sum_probs=212.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|++++.||+|+||.||+|.+..++..||+|+..... ...|+.+|+.++||||+++++++.. ....|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 457999999999999999999999999999999854321 2469999999999999999999877 667899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.+++...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9999999888877766668999999999999999999999999999999999999999999999999999753221 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhhCCCChhhhh
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRT---------EVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~---------~~e~l~~I~k~~g~p~~~~w~ 358 (709)
.....||+.|+|||++.+.. |+.++|||||||+||||+++. ++|.... ....+..++..++..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 23457899999999988755 799999999999999999854 5554322 123445555555544333221
Q ss_pred hcCCCCcccc-----CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 359 KSKLPHATIF-----KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 359 ~~~lp~~~~~-----~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.........+ ....++..........++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000000000 00011111111112357788999999999999999999999999999974
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.58 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=201.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+++++++.. .+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999999999999999986532 334456677899998877 89999999999877 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 976554444444579999999999999999999999999999999999999999999999999987542221 2234467
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC--------hHHHH-HHHHHhhCCCChhhhhhcCCCC
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT--------EVEQL-HKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~--------~~e~l-~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.+ ..+...
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 220 (329)
T cd05618 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------------
Confidence 999999999998755 7999999999999999999999995311 11111 111110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC------HHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT------a~e~L~hp~f~~ 418 (709)
.......++..+.+||.+||+.||.+|+| ++++++||||..
T Consensus 221 -------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 221 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 00122457888999999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=366.78 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=204.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHH-HHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREI-HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi-~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||+|++...... ......+..|. .+++.++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999999754321 12223344444 45678899999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 97655544444557899999999999999999999999999999999999999999999999999754322 22234567
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (325)
T cd05602 158 GTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------ 212 (325)
T ss_pred CCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence 999999999988754 7999999999999999999999999988877777664310
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH----HHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAA----SALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~----e~L~hp~f~~ 418 (709)
....++++..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 011246788999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=367.39 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=205.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHH-HHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+|+.||||++..... .......+..|.. +++.++||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 369999999999999999999999999975422 2233344555554 5677999999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 97655544445567999999999999999999999999999999999999999999999999998753221 12234567
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 999999999987755 7899999999999999999999999988777666654310
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f~~ 418 (709)
....+.++..+.+||.+||..||.+||++ .+++.||||..
T Consensus 213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 01123578889999999999999999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.79 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=204.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|++..+++.||||+++.... ..........|+.++..+ +||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986432 122344556788888764 99999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 865444444344578999999999999999999999999999999999999999999999999987532211 2234457
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+... .+.
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~-------------------- 214 (316)
T cd05619 158 GTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC-------------------- 214 (316)
T ss_pred CCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC--------------------
Confidence 899999999987755 799999999999999999999999988877666655321 110
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH-HHHhcccCCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 419 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~-e~L~hp~f~~~ 419 (709)
....++..+.+||.+||+.||.+|+++. ++++||||...
T Consensus 215 -------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 215 -------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 1123678899999999999999999996 89999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.21 Aligned_cols=286 Identities=37% Similarity=0.628 Sum_probs=225.5
Q ss_pred CeeEEeeecccCceEEEEEEECC--CCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLD--QKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~--tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.|++.+.||+|+||.||+|.+.. ++..||||.+..... .......+.+|+.+++.++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 899999999876431 122234567899999999999999999999875457899
Q ss_pred EEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC----CCcEEEeeccccc
Q 005210 208 LVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLAS 279 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~----~g~vKL~DFGla~ 279 (709)
+||||+++++...+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999877665432 2237899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---------HHHHHHHHHh
Q 005210 280 FYDPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKL 348 (709)
Q Consensus 280 ~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---------~e~l~~I~k~ 348 (709)
.+..... ......++|+.|+|||++.+...++.++|||||||+||+|++|++||.+... ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543222 1223456799999999988766689999999999999999999999987654 3467788888
Q ss_pred hCCCChhhhhhcC-CCCcccc---CCCCccc----cchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 349 CGSPSEDYWRKSK-LPHATIF---KPQQPYK----RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 349 ~g~p~~~~w~~~~-lp~~~~~---~~~~~~~----~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
++.+....|.... ++..... .....+. ..+.+.....+..+.+||.+||+.||.+|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8888877664311 2111110 0001111 01112223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=380.72 Aligned_cols=277 Identities=24% Similarity=0.298 Sum_probs=211.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 224579999999999999999998876 678899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 287 (709)
|||++.++|...+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999998888777665557999999999999999999999999999999999999999999999999999876432222
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhhCCCChhhhh--
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRT------EVEQLHKIFKLCGSPSEDYWR-- 358 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~------~~e~l~~I~k~~g~p~~~~w~-- 358 (709)
.....+||+.|+|||++.+.. ++.++||||||||||||++|..+ |.... ...++.++++..+....++-.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 123457999999999998765 79999999999999999998754 43321 134455555544332211100
Q ss_pred ------hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 359 ------KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 359 ------~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...........+... ...|. .+..++..+.+||.+||++||.+|||++|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYT-RPAWT-RYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccC-Ccchh-hhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000000000 00111 12246778999999999999999999999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=368.78 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=203.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc---CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL---DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
||+|+||.||+|.+..+++.||||++..... .......+..|..++..+ .||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999875432 222334455677777765 79999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 865443333445579999999999999999999999999999999999999999999999999987543222 2234567
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+...++.++|||||||+||+|++|+.||.+.+..+.+..|... .. .+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------~~----------- 216 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KV--------RF----------- 216 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CC--------CC-----------
Confidence 9999999999987666899999999999999999999999988877666655321 00 00
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCC----CHHHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRG----SAASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp----Ta~e~L~hp~f~~ 418 (709)
....+++.+.+||.+||..||.+|| ++.++++||||..
T Consensus 217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 0123688899999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.82 Aligned_cols=291 Identities=37% Similarity=0.586 Sum_probs=239.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ly 207 (709)
+|++.+.||.|+||.||+|.+..++..||||++..........+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999999999999999998765433455567889999999999999999999886632 24789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~- 286 (709)
+||||+++++...+.... .+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999987776665433 899999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 -~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2234557899999999998775689999999999999999999999999999999999999999998877753222222
Q ss_pred cccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 366 TIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 366 ~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
..+.. .......+....+.++..+.+||.+||++||.+|||++++|+||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 11111 1111122344456689999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.49 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=203.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHH-HHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREI-HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi-~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|++..+++.||||++..... .......+..|+ .+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 379999999999999999999999999975432 222233444555 46788999999999988876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
+++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 97655444444557999999999999999999999999999999999999999999999999998753221 12234457
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....+... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------------- 212 (321)
T cd05603 158 GTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------------- 212 (321)
T ss_pred CCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C---------------------
Confidence 899999999987654 799999999999999999999999998876666655421 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f~~ 418 (709)
.......+..+.+||.+||+.||.+|+++ .++++|+||..
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 01123467889999999999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.21 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=211.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC---hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
++|++.+.||+|+||.||+|.+..++..||||.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 5789999999999999999999999999999998755432 2234567899999999999999999999877 5689
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||+.++.+.........+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998754443333344689999999999999999999999999999999999999999999999999976543221
Q ss_pred CCc--cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 QPL--TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 ~~~--~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
... ....++..|+|||++.+.. ++.++|||||||++|||++|++||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------------- 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--------------
Confidence 111 3346788999999998765 78999999999999999999999987766555544422100
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||..||..||.+|||+.++|+|+||
T Consensus 225 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 -------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001123578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.56 Aligned_cols=282 Identities=43% Similarity=0.728 Sum_probs=234.9
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+|+.++|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 677889999999999999999999999999987665554455677889999999999999999999876 578999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
|+++++...+......+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||.+..+.... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998887776655689999999999999999999999999999999999999999999999999998765433 22344
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc-cccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~-~~~~~ 370 (709)
..++..|+|||.+.+...++.++|||||||++|+|++|+++|.+.+..+++.++...++.+....|........ ..+..
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 56889999999998765689999999999999999999999999999999999999999888877755322000 00000
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
..............++..+.+||.+||..||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000111223345678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.48 Aligned_cols=290 Identities=36% Similarity=0.588 Sum_probs=237.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
.++|++...||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 678999999999999999999999999999999987554344455667789999999999999999987755221 3
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+|+||++++|..++.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 5899999998877666543 36999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+|..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+.+..|.+.....
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3345778999999998765567899999999999999999999999999999999999999988887776543222
Q ss_pred ccccCCCCc--cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 365 ATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 365 ~~~~~~~~~--~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
...+....+ ....+...+..+++.+.+||.+||..||.+|||+.++|+||||.....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 211111100 011123344567899999999999999999999999999999987655543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.90 Aligned_cols=299 Identities=34% Similarity=0.563 Sum_probs=235.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
.++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 678999999999999999999999999999999986543333344567789999999999999999998865321 3
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 5699999997766555443 36899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.+....+.++++..+.+..+++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2334678999999998765557899999999999999999999999999888888888887777666554322111
Q ss_pred ccccCCCC--ccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCCCCC
Q 005210 365 ATIFKPQQ--PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 433 (709)
Q Consensus 365 ~~~~~~~~--~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~pp 433 (709)
...+.... .....+......+++.+.+||.+||+.||.+|||+.++|.||||+...........++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~ 318 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDD 318 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccc
Confidence 11110000 0011123344678889999999999999999999999999999987644433333334433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=350.56 Aligned_cols=282 Identities=42% Similarity=0.719 Sum_probs=235.0
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|++.+.||+|+||.||+|.+..+++.||+|++............+..|+.+++.++|+||+++++++.. ...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 677889999999999999999999999999998654333344566789999999999999999999876 578999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
|++++|...+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999887777665545799999999999999999999999999999999999999999999999999987643222 2334
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
..++..|+|||.+.+...++.++|||||||++|||++|++||.+.+..+.+.++...++.+....|..............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 46688999999988765689999999999999999999999999999999999999999999988865322211111111
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
..........++.++..+.+||.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111122345566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.72 Aligned_cols=285 Identities=34% Similarity=0.576 Sum_probs=230.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|.+.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999999999999999998754333333455778999999999999999999886422 13
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+..++.... +..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 57999999987554433 23689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....|.+....+.......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 12345778999999998775557899999999999999999999999999888999999988888877765433222
Q ss_pred ccccCCC--CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 365 ATIFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 365 ~~~~~~~--~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
...+... ......+...++.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 1111100 0011123334456888999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=381.78 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=218.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC-----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----- 203 (709)
.++|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 578999999999999999999999999999999998776666667778899999999999999999877653221
Q ss_pred -CeEEEEEeecccc-ccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 204 -CSLYLVFEYMEHD-LAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 204 -~~lyLVmEy~~g~-L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
..+++||||+.++ |...+.. ....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 2478999999864 4443322 2346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 279 SFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 279 ~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
+.+.... .......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+.++.....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------
Confidence 8764322 12234567999999999998755 79999999999999999999999999887777766643210
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......+++.+.+||..||+.||.+|||+.++|+|||++.
T Consensus 263 ---------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 ---------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0122457889999999999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.06 Aligned_cols=291 Identities=36% Similarity=0.583 Sum_probs=235.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.+ +||||+++++++.......+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 36789999999999999999999999999999999865433334445667899999999 99999999998866445678
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||+.++|...+... .+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999998776665443 788999999999999999999999999999999999999999999999999986643322
Q ss_pred ----CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 287 ----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 287 ----~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
......++|..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+.++....+.+..+.|.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1233457899999999987766678999999999999999999999999999999999988888877665543211
Q ss_pred CCccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 363 PHATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 363 p~~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+....+.. ...........++.++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 11110000 00011112344556899999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=359.41 Aligned_cols=289 Identities=34% Similarity=0.532 Sum_probs=230.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 57899999999999999999999999999999998765433444556778999999999999999999875421 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+|++++.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 5799999997776655433 3689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+|..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+....+.......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 22345779999999998775568899999999999999999999999988888888888888877766554321111
Q ss_pred ccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 365 ATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 365 ~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
...+.. ...........+...++.+.+||..||+.||.+|+|+.++|.||||.....|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 000000 00001112222335688899999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=361.05 Aligned_cols=283 Identities=23% Similarity=0.354 Sum_probs=212.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.++||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 578999999999999999999999999999999987643 34455678899999999999999999999987 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+||||+.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999998754444434445789999999999999999999975 7999999999999999999999999999765322
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHH--hhCCCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k--~~g~p~~~~w~~~~lp~~ 365 (709)
.....+||..|+|||++.+.. ++.++|||||||++|+|++|+.||......+. ..++. ..+.+..........+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCcc
Confidence 123457899999999987754 78999999999999999999999987655333 22221 111111110000000000
Q ss_pred ---cccCCCC----cccc----chhcc-----cCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 ---TIFKPQQ----PYKR----CVAET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ---~~~~~~~----~~~~----~~~~~-----~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+.+.. .... .+... ...++.++.+||.+||++||.+|||++++|.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000 0000 00000 01357889999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=360.35 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=203.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++.++ .||||+++++++.. ...+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 379999999999999999999999999986533 234556788999999888 69999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 87555444334457999999999999999999999999999999999999999999999999998753221 12234568
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~------~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
||+.|+|||++.+.. |+.++|||||||+||||++|+.||.... ..+.+.++... .+
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--------------- 219 (327)
T ss_pred CCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC---------------
Confidence 999999999987754 7999999999999999999999996432 11222222110 00
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC------HHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT------a~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|++ .++++.||||...
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 0112357888999999999999999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=361.95 Aligned_cols=268 Identities=27% Similarity=0.427 Sum_probs=222.5
Q ss_pred cCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH-HHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE-SVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.|...+.|..-++||+|+||.||-|+...||+-||.|++.+..+... .....+.|..||.+++.+.||.|-..|+. .
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--k 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--K 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--C
Confidence 56778899999999999999999999999999999999876554322 22335689999999999999999766765 6
Q ss_pred CeEEEEEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 204 CSLYLVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
+.++|||..|+| ||..++.+.+ .-|+|..++.|+.+|+.||++||..+||+|||||+|||||+.|+++|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 789999999985 6766666544 35999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
. ..++.+.++||..|||||++.+.. |+..+|+|||||+||||+.|+.||....+-.-...+-+..-.-+
T Consensus 338 ~--~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------- 406 (591)
T KOG0986|consen 338 P--EGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------- 406 (591)
T ss_pred C--CCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------
Confidence 4 345667789999999999998877 99999999999999999999999987654333222222111111
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKPLP 422 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~~~~ 422 (709)
.+....+++++++|.+.+|++||.+|. .++++.+||||+...+.
T Consensus 407 -----------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 407 -----------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -----------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 112246899999999999999999996 57899999999986554
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=376.31 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=213.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
...|.+.+.||+|+||.||+|.+..+ +..||+|++... .......+.+|+.+|+.++|||||++++++.. .+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEE
Confidence 45599999999999999999998887 788999987543 23444567789999999999999999999987 67899
Q ss_pred EEEeecccc-cccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 208 LVFEYMEHD-LAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
|||||+.++ |...+. .....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999864 433322 2345689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 284 DQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 284 ~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
... ......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------- 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------- 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 222 1234567999999999887654 799999999999999999999999998887777776532110
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||..||.+|||++++|.|+|+..
T Consensus 290 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 011347788999999999999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.83 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=207.3
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|+..+.||+|+||.||+|.+..+++.||||.+...... ......+..|+.+++.++|+||+.+++.+.. ...+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 478899999999999999999999999999998765332 2333456789999999999999999988876 5789999
Q ss_pred Eeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+.++ |...+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999865 4443322 23368999999999999999999999999999999999999999999999999987653222
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH---HHHHHHHhhCCCChhhhhhcCCCC
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE---QLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e---~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+||..|+|||++.+.. ++.++|||||||++|+|++|++||.+..... ....+... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~------------ 220 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V------------ 220 (285)
T ss_pred cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---h------------
Confidence 223457899999999997755 7999999999999999999999998754322 12211110 0
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.......+++.+.+||..||+.||.+|+| ++++++||||...
T Consensus 221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 221 -------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 00112457888999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.57 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=211.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.|++++.||.|+||.||++.+..+++.||||++..........+.+.+|+.+++.++|+|++++++.+.. ..+.+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 4899999999999999999999999999999998665555556678899999999999999999887753 245789999
Q ss_pred eecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.++ +...+.. ....+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 999864 4433332 24468999999999999999999999999999999999999999999999999998764322 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------------- 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L---------------- 219 (257)
T ss_pred cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------------
Confidence 33457899999999987754 7889999999999999999999998877655554443210 0
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=393.60 Aligned_cols=264 Identities=27% Similarity=0.447 Sum_probs=217.2
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
+...++|++++.||+|+||.||+|.+..++..||+|++............+..|+.+|+.|+|||||+++++|.......
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34578999999999999999999999999999999999877666666677889999999999999999999987665678
Q ss_pred EEEEEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhC-------CeeeccCCCccEEEcC--------
Q 005210 206 LYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR-------GVLHRDIKGSNLLIDN-------- 266 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~-------gIvHrDLKP~NILld~-------- 266 (709)
+||||||+.+ +|...+.. ....|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999986 45444432 234799999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCC
Q 005210 267 ---------NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGR 336 (709)
Q Consensus 267 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~ 336 (709)
.+.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||||++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998654322 22445799999999998653 44789999999999999999999999877
Q ss_pred ChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 337 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 337 ~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+...++..++... | . ..+..++..+.+||..||.++|.+|||+.++|.|+||
T Consensus 247 ~~~~qli~~lk~~--p------------------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFSQLISELKRG--P------------------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHHHHHHHHhcC--C------------------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 7666554443311 0 0 0113467889999999999999999999999999999
Q ss_pred CCC
Q 005210 417 TMK 419 (709)
Q Consensus 417 ~~~ 419 (709)
...
T Consensus 299 k~i 301 (1021)
T PTZ00266 299 KNV 301 (1021)
T ss_pred hhc
Confidence 854
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.51 Aligned_cols=286 Identities=36% Similarity=0.596 Sum_probs=224.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC-----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----- 203 (709)
..+|.+.+.||.|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4689999999999999999999999999999999876543 344567789999999999999999987654321
Q ss_pred -------CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeec
Q 005210 204 -------CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADF 275 (709)
Q Consensus 204 -------~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DF 275 (709)
..+|+||||+++++...+.. ..+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999999876655532 36899999999999999999999999999999999999984 567899999
Q ss_pred ccccccCCCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 276 GLASFYDPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 276 Gla~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
|++..+..... ......+++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++.....+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99976532211 1122346789999999887666688999999999999999999999999998888888877655544
Q ss_pred hhhhhhcC--CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 354 EDYWRKSK--LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 354 ~~~w~~~~--lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+.+.... .+.. ................+.++.++.+||.+||+.||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 240 EEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 43322110 0000 00011111222334456788999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=371.56 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=222.3
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
-|.-++.||.|+||.||-|++..+...||||++.+... ..+.+..+..|+.+|++|.|||+|.+.++|.. ....|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 37778999999999999999999999999999987754 34667889999999999999999999999977 5678999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||-|+-.+++.-...+|-|.+|..|+.+.|.||.|||+++.||||||..||||++.|.|||+|||.|....+.
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 999998777766666668999999999999999999999999999999999999999999999999999876554
Q ss_pred cccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 290 TSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.+++|||+|||||+++. ...|+-++||||||++..||.-.+||+...+....+.-|.+. .+|+-.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLq------------ 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQ------------ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCC------------
Confidence 46799999999999873 556899999999999999999999999888888877777542 222110
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
-.+.+..++.||+.||++-|.+|||.+++|+|+|....
T Consensus 247 --------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 --------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 13456778999999999999999999999999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.66 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=212.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|+..+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.++|+||+.+++++.. .+.+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 4788899999999999999999999999999987654332 234456789999999999999999988876 6789999
Q ss_pred Eeecccccc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g~L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+.++.+ ..+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 999986544 33322 2346999999999999999999999999999999999999999999999999998765322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------------- 221 (285)
T ss_pred cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--------------
Confidence 223457899999999987754 79999999999999999999999998776655555433221110
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
......++..+.+||..||+.||.+||| +.+++.|+||...
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 -----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0112457888999999999999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=354.18 Aligned_cols=291 Identities=35% Similarity=0.567 Sum_probs=231.4
Q ss_pred CeeEEeeecccCceEEEEEEECCC--CeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee--cCCCe
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQ--KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS--RMSCS 205 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~t--g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~--~~~~~ 205 (709)
+|++.+.||+|+||.||++.+..+ +..||||++..........+.+.+|+.+++++ .||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999988 89999999875433333455677899999999 59999999886532 12356
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|++|||++++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 899999999887776654 4479999999999999999999999999999999999999999999999999998654322
Q ss_pred C---CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 286 N---QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 286 ~---~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..+|.|..+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1223457899999999887755689999999999999999999999999999999999999999888776554322
Q ss_pred CCccccCCC--CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 363 PHATIFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 363 p~~~~~~~~--~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
+....+... ......+....+.++..+.+||.+||+.||.+|||+.++|.||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 211111000 000011223345568899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.28 Aligned_cols=264 Identities=28% Similarity=0.382 Sum_probs=216.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+++.||||.+....... ...+.+..|+.+++.++|+||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36999999999999999999999999999999998665432 455678899999999999999999998876 678999
Q ss_pred EEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.++ |...+.. .+..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999874 4444332 335799999999999999999999999999999999999999999999999999875432111
Q ss_pred C----------------------------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh
Q 005210 287 Q----------------------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 338 (709)
Q Consensus 287 ~----------------------------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~ 338 (709)
. .....+||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 111346889999999997755 78999999999999999999999998887
Q ss_pred HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC----HHHHHhcc
Q 005210 339 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS----AASALRSE 414 (709)
Q Consensus 339 ~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT----a~e~L~hp 414 (709)
...+..+...... ......++..+.+||.+||..||.+||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVT---------------------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCcc---------------------------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 7766665421000 0011227889999999999999999999 99999999
Q ss_pred cCCCCCCCC
Q 005210 415 FFTMKPLPC 423 (709)
Q Consensus 415 ~f~~~~~~~ 423 (709)
||+...++.
T Consensus 291 ~~~~~~~~~ 299 (316)
T cd05574 291 FFRGVNWAL 299 (316)
T ss_pred hhhcCChhh
Confidence 998865544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.16 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=199.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||+|+||.||++.+..+|+.||+|++....... .....+..|+.+++.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999987543322 223345579999999999999999998876 67899999999865
Q ss_pred cc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 217 LA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 217 L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
.+ ..+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 44 33322 2335899999999999999999999999999999999999999999999999999766432 22234578
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+....-..
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------------------- 213 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------------
Confidence 99999999988766 8999999999999999999999997654322111221110000
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccCCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMK 419 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f~~~ 419 (709)
........+++++.+||.+||++||.+||++ ++++.|+||...
T Consensus 214 --~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 214 --EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred --ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0001123578899999999999999999999 778899999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=336.89 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=214.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|+||.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4888999999999999999999999999999998766666666778899999999999999999998876 57899999
Q ss_pred eecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+. |...+.. .+..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 999864 4444333 245789999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..+...++......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP----------------- 219 (256)
T ss_pred hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 23457889999999987755 789999999999999999999999988876666655431100
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.....++..+.++|.+||+.+|++||++.++|+|||+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 -----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0112467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.12 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=198.7
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 468999999999999999999753 345789999987432 334456688999999999 899999999987652
Q ss_pred CCeEEEEEeecccc-ccccccCC---------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHD-LAGLASHP--------------------------------------------------------- 224 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~~--------------------------------------------------------- 224 (709)
...+|+||||++++ |...+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45689999999864 43332211
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-CCccccccccCCC
Q 005210 225 ----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYR 299 (709)
Q Consensus 225 ----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~ 299 (709)
...+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.+..... .......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12488899999999999999999999999999999999999999999999999986532211 1122334578899
Q ss_pred CchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccch
Q 005210 300 PPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCV 378 (709)
Q Consensus 300 APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~ 378 (709)
|||++.+.. |+.++|||||||+||||++ |.+||.+....+.+...+.. +..
T Consensus 244 aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------------- 295 (338)
T cd05102 244 APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-------------------------- 295 (338)
T ss_pred CcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------
Confidence 999987755 7999999999999999997 99999886654444333221 100
Q ss_pred hcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 379 AETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 379 ~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.82 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=208.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.+|+..+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875532 22345667899999999999999999998876545788
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ- 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~- 285 (709)
|+||||+.++.+.........+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999865444333334468999999999999999999999999999999999999999999999999987653211
Q ss_pred -CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 -NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 -~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........++..|+|||.+.+.. ++.++|||||||++|||++|++||......+.+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~---------- 227 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN---------- 227 (266)
T ss_pred cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC----------
Confidence 11122346789999999987754 78999999999999999999999987765554444321 1100
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
......+++.+.+|| .||..||.+|||++++|+||||+
T Consensus 228 --------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 --------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 011124677889999 56778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.90 Aligned_cols=281 Identities=22% Similarity=0.295 Sum_probs=207.3
Q ss_pred EEeeeccc--CceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 134 KLDKIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 134 ~~~~LG~G--~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
++++||+| +|++||++.+..+|+.||||++............+.+|+.+++.++||||+++++++.. .+.+|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56789999 78899999999999999999998765555566778899999999999999999999977 678999999
Q ss_pred ecccccc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC---
Q 005210 212 YMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--- 286 (709)
Q Consensus 212 y~~g~L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~--- 286 (709)
|++++.+ +++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9986544 44332 234589999999999999999999999999999999999999999999999987543311100
Q ss_pred ---CCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---------
Q 005210 287 ---QPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--------- 353 (709)
Q Consensus 287 ---~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~--------- 353 (709)
......+++..|+|||++.+. ..|+.++|||||||++|||++|+.||.............. +...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 011223567889999998763 3489999999999999999999999987655444333321 1111
Q ss_pred -hhhhhhcC-------CCCccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 354 -EDYWRKSK-------LPHATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 354 -~~~w~~~~-------lp~~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
++...... ........ ...............+++.+.+||.+||++||.+|||++++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000000 00000000 0000001111223356788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.43 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=217.0
Q ss_pred CCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 130 DSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 130 ~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
+-|++. +.||+|+|+.|-.|....+|..||||+|.+. ......++.||++++... .|+||++|+++|++ +..+|
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FY 152 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFY 152 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEE
Confidence 345543 5899999999999999999999999999866 345566788999999998 79999999999988 67899
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEeecccccccC-
Q 005210 208 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYD- 282 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGla~~~~- 282 (709)
||||-|.|+ ++..+.. ...|+|.++..++++|+.||+|||.+||.||||||+|||..... .||||||.|..-..
T Consensus 153 LVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999999865 5555554 45899999999999999999999999999999999999997655 58999999876432
Q ss_pred -----CCCCCCccccccccCCCCchhhc----CCccCCccccccchhHHHHHHHhCCCCCCCCCh---------------
Q 005210 283 -----PDQNQPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--------------- 338 (709)
Q Consensus 283 -----~~~~~~~~~~~gT~~Y~APE~l~----~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--------------- 338 (709)
+.....+.+.+|+..|||||++. ....|+.++|+||||||||.||+|.+||.|.-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 23334456789999999999864 356799999999999999999999999987532
Q ss_pred HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 339 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 339 ~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+.+.|......+++..| .+++.+++|||..||..|+..|.++.++|+|||++.
T Consensus 312 ~~LFesIQEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHHHHHHhccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 2234555554445555555 568999999999999999999999999999999986
Q ss_pred CC
Q 005210 419 KP 420 (709)
Q Consensus 419 ~~ 420 (709)
..
T Consensus 367 ~~ 368 (463)
T KOG0607|consen 367 CA 368 (463)
T ss_pred cc
Confidence 53
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=364.00 Aligned_cols=264 Identities=30% Similarity=0.482 Sum_probs=215.3
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
.....|+++++||.||-+.||++.. .+...||+|++.....+...+.-+..||.+|.+| .|.+||+|++|-.. ++.
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~ 434 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGY 434 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cce
Confidence 3456699999999999999999986 4456788888887777888889999999999999 69999999998766 789
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||-+.||...+......++.-.++.|..|||.++.++|.+||||.||||.|+|+ -.|.+||+|||+|..+.++.
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 99999999999999888777667767999999999999999999999999999999999 57999999999999887665
Q ss_pred CCC-ccccccccCCCCchhhcCCcc----------CCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 286 NQP-LTSRVVTLWYRPPELLLGATY----------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 286 ~~~-~~~~~gT~~Y~APE~l~~~~~----------y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
... ..+.+||+.||+||.+..... .+.++||||||||||+|+.|++||..-. .++.++.. +..|..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a-I~~P~~ 590 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA-ITDPNH 590 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh-hcCCCc
Confidence 543 346899999999999864221 4678999999999999999999995432 12233322 122211
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCH--HHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPA--PALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~--~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
+ -.|+.+|+ ++.++++.||..||.+|||+.++|+|||++..+.
T Consensus 591 ~------------------------Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 591 E------------------------IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred c------------------------ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 0 11233332 3899999999999999999999999999985433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.23 Aligned_cols=280 Identities=40% Similarity=0.677 Sum_probs=224.3
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeecCC---Ce
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSRMS---CS 205 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~~~---~~ 205 (709)
|++.+.||.|+||.||+|.+..++..||||+++...........+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999998999999999976544333344566788887766 59999999999876321 24
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|++|||+.+++...+... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998776655432 236899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
. ......++..|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+.+++...+.+....|.....-.
T Consensus 161 ~--~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 M--ALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred c--ccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2 223346788999999998765 7899999999999999999999999999999999999887777665554322111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...+. ...........+.+++.+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111 111122344455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=344.91 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=213.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 469999999999999999999999999999999875432 23445678899999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999965444433333457999999999999999999999999999999999999999999999999999876433
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....++++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+....+... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc----------------
Confidence 23447899999999987654 688999999999999999999999888765555555321 10
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||..||.+|+ +++++++||||...
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 11234678899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.63 Aligned_cols=257 Identities=23% Similarity=0.300 Sum_probs=209.4
Q ss_pred CCCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec--CCC
Q 005210 129 ADSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR--MSC 204 (709)
Q Consensus 129 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~--~~~ 204 (709)
+++|.+- ++||-|-.|.|..|.++.|++.+|+|++... ....+|+++.-.. .|||||.++++|.+. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 6677765 4899999999999999999999999998532 2345788876655 799999999998653 246
Q ss_pred eEEEEEeeccccccc-cccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeeccccc
Q 005210 205 SLYLVFEYMEHDLAG-LASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLAS 279 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~-~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~ 279 (709)
++.+|||+|+|+.+. .+.. ....|+|.++..|+.||..|+.|||+.+|.||||||+|+|... |..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 789999999976444 4433 3345999999999999999999999999999999999999974 4589999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH----HHHHHHhhCCCChh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ----LHKIFKLCGSPSED 355 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~----l~~I~k~~g~p~~~ 355 (709)
.... ...+.+.|.||+|.|||++-..+ |+..+|+||+|||+|-||||.|||........ -.+|...-..++.+
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 6432 34566779999999999886655 89999999999999999999999987654322 23343333333333
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.| ..+|..++|||+.||..+|.+|.|+++++.|||++..+
T Consensus 290 EW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 290 EW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 34 45899999999999999999999999999999998753
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.27 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=214.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47999999999999999999999999999999987654433 56778899999999999999999998876 6789999
Q ss_pred Eeeccccccc-cccCC--CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 210 FEYMEHDLAG-LASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 210 mEy~~g~L~~-~~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||+.++.+. .+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999875444 33221 24689999999999999999999999999999999999999999999999999977643322
Q ss_pred C---CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 287 Q---PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 287 ~---~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. .....+++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++.+.. .+ .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--~-------- 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PP--S-------- 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CC--C--------
Confidence 2 12334689999999998876567999999999999999999999998877666555554320 00 0
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+. .......+++.+.+||.+||..||.+|||+.++|+||||
T Consensus 227 ----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 ----LE--------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----cC--------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 001134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.20 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=205.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHH-HHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI-LRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~i-L~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+|+.||||+++......... .+..|+.+ ++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 47999999999999999999999999999999997654433333 34456654 666799999999999876 667999
Q ss_pred EEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 209 VFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
||||+++++...+. .....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999986654432 2345799999999999999999999997 9999999999999999999999999999865322
Q ss_pred CCCCccccccccCCCCchhhcCC---ccCCccccccchhHHHHHHHhCCCCCCCC-ChHHHHHHHHHhhCCCChhhhhhc
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGA---TYYGTAVDLWSTGCILAELYAGKPIMPGR-TEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~---~~y~~~~DIWSLG~iL~ELltG~~pF~g~-~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
. ..+...++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+.... .+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-------- 226 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SP-------- 226 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-CC--------
Confidence 1 12335688999999988652 34688999999999999999999999643 3344444443210 00
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.. ....+|.++.+||.+||..+|.+|||+.+++.||||...
T Consensus 227 ----------~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 227 ----------QL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ----------CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 012368889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.27 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=207.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEE
Confidence 357999999999999999999999999999999987553 2233456789999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999987544444444457999999999999999999999999999999999999999999999999998765422 122
Q ss_pred ccccccccCCCCchhhc--CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 289 LTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~--~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.....||..|+|||++. ....++.++|||||||++|+|++|.+||........+..+......+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP-------------- 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC--------------
Confidence 23457899999999874 23347889999999999999999999987665444433322110000
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
. .......++..+.+||.+||..||++|||++++|+|||
T Consensus 229 ----~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 229 ----P------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----C------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 00011246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.78 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=206.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 36889999999999999999999999999999987543 33445668899999999999999999999887 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+... ..
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999998766543 25789999999999999999999999999999999999999999999999999765432 22
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH---HHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ---LHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~---l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
...++|..|+|||++.+.. ++.++|||||||++|+|++|+.||......+. ...+.+....+.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 216 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------------- 216 (279)
T ss_pred cCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------------
Confidence 3457899999999987654 79999999999999999999999965322110 011111100000
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+ ......+++.+.+||.+||+.||.+||+++++|+||||...
T Consensus 217 --~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 --PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00 00113467889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=332.33 Aligned_cols=281 Identities=31% Similarity=0.572 Sum_probs=232.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+++|+|.|+.||.|.+..+...++||+++. -..+.+.||+.||..|. ||||++|+++..+..+...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 37899999999999999999999999999999999874 34567889999999995 9999999999998888889
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~~~~~~~ 285 (709)
.|||||+++.-...+-. .|+.-.++.++.|||.||.|||+.||+|||+||.|++||.. -.++|+|+|||.++.+..
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999998643333222 58889999999999999999999999999999999999964 479999999999987653
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCChh-hhhhcCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSED-YWRKSKLP 363 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~~~e~l~~I~k~~g~p~~~-~w~~~~lp 363 (709)
....++.+..|--||+|..-..|+.+.|+|||||+|+.|+..+ |.|.|.+..+|+.+|.+++|+..-. |..+..+.
T Consensus 188 --eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred --eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3456788999999999999888999999999999999999876 5678999999999999999975432 33333322
Q ss_pred Ccccc------CCCCccccchhcccCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 364 HATIF------KPQQPYKRCVAETFKD-FPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 364 ~~~~~------~~~~~~~~~~~~~~~~-~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....| -...++.+++...-.. +++++.|||.++|.+|-.+|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11111 1223334444333333 4699999999999999999999999999999974
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.33 Aligned_cols=280 Identities=23% Similarity=0.313 Sum_probs=211.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 46999999999999999999999999999999987542 34445668899999999999999999999877 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||++++.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999875554444444579999999999999999999997 59999999999999999999999999998765322 1
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....++++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.... ..++........ +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGE--AKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCcccccc--ccCCcccccCCC
Confidence 23457899999999987654 78999999999999999999999987764332 222221110000 000000000000
Q ss_pred CCCCc---c----ccchhc-----ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQP---Y----KRCVAE-----TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~---~----~~~~~~-----~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..... . ...... ....++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 0 000000 011367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.21 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=206.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 4579999999999999999999999999999999875432 233457789999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+..+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999975554433344578999999999999999999999999999999999999999999999999998664322 12
Q ss_pred ccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 289 LTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.....+++.|+|||.+.+ ...++.++|||||||++|||++|++||......+....+.+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 225 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN----------------- 225 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC-----------------
Confidence 234578899999998753 3346789999999999999999999986554433322221100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
+.+.. ......++..+.+||.+||..||++|||++++|+|+|
T Consensus 226 -~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 -FQPPK------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -CCCCC------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 0112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.06 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=208.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-------HHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-------ESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-------~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
+|.+...||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 3677889999999999999999999999999987543221 233567889999999999999999998876 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..+|+||||+++..+..+......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++..+..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 78999999998765544444445789999999999999999999999999999999999999999999999999987642
Q ss_pred CCC-----CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 284 DQN-----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 284 ~~~-----~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
... .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 111 1112345788999999987654 6889999999999999999999998876655544443210
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||+.||.+||++.++|+||||
T Consensus 229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 011123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=375.00 Aligned_cols=287 Identities=23% Similarity=0.323 Sum_probs=208.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCC-eEEEEEEEe--------------c-CCCChHHHHHHHHHHHHHHhcCCCce
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQK-KIVALKKVR--------------F-DNLEPESVRFMAREIHILRRLDHINV 191 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAIK~i~--------------~-~~~~~~~~~~~~rEi~iL~~L~HpnI 191 (709)
..++|++++.||+|+||.||+|...... ..+++|.+. . ..........+.+|+.+|+.|+||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998765432 222222111 0 01122334567899999999999999
Q ss_pred eeeeceEeecCCCeEEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 192 v~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~----~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
|++++++.. ....|+|||++.++++..+... .......+++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 226 v~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999987 5678999999988776654332 1234567888999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCC--CChHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPG--RTEVEQLHK 344 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g--~~~~e~l~~ 344 (709)
+.+||+|||++..+...........+||+.|+|||++.+.. |+.++||||||||||||++|..+ |.+ .....++.+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999877544333334568999999999998755 79999999999999999998754 432 345566777
Q ss_pred HHHhhCCCChhhhhhc----C-CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 345 IFKLCGSPSEDYWRKS----K-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~----~-lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
++..++.+..++.... . +...............+. ...++..+.+||.+||++||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 7666654433321100 0 000000000000011111 12467889999999999999999999999999999764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.43 Aligned_cols=280 Identities=36% Similarity=0.653 Sum_probs=226.9
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
|++.+.||.|+||.||+|....+++.||||++........ .....+|+..++++. |+||+++++++.. ....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 6788999999999999999999999999999865432222 223457999999998 9999999999877 67899999
Q ss_pred eeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||+.+++...+.... ..+++.++..++.||+.+|.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 999887776665433 478999999999999999999999999999999999999999999999999998654321 22
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc-cc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT-IF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~-~~ 368 (709)
....++..|+|||++.+...++.++|+|||||++++|++|++||++.+..+.+.++...++.+....|......... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34578899999999876666789999999999999999999999999999999999999999888777542211100 00
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.............+...+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000011233344557889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.18 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=230.3
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
....+.|.+.+.||+|.|+.|.+|++..|+..||||.+.+..++....+.+.+|+++|+.|+|||||+|+.++.. ...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EAT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cce
Confidence 345788999999999999999999999999999999999988888877789999999999999999999999987 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|+||||+.++.++.+......+.+..++.++.|+++|++|||+++|||||||.+||||+.+.++||+|||++..+..
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999998776666666666888999999999999999999999999999999999999999999999999998863
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....+.||++.|.|||++.|..+.++.+|+||+|++||.|++|..||.|.+-.+.-...+.. .
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k-------------- 271 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--K-------------- 271 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--e--------------
Confidence 445677899999999999999998899999999999999999999999998766554443211 0
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+.--++.++.+||+++|.++|.+|+++++++.|.|....
T Consensus 272 -------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 272 -------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 01112367889999999999999999999999999999764
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.03 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=212.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
-|++.+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 368889999999999999999999999999998643 23445667889999999999999999998876 67899999
Q ss_pred eecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||+.++.+.. +......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... ....
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 9999765544 3333457999999999999999999999999999999999999999999999999998764322 1222
Q ss_pred cccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 290 TSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+|+.|+|||++.. ...++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------------
Confidence 34568999999998842 3346789999999999999999999999887777666654321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||++++|+||||...
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00123467889999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.79 Aligned_cols=280 Identities=25% Similarity=0.430 Sum_probs=222.2
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--C----ceeeeeceEe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--I----NVIKLEGLVT 199 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--p----nIv~l~~~~~ 199 (709)
....++|+++..||+|+||.|..+.+..++..||||+++... ...+..+-|+++|.+|.+ | -+|++.++|.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 344788999999999999999999999999999999987432 222334569999999932 2 2678888886
Q ss_pred ecCCCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC------------
Q 005210 200 SRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN------------ 266 (709)
Q Consensus 200 ~~~~~~lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~------------ 266 (709)
. .+++|||+|.++.++.+.+.. .-.+|+..+++.+..||+.++.|||+.+++|.||||+|||+.+
T Consensus 162 y--rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 162 Y--RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred c--cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 6 688999999999877776655 3457999999999999999999999999999999999999943
Q ss_pred --------CCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh
Q 005210 267 --------NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 338 (709)
Q Consensus 267 --------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~ 338 (709)
+..|+|+|||.|+.... .....+.|..|+|||++++-. ++..+||||+||||+||.+|..+|.+.++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCc
Confidence 23589999999986433 235668899999999999876 89999999999999999999999999999
Q ss_pred HHHHHHHHHhhCCCChhhhhhc---------CCCCccccC---------CCCccccchhcccCCCC---HHHHHHHHHhc
Q 005210 339 VEQLHKIFKLCGSPSEDYWRKS---------KLPHATIFK---------PQQPYKRCVAETFKDFP---APALALMETLL 397 (709)
Q Consensus 339 ~e~l~~I~k~~g~p~~~~w~~~---------~lp~~~~~~---------~~~~~~~~~~~~~~~~s---~~~~dLI~~lL 397 (709)
.|.+..+-..+|.++.....+. .+.+..... +..+. .......+ .++.|||++||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl----~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL----KKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccH----HHHhccCcHHHhHHHHHHHHHH
Confidence 9999999999997665543332 222211111 11111 11111112 34889999999
Q ss_pred ccCCCCCCCHHHHHhcccCCCC
Q 005210 398 SIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 398 ~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+||.+|+|+.|||.||||+..
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999853
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.59 Aligned_cols=259 Identities=21% Similarity=0.356 Sum_probs=210.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+..++..||+|.+... ........+.+|+.++++++|+||+++++.+.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 4689999999999999999999999999999998754 234445678899999999999999999998876 6789999
Q ss_pred EeeccccccccccCC---CCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 210 FEYMEHDLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 210 mEy~~g~L~~~~~~~---~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||++++.+..+... ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 999997655444332 2368999999999999999999996 59999999999999999999999999999765322
Q ss_pred CCCccccccccCCCCchhhcCCc-----cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~-----~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
......+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+......+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 123346788999999885432 357899999999999999999999977654443333322111110
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++.++.+||.+||..+|.+||++.+++.||||...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 11223578899999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.30 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=218.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.|+++..||.|+||.||+|.++.++-..|.|+|... ..+.++.++-||.||..++||+||+|++.|.. .+.+||.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEE
Confidence 4578889999999999999999999998999998643 35667788899999999999999999998877 6789999
Q ss_pred Eeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
.|||+|+-.+. +..-+..|++.+|..+++|+|.||.|||+++|||||||..|||++.+|.++|+|||.+.... ...+.
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 99999876553 34445579999999999999999999999999999999999999999999999999875432 12234
Q ss_pred ccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 289 LTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
..+++|||+|||||++.. ...|+.++||||||++|.||..+.||-..-+....+-+|.+.- .|+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPT----------- 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPT----------- 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCc-----------
Confidence 467899999999999863 4569999999999999999999999999888888888876521 111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
. -.+...+..+.|||.+||.+||..||+++++|+||||+..
T Consensus 255 --L------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 255 --L------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --c------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0 0112356678999999999999999999999999999854
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.38 Aligned_cols=286 Identities=35% Similarity=0.549 Sum_probs=231.3
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEE
Confidence 46789999999999999999999999999999999875443334456677899999999999999999988652 45789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+++++...+.. ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++.....
T Consensus 87 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 9999998876655542 3688999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.+.+|.++++.+..........
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 12344678899999988765568999999999999999999999999998888888888888888877654321111100
Q ss_pred cCCCC--ccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 368 FKPQQ--PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 368 ~~~~~--~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+.... .......+.++.++..+.+||.+||+.+|++|||++++|.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00000 001112344567889999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.05 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=209.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.+|++.+.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.+.||||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999875432 23446678899999999999999999998876545678
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||++++.+..+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999998654443333334689999999999999999999999999999999999999999999999999976532111
Q ss_pred --CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 --QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 --~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.......++..|+|||++.+.. ++.++|||||||++|+|++|++||........+..+.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 1123346889999999987754 78999999999999999999999987655554443321 1100
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
......++..+.++|.+||. +|.+|||++++++|||+.
T Consensus 228 --------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 --------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 01123467789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.10 Aligned_cols=256 Identities=30% Similarity=0.511 Sum_probs=213.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++++.||.|+||.||+|.+..++..||+|++..........+.+..|+.+++.++|+||+++++++.......+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999999999999999999987666666677788999999999999999999988765567899999
Q ss_pred eecccc-ccccccC---CCCCCCHHHHHHHHHHHHHHHhhhh-----hCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 211 EYMEHD-LAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCH-----SRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 211 Ey~~g~-L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH-----~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
||+.++ |...+.. ....+++..++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999864 4333322 2457999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
..... ......+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+... .
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~---------- 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--K---------- 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--C----------
Confidence 43322 123457899999999987755 789999999999999999999999988754444443221 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||..+|.+|||+.++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ----------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 001123567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.84 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=216.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|+.++.||.|+||.||.+++..++..|++|.+............+.+|+.++++++|+||+++++++.. .+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5899999999999999999999999999999998766666666778899999999999999999999977 67899999
Q ss_pred eeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+ +|...+... ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99986 455444332 45689999999999999999999999999999999999999999999999999987643321 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .+.
T Consensus 158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------------- 219 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------------- 219 (256)
T ss_pred ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------------
Confidence 34457899999999987765 688999999999999999999999988877777766431 110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.....++..+.+||.+||..||.+|||+.++|+|+|+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113578889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.99 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEE
Confidence 46799999999999999999999999999999998654 34456678889999999999999999998876 568999
Q ss_pred EEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++.+.. +......+++..++.++.||+.+|.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 999999765543 3333457899999999999999999999999999999999999999999999999998754322 12
Q ss_pred CccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++.+.. .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~----------- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PP----------- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC-Cc-----------
Confidence 2234567899999998853 3346889999999999999999999998877655554443210 00
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.......++..+.+||.+||..||.+||+++++|+||||..
T Consensus 234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 234 --------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred --------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00112356788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=360.22 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=217.0
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.+.||+|-||+||-|.+..+|+.||||+|.+-.+.......+..|+.||+.+.||.||.|.-.|+. ...+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhc
Confidence 468999999999999999999999999999887766666888999999999999999999888876 678999999999
Q ss_pred cccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---CcEEEeecccccccCCCCCCCcc
Q 005210 215 HDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 215 g~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
|+.+..++ ...++|++...+.++.|||.||.|||.++|+|+||||+|||+.+. -.+||||||+|+.+... ....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRr 724 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRR 724 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhhh
Confidence 99887654 456789999999999999999999999999999999999999754 37999999999998654 3456
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
+.+|||.|+|||+|..+. |....||||+|||+|--|+|.-||..+++ +-.+|....... |
T Consensus 725 sVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMy-----------------P 784 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMY-----------------P 784 (888)
T ss_pred hhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhcccccc-----------------C
Confidence 789999999999998766 89999999999999999999999976543 223332221111 2
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.. .+..+++.+.|||..+|++.-++|.|.+..|.|||++..
T Consensus 785 p~--------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 785 PN--------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CC--------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 22 235689999999999999999999999999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.78 Aligned_cols=261 Identities=27% Similarity=0.349 Sum_probs=211.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++++.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 479999999999999999999999999999999876543 23345567789999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
||||++++.+..+......+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||+++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999998755544444445799999999999999999999999999999999999999999999999999864211100
Q ss_pred ------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 287 ------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 287 ------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
.......++..|+|||.+.+.. ++.++|||||||++|||++|..||.+.+..+.+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-- 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--
Confidence 0111235788999999987654 7999999999999999999999999887766665554321000
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMK 419 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.||.+||+ +.++|+||||...
T Consensus 236 ------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 236 ------------------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ------------------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 0011247888999999999999999998 7999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.62 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=212.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 468899999999999999999999999999999876542 3344567899999999999999999998877 5789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
+||+.++.+..+.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999875444443333 78999999999999999999999999999999999999999999999999998765432 222
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....+++.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+....+..+.+.. +
T Consensus 156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~----------------- 215 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--P----------------- 215 (274)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--C-----------------
Confidence 3457888999999998765 7999999999999999999999998776555444433210 0
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+. +. ...++..+.+||.+||..||.+|||++++++||||+..
T Consensus 216 ~~------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 216 PS------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CC------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00 00 01268889999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=344.64 Aligned_cols=283 Identities=32% Similarity=0.546 Sum_probs=235.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
..+|..+..+|.|.- .|..|.+.-+++.||+|++..........+...+|..++..+.|+||++++.+|+... ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467889999999998 8999999999999999998765444555677789999999999999999999987532 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+|||||..++...+.. .+.-..+..++.|++.|++|||+.||+||||||+||+|..++.+||.|||+|+..+.+
T Consensus 95 e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 6899999999988877663 5788899999999999999999999999999999999999999999999999875543
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
-.++..++|..|+|||++.+.. |...+||||+|||+.||++|+.+|+|.+..++..+|...+|.|.+.+..+..-..
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4578889999999999999977 8999999999999999999999999999999999999999999998876532111
Q ss_pred ccccCCCCccc-cchhcccC------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIFKPQQPYK-RCVAETFK------------DFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~-~~~~~~~~------------~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+..+.....|. ....+.++ --...+++|+.+||..||++|.++.++|+||||+.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 11111111110 11112222 12346899999999999999999999999999984
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.33 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=213.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||.|+||.||++.+..++..||+|++... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999998754 34455678889999999999999999999876 678999
Q ss_pred EEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++.+. .+...+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999975544 444444579999999999999999999999999999999999999999999999999987543222 2
Q ss_pred CccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+|+.|+|||++.. ...++.++|||||||++|+|++|++||.+.+....+.++.... .+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPT---------- 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-CCC----------
Confidence 2234578999999999853 2346789999999999999999999998887666655553210 000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||..||..||.+|||+.++|+||||...
T Consensus 228 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 ---------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 01113467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=341.59 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=212.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.+.|+||+++++.+.. ...+|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 56899999999999999999999999999999998765433 24567789999999999999999998876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++........ .
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 9999987544444432 3689999999999999999999999999999999999999999999999999876543222 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|++||...+....+..+... +.+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------------
Confidence 23457899999999887654 689999999999999999999999887765544333211 1110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01123577889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.09 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=205.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM----S 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~----~ 203 (709)
.+.|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.+++.+ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46789999999999999999999999999999998754322 24567899999998 7999999999886532 2
Q ss_pred CeEEEEEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 204 CSLYLVFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
..+|+||||+.++ |...+.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999864 4444443 2346899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
.... .......|++.|+|||++.+ ...|+.++|||||||++|||++|..||...........+... +
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 4322 22344578999999999863 234788999999999999999999999765544333322110 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
. .......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 233 -----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -----------A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----------C--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 000113467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.06 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=211.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEE
Confidence 3689999999999999999999999999999999976532 245678899999999999999999998877 678999
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++.+..+. .....+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999976555443 333679999999999999999999999999999999999999999999999999997654322 1
Q ss_pred CccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....+++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+.+....+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------ 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc------------
Confidence 22345788999999998764 2478899999999999999999999988776655544432100000
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
.......++.++.+||.+||..||..|||+.++|.|+|
T Consensus 225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.83 Aligned_cols=261 Identities=29% Similarity=0.519 Sum_probs=208.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC--------hHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--------PESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~--------~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
+|.+.+.||.|+||.||+|.+..+++.||||.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 478899999999999999999999999999998643211 1224567789999999999999999998876
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
...+|+||||+.++.+.........+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 67899999999875544444444579999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCC-CccccccccCCCCchhhcCCc-cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 283 PDQNQ-PLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 283 ~~~~~-~~~~~~gT~~Y~APE~l~~~~-~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
..... ......++..|+|||++.... .++.++|+|||||++|+|++|..||...+..+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 22111 123446788999999987643 47889999999999999999999997665554444332110000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 232 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ---------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00112234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.79 Aligned_cols=254 Identities=26% Similarity=0.483 Sum_probs=212.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|+||.||++.+..+++.||||.+............+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 5899999999999999999999999999999998655545555678899999999999999999998876 67899999
Q ss_pred eeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+ .+...+.. ....+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+.... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 99986 45444433 23368999999999999999999999999999999999999999999999999997654322 11
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..+....+... ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------------- 218 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SY---------------- 218 (256)
T ss_pred hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CC----------------
Confidence 22346788999999987655 788999999999999999999999887777766665431 11
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......++..+.+||.+||+.+|.+||++.++|+||||
T Consensus 219 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ----------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.52 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=215.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||.|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV--GDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEE
Confidence 45799999999999999999999999999999998754332 34567889999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+..+.... .+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999876665544433 689999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|++||.+.+....+..+... +.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------------- 234 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------- 234 (296)
T ss_pred CCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------------
Confidence 23346889999999887654 789999999999999999999999998877666555321 1110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ----------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ----------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123578889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=330.15 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=211.1
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|.+.+.||+|+||.||+|.+..+++.||||+++.........+.+.+|+.+++.++|+||+++++++.. .+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 4889999999999999999999999999999998776555677888999999999999999999998765 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc-
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL- 289 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~- 289 (709)
||+.++.+..+...+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999765555555555689999999999999999999999999999999999999999999999999987643322211
Q ss_pred --cccccccCCCCchhhcCCc--cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 290 --TSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 290 --~~~~gT~~Y~APE~l~~~~--~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||.+............. +.+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------ 225 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP------------ 225 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC------------
Confidence 1346788999999987643 3688999999999999999999999765432222222111 1100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
. ......++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -----~-------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----P-------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----C-------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 00123468889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.14 Aligned_cols=260 Identities=29% Similarity=0.501 Sum_probs=207.7
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
+|+..+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++.. .+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 478889999999999999999999999999998754321 2245678899999999999999999999876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 285 (709)
++||||+.+..+..+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .+||+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999765554444445789999999999999999999999999999999999998776 69999999987664321
Q ss_pred C---CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 286 N---QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 286 ~---~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
. .......+|..|+|||++.+.. ++.++|||||||++|+|++|..||...........+.+..-..
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------- 227 (268)
T ss_pred ccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC----------
Confidence 1 1112346789999999987654 7899999999999999999999997654433333332211000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
. .......+++.+.+||.+||..||.+|||+.++|+||||.
T Consensus 228 -----~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 -----T---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -----C---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0112234788899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=332.79 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=207.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
+|.+.+.||.|+||.||+|.+ .++..||||.+...... ......+.+|+.+|+.++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 477889999999999999986 57889999998754321 2334568899999999999999999999876 5789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC--
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-- 284 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-- 284 (709)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999987655544444457899999999999999999999999999999999999999999999999998754211
Q ss_pred ---CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 ---QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ---~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.........++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 111223456899999999987654 789999999999999999999999877665554443321110
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011223578889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=328.35 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=211.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|+..+.||+|+||.||+|.+..++..||||.+............+.+|+.+|+.++||||+++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 5899999999999999999999999999999998766555566778899999999999999999998876 67899999
Q ss_pred eecccc-ccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccccccCCCCCC
Q 005210 211 EYMEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 211 Ey~~g~-L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~~~~~~~~~ 287 (709)
||++++ |...+... +..+++..+..++.||+.+|.|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 999874 44444332 3458999999999999999999999999999999999999855 468999999998764322
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---------------- 219 (256)
T ss_pred cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----------------
Confidence 222356889999999987654 788999999999999999999999888766665555431100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.....++..+.+||..||..||.+|||+.++|+||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1112478889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=332.47 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=209.2
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC---
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM--- 202 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~--- 202 (709)
...++|++.+.||+|+||.||+|.+..+++.|++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 446899999999999999999999999999999999875532 235678999999999 7999999999987532
Q ss_pred -CCeEEEEEeeccccccc-cccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccc
Q 005210 203 -SCSLYLVFEYMEHDLAG-LASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 277 (709)
Q Consensus 203 -~~~lyLVmEy~~g~L~~-~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 277 (709)
...+|+||||+++..+. .+.. .+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 35689999999974333 3222 245799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccccccccCCCCchhhcCC----ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
+....... .......++..|+|||++... ..++.++|||||||+||+|++|++||........+.++.+.. +
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~- 235 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--P- 235 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--C-
Confidence 87654322 222345689999999988542 346788999999999999999999998766655555543210 0
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
. . ......++..+.+||.+||..||.+|||+.++++|||+
T Consensus 236 ~----------------~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 P----------------T-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C----------------C-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 00112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=328.92 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=210.1
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+|+..+.||+|+||.||+|.+..++..|+||.+..... ..+..+.+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 36778899999999999999998999999999875432 23455678899999999999999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999875444444444468999999999999999999999999999999999999999999999999987654322
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......++..|++||.+.....++.++|+|||||++|+|++|++||......+....+.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------- 219 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------------
Confidence 224457899999999987654478999999999999999999999987765554444322100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 220 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 011123578889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=341.95 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=213.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.|.....||+|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++|+||+++++.+.. .+.+|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 44556678999999999999999999999999986533 3345567899999999999999999998876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++.+..+... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999997655544433 368999999999999999999999999999999999999999999999999987653322 222
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------- 237 (292)
T ss_pred ceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------
Confidence 3457899999999887654 7899999999999999999999998877766555443211000
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
......++..+.+||..||..||.+|||++++|+||||...+.|.
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 ---------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ---------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001124678899999999999999999999999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=341.79 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=211.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|.+.+.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 47899999999999999999999999999999998755432 23557789999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+..+... ..+++.++..++.|++.||.|||+.||+|+||||+||||+.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 9999987655544433 3589999999999999999999999999999999999999999999999999976543322 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------
Confidence 23457899999999987654 78999999999999999999999987665444332211 11110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||++++|+||||...
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 ----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 01123467889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=331.81 Aligned_cols=253 Identities=30% Similarity=0.429 Sum_probs=209.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 48999999999999999999999999999999986543 23456778899999999999999999998866 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.+..+.........+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999876554444434579999999999999999999999999999999999999999999999999987654332 22
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 3456788999999987755 79999999999999999999999987764 2222222110 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH--HHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA--ASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa--~e~L~hp~f 416 (709)
.......++..+.+||.+||..||.+|+++ .+++.||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001123467889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=337.44 Aligned_cols=244 Identities=20% Similarity=0.195 Sum_probs=201.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEee--cCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTS--RMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~--~~~~~lyLVmEy 212 (709)
..||+|+++.||+|.. +|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 6889999999765432 2335677899999999999999999998866 334678999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 213 ~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
+.++.+..+......+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..+.... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 99765555555555799999999999999999999984 99999999999999999999999999998653321 23
Q ss_pred cccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 292 RVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
.++|..|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+..+.+..+.+....+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 4788999999998752 4589999999999999999999999998887776666643211110
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++.+.+||.+||+.||.+|||+.++|+
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11246888999999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=333.05 Aligned_cols=252 Identities=17% Similarity=0.248 Sum_probs=203.0
Q ss_pred CCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..+|++.+.||+|+||.||+|.+. ..+..||+|+++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 357999999999999999999865 456789999987543 23344567899999999999999999999876 678
Q ss_pred EEEEEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||++++.+.. +......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999765554 3333457899999999999999999999999999999999999999999999999987654222
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.........++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------ 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------------
Confidence 111111234467899999887654 7999999999999999775 99999988877766655321110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+|+..||+.+|.+|||++++++
T Consensus 228 ----------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ----------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112357888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.15 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=207.9
Q ss_pred ccCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee--
Q 005210 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS-- 200 (709)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~-- 200 (709)
+.+...++|++++.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445568899999999999999999999999999999998764322 124466899999999 79999999998743
Q ss_pred -cCCCeEEEEEeecccccccc-c---cCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 201 -RMSCSLYLVFEYMEHDLAGL-A---SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 201 -~~~~~lyLVmEy~~g~L~~~-~---~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
.....+|+||||++++.+.. + ......+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 22467999999998754432 2 223456899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|++..+.... .......|++.|+|||++.. ...|+.++|||||||++|||++|+.||........+.++... .
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~ 245 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--P 245 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--C
Confidence 9997654322 12234478999999998853 234788999999999999999999999877655444333211 0
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+. . ......++..+.+||.+||+.||.+|||+.++|+|+||
T Consensus 246 ~~------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PP------------T------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CC------------c------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 0 00012356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.62 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=207.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC---C
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM---S 203 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~---~ 203 (709)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++.... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 37889999999999999999999999999999999865322 234566899999999 8999999999886432 2
Q ss_pred CeEEEEEeeccccccc-ccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 204 CSLYLVFEYMEHDLAG-LAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~-~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..+|+||||++++.+. ++. ..+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999875443 322 234578999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCc----cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGAT----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~----~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
.+...... .....++..|+|||++.... .++.++|||||||++|||++|++||...+....+..+.+.. +
T Consensus 177 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~--- 250 (291)
T cd06639 177 QLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--P--- 250 (291)
T ss_pred hccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--C---
Confidence 65432211 12346889999999886432 25789999999999999999999998877665555443210 0
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
+. ......++..+.+||.+||+.||++||++.++|+||||+
T Consensus 251 -------~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 -------PT--------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------CC--------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 001123567799999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=334.54 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=206.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR----MS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~----~~ 203 (709)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 467999999999999999999999999999999986542 2334577899999998 799999999987532 24
Q ss_pred CeEEEEEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 204 CSLYLVFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
..+|+||||+.++ +..++.. ....+++..++.++.||+.||.|||+.||+|+||||+||+|+.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 5789999999874 4444432 2346899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
..... .....++++.|+|||++.. ...++.++|||||||++|||++|.+||........+..+.... +
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~----- 243 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--P----- 243 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--C-----
Confidence 32221 2234578999999998863 2347889999999999999999999997766544443332110 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.89 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=213.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
...|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ....|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEE
Confidence 345999999999999999999999999999999987543 234455678899999999999999999999877 66799
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.+++...+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 99999998877766655557999999999999999999999999999999999999999999999999998765322
Q ss_pred CccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+++.|+|||++.+ ...++.++|||||||++|||++|++||.+.+.......+... ..+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~------------ 233 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT------------ 233 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCC------------
Confidence 23467889999998753 344788999999999999999999999887765554443211 0000
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 234 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 --------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred --------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0011356789999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=337.09 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=206.6
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|+..+.||+|+||.||++.+..+++.||||++...... .....+.+|+.++.++. |+||+++++++.. ....|+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4677888999999999999999999999999998755433 44556788999999995 9999999998876 567899
Q ss_pred EEeeccccccccc----cCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 209 VFEYMEHDLAGLA----SHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 209 VmEy~~g~L~~~~----~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
||||+...+..+. ......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999986543322 12335799999999999999999999975 999999999999999999999999999976532
Q ss_pred CCCCCccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.. ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 230 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------ 230 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc------
Confidence 22 12334688999999998766 3689999999999999999999999976542 222222211110000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
........++..+.+||.+||+.||.+|||+++++.||||..
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 231 ---------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ---------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 001111357889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.79 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=212.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+-|.++.+||+|+||.||+|.++++|..||||.+..+ ..++.+..||.||++++.|+||++||.|.. ...+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEee
Confidence 3488899999999999999999999999999998654 346678899999999999999999998766 5679999
Q ss_pred Eeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+. ...+.+..++..|+|.++..+++..|.||+|||...-||||||..||||+.+|..||+|||.|-.+..... .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 999984 55566666777899999999999999999999999999999999999999999999999999976643322 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
..+.+|||.|||||++..-. |+.++||||||++..||.-|+|||........ ||-.-..|++.+
T Consensus 186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF------------ 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTF------------ 249 (502)
T ss_pred hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCC------------
Confidence 34679999999999997644 89999999999999999999999976544332 322111221111
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+.++.|||+.||.++|++|.||.++++|+|++..
T Consensus 250 -----------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 250 -----------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred -----------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 0112356778999999999999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.24 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=222.0
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (709)
.++.+|..+.+||+|+||+|.+|..+.+.+.||||+++++.+ ..+.++-.+.|-++|... +-|.+++|+.+|+. .+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mD 423 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MD 423 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hh
Confidence 346789999999999999999999999999999999998754 445556566788888877 56889999998876 67
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
++|+||||+.| +|...++.- ++|.|+.+..|+..|+-||-|||++|||+||||.+|||||.+|++||+|||+++.--.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 89999999986 566666554 4899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+.||||.|+|||++.-.. |+.++|+||+||+|||||.|++||.|.++.++...|....
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-------------- 566 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-------------- 566 (683)
T ss_pred -CCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--------------
Confidence 223345789999999999887654 8999999999999999999999999999999999886531
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-----~e~L~hp~f~~~ 419 (709)
....+.+|.++.++++.+|.+.|.+|..+ .++-.||||...
T Consensus 567 ---------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 567 ---------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred ---------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 12346789999999999999999999753 678899999854
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=332.47 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=208.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|+..+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 468889999999999999999999999999999876543 3445667899999999999999999998877 5789999
Q ss_pred Eeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+.+ +|...+......+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999995 4544444333689999999999999999999999 99999999999999999999999999998765322211
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-----EVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-----~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
...++..|+|||.+.+. .++.++|||||||++|+|++|..||.... ..+.+..+... +.
T Consensus 158 ---~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~--------- 221 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PP--------- 221 (265)
T ss_pred ---cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CC---------
Confidence 25788899999998776 47999999999999999999999997642 22333333210 00
Q ss_pred CCccccCCCCccccchhcccC-CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+ .... .++..+.+||..||..||.+|||+.++|.||||+..
T Consensus 222 -------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0 0011 178889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=328.25 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=209.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEE
Confidence 367999999999999999999999989999999986432 15678899999999999999999999877 578999
Q ss_pred EEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.+..+ ..+...+..+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999997544 44433455789999999999999999999999999999999999999999999999999987643321
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......++..|+|||++.+.. ++.++||||||||+|+|++|++||...........+... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~------------- 217 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPP------------- 217 (256)
T ss_pred ccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCC-------------
Confidence 223345788999999987764 789999999999999999999999876654443332110 000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 ----------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.67 Aligned_cols=254 Identities=28% Similarity=0.519 Sum_probs=209.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||.|+||.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 5889999999999999999999999999999997654444455667899999999999999999998876 67899999
Q ss_pred eeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCCCC
Q 005210 211 EYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 211 Ey~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~ 287 (709)
||+.+ .|...+.. .+..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .+||+|||++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99986 44444433 233589999999999999999999999999999999999999886 56999999998764322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 223346889999999887654 7899999999999999999999998877665555443210
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+....+.++..+.++|.+||..+|++|||+.++|+||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 111123577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.98 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=205.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-----eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--C
Confidence 457999999999999999999976655 689999986443 34445668899999999999999999998876 5
Q ss_pred CeEEEEEeecccc-ccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 204 CSLYLVFEYMEHD-LAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
...|++|||++++ |...+... ...+++..+..++.||+.||.|||++||+|+||||+||||+.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 6789999999864 44333221 1458899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCC-CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I 345 (709)
+.+||+|||++....... ........+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....|
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999997653222 12233446788999999887655 7999999999999999998 99999988776666555
Q ss_pred HHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.. ......++|.++.+|+.+||+.||.+|||+.+++++
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQ----------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCC----------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3311 001124578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.39 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=212.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.|+....||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence 35556689999999999999999999999999875432 223557789999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99997655444433 468999999999999999999999999999999999999999999999999987654322 2223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..+++..|+|||++.+.. ++.++|||||||++|||++|++||...+..+.+..+.. .+. .
T Consensus 176 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~--------------- 235 (297)
T cd06659 176 SLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-P--------------- 235 (297)
T ss_pred ceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-C---------------
Confidence 457899999999987654 78999999999999999999999988877666654421 100 0
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.......++..+.+||..||+.||.+|||+.++++||||....++.
T Consensus 236 -------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 236 -------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred -------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 0111235778899999999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.81 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=205.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 7999999999999999999999999976543 23445678899999999999999999998876 67899999999865
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccccc
Q 005210 217 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296 (709)
Q Consensus 217 L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~ 296 (709)
.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+|+.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 554444444568999999999999999999999999999999999999999999999999998764332 223347889
Q ss_pred CCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT--EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 297 ~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~--~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
.|++||++.+.. ++.++|+|||||++|+|++|..||.... ..+.+.++......+
T Consensus 157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 999999987654 7899999999999999999999998776 444454443210000
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTM 418 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~ 418 (709)
.....+++.+.+||.+||..||.+|+| ++|+++||||+.
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 011234788999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.26 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=196.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCCChH-HHHHHHHHHHHHHh---cCCCceeeeeceEeecCCCeEEEEEee
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE-SVRFMAREIHILRR---LDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~-~~~~~~rEi~iL~~---L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
.||+|+||.||++.+..+++.||||.+........ ......+|..+++. ..||||+.+++++.. .+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 48999999999999999999999999876543222 12223345444443 479999999988876 5689999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 005210 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292 (709)
Q Consensus 213 ~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 292 (709)
+.++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9976555444445579999999999999999999999999999999999999999999999999987553221 2234
Q ss_pred ccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH--HHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV--EQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 293 ~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~--e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
.||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... ..+..+... .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~------------------ 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---V------------------ 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---C------------------
Confidence 78999999999875555789999999999999999999999764321 111111100 0
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||..||.+|+ |+.++++||||+..
T Consensus 215 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 215 -------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred -------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 0012245788999999999999999999 69999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.48 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999986432 123455678899999999999999999998876555679
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ- 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~- 285 (709)
++||||+.+..+.........+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999865444333333468999999999999999999999999999999999999999999999999998653211
Q ss_pred -CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 -NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 -~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........++..|+|||++.+.. ++.++|+|||||++|+|++|++||......+.+.++. ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC----------
Confidence 11123456899999999987755 6899999999999999999999998776655554442 11110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......+++.+.++|..||. +|.+|||+.++|.|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01224578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.12 Aligned_cols=254 Identities=34% Similarity=0.541 Sum_probs=211.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.+. |+||+++++++.. ...+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 479999999999999999999999999999999876433 2334466788999999998 9999999998876 67899
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
+||||+.+ +|...+. ....+++..++.++.||+.||.|||+.|++|+||+|+||+|+.++.++|+|||++..+.....
T Consensus 79 lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999965 4544444 344799999999999999999999999999999999999999999999999999986643221
Q ss_pred -------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 005210 287 -------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 287 -------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k 347 (709)
.......++..|+|||++.+.. ++.++|||||||++++|++|+.||...+....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 1223346789999999887654 78899999999999999999999998876665555532
Q ss_pred hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccC
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFF 416 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f 416 (709)
.. ......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 237 ~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LE-----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cC-----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 10 01123458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.51 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=196.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHH---HHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMARE---IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rE---i~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
.||+|+||.||+|.+..+++.||||++....... ........| +.+++.+.||||+.+++++.. ...+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999999999999999987654321 111122233 344555689999999998876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 005210 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292 (709)
Q Consensus 213 ~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 292 (709)
+.++.+.........+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9876555444445579999999999999999999999999999999999999999999999999987653221 2234
Q ss_pred ccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH--HHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE--QLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 293 ~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e--~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
+|+..|+|||++.+...++.++||||+||++|+|++|+.||.+..... ....... . .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~------------------ 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T-M------------------ 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c-c------------------
Confidence 789999999999765558999999999999999999999998763221 1111110 0 0
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||..||.+|+ ++.++++||||...
T Consensus 215 -------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 215 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0011234688999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.05 Aligned_cols=256 Identities=32% Similarity=0.441 Sum_probs=211.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 4689999999999999999999999999999998765432 445678899999999999999999999876 5789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||++++.+..+......+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999965444444333579999999999999999999999 99999999999999999999999999999876433222
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~---~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|++||.... ..+....+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------------- 219 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------------- 219 (264)
T ss_pred ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------------
Confidence 2345678999999988765 47899999999999999999999998774 2333333321 00
Q ss_pred cccCCCCccccchhcccCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 366 TIFKPQQPYKRCVAETFKD-FPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....... ++..+.+||..||..+|.+|||+.++|+||||+.
T Consensus 220 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 220 ------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0011123 7889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.38 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=211.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.|+||+++++++.. .+.+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 357888999999999999999999999999999875432 3445678899999999999999999999877 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||++++.+..+... .++++.++..++.||+.||.|||+.+++|+||+|+|||++.++.++|+|||++..+.... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 999987554444433 368999999999999999999999999999999999999999999999999997664322 222
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||++.+.. ++.++|+|||||++|||++|.+||...+.......+... .+
T Consensus 159 ~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~----------------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NP----------------- 218 (277)
T ss_pred ccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CC-----------------
Confidence 3446788999999987654 689999999999999999999999877655444333110 00
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..+|.+||++.++|+|+||...
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 01123467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=321.85 Aligned_cols=254 Identities=31% Similarity=0.504 Sum_probs=213.7
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|+|++++++.+.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5889999999999999999999999999999998766655666778899999999999999999998876 57899999
Q ss_pred eecccc-ccccccCC---CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 211 EYMEHD-LAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 211 Ey~~g~-L~~~~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||+++. |...+... +..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999864 44444332 3679999999999999999999999999999999999999999999999999998764432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------- 219 (258)
T ss_pred ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------------
Confidence 2233457889999999887655 7899999999999999999999998877555544443211
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.++|..||..+|.+|||+.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 -----------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 001112577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.12 Aligned_cols=259 Identities=23% Similarity=0.272 Sum_probs=199.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECC----------------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD----------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 192 (709)
.++|.+.++||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4679999999999999999998532 34579999987543 344456688999999999999999
Q ss_pred eeeceEeecCCCeEEEEEeecccc-ccccccC------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCee
Q 005210 193 KLEGLVTSRMSCSLYLVFEYMEHD-LAGLASH------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253 (709)
Q Consensus 193 ~l~~~~~~~~~~~lyLVmEy~~g~-L~~~~~~------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIv 253 (709)
++++++.. ...+||||||+.++ |...+.. ....+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999876 56799999999864 4333221 112478889999999999999999999999
Q ss_pred eccCCCccEEEcCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh--CC
Q 005210 254 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GK 330 (709)
Q Consensus 254 HrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt--G~ 330 (709)
||||||+||||+.++.+||+|||++..+...... ......++..|+|||++.+.. ++.++|||||||++|||++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999865432221 122345578899999987655 7999999999999999986 56
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005210 331 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410 (709)
Q Consensus 331 ~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~ 410 (709)
.||.+.+..+.+..+....-..... ........++..+.+||..||..||.+|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 7887776665555443211000000 0001123567889999999999999999999999
Q ss_pred Hh
Q 005210 411 LR 412 (709)
Q Consensus 411 L~ 412 (709)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.43 Aligned_cols=257 Identities=27% Similarity=0.497 Sum_probs=209.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~ly 207 (709)
.|++.+.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. ||||+++++++.. ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 4788999999999999999999999999999987543 2334456778999999996 9999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++.+..+...+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 999999875444444333 78999999999999999999999999999999999999999999999999998765433 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~---------------- 218 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--K---------------- 218 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--C----------------
Confidence 2334578999999999876666789999999999999999999999876554333222110 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+.. ....++..+.+||..||..||.+|||+.+++.|+||+..
T Consensus 219 -~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 219 -PPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred -CCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 0000 001267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=334.66 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=213.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
-|...+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++|||++++++++.. ....|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 37778899999999999999999999999999876533 33445667889999999999999999999877 5789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.+++...+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... .
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 99999888777766566799999999999999999999999999999999999999999999999999864321 2
Q ss_pred cccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 290 TSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+... ..+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------- 239 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT-------------- 239 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC--------------
Confidence 34578899999999853 344788999999999999999999999888776666655431 0000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||+.+|.+||++.++|.||||...
T Consensus 240 ------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 240 ------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0113466789999999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=320.09 Aligned_cols=254 Identities=29% Similarity=0.496 Sum_probs=213.3
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++|+|++++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4889999999999999999999999999999998776555666788899999999999999999998876 57899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||+++..+..+......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......... ..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99987544443333457999999999999999999999999999999999999999999999999999876543221 23
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
...++..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+....+.++... .
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------------- 215 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-D-------------------- 215 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-C--------------------
Confidence 456789999999887655 789999999999999999999999877665555444210 0
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.......++..+.+||.+||..+|++|||+.++|.||||
T Consensus 216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001123568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=330.07 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=211.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.|...+.||+|++|.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++.. .+..|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 4666789999999999999999999999999986433 2334557799999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||+.+..+..+... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99987555444433 4689999999999999999999999999999999999999999999999998875533221 223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
...+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+... ..+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~----------------- 234 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK----------------- 234 (285)
T ss_pred cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------------
Confidence 356899999999987654 789999999999999999999999888777666655431 0000
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
......++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 --------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 011123778899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.89 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=208.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
..+.+++.||+|-||.||.|.+..+ ..||+|.++...+.. +.+.+|+++|++|+|+|||+|+++++. ...+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEec--CCceEEE
Confidence 4577889999999999999998654 369999998765443 346699999999999999999999987 4579999
Q ss_pred Eeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 210 FEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 210 mEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||.. .|++.+.. .+..+...+...|+.||++|++||+++++|||||-..||||+++..+||+|||||+....+...
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999985 56666654 5678999999999999999999999999999999999999999999999999999965544443
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.....--...|.|||.+.-.. |+.++|||||||+||||+| |+.|+++.+..+.+..+-+..--|
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------------- 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------------- 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------------
Confidence 333334466799999998766 7999999999999999998 999999999999999886532211
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L 411 (709)
.+..+|+.+-+|+..|+..+|++|||.+.+.
T Consensus 425 --------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 --------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2346899999999999999999999998654
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=322.94 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=206.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||.|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.. .+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 58899999999999999999999999999999875432 3345667789999999999999999999876 67899999
Q ss_pred eeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||+.+ ++...+.. .+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99986 45444432 34468999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|.+||...+....+..+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 23457899999999987654 789999999999999999999999887766655554321100
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||.+||+.||.+|||+.++|.-
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.82 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=208.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEE
Confidence 467999999999999999999999999999999987543 23345677899999999999999999999877 578999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999976665555445579999999999999999999997 699999999999999999999999999986542211
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH-----------HHHHHHHhhCCCChhh
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-----------QLHKIFKLCGSPSEDY 356 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e-----------~l~~I~k~~g~p~~~~ 356 (709)
....++|..|+|||++.+. .++.++|||||||++|+|++|+.||......+ .+..+... .
T Consensus 159 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 229 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---P---- 229 (284)
T ss_pred -cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---c----
Confidence 1235789999999998765 47899999999999999999999998655421 11111100 0
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+.. ....++..+.+||.+||.+||.+|||+.++++|+||...
T Consensus 230 ------------~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 230 ------------PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ------------CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000 001367889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.61 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=208.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.|+..+.||+|+||.||+|.+..++..||||.+..... ......+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 357788899999999999999999999999999875432 3345678899999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++.+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999997554444433 368999999999999999999999999999999999999999999999999997654322 122
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||++.+.. ++.++|||||||++|||++|++||...........+... .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~----------------- 218 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SP----------------- 218 (277)
T ss_pred hcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CC-----------------
Confidence 2346789999999987654 789999999999999999999999766544433322110 00
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......++..+.+||.+||..+|.+|||+.++|+||||..
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 219 ---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 0111246788999999999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.29 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=198.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-----eEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.... ......+.+|+.+++.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 568999999999999999999865443 5799999975432 33456688999999999 89999999998876
Q ss_pred CCeEEEEEeecccc-ccccccC----------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHD-LAGLASH---------------------------------------------------------- 223 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~---------------------------------------------------------- 223 (709)
...+|+|||||.++ |...+..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 66899999999854 3322211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-Cccc
Q 005210 224 -----------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTS 291 (709)
Q Consensus 224 -----------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~ 291 (709)
....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... ....
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1125788999999999999999999999999999999999999999999999999765432211 1112
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..++..|||||++.+.. |+.++|||||||++|||++ |++||........+.++.+....+
T Consensus 274 ~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------------ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------------ 334 (374)
T ss_pred CCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------------
Confidence 23466799999987654 8999999999999999997 999998765544444443211000
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++++.+||..||+.||.+|||+.++++
T Consensus 335 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ---------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001235788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=334.80 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=213.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..|+..+.||+|+||.||++.+..++..||||++..... ..+....+.+|+.+++.++|||++++++++.. ....||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 348889999999999999999999999999999875533 33445678889999999999999999999877 567899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.+++...+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9999998877776655667999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 289 LTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
....+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+..+......+
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 23468889999999752 3347889999999999999999999998877666666554321100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....++..+.+||.+||+.+|.+|||+.++++|+|+..
T Consensus 244 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 011246778999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.33 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=206.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.....+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468999999999999999999999999999999875432 2445668899999999999999999998876556789999
Q ss_pred Eeecccc-cccc---ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 210 FEYMEHD-LAGL---ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 210 mEy~~g~-L~~~---~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||++++ |... .......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999864 3332 22334568999999999999999999999999999999999999999999999999987653221
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhhCCCChhhhhhc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-----EVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-----~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
. ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.... ..+....+... .... .
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-~--- 228 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPE-L--- 228 (287)
T ss_pred c---ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchh-h---
Confidence 1 2345788999999887654 7899999999999999999999998662 22222222110 0000 0
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+.. ...-...++.+.+||..||..||.+|||+.|+++||||..
T Consensus 229 ---------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 ---------KDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ---------ccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 0000124678999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=354.10 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=206.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
+||+|+||+||.|++..|...+|||-|... +...++-+..||.+.++|+|.|||+++|.+.. ++.+-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 799999999999999999999999998643 23445667899999999999999999998755 67888999999976
Q ss_pred cc-ccccCCCCCC--CHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeecccccccCCCCCCCcccc
Q 005210 217 LA-GLASHPGLKF--SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSR 292 (709)
Q Consensus 217 L~-~~~~~~~~~l--se~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~ 292 (709)
.+ .++...-+++ .|..+-.|.+||++||.|||++.|||||||.+|+||+ -.|.+||+|||.++.+.. -+....+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 54 4555555567 8999999999999999999999999999999999997 579999999999987643 23334467
Q ss_pred ccccCCCCchhhc-CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 293 VVTLWYRPPELLL-GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 293 ~gT~~Y~APE~l~-~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
-||..|||||++. |...|+.++|||||||++.||.||+|||..-.... ..+|++ .+|+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-----------------GmyKv- 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-----------------GMYKV- 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-----------------cceec-
Confidence 8999999999986 45669999999999999999999999996432211 112221 11110
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
-...+..++.+++.||.+|+..||.+||+|.++|+.||++..+
T Consensus 797 ------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 797 ------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred ------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 1122345778899999999999999999999999999998763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.14 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=201.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||+|+||.||+|.+..+|+.||+|++...... ......+..|+.+|+.++||||+++++++.. ...+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999998754332 2234455689999999999999999998876 57899999999864
Q ss_pred -ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 217 -LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 217 -L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
|...+.. ....+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 4434333 223699999999999999999999999999999999999999999999999999876543 222234567
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....-.
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 212 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------------------- 212 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------------
Confidence 88999999987765 789999999999999999999999876542222222111000
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
........+++.+.+||.+||+.||.+|| ++.+++.||||...
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 00112235788999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.17 Aligned_cols=278 Identities=23% Similarity=0.307 Sum_probs=204.7
Q ss_pred eeeccc--CceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G--~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
..||.| +||.||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 467776 99999999999999999999998765555666788899999999999999999999987 66799999999
Q ss_pred ccc-ccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC---
Q 005210 214 EHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--- 288 (709)
Q Consensus 214 ~g~-L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~--- 288 (709)
.++ +..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 864 44433322 2358999999999999999999999999999999999999999999999998654331111000
Q ss_pred ---ccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 289 ---LTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 289 ---~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....++..|+|||++.+. ..++.++|||||||++|+|++|++||.+....+.+..++...... .|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS---PLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC---Cccccccch
Confidence 0112346679999998764 347899999999999999999999998877666555544321111 110000000
Q ss_pred cc-----------------ccC----CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 AT-----------------IFK----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~-----------------~~~----~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.. ... ........-......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00 000 0000000001112346778999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=324.84 Aligned_cols=250 Identities=29% Similarity=0.401 Sum_probs=200.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHH-HhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHIL-RRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL-~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||.|+||.||+|.+..+++.||||++...... ......+..|..++ ..++|+||+++++++.. .+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5799999999999999999999999998754332 22233344555544 45589999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~ 293 (709)
.++.+..+......+++.++..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 8755554444445789999999999999999999999999999999999999999999999999875432 12346
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...... |
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~---------------- 212 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----W---------------- 212 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----C----------------
Confidence 788999999988765 789999999999999999999999888776655554321000 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccCCC
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTM 418 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~e~L~hp~f~~ 418 (709)
.......++..+.+||.+||+.||.+||| ++|+|.||||..
T Consensus 213 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 213 ----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 00112357889999999999999999995 589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=367.48 Aligned_cols=149 Identities=28% Similarity=0.432 Sum_probs=131.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|.++++||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 5789999999999999999999999999999999976433 44556778899999999999999999988866 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
|||||+.++.+..++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999765444343334478999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=324.12 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=203.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEE
Confidence 346899999999999999999999999999999986432 234567789999999999999999998876 667899
Q ss_pred EEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.++ |...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999854 4444432 234689999999999999999999999999999999999999999999999999987643322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------------- 222 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------------- 222 (263)
T ss_pred eccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------------
Confidence 2222223466799999887654 7899999999999999998 999999877665554443210
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. ......++..+.+||.+||..||.+|||+.++++.
T Consensus 223 ---~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 ---R---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ---C---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 0 01124578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.47 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=209.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 47788999999999999999999999999999865432 3345668899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||+.++.+..+... ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99987655444433 368999999999999999999999999999999999999999999999999987654322 1223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
...++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+... .+
T Consensus 160 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------ 218 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP------------------ 218 (277)
T ss_pred cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC------------------
Confidence 456889999999887654 688999999999999999999999876655544443210 00
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.++|..||..+|.+||++.++|+||||...
T Consensus 219 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 --------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01123467889999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.78 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=201.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEE
Confidence 344555679999999999999999999999999986543 3345678899999999999999999998876 678999
Q ss_pred EEeecccc-ccccccCCCCCC--CHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKF--SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~l--se~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~ 284 (709)
||||+.++ |...+......+ ++..+..++.||+.||.|||+.||+||||||+||||+. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999865 444443333345 88999999999999999999999999999999999986 679999999998765322
Q ss_pred CCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChhhhhhcCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~-l~~I~k~~g~p~~~~w~~~~l 362 (709)
. .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||........ +..+ ...
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~------------- 227 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMF------------- 227 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhh-------------
Confidence 2 222334678999999998653 3478899999999999999999999975432211 1111 000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.........+++.+.+||.+||..+|.+|||+.+++.||||
T Consensus 228 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 -------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00111223578889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.26 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=200.3
Q ss_pred eeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
|.+.+.||+|+||.||+|....+ +..||||+++...........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999998765555566778899999999999999999988754221 3
Q ss_pred eEEEEEeecccccc-cccc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 205 SLYLVFEYMEHDLA-GLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 205 ~lyLVmEy~~g~L~-~~~~-----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
..++||||+.++.+ ..+. .....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 47999999986433 3321 12246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 279 SFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 279 ~~~~~~~~~~-~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
+.+....... .....++..|+|||.+.+. .++.++|||||||++|||++ |.+||.+....+.+..+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~---- 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NR---- 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC----
Confidence 8664322211 1122346789999988654 47999999999999999999 99999887776655544321 00
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||+.||.+|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.65 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=203.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 57999999999999999999999999999999987533 344555667899999999999999999999876 578999
Q ss_pred EEeecccccc-cccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 209 VFEYMEHDLA-GLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~L~-~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
||||++++.+ ..+. .....+++..+..++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999996433 3322 23346899999999999999999999999999999999999999999999999998876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~-~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.. ......+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||..... ...+...+...+.+..
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------- 228 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC---------
Confidence 21 122346888999999987655 68899999999999999999999865432 1222222222121110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 229 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=322.93 Aligned_cols=249 Identities=22% Similarity=0.381 Sum_probs=202.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|+++++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 578999999999999999999864 556799998764332 34567889999999999999999988866 567899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+.. ....+++..+..++.||+.||.|||+.+++|+||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999975 55554432 345689999999999999999999999999999999999999999999999999987643322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2223334567899999887654 7889999999999999998 99999988776666655332100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||..||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.20 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=200.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.+|++++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 568999999999999999998754 557999988644332 2456789999999999999999998876 5679999
Q ss_pred Eeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||+.++ |...+......+++..++.++.||+.||.|||++||+|+||||+||+|+.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999854 554444334468999999999999999999999999999999999999999999999999987653322222
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....++..|+|||++.+.. ++.++|||||||++|||++ |++||...+..+.+..+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------- 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------- 220 (256)
T ss_pred cCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence 22234466899999987654 7899999999999999999 99999988877777766431100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+..+.+||.+||..||.+|||++++++
T Consensus 221 ------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001225678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.62 Aligned_cols=273 Identities=22% Similarity=0.274 Sum_probs=200.4
Q ss_pred CceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccccccccc
Q 005210 142 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA 221 (709)
Q Consensus 142 ~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~ 221 (709)
++|.||.+++..+++.||||++............+.+|+.+++.++|+||+++++++.. ...+|++|||+.++.+..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44566777777799999999998765566677789999999999999999999999876 6789999999997654433
Q ss_pred cC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC------CCccccc
Q 005210 222 SH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------QPLTSRV 293 (709)
Q Consensus 222 ~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~------~~~~~~~ 293 (709)
.. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||.+..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 32 234689999999999999999999999999999999999999999999999998875532111 1122345
Q ss_pred cccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc-----
Q 005210 294 VTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI----- 367 (709)
Q Consensus 294 gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~----- 367 (709)
++..|+|||++.+. ..|+.++|||||||++|||++|+.||........+..... +.... .+.....+....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYEDSMSQS 246 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhcCCcCcc
Confidence 67889999998763 3478999999999999999999999987665544332222 11110 000000000000
Q ss_pred ---cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 ---FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ---~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+................++..+.+||..||..||.+|||+.++|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000000001111123456789999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.80 Aligned_cols=259 Identities=29% Similarity=0.495 Sum_probs=210.6
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++|+||+++++.+.......+|+||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999999999999999987655456677888999999999999999999988763237899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-Cc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PL 289 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~ 289 (709)
||+.+..+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99976544443333448999999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ....+.+... .
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-~----------------- 219 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS-S----------------- 219 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc-c-----------------
Confidence 3457889999999887655 78999999999999999999999987762 1111211110 0
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.........++..+.+||.+||..||.+||++.++|+||||
T Consensus 220 ------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00111223458899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.38 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=206.4
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
.+.++|++...||.|+|+.|-.+.+..+++.+++|++.....+ ..+|+.++... +||||+++.+++.+ ...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~--~~~ 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYED--GKE 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecC--Cce
Confidence 3578899999999999999999999999999999999765211 23577666665 89999999999977 788
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE-cCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI-DNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl-d~~g~vKL~DFGla~~~~~~ 284 (709)
+|+|||++.|+++...+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999876554444443344 7888899999999999999999999999999999 59999999999999876543
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
+.+.+.|..|.|||++.. ..|+.++||||||++||+||+|+.||........+.. .++.+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccc---------
Confidence 445578999999999885 4589999999999999999999999987665533222 22222111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+|..+++||..||++||.+|+++.+++.||||...
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 3589999999999999999999999999999999443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=327.00 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=203.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..+|.+.+.||+|+||.||+|.+.. ++..||||++..... .+....+.+|+.+|+.+.|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 4578999999999999999998753 467899999875432 3345678899999999999999999999877 5
Q ss_pred CeEEEEEeeccccccc-cccC-------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 204 CSLYLVFEYMEHDLAG-LASH-------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~-~~~~-------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
..+|+||||+.++.+. .+.. ....+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 7899999999865433 3221 1235889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 005210 270 LKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 270 vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k 347 (709)
+||+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999975432211 1123345678899999987755 7999999999999999998 9999988877666655532
Q ss_pred hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. .+ ......++..+.+||.+||..||.+|||+.|+++
T Consensus 240 ~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 G--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred C--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 10 0112357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.74 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=210.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|+||.||++.+..++..||+|++............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4889999999999999999999999999999998765555556677889999999999999999998876 57899999
Q ss_pred eecccccc-ccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 211 EYMEHDLA-GLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 211 Ey~~g~L~-~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||+.+..+ ..+.. ....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99986443 33222 2346899999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+++.|++||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------------- 218 (256)
T ss_pred -CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 223356889999999987654 78899999999999999999999988876655444422100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 219 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 ------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.64 Aligned_cols=252 Identities=31% Similarity=0.522 Sum_probs=208.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
+|++.+.||+|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 48889999999999999999999999999999876543 345678899999999999999999998876 57899999
Q ss_pred eecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||+++. |...+......+++..+..++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999954 4444444335799999999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+... ..+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------- 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG---------------- 216 (253)
T ss_pred cceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC----------------
Confidence 3457889999999987655 789999999999999999999999887655555444321 0000
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
. .....++..+.+||..||+.||.+|||+.++|+|||
T Consensus 217 --~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 --L-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred --c-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 000124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=330.66 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=210.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 5789999999999999999999999999999999864432 234567889999999999999999999876 668999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+.++.+..+... ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999987554444333 2588999999999999999999999999999999999999999999999999876543322 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....+++.|+|||.+.+.. ++.++|+|||||++|+|++|++||...+..+++..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------
Confidence 23346889999999987654 78999999999999999999999988766554433321 01110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||..||..+|.+||++.++|.|+||...
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00122467889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.80 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=199.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++... .......+.+|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3579999999999999999997543 45789999987543 234456677899999999 899999999987643
Q ss_pred CCeEEEEEeeccccccccccCC----------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHDLAGLASHP---------------------------------------------------------- 224 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~---------------------------------------------------------- 224 (709)
...+|+||||+.++.+..++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999986543322110
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-CccccccccCCCC
Q 005210 225 ---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRP 300 (709)
Q Consensus 225 ---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~A 300 (709)
...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ......++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126899999999999999999999999999999999999999999999999999876332221 1223455778999
Q ss_pred chhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchh
Q 005210 301 PELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVA 379 (709)
Q Consensus 301 PE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~ 379 (709)
||++.+.. ++.++|||||||+||||++ |..||.+....+.+...++.. .. .
T Consensus 244 PE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--------------------------~ 295 (337)
T cd05054 244 PESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TR--------------------------M 295 (337)
T ss_pred cHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-CC--------------------------C
Confidence 99988755 7999999999999999998 999998765544443333210 00 0
Q ss_pred cccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 380 ETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 380 ~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++++.+|+.+||+.+|++|||+.++++|
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=344.32 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=198.4
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 45799999999999999999974 35677899999875432 33445678999999999 89999999999876
Q ss_pred CCeEEEEEeeccc-cccccccC----------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEH-DLAGLASH---------------------------------------------------------- 223 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~---------------------------------------------------------- 223 (709)
....|+|||||.+ +|...+..
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 6679999999985 44333321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 224 ----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 224 ----------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125788999999999999999999999999999999999999999999999999865432221
Q ss_pred -CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 -PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 -~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+......+.+++.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-------------- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc--------------
Confidence 112234466799999997755 7999999999999999998 89999876554444333321000
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+ ......+.++.+||..||+.||.+|||+.++++.
T Consensus 336 ----~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 ----M---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ----C---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 0112357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.45 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=205.9
Q ss_pred CeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (709)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... .....+.+.+|+.+|+.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999875 4789999999875432 122345677899999999 69999999988876 57
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++.+.........+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 89999999996544433333457899999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.........++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.+.+-..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----------- 227 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence 33333345789999999998753 346789999999999999999999997543322222222111000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......+++.+.+||.+||..||.+|+ ++++++.||||+..
T Consensus 228 --------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 --------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred --------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0001234778899999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.72 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=202.1
Q ss_pred CCCeeEEeeecccCceEEEEEEEC----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 467999999999999999999853 456789999987433 34445667899999999999999999998876 56
Q ss_pred eEEEEEeecccc-ccccccCC----------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 205 SLYLVFEYMEHD-LAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 205 ~lyLVmEy~~g~-L~~~~~~~----------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
..|+||||+.++ |...+... ...+++.++..++.||+.||.|||++||+||||||+||||+.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 789999999864 43333211 1247899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I 345 (709)
+.+||+|||++..+..... .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976533221 1123344577899999987655 7999999999999999998 99999887766555555
Q ss_pred HHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.... . ......+++.+.+||..||+.||.+||++.+++++
T Consensus 240 ~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3210 0 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.82 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=212.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
...|...+.||.|+||.||+|++..++..||||.+..... .......+.+|+.+++.++|+|++++++++.. ....|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeE
Confidence 3458888999999999999999999999999999875432 33445567789999999999999999998877 57899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.+++...+......+++.++..++.||+.||.|||+.+++|+||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99999998877766555567999999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+.+..+.... .+
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~------------- 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP------------- 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC-------------
Confidence 23467889999999853 2346889999999999999999999998766555554443210 00
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..+|.+||++.+++.|+||...
T Consensus 233 -------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00112467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.76 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=204.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccc
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999875533 23455678899999999999999999998876 67899999999864
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-------CCc
Q 005210 217 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-------QPL 289 (709)
Q Consensus 217 L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-------~~~ 289 (709)
.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 4433333333799999999999999999999999999999999999999999999999999876432211 122
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
....++..|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+... ... |
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---~------------ 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE---W------------ 220 (265)
T ss_pred cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC---C------------
Confidence 3446788999999987765 788999999999999999999999888776665555321 100 0
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH---HHHHhcccCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA---ASALRSEFFTM 418 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa---~e~L~hp~f~~ 418 (709)
. ....++..+.+||.+||+.+|.+|||+ .++|+||||+.
T Consensus 221 ---------~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 ---------P-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ---------C-ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 0 001258889999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.46 Aligned_cols=245 Identities=23% Similarity=0.384 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 215 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g 215 (709)
+.||+|+||.||+|.+..+++.||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3699999999999999999999999987643 334455678899999999999999999998876 5679999999986
Q ss_pred c-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC-ccccc
Q 005210 216 D-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRV 293 (709)
Q Consensus 216 ~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~~ 293 (709)
+ |...+...+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 4 444444445568999999999999999999999999999999999999999999999999987643221111 01112
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCC
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 372 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~ 372 (709)
.+..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+.......+......
T Consensus 158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 245699999887655 7899999999999999998 88999776655444433221000
Q ss_pred ccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 373 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 373 ~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.16 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=198.8
Q ss_pred eEEeeecccCceEEEEEEECCCCe--EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCCeE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSCSL 206 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~~l 206 (709)
.+.+.||+|+||.||+|.+..++. .||+|.++.........+.+.+|+.+++.++|+||+++++++... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467899999999999999887775 589999876655566677788999999999999999999876432 12357
Q ss_pred EEEEeecccc-cccccc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 207 YLVFEYMEHD-LAGLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 207 yLVmEy~~g~-L~~~~~-----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
++||||+.++ +...+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 9999999854 433221 1234589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 281 YDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 281 ~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
+...... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |++||.+....+....+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~------ 232 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NR------ 232 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CC------
Confidence 6432211 112234567899999887654 7999999999999999999 89999887766555444321 00
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||+.||.+|||+.++++.
T Consensus 233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=371.21 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=207.8
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee------
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS------ 200 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~------ 200 (709)
+...+|+.+..||+||||.||+++++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..|..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35788999999999999999999999999999999998765 56667789999999999999999998764321
Q ss_pred -------------------------------------------------c------------------------------
Q 005210 201 -------------------------------------------------R------------------------------ 201 (709)
Q Consensus 201 -------------------------------------------------~------------------------------ 201 (709)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ------------------------CC--------CeEEEEEeeccccccccccCCCCCC-CHHHHHHHHHHHHHHHhhhh
Q 005210 202 ------------------------MS--------CSLYLVFEYMEHDLAGLASHPGLKF-SEAQVKCYMQQLLCGLDHCH 248 (709)
Q Consensus 202 ------------------------~~--------~~lyLVmEy~~g~L~~~~~~~~~~l-se~~i~~i~~QIl~aL~yLH 248 (709)
.+ ..+||-||||+..++..++..+... ....++++++||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 3579999999999998888766443 47889999999999999999
Q ss_pred hCCeeeccCCCccEEEcCCCcEEEeecccccccC-----------------CCCCCCccccccccCCCCchhhcCCc--c
Q 005210 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD-----------------PDQNQPLTSRVVTLWYRPPELLLGAT--Y 309 (709)
Q Consensus 249 ~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~-----------------~~~~~~~~~~~gT~~Y~APE~l~~~~--~ 309 (709)
++|||||||||.||||+.++.|||+|||+|.... .......|+.+||.-|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 11223567889999999999998766 6
Q ss_pred CCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHH
Q 005210 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPA 389 (709)
Q Consensus 310 y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~ 389 (709)
|+.++||||||+|||||+. ||... .|....+.++- . ..+|.... .+.+--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-~--------g~iP~~~~-------------f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-K--------GSIPEPAD-------------FFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-c--------CCCCCCcc-------------cccccchHH
Confidence 9999999999999999985 35433 33332222211 1 11111100 011112345
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 390 LALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 390 ~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
..+|..||+.||.+||||.|+|.+.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 6899999999999999999999999985
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.70 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=200.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeE----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..+|++.+.||+|+||.||+|.+..++.. ||||+++... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---S 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---C
Confidence 46799999999999999999998766654 8999986432 33445667889999999999999999998865 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++|+||+.+ .+.+.+......+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 47899999985 45555555455689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~~-~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
..... .....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+. ..++.....+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--------- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL--------- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC---------
Confidence 32211 12233467899999987654 7999999999999999997 9999987665443 3333211000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||..||..||.+|||+.+++.+
T Consensus 231 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.15 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=194.3
Q ss_pred CCCeeEEeee--cccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKI--GQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~L--G~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
.+.|++.+.+ |.|+||.||++.+..++..+|+|.+....... .|+.+...+ +||||+++++.+.. .+.
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~ 83 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKG 83 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCe
Confidence 4456666665 99999999999999999999999987543221 133333323 79999999999877 568
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDP 283 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~ 283 (709)
+|+||||+.+ +|...+.. ...+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999986 45554443 34899999999999999999999999999999999999999988 999999999876542
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChhhhhhcCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~-l~~I~k~~g~p~~~~w~~~~l 362 (709)
. ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||......+. ...+.... ..
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~---------- 225 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK---------- 225 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc----------
Confidence 2 2236789999999987655 78999999999999999999999986543321 11111110 00
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-HHHHHhcccCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFT 417 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-a~e~L~hp~f~ 417 (709)
.....+.+++.+.+||.+||+.||.+|++ .+++|+||||.
T Consensus 226 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 ---------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00122358899999999999999999996 59999999996
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=348.44 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=216.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.-|..++.||-|+||.|.+++..+|...||+|.+++. .+....+..+..|..||..-+.+-||+||..|.+ ...+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEE
Confidence 3489999999999999999999999999999999764 4566777888899999999999999999877776 778999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~- 286 (709)
||||+.| ++..+++..+ .|.|..++.|+.+|.+|+++.|..|+|||||||+|||||.+|+|||+|||||.-+....+
T Consensus 707 VMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999985 6777777765 799999999999999999999999999999999999999999999999999975421000
Q ss_pred ----------------------------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHH
Q 005210 287 ----------------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 326 (709)
Q Consensus 287 ----------------------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~EL 326 (709)
-...+.+||+.|+|||+|.... |+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHH
Confidence 0113568999999999998755 89999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC
Q 005210 327 YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 327 ltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
+.|++||...+..+.-.+|.. |...- -.....+++.++++||.+|++ ++++|+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~l----------------~~~~~~~ls~e~~~li~kLc~-sad~RLG 918 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNFL----------------HIPYQGNLSKEALDLIQKLCC-SADSRLG 918 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhcc----------------ccccccccCHHHHHHHHHHhc-Chhhhhc
Confidence 999999988887666555532 32100 011235689999999999876 7888874
Q ss_pred ---HHHHHhcccCCCC
Q 005210 407 ---AASALRSEFFTMK 419 (709)
Q Consensus 407 ---a~e~L~hp~f~~~ 419 (709)
++++-.||||+..
T Consensus 919 kng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGI 934 (1034)
T ss_pred ccchhhhhcCcccccc
Confidence 7789999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.21 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=203.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..+ ...||||+++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 46799999999999999999998654 4579999986543 33345567889999999999999999998876 567
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||+.++ |...+......+++..+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999875 44444444457999999999999999999999999999999999999999999999999999877422
Q ss_pred CCCC-ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 285 QNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 285 ~~~~-~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.+....+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---------- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 2111 11223467899999887654 7899999999999999998 999998777666555553211000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+..+.+||..||+.||.+||++.+++++
T Consensus 229 ------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=380.04 Aligned_cols=261 Identities=30% Similarity=0.475 Sum_probs=219.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
-++.....||.|.||.||.|.+.+||...|+|-++...........+.+|..+|..|+|||+|+.||+-.. ...+||.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IF 1312 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIF 1312 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHH
Confidence 34566789999999999999999999999999998776555666778899999999999999999998766 5578999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC---C
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ---N 286 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~---~ 286 (709)
||||+++.+..+...+...+|.-.+.|..|++.||.|||++|||||||||.||||+.+|.+|++|||.|..+.+.. .
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999988777777777788999999999999999999999999999999999999999999999999998775432 1
Q ss_pred CCccccccccCCCCchhhcCCc--cCCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~--~y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+||+.|||||++.+.. ..+-+.||||||||+.||+||+.||..-+ ++.++.++-. |.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--gh------------ 1458 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--GH------------ 1458 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--cC------------
Confidence 2344679999999999998754 34678999999999999999999997644 4444444421 11
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+|+. +..++++.+|||+.||.-||.+|.++.|+|+|.|-+...
T Consensus 1459 -----~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1459 -----KPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred -----CCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 1111 223889999999999999999999999999999977543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.60 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=198.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 5789999999999999999998652 456799999864332 2334557789999999999999999998865 5
Q ss_pred CeEEEEEeecccc-ccccccCC---------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEe
Q 005210 204 CSLYLVFEYMEHD-LAGLASHP---------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~~---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 273 (709)
...|+||||+.++ |...+... ...+++..+..++.||+.||.|||+.|++|+||||+||||+.++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 6899999999864 33333221 1236788899999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||++..+..... .......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GL 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 9999875532211 1112235578899999987654 7999999999999999998 78999887766555544321 00
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+ .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 1113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.98 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=203.0
Q ss_pred eeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++|+||+++++++.. ...+|+||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999999866 8899999987654433 46778899999999999999999998876 6789999999
Q ss_pred ccc-cccccccCC--------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 213 MEH-DLAGLASHP--------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 213 ~~g-~L~~~~~~~--------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
+.+ +|...+... ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 965 555554443 36799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... .......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~--------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--YR--------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC---------
Confidence 321 122344678899999988775 47999999999999999999 69999988776665555421 00
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||..||.+|||+.+++.+
T Consensus 226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 -----------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.23 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=209.8
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|....+||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++|+||+++++++.. .+..|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEe
Confidence 344568999999999999999999999999985432 2344567889999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
|+.++.+..+... ..+++..+..++.||+.||.|||+.||+|+||+|+||+|+.++.++|+|||++....... .....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9987655544433 368999999999999999999999999999999999999999999999999987654322 12234
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
..+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+......
T Consensus 176 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------------- 234 (292)
T cd06657 176 LVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------------- 234 (292)
T ss_pred cccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------------
Confidence 56889999999887644 688999999999999999999999987776665544321100
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
.......++..+.+||.+||..||.+||++.++|.||||.....
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 235 ------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00112346888999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.02 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=208.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..+++.||||.++...... ....+.+|+.++..+ .||||+++++++.. ...+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeec--CCeE
Confidence 4688999999999999999999999999999999997553322 334455677766666 59999999999876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|+||||+.+.+..+.......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999876666655544579999999999999999999997 599999999999999999999999999997653322
Q ss_pred CCCccccccccCCCCchhhcCC---ccCCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhcC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGA---TYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~---~~y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.... ..+.+..++... .+
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~--------- 237 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PP--------- 237 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CC---------
Confidence 1 2233578899999998754 236889999999999999999999997643 233444433210 00
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.. .....++.++.+||.+||..||.+|||+.++++|+||...
T Consensus 238 ---------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 238 ---------SL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ---------CC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 0011467889999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.62 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-----eEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||++.+.... ..||+|.+..... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 567999999999999999999976443 7899999875432 33445678999999999 89999999998876
Q ss_pred CCeEEEEEeecccc-cccccc---------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 203 SCSLYLVFEYMEHD-LAGLAS---------------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~---------------~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
...+|+||||+.++ |...+. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 56799999999864 433332 22456899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHH
Q 005210 267 NGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 344 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~ 344 (709)
++.+||+|||++..+..... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999986643221 1112223467799999887654 7899999999999999997 9999988776555444
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+.... . ......++..+.+||.+||..||.+|||+.++|++
T Consensus 247 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGY--R--------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 32110 0 01123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=360.57 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=203.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeec-eEeecC----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEG-LVTSRM---- 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~-~~~~~~---- 202 (709)
..++++.+.|.+|||+.||+|++...|..||+|++-.. +.+..+.+.+||.+|++|. |+|||.+++ ....+.
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 45688999999999999999999998899999998654 6778889999999999995 999999998 333221
Q ss_pred CCeEEEEEeecc-ccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeecccc
Q 005210 203 SCSLYLVFEYME-HDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 203 ~~~lyLVmEy~~-g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
...++|.||||. |+|.+.+.. -...|+|.+++.|+.|+++|+.+||... |||||||-|||||+.+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 246789999999 577776653 2235999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCCC--------ccccccccCCCCchhhc--CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 005210 279 SFYDPDQNQP--------LTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 279 ~~~~~~~~~~--------~~~~~gT~~Y~APE~l~--~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~ 348 (709)
.......... .-...-|+.|+|||++. .....+.|+|||+|||+||-|+....||.+.....++.--+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~- 272 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS- 272 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc-
Confidence 6532211110 01224499999999974 234479999999999999999999999987654333222111
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
...++.++..+.+||..||+.||.+||++.+++.+-+.
T Consensus 273 ------------------------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 273 ------------------------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ------------------------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 01124577889999999999999999999999986554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=317.46 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=200.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+. +++.||||.++..... .+.+.+|+.++++++||||+++++++.. .+.+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 457999999999999999999975 4567999998754432 3457789999999999999999998876 567899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+.. .+..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999964 55555433 234689999999999999999999999999999999999999999999999999987643221
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
........+..|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+....+..+.+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1111222345799999887654 7899999999999999999 99999988776666655321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||+.||.+||++.++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 --------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.61 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=200.3
Q ss_pred CCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
++|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++.. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 5789999999999999999985 335667999988643 23445668899999999999999999999876 67
Q ss_pred eEEEEEeecccccc-ccccC------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEE
Q 005210 205 SLYLVFEYMEHDLA-GLASH------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILK 271 (709)
Q Consensus 205 ~lyLVmEy~~g~L~-~~~~~------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vK 271 (709)
.+|+||||+.++.+ ..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 89999999986443 33321 112489999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 005210 272 IADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLC 349 (709)
Q Consensus 272 L~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~ 349 (709)
|+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+..+...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~- 238 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG- 238 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999976532221 1122334577899999887654 7899999999999999998 99999888776666665431
Q ss_pred CCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 350 g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.. ......++.++.+||.+||+.||.+|||+.+++.
T Consensus 239 -~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 -RV--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -Cc--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 0011246788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.22 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=202.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC----------------eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK----------------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----------------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 192 (709)
..+|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 457999999999999999999877644 568999987543 234566788999999999999999
Q ss_pred eeeceEeecCCCeEEEEEeecccc-ccccccCCC----------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCcc
Q 005210 193 KLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPG----------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 261 (709)
Q Consensus 193 ~l~~~~~~~~~~~lyLVmEy~~g~-L~~~~~~~~----------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~N 261 (709)
++++++.. ...+++||||+.++ |...+.... ..+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99998876 57899999999864 433332211 268999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCCCC-CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh--CCCCCCCCCh
Q 005210 262 LLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTE 338 (709)
Q Consensus 262 ILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt--G~~pF~g~~~ 338 (709)
||++.++.++|+|||++..+.... ........+++.|+|||++.+.. ++.++|||||||++|||++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999987653222 11223445678899999987654 7999999999999999998 7788877766
Q ss_pred HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 339 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 339 ~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+.+..+........ ..........++.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDG---------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccc---------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555432110000 00001112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.76 Aligned_cols=244 Identities=22% Similarity=0.307 Sum_probs=196.8
Q ss_pred eecccCceEEEEEEE--CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~--~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.||+|+||.||+|.+ ..++..||||+++.........+.+.+|+.+++.+.||||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 689999999999964 4678899999987665555566778899999999999999999988743 45799999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC--Ccccc
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSR 292 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~ 292 (709)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 6544433334457999999999999999999999999999999999999999999999999999876433221 11222
Q ss_pred ccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 293 ~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
.++..|+|||.+.... ++.++|||||||++|||++ |.+||.+.+..+....+.+... +
T Consensus 159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~------------------- 217 (257)
T cd05116 159 KWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M------------------- 217 (257)
T ss_pred CCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C-------------------
Confidence 3467899999886544 7889999999999999998 9999988877766665532100 0
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++++.+||..||+.||.+||++.++.+
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 112357889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.14 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=200.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|.+.+.||+|+||.||+|.+.. +..||||.+...... ...+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEE
Confidence 3578999999999999999998754 446999998754332 2457789999999999999999999876 567899
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++ |...+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999865 44444443447899999999999999999999999999999999999999999999999998765332211
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC--------------
Confidence 112234567899999987654 7899999999999999998 999998877666655554321100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+..+.+||..||..||.+|||+.+++.+
T Consensus 222 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 --------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.56 Aligned_cols=258 Identities=20% Similarity=0.302 Sum_probs=202.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 6789999999999999999997653 355799998864432 2233456789999999999999999998876 5
Q ss_pred CeEEEEEeeccc-cccccccCC---------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEe
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP---------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 273 (709)
...|+||||+.+ +|...+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 678999999985 444443221 1345678899999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+... +.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~ 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GY 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 9999876532221 1122234567899999987654 7899999999999999998 78999887766655544321 00
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh------cccCCC
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR------SEFFTM 418 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~------hp~f~~ 418 (709)
+ .....+++.+.+||.+||+.||.+|||+.++++ ||||..
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 L---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 011245788999999999999999999999987 898875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.66 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=199.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.+|++.+.||+|+||.||+|.+. ++..+|+|++....... ..+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 45889999999999999999875 46679999986543322 346679999999999999999998866 5679999
Q ss_pred Eeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||++++ |.+.+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999864 555544434478999999999999999999999999999999999999999999999999997653222111
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 11222345799999887654 7899999999999999998 89999887776665554321100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......+..+.+|+.+||..+|.+|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1113468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.23 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=200.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 4679999999999999999999987 78889999886443 23334557789999999999999999998876 5
Q ss_pred CeEEEEEeecccc-ccccccCCC------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEe
Q 005210 204 CSLYLVFEYMEHD-LAGLASHPG------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~~~------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~ 273 (709)
...|+||||+.++ |...+.... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 6789999999764 444433221 2589999999999999999999999999999999999998765 69999
Q ss_pred ecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||++..+...... .......+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 99999865322111 111223356799999997655 7999999999999999997 99999988776655444321 00
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+ .....++..+.+||.+||+.||.+|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.20 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=202.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..+|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~ 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--E 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 34688899999999999999987643 5789999987543 23345667889999999999999999999876 5
Q ss_pred CeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 204 CSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
..+++++||+.+. +...+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 6789999999854 3332211 12358899999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I 345 (709)
+.+||+|||+++.+..... .......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876533221 1223345678999999987655 7899999999999999998 88999888777666665
Q ss_pred HHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
...... ....+++..+.+||..||+.||.+||++.+++..
T Consensus 240 ~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 431100 1124578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.35 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=199.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.++||+|+||.||+|.+..+. .||||++...... ...+.+|+.+++.++||||+++++++. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEE
Confidence 457999999999999999999987664 5999998754332 245778999999999999999998764 345899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ ++...+.. .+..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999986 45554433 234689999999999999999999999999999999999999999999999999986643322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+..+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 222 (262)
T ss_pred ccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--------------
Confidence 2222334567899999887655 7999999999999999999 88999888776666555321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 223 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011347788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.85 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=199.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+. ++..||+|.+....... ..+.+|+.++++++|+||+++++++. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEE
Confidence 467999999999999999999865 55679999987654433 34778999999999999999998774 345899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999986 45444432 234589999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-------------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2222234567899999887654 7899999999999999999 99999988777666655321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+..+.+||.+||..||.+|||+.+++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 --------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112357788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.18 Aligned_cols=252 Identities=31% Similarity=0.483 Sum_probs=202.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ........+.+|+.++++++|+||+++++++.. .+..|+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 57999999999999999999999999999999987533 334446678899999999999999999999877 578999
Q ss_pred EEeeccc-ccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 209 VFEYMEH-DLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g-~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
||||+.+ +|...+. .....+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999986 4444332 23456899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChhhhhhcCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.. ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+....+....
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 224 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------------- 224 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-------------
Confidence 21 223456889999999987654 78999999999999999999999965532 11222221100
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+ +.. ....++..+.++|.+||..+|.+|||+.++++
T Consensus 225 -----~-~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -----Y-PPL--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----C-CCC--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 000 01246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.06 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=217.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..++.+.+..||.|+.|.|++++...+|...|||.++... +.+..+++++.+.++..- ++|+||+++|+|.. +..+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV 166 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDV 166 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchH
Confidence 3567788889999999999999999999999999997653 456667788888877665 58999999999987 5678
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|.||.|..-+..++..-..+++|..+-.+...++.||.||-++ ||+|||+||+|||+|..|++||||||++-.+-..
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 89999998655455544455799999999999999999999975 8999999999999999999999999999776432
Q ss_pred CCCccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
...+...|-+.|||||.+.- ...|+..+||||||+.|+||.||+.||.+ .++.+.+.+|+.... |.
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~--------- 314 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PL--------- 314 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CC---------
Confidence 23345578899999999863 45589999999999999999999999998 468888888876321 11
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+.. -..+++.+.+|+..||++|+.+||.-.++|+|||+...
T Consensus 315 ---------------L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 315 ---------------LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ---------------CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111 12389999999999999999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.81 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=214.3
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
...+||+|+|-+||+|.|..+|..||.-.++...+ .+...+.+..|+.+|+.|+|||||++|+.|.+....++.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34589999999999999999999999866655433 4566789999999999999999999999999877788999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEc-CCCcEEEeecccccccCCCCCCC
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
+|..+.+..+..+..++...-++.|++|||.||.|||++. |||||||.+||||+ ..|.|||+|+|||...... .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---c
Confidence 9998888877777778999999999999999999999995 99999999999998 4589999999999987543 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
..+.+|||.|||||++.. .|+..+||||||++|+||+|+..||.......++.+-+. -|..+.-+-
T Consensus 201 aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~----------- 266 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALS----------- 266 (632)
T ss_pred cceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhh-----------
Confidence 355799999999999873 489999999999999999999999988766555544332 232221111
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+--.+++++||.+||.. ...|+|+.|+|.||||...
T Consensus 267 --------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 --------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11257899999999999 8999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.48 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=201.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 56899999999999999999998644 4789999986442 23334567789999999999999999999876 5
Q ss_pred CeEEEEEeeccc-cccccccC---------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEe
Q 005210 204 CSLYLVFEYMEH-DLAGLASH---------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~---------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 273 (709)
..+|+||||+.+ +|...+.. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 789999999985 44443322 12347888999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||++..+..... .......+|..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.. .+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCC
Confidence 9999876533221 1223445678899999887654 7899999999999999998 9999988776665544431 000
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+ .....++..+.+||.+||+.+|.+|||+.+++.
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.16 Aligned_cols=257 Identities=29% Similarity=0.503 Sum_probs=212.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|+..+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 5679999999999999999999998999999999976543 44567789999999999999999999877 578999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+++ +|.+.+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999995 45544444333799999999999999999999999999999999999999999999999999876533211
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......++..|+|||++.+.. ++.++|+||||||+|+|++|+.||...........+... +.+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------------- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-------------- 235 (286)
T ss_pred hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC--------------
Confidence 223346788999999887654 799999999999999999999999887766555544321 0000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......++..+.+||..||+.+|.+|||+.++|.|+||..
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0111236788999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.56 Aligned_cols=252 Identities=31% Similarity=0.469 Sum_probs=201.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.+.|+||+++++++.. .+.+|+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 57889999999999999999999999999999886533 234445677899999999999999999999876 678999
Q ss_pred EEeecccc-cccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
||||+.++ |...+. .....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999864 433332 23446899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH--HHHHHHHHhhCCCChhhhhhcCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV--EQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~--e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
. .......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.... +....+.. ...+
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---------- 226 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP---------- 226 (267)
T ss_pred C-cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCC----------
Confidence 2 2223457889999999987655 688999999999999999999999765431 12222211 0000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. .....++..+.+||.+||..||.+|||+.++++
T Consensus 227 --------~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 --------P--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred --------C--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 011247788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.21 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=204.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||.|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEE
Confidence 5679999999999999999999987 8899999987543 2234567889999999999999999998876 667999
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+++ +|...+.. .+..+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999986 55555443 345689999999999999999999999999999999999999999999999999976643222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
. .....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-------------- 223 (261)
T ss_pred c-ccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC--------------
Confidence 1 22334577899999887654 7899999999999999998 89999988877666665431110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 --------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.22 Aligned_cols=281 Identities=33% Similarity=0.548 Sum_probs=223.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC------CCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD------HINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~------HpnIv~l~~~~~~~~ 202 (709)
...|.+....|+|-|++|..|.+...|..||||+|+....- .+.=++|++||++|+ --|+++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 56799999999999999999999999999999999865321 122347999999995 3489999988876
Q ss_pred CCeEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeeccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLAS 279 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~ 279 (709)
.+++|||||-+.-+|-.++..-+ ..|....++.|+.||+.||..|-.+||+|.||||+||||+.. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 78999999999887777665433 347788999999999999999999999999999999999854 578999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
..... ..+.+..+..|+|||+++|.. |+...|+||+||+||||+||+.+|+|.+....+.....+-|..+-.+..+
T Consensus 586 ~~~en---eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASEN---EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc---cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 76432 346678889999999999977 89999999999999999999999999999999888888888777665544
Q ss_pred cCCCC-----ccccC-----------------CCCccccchhccc--CCCC-------HHHHHHHHHhcccCCCCCCCHH
Q 005210 360 SKLPH-----ATIFK-----------------PQQPYKRCVAETF--KDFP-------APALALMETLLSIDPADRGSAA 408 (709)
Q Consensus 360 ~~lp~-----~~~~~-----------------~~~~~~~~~~~~~--~~~s-------~~~~dLI~~lL~~DP~kRpTa~ 408 (709)
..+.. ...|. .-.|-+...++.. +.++ ..+++||.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 32211 01110 0011111111111 1123 3588999999999999999999
Q ss_pred HHHhcccCCC
Q 005210 409 SALRSEFFTM 418 (709)
Q Consensus 409 e~L~hp~f~~ 418 (709)
++|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999975
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.97 Aligned_cols=251 Identities=27% Similarity=0.345 Sum_probs=197.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeE--EEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 56899999999999999999999887764 476665432 2344556788899999999 89999999999876 667
Q ss_pred EEEEEeeccc-cccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 206 LYLVFEYMEH-DLAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
+|+||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999985 44443322 1235899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 005210 270 LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 270 vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~ 348 (709)
+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986432111 111123466799999886654 7899999999999999998 99999887765554433210
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. .. .....+++.+.+||.+||+.||.+||+++++|++
T Consensus 240 ---~----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ---Y----------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---C----------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0112467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.89 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=197.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCe--EEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.. .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999887765 4688887632 2334456678899999999 79999999998876 5679
Q ss_pred EEEEeeccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcE
Q 005210 207 YLVFEYMEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 270 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~v 270 (709)
|+||||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 999999985 444443221 1358899999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 005210 271 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLC 349 (709)
Q Consensus 271 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~ 349 (709)
||+|||++........ ......+..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+...++....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864321111 11112345799999887654 7899999999999999997 999998887766655543210
Q ss_pred CCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 350 g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. ......++..+.+||.+||..||.+|||++++++.
T Consensus 236 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.01 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=200.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..+|++++.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 5689999999999999999999887776 48999986543 33445667899999999999999999998764 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..+++|||+++ ++...+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 47899999985 55555544455799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||...........+ .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC---------
Confidence 2221 111223467899999987654 7899999999999999998 99999776554443322 211110
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+..+.+||..||..||.+|||+.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=362.23 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=201.3
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++|++.++||+|+||.||+|.+..+++.||||+++.... .....+.+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 689999999999999999999999999999999975433 23345568899999999999999999998876 678999
Q ss_pred EEeeccccccc-cccC----------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccc
Q 005210 209 VFEYMEHDLAG-LASH----------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 277 (709)
Q Consensus 209 VmEy~~g~L~~-~~~~----------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 277 (709)
||||++++.+. .+.. ....++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999875433 3221 112456778899999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-----------------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH
Q 005210 278 ASFYDPDQ-----------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 340 (709)
Q Consensus 278 a~~~~~~~-----------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e 340 (709)
+....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.....
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 98652110 01112357999999999988765 7999999999999999999999998755433
Q ss_pred HHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 341 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 341 ~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..... ....|. ......++|+.+.+++.+||..||.+|++..+.|..
T Consensus 239 i~~~~--~i~~P~------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILSPI------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccChh------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211 111110 001124678899999999999999999988777765
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.15 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=202.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|.+.+.||+|+||.||+|.+. .+..||||.+...... ...+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 578999999999999999999975 4577999998755433 3457789999999999999999998865 567999
Q ss_pred EEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.++ |...+.. .+..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999864 4444433 234689999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
........+..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+....+..+......+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------------- 224 (261)
T ss_pred hhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 1112223457899999887654 7899999999999999998 999999888777776664321111
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....++..+.++|.+||+.||.+||+++++++
T Consensus 225 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ---------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.80 Aligned_cols=248 Identities=22% Similarity=0.401 Sum_probs=200.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|+++++||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++|+||+++++++.. ..+|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 568999999999999999999864 5678999998755433 3457789999999999999999987643 46899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+.. .+..+++.++..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999975 45554432 345789999999999999999999999999999999999999999999999999987653222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||++.+.. ++.++|||||||++|||++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 2223345577899999887654 7899999999999999999 99999988776665554321110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||..||.+|||+++++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.18 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=202.9
Q ss_pred CeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~ 204 (709)
+|++.+.||+|+||.||++.+. .+++.||||+++.... .......+..|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 4678899999875432 122345677899999999 69999999988866 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++.+.........+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 89999999986544433333457899999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCccccccccCCCCchhhcCCc-cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~-~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.........++..|+|||.+.+.. .++.++|||||||++|+|++|..||...........+.+..-..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----------- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----------
Confidence 222223346889999999986643 35789999999999999999999996543222212221110000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||+.||.+||| +.++|.||||+..
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 00112346788999999999999999998 5677999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.39 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC---eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..+|++.+.||+|+||.||+|.+..++ ..||+|.++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence 457899999999999999999986544 379999986543 23445678899999999999999999999876 568
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||++++ |...+......+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999864 54454444457899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcc--ccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQPLT--SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~~~--~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.....+ ...++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+....+....+.+....|
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP--------- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC---------
Confidence 221111 122356899999987654 7999999999999999886 999998877666555553311100
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+++.+.+|+.+||+.+|.+|||+.++++
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 -------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=342.37 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=209.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..+.+.+...||+|.||+||+|++..+ ||||+++.+...++..+.|..|+.+|++-+|.||+-+.|++... .+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLA 463 (678)
T ss_pred CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---cee
Confidence 367788899999999999999998764 99999999988889999999999999999999999999999762 359
Q ss_pred EEEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC-CC
Q 005210 208 LVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQ 285 (709)
Q Consensus 208 LVmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~-~~ 285 (709)
||.-+|+|..++ ++-....+|....++.|++||++|+.|||.++|||||||..||||.+++.|||+||||+..-.- ..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999986554 4444556899999999999999999999999999999999999999999999999999965321 12
Q ss_pred CCCccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.......-|...|||||++.. ...|+..+||||||||+|||+||..||.......++..+-+..+.|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd---------- 613 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD---------- 613 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc----------
Confidence 222333456788999999874 34589999999999999999999999995554444444422222221
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+.+.++++|+..|+.+++++||+..++|.
T Consensus 614 --------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 --------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22334567889999999999999999999999987
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=323.00 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=199.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC--------------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ--------------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t--------------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l 194 (709)
.++|++.+.||+|+||.||+|.+..+ ...||||+++... .......+.+|+.++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 35799999999999999999987543 2358999987543 34455678899999999999999999
Q ss_pred eceEeecCCCeEEEEEeecccc-ccccccCC-----------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccE
Q 005210 195 EGLVTSRMSCSLYLVFEYMEHD-LAGLASHP-----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNL 262 (709)
Q Consensus 195 ~~~~~~~~~~~lyLVmEy~~g~-L~~~~~~~-----------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NI 262 (709)
++++.. ...+|+||||+.+. |...+... ...+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999876 67899999999864 33333211 12478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh--CCCCCCCCChH
Q 005210 263 LIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEV 339 (709)
Q Consensus 263 Lld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt--G~~pF~g~~~~ 339 (709)
||+.++.+||+|||++..+..... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999976532221 1122334577899999887655 7999999999999999988 66888887766
Q ss_pred HHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 340 e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+.+..+.+....... .........+++.+.+||.+||..||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGR---------------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccc---------------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 655554332100000 0001112346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.52 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=203.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|+..+.||+|+||.||+|.+..++. .||||++.... .....+.+..|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 4578999999999999999999876654 79999986543 23345667899999999999999999999876 567
Q ss_pred EEEEEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||++++.+. .+......+++.++..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999875444 44344457899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCCccc--cccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQPLTS--RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~~~~--~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.....+. ...+..|+|||++.+.. ++.++|||||||++|||++ |+.||...+..+....|......|
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 2221111 12345799999887654 7899999999999999997 999998877766666664321111
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
...+++..+.+||..||+.||.+||++.++++
T Consensus 231 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.49 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEECCCC---eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
++||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.+.|+||+++++++.. ..+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999876655 78999998765443 345567889999999999999999997753 468999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc--
Q 005210 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT-- 290 (709)
Q Consensus 213 ~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~-- 290 (709)
+.++.+..+......+++..+..++.||+.||.|||..+|+|+||||+||||+.++.+||+|||++..+.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 986443333333447999999999999999999999999999999999999999999999999999876433222111
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
...++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~~----------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ER----------------- 216 (257)
T ss_pred CccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--Cc-----------------
Confidence 112346799999887654 7999999999999999998 99999887765554444221 00
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=342.23 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=228.0
Q ss_pred cCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
......+++++..||-|+||.|=++........+|+|++++..+ +....+.+..|.+||..++.|.||+||..|.+ .
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~ 492 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--S 492 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--c
Confidence 34456788999999999999999998777666799999986643 55666788899999999999999999998876 7
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.++||.||-|-|+.+..+.+..+.|.+..++.|+..+++|++|||++|||+|||||+|+||+.+|.+||.|||+|+.+..
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 89999999987665555555566899999999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. ....+.||||.|.|||++++.. .+.++|.||||+++||||+|.|||.+.+....+..|++.+. .|
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----~i------ 638 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----KI------ 638 (732)
T ss_pred C--CceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----hh------
Confidence 4 3446789999999999999877 59999999999999999999999999999999999987531 11
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
+.+..++..+.+||+++...+|.+|.. ..++-+|.||..-
T Consensus 639 ----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 639 ----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred ----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 223457888999999999999999976 8999999999753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.75 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=199.2
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--G 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--C
Confidence 356899999999999999999854 345678999875432 3334567899999999999999999999876 6
Q ss_pred CeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 204 CSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
..+++||||+.++ |...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 6799999999864 3333321 12358999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I 345 (709)
+.+||+|||++........ .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976533221 1223345688899999987754 7899999999999999998 99999887776655544
Q ss_pred HHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
... .. ......+|..+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQG--RV--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCC--CC--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221 00 0111236788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.13 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=199.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++...||+|+||.||+|.+..+. .||||.+...... .+.+.+|+.+++.+.|+|++++++++. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEE
Confidence 467999999999999999999886654 5899987654322 245678999999999999999998774 345899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+.. ....+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999986 55555433 334589999999999999999999999999999999999999999999999999976643222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||.+.+.. ++.++|||||||++|+|++ |++||.+....+.+..+.... .+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~------------- 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM------------- 222 (260)
T ss_pred cccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-------------
Confidence 2222334567899999887655 7899999999999999999 999999887776666553210 00
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+++..+.+||.+||.+||.+||+++++++
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 --------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.43 Aligned_cols=284 Identities=28% Similarity=0.440 Sum_probs=221.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----C---CceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----H---INVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----H---pnIv~l~~~~~~ 200 (709)
.++|.+.++||.|-|++||+|.+..+.+.||+|+++-. ....+..+.||.+|+.++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37899999999999999999999999999999998754 334455678999999982 3 469999999864
Q ss_pred --cCCCeEEEEEeeccccccccccCCCC-CCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCC---------
Q 005210 201 --RMSCSLYLVFEYMEHDLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNN--------- 267 (709)
Q Consensus 201 --~~~~~lyLVmEy~~g~L~~~~~~~~~-~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~--------- 267 (709)
..+.++|||||+++..|+.++..... -++...++.|++|||.||.|||.. ||||.||||+||||..+
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 33579999999999999998876443 499999999999999999999975 99999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 005210 268 -------------------------------------------------------------------------------- 267 (709)
Q Consensus 268 -------------------------------------------------------------------------------- 267 (709)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 005210 268 -----------------------------------------------------------------------------GIL 270 (709)
Q Consensus 268 -----------------------------------------------------------------------------g~v 270 (709)
-.|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 025
Q ss_pred EEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC------hHHHHHH
Q 005210 271 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHK 344 (709)
Q Consensus 271 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~------~~e~l~~ 344 (709)
||+|||.|..+. ...|.-+-|..|+|||+++|.. |++.+||||++||+|||+||-.+|...+ +.+.+..
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 666777666532 2234456689999999999987 8999999999999999999999996432 5677899
Q ss_pred HHHhhCCCChhhhhh-----------cCCCCccccCCCCccccchhcccCCCCH----HHHHHHHHhcccCCCCCCCHHH
Q 005210 345 IFKLCGSPSEDYWRK-----------SKLPHATIFKPQQPYKRCVAETFKDFPA----PALALMETLLSIDPADRGSAAS 409 (709)
Q Consensus 345 I~k~~g~p~~~~w~~-----------~~lp~~~~~~~~~~~~~~~~~~~~~~s~----~~~dLI~~lL~~DP~kRpTa~e 409 (709)
|+.++|..+...... ..|.+...+++...+ ..+.+. ..+|. ++.+||.-||+++|++|+||.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~-~VL~eK-Y~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLY-EVLIEK-YEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHH-HHHHHH-hCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 999999876543222 333333333332222 222222 23443 4779999999999999999999
Q ss_pred HHhcccCCCCCCC
Q 005210 410 ALRSEFFTMKPLP 422 (709)
Q Consensus 410 ~L~hp~f~~~~~~ 422 (709)
+|+|||+...+.+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999976655
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.48 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~ 202 (709)
.+.|.+.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. |||||++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 56899999999999999999987533 3569999986543 2334567889999999996 9999999999876
Q ss_pred CCeEEEEEeecccc-ccccccC----------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHD-LAGLASH---------------------------------------------------------- 223 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~---------------------------------------------------------- 223 (709)
...+|||||||.++ |...+..
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 67899999999854 3322211
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 224 -------------------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 224 -------------------------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
....+++.++..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 0124788999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHH
Q 005210 267 NGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 344 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~ 344 (709)
++.+||+|||++..+..... .......+++.|+|||++.+.. ++.++|||||||+||||++ |..||.+......+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999986533221 1122345678899999987754 7999999999999999997 9999987654443333
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+....+ .....++..+.+||.+||+.||.+|||+.++.+
T Consensus 352 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 32210000 011357888999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.39 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 215 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g 215 (709)
+.||+|+||.||+|... ++..||+|+++... .......+.+|+.+++.++||||+++++++.. ....|+||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 36999999999999864 67889999986543 33444567889999999999999999998876 5678999999986
Q ss_pred c-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 216 D-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 216 ~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
+ +...+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 4 444444444568999999999999999999999999999999999999999999999999987543222211122244
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+.... .
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--~--------------------- 212 (250)
T cd05085 157 PIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--R--------------------- 212 (250)
T ss_pred cccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 66799999887654 7889999999999999998 999998887666555443210 0
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||..+|.+|||+.++++.
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 01123478899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.08 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=201.0
Q ss_pred eeEEeeecccCceEEEEEEECCCC----eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
|++.+.||.|+||.||+|.+..++ ..||+|++..... ......+..|+.+++.++|+||+++++++.. .+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 356789999999999999998876 8999999865532 2245678899999999999999999998876 57899
Q ss_pred EEEeecccc-ccccccCCCCC-CCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEHD-LAGLASHPGLK-FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~~~~~-lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||+.++ +...+...... +++.++..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999864 44444333323 8999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+.+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 2111122367899999988554 47999999999999999998 8999988777666665533110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......++..+.++|.+||..||.+|||+.++++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0111236888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.87 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.+|...++||+|+||.||++... .++..||+|.+... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 56888999999999999999743 35678999987643 23445678899999999999999999998876 56
Q ss_pred eEEEEEeeccccccc-cccCC--------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 205 SLYLVFEYMEHDLAG-LASHP--------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~-~~~~~--------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
.+|+||||+.++.+. .+... ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 789999999864433 33221 135899999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 005210 270 LKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 270 vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k 347 (709)
+||+|||++..+...... ......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||......+.+..+.+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999765332211 112234578899999887755 7999999999999999998 9999988777666655533
Q ss_pred hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.. +. .....+++.+.+||.+||+.||.+||++.+++.
T Consensus 240 ~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GR--EL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred Cc--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 00 111347888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.93 Aligned_cols=245 Identities=32% Similarity=0.500 Sum_probs=203.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc-
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH- 215 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g- 215 (709)
||.|+||.||++.+..+++.||+|++..... .......+..|+.+++.++|+||+++++.+.. ...+|+||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 7999999999999998999999999876543 23355678899999999999999999998876 6789999999964
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccc
Q 005210 216 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 295 (709)
Q Consensus 216 ~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT 295 (709)
+|...+.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 79 ELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 45444443 3468999999999999999999999999999999999999999999999999997754322 123345678
Q ss_pred cCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccc
Q 005210 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 375 (709)
Q Consensus 296 ~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~ 375 (709)
..|++||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+.. +.+
T Consensus 157 ~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~----------------------- 210 (250)
T cd05123 157 PEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL----------------------- 210 (250)
T ss_pred ccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC-----------------------
Confidence 8999999987655 68899999999999999999999988776555444432 000
Q ss_pred cchhcccCCCCHHHHHHHHHhcccCCCCCCCH---HHHHhcccC
Q 005210 376 RCVAETFKDFPAPALALMETLLSIDPADRGSA---ASALRSEFF 416 (709)
Q Consensus 376 ~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa---~e~L~hp~f 416 (709)
.....++..+.+||.+||..||.+|||+ ++++.||||
T Consensus 211 ----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1112357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.28 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=198.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|.+.+.||+|+||.||+|.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4689999999999999999998653 23569999987543 233455677899999999 89999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+.+ +|...+... ...+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 5689999999986 454444321 2358899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+...... ......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999998765322111 111223457899999987754 7899999999999999998 88999876654444
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+... .. .+....++..+.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEG--HR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcC--CC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333210 00 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.75 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=200.6
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|.+.+.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 467999999999999999999853 345689999987543 234456688999999999 89999999998876
Q ss_pred CCeEEEEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 203 SCSLYLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.+.+|+||||+.+ +|...+.. ....+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 5679999999985 45444433 223489999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 281 YDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 281 ~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
+...... ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+...++... +.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~~~------ 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-GYR------ 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-CCc------
Confidence 5332211 112234578899999987765 7899999999999999998 99999887765554444321 000
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+ .....++..+.+||.+||..+|++|||+.++++
T Consensus 263 -----------~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 -----------M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----------C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.22 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=196.3
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 35678999999975432 33456678899999999 789999999987653
Q ss_pred CCeEEEEEeeccccccc-cccCC---------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHDLAG-LASHP--------------------------------------------------------- 224 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~-~~~~~--------------------------------------------------------- 224 (709)
...+|+||||++++.+. .+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45789999999864332 22110
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-CCcccccc
Q 005210 225 ---------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVV 294 (709)
Q Consensus 225 ---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~g 294 (709)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12478889999999999999999999999999999999999999999999999976532211 11122345
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCc
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 373 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~ 373 (709)
+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+...+.....+
T Consensus 244 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 301 (343)
T cd05103 244 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 301 (343)
T ss_pred CcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------------
Confidence 67899999987654 7999999999999999997 999998765433333222110000
Q ss_pred cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 374 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 374 ~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+++..||+.||.+|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.50 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=202.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+|.+.+.||+|+||.||++.+..++..+++|+++... ........+.+|+.+++.++||||+++++++.. ....|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 4889999999999999999998887777777765422 223334456689999999999999999998876 56789
Q ss_pred EEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 208 LVFEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g~L~~~~~----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
+||||+.+..+..+. .....+++.+++.++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999875443322 23457999999999999999999999999999999999999974 6799999999876643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+.......+... .+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~----------- 222 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT----------- 222 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-----------
Confidence 221 122346788999999886644 688999999999999999999999887766655554321 10
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......++.++.+||.+||..||.+||++.++|+||||
T Consensus 223 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 ---------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.22 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=200.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||+|+||.||+|.+. .+..+|+|++....... ..+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEE
Confidence 457899999999999999999875 46689999987544332 346789999999999999999998876 567899
Q ss_pred EEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++.+. .+......+++..++.++.||+.||.|||+.+++|+||||+||+++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999875444 44334456899999999999999999999999999999999999999999999999998765332221
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......++..|+|||++.+.. ++.++|||||||++|||++ |.+||......+.+..+.+.. .
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--------------- 219 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-R--------------- 219 (256)
T ss_pred ccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-C---------------
Confidence 122234567899999887654 7899999999999999998 999998877766665553210 0
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. ......+..+.+|+.+||+.+|.+|||+.++++.
T Consensus 220 ~------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 L------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred C------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0 0012257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.77 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=201.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...|++.+.||+|+||.||+|.+..+++ .||||++... ........+..|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence 3468999999999999999999887665 5999998653 234456678899999999999999999998865 677
Q ss_pred EEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||+.++.+ ..+......+++.+++.++.|++.||.|||++|++|+||||+||||+.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999987544 444444557899999999999999999999999999999999999999999999999998765332
Q ss_pred CCC-Cccccc---cccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 285 QNQ-PLTSRV---VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 285 ~~~-~~~~~~---gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
... ...... .+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+......|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP------- 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC-------
Confidence 211 111111 245799999987654 7899999999999999886 999998877766655553211000
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
...+++..+.+||..||..+|.+||++.+++.
T Consensus 232 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 ---------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.60 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=201.1
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-------CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 578999999999999999999753 234579999886432 334456788999999999 89999999998876
Q ss_pred cCCCeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+.++ |...+.. ....++..++..++.||+.||.|||++||+||||||+||||
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 56899999999864 4433322 12357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+...... ......+++.|+|||++.+.. |+.++|||||||++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999876432221 122234567899999987754 7899999999999999998 88999888766655
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+... .. ......++..+.+||.+||..+|.+|||+.++|+.
T Consensus 250 ~~~~~~--~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEG--HR--------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 544221 00 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.87 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=198.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+..|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4689999999999999999998642 34579999987443 344456678899999999 69999999998876
Q ss_pred cCCCeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+.++ |...+.. ....+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 56799999999864 4333322 12358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||+++.+...... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999865432111 111223456799999987654 7999999999999999999 89999887766655
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+... .. ......++.++.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREG--HR--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcC--CC--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 544321 00 0112356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.67 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=201.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CC
Confidence 35688999999999999999987654 4568999876432 34455678899999999999999999998764 45
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.|+||||+.+ +|...+......+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999985 455555444446899999999999999999999999999999999999999999999999999866433
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+...++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.+.. .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--~----------- 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE--R----------- 226 (270)
T ss_pred cceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--c-----------
Confidence 222222223456899999886554 7899999999999999986 999999888776665543210 0
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||..+|.+|||+.+++..
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 ---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.20 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=197.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeE----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|.+..++.. |++|.+... ........+..|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GA 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CC
Confidence 46799999999999999999999877764 677776432 22334456778899999999999999999874 34
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+++||||+.+ +|...+......+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999984 56666555556799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ..+...++..|+|||.+.+.. |+.++|||||||++|||++ |..||.+.........+ .....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~-------- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA-------- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC--------
Confidence 3222 122345677899999987654 7999999999999999998 99999887654433222 2110000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+.++.+++..|+..||.+|||+.++++
T Consensus 232 -------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01124667899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.56 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||.|+||.||+|... ++.||||.+..... ..+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 567999999999999999999864 78899999875432 45668889999999999999999999876 678999
Q ss_pred EEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+++ +|...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999986 4544443322 268999999999999999999999999999999999999999999999999998653221
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+.+. .
T Consensus 157 ---~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~--------------- 216 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-Y--------------- 216 (256)
T ss_pred ---ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-C---------------
Confidence 1234466799999887654 7889999999999999997 99999877655544433210 0
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. ......+++.+.+||.+||..+|.+|||+.+++.
T Consensus 217 ---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 ---R---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---C---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.12 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=193.4
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+|+||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999765 456679999986543 34445668899999999999999999998743 46899999998
Q ss_pred cc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC--ccc
Q 005210 215 HD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTS 291 (709)
Q Consensus 215 g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~ 291 (709)
++ |...+......+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+....... .+.
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 65 444444345579999999999999999999999999999999999999999999999999998654332211 112
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.+. .+
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~------------------ 216 (257)
T cd05115 158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR------------------ 216 (257)
T ss_pred CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC------------------
Confidence 23357899999887654 7899999999999999996 99999888776665544321 00
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......++++.+||..||..||.+||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.33 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=199.9
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++...||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 467999999999999999999874 367889999987443 33445668889999999999999999998876 5
Q ss_pred CeEEEEEeecccc-ccccccC---------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCcc
Q 005210 204 CSLYLVFEYMEHD-LAGLASH---------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 261 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~---------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~N 261 (709)
..+|+||||+.++ |...+.. ....+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 6789999999864 4333321 11247899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChH
Q 005210 262 LLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEV 339 (709)
Q Consensus 262 ILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~ 339 (709)
||++.++.+||+|||++..+..... ........+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876532211 1112234466799999887655 7999999999999999997 88899887776
Q ss_pred HHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 340 e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+.+..+.... .......++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGN----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6555443210 00112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.49 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=196.2
Q ss_pred CeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998753 33578988886443 33445678899999999999999999998876 567
Q ss_pred EEEEEeeccccccccccC------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCcc
Q 005210 206 LYLVFEYMEHDLAGLASH------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 261 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~------------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~N 261 (709)
.|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 899999998644332211 12358899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChH
Q 005210 262 LLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEV 339 (709)
Q Consensus 262 ILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~ 339 (709)
|||++++.+||+|||++..+...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999765332211 112234567899999887654 7899999999999999998 99999887655
Q ss_pred HHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 340 e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+....+.+.. . ......++.++.+||..||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY-------------------R---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC-------------------C---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5443332110 0 0012346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.80 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=195.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 215 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g 215 (709)
++||+|+||.||+|.+.. ++.||+|++...... .....+..|+.+++.++|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 369999999999999877 999999998765433 455678899999999999999999998876 5689999999976
Q ss_pred c-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc-cccc
Q 005210 216 D-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL-TSRV 293 (709)
Q Consensus 216 ~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~-~~~~ 293 (709)
+ +...+......+++..+..++.|++.||.|||+++|+||||||+||||+.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 4 5444444445789999999999999999999999999999999999999999999999999976532211111 1123
Q ss_pred cccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCC
Q 005210 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 372 (709)
Q Consensus 294 gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~ 372 (709)
.+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+......
T Consensus 157 ~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 356799999887654 7999999999999999998 88999887765544443221000
Q ss_pred ccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 373 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 373 ~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||..+|.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.82 Aligned_cols=269 Identities=22% Similarity=0.329 Sum_probs=198.4
Q ss_pred CCeeEEeeecccCceEEEEEEE----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 130 DSFEKLDKIGQGTYSNVYRARD----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478999999999999999974 4578899999986543 2344567889999999999999999999887654567
Q ss_pred EEEEEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||++++.+. .+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999865444 43333346899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 285 QNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 285 ~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
... ......++..|+|||++.+.. ++.++|||||||++|||++++.++..... . +.+..+....+......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~- 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQMTVTRL- 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcccccccccHHHH-
Confidence 211 112345677899999987654 78999999999999999998765433211 1 11111111111000000
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
...... .........++..+.+||.+||+.||.+|||+.++++.
T Consensus 236 --~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 --VRVLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000000 00011234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.11 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=196.5
Q ss_pred CCe-eEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 130 DSF-EKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 130 ~~y-~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
++| ++++.||+|+||.||++. ...++..||+|.++.... ......+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 899999999999998764 345788999999875532 23445677899999999999999999988765456
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++.+..+... ..+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 78999999997655444333 35999999999999999999999999999999999999999999999999999866432
Q ss_pred CCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHh-hCCCChhhhhhcC
Q 005210 285 QNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL-CGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~-~g~p~~~~w~~~~ 361 (709)
... ......++..|+|||.+.+.. ++.++|||||||++|||++|..||...... +..+... .+......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-
Confidence 211 111224566799999887654 789999999999999999999888654321 1111110 000000000000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.... ........++..+.+|+..||+.||.+|||+.++++
T Consensus 237 ------~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 ------LERG-----MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ------hhcC-----CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 000112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.76 Aligned_cols=244 Identities=22% Similarity=0.367 Sum_probs=196.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||+|+||.||++... +..||+|.++... ..+.+.+|+.+++.++|+||+++++++... ...+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 467999999999999999999764 7789999986432 234577899999999999999999876542 467899
Q ss_pred EEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+++ +|...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999986 555544432 2348999999999999999999999999999999999999999999999999987643221
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....++..|+|||++.+.. ++.++|||||||++|+|++ |++||...+..+....+.+.. +
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~------------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K------------- 217 (256)
T ss_pred ---CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C-------------
Confidence 2234466799999887654 7899999999999999997 999998776655554443210 0
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.51 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=200.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec---CCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR---MSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~---~~~~ 205 (709)
..+|.+.+.||+|||+.||++....++..||+|++.... .+..+..++|+...++++||||++++++.... ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 578999999999999999999999999999999998765 45567788999999999999999998875432 2356
Q ss_pred EEEEEeecccc-ccccc---cCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 206 LYLVFEYMEHD-LAGLA---SHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~---~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.||+++|...+ +++.+ ...+..++|.++..|+.+|++||++||+.. +.||||||.|||+.+.+.++|.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999998754 65544 345668999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCC--------CCCCccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 005210 280 FYDPD--------QNQPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349 (709)
Q Consensus 280 ~~~~~--------~~~~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~ 349 (709)
...-. .-+.......|..|+|||++.-. ...+.++|||||||+||+|+.|..||.. ++...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcC
Confidence 54210 00112233458899999987532 2257899999999999999999999942 22222
Q ss_pred CCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 350 g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
|+..-.. ..+.+..|+. ..+|+.+.+||+.||+.||.+||++.++|.+
T Consensus 249 gSlaLAv------~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAV------QNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEee------eccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2111000 0000111111 1278899999999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=313.37 Aligned_cols=268 Identities=24% Similarity=0.355 Sum_probs=197.6
Q ss_pred CCCeeEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..+|++++.||+|+||.||+|. +..++..||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3579999999999999999997 4467889999998644 244456788999999999999999999987654456
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999975 55555544445689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC--ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CCChhhhhhc
Q 005210 284 DQNQP--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG-SPSEDYWRKS 360 (709)
Q Consensus 284 ~~~~~--~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g-~p~~~~w~~~ 360 (709)
..... .....++..|+|||++.+.. ++.++|||||||++|||++|..++..... ..+..+..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIE- 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHH-
Confidence 22211 11122345699999987654 78999999999999999998876644321 11111100000 000000000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..... ........++..+.+||.+||..+|++|||+.++++
T Consensus 238 ------~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 ------LLKNN-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ------HHhcC-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 000112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.12 Aligned_cols=253 Identities=21% Similarity=0.385 Sum_probs=200.0
Q ss_pred CCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
++|+++..||.|+||.||+|+... +.+.||+|.+.... .......+.+|+.+|++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 579999999999999999999754 35679999876432 23345668899999999999999999998866 56
Q ss_pred eEEEEEeecccc-ccccccCCC--------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 205 SLYLVFEYMEHD-LAGLASHPG--------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 205 ~lyLVmEy~~g~-L~~~~~~~~--------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
..|+||||++++ |...+.... ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 789999999864 444433222 16899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
|++...............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+..+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~-- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KL-- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--Cc--
Confidence 998754332222333446678899999887654 6889999999999999998 88899776655444443210 00
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.| .....++..+.+||.+||+.||.+|||+.+++..
T Consensus 237 -~~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -EL----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -CC----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.95 Aligned_cols=245 Identities=27% Similarity=0.358 Sum_probs=198.2
Q ss_pred eeecccCceEEEEEEECC-CC--eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLD-QK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~-tg--~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
+.||+|+||.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+|+||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999865 33 36999998866544 556778899999999999999999998865 678999999
Q ss_pred ccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC--C
Q 005210 213 MEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--P 288 (709)
Q Consensus 213 ~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~--~ 288 (709)
+++ .|...+.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 975 4555444433 46899999999999999999999999999999999999999999999999999876432211 1
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |++||...+..+.+..+.... .. +
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----~---------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ER----L---------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-Cc----C----------
Confidence 12345678899999887655 7999999999999999998 999998887777666664310 00 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+|..+.+||..||..+|.+|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=345.97 Aligned_cols=278 Identities=23% Similarity=0.307 Sum_probs=189.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCC----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEe----
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQ----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVT---- 199 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~---- 199 (709)
..++|++.+.||+|+||.||+|.+..+ +..||||++...... +....| .++...+.+++.+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 468999999999999999999999998 999999987643211 111111 112222233332222111
Q ss_pred ecCCCeEEEEEeecccccc-ccccCCC-------------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCC
Q 005210 200 SRMSCSLYLVFEYMEHDLA-GLASHPG-------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259 (709)
Q Consensus 200 ~~~~~~lyLVmEy~~g~L~-~~~~~~~-------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP 259 (709)
......+||||||++++.+ .++.... ....+..+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 1235678999999986533 3332211 1123455778999999999999999999999999
Q ss_pred ccEEEcC-CCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCc---------------------cCCcccccc
Q 005210 260 SNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT---------------------YYGTAVDLW 317 (709)
Q Consensus 260 ~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---------------------~y~~~~DIW 317 (709)
+||||+. ++.+||+|||+|+.+...........++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 689999999999876544444445668899999999764321 134567999
Q ss_pred chhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhc
Q 005210 318 STGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLL 397 (709)
Q Consensus 318 SLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL 397 (709)
|||||||||+++. |...+...++..++..++... ..|.....+. ..+. .....+.+......+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcH-HHHHHhhccc---cchh---hhhhhhhccccchHHHHHHHHHc
Confidence 9999999999854 555666667777776655543 3343211110 0000 00011222233456779999999
Q ss_pred ccCCCCCCCHHHHHhcccCCCCC
Q 005210 398 SIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 398 ~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
++||.+|||+.++|+||||+...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999998753
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.36 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=199.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||++.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 578999999999999999999864 4556999987643 2234567889999999999999999988765 56899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ ++...+.. .+..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999985 55555543 345688999999999999999999999999999999999999999999999999976543222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......++..|+|||++.+.. ++.++|+|||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence 2222334567799999987654 7889999999999999998 99999988766665554321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||.+||+.||.+||++.+++.
T Consensus 223 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 --------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 112357788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.59 Aligned_cols=248 Identities=29% Similarity=0.417 Sum_probs=195.9
Q ss_pred eEEeeecccCceEEEEEEEC----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDL----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
++.+.||.|.||.||+|... ..+..|+||.++. .........+.+|++++++++||||+++++++.. ...+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 46789999999999999988 4567899999954 3344556778899999999999999999999984 566999
Q ss_pred EEeecccc-ccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-C
Q 005210 209 VFEYMEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-Q 285 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~ 285 (709)
||||+.++ |...+... ...+++.++..|+.||+.||.|||+++|+|+||+++||||+.++.+||+|||++...... .
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999854 55444443 567999999999999999999999999999999999999999999999999999876221 1
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
............|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+.+.++.+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------------
Confidence 11122345677899999987765 7999999999999999999 789998888777777764311
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......++..+.+||..||..||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01122357888999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.93 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEECC------------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 136 DKIGQGTYSNVYRARDLD------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~------------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 368999999999998532 23358888865432 3334467789999999999999999999876 5
Q ss_pred CeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc-------EEEeec
Q 005210 204 CSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------LKIADF 275 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~-------vKL~DF 275 (709)
...++||||++++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++. +|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 67899999999776555443 3457999999999999999999999999999999999999987664 899999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHH-hCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELl-tG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
|++..+... ....++..|+|||.+.+...++.++|||||||+||||+ +|..||.+....+.. .+... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~--~--- 225 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG--Q--- 225 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc--C---
Confidence 998754321 23467888999998876566899999999999999997 588888766543322 11110 0
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.......+.++.+||.+||+.||.+||++.++|++
T Consensus 226 ------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00012245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.97 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=197.3
Q ss_pred CCeeEEeeecccCceEEEEEEECC----------------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceee
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLD----------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 193 (709)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 569999999999999999986432 34579999987542 3444567889999999999999999
Q ss_pred eeceEeecCCCeEEEEEeeccc-cccccccCC----------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccE
Q 005210 194 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHP----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNL 262 (709)
Q Consensus 194 l~~~~~~~~~~~lyLVmEy~~g-~L~~~~~~~----------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NI 262 (709)
+++++.. ...+|+||||+.+ +|...+... ...+++..+..++.||+.||.|||+.||+|+||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9998876 5678999999985 444433221 12478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccccCCCCCCC-ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh--CCCCCCCCChH
Q 005210 263 LIDNNGILKIADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEV 339 (709)
Q Consensus 263 Lld~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt--G~~pF~g~~~~ 339 (709)
||+.++.++|+|||++..+....... .....+++.|++||.+.+.. ++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999997653322111 12234467899999887654 7999999999999999998 77888877665
Q ss_pred HHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 340 e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+.+...... +..... .. .......+++.+.+||..||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~--------~~~~~~---~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEF--------FRDQGR---QV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHH--------Hhhccc---cc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 554433211 100000 00 00112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.40 Aligned_cols=240 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
...++-||.|+.|.||+|+. .++.||||+++.- -..+|+-|++|+||||+.+.|+|+. ..++|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeee
Confidence 44467899999999999975 4568999997632 1268999999999999999999987 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 291 (709)
||..+-+..++..+..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ....+
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 9997766666666778999999999999999999999999999999999999999999999999999876433 33456
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~ 371 (709)
++||..|||||++.+.. .+.++|||||||||||||||..||..-+...++.-+ |.-. +
T Consensus 271 FaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----GsNs--------------L--- 328 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GSNS--------------L--- 328 (904)
T ss_pred hhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEec----cCCc--------------c---
Confidence 79999999999998876 799999999999999999999999765543332111 1110 0
Q ss_pred CccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 372 ~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
-.......|+.++=||+.|++-.|..||+..++|.|=
T Consensus 329 ------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 ------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 0112235788899999999999999999999999874
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.64 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=200.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECC----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.. .........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4689999999999999999999876 357899998763 33455567788999999999999999999987653 46
Q ss_pred eEEEEEeecccc-ccccccCC-------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 205 SLYLVFEYMEHD-LAGLASHP-------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 205 ~lyLVmEy~~g~-L~~~~~~~-------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
..++++||+.++ +...+... +..+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999854 43333221 1468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 277 LASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 277 la~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
+++.+...... ......++..|+|||++.+.. ++.++|||||||++|||++ |++||...+..+....+.... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL-- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC--
Confidence 99865433221 112234567799999987654 7999999999999999998 999998876655443332110 00
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.++|..||..||++|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 -------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=327.49 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=193.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC-eE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC-SL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~-~l 206 (709)
.+++|.....||+|+||.||+|.... +..||||++....... ...|.+|+.+|.+++|||+|+|+|||.+ .. ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e--~~~~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE--GGEHR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec--CCceE
Confidence 36889999999999999999998654 4889999887654332 3348899999999999999999999987 34 59
Q ss_pred EEEEeeccc-cccccccCCCC-CCCHHHHHHHHHHHHHHHhhhhhCC---eeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 207 YLVFEYMEH-DLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSRG---VLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~-~lse~~i~~i~~QIl~aL~yLH~~g---IvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
+||||||.. +|.+.+..... .+++.....|+.+++.||+|||+.. |||||||++|||||.+++.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999999986 45455544444 8999999999999999999999864 999999999999999999999999999654
Q ss_pred CCCCCCCcccc-ccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChhhhh
Q 005210 282 DPDQNQPLTSR-VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~~~~~~~~~~-~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--~e~l~~I~k~~g~p~~~~w~ 358 (709)
..... ..... .||..|+|||++.... .+.++|||||||+|+||+||+++...... ...+..... ..|.
T Consensus 228 ~~~~~-~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~-------~~~~ 298 (361)
T KOG1187|consen 228 PEGDT-SVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK-------PLLE 298 (361)
T ss_pred Ccccc-ceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH-------HHHH
Confidence 32111 11222 8999999999987643 79999999999999999999987764321 110111100 0111
Q ss_pred hcCCCCccccCCCCccccchhcccCCCC-----HHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFP-----APALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s-----~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+. ....++.+.... ...+ ..+..+...|++.+|.+||++.++++
T Consensus 299 ~~--~~~eiiD~~l~~--------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 299 EG--KLREIVDPRLKE--------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred Cc--chhheeCCCccC--------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 10 001111111100 1111 12667888999999999999999754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.59 Aligned_cols=238 Identities=22% Similarity=0.307 Sum_probs=186.1
Q ss_pred eecccCceEEEEEEECCC------------------------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCcee
Q 005210 137 KIGQGTYSNVYRARDLDQ------------------------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~t------------------------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 192 (709)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999975322 2458888875432 23345677899999999999999
Q ss_pred eeeceEeecCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---
Q 005210 193 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--- 268 (709)
Q Consensus 193 ~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g--- 268 (709)
++++++.. ....||||||++++.+..+. .....+++..+..++.||+.||.|||++||+||||||+||||+..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999876 56789999999977655444 3455789999999999999999999999999999999999997644
Q ss_pred ----cEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHH-HhCCCCCCCCChHHHHH
Q 005210 269 ----ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL-YAGKPIMPGRTEVEQLH 343 (709)
Q Consensus 269 ----~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~EL-ltG~~pF~g~~~~e~l~ 343 (709)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++||| ++|.+||.+....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999988643221 2236788899999987656689999999999999998 47999998766544322
Q ss_pred HHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 344 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 344 ~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
++.... ......++.+.+||.+||+.+|.+|||+.++|++
T Consensus 233 -~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKH-----------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhcc-----------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 211000 0011244678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=311.05 Aligned_cols=243 Identities=28% Similarity=0.364 Sum_probs=189.9
Q ss_pred eeecccCceEEEEEEECCCCe--EEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+.++.++ .||||+++++++.. .+.+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEe
Confidence 368999999999999988876 4688877632 2344556778999999999 89999999999876 5678999999
Q ss_pred ccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 213 MEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 213 ~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
+.+ +|...+... ...+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 985 444443221 1258899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
++........ ......+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------ 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC------
Confidence 9864321111 11123356799999886644 7999999999999999997 999998876655544442100
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. .+....++.++.+||.+||..||.+|||+.+++.
T Consensus 229 -------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 -------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 0111246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=321.63 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=199.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-------KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
..+|.+.+.||+|+||.||+|++... ...||+|.+... ........+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 35799999999999999999986532 236899987643 3344556788999999999 89999999999876
Q ss_pred cCCCeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+.++ |...+.. ....++..++..++.||+.||.|||++||+||||||+||||
T Consensus 90 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 90 --DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 56799999999864 4443322 12347888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||+++.+...... ......++..|+|||++.+.. ++.++|||||||+||||++ |.+||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999865432211 112223456799999987654 7899999999999999998 88999888766665
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+.... . ......++..+.+||.+||..+|.+|||+.++|.+
T Consensus 247 ~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGH--R--------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCC--C--------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5543210 0 01123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.77 Aligned_cols=239 Identities=17% Similarity=0.242 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEECCCCeE-------EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 136 DKIGQGTYSNVYRARDLDQKKI-------VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~-------vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
+.||.|+||.||+|.+..++.. ||+|.+.... ....+.+..|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 3699999999999998665543 8888875332 3334567789999999999999999999876 567899
Q ss_pred EEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc--------EEEeeccccc
Q 005210 209 VFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--------LKIADFGLAS 279 (709)
Q Consensus 209 VmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~--------vKL~DFGla~ 279 (709)
||||+.++.+ ..+...+..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999987654 444444456899999999999999999999999999999999999987764 6999999987
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..... ....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+...... +....
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~--------- 221 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDR--------- 221 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcc---------
Confidence 54321 23467889999999987666789999999999999999984 6666555443322 11100
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.......+..+.+||.+||+.||.+|||++++++.
T Consensus 222 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 --------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00112345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.71 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=200.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..+|++.+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4679999999999999999999877665 589998765432 4455667899999999999999999998865 5
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++||||+.+ +|...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 78999999985 55555555455699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCc-cccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQPL-TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~~~-~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
...... ....++..|+|||.+.... ++.++|+|||||++|||++ |++||.+....+....+.+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~--------- 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG--ER--------- 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--CC---------
Confidence 322111 1222356799999886544 7899999999999999998 99999887765554444321 00
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+..+.++|..||..||.+|||+.++++
T Consensus 230 -----------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 -----------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011235678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.29 Aligned_cols=273 Identities=24% Similarity=0.425 Sum_probs=217.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..+|.++.+||+|+|++|.+++.+.|.+.||+|++++... +.+...-+..|-.+...- +||.+|-|+.+|.. +..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 6789999999999999999999999999999999987644 334455566788887766 89999999999977 7789
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
++|.||++| +|...+.+ ..+|+|++++.|-..|+.||.|||++|||+||||.+|+|||..|++||+|+|+++.--. .
T Consensus 327 ffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~-~ 404 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-P 404 (593)
T ss_pred EEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-C
Confidence 999999986 56666655 44899999999999999999999999999999999999999999999999999975321 2
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCC--C-----CChHHHHHHHHHhhCCCChhhhh
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--G-----RTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~--g-----~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
.....+.||||.|+|||+|.|.. |+..+|+|+|||+++||+.|+.||. | .+..+.+.+++-.
T Consensus 405 gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---------- 473 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---------- 473 (593)
T ss_pred CcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----------
Confidence 23345689999999999998876 8999999999999999999999995 1 2222233332210
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC------HHHHHhcccCCCCCCC--CCCCCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTMKPLP--CDPSSLPK 430 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT------a~e~L~hp~f~~~~~~--~~p~~~p~ 430 (709)
....+...++-.+-.+++..|++||.+|.. ..++-.|+||....+. .....+|.
T Consensus 474 ------------------kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 474 ------------------KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred ------------------hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 011223456777889999999999999964 6899999999854322 22334555
Q ss_pred CCCC
Q 005210 431 YPPS 434 (709)
Q Consensus 431 ~pp~ 434 (709)
|.|.
T Consensus 536 f~p~ 539 (593)
T KOG0695|consen 536 FQPQ 539 (593)
T ss_pred CCCc
Confidence 5443
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.36 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEECC---CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEee
Q 005210 136 DKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
+.||+|+||.||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++... ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 368999999999998754 3467999987532 2344556778899999999999999999976542 4568999999
Q ss_pred cccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC---CC
Q 005210 213 MEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---QP 288 (709)
Q Consensus 213 ~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~---~~ 288 (709)
+.++ |...+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9864 4444444344578888899999999999999999999999999999999999999999999975432111 11
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+... .+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------------- 220 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------------- 220 (262)
T ss_pred cccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC---------------
Confidence 12334577899999887654 7899999999999999999 57788777665554443221 00
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+ .....++..+.+|+..||..+|++||++.++++.
T Consensus 221 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0012367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.97 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=188.2
Q ss_pred eecccCceEEEEEEECC--CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCC
Confidence 69999999999996533 44578888775432 33344567789999999999999999998876 567999999998
Q ss_pred cc-ccccccCCC----CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-CC
Q 005210 215 HD-LAGLASHPG----LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QP 288 (709)
Q Consensus 215 g~-L~~~~~~~~----~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~~ 288 (709)
++ |...+.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 64 444332211 2356788899999999999999999999999999999999999999999999865422211 11
Q ss_pred ccccccccCCCCchhhcC------CccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 289 LTSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~------~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.....+++.|+|||++.. ...++.++|||||||++|||++ |.+||......+.+..+........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------- 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL-------- 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------
Confidence 123355778999998743 2346889999999999999999 7889988877766666543211110
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+ .......++..+.+++..|+ .||.+|||++++++
T Consensus 231 -~--------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 -P--------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -C--------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 00112357788899999988 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.52 Aligned_cols=251 Identities=24% Similarity=0.442 Sum_probs=202.2
Q ss_pred CeeEEeeecccCceEEEEEEECC-CCeEEEEEEEecCC--------CChHHHHHHHHHHHHHHh-cCCCceeeeeceEee
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDN--------LEPESVRFMAREIHILRR-LDHINVIKLEGLVTS 200 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~--------~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~~~~~ 200 (709)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999988 78899999986432 123345567789998875 799999999998876
Q ss_pred cCCCeEEEEEeecccc-ccccc---cCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeec
Q 005210 201 RMSCSLYLVFEYMEHD-LAGLA---SHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~-L~~~~---~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
...+|+||||+++. +...+ ......+++..++.++.||+.||.|||+ .||+|+||+|+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 67899999999864 33332 2344579999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
|++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++|++||...........+......+.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9998754332 334557899999999998655 79999999999999999999999987766655555433111110
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....+++.+.+||.+||+.||.+||++.++..+
T Consensus 234 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012367889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.92 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~ 202 (709)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ....+.+.+|+.+|.++. |||||++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 456888999999999999999864 3557899999975432 333456789999999997 9999999999876
Q ss_pred CCeEEEEEeecccc-ccccccC----------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEHD-LAGLASH---------------------------------------------------------- 223 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~---------------------------------------------------------- 223 (709)
...+||||||+.++ |.+.+..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 56799999999854 3332211
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 224 ---------------------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 224 ---------------------------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
....+++..+..|+.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 11247788899999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+..... ......+++..|+|||++.+.. ++.++|||||||++|||++ |..||......+.+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999986532221 1222346788899999987654 7899999999999999998 88999876665554
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
...+.. +.. ......++..+.+||.+||..+|.+||++.++|+.
T Consensus 352 ~~~~~~-~~~--------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKR-GYR--------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHc-CCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444321 100 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.11 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=197.6
Q ss_pred eeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 132 FEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
|.+.+.||+|+||.||+|.+. .++..||||++..........+.+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999865 357899999997665555566778899999999999999999998764321 1
Q ss_pred eEEEEEeecccccc-cccc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 205 SLYLVFEYMEHDLA-GLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 205 ~lyLVmEy~~g~L~-~~~~-----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
..++++||+.++.+ ..+. .....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 34788999985433 3221 11235799999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 279 SFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 279 ~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
..+...... ......+++.|++||.+.+.. ++.++|||||||++|+|++ |++||.+.+..+....+.+. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~---- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NR---- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--Cc----
Confidence 865332211 112234567899999887654 7889999999999999999 89999887765554444321 00
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+|+..||..+|.+|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.07 Aligned_cols=261 Identities=18% Similarity=0.191 Sum_probs=189.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCCh--HH-------HHHHHHHHHHHHhcCCCceeeeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEP--ES-------VRFMAREIHILRRLDHINVIKLEG 196 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~--~~-------~~~~~rEi~iL~~L~HpnIv~l~~ 196 (709)
...|++.+.||+|+||.||+|.+..+ +..+|+|+........ +. ......+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999999887 6778888754433211 10 011123344556678999999998
Q ss_pred eEeecCC--CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEee
Q 005210 197 LVTSRMS--CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 274 (709)
Q Consensus 197 ~~~~~~~--~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 274 (709)
++..... -..|++||++...+...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7654322 13477888876555444332 22468899999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 005210 275 FGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 275 FGla~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~ 348 (709)
||+|+.+..... .......||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+......+....+.
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999987642211 1122346899999999887755 799999999999999999999999887433322221110
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+++..... ....+.+.+..+.+++..|+..+|.+||+..++++
T Consensus 249 ------~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01100000 00112456788999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.00 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=198.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS---P 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---C
Confidence 5678999999999999999999887776 46888876443 23334457789999999999999999998864 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++|+||+.+ .+...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 46799999985 45555555455689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+. ..+......+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC---------
Confidence 2221 122334577899999987654 7899999999999999997 8999987654333 2332211000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......+..+.+||..|+..||++||++.++++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.00 Aligned_cols=250 Identities=21% Similarity=0.259 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999864 3556799999875543 2333467789999999999999999998876 56789999999
Q ss_pred ccc-ccccccC----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC-
Q 005210 214 EHD-LAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 287 (709)
Q Consensus 214 ~g~-L~~~~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~- 287 (709)
.++ |...+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++++||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 864 4333322 1224677788899999999999999999999999999999999999999999998754322111
Q ss_pred CccccccccCCCCchhhcCC------ccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 288 PLTSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~------~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
......++..|+|||++.+. ..++.++|||||||++|||++ |++||...+..+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL--------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC---------
Confidence 11234568889999988642 135789999999999999996 99999877655543332211000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+ . .......+..+.+|+..|+ .+|.+|||+++++.
T Consensus 229 ~~~-----~---------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLP-----K---------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCC-----C---------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 0 0111236778899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.92 Aligned_cols=236 Identities=22% Similarity=0.280 Sum_probs=184.8
Q ss_pred eeecccCceEEEEEEECCCC----------eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 136 DKIGQGTYSNVYRARDLDQK----------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg----------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 46999999999999998777 35788876543211 4567789999999999999999998765 45
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-------cEEEeeccc
Q 005210 206 LYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-------ILKIADFGL 277 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-------~vKL~DFGl 277 (709)
.|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 799999999765554443 333789999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... .
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~--- 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q--- 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C---
Confidence 986533 1233567789999998775 357899999999999999999 5777766543322221110 0
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.. ........+.+||.+||..||.+|||+.++|+
T Consensus 223 ----~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----HR-------------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----CC-------------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00011267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.94 Aligned_cols=245 Identities=23% Similarity=0.375 Sum_probs=193.0
Q ss_pred eeecccCceEEEEEEECCCC------eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 136 DKIGQGTYSNVYRARDLDQK------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999986544 789999886432 22344567789999999999999999998876 5679999
Q ss_pred Eeeccc-cccccccC------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-----cEEEeeccc
Q 005210 210 FEYMEH-DLAGLASH------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-----ILKIADFGL 277 (709)
Q Consensus 210 mEy~~g-~L~~~~~~------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-----~vKL~DFGl 277 (709)
|||+.+ +|...+.. ....+++.++..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999985 44444322 223588999999999999999999999999999999999999877 899999999
Q ss_pred ccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 278 ASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 278 a~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
+..+..... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~---- 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR---- 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc----
Confidence 976532211 1122335578899999987655 7999999999999999998 99999887766655444211 00
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+|..+.+||.+||..+|.+||++.++++
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 -----------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.13 Aligned_cols=229 Identities=25% Similarity=0.307 Sum_probs=182.1
Q ss_pred cCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccccccc
Q 005210 141 GTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 220 (709)
Q Consensus 141 G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~ 220 (709)
|.||.||+|++..+++.||+|+++... ...+|...+....||||+++++++.. ...+|+||||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999987542 12345555566679999999999876 678999999999754433
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCC
Q 005210 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300 (709)
Q Consensus 221 ~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~A 300 (709)
.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 3333346999999999999999999999999999999999999999999999999988655332 223456778999
Q ss_pred chhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhc
Q 005210 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 380 (709)
Q Consensus 301 PE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~ 380 (709)
||.+.+.. ++.++||||+||++|||++|+.+|...... +. . . . ...
T Consensus 151 PE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~----------~------~-~-----------~~~ 196 (237)
T cd05576 151 PEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----IN----------T------H-T-----------TLN 196 (237)
T ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc----------c------c-c-----------ccC
Confidence 99886544 688999999999999999999877432110 00 0 0 0 001
Q ss_pred ccCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHhcccC
Q 005210 381 TFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFF 416 (709)
Q Consensus 381 ~~~~~s~~~~dLI~~lL~~DP~kRpTa-----~e~L~hp~f 416 (709)
....+++.+.+||.+||+.||.+|+|+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 123478889999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.35 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECC----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
...|++.+.||+|+||.||+|.... ++..||||++...... .....+.+|+.+++.+.|+||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3568889999999999999998653 4889999998765433 3456788999999999999999999988765566
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+++ ++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 89999999986 45555444444699999999999999999999999999999999999999999999999999987642
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CCCChhhhhhc
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC-GSPSEDYWRKS 360 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~-g~p~~~~w~~~ 360 (709)
.... ......++..|+|||.+.+.. ++.++|||||||++|||++|..||........ .+.... +......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHHHHHHH
Confidence 2211 111224456799999887654 78999999999999999999988865432110 000000 00000000000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..... .......++..+.+|+.+||..||.+|||+.++++
T Consensus 239 -------~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 -------LKEGE-----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred -------HHcCC-----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.48 Aligned_cols=264 Identities=28% Similarity=0.446 Sum_probs=215.6
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec---
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR--- 201 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~--- 201 (709)
|..++.|++.+.||.|.||.||+++++.+++.+|||++..+....+ .+.-|.+||+.+ .|||++.++++|...
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 4558889999999999999999999999999999999887654333 355799999988 799999999988642
Q ss_pred CCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..+.+|||||||.++....+.. .+.++.|+.+.+|++.++.||.+||.+.++|||||..|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 3578999999999754433221 26689999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
.++..-.. ..+.+|||.|||||++.. ...|+..+|+||||++..||.-|.||+...-..-.+.+|-. -|++.
T Consensus 172 QldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk 247 (953)
T KOG0587|consen 172 QLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK 247 (953)
T ss_pred eeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence 77654333 345699999999999864 23478899999999999999999999977766555544421 11111
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
. ..+...+..+.+||..||.+|-.+||+..++|+|||++..
T Consensus 248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 0 1122346678999999999999999999999999999843
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=301.26 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=195.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||+|+||.||++. .+++.||+|+++... ....+.+|+.+++.++||||+++++++.. ..+|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEE
Confidence 4679999999999999999986 477889999986432 23457789999999999999999998754 34799
Q ss_pred EEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999985 555554432 335899999999999999999999999999999999999999999999999998764321
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+..|+|||.+.+.. ++.++|+|||||++|+|++ |++||.+.+..+....+.+..
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------- 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------- 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence 11223456799999887654 7899999999999999997 999998887666554443210
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+ .....++..+.+||..||+.+|.+|||+.+++.
T Consensus 215 ---~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 ---RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 012357888999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.16 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=187.5
Q ss_pred eecccCceEEEEEEECCC--CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTYSNVYRARDLDQ--KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~t--g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.||+|+||.||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 699999999999975433 23466776654332 3345678899999999999999999999876 567899999998
Q ss_pred c-cccccccCC---CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-CCCCc
Q 005210 215 H-DLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QNQPL 289 (709)
Q Consensus 215 g-~L~~~~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~ 289 (709)
+ +|...+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 6 444444321 234677888999999999999999999999999999999999999999999998643211 11122
Q ss_pred cccccccCCCCchhhcCC------ccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 290 TSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~------~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
...+++..|+|||++... ..++.++|||||||++|||++ |.+||...+..+.+..+.+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 345778999999987531 235778999999999999996 578898887777777664321100
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+.+ .....+++.+.+||..|+ .+|.+|||+.++++
T Consensus 229 ----~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----LFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011 111246788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=324.42 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=208.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCe---E-EEEEEEecC-CCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKK---I-VALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~-vAIK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
..++-.+.++||+|+||.||+|.....+. . ||||..+.. ....+....+..|+++|+.|+|||||++||+...
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-- 232 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-- 232 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence 36677778999999999999999776432 3 899998863 3567788889999999999999999999999887
Q ss_pred CCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+|||||+|.|+ |...+......++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++.-
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 67799999999975 55555555546999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCCcc-ccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 282 DPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 282 ~~~~~~~~~-~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
.. ..... ..-....|+|||.+... .|+.++|||||||++||+++ |..||++....+...+|.......
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~------- 382 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM------- 382 (474)
T ss_pred cc--eeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-------
Confidence 21 11111 12346789999999876 58999999999999999998 889999999999998885421111
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......|..+..++..|+..||++|+|+.++.+
T Consensus 383 --------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 --------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011246778899999999999999999998865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=336.21 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=209.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..+.+..+.||+|+||+||+|.... ....||||.++... +......|.||+.+|..|+|||||+|+|++.. .
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE--G 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--C
Confidence 3456778899999999999997542 34679999997543 34456789999999999999999999999987 7
Q ss_pred CeEEEEEeecc-ccccccccC---------CCC----CCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 204 CSLYLVFEYME-HDLAGLASH---------PGL----KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 204 ~~lyLVmEy~~-g~L~~~~~~---------~~~----~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
+.+|||||||. |||...+.. .+. +|+..+...|+.||+.|+.||-++.+|||||-..|+||.++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 88999999998 466554432 122 3899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccc-CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 005210 270 LKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 270 vKL~DFGla~~~-~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k 347 (709)
|||+||||++.. ..+.........-...|||||.++-.+ |+.++||||+||||||+++ |+-|+.|-+..|.+..|.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999753 333333332335578899999998766 8999999999999999987 9999999999999998864
Q ss_pred hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~ 410 (709)
. .+.+...+.|.++.+|+..|++.+|.+||+..||
T Consensus 721 g----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 721 G----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred C----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 2 1234456789999999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.75 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=213.1
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-----EPESVRFMAREIHILRRLDHINVIKLEGLVTSR 201 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-----~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~ 201 (709)
.-.++|-++..||+|||+.||+|.+....++||+|+-..... .....+...||..|.+.|+||-||++|++|.-.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345779999999999999999999999999999998654322 123345677999999999999999999999763
Q ss_pred CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC--CeeeccCCCccEEEcC---CCcEEEeecc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--GVLHRDIKGSNLLIDN---NGILKIADFG 276 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--gIvHrDLKP~NILld~---~g~vKL~DFG 276 (709)
...+|-|+|||+|+-++.++.....++|.+++.|+.||+.||.||.+. -|||-||||.||||.+ -|.+||+|||
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 577999999999988887777777899999999999999999999987 4999999999999964 3689999999
Q ss_pred cccccCCCCCC-----Cc-cccccccCCCCchhhcC---CccCCccccccchhHHHHHHHhCCCCCCCCChHHHH---HH
Q 005210 277 LASFYDPDQNQ-----PL-TSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL---HK 344 (709)
Q Consensus 277 la~~~~~~~~~-----~~-~~~~gT~~Y~APE~l~~---~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l---~~ 344 (709)
|++.++.+... .+ ....||.||++||.+.- .+..+.++||||+|||+|.+|.|+.||........+ ..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99998654322 22 24578999999998763 233688999999999999999999999655433222 22
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
|++... .....-+.+++++.+||++||++--++|....++..||||.
T Consensus 699 IlkAtE--------------------------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 699 ILKATE--------------------------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhccee--------------------------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 322110 00011245889999999999999999999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=329.32 Aligned_cols=203 Identities=31% Similarity=0.493 Sum_probs=172.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CCe
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCS 205 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~~ 205 (709)
..+...+.||+|+||.||+++++.+|+.||||.++... .....+.+.+|+++|++|+|+|||+++++-+... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 44677889999999999999999999999999987643 2334566789999999999999999998765544 445
Q ss_pred EEEEEeeccccccc-cccCC--CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc--CCC--cEEEeecccc
Q 005210 206 LYLVFEYMEHDLAG-LASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNG--ILKIADFGLA 278 (709)
Q Consensus 206 lyLVmEy~~g~L~~-~~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld--~~g--~vKL~DFGla 278 (709)
..+|||||.|+.+. .+..+ ...|+|.++..++..+..||.|||++||+||||||+||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999975544 44332 23599999999999999999999999999999999999985 334 4699999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG 335 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g 335 (709)
+.++. +...++.+||+.|.+||++.....|+..+|.|||||++|+++||..||..
T Consensus 172 rel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 98754 34788999999999999998666799999999999999999999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=337.27 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=209.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe-----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
-...++.+.||+|+||.||.|....... .||||.++... +.+....|.+|..+|+.++|||||+++|++.+ .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--S 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--C
Confidence 3567888999999999999998765433 48999987543 45666778899999999999999999999987 6
Q ss_pred CeEEEEEeeccc-cccccccCC------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
...+|++|||+| ||+..+... ...|+..+...++.||+.|+.||+++++|||||-..|+||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 778999999985 677776665 4569999999999999999999999999999999999999999999999999
Q ss_pred cccc-cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 277 LASF-YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 277 la~~-~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
+|+. ++.+.........-...|||||.+.... |+.++|||||||+|||++| |..||++.+..+.+.-..... .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R--- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R--- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c---
Confidence 9993 3333222222223356799999998754 8999999999999999998 999999999999887665421 1
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+.+..+|+.+.+|+..|++.+|++||+...+++
T Consensus 923 ------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1123468889999999999999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.73 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=210.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++.+-+..||.|+||+|++..++.+|+..|||.|+..+.+.+. .+++.|.....+- +.||||++||.+.. ++..|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-KRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-HHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCcee
Confidence 45566678999999999999999999999999999987765544 4566777766554 89999999998877 56789
Q ss_pred EEEeeccccccccc----cCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLA----SHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~----~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
|-||+|.-++-.++ .-....++|.-+-.|...++.||.||-.. .||||||||+||||+..|.+||||||++-.+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99999986543332 22345789999999999999999999865 89999999999999999999999999987653
Q ss_pred CCCCCCccccccccCCCCchhhcCCcc-CCccccccchhHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhhc
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~-y~~~~DIWSLG~iL~ELltG~~pF~g~~-~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
... ..+.-.|-..|||||.+..... |+.++|+||||++|||+.||+-|+.+-+ ..+|+.++.. |.|+.-
T Consensus 220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l----- 290 (361)
T KOG1006|consen 220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPIL----- 290 (361)
T ss_pred HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCee-----
Confidence 322 2344578889999999976444 9999999999999999999999998744 5566666643 433210
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......-+++..+..+|..||.+|-.+||...+++++||+...
T Consensus 291 ----------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 291 ----------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ----------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 0112223588899999999999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=316.33 Aligned_cols=275 Identities=25% Similarity=0.331 Sum_probs=187.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEEC----------------CCCeEEEEEEEecCCCCh--H----------HHHHHHHH
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDL----------------DQKKIVALKKVRFDNLEP--E----------SVRFMARE 179 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~tg~~vAIK~i~~~~~~~--~----------~~~~~~rE 179 (709)
..++|++.++||+|+||.||+|.+. ..++.||||++....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999753 234679999986542110 0 11223457
Q ss_pred HHHHHhcCCCce-----eeeeceEeec------CCCeEEEEEeeccccccc-cccCC-----------------------
Q 005210 180 IHILRRLDHINV-----IKLEGLVTSR------MSCSLYLVFEYMEHDLAG-LASHP----------------------- 224 (709)
Q Consensus 180 i~iL~~L~HpnI-----v~l~~~~~~~------~~~~lyLVmEy~~g~L~~-~~~~~----------------------- 224 (709)
+.++.+++|.++ ++++++|... .....||||||+.++.+. ++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 788888876654 6677776532 134689999999864332 22110
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhh
Q 005210 225 GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304 (709)
Q Consensus 225 ~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l 304 (709)
...+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++..+............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12356778999999999999999999999999999999999999999999999976543222222223458999999998
Q ss_pred cCCcc-------------------CC--ccccccchhHHHHHHHhCCC-CCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 305 LGATY-------------------YG--TAVDLWSTGCILAELYAGKP-IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 305 ~~~~~-------------------y~--~~~DIWSLG~iL~ELltG~~-pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
..... |+ ...||||+|||||+|++|.. +|.+........+. + ......|.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---Y-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---c-cchHHHHHhhcc
Confidence 64221 12 24799999999999999874 66543222111111 0 001112322110
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCC---CCCCCHHHHHhcccCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP---ADRGSAASALRSEFFTM 418 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP---~kRpTa~e~L~hp~f~~ 418 (709)
. .+ -...+..+++.++|||.+||.++| .+|+|++|+|+||||..
T Consensus 459 ~---------~~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 Q---------KY---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred c---------CC---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 00 011245578999999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=281.08 Aligned_cols=243 Identities=39% Similarity=0.626 Sum_probs=196.4
Q ss_pred CceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc-ccccc
Q 005210 142 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL 220 (709)
Q Consensus 142 ~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g-~L~~~ 220 (709)
+||.||+|.+..+++.||+|++........ ...+.+|+.++++++|+||+++++++.. ....++||||+++ .|...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999999999999999876543322 5678899999999999999999998876 5789999999998 45444
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCC
Q 005210 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300 (709)
Q Consensus 221 ~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~A 300 (709)
+.. ...+++..+..++.+|+.+|.|||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++
T Consensus 78 ~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKK-RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred HHh-ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 433 3248999999999999999999999999999999999999999999999999998764432 2344578899999
Q ss_pred chhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhc
Q 005210 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 380 (709)
Q Consensus 301 PE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~ 380 (709)
||.+.+.. ++.++|||+||+++++|++|..||......+.+...+...... ...
T Consensus 155 pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 208 (244)
T smart00220 155 PEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-------------------------FPP 208 (244)
T ss_pred HHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------------Ccc
Confidence 99887544 6889999999999999999999998744444333332211000 000
Q ss_pred ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 381 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 381 ~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
....++..+.++|.+||..||.+||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 111277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.92 Aligned_cols=282 Identities=32% Similarity=0.514 Sum_probs=215.1
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECC---CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
...+.|..+++||+|+|++||++.+.. ..+.||+|.+..... ...+..|+++|..+ .+.||+++.+++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 335679999999999999999999888 788999999875432 34578999999999 68999999998866
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~ 281 (709)
++.+.+||||+++.-...+.. .++..+++.|++.++.||.++|.+|||||||||+|+|.+ ..+.-.|+|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 788999999999876555544 578999999999999999999999999999999999998 4578899999999722
Q ss_pred CCC---------------------------------C----------CCCccccccccCCCCchhhcCCccCCccccccc
Q 005210 282 DPD---------------------------------Q----------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWS 318 (709)
Q Consensus 282 ~~~---------------------------------~----------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWS 318 (709)
+.. . ......+.||+.|+|||++.....-++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 100 0 001124578999999999998777789999999
Q ss_pred hhHHHHHHHhCCCCC-CCCChHHHHHHHHHhhCCCChh----------hhhhcCCCCc------------cccCCCCccc
Q 005210 319 TGCILAELYAGKPIM-PGRTEVEQLHKIFKLCGSPSED----------YWRKSKLPHA------------TIFKPQQPYK 375 (709)
Q Consensus 319 LG~iL~ELltG~~pF-~g~~~~e~l~~I~k~~g~p~~~----------~w~~~~lp~~------------~~~~~~~~~~ 375 (709)
.|||+.-+++++.|| ...++.+.+..|....|.-.-. +|.+...+.. ..+.+...+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~- 342 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP- 342 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc-
Confidence 999999999998665 4566666666666665542211 3332211111 000110000
Q ss_pred cchhcccCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 376 RCVAETFKD-FPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 376 ~~~~~~~~~-~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+..+...+ ++..+.+|+++||..||.+|+||+++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 123333333 4558999999999999999999999999999983
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=301.37 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=201.6
Q ss_pred EeeecccCceEEEEEEECCC----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQ----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~t----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.+.||.|-||.||+|..... .-.||||.++.+. +++..+.|+.|+.+|+.++|||||+|+|++.. ...||||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wivm 469 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIVM 469 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEEE
Confidence 45799999999999987543 3458999987654 44557888999999999999999999999975 4689999
Q ss_pred eecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|++. |.|...+......|+......|+.||+.||.|||+..+|||||-..||||.+...|||+||||++.++.+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 9998 455556666677899999999999999999999999999999999999999999999999999998865544333
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
+..--..-|||||.+.- ..++.++|||-|||.+||++. |..||.|-...+.+..|-+.--
T Consensus 550 S~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR------------------ 610 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER------------------ 610 (974)
T ss_pred cccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC------------------
Confidence 32233677999998854 458999999999999999876 9999999877666655533110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+++|+.+..|+.+|+.+||.+||+..++..
T Consensus 611 ----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 611 ----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 1123578999999999999999999999888753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=307.86 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=217.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|+++..+|.|+||.||+|+++.+++..|+|+++..-. +...-+..||-+++..+|||||.+++-|.. ...++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 5789999999999999999999999999999999986542 334556689999999999999999998876 567999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
.||||+++.++.+..-.++++|.++..+++..+.||+|||+.|-+|||||..|||+++.|.+|++|||.+..+...- ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 99999998888887777799999999999999999999999999999999999999999999999999987664322 23
Q ss_pred ccccccccCCCCchhhc--CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 289 LTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~--~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
..+.+||++|||||+-. ....|...+|||++|+...||---++|....-....+..+.+....|+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------------ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------------ 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------------
Confidence 45679999999999853 3455899999999999999998777777665555555555443332211
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+.-...++.+.+|++.+|.++|.+|||++.+|+|||.+.
T Consensus 237 ------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 ------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0111234566889999999999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=296.48 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred cCccCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 005210 122 QGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR 201 (709)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~ 201 (709)
..|-..+. +.....+||-|-||.||.|.++.-...||||.++.+. ..++.|+.|+.+|+.+.|||+|+|+++|+.
T Consensus 260 DkWEmeRt-dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~- 334 (1157)
T KOG4278|consen 260 DKWEMERT-DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH- 334 (1157)
T ss_pred chhhccch-heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-
Confidence 34533322 3566789999999999999999999999999998654 346678899999999999999999999987
Q ss_pred CCCeEEEEEeecc-ccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 202 MSCSLYLVFEYME-HDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 202 ~~~~lyLVmEy~~-g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
+..+|||.|||. |+|++.+... ...++.--..+++.||..|+.||..+++|||||-..|+||..+..|||+||||++
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 677999999997 6777766543 3347777888999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
++..+........-...-|.|||-|.-.. ++.++|||+|||+|||+.| |..||+|.+....+..+-+.+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--------- 483 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--------- 483 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---------
Confidence 98766555444445577899999887655 7899999999999999987 889999987665555443211
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
-.+....+|+.+.+|++.|++++|.+||+.+|+-+
T Consensus 484 -------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 -------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 01123468899999999999999999999988743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=297.27 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=203.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
....+.++||+|-||.|.+|.. ..+..||+|+++... ..+....|.+||++|.+|+|||||.|+++|.. .+.++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHH
Confidence 3467788999999999999984 447899999998654 23445678899999999999999999999987 6779999
Q ss_pred Eeecc-ccccccccCCCCC-CCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc-CCCCC
Q 005210 210 FEYME-HDLAGLASHPGLK-FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY-DPDQN 286 (709)
Q Consensus 210 mEy~~-g~L~~~~~~~~~~-lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~-~~~~~ 286 (709)
+|||+ |+|-..+.....+ +.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+ ..+..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99998 5565555554323 355667779999999999999999999999999999999999999999999854 22222
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHH--HhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~EL--ltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+-...|||+|.++..+ ++.++|+|+||++|||+ +|...||...++.+........+..+..
T Consensus 694 ~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---------- 762 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---------- 762 (807)
T ss_pred eeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------
Confidence 2333445578999999998766 79999999999999997 5678899887776666555443322211
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
........-+|..+.+|+..|+..|-.+|||.+++-.
T Consensus 763 -----------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 -----------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -----------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1122233457888999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=306.43 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=215.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC---eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
+....+.++||.|.||.||+|+.+..| ..||||.++... .......|+.|+.||-+++||||++|.|+.+. ...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--Cce
Confidence 345678899999999999999988766 459999997544 34455678899999999999999999999987 678
Q ss_pred EEEEEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+.||.|||+.+.++ .+....+.|+..++.-+++.|+.|++||-+.++|||||-..||||+.+-.+||+||||++.+..+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999976555 44445567999999999999999999999999999999999999999999999999999988665
Q ss_pred CCCCcccccc--ccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQPLTSRVV--TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~~~~~~g--T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.....++.-| ...|.|||.+.-.+ ++.++||||+|+||||.++ |..||-..+..+.+..|-+...-|+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-------- 855 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-------- 855 (996)
T ss_pred CCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--------
Confidence 5444444444 57899999997665 7999999999999999765 9999999999999999976544432
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+.+.|..+.+|+..|+++|-..||...+++.
T Consensus 856 --------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 --------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 2478999999999999999999999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=302.45 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=209.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCC-C--eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQ-K--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
+...++++||+|.||.|++|.+... | -.||||.++.+.+.. ....|.+|+.+|.+|+|+|+|+|||++.+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chh
Confidence 4566788999999999999998753 3 358999998776554 66788999999999999999999999875 457
Q ss_pred EEEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 207 YLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.||||++.. .|++.+.. ....|.......|+.||+.|+.||.++++|||||-..||||-..-.|||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999984 56655544 5567999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCC-c-cccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQP-L-TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~-~-~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... + ...-....|+|||.|...+ ++.++|||++||+||||++ |..||.|....+++++|-+.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------------- 331 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------------- 331 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------------
Confidence 2221 1 1233466799999987665 7999999999999999998 88999999999998888421
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
-.....+.++.++.+++..|+..+|.+|||..++...-++
T Consensus 332 ---------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ---------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ---------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 0122346789999999999999999999999888654333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=324.76 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=183.4
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.|...+.||+|+||.||+|.+..++..||||++...... ...|+.++++++|||||++++++.. ....|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 456677999999999999999999999999998643211 1246889999999999999999976 56789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhh---hCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH---SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH---~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||+++.+..+.. .+++.++..++.||+.||.||| +.+|+||||||+|||++.++..++. ||........
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9998655544443 4789999999999999999999 6699999999999999998888876 6665433211
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH-HHHHHHHHhhC-CCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCG-SPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~-e~l~~I~k~~g-~p~~~~w~~~~lp~~ 365 (709)
....+|+.|+|||++.+.. |+.++|||||||++|||++|+.||...... ..+....+... ......|.
T Consensus 836 --~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 905 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI------- 905 (968)
T ss_pred --CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee-------
Confidence 2337889999999987654 899999999999999999999998542210 11111111100 00001110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+..... .........++.+|+.+|++.||.+|||+.++++.
T Consensus 906 ---~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 906 ---DPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ---CccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0100000 00000112357789999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=304.81 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=191.1
Q ss_pred eeEEeeecccCceE-EEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEEE
Q 005210 132 FEKLDKIGQGTYSN-VYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 132 y~~~~~LG~G~fG~-Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
|.-.+.+|.|+-|+ ||+|.. .|+.||||.+- .+...+..|||..|+.- .|||||++|+.- .....+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEE
Confidence 55567899999974 799975 57799999875 33455677999999988 799999997654 447899999
Q ss_pred EeeccccccccccCCCCC--C-CHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CC--cEEEeeccccccc
Q 005210 210 FEYMEHDLAGLASHPGLK--F-SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NG--ILKIADFGLASFY 281 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~--l-se~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g--~vKL~DFGla~~~ 281 (709)
.|.|...|-+++...... + .....+.++.|++.||.+||+.+||||||||.||||+. ++ .++|+|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999887777653111 1 11456788999999999999999999999999999986 34 7899999999988
Q ss_pred CCCCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 282 DPDQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG-~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+... ...+..||-.|+|||++..... ..++||+|||||+|+.++| ..||...-. .-..|++. ...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~--~~~----- 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG--NYT----- 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC--ccc-----
Confidence 654433 2345678999999999987663 7799999999999999886 788855422 22334321 110
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+...-..-..++.|||.+||.+||..||+|.++|.||||-.
T Consensus 732 -------------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 732 -------------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -------------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 01111111127999999999999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=260.10 Aligned_cols=215 Identities=24% Similarity=0.385 Sum_probs=180.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..++...+..||+|+||.|-+.++..+|...|+|.++... .....+++++|+.+..+. .+|.+|++||.+.. ...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdv 120 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDV 120 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccE
Confidence 3566777889999999999999999999999999997553 344456678899988765 89999999998766 6789
Q ss_pred EEEEeecccccc---ccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 207 YLVFEYMEHDLA---GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g~L~---~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
+|.||.|..++. ......+..++|.-+-.|+..++.||.|||++ .|||||+||+||||+.+|++||||||++-.+.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999999986543 34455778899999999999999999999987 89999999999999999999999999997764
Q ss_pred CCCCCCccccccccCCCCchhhcC---CccCCccccccchhHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMP-GRTEVEQLHKIFK 347 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~---~~~y~~~~DIWSLG~iL~ELltG~~pF~-g~~~~e~l~~I~k 347 (709)
..-. .+...|-..|||||.+.. ...|+.++||||||+.++||.+++.||. ..++.+|+.++++
T Consensus 201 dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 3222 222456778999999863 3468999999999999999999998886 4788999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=285.03 Aligned_cols=203 Identities=28% Similarity=0.480 Sum_probs=175.5
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHH-----HHHHHHHHHHHHhcC---CCceeeeec
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PES-----VRFMAREIHILRRLD---HINVIKLEG 196 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~-----~~~~~rEi~iL~~L~---HpnIv~l~~ 196 (709)
.....+|..+..||.|+||.|++|.++.+...|+||.|.+...- ... +-.+-.||.||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 44567799999999999999999999999999999999776431 111 223557999999997 999999999
Q ss_pred eEeecCCCeEEEEEeeccc--cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEee
Q 005210 197 LVTSRMSCSLYLVFEYMEH--DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 274 (709)
Q Consensus 197 ~~~~~~~~~lyLVmEy~~g--~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~D 274 (709)
+|++ ...+||+||--.. +|.+.+. ....++|.+++.|++|++.|+++||+.||||||||-+|+.|+.+|-+||+|
T Consensus 637 fFEd--dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 637 FFED--DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeec--CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 9988 7889999998764 4444444 455899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCC
Q 005210 275 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 334 (709)
Q Consensus 275 FGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~ 334 (709)
||.|.... +.+....+||..|.|||+|.|..+.+..-|||+||++||.++....||.
T Consensus 714 fgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997643 3456778999999999999999988999999999999999998887774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=241.04 Aligned_cols=213 Identities=39% Similarity=0.631 Sum_probs=179.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccc-c
Q 005210 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-D 216 (709)
Q Consensus 138 LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g-~ 216 (709)
||+|.+|.||++.+..+++.++||++....... ....+.+|+.+++.+.|++|+++++++.. ....++||||+.+ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999987654322 34668899999999999999999998876 4789999999994 5
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccccCCCCCCCccccccc
Q 005210 217 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVT 295 (709)
Q Consensus 217 L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~gT 295 (709)
+...+......+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 55544433246899999999999999999999999999999999999998 89999999999987643321 12334678
Q ss_pred cCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccc
Q 005210 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 375 (709)
Q Consensus 296 ~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~ 375 (709)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999887653578999999999999998
Q ss_pred cchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 376 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 376 ~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
..+.++|..||..||.+||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2366899999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=285.63 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=196.8
Q ss_pred CeeEEeeecccCceEEEEEEEC----C---CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 131 SFEKLDKIGQGTYSNVYRARDL----D---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~----~---tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
+..+.+.||+|.||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+ .|+||+.++++++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 3456669999999999999743 1 2457999998765544 6677889999999998 69999999999987
Q ss_pred CCeEEEEEeeccc-cccccccCCC---------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG---------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~---------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
.+.+++|+||+.. +|+..+...+ ..++..+...++.||+.|++||++..+|||||-..||||..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 7789999999984 5555544433 24899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCCCcccccc--ccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCC-hHHHH
Q 005210 267 NGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRT-EVEQL 342 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~-~~e~l 342 (709)
+..+||+|||+|+..............+ ...|||||.+.. ..|+.++||||+|++||||++ |..|+++-. ..+.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999998643333222122222 344999999988 458999999999999999998 889998854 33343
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+.. |. -.+.+...++++.+|+..|++.+|++||+..++.+
T Consensus 533 ~~l~~--G~--------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKE--GN--------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhc--CC--------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 32221 10 01222456888999999999999999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=244.58 Aligned_cols=213 Identities=38% Similarity=0.597 Sum_probs=175.2
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|.+.+.||.|++|.||++.+..+++.+|||.+...... .....+.+|+..++.++|+|++++++++.. ....|+|+|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56789999999999999999988999999998765433 245678899999999999999999998866 567999999
Q ss_pred eccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 212 YMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 212 y~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
|+.+ .|...+......+++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++..+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998 555544433222899999999999999999999999999999999999999999999999999876443211223
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC-CChH-HHHHHHHH
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEV-EQLHKIFK 347 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~-e~l~~I~k 347 (709)
...++..|++||.+.+...++.++|+|+|||++++|++|++||.+ .+.. +....|..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 457788999999884444577899999999999999999999988 4444 44555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=269.45 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=187.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeecC--CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSRM--SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~~~~~~~--~~ 204 (709)
....++++.||+|.||.||+|.. +++.||||++.. ...+.+..|.+|.+. |.|+||++++++-.... ..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34567788999999999999975 458999999864 345566677777665 58999999987654311 34
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC---------CeeeccCCCccEEEcCCCcEEEeec
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---------GVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~---------gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
.++||+||.+.+.+..++... .+++....+++..|++||.|||+- .|+|||||..||||.+|+++.|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 789999999865555444433 589999999999999999999973 5999999999999999999999999
Q ss_pred ccccccCCCCCC-CccccccccCCCCchhhcCCccCC-----ccccccchhHHHHHHHhCCCCCC-CCChHHHHHHHHHh
Q 005210 276 GLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYG-----TAVDLWSTGCILAELYAGKPIMP-GRTEVEQLHKIFKL 348 (709)
Q Consensus 276 Gla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~-----~~~DIWSLG~iL~ELltG~~pF~-g~~~~e~l~~I~k~ 348 (709)
|||..+.+.... .....+||..|||||+|.|...+. .+.||||+|.|||||++....+. +....=++.---.+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988754433 234579999999999998865544 36899999999999998765543 22211111111111
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccC--CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASA 410 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~lL~~DP~kRpTa~e~ 410 (709)
.-.|+-+.....-+. +...| .+...+. .-...+.+.|+.|+..||+.|.||.=+
T Consensus 441 G~hPt~e~mq~~VV~-----kK~RP---~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVR-----KKQRP---KIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHh-----hccCC---CChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 223332222110000 00000 0111111 123458899999999999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=303.58 Aligned_cols=203 Identities=18% Similarity=0.207 Sum_probs=146.8
Q ss_pred hcCC-CceeeeeceEeec-----CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCC
Q 005210 185 RLDH-INVIKLEGLVTSR-----MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIK 258 (709)
Q Consensus 185 ~L~H-pnIv~l~~~~~~~-----~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLK 258 (709)
.+.| .||+++++++... ....++++|||++++|...+......+++.+++.|+.||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3345 5777777766211 124688899999998888876655679999999999999999999999999999999
Q ss_pred CccEEEcCCC-------------------cEEEeecccccccCCCC---------------CCCccccccccCCCCchhh
Q 005210 259 GSNLLIDNNG-------------------ILKIADFGLASFYDPDQ---------------NQPLTSRVVTLWYRPPELL 304 (709)
Q Consensus 259 P~NILld~~g-------------------~vKL~DFGla~~~~~~~---------------~~~~~~~~gT~~Y~APE~l 304 (709)
|+||||+..| .+||+|||+++...... .......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 45566666654321000 0001224689999999998
Q ss_pred cCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCC
Q 005210 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD 384 (709)
Q Consensus 305 ~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~ 384 (709)
.+.. |+.++||||||||||||++|.++|.... ..+..+.... .|. . ...
T Consensus 188 ~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~--------------------------~~~ 236 (793)
T PLN00181 188 NGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q--------------------------ILL 236 (793)
T ss_pred ccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h--------------------------hhh
Confidence 8765 7999999999999999999998875422 1222221110 000 0 001
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 385 FPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 385 ~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
-.+.+.+++..||++||.+|||+.++|+||||..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1344678999999999999999999999999975
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=257.71 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=180.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHH--hcCCCceeeeeceEeecC--CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR--RLDHINVIKLEGLVTSRM--SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~--~L~HpnIv~l~~~~~~~~--~~ 204 (709)
..+..+.+.||+|.||.||+|.+. |..||||++.-.. . +.+.||.+|.+ .|+|+||+.+++.-.... -.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--E---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc--h---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 466889999999999999999885 6789999986332 1 22445666655 469999999987543221 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC--------CeeeccCCCccEEEcCCCcEEEeecc
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
.+|||.+|.+.+.+..++.. ..++......++..++.||.|||.. .|.|||||..||||..+|.+-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 68999999997655555554 4789999999999999999999963 49999999999999999999999999
Q ss_pred cccccCCCCCC---CccccccccCCCCchhhcCCcc---C--CccccccchhHHHHHHHhC----------CCCCCC---
Q 005210 277 LASFYDPDQNQ---PLTSRVVTLWYRPPELLLGATY---Y--GTAVDLWSTGCILAELYAG----------KPIMPG--- 335 (709)
Q Consensus 277 la~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~~---y--~~~~DIWSLG~iL~ELltG----------~~pF~g--- 335 (709)
||......... ....++||..|||||+|..... + -..+||||||.||||++.. ++||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99887554332 3457899999999999865321 1 1358999999999998753 245533
Q ss_pred -CChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCC--HHHHHHHHHhcccCCCCCCCHHHHH
Q 005210 336 -RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP--APALALMETLLSIDPADRGSAASAL 411 (709)
Q Consensus 336 -~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLI~~lL~~DP~kRpTa~e~L 411 (709)
+-..+.+.+++ |- ..++|. +...+...+ ..+-.|++.|+..||.-|.||-.+-
T Consensus 442 ~DPs~eeMrkVV--Cv---------------~~~RP~------ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVV--CV---------------QKLRPN------IPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcce--ee---------------cccCCC------CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 22333333331 00 001111 111111111 1356789999999999999986553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=271.78 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=200.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.....++||+|+||+||+|.+...|+ +||||++...... .....++.|+.+|.+|+|||+++|++++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 35567899999999999999876654 5899988654433 3345678899999999999999999998753 37
Q ss_pred EEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
-||++||+ |.|++.+......+-......|+.||+.|+.|||.+.+|||||-..|+||..-.++||.|||+++.+.++.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 89999999 56778777777789999999999999999999999999999999999999999999999999999987766
Q ss_pred CCCcccc-ccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 NQPLTSR-VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 ~~~~~~~-~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
....... -..+.|||=|.+.... |+.++|||||||++|||+| |..|+.+....++- .+++.- .
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~g-e------------ 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEKG-E------------ 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhcc-c------------
Confidence 5543321 2256688888776654 8999999999999999988 88999887655543 333210 0
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+ ....+..+-++.-++.+|+..|+..||+++++..
T Consensus 918 ------------R--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 ------------R--LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------c--CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0 1122346677888999999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=238.83 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=192.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.+.|.+.+.||+|.||.+.+|.++.+...++||.+... ....+.|.+|...--.| .|.||+.-|++... ..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEE
Confidence 67899999999999999999999999999999998754 33456677888776666 58999988765432 256888
Q ss_pred EEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc--CCCcEEEeecccccccCCC
Q 005210 208 LVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFYDPD 284 (709)
Q Consensus 208 LVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld--~~g~vKL~DFGla~~~~~~ 284 (709)
+++||++ |+|...+... .+-|.-.+.++.|+++||.|||+.++||||||.+||||- +...|||||||+....+..
T Consensus 99 F~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999998 5666665554 378999999999999999999999999999999999995 3448999999998754321
Q ss_pred CCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChhhhhh
Q 005210 285 QNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~-l~~I~k~~g~p~~~~w~~ 359 (709)
....--+..|.+||++.. .-...+.+|||.||+|+|.+|||.+||......+. +.... .|.+
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~---------~w~~ 243 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE---------QWLK 243 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH---------HHhc
Confidence 111223567999998753 22246789999999999999999999964322111 11111 1322
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GSAASALRSEFF 416 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kR---pTa~e~L~hp~f 416 (709)
.+.+ .+...|..+++.+..++++-|..+|.+| -++......-|.
T Consensus 244 rk~~-------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 244 RKNP-------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCc-------------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 2222 1345667799999999999999999999 555555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-25 Score=226.80 Aligned_cols=263 Identities=34% Similarity=0.509 Sum_probs=206.4
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-HHHHHHHHHHHHHHhcCCC-ceeeeeceEeecCCCeEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHI-NVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~L~Hp-nIv~l~~~~~~~~~~~lyLV 209 (709)
|.+...||.|+||.||++.+. ..+++|.+....... .....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 788999999999999999987 778999987664433 2567788999999999988 79999998854 4558999
Q ss_pred EeeccccccccccCCCC---CCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCC
Q 005210 210 FEYMEHDLAGLASHPGL---KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQ 285 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~---~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~ 285 (709)
++|+.+..+..+..... .+++..+..++.|++.+|.|+|..+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999765554433332 689999999999999999999999999999999999999888 79999999998654332
Q ss_pred CC-----CccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCC-Ch
Q 005210 286 NQ-----PLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSP-SE 354 (709)
Q Consensus 286 ~~-----~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---~e~l~~I~k~~g~p-~~ 354 (709)
.. .....+||..|++||.+.+. ..+....|+|++|++++++++|..||..... ......++.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 21 34667899999999999874 4578999999999999999999999888764 34444444333322 00
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
... ..... ......+.+++..++..+|..|.+..+...++|....
T Consensus 237 ~~~--------------~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 SPL--------------SPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccc--------------Ccccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 000 00000 2233578899999999999999999999999777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=271.74 Aligned_cols=264 Identities=27% Similarity=0.356 Sum_probs=201.5
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEec----CCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~----~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.....+|.|++|.|+.+......+.++.|..+. ..........+..|..+-..|.|||++..+..+.. ....+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchh
Confidence 346789999999999998888777777776542 11122222336678888889999999887776655 333445
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
+||||+.+|..++... ..++..++.+++.||+.||.|||+.||.||||||+|||++.+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999776666554 4789999999999999999999999999999999999999999999999999987743322
Q ss_pred -CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 -~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+|+..|+|||++.+..+....+||||.|+|++.|++|+.||.-....+....-... ..|.
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~------~~~~------- 544 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY------SDQR------- 544 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc------cccc-------
Confidence 34557789999999999998886677899999999999999999999765433322100000 0000
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..... ....+..++...+.+|.+||++||.+|.|+++||+.+||+..
T Consensus 545 ---~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 545 ---NIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ---ccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00011 122334578889999999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=223.14 Aligned_cols=165 Identities=24% Similarity=0.312 Sum_probs=126.0
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccc
Q 005210 216 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 295 (709)
Q Consensus 216 ~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT 295 (709)
+|.+.+...+..|++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..||
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCCc
Confidence 344445444557999999999999999999999999 999999999999999 99998754322 2689
Q ss_pred cCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 296 ~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~-l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
+.|||||++.+.. |+.++|||||||++|||++|++||........ +..+....... . +.
T Consensus 68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~----------------~~ 127 (176)
T smart00750 68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---D----------------PR 127 (176)
T ss_pred ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---C----------------cc
Confidence 9999999998765 79999999999999999999999976554332 33332211000 0 00
Q ss_pred ccchhcccCCCCH--HHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 375 KRCVAETFKDFPA--PALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 375 ~~~~~~~~~~~s~--~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
.+. ....++. .+.+||.+||..||.+|||+.++++|+|+.
T Consensus 128 ~~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 DRS---NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccc---cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000 0112333 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=238.23 Aligned_cols=168 Identities=22% Similarity=0.249 Sum_probs=131.6
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECC-CCeEEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCceee-eeceEee
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIK-LEGLVTS 200 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~-l~~~~~~ 200 (709)
+...+.|.+.+.||+|+||.||+|++.. ++..||||++..... .......+.+|+.+|+.|+|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3447889999999999999999999876 788889998753311 2334566889999999999999985 4331
Q ss_pred cCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccC-CCccEEEcCCCcEEEeeccccc
Q 005210 201 RMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI-KGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDL-KP~NILld~~g~vKL~DFGla~ 279 (709)
...|||||||+|..+..... .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 34799999999876553221 11 1467899999999999999999999 9999999999999999999998
Q ss_pred ccCCCCC-------CCccccccccCCCCchhhcC
Q 005210 280 FYDPDQN-------QPLTSRVVTLWYRPPELLLG 306 (709)
Q Consensus 280 ~~~~~~~-------~~~~~~~gT~~Y~APE~l~~ 306 (709)
.+..... ...+..++++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7643221 11245678889999998854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-26 Score=251.29 Aligned_cols=241 Identities=27% Similarity=0.400 Sum_probs=198.7
Q ss_pred eecccCceEEEEEEE---CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEEEee
Q 005210 137 KIGQGTYSNVYRARD---LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~---~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLVmEy 212 (709)
.+|+|+||.|++++. .+.+..||+|++++.............|..++...+ ||.+|+++..+.. ...+|++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 379999999998753 356778999998765443222224557889999986 9999999888876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccc
Q 005210 213 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292 (709)
Q Consensus 213 ~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~ 292 (709)
..++.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 998666555555668999999999999999999999999999999999999999999999999999875432221
Q ss_pred ccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCC
Q 005210 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 372 (709)
Q Consensus 293 ~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~ 372 (709)
|||..|||||++.+ ...++|+||||+++|||++|..||.+ +.+..|.+..-..+
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------- 207 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------- 207 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------
Confidence 99999999999973 57899999999999999999999988 77888876322221
Q ss_pred ccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCCC
Q 005210 373 PYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMKP 420 (709)
Q Consensus 373 ~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~~ 420 (709)
..++..+.+++..|+..+|..|.- +.++++|+||+..-
T Consensus 208 ----------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 208 ----------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred ----------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 346677999999999999999975 57999999998653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=226.39 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=199.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-----eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
-.++.....+-+|.||.||.|.+.+.. +.|-+|.++. ...+-.+..+..|...|..+.|||+..+.++.... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-c
Confidence 345888889999999999999776543 3355666543 33445567788999999999999999999887653 4
Q ss_pred CeEEEEEeecc-cccccccc-----C--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 204 CSLYLVFEYME-HDLAGLAS-----H--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 204 ~~lyLVmEy~~-g~L~~~~~-----~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
...+.++.+++ ++|...+. . ....++..++..++.||+.|++|||.+||||.||-..|.+||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 56788889988 34433332 1 1124788899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcc-ccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 276 GLASFYDPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 276 Gla~~~~~~~~~~~~-~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
.+++-+.+.....+. ...-...||+||.+.+.. |+.++|+|||||+||||+| |+.|+...+..|..+-+.+..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy---- 515 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY---- 515 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----
Confidence 999877655443322 122356799999998765 8999999999999999987 999999998888877664321
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+-.+ +-+.|+++..++..|+..+|++||+.+++..
T Consensus 516 ---------------RlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 ---------------RLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------eecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111 2368999999999999999999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=219.40 Aligned_cols=254 Identities=26% Similarity=0.247 Sum_probs=188.9
Q ss_pred CeeEEeeecccCceEEEEEEECCCC-eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC----CceeeeeceEeecCCCe
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQK-KIVALKKVRFDNLEPESVRFMAREIHILRRLDH----INVIKLEGLVTSRMSCS 205 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H----pnIv~l~~~~~~~~~~~ 205 (709)
.|.+.+.||+|+||.||+|.+..++ ..+|+|........... .+..|+.+|..+.. .++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999998875 67899887654222111 46679999998863 57888877764 22567
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-----CcEEEeeccccc
Q 005210 206 LYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-----GILKIADFGLAS 279 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-----g~vKL~DFGla~ 279 (709)
-||||+.++.+|.++.... ...|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999999999988877443 3689999999999999999999999999999999999999865 369999999998
Q ss_pred --ccCCCCCC----C---ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 005210 280 --FYDPDQNQ----P---LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 350 (709)
Q Consensus 280 --~~~~~~~~----~---~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g 350 (709)
.+...... . .....||..|.++....+.. .+.+.|+||++.++.+|+.|..||.+........++.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 43222211 1 12345999999999888766 59999999999999999999999977664433333332110
Q ss_pred CCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.... .......+..+..+...+-..+...+|....+..
T Consensus 255 ~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLT------------------------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhcc------------------------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 0000 0012234456666777666677778887666544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=242.87 Aligned_cols=223 Identities=30% Similarity=0.417 Sum_probs=169.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|+.++.|-.|+||.||.++++.+.+.+|+ +++++++ +.|- ||.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee----------------
Confidence 57899999999999999999999999999999 5554432 1111 22222233322
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC-----
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP----- 283 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~----- 283 (709)
||-..++...+ +++... +.+++|||+.||+|||+||+|+||+.-|++|++|||+.+.-.-
T Consensus 136 ------gDc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 44444444333 455433 7899999999999999999999999999999999999864210
Q ss_pred --------CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 284 --------DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 284 --------~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
...+ .....||||.|+|||++.... |+..+|+|++|+|+||.+-|..||.|++..+++...+.....-+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-
Confidence 0001 113458999999999998765 89999999999999999999999999999999888766432222
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG---SAASALRSEFFTMK 419 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp---Ta~e~L~hp~f~~~ 419 (709)
+.-..+++++.+||..||+.+|..|. .+-++.+|+||+.-
T Consensus 279 -------------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 279 -------------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred -------------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 22235789999999999999999994 56778899999854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-23 Score=238.02 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=182.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN--LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.|...+.||.+.|=+|.+|++.+ | .|+||++-+.. ..-....+..+|++ ...+++||++.+.-+... ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 68889999999999999998754 4 48999975443 22233344455666 667799999998766544 566799
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc-CC-CCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY-DP-DQN 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~-~~-~~~ 286 (709)
|-+|+.++|.+.+..+. -|.+-+-+.|+.||+.||..||..||+|+|||.+||||+..+.+.|+||...+.. -+ ++.
T Consensus 99 vRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999999999887643 5888999999999999999999999999999999999999999999999876532 11 221
Q ss_pred CCcccccc----ccCCCCchhhcCCc----------cCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 287 QPLTSRVV----TLWYRPPELLLGAT----------YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 287 ~~~~~~~g----T~~Y~APE~l~~~~----------~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
...+...- -.+|+|||.+.... ..+++.||||+||+++||++ |+|||. ..|+-..... +.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~-~~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSG-NA 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhcc-Cc
Confidence 22222222 35699999986522 15678999999999999987 899993 2232222110 01
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
... ..+.+...+ ..++.||..|++.||.+|.+|++.|+-
T Consensus 253 ~~~---------------------e~~Le~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDP---------------------EQLLEKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCH---------------------HHHHHhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 100 111111222 268999999999999999999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=200.04 Aligned_cols=141 Identities=22% Similarity=0.218 Sum_probs=109.2
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHH------------------------HHHHHHHHHHHHhcCCCc
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES------------------------VRFMAREIHILRRLDHIN 190 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~------------------------~~~~~rEi~iL~~L~Hpn 190 (709)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 458999999999999986 8999999999765321111 122345999999998877
Q ss_pred eeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhh-hhCCeeeccCCCccEEEcCCCc
Q 005210 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 191 Iv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yL-H~~gIvHrDLKP~NILld~~g~ 269 (709)
+.....+... ..||||||++++.+.........+++..+..++.||+.+|.|| |+.||+||||||+||||+ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7443322211 2389999999865433222335789999999999999999999 799999999999999998 588
Q ss_pred EEEeeccccccc
Q 005210 270 LKIADFGLASFY 281 (709)
Q Consensus 270 vKL~DFGla~~~ 281 (709)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=195.88 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=194.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~~~~l 206 (709)
..++|.++++||.|+||.+|+|....+|..||||+-+.....+ .+..|..+.+.|++ ..|..+..+... ..+-
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~yn 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDYN 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--cccc
Confidence 3688999999999999999999999999999999865443332 35678898888854 566666555554 4566
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---CcEEEeecccccccCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDP 283 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGla~~~~~ 283 (709)
.|||++++.+|.+++......|+...+..++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+..
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8999999998888777666689999999999999999999999999999999999999643 4699999999987743
Q ss_pred CCCC------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH---HHHHHHhhCCCCh
Q 005210 284 DQNQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ---LHKIFKLCGSPSE 354 (709)
Q Consensus 284 ~~~~------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~---l~~I~k~~g~p~~ 354 (709)
.... ......||..|.+=-...+.. -+...|+=|+|.+|..+.-|..||.|-..... +++|...--+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s--- 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS--- 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC---
Confidence 2111 223457899998876666544 37789999999999999999999998655443 4444332111
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFT 417 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT---a~e~L~hp~f~ 417 (709)
-.+...++.+|.++.-.|.-|=..-=++-|. ..++.+.-|++
T Consensus 243 ---------------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 243 ---------------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred ---------------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1133445678888887777776555455554 34445554544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=201.84 Aligned_cols=209 Identities=23% Similarity=0.307 Sum_probs=171.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~lyL 208 (709)
-+|.+.++||+|+||..+.|.+.-++++||||.=.... ...++..|....+.| ..++|..+|.+... +.+=.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhh
Confidence 47999999999999999999999999999999744322 223456788888877 57888888654433 555679
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-----cEEEeecccccccCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-----ILKIADFGLASFYDP 283 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-----~vKL~DFGla~~~~~ 283 (709)
|||+++.+|.+++.-.+.+|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+|+.+..
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999999988888877788999999999999999999999999999999999999997543 699999999998743
Q ss_pred CCC-C-----CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 005210 284 DQN-Q-----PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR---TEVEQLHKI 345 (709)
Q Consensus 284 ~~~-~-----~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~---~~~e~l~~I 345 (709)
... + ...+..||..||+=-..+|.. -+...|+=|||-|++..|-|..||.|- +..+.+++|
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 222 1 234668999999988877765 488999999999999999999999874 444455554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=192.40 Aligned_cols=141 Identities=23% Similarity=0.266 Sum_probs=111.5
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh------------------------HHHHHHHHHHHHHHhcCCCc
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------------------------ESVRFMAREIHILRRLDHIN 190 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~------------------------~~~~~~~rEi~iL~~L~Hpn 190 (709)
...||+|+||.||+|.+. +|+.||||+++...... .....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 89999999998653210 00123457999999999998
Q ss_pred eeeeeceEeecCCCeEEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCC
Q 005210 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 191 Iv~l~~~~~~~~~~~lyLVmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g 268 (709)
|.....+... ..||||||+++... ..... ...+++.++..++.|++.+|.+||+ .||+||||||+||||+ ++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 7554433322 24899999998632 22222 3468899999999999999999999 9999999999999998 89
Q ss_pred cEEEeecccccccC
Q 005210 269 ILKIADFGLASFYD 282 (709)
Q Consensus 269 ~vKL~DFGla~~~~ 282 (709)
.++|+|||++..+.
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=197.50 Aligned_cols=174 Identities=14% Similarity=0.137 Sum_probs=131.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH-HHHH------HHHHHHHHHhcCCCceeeeeceEeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE-SVRF------MAREIHILRRLDHINVIKLEGLVTSR 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~-~~~~------~~rEi~iL~~L~HpnIv~l~~~~~~~ 201 (709)
.++|..++.||.|+||.||++.. ++..+|||+++......+ .... +.+|+..+.+|.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999755 466899999976543322 2222 57899999999999999998876543
Q ss_pred C------CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 202 M------SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 202 ~------~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
. .+..||||||++|..+..+. .+++ ..+.+|+.+|..||..||+||||||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 24689999999986444332 2333 2466999999999999999999999999999988 999999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHH
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELl 327 (709)
|....+..... -+.+.-...|+.++|+|+||++|..+.
T Consensus 179 g~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 98875432111 112333344778999999999887653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=205.48 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=151.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCC----------CceeeeeceE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH----------INVIKLEGLV 198 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~H----------pnIv~l~~~~ 198 (709)
..+.....||.|+++.||.+++.+|++.+|||++..... .....+.+.+|......+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356778899999999999999999999999999876543 23456677777765555432 1122222221
Q ss_pred e---------ecCC-C-----eEEEEEeeccccccccccC----CCCC--CCHHHHHHHHHHHHHHHhhhhhCCeeeccC
Q 005210 199 T---------SRMS-C-----SLYLVFEYMEHDLAGLASH----PGLK--FSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 257 (709)
Q Consensus 199 ~---------~~~~-~-----~lyLVmEy~~g~L~~~~~~----~~~~--lse~~i~~i~~QIl~aL~yLH~~gIvHrDL 257 (709)
. .... . ..+++|+-+.++|..++.. .... +...-...+..|++..+++||..||+|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1111 1 2367888888777655321 1111 222223344589999999999999999999
Q ss_pred CCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCC-------ccCCccccccchhHHHHHHHhCC
Q 005210 258 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA-------TYYGTAVDLWSTGCILAELYAGK 330 (709)
Q Consensus 258 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-------~~y~~~~DIWSLG~iL~ELltG~ 330 (709)
||+|+|++.+|.++|+||+.....+.. ......+..|.+||+.... ..++.+.|.|+||+++|.|+||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988764321 1113556789999976432 34788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCC
Q 005210 331 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404 (709)
Q Consensus 331 ~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kR 404 (709)
.||......... .| .+. .+.++|+.+++||..||+.||.+|
T Consensus 248 lPf~~~~~~~~~-------------~~-------------------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADP-------------EW-------------------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTS-------------GG-------------------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccc-------------cc-------------------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 999765321100 00 111 223799999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=188.93 Aligned_cols=191 Identities=17% Similarity=0.115 Sum_probs=140.0
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC--hHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.+...|++|+||.||.+.. .+..++.+.+...... .-....+.+|+++|++|. |++|++++++ +..|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 3467999999999998764 6677777776544321 111225679999999995 5789998775 236899
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccC-CCccEEEcCCCcEEEeecccccccCCCCCC-
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI-KGSNLLIDNNGILKIADFGLASFYDPDQNQ- 287 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDL-KP~NILld~~g~vKL~DFGla~~~~~~~~~- 287 (709)
|||+.|..+.... +.. ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999987654322 111 2457889999999999999999999 799999999999999999999865432210
Q ss_pred ---C--------ccccccccCCCCchhhcCCccCC-ccccccchhHHHHHHHhCCCCCCCCCh
Q 005210 288 ---P--------LTSRVVTLWYRPPELLLGATYYG-TAVDLWSTGCILAELYAGKPIMPGRTE 338 (709)
Q Consensus 288 ---~--------~~~~~gT~~Y~APE~l~~~~~y~-~~~DIWSLG~iL~ELltG~~pF~g~~~ 338 (709)
. ..-...++.|+.|+.-.-....+ ...++++.|+.+|.++|+..++-++++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 01123578889998654322223 567899999999999999988766543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=202.51 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=174.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCe-----------------------------------EEEEEEEecCCC---C
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKK-----------------------------------IVALKKVRFDNL---E 169 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----------------------------------~vAIK~i~~~~~---~ 169 (709)
+.++|++...||+|.-+.||.|+...+|. +.|||.+-.-.. .
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 36779999999999999999987543211 345665421111 1
Q ss_pred hHHHHHHHHHHH-------H-------HHh-------c-CCCceeeeeceEeec-------------------------C
Q 005210 170 PESVRFMAREIH-------I-------LRR-------L-DHINVIKLEGLVTSR-------------------------M 202 (709)
Q Consensus 170 ~~~~~~~~rEi~-------i-------L~~-------L-~HpnIv~l~~~~~~~-------------------------~ 202 (709)
....+.+.+|.- . .+. | +|||||+++++|.+. .
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 122333333321 0 011 1 599999999887652 1
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc--CCC--cEEEeecccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNG--ILKIADFGLA 278 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld--~~g--~vKL~DFGla 278 (709)
...+|+||.-..+.|..++-.. ..+......++.|+++|+.|||.+||.|||||.+||||. +|+ .+.|+|||.+
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3578999999988887766544 357777888999999999999999999999999999995 333 6899999987
Q ss_pred cccCC-----CCCCCccccccccCCCCchhhcCCcc-----CCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 005210 279 SFYDP-----DQNQPLTSRVVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 279 ~~~~~-----~~~~~~~~~~gT~~Y~APE~l~~~~~-----y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~ 348 (709)
-..+. ......-..-|.-..||||+...... .-.++|.|+.|.+.||+++...||.+..+..+-..
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---- 468 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---- 468 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----
Confidence 54322 11112223456777899998754221 12368999999999999999999988543221111
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH---HHHHh
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA---ASALR 412 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa---~e~L~ 412 (709)
.+....+| .....+|+.+++||..+|+.||.+|+++ +.+|+
T Consensus 469 -------~Yqe~qLP----------------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 469 -------TYQESQLP----------------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -------hhhhhhCC----------------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11112222 2234588899999999999999999984 45555
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=183.06 Aligned_cols=147 Identities=20% Similarity=0.162 Sum_probs=112.9
Q ss_pred CCeeEEeeecccCceEEEEEE-ECCCCeEEEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 005210 130 DSFEKLDKIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEP----------------------ESVRFMAREIHILRRL 186 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~-~~~tg~~vAIK~i~~~~~~~----------------------~~~~~~~rEi~iL~~L 186 (709)
.-|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.+|
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999998 77899999999998543210 0112456899999999
Q ss_pred CCCceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-eeeccCCCccEEEc
Q 005210 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG-VLHRDIKGSNLLID 265 (709)
Q Consensus 187 ~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g-IvHrDLKP~NILld 265 (709)
.+.. +.+..++.. ...||||||++++.+.........+.+.++..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 108 ~~~~-i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAG-VPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcC-CCCCeeeEe---cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7532 222222222 124899999998655443323345677778899999999999999999 99999999999998
Q ss_pred CCCcEEEeeccccccc
Q 005210 266 NNGILKIADFGLASFY 281 (709)
Q Consensus 266 ~~g~vKL~DFGla~~~ 281 (709)
++.++|+|||++...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=175.25 Aligned_cols=136 Identities=18% Similarity=0.247 Sum_probs=104.2
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-----CCCceeeeeceEeecCC-CeEE
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-----DHINVIKLEGLVTSRMS-CSLY 207 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HpnIv~l~~~~~~~~~-~~ly 207 (709)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++++++....+ ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 457899999999995 7777665 6999875432 2345688999999999 67999999999987432 3434
Q ss_pred -EEEeecc--c-cccccccCCCCCCCHHHHHHHHHHHHHHH-hhhhhCCeeeccCCCccEEEcC----CCcEEEeecccc
Q 005210 208 -LVFEYME--H-DLAGLASHPGLKFSEAQVKCYMQQLLCGL-DHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLA 278 (709)
Q Consensus 208 -LVmEy~~--g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL-~yLH~~gIvHrDLKP~NILld~----~g~vKL~DFGla 278 (709)
+||||++ + +|...+.. + .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-C-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-c-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 7899954 4 55555543 3 46666 46688888888 9999999999999999999974 338999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-20 Score=212.06 Aligned_cols=264 Identities=28% Similarity=0.415 Sum_probs=206.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~l 206 (709)
...|.+.+.||+|+|+.|-.+.... +...+|+|.+............+..|..+-+.+. |.|++++++.... ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence 4567888899999999999887644 4455777776654433444555667899988887 9999999998766 6678
Q ss_pred EEEEeecccccccccc-CCCC-CCCHHHHHHHHHHHHHHHhhhh-hCCeeeccCCCccEEEcCCC-cEEEeecccccccC
Q 005210 207 YLVFEYMEHDLAGLAS-HPGL-KFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~-~~~~-~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~ 282 (709)
+++++|..++.+...+ .... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+|++|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999998876555444 4444 6788899999999999999999 99999999999999999999 99999999998875
Q ss_pred C--CCCCCcccccc-ccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 283 P--DQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 283 ~--~~~~~~~~~~g-T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
. .........+| ++.|+|||.+.+..+.++..|+||+|+++.-+++|..|+.-....... ...|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~ 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKS 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeecc
Confidence 5 23333446788 999999999988767789999999999999999999887544332210 011111
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+ ...-...+..++..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 246 ~~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NK-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cc-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 10 00012234568888999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-19 Score=194.23 Aligned_cols=177 Identities=29% Similarity=0.439 Sum_probs=133.4
Q ss_pred CeEEEEEeeccccccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 204 CSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.++||.|++|..+.+..++. .....+...++.++.|+..|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999766665553 23346778899999999999999 9999999999999999999999999999987
Q ss_pred cCCCC-----CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH--HHHhhCCCC
Q 005210 281 YDPDQ-----NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK--IFKLCGSPS 353 (709)
Q Consensus 281 ~~~~~-----~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~--I~k~~g~p~ 353 (709)
..... ....+..+||.+||+||.|.+.. |+.++||||||+|||||+.- |. +..+.+.. .++ -|..+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d~r-~g~ip 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQ---FS--TQFERIATLTDIR-DGIIP 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhhhh-cCCCC
Confidence 65443 34567789999999999999876 89999999999999999872 21 11121111 111 01111
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
+.+|. =-+.-.+|+..||...|.+||++.+.-.|+|.
T Consensus 479 ~~~~~--------------------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQ--------------------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhh--------------------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11211 12335689999999999999988887777775
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=165.35 Aligned_cols=140 Identities=23% Similarity=0.195 Sum_probs=107.5
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH--------------------HHHHHHHHHHHHHhcCCCc
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE--------------------SVRFMAREIHILRRLDHIN 190 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~--------------------~~~~~~rEi~iL~~L~Hpn 190 (709)
.|.+.+.||+|+||.||++.+. +|+.||||+++....... ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3777899999999999999874 799999999875431100 1113567999999997774
Q ss_pred --eeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC
Q 005210 191 --VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 191 --Iv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g 268 (709)
++.+++ .+..++||||+++..+..+.. ......++.+|+.+|.++|+.||+|+||||+||||+.++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 333332 234589999999865443322 134677889999999999999999999999999999999
Q ss_pred cEEEeecccccccCC
Q 005210 269 ILKIADFGLASFYDP 283 (709)
Q Consensus 269 ~vKL~DFGla~~~~~ 283 (709)
.++|+|||++..+..
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=197.22 Aligned_cols=192 Identities=23% Similarity=0.295 Sum_probs=149.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~ 205 (709)
.+.|.+-+.||+|+||+||+|.... |+.||||+-+..+...-. --.+++.+|+ -+.|+.+...+.. .+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~--~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVF--QNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHcc--CCc
Confidence 5679999999999999999999877 999999997765432111 1123333443 2345555544444 344
Q ss_pred EEEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-------CCcEEEeeccc
Q 005210 206 LYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-------NGILKIADFGL 277 (709)
Q Consensus 206 lyLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-------~g~vKL~DFGl 277 (709)
-+||+||.+ |.|++++. ....+++.-+..+..|||..+++||..+|||+||||+|+||.. ..-++|+|||-
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 689999999 55666655 5557999999999999999999999999999999999999942 33699999999
Q ss_pred ccccCC-CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC
Q 005210 278 ASFYDP-DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330 (709)
Q Consensus 278 a~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~ 330 (709)
+.-+.. .........+.|-.+-++|++.|.. ++..+|.|.|..+++-||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 865521 2224566778899999999998866 899999999999999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=164.86 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=107.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE------SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~------~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.||+|++|.||+|.+ +|..|+||+......... ....+.+|+.++..+.|++|+....++.. ....++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999987 667799998654332111 12357789999999999988766655544 4567999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
|||++|..+..+.... .. ....++.+|+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999875544433322 22 7889999999999999999999999999999998 88999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.4e-18 Score=170.09 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=186.7
Q ss_pred ccCCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
+......+..++.+|.+.-.|..|+|++..+. +++|++..........+.|..|.-.|+-+.||||+.+++.+.+ .
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--p 259 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--P 259 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--C
Confidence 33444556677788999999999999987654 6678877665555555678889999999999999999999977 5
Q ss_pred CeEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 204 CSLYLVFEYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..+.++..||+-+.++.+...+ .-....++..++.+|++|+.|||+.. |.---|....++||++-+.+|. .+-++
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~k 338 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTK 338 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccce
Confidence 6789999999965444444333 23677899999999999999999984 4444688889999998877764 22222
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccC--CccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYY--GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y--~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
+. .....+...|.||+||.+...... -.++|+|||.++||||.|...||..-...|--.+|.-. |
T Consensus 339 fs-----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale-g------- 405 (448)
T KOG0195|consen 339 FS-----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE-G------- 405 (448)
T ss_pred ee-----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-c-------
Confidence 11 111234668899999999765432 35799999999999999999999888877765555210 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~ 410 (709)
.-..+.+.++.....|+.-|+..||.+||..+.+
T Consensus 406 -------------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 406 -------------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred -------------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 0112346788889999999999999999987654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=158.56 Aligned_cols=132 Identities=18% Similarity=0.212 Sum_probs=100.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCCCh------HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~------~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.||+|+||.||+|.. ++..|++|+........ -....+.+|+.++..+.|+++....-++.. ....+|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 489999999999984 56789999865432211 123557789999999988775544333333 34568999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
||++|..+........ ..++.||+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9998754443322211 07899999999999999999999999999998 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=156.01 Aligned_cols=138 Identities=25% Similarity=0.248 Sum_probs=98.6
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHH----------------------HHHHHHHHHhcCCCc--
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF----------------------MAREIHILRRLDHIN-- 190 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~Hpn-- 190 (709)
.+.||+|+||.||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 7899999998764322111111 135666666664432
Q ss_pred eeeeeceEeecCCCeEEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCC
Q 005210 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 191 Iv~l~~~~~~~~~~~lyLVmEy~~g~L~-~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g 268 (709)
+.+++++ ...+|||||++++.. ....... .. ..++..++.+++.+|.++|. .||+|+||||+||||+ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3333332 235899999998322 1111111 11 16788999999999999999 9999999999999999 99
Q ss_pred cEEEeecccccccC
Q 005210 269 ILKIADFGLASFYD 282 (709)
Q Consensus 269 ~vKL~DFGla~~~~ 282 (709)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=178.82 Aligned_cols=138 Identities=16% Similarity=0.173 Sum_probs=105.2
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-C-----hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-E-----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~-----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..|...+.||+|+||.||++.+.... +++|+...... . ....+.+.+|+.+++.++|++|+..+.++.. .
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence 34566889999999999999875443 44444322111 1 1123567899999999999999877655554 4
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
...++||||+++..+..... ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 45789999998754433221 457789999999999999999999999999999 678999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=167.59 Aligned_cols=206 Identities=26% Similarity=0.389 Sum_probs=153.4
Q ss_pred HHhcCCCceeeeeceEeecCCCeEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCe-eeccCCCc
Q 005210 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV-LHRDIKGS 260 (709)
Q Consensus 183 L~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gI-vHrDLKP~ 260 (709)
|+.+.|.|+.+++|.+.+ ...+++|.+||. |.|.+.+......++.-....++++|+.||.|||...| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 456789999999999988 478999999998 55666666666788899999999999999999999865 99999999
Q ss_pred cEEEcCCCcEEEeecccccccCCC-CCCCccccccccCCCCchhhcCCcc------CCccccccchhHHHHHHHhCCCCC
Q 005210 261 NLLIDNNGILKIADFGLASFYDPD-QNQPLTSRVVTLWYRPPELLLGATY------YGTAVDLWSTGCILAELYAGKPIM 333 (709)
Q Consensus 261 NILld~~g~vKL~DFGla~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~------y~~~~DIWSLG~iL~ELltG~~pF 333 (709)
|.++|....+||+|||+....... .........-..-|.|||++.+... .+.+.||||+|+|++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765320 1111111122455899999987421 356799999999999999999999
Q ss_pred CCCCh----HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 005210 334 PGRTE----VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409 (709)
Q Consensus 334 ~g~~~----~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e 409 (709)
..... .+.+..+.+ .+.+ .++|. +. ....+++.+..++..|+..+|.+||+++.
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~--------------~~rP~------i~-~~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSN--------------PFRPS------IE-LLNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCC--------------CcCcc------hh-hhhhcchHHHHHHHHhcccChhhCccHHH
Confidence 86332 233444333 1111 01111 11 01146668999999999999999999988
Q ss_pred HHh
Q 005210 410 ALR 412 (709)
Q Consensus 410 ~L~ 412 (709)
+-.
T Consensus 217 i~~ 219 (484)
T KOG1023|consen 217 IRS 219 (484)
T ss_pred HHh
Confidence 743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.8e-15 Score=136.77 Aligned_cols=132 Identities=26% Similarity=0.269 Sum_probs=108.2
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeecCCCeEEEEEe
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~lyLVmE 211 (709)
+++.||.|.++.||++.... ..++||.+..... ...+.+|+.+++.+.| .++++++.++.. .+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 46789999999999998744 6799998765432 3457789999999976 588888776654 467899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC---CeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---GVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~---gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
|+.+..+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9987654432 5567778899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.1e-15 Score=151.88 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=100.6
Q ss_pred eeec-ccCceEEEEEEECCCCeEEEEEEEecCCC-----------ChHHHHHHHHHHHHHHhcCCCce--eeeeceEeec
Q 005210 136 DKIG-QGTYSNVYRARDLDQKKIVALKKVRFDNL-----------EPESVRFMAREIHILRRLDHINV--IKLEGLVTSR 201 (709)
Q Consensus 136 ~~LG-~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-----------~~~~~~~~~rEi~iL~~L~HpnI--v~l~~~~~~~ 201 (709)
..|| .|+.|+||.+... +..++||.+..... .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888889988753 67799998854221 11223457789999999988775 6666654332
Q ss_pred CCC--eEEEEEeeccc--cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccc
Q 005210 202 MSC--SLYLVFEYMEH--DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 277 (709)
Q Consensus 202 ~~~--~lyLVmEy~~g--~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGl 277 (709)
... ..+|||||+++ ++...+ .. ..+++.. +.||+.+|.+||++||+||||||+||||+.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l-~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALL-QE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHH-hc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 221 23599999996 344443 22 2456543 56899999999999999999999999999999999999998
Q ss_pred ccc
Q 005210 278 ASF 280 (709)
Q Consensus 278 a~~ 280 (709)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-15 Score=170.81 Aligned_cols=256 Identities=20% Similarity=0.240 Sum_probs=201.1
Q ss_pred CCCeeEEeeecc--cCceEEEEEEE--CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQ--GTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~--G~fG~Vy~a~~--~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 203 (709)
...|.+...+|. |.+|.||.+.. ..++..+|+|+-+.....+.....-.+|+...+.+ .|+|.++.+..+.. .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 455777889999 99999999998 88899999998443322222222234677777777 59999998888876 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHH----HHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccc
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC----GLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLA 278 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~----aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla 278 (709)
+.+|+-+|+|...+..........+++..++.++.+... ||.++|+.+++|-|+||.||++..+ ..++++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 789999999998888877777767999999999999999 9999999999999999999999999 88999999999
Q ss_pred cccCCCCCCC----ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC--ChHHHHHHHHHhhCCC
Q 005210 279 SFYDPDQNQP----LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR--TEVEQLHKIFKLCGSP 352 (709)
Q Consensus 279 ~~~~~~~~~~----~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~--~~~e~l~~I~k~~g~p 352 (709)
..+....... .....+...|++||++.+. ++...||++||.++.+..++..++... +.+.++..++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 8775433211 1122567789999988664 689999999999999999887666544 3333332221
Q ss_pred ChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 353 ~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+.+...+..+..++..||..+|..|+++..++.|+++..
T Consensus 343 ------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 112334456667777999999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.5e-15 Score=173.85 Aligned_cols=265 Identities=23% Similarity=0.239 Sum_probs=195.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..+.|.+.+.+-+|+++.++.+.-..+|...++|+..... +.....+...++-.++-...+|-++...--+. ....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~--~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP--CRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC--CCCCc
Confidence 4678999999999999999999888888777877765432 22223333444444444445566665543322 24568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC---
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP--- 283 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~--- 283 (709)
+|||+|+++.-+.-....-+..+++-++.++..+..+++|||...++|+|++|.|+|+..+|+.+++|||+......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999998643333333333577888889999999999999999999999999999999999999999984322110
Q ss_pred ---------------------------CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC
Q 005210 284 ---------------------------DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 336 (709)
Q Consensus 284 ---------------------------~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~ 336 (709)
+........++|+.|.+||.+++.. .+..+|+|++|++++|.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0001123457899999999999877 488999999999999999999999988
Q ss_pred ChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhc
Q 005210 337 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA---SALRS 413 (709)
Q Consensus 337 ~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~---e~L~h 413 (709)
+.......|...- .- |..-....+..+.+++..+|..+|.+|..+. +.-.|
T Consensus 1039 tpq~~f~ni~~~~-----~~---------------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNRD-----IP---------------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred chhhhhhccccCC-----CC---------------------CCCCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 8766665554310 01 2223345778899999999999999999887 88899
Q ss_pred ccCCCCCC
Q 005210 414 EFFTMKPL 421 (709)
Q Consensus 414 p~f~~~~~ 421 (709)
+||+...+
T Consensus 1093 ~~~~~~~~ 1100 (1205)
T KOG0606|consen 1093 PFFQDVDW 1100 (1205)
T ss_pred CccCCCCc
Confidence 99987644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-12 Score=128.25 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=100.3
Q ss_pred eeecccCceEEEEEEECC------CCeEEEEEEEecCCC-----------C---------hHHHHHH----HHHHHHHHh
Q 005210 136 DKIGQGTYSNVYRARDLD------QKKIVALKKVRFDNL-----------E---------PESVRFM----AREIHILRR 185 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~------tg~~vAIK~i~~~~~-----------~---------~~~~~~~----~rEi~iL~~ 185 (709)
..||.|--+.||.|.... .+..+|||+.+.... + ......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998654 357899998753210 0 0111122 279999999
Q ss_pred cCC--CceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhh-hhCCeeeccCCCccE
Q 005210 186 LDH--INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLHRDIKGSNL 262 (709)
Q Consensus 186 L~H--pnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yL-H~~gIvHrDLKP~NI 262 (709)
|.. -++.+++.+. .-+|||||++++.+....-....+++.++..++.+++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 843 4556665431 2379999998753221111223466677888899999999998 899999999999999
Q ss_pred EEcCCCcEEEeecccccccC
Q 005210 263 LIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 263 Lld~~g~vKL~DFGla~~~~ 282 (709)
|++ ++.+.|+|||.+...+
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 996 5789999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-13 Score=153.46 Aligned_cols=146 Identities=21% Similarity=0.291 Sum_probs=97.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---------------------------Ch-----HHHHHH
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---------------------------EP-----ESVRFM 176 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---------------------------~~-----~~~~~~ 176 (709)
..+|+. +.||.|++|.||+|+...+|+.||||+++.... .. +..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999988899999999975421 00 111223
Q ss_pred H------HHHHHHHhc----CCCceeeeeceEeecCCCeEEEEEeeccccccccc---cCCCC---CCCHHHHHHHHHHH
Q 005210 177 A------REIHILRRL----DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA---SHPGL---KFSEAQVKCYMQQL 240 (709)
Q Consensus 177 ~------rEi~iL~~L----~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~---~~~~~---~lse~~i~~i~~QI 240 (709)
. +|+..+.++ .+.+.+.+-.++.+ .....+|||||+.|.-+..+ ...+. .+.+..+..++.||
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3 344333333 13333333333322 13456899999998544321 12221 35566666677666
Q ss_pred HHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeecccccccCC
Q 005210 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFYDP 283 (709)
Q Consensus 241 l~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~~~~ 283 (709)
+ ..|++|+|+||.||||+.+| .++++|||++..+..
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 48999999999999999888 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-13 Score=151.74 Aligned_cols=258 Identities=21% Similarity=0.219 Sum_probs=189.0
Q ss_pred cCccCCCCCCeeEEeeecccCceEEEEEEEC-CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEe
Q 005210 122 QGWVPRRADSFEKLDKIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVT 199 (709)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~ 199 (709)
..|.-....+|..+..||.|.|+.|+.+... .++..|++|.+...........+-..|+.+...+ .|.+++..+..|.
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 4455556788999999999999999988755 6788999998765544433333445688877777 6889998876665
Q ss_pred ecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccc
Q 005210 200 SRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLA 278 (709)
Q Consensus 200 ~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla 278 (709)
. ....||-.|||++....+...-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+
T Consensus 337 ~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 337 Q--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred c--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence 4 44567999999876655544433468889999999999999999999999999999999999886 78999999998
Q ss_pred cccCCCCCCCccccccccCCC-CchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYR-PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~-APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
..+.... .....+-+++ ..|++.....+..+.|++|||.-+.+.++|.++-...+... .|..
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~---------- 477 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS---------- 477 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec----------
Confidence 7532111 1122344555 36666666668999999999999999999986543322211 1110
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
......+.....+..+.+.++..|+..|+.+.++..|.=|-
T Consensus 478 -------------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 -------------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00111223346678899999999999999999988876553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-12 Score=143.04 Aligned_cols=143 Identities=19% Similarity=0.197 Sum_probs=94.6
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----------------------------HH----HH------HH
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----------------------------ES----VR------FM 176 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----------------------------~~----~~------~~ 176 (709)
.+.||.|++|.||+|+. .+|+.||||+.+...... .. .. .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36899999999999986 478999999987542110 00 00 13
Q ss_pred HHHHHHHHhc----CCCceeeeeceEeecCCCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHH-HHhhhhhC
Q 005210 177 AREIHILRRL----DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLC-GLDHCHSR 250 (709)
Q Consensus 177 ~rEi~iL~~L----~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~-aL~yLH~~ 250 (709)
.+|+..+.++ .|.+-+.+-.++... ....+|||||++|..+..+.. ....+ ....++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 3455555555 233333333333221 334689999999865443321 11112 22345555655 47889999
Q ss_pred CeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 251 gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
|++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-11 Score=138.38 Aligned_cols=183 Identities=18% Similarity=0.296 Sum_probs=134.0
Q ss_pred eeEEeeecccCceEEE-EEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 132 FEKLDKIGQGTYSNVY-RARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy-~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
|.+ ....-++.+ || .|..+.++.+|.|.+.+..+. .......+-++-|+.|+||||+++++.+.. ...+|||+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEe
Confidence 444 333334443 34 466678888999998876654 445567788999999999999999998876 66899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|-+..-- ..+. .+....+..-+.||+.||.||| ..+++|++|.-.-|+|+..|..||++|-++........ +.
T Consensus 89 ErV~Pl~-~~lk----~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~ 162 (690)
T KOG1243|consen 89 ERVRPLE-TVLK----ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PA 162 (690)
T ss_pred eccccHH-HHHH----HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cc
Confidence 9986311 1111 2347788889999999999998 56899999999999999999999999998865432221 11
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG 329 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG 329 (709)
....---.|..|+.+... +-..|.|.|||+++|++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 122223346777755332 2467999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=120.03 Aligned_cols=127 Identities=17% Similarity=0.139 Sum_probs=93.3
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCcee-eeeceEeecCCCeEEEEEeec
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI-KLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv-~l~~~~~~~~~~~lyLVmEy~ 213 (709)
++.|+.|.++.||++... +..|+||+...... ....+.+|+.+++.+.+.+++ +++.+.. ..-++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 568899999999999864 77899998754321 112346799999998655543 4444322 2347999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCe-----eeccCCCccEEEcCCCcEEEeeccccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV-----LHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gI-----vHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
+|..+... ......++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98644322 01123456799999999999985 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-12 Score=132.50 Aligned_cols=240 Identities=19% Similarity=0.203 Sum_probs=152.0
Q ss_pred EEEEEEECCCCeEEEEEEEecCCC-Ch-HHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCeEEEEEeeccccccc
Q 005210 145 NVYRARDLDQKKIVALKKVRFDNL-EP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYLVFEYMEHDLAG 219 (709)
Q Consensus 145 ~Vy~a~~~~tg~~vAIK~i~~~~~-~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~lyLVmEy~~g~L~~ 219 (709)
.||++.+...|..|..-.+.+... +. ...+.+..-..-|-.+.|-|||+++.||.+.. ...+.++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 578887777777665444332211 00 11111111223344557999999999987632 24678999999854333
Q ss_pred c----ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeecccccccCCCCC----CCc
Q 005210 220 L----ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN----QPL 289 (709)
Q Consensus 220 ~----~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~----~~~ 289 (709)
. ....+..+.....++|+.||+.||.|||+.. |+|+++...-|++..+|-+||+---.. ...+..+ ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhh
Confidence 2 2234556889999999999999999999985 999999999999999998887532211 1110000 001
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
...-+-+.|.+||.=.... .+.++|||++|....||..+..- -.+....+.-..|....
T Consensus 240 ~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 1123467899999543322 46689999999999999877632 22222222211221110
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+.--.+.-+++|.+||+-.|..||++.++|.||.+-.
T Consensus 300 -------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 -------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred -------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 0001112357899999999999999999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.8e-10 Score=111.02 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=104.3
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeecC-CCeEEEEEe
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRM-SCSLYLVFE 211 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~-~~~lyLVmE 211 (709)
++.|+.|.++.||++.... |..|+||+....... .....+.+|+.+++.+.+ .++.+++.+..... .+..|+|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 4678999999999998643 678999987543221 123456789999999965 34566665543311 135689999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh------------------------------------------
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS------------------------------------------ 249 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~------------------------------------------ 249 (709)
|++|..+...... ..+++.+...++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998655443321 257788888888888888888884
Q ss_pred --------------CCeeeccCCCccEEEcC--CCcEEEeecccccc
Q 005210 250 --------------RGVLHRDIKGSNLLIDN--NGILKIADFGLASF 280 (709)
Q Consensus 250 --------------~gIvHrDLKP~NILld~--~g~vKL~DFGla~~ 280 (709)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-10 Score=131.04 Aligned_cols=157 Identities=24% Similarity=0.330 Sum_probs=117.3
Q ss_pred HHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc--------ccccccCCCCchhhcCCcc
Q 005210 239 QLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT--------SRVVTLWYRPPELLLGATY 309 (709)
Q Consensus 239 QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~--------~~~gT~~Y~APE~l~~~~~ 309 (709)
+++.||.|+|.. ++||+.|.|++|.++.++..||+.|+++....+....+.. ...-...|.|||++.+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 444999999976 8999999999999999999999999998755432111111 11225679999999874 4
Q ss_pred CCccccccchhHHHHHHH-hCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHH
Q 005210 310 YGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP 388 (709)
Q Consensus 310 y~~~~DIWSLG~iL~ELl-tG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~ 388 (709)
.+.++|++||||++|.+. .|+++|.+.........-....+.. ....-.++|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcHH
Confidence 689999999999999998 7888877665433333222111111 01111579999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 389 ALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 389 ~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
+++=|.++|..++..||++..++..|||++...
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 999999999999999999999999999997543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-09 Score=115.87 Aligned_cols=236 Identities=22% Similarity=0.286 Sum_probs=165.1
Q ss_pred CCCCCCeeEEeeecc--cCc-eEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec-
Q 005210 126 PRRADSFEKLDKIGQ--GTY-SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR- 201 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~--G~f-G~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~- 201 (709)
+.-+..|..+..|-. +-| .+.|+|....+|..|++|+++.+.... ......-+++++++.|+|||++.++|...
T Consensus 269 p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~t 346 (655)
T KOG3741|consen 269 PSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYT 346 (655)
T ss_pred CcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhc
Confidence 444556666554432 224 578999999999999999995433211 11123457889999999999999988632
Q ss_pred -CCCeEEEEEeeccc--ccccccc--------------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 202 -MSCSLYLVFEYMEH--DLAGLAS--------------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 202 -~~~~lyLVmEy~~g--~L~~~~~--------------~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
....++|||+|.++ .|.++.- ..+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||+
T Consensus 347 F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv 426 (655)
T KOG3741|consen 347 FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV 426 (655)
T ss_pred cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe
Confidence 24678999999885 3444322 123468899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~ 344 (709)
+.+.+++|.-.|....+..+.. |.+.+ -.+-|.=.||.+++.|.||..--...+.....+
T Consensus 427 ~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~- 486 (655)
T KOG3741|consen 427 TGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH- 486 (655)
T ss_pred eCcceEEEecccceeeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHH-
Confidence 9888999988887766654431 11222 235688899999999999963211111111110
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc---ccCC
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS---EFFT 417 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h---p~f~ 417 (709)
+..+-..++.+++++|.-+...++++ -+..++|.+ -||.
T Consensus 487 ---------------------------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~ 528 (655)
T KOG3741|consen 487 ---------------------------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFT 528 (655)
T ss_pred ---------------------------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence 11112346788999999999999997 678888764 4554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-09 Score=103.69 Aligned_cols=143 Identities=16% Similarity=0.226 Sum_probs=96.4
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEe-cC----CCCh-HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FD----NLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~-~~----~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.+..|-+|+-+.|+++.+ .|+.+.||.-. +. .++. -...+..+|+.+|.++.--.|..-.=++.+. ..-.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 577899999999999975 57777777522 11 1111 1345677899999998533332211133332 2235
Q ss_pred EEEeeccc--cccccccCCCC-CCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEeecccccc
Q 005210 208 LVFEYMEH--DLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASF 280 (709)
Q Consensus 208 LVmEy~~g--~L~~~~~~~~~-~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGla~~ 280 (709)
|+|||++| .+.+.+..... .....-...++++|=+.|.-||.++|||+||..+||+|..++ .+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 88999987 34333332111 222333378888999999999999999999999999998665 468999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-09 Score=104.49 Aligned_cols=131 Identities=24% Similarity=0.288 Sum_probs=91.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEE-ecCCCChH-----HHHHHHHHHHHHHhcCCC--ceeeeeceEeecCCCeEE
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPE-----SVRFMAREIHILRRLDHI--NVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i-~~~~~~~~-----~~~~~~rEi~iL~~L~Hp--nIv~l~~~~~~~~~~~ly 207 (709)
..|++|+-+.+|.+... |..+.+|.= .+.--.++ ......+|+.+|.++.-- ++..++++. .....
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD----~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD----PDNGL 75 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc----CCCCE
Confidence 36789999999999663 334555542 22211222 234567899999988543 334444433 33457
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
|+|||++|.++....... ...++..+=.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998776444332 145666777778889999999999999999996554 99999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.8e-09 Score=103.25 Aligned_cols=127 Identities=25% Similarity=0.290 Sum_probs=82.1
Q ss_pred EEEEEEECCCCeEEEEEEEecCCC--C---------------------h-HHHHHHHHHHHHHHhcCCC--ceeeeeceE
Q 005210 145 NVYRARDLDQKKIVALKKVRFDNL--E---------------------P-ESVRFMAREIHILRRLDHI--NVIKLEGLV 198 (709)
Q Consensus 145 ~Vy~a~~~~tg~~vAIK~i~~~~~--~---------------------~-~~~~~~~rEi~iL~~L~Hp--nIv~l~~~~ 198 (709)
.||.|.. ..|..+|||+.+.... . . -......+|..+|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 4577999998864210 0 0 0123456899999999765 456665442
Q ss_pred eecCCCeEEEEEeecc--ccccccccCCCCCCCHHHHHHHHHHHHHHHhh-hhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 199 TSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH-CHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 199 ~~~~~~~lyLVmEy~~--g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~y-LH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1 269999999 6444433322 12245567788888885555 679999999999999999876 9999999
Q ss_pred cccccc
Q 005210 276 GLASFY 281 (709)
Q Consensus 276 Gla~~~ 281 (709)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=99.83 Aligned_cols=132 Identities=17% Similarity=0.151 Sum_probs=89.1
Q ss_pred EEEEEECCCCeEEEEEEEecCCCChHHHH----------HHHHHHHHHHhcCCCce--eeeeceEeecC---CCeEEEEE
Q 005210 146 VYRARDLDQKKIVALKKVRFDNLEPESVR----------FMAREIHILRRLDHINV--IKLEGLVTSRM---SCSLYLVF 210 (709)
Q Consensus 146 Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~----------~~~rEi~iL~~L~HpnI--v~l~~~~~~~~---~~~lyLVm 210 (709)
|++... .|+.|.||........ +..+ ...+|...+.+|...+| +.++.+..... ...-||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 555543 5667899976432211 1111 35689988888843333 33344443321 23468999
Q ss_pred eecccc--ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-------CCcEEEeecccccc
Q 005210 211 EYMEHD--LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-------NGILKIADFGLASF 280 (709)
Q Consensus 211 Ey~~g~--L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-------~g~vKL~DFGla~~ 280 (709)
|++++. +.+.+.. .....++.....++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999974 4333321 1234567788899999999999999999999999999999975 46899999998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-07 Score=98.74 Aligned_cols=137 Identities=26% Similarity=0.241 Sum_probs=100.0
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC--------------------hHHHHHHHHHHHHHHhcCCC--
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--------------------PESVRFMAREIHILRRLDHI-- 189 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~--------------------~~~~~~~~rEi~iL~~L~Hp-- 189 (709)
+.+..+||-|--+.||.|.+. .|..+|||.=+..... .-......+|..+|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 445689999999999999975 6788999965421100 01122356899999999544
Q ss_pred ceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 190 nIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
.|.+.+++ +.-.+||||++|-.+..+. +....+..++..|+.-+.-+-..||||+|+.+-||||+.+|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666553 3447999999985554332 234555666667777777666899999999999999999999
Q ss_pred EEEeecccccc
Q 005210 270 LKIADFGLASF 280 (709)
Q Consensus 270 vKL~DFGla~~ 280 (709)
+.|+||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.3e-08 Score=114.79 Aligned_cols=248 Identities=17% Similarity=0.116 Sum_probs=169.1
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeecCCCeEEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~~~~lyLVm 210 (709)
|.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ ..+..++++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhh
Confidence 666778899999999999987776655 6666433 22345899999999999 44443333 3367889999
Q ss_pred eecccc--ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 211 EYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 211 Ey~~g~--L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
+|+.++ ...........|-+-+...+++.-+.+|++||+.-=+|+| |||.. ++..|..||+....+.... .
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc--c
Confidence 999865 2222222222355556667777778999999998778999 88774 4789999999987765433 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
..+..+|+.++|||+..... +....|.|++|+--.+|.-|-+|-.. |......-..-+.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~----------------P~~~~~~~g~~p~---- 445 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS----------------PPAVLPMIGNGPN---- 445 (829)
T ss_pred cccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC----------------CccccCCCCCCCC----
Confidence 34568899999999887765 78899999999877777777766533 1110000000000
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.+....+..|...+. .++...||...|..|++...++-|.+|...++-.
T Consensus 446 s~~L~~~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 446 SPMLTDKSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred ccccchhhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 000000111221111 1578899999999999999999999999877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.9e-07 Score=92.37 Aligned_cols=106 Identities=23% Similarity=0.286 Sum_probs=78.9
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeeceEeecCC--CeEEEEEeeccc--cccccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 005210 174 RFMAREIHILRRLDHI--NVIKLEGLVTSRMS--CSLYLVFEYMEH--DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247 (709)
Q Consensus 174 ~~~~rEi~iL~~L~Hp--nIv~l~~~~~~~~~--~~lyLVmEy~~g--~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yL 247 (709)
....+|...+..|... .+.+.+.+.+.+.. ...|||+|++++ +|...+... ..++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHH
Confidence 3466788888877432 33444555544222 345899999987 344444332 2367778899999999999999
Q ss_pred hhCCeeeccCCCccEEEcCCC---cEEEeecccccc
Q 005210 248 HSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASF 280 (709)
Q Consensus 248 H~~gIvHrDLKP~NILld~~g---~vKL~DFGla~~ 280 (709)
|.+||+|+|+++.||||+.++ .+.|+||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=89.04 Aligned_cols=140 Identities=21% Similarity=0.266 Sum_probs=96.8
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHH--------------------H--HHHHHHHHHHHhcC--CCc
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES--------------------V--RFMAREIHILRRLD--HIN 190 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~--------------------~--~~~~rEi~iL~~L~--Hpn 190 (709)
...|..|--+.||+|.. .++..||+|+++........ . .-...|..-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788899999999974 56889999998653221110 0 11235777777773 333
Q ss_pred eeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCc
Q 005210 191 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 191 Iv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~ 269 (709)
+.+-+.+... .|||||++.+..-.-.-....+...++..+..+++..+.-|-. .++||+||..-|||+. ++.
T Consensus 132 vP~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFRNN------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeecCC------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 4444444322 6999999865211111112234444788889999999988877 8999999999999998 899
Q ss_pred EEEeecccccccC
Q 005210 270 LKIADFGLASFYD 282 (709)
Q Consensus 270 vKL~DFGla~~~~ 282 (709)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=93.36 Aligned_cols=255 Identities=14% Similarity=0.141 Sum_probs=150.7
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceee-e---ece-EeecCCCeEEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK-L---EGL-VTSRMSCSLYL 208 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~-l---~~~-~~~~~~~~lyL 208 (709)
...||+|+-+.+|..-.. +..| .|++...... .. . ..+..|... .||-+-. + ... +-.+....+-+
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Pppa-~~-a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPPA-AQ-A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecchh--hchh-heeecCCCch-HH-H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 468999999999976432 2234 4776543221 11 1 122333333 5554322 1 000 11111233677
Q ss_pred EEeecccc--cccccc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 209 VFEYMEHD--LAGLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 209 VmEy~~g~--L~~~~~-----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
.|..+.+. ...++. ..-..+.+....+..+.|+.+..-||.+|.+-+|+.++|+||++++.|.|+|-......
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88887752 222221 12234778899999999999999999999999999999999999999999986654433
Q ss_pred CCCCCCCccccccccCCCCchhhc-----CCccCCccccccchhHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~-----~~~~y~~~~DIWSLG~iL~ELltG-~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
.+.......+|...|.+||+-. +.. -+...|.|.||+++|+||.| +.||.|..... .-+.|-+.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E~ 237 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLET 237 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcchh
Confidence 2333445668999999999643 222 25678999999999999886 89998742100 00111110
Q ss_pred hhhhcCCCCccccCCCCcccc-chhcccCCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 005210 356 YWRKSKLPHATIFKPQQPYKR-CVAETFKDFPAPALALMETLLSI--DPADRGSAAS 409 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~-~~~~~~~~~s~~~~dLI~~lL~~--DP~kRpTa~e 409 (709)
......+..+. +....++. ...-.+.-+++++..|+..|+.. ++.-|||++.
T Consensus 238 ~Ia~g~f~ya~--~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYAS--DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeech--hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00000000000 00000000 01112334788899999999975 3568999753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.1e-06 Score=98.05 Aligned_cols=143 Identities=20% Similarity=0.236 Sum_probs=86.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCC---------------------------h-HHH----H------HHH
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---------------------------P-ESV----R------FMA 177 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~---------------------------~-~~~----~------~~~ 177 (709)
+.|+.++-|.||+|+... |+.||||+.++.... . +.+ + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999754 999999998753211 0 000 1 133
Q ss_pred HHHHHHHhcC-----CCceeeeeceEeecCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCC
Q 005210 178 REIHILRRLD-----HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251 (709)
Q Consensus 178 rEi~iL~~L~-----HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~g 251 (709)
+|+..+.++. .++| .+=.+|.+ ....-.|+|||++|--...+. .....++...+...+.++. +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehh-ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4555555441 2332 22222221 134458999999984332221 1112233222222222211 23333479
Q ss_pred eeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 252 IvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-05 Score=81.58 Aligned_cols=139 Identities=24% Similarity=0.317 Sum_probs=79.4
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCC--ceeeeeceEeec-CCCeEEEEEe
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI--NVIKLEGLVTSR-MSCSLYLVFE 211 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp--nIv~l~~~~~~~-~~~~lyLVmE 211 (709)
++.|+.|..+.||++.... ..++||..... .....+.+|+.+++.|... .+.+++.+.... .....|++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999998755 47899986532 3456677899999888432 345665533221 2345799999
Q ss_pred ecccccccc--------------------c-cC--CCCCCCHHH------HHHH---------------HHHHHH-HHhh
Q 005210 212 YMEHDLAGL--------------------A-SH--PGLKFSEAQ------VKCY---------------MQQLLC-GLDH 246 (709)
Q Consensus 212 y~~g~L~~~--------------------~-~~--~~~~lse~~------i~~i---------------~~QIl~-aL~y 246 (709)
+++|..+.. + .. ....+.... ...+ +..+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998743332 0 00 001111000 0000 011111 2233
Q ss_pred hh-------hCCeeeccCCCccEEEc-CCCcEEEeeccccc
Q 005210 247 CH-------SRGVLHRDIKGSNLLID-NNGILKIADFGLAS 279 (709)
Q Consensus 247 LH-------~~gIvHrDLKP~NILld-~~g~vKL~DFGla~ 279 (709)
++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33 24699999999999999 66777899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.6e-05 Score=81.05 Aligned_cols=141 Identities=20% Similarity=0.246 Sum_probs=89.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH-HHH------HHHHHHHHHHhcCC---CceeeeeceE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE-SVR------FMAREIHILRRLDH---INVIKLEGLV 198 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~-~~~------~~~rEi~iL~~L~H---pnIv~l~~~~ 198 (709)
..+|..++.+-......|.+.. -+|+.+.+|..+....-.+ ... ...+++..+.++.. -.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 5678889999888877777764 4567899998764432111 111 12344444444422 2222222222
Q ss_pred ee---cCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 199 TS---RMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 199 ~~---~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
+- ......+|||||++|--+..+. .+++ .+...|..+|.-||..|++|+|+.|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 21 1123457899999985443322 1233 2445677889999999999999999999998554 999999
Q ss_pred ccccc
Q 005210 276 GLASF 280 (709)
Q Consensus 276 Gla~~ 280 (709)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.2e-05 Score=82.85 Aligned_cols=133 Identities=17% Similarity=0.145 Sum_probs=78.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
..||+|..+.||+. .+..+++|...... . ...+.+|.++++.+..-. +.+++.+... .+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57899999999984 24457788865422 2 234578999999885433 3555555544 55678999999
Q ss_pred cccc-cc-ccc--------------------CC--CCCCCHHHH-HHHHHHH----------HHH-Hhhhh----hCCee
Q 005210 214 EHDL-AG-LAS--------------------HP--GLKFSEAQV-KCYMQQL----------LCG-LDHCH----SRGVL 253 (709)
Q Consensus 214 ~g~L-~~-~~~--------------------~~--~~~lse~~i-~~i~~QI----------l~a-L~yLH----~~gIv 253 (709)
+|.. .. ... +. -........ ..+..++ ... ..+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9841 11 000 00 000111110 0010000 010 11121 12478
Q ss_pred eccCCCccEEEcCCCcEEEeeccccc
Q 005210 254 HRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 254 HrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
|+|+.|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.7e-05 Score=80.35 Aligned_cols=138 Identities=15% Similarity=0.165 Sum_probs=95.5
Q ss_pred cccCceEEEEEEECCCCeEEEEEEEecC---CC-ChHHHHHHHHHHHHHHhcCCCc--eeeeeceEe---ecCCCeEEEE
Q 005210 139 GQGTYSNVYRARDLDQKKIVALKKVRFD---NL-EPESVRFMAREIHILRRLDHIN--VIKLEGLVT---SRMSCSLYLV 209 (709)
Q Consensus 139 G~G~fG~Vy~a~~~~tg~~vAIK~i~~~---~~-~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~~---~~~~~~lyLV 209 (709)
|+||-+.|+..... |..|-||.-... .. .+.....+.+|+..|..|..-+ +.++. ++. ....-..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 66888889987643 335777865411 11 1223456789999999984332 44443 222 1112346899
Q ss_pred Eeeccc--cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc--EEEeeccccc
Q 005210 210 FEYMEH--DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLAS 279 (709)
Q Consensus 210 mEy~~g--~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGla~ 279 (709)
+|-+++ +|...+... -.+.++.+...++.+|+..|.-||..|+.|+|+-+.|||++.+|. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998884 554444332 224677778899999999999999999999999999999987776 9999998654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.2e-05 Score=89.63 Aligned_cols=142 Identities=18% Similarity=0.155 Sum_probs=87.9
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-----------------------------HHHHH------HHHH
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----------------------------ESVRF------MARE 179 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-----------------------------~~~~~------~~rE 179 (709)
.+.||.-+.|.||+|+.+. |+.||||+-+...... +..+. +.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3589999999999999766 9999999986532110 01111 2233
Q ss_pred HHHHHh----cCCCc------eeeeeceEeecCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhh
Q 005210 180 IHILRR----LDHIN------VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCH 248 (709)
Q Consensus 180 i~iL~~----L~Hpn------Iv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH 248 (709)
++-..+ +.|-+ |.++|-.+ ...-.|+||||+|.-...+. -....++...+...+.++..- -|=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHH
Confidence 333222 33444 34443222 34568999999983222211 111235555555444444332 233
Q ss_pred hCCeeeccCCCccEEEcC----CCcEEEeecccccccCC
Q 005210 249 SRGVLHRDIKGSNLLIDN----NGILKIADFGLASFYDP 283 (709)
Q Consensus 249 ~~gIvHrDLKP~NILld~----~g~vKL~DFGla~~~~~ 283 (709)
..|++|+|-+|.||+|.. ++.+.+.|||+...+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 458999999999999984 66899999999976543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=89.58 Aligned_cols=82 Identities=24% Similarity=0.357 Sum_probs=56.0
Q ss_pred EeeecccCceEEEEEEECCCC--eEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCce--eeeeceEeec-CCCeEEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINV--IKLEGLVTSR-MSCSLYL 208 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg--~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--v~l~~~~~~~-~~~~lyL 208 (709)
+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+. ..+..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 678899999999998765432 45777775433221 12345779999999995 6665 6666666542 1246789
Q ss_pred EEeeccccc
Q 005210 209 VFEYMEHDL 217 (709)
Q Consensus 209 VmEy~~g~L 217 (709)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=73.78 Aligned_cols=130 Identities=24% Similarity=0.299 Sum_probs=92.1
Q ss_pred CCCeeEEeeecccCc-eEEEEEEECCCCeEEEEEEEec---CCC-------Ch---------HHHHHHHHHHHHHHhc--
Q 005210 129 ADSFEKLDKIGQGTY-SNVYRARDLDQKKIVALKKVRF---DNL-------EP---------ESVRFMAREIHILRRL-- 186 (709)
Q Consensus 129 ~~~y~~~~~LG~G~f-G~Vy~a~~~~tg~~vAIK~i~~---~~~-------~~---------~~~~~~~rEi~iL~~L-- 186 (709)
..+++.++.||.|.- |.||++.. .|+.||||+++. ... .. ....-+..|.++..+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 99999975 677999999432 110 00 1123466787777776
Q ss_pred -CCCce--eeeeceEeec----------------CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 005210 187 -DHINV--IKLEGLVTSR----------------MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247 (709)
Q Consensus 187 -~HpnI--v~l~~~~~~~----------------~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yL 247 (709)
.+.++ |+++||..-. ......||.||+.... .++.. -+.+|++-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 44566 8999987332 1123467888877543 22333 345788889999
Q ss_pred hhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 248 H~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 2489999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.7e-05 Score=77.54 Aligned_cols=72 Identities=18% Similarity=0.160 Sum_probs=46.8
Q ss_pred eecccCc-eEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTY-SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~f-G~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.|-.|.. ..||++... +..+.||+..... ...+.+|+.+++.+. +--+.+++.+... ....++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 4555555 789998643 3567888764332 234568999998883 3345566665544 346789999998
Q ss_pred ccc
Q 005210 215 HDL 217 (709)
Q Consensus 215 g~L 217 (709)
|..
T Consensus 76 G~~ 78 (244)
T cd05150 76 GVP 78 (244)
T ss_pred Ccc
Confidence 743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.3e-05 Score=74.34 Aligned_cols=130 Identities=23% Similarity=0.229 Sum_probs=89.9
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCcee-eeeceEeecCCCeEEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI-KLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv-~l~~~~~~~~~~~lyLVm 210 (709)
-...+.|++|++|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.-.++- ++|.|-. .++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech------hhhhh
Confidence 345678999999999999874 4589999876543 234577899999998766653 4443322 24679
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCC-CccEEEcCCCcEEEeecccccc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIK-GSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLK-P~NILld~~g~vKL~DFGla~~ 280 (709)
||+.|--+..+.... . +.-+..+++.-.-|-..||-|..|. |..++|..++.+.|+||..|+.
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 999984333222211 1 2334456666666777899999986 6666666777999999998874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.2e-05 Score=92.12 Aligned_cols=205 Identities=20% Similarity=0.182 Sum_probs=134.3
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeceEeecCCCe--EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC
Q 005210 173 VRFMAREIHILRRLDHINVIKLEGLVTSRMSCS--LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250 (709)
Q Consensus 173 ~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~--lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~ 250 (709)
......|+..+.++.|+|++.++.|-..+.... +.+..|+|...........-...+....+.+..+++.||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334456777788889999999887654432211 223335666533333333344789999999999999999999999
Q ss_pred CeeeccCCCc---cEEEcCCCcEEEe--ecccccccCCCCCCCccccccccCCCCchhhcCCccCCc--cccccchhHHH
Q 005210 251 GVLHRDIKGS---NLLIDNNGILKIA--DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT--AVDLWSTGCIL 323 (709)
Q Consensus 251 gIvHrDLKP~---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~--~~DIWSLG~iL 323 (709)
.+.|.-|-.+ +-.++..+.+.+. ||+....+..... .....-+..+.++|.+.... +.. ..|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccccc-chhhhhhHHHHHHHHH
Confidence 6666655544 4444556667776 8888776543222 22334456678888765433 333 36999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCC-CCHHHHHHHHHhcccCCC
Q 005210 324 AELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD-FPAPALALMETLLSIDPA 402 (709)
Q Consensus 324 ~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~lL~~DP~ 402 (709)
..+..|..+-.-. ..+. ..... ......+++.+|+.-+++
T Consensus 383 ~~~~~~~~i~~~~------~~~~---------------------------------~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS------AVPV---------------------------------SLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhcCcccccc------cchh---------------------------------hhhccccchhhhhhhhhhcchhhh
Confidence 9998876432100 0000 00111 112578899999999999
Q ss_pred CCCCHHHHHhcccCCCC
Q 005210 403 DRGSAASALRSEFFTMK 419 (709)
Q Consensus 403 kRpTa~e~L~hp~f~~~ 419 (709)
+|+++.++|.|+|....
T Consensus 424 ~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFP 440 (1351)
T ss_pred hccchhhhhhchhcccc
Confidence 99999999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=2.7e-06 Score=103.55 Aligned_cols=261 Identities=15% Similarity=0.038 Sum_probs=167.1
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEE---ecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV---RFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i---~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
+.+..+|++.--+|-|.++..-.-+.+..+ +-+|+. .+.++.....+....|..-++...|+++...+.-+....
T Consensus 1225 ~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~ 1302 (2724)
T KOG1826|consen 1225 FSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSE 1302 (2724)
T ss_pred HHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCC
Confidence 455777888777777766443222222222 233333 233443444555566777777889999988766665555
Q ss_pred CCeEEEEEeecccc-ccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhC-----CeeeccCCCccEEEcCCCcEEEe
Q 005210 203 SCSLYLVFEYMEHD-LAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR-----GVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~-----gIvHrDLKP~NILld~~g~vKL~ 273 (709)
....|.+++|+.++ +...+.. +...+.+.-+.+...+.+.+..-+|+. -.+|++||+-|.+|..+..+|++
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 66789999999865 4444332 223455666666676668888888865 27999999999999999999999
Q ss_pred ecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 274 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 274 DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
++|+.+...+ ........++++.|+.|++...- .++.++|+|..||-+|++-.|.++| ..++..+.+.. .
T Consensus 1383 k~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~rs~~n~~f-----i~flq~~Lkgi---i 1452 (2724)
T KOG1826|consen 1383 KGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYLRSDGNAYF-----IFFLQPALKGI---I 1452 (2724)
T ss_pred ccccccccCc-hHhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHHHhcccHHH-----HHHHHHHHcCc---c
Confidence 9999984332 22333455778899999976543 3677799999999999999888776 22333333211 0
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+...+ +...-.|.++..+...+|-+.-..||.-...+.-+.|..
T Consensus 1453 ---------dn~tf~-----------sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1453 ---------DNHTFF-----------SIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred ---------cccccc-----------cccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 000000 111112344445555555566677888888887776653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00026 Score=72.89 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=26.1
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00042 Score=69.39 Aligned_cols=98 Identities=23% Similarity=0.182 Sum_probs=77.4
Q ss_pred HHHHHHHhcCC-CceeeeeceEeecCCCeEEEEEeecccc-ccccc--cCCCCCCCHHHHHHHHHHHHHHHhhhhh---C
Q 005210 178 REIHILRRLDH-INVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLA--SHPGLKFSEAQVKCYMQQLLCGLDHCHS---R 250 (709)
Q Consensus 178 rEi~iL~~L~H-pnIv~l~~~~~~~~~~~lyLVmEy~~g~-L~~~~--~~~~~~lse~~i~~i~~QIl~aL~yLH~---~ 250 (709)
.|.-+|+.|.+ +++++++|++-. ++|.||+... +.... ...-...++.....++.+++..+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888999966 699999998732 6799999853 32110 0111235899999999999999999998 3
Q ss_pred CeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 251 gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
.+.-+|++++|+-|+++|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0015 Score=67.00 Aligned_cols=73 Identities=14% Similarity=0.216 Sum_probs=45.5
Q ss_pred EeeecccCceEEEEEEECC-CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCeEEEEEee
Q 005210 135 LDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~lyLVmEy 212 (709)
++.|..|-...||++.... .+..|++|+...... ..-...+|+.+++.+...++ ++++..+. . .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 5678888889999987543 356788997653211 11123478989988844333 44443321 1 389999
Q ss_pred cccc
Q 005210 213 MEHD 216 (709)
Q Consensus 213 ~~g~ 216 (709)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 9873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0016 Score=70.53 Aligned_cols=142 Identities=23% Similarity=0.297 Sum_probs=97.9
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC----------------------Ch-HHHH-HHHHHHHHHHhcCC
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----------------------EP-ESVR-FMAREIHILRRLDH 188 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~----------------------~~-~~~~-~~~rEi~iL~~L~H 188 (709)
++-..|..|--+.||.|.. .+|..+|||+++-..+ .+ .-++ -...|+.-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3445788999999999985 5677899998753210 01 1111 12368888888865
Q ss_pred CceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCeeeccCCCccEEEcCC
Q 005210 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 189 pnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDLKP~NILld~~ 267 (709)
..|.-..-+... .-.|||+|++.+-+..-.-....++...+..+..|++.-+.-|- .+++||.||.--|+|+ .+
T Consensus 226 aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 226 AGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred cCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 554322212211 23699999986443333333456888889999999988887664 5689999999999998 68
Q ss_pred CcEEEeecccccc
Q 005210 268 GILKIADFGLASF 280 (709)
Q Consensus 268 g~vKL~DFGla~~ 280 (709)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 9999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0016 Score=65.78 Aligned_cols=129 Identities=22% Similarity=0.288 Sum_probs=86.5
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCC--------------CChHHHHHHHHHHHHHHhcC------CCceeee
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN--------------LEPESVRFMAREIHILRRLD------HINVIKL 194 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HpnIv~l 194 (709)
...||+|+.=.||.- .......||++.... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999964 333446889987665 11112345567777766665 7889999
Q ss_pred eceEeecCCCeEEEEEeeccc-------cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 195 EGLVTSRMSCSLYLVFEYMEH-------DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 195 ~~~~~~~~~~~lyLVmEy~~g-------~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
+|+.+. +.-+-+|+|.+.. .|...+ ..+ .+++ . +...+-.-..||-.++|+.+||+|.||++...
T Consensus 83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYL-KEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEec--CCceEEEEEEEECCCCCcCccHHHHH-HcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 999877 5557899998752 122223 222 3555 2 33334455668888999999999999999643
Q ss_pred C----cEEEee
Q 005210 268 G----ILKIAD 274 (709)
Q Consensus 268 g----~vKL~D 274 (709)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0014 Score=68.38 Aligned_cols=133 Identities=24% Similarity=0.279 Sum_probs=74.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCeEEEEEeeccc
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYMEH 215 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~lyLVmEy~~g 215 (709)
.+..|-...+|+.. .++..+++|......... .. ...+|..+++.+....+ .+++... . -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~----~--~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN----E--HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe----C--CEEEEEeccC
Confidence 35567778899886 456678888754321110 01 23579999998854333 3333322 1 2689999987
Q ss_pred cccccc-----------------cC----CCCCCCH-HHHHHHHHHH---------HHHHhhhhh--------CCeeecc
Q 005210 216 DLAGLA-----------------SH----PGLKFSE-AQVKCYMQQL---------LCGLDHCHS--------RGVLHRD 256 (709)
Q Consensus 216 ~L~~~~-----------------~~----~~~~lse-~~i~~i~~QI---------l~aL~yLH~--------~gIvHrD 256 (709)
..+... .+ .+.+++. ..+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 433211 00 1111221 1222322222 111111211 2589999
Q ss_pred CCCccEEEcCCCcEEEeecccccc
Q 005210 257 IKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 257 LKP~NILld~~g~vKL~DFGla~~ 280 (709)
+.|.|||++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00033 Score=74.65 Aligned_cols=136 Identities=17% Similarity=0.232 Sum_probs=92.2
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-------hH-----------HHH--HHHHHHHHHHhcC-C-
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-------PE-----------SVR--FMAREIHILRRLD-H- 188 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-------~~-----------~~~--~~~rEi~iL~~L~-H- 188 (709)
-+.+.+.||-|.-+.||.+.+ ..|++.++|.-+..... .+ .+. ...+|...|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467788999999999999986 45778888854322110 00 011 2346888888883 2
Q ss_pred CceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC
Q 005210 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 189 pnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g 268 (709)
--|.+.+++ +.-++|||++.+--+..... ...+..+...+..-+--|-.+|+||+|+.-=||+|+.++
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 234444443 45589999998754433321 111233445556666778899999999999999999999
Q ss_pred cEEEeeccccc
Q 005210 269 ILKIADFGLAS 279 (709)
Q Consensus 269 ~vKL~DFGla~ 279 (709)
.++++||--+.
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999997554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0058 Score=65.59 Aligned_cols=78 Identities=14% Similarity=0.129 Sum_probs=52.7
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC---CceeeeeceEeec-CCCeEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH---INVIKLEGLVTSR-MSCSLYL 208 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H---pnIv~l~~~~~~~-~~~~lyL 208 (709)
...+.||.|..+.||...... + .+.+|..+. .. ....+..|+..|+.|.- -.+.++++++... ..+..||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 346789999999999986422 3 466777432 11 12457789999998843 3567777765432 2356899
Q ss_pred EEeecccc
Q 005210 209 VFEYMEHD 216 (709)
Q Consensus 209 VmEy~~g~ 216 (709)
|||++++.
T Consensus 91 VmE~i~G~ 98 (297)
T PRK10593 91 LLERLRGV 98 (297)
T ss_pred EEeccCCE
Confidence 99998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0062 Score=67.95 Aligned_cols=77 Identities=22% Similarity=0.167 Sum_probs=52.6
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecC-CC--C--hHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCeE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NL--E--PESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~-~~--~--~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~l 206 (709)
.+.||.|.+..||++.....++.|+||.-... .. + +-...+...|...|+.+. -.++.+++.+. ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 57899999999999998654468999985321 00 1 123456677888888862 24567776553 2346
Q ss_pred EEEEeeccc
Q 005210 207 YLVFEYMEH 215 (709)
Q Consensus 207 yLVmEy~~g 215 (709)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0009 Score=75.05 Aligned_cols=173 Identities=24% Similarity=0.311 Sum_probs=114.0
Q ss_pred HHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeee
Q 005210 175 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 254 (709)
Q Consensus 175 ~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvH 254 (709)
.+.-...+++.+.|+|+...+++.... ..+..+|||+++-++.+...... +-.. +++ .+++.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchh-------hhc-------ccccce
Confidence 355677889999999999988776543 34589999999977666544322 1111 111 223332
Q ss_pred ccCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCC
Q 005210 255 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 334 (709)
Q Consensus 255 rDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~ 334 (709)
- | .++++| -++. . | |- ..++++|||++|.|+.++.-|..++.
T Consensus 91 ~-----~-------~~~~td-~~~t-----~------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLT-----K------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----h-------hhhccc-cccc-----c------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 1 233344 0000 0 0 11 11259999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 335 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 335 g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
.-+..+++..|.+....+..-.- ..+.......++....+++.+|+-..|..||...++++++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 99999998888876544322110 0111122334677788999999999999999999999999
Q ss_pred cCCCC
Q 005210 415 FFTMK 419 (709)
Q Consensus 415 ~f~~~ 419 (709)
-|+..
T Consensus 196 i~~ev 200 (725)
T KOG1093|consen 196 SFTEV 200 (725)
T ss_pred cHHHH
Confidence 98754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.009 Score=63.48 Aligned_cols=141 Identities=16% Similarity=0.164 Sum_probs=81.7
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeece----EeecCCCe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGL----VTSRMSCS 205 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~----~~~~~~~~ 205 (709)
..-++.|..|....+|+... .+..+++|+... .. ...+..|+.++..|.+.. +.+++.. ......+.
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 34467888888889999864 234688898753 11 234567888888884322 4444321 11112356
Q ss_pred EEEEEeecccccccccc-----------------CCCCC------CCHHHHHH------------HHHHHHHHHhhhhh-
Q 005210 206 LYLVFEYMEHDLAGLAS-----------------HPGLK------FSEAQVKC------------YMQQLLCGLDHCHS- 249 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~-----------------~~~~~------lse~~i~~------------i~~QIl~aL~yLH~- 249 (709)
.++||+|++|....... ..+.. ........ ....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 78999999874332100 00000 00000000 11112233344432
Q ss_pred ------CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 ------RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ------~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0078 Score=64.80 Aligned_cols=30 Identities=33% Similarity=0.595 Sum_probs=26.1
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866666899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0055 Score=65.42 Aligned_cols=73 Identities=23% Similarity=0.266 Sum_probs=45.1
Q ss_pred EeeecccCceEEEEEEECC------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCeEE
Q 005210 135 LDKIGQGTYSNVYRARDLD------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLY 207 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~ly 207 (709)
++.|..|-...||++.... +++.|++|+...... ......+|+.++..+....+ .+++.++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 4567777778999987543 257888998654321 11234578888888843333 344444321 2
Q ss_pred EEEeecccc
Q 005210 208 LVFEYMEHD 216 (709)
Q Consensus 208 LVmEy~~g~ 216 (709)
+||||++|.
T Consensus 74 ~v~e~i~G~ 82 (302)
T cd05156 74 RIEEFIPSR 82 (302)
T ss_pred chhheeCCC
Confidence 689998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=63.38 Aligned_cols=142 Identities=19% Similarity=0.161 Sum_probs=80.3
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceE----eecCCCe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLV----TSRMSCS 205 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~----~~~~~~~ 205 (709)
...+..|+.|....||++.. .++ .+++|+.+... .. ..+..|+.++..|.... +.+++... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 44577788888889999864 344 57788865421 12 23456777777773222 33333211 1112456
Q ss_pred EEEEEeecccccccc---------------cc--CCCCC------CCHHH-----HH----------HHHHHHHHHHhhh
Q 005210 206 LYLVFEYMEHDLAGL---------------AS--HPGLK------FSEAQ-----VK----------CYMQQLLCGLDHC 247 (709)
Q Consensus 206 lyLVmEy~~g~L~~~---------------~~--~~~~~------lse~~-----i~----------~i~~QIl~aL~yL 247 (709)
.|+||||++|..... +- ..+.. ..... .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 789999998732110 00 00000 00000 00 0011122344444
Q ss_pred h-------hCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 248 H-------SRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 248 H-------~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
. ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 2589999999999999988877999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.022 Score=61.68 Aligned_cols=146 Identities=19% Similarity=0.224 Sum_probs=80.4
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeecCCCeEEEEEe
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~lyLVmE 211 (709)
+++.+-.|.--.+|..... ++.++|. ...............+|..+|+.+.- --+...++++....-...|.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3444433333345555433 6677777 32222233445667789999988832 22333455555432246799999
Q ss_pred eccccccc-cccCC-----------------------------C--CCCCHHHHHHHHHHH--------------HHHHh
Q 005210 212 YMEHDLAG-LASHP-----------------------------G--LKFSEAQVKCYMQQL--------------LCGLD 245 (709)
Q Consensus 212 y~~g~L~~-~~~~~-----------------------------~--~~lse~~i~~i~~QI--------------l~aL~ 245 (709)
|++|.... ..... + ..+...++..+..+. ..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 99883111 00000 0 001112222222222 11222
Q ss_pred hhhhC--------CeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 246 HCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 246 yLH~~--------gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
||+.+ .++|+|+.+.||+|+.++-+=|+||+++..-+
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 33322 48999999999999998889999999987543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.033 Score=60.70 Aligned_cols=150 Identities=17% Similarity=0.293 Sum_probs=82.2
Q ss_pred ccCccCCCCCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeec
Q 005210 121 IQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEG 196 (709)
Q Consensus 121 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~ 196 (709)
+++|-....+..++ +.|..|-...+|++..... +..|++|+..... . ..+ .-.+|+.+++.+..-++ .++++
T Consensus 6 ~~~w~~~~~~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~I-dR~~E~~il~~l~~~gl~P~~l~ 81 (330)
T PLN02421 6 FKGWSDLDDSDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVI-DRERELQAIKYLSAAGFGAKLLG 81 (330)
T ss_pred CCccccCCcCceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEe-chHHHHHHHHHHHhcCCCCceeE
Confidence 45564443445554 4555577788999875432 2378888764321 1 111 12468889888855444 34554
Q ss_pred eEeecCCCeEEEEEeeccccccccc------------------cC---CCC-CC-CHHHHHHHHHHHH------------
Q 005210 197 LVTSRMSCSLYLVFEYMEHDLAGLA------------------SH---PGL-KF-SEAQVKCYMQQLL------------ 241 (709)
Q Consensus 197 ~~~~~~~~~lyLVmEy~~g~L~~~~------------------~~---~~~-~l-se~~i~~i~~QIl------------ 241 (709)
++. .. +|.+|+++..+... -. ... .+ ....+..|+.++-
T Consensus 82 ~~~---~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~ 155 (330)
T PLN02421 82 VFG---NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKK 155 (330)
T ss_pred EeC---Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhh
Confidence 442 22 58888876432110 00 000 01 1223333333221
Q ss_pred -------------HHHh-hhhhC----CeeeccCCCccEEEcC-CCcEEEeecccccc
Q 005210 242 -------------CGLD-HCHSR----GVLHRDIKGSNLLIDN-NGILKIADFGLASF 280 (709)
Q Consensus 242 -------------~aL~-yLH~~----gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 280 (709)
..+. ++... -++|.||.+.|||++. ++.++++||..|..
T Consensus 156 ~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 156 YETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 11112 2799999999999974 57899999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.043 Score=60.16 Aligned_cols=152 Identities=16% Similarity=0.189 Sum_probs=84.5
Q ss_pred cccCccCCCCCCeeEEeeecccCceEEEEEEECC----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eee
Q 005210 120 AIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKL 194 (709)
Q Consensus 120 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l 194 (709)
....|..........+..|-.|-...+|++.... +++.|++|+..... ...+. ..+|..+++.+..-++ .++
T Consensus 26 ~~~~w~~~~~~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~ 102 (344)
T PLN02236 26 LASKWGDVVDDEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRL 102 (344)
T ss_pred hcchhcCCCCcCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCce
Confidence 3445643212333445567668888999987532 34678888765432 11111 2468999888854343 344
Q ss_pred eceEeecCCCeEEEEEeeccccccccc--c------------------C-CCC--CCCHHHHHHHHHHHH----------
Q 005210 195 EGLVTSRMSCSLYLVFEYMEHDLAGLA--S------------------H-PGL--KFSEAQVKCYMQQLL---------- 241 (709)
Q Consensus 195 ~~~~~~~~~~~lyLVmEy~~g~L~~~~--~------------------~-~~~--~lse~~i~~i~~QIl---------- 241 (709)
++.+.. . .|.||+++..+... . . .+. .....++..++.++.
T Consensus 103 ~~~~~~---g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~ 176 (344)
T PLN02236 103 LGRFPN---G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKE 176 (344)
T ss_pred EEEECC---c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhh
Confidence 554422 2 58899876332210 0 0 111 111233444432221
Q ss_pred ----------HHHh-h----hhhCCeeeccCCCccEEEcC-CCcEEEeecccccc
Q 005210 242 ----------CGLD-H----CHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASF 280 (709)
Q Consensus 242 ----------~aL~-y----LH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 280 (709)
..|. . .+...++|+||++.|||++. ++.+.|+||..|..
T Consensus 177 ~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 177 FRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1111 1 12236899999999999986 47899999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.051 Score=57.74 Aligned_cols=30 Identities=23% Similarity=0.409 Sum_probs=25.5
Q ss_pred CeeeccCCCccEEEcCCCc-EEEeecccccc
Q 005210 251 GVLHRDIKGSNLLIDNNGI-LKIADFGLASF 280 (709)
Q Consensus 251 gIvHrDLKP~NILld~~g~-vKL~DFGla~~ 280 (709)
.++|+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.075 Score=59.43 Aligned_cols=76 Identities=17% Similarity=0.138 Sum_probs=50.3
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-C----hHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCe
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-E----PESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~----~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~ 205 (709)
..+.||.|....||+..+. +..|+||.-..... . +....+...|+..|+.+. ..++.+++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 3778999999999998863 44688987542111 1 123444556777777663 2467778776643 3
Q ss_pred EEEEEeeccc
Q 005210 206 LYLVFEYMEH 215 (709)
Q Consensus 206 lyLVmEy~~g 215 (709)
-++||||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999966
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.043 Score=60.30 Aligned_cols=74 Identities=16% Similarity=0.112 Sum_probs=47.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecC-----CCChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeecCCCeEEE
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFD-----NLEPESVRFMAREIHILRRLD--HI-NVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~-----~~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~~~~~~~~~~lyL 208 (709)
.||.|....||++.+...++.|+||.-... ...+-...+...|..+|+... -| .+.++|.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 579999999999997644467999964311 111233445567888887762 24 455565432 234569
Q ss_pred EEeecc
Q 005210 209 VFEYME 214 (709)
Q Consensus 209 VmEy~~ 214 (709)
|||+++
T Consensus 78 vMEdL~ 83 (370)
T TIGR01767 78 VMEDLS 83 (370)
T ss_pred hHhhCc
Confidence 999985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.057 Score=60.13 Aligned_cols=90 Identities=22% Similarity=0.277 Sum_probs=49.4
Q ss_pred hhcccCccCCCCCCeeEEeeecccCceEEEEEEECCC-CeE-----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce
Q 005210 118 GEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQ-KKI-----VALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191 (709)
Q Consensus 118 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~-----vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI 191 (709)
.+..++|.....+..+ ++.|..|-...+|++..... +.. |.+.... .. ....-.-.+|+.+++.|...++
T Consensus 39 ~~~~p~w~~~~~~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~-~~l~IdR~~E~~i~~~Ls~~gl 114 (383)
T PTZ00384 39 IRHVPFWNNVNPEFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TY-NSLVIDNDLQYNIAKLLGDNNF 114 (383)
T ss_pred HHHCCccccCCcccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CC-CceEeccHHHHHHHHHHHhCCC
Confidence 3444455433334444 45666688899999975433 222 3333211 11 1111112469999999965554
Q ss_pred -eeeeceEeecCCCeEEEEEeeccccc
Q 005210 192 -IKLEGLVTSRMSCSLYLVFEYMEHDL 217 (709)
Q Consensus 192 -v~l~~~~~~~~~~~lyLVmEy~~g~L 217 (709)
.++++.+.. ++|.||++|..
T Consensus 115 gP~l~~~f~~------g~l~efIeGr~ 135 (383)
T PTZ00384 115 GPKIIGRFGD------FTIQEWVEGNT 135 (383)
T ss_pred CCeEEEecCC------EEEEEEecccc
Confidence 455555532 59999998743
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.28 Score=55.70 Aligned_cols=94 Identities=13% Similarity=0.217 Sum_probs=56.3
Q ss_pred HHhhhhhcccCccCCCCCCeeEEeeecccCceEEEEEEECCC--------CeEEEEEEEecCCCChHHHHHHHHHHHHHH
Q 005210 113 LAAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQ--------KKIVALKKVRFDNLEPESVRFMAREIHILR 184 (709)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t--------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~ 184 (709)
+.....+.+++|.....++. .++.|..|-.-.+|++..... ++.|.+++.-... .... ....|..+++
T Consensus 89 ~~~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~ 164 (442)
T PTZ00296 89 IKKICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYK 164 (442)
T ss_pred HHHHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHH
Confidence 33444555677864444555 677888888889999975422 4578888754321 1111 2346888888
Q ss_pred hcCCCcee-eeeceEeecCCCeEEEEEeecccc
Q 005210 185 RLDHINVI-KLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 185 ~L~HpnIv-~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
.+...+|- ++++.+.. +.|.||++|.
T Consensus 165 ~ls~~gi~P~l~~~f~g------g~I~efi~g~ 191 (442)
T PTZ00296 165 TMSKYRIAPQLLNTFSG------GRIEEWLYGD 191 (442)
T ss_pred HHHHCCCCCceEEEeCC------CEEEEeeCCc
Confidence 87544443 45554422 3678888864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.076 Score=57.96 Aligned_cols=72 Identities=22% Similarity=0.338 Sum_probs=56.9
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.-++|++|++-.+.+.-.-. -..+++..|+.+.+..|+-+... .+=|||+.-.||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 45678888887765543322 24677888888888877777665 689999999999999 99999999999984
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.081 Score=58.92 Aligned_cols=76 Identities=21% Similarity=0.137 Sum_probs=49.9
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEec----CCCChHHHHHHHHHHHHHHhcC--CC-ceeeeeceEeecCCCeEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLD--HI-NVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~----~~~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~~~~~~~~~~ly 207 (709)
++.||.|.-..||++.+...++.|+||.-.. ....+-...+...|..+|+.+. .| ++.++|.+- .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhh
Confidence 7789999999999999854456789886321 1111334556667888888762 34 455665432 23356
Q ss_pred EEEeecc
Q 005210 208 LVFEYME 214 (709)
Q Consensus 208 LVmEy~~ 214 (709)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 8999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.18 Score=54.01 Aligned_cols=75 Identities=17% Similarity=0.229 Sum_probs=45.3
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCeEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~lyL 208 (709)
-+..+.|+.|....+|+.. .+++.+.||+-... ....+..|..-|+.|. --.+.+++.+... ...-||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceE
Confidence 3456789999999999986 67778999987622 2234667888888883 3456677776655 334599
Q ss_pred EEeeccc
Q 005210 209 VFEYMEH 215 (709)
Q Consensus 209 VmEy~~g 215 (709)
||||++.
T Consensus 90 lle~l~~ 96 (288)
T PF03881_consen 90 LLEFLEM 96 (288)
T ss_dssp EEE----
T ss_pred EEEeecC
Confidence 9999864
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.39 Score=51.66 Aligned_cols=30 Identities=27% Similarity=0.282 Sum_probs=27.7
Q ss_pred CeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 251 GVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 251 gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.31 Score=53.22 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=76.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeecCCC--eEE
Q 005210 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSRMSC--SLY 207 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------Iv~l~~~~~~~~~~--~ly 207 (709)
..|.+ .-..||+....+ |+ ++||+.+.. ... ..+..|+..|..|.-.. |..+-|-....... +.+
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-GR-YILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEecC-CC-eEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 456789987533 33 488988765 333 33456788888773211 22222222111233 788
Q ss_pred EEEeeccccccc-ccc-----------------CCCCC---------CCHH----HH---------HHHHHHHHHHHhhh
Q 005210 208 LVFEYMEHDLAG-LAS-----------------HPGLK---------FSEA----QV---------KCYMQQLLCGLDHC 247 (709)
Q Consensus 208 LVmEy~~g~L~~-~~~-----------------~~~~~---------lse~----~i---------~~i~~QIl~aL~yL 247 (709)
-|++|++|.... ... ..+.+ ..+. .. .....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 899999985544 110 00000 0010 00 01122333444444
Q ss_pred hh--------CC--eeeccCCCccEEEcCCCc-EEEeeccccc
Q 005210 248 HS--------RG--VLHRDIKGSNLLIDNNGI-LKIADFGLAS 279 (709)
Q Consensus 248 H~--------~g--IvHrDLKP~NILld~~g~-vKL~DFGla~ 279 (709)
.+ .+ +||+|+.|.|||++.+.. +-++||+-|.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 33 34 999999999999998874 8999999775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.91 Score=56.94 Aligned_cols=31 Identities=32% Similarity=0.563 Sum_probs=26.2
Q ss_pred CCeeeccCCCccEEEcCCC--cEE-Eeecccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNG--ILK-IADFGLASF 280 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g--~vK-L~DFGla~~ 280 (709)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999775 565 999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.27 Score=50.46 Aligned_cols=116 Identities=17% Similarity=0.153 Sum_probs=70.9
Q ss_pred cCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeecccccccc
Q 005210 141 GTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 220 (709)
Q Consensus 141 G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~ 220 (709)
|+-++...+...- | ...+|+++.-...- ....+..+..++.++. .|++|.. + ..-.+-+++|+|-.--
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N---D-n~~~yGvIlE~Cy~~~--- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN---D-NNYKYGVILERCYKIK--- 140 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec---C-CCceeEEEEeeccCcc---
Confidence 3444444443222 3 34566654322211 1234567888998884 6787752 1 2445668889885210
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHhhhhh--CCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHS--RGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 221 ~~~~~~~lse~~i~~i~~QIl~aL~yLH~--~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
-.+ ..++.--+..|.-.|+ .+.+|+|..|+||+-|..|.+||.|-+..
T Consensus 141 ------i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ------INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 011 1222233567888884 37999999999999999999999998754
|
The function of this family is unknown. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.77 E-value=0.26 Score=53.12 Aligned_cols=135 Identities=19% Similarity=0.222 Sum_probs=89.5
Q ss_pred EeeecccCceEEEEEEE-------CC---CCeEEEEEEEecC----------------------CCChHHHHHH--HHHH
Q 005210 135 LDKIGQGTYSNVYRARD-------LD---QKKIVALKKVRFD----------------------NLEPESVRFM--AREI 180 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~-------~~---tg~~vAIK~i~~~----------------------~~~~~~~~~~--~rEi 180 (709)
...|..|.-+.|+.|+- .. ..+.+|||+++.. ...+..+-.+ .+|+
T Consensus 257 ~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkEm 336 (531)
T KOG2269|consen 257 DGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKEM 336 (531)
T ss_pred hhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHHH
Confidence 34778899999988843 11 2345789876421 0011111122 2566
Q ss_pred HHHHhc-----CCCceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhh-hhCCeee
Q 005210 181 HILRRL-----DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLH 254 (709)
Q Consensus 181 ~iL~~L-----~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yL-H~~gIvH 254 (709)
.-|.+| .+|-+|.|.. -.|||-|++.+-+..-.-....|+..+.+....|++.++.-| |++-+||
T Consensus 337 hNL~RMq~~GlpcP~vV~lkk---------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVH 407 (531)
T KOG2269|consen 337 HNLSRMQKHGLPCPQVVKLKK---------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVH 407 (531)
T ss_pred HHHHHHHhcCCCCCceeeeec---------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheee
Confidence 666665 4677776632 369999998643333222344699999999999999988765 5778999
Q ss_pred ccCCCccEEEcCCCcEEEeeccccc
Q 005210 255 RDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 255 rDLKP~NILld~~g~vKL~DFGla~ 279 (709)
-||.--|||...+ .+-++|..-+.
T Consensus 408 ADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 408 ADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred cchhhhhheecCC-ceEEEechhcc
Confidence 9999999999654 88888876543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.20 E-value=2.7 Score=45.60 Aligned_cols=28 Identities=25% Similarity=0.169 Sum_probs=24.0
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.25 Score=52.67 Aligned_cols=29 Identities=28% Similarity=0.534 Sum_probs=25.7
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.62 E-value=0.53 Score=52.34 Aligned_cols=59 Identities=24% Similarity=0.166 Sum_probs=36.7
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCeeeccCCCccEEEcC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDLKP~NILld~ 266 (709)
..||-+|+.|- +...+... ..+|.-.+.+..-...||.-+- -.+++|.|+.|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 34555666652 22233222 3466666666666666655433 457999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 709 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-59 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-59 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-59 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-59 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-55 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-55 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-55 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-55 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-55 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-55 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-55 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-55 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-54 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-54 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-54 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-54 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-54 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-54 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-54 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-54 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-54 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-54 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-54 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-54 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-54 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-54 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-54 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-54 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-54 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-54 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-54 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-54 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-54 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-54 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-54 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-54 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-54 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-54 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-54 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-54 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-54 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-54 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-54 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-53 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-49 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-49 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-49 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-49 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-47 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-46 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-46 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-46 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-46 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-46 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-45 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-45 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-43 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-43 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-43 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-43 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-42 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-42 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-42 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-42 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-42 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-42 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-42 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-42 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-42 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-42 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-42 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-42 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-42 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-42 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-41 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-41 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-40 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-40 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-40 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-40 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-40 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-40 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-40 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-40 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-40 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-40 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-40 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-40 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-40 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-40 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-40 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-40 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-40 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-40 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-40 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-40 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-40 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-40 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-40 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-39 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-39 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-39 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-39 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-39 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-38 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-38 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-38 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-38 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-37 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-37 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-36 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-36 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-36 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-36 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-36 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-36 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-36 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-36 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-36 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-36 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-36 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-36 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-36 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-36 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-36 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-36 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-36 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-36 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-36 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-36 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-36 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-36 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-36 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-36 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-36 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-36 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-36 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-36 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-36 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-36 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-36 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-36 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-36 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-36 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-36 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-36 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-36 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-36 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-36 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-36 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-36 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-36 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-36 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-36 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-35 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-35 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-35 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-35 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-35 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-35 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-35 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-35 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-35 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-35 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-35 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-35 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-35 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-34 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-34 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-33 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-33 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-32 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-31 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-31 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-31 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-31 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-31 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-30 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-29 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-28 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-20 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-19 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-12 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 539 bits (1392), Expect = 0.0
Identities = 135/344 (39%), Positives = 189/344 (54%), Gaps = 14/344 (4%)
Query: 119 EAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 177
++++ +EKL KIGQGT+ V++AR + VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 178 REIHILRRLDHINVIKLEGLVTSRMS------CSLYLVFEYMEHDLAGLASHPGLKFSEA 231
REI IL+ L H NV+ L + ++ S S+YLVF++ EHDLAGL S+ +KF+ +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 232 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP---DQNQP 288
++K MQ LL GL + H +LHRD+K +N+LI +G+LK+ADFGLA + Q
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348
T+RVVTLWYRPPELLLG YG +DLW GCI+AE++ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 349 CGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAP--ALALMETLLSIDPADRG 405
CGS + + W + + KR V + K + AL L++ LL +DPA R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 406 SAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
+ AL +FF P+P D + + F+
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 484 bits (1247), Expect = e-167
Identities = 126/349 (36%), Positives = 191/349 (54%), Gaps = 15/349 (4%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMA-REIH 181
V RA +EKLD +G+G ++ VY+ARD + +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
+L+ L H N+I L + + + LVF++ME DL + L + + +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRP 300
GL++ H +LHRD+K +NLL+D NG+LK+ADFGLA SF P N+ T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRA 180
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK- 359
PELL GA YG VD+W+ GCILAEL P +PG ++++QL +IF+ G+P+E+ W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
LP FK + F L L++ L +P R +A AL+ ++F+ +
Sbjct: 241 CSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
Query: 420 PLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESR 468
P P LP+ E E++ K +R + +G +
Sbjct: 299 PGPTPGCQLPRPNCPVETL----KEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-139
Identities = 121/394 (30%), Positives = 185/394 (46%), Gaps = 46/394 (11%)
Query: 122 QGWVPRRADSFEKLD-KIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAR 178
R D FE K+G+GTY +VY+A+ D K K ALK++ + + R
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR---- 67
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL--------ASHPGLKFSE 230
EI +LR L H NVI L+ + S ++L+F+Y EHDL + A+ ++
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLA-SFYDPDQ 285
VK + Q+L G+ + H+ VLHRD+K +N+L+ G +KIAD G A F P +
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 286 NQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV----- 339
L VVT WYR PELLLGA +Y A+D+W+ GCI AEL +PI R E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 340 ----EQLHKIFKLCGSPSEDYWRK-SKLPHATIFKP---QQPYKRCVAETF--KDFPAP- 388
+QL +IF + G P++ W K+P + + Y C + K P
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 389 --ALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP---KYPPSKEFDAKIRD 443
A L++ LL++DP R ++ A++ +F PLP YP + + D
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPD 367
Query: 444 EEARRQGGSKGQRMD----LERRGTRESRAIPAP 473
++ ++ + Q + G ++S P
Sbjct: 368 DKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGP 401
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-138
Identities = 111/328 (33%), Positives = 170/328 (51%), Gaps = 9/328 (2%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+++ KLDK+G+GTY+ VY+ + +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N++ L ++ + S L LVFEY++ DL G + VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
+ VLHRD+K NLLI+ G LK+ADFGLA + P + + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGST 176
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATI 367
Y T +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+E+ W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 427
+ + + + L+ LL + +R SA A++ FF
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK-- 294
Query: 428 LPKYPPSKEFDAKIRDEEARRQGGSKGQ 455
LP +EA +
Sbjct: 295 LPDTTSIFALKEIQLQKEASLRSAHHHH 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-138
Identities = 111/322 (34%), Positives = 167/322 (51%), Gaps = 20/322 (6%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRL 186
+ F++L+K+G GTY+ VY+ + VALK+V+ D+ E E A REI +++ L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK-----FSEAQVKCYMQQLL 241
H N+++L ++ + L LVFE+M++DL + VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRP 300
GL CH +LHRD+K NLLI+ G LK+ DFGLA +F P +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRA 176
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK- 359
P++L+G+ Y T++D+WS GCILAE+ GKP+ PG + EQL IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAP-----ALALMETLLSIDPADRGSAASALRSE 414
+KLP Q+P + + + + + + LL ++P R SA AL
Sbjct: 237 TKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 415 FFTMKPLPCDPSSLPKYPPSKE 436
+F +
Sbjct: 296 WFAEYYHHASMGGSRSHHHHHH 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-136
Identities = 114/308 (37%), Positives = 158/308 (51%), Gaps = 18/308 (5%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF---MAREIHIL 183
+E + +IG G Y VY+ARD VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 184 RRL---DHINVIKLEGLVTSR---MSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCY 236
RRL +H NV++L + + + LVFE+++ DL L P +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
M+Q L GLD H+ ++HRD+K N+L+ + G +K+ADFGLA Y LT VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVVTL 183
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
WYR PE+LL +T Y T VD+WS GCI AE++ KP+ G +E +QL KIF L G P ED
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 357 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
W + LP F P+ P R V + L+ +L+ +P R SA AL+ +
Sbjct: 243 WPRDVSLPRGA-FPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 416 F-TMKPLP 422
+ P
Sbjct: 300 LHKDEGNP 307
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-136
Identities = 124/297 (41%), Positives = 177/297 (59%), Gaps = 10/297 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+EKL+KIG+GTY V++A++ + +IVALK+VR D+ + E V A REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+++L ++ S L LVFE+ + DL VK ++ QLL GL CH
Sbjct: 61 KNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
SR VLHRD+K NLLI+ NG LK+A+FGLA +F P + ++ VVTLWYRPP++L GA
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176
Query: 308 TYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHA 365
Y T++D+WS GCI AEL AG+P+ PG +QL +IF+L G+P+E+ W +KLP
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
+ P P + A L++ LL +P R SA AL+ +F+ P
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-135
Identities = 119/297 (40%), Positives = 175/297 (58%), Gaps = 9/297 (3%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHI 182
+ + ++KL+K+G+GTY VY+A+D +IVALK++R D E E + A REI +
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDA-EDEGIPSTAIREISL 72
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
L+ L H N++ L ++ S L LVFE+ME DL + ++Q+K Y+ QLL
Sbjct: 73 LKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPP 301
G+ HCH +LHRD+K NLLI+++G LK+ADFGLA +F P + T VVTLWYR P
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAP 188
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-S 360
++L+G+ Y T+VD+WS GCI AE+ GKP+ PG T+ +QL KIF + G+P+ W +
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+LP Q K+ + F + L+ +L DP R SA A+ +F
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-135
Identities = 119/328 (36%), Positives = 170/328 (51%), Gaps = 19/328 (5%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMA-REIH 181
+ R +E + +IG+G Y V++ARDL + VALK+VR E + RE+
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVA 63
Query: 182 ILRRL---DHINVIKLEGLVTSRMS---CSLYLVFEYMEHDLAG-LASHPGLKFSEAQVK 234
+LR L +H NV++L + T + L LVFE+++ DL L P +K
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
M QLL GLD HS V+HRD+K N+L+ ++G +K+ADFGLA Y LTS VV
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVV 181
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
TLWYR PE+LL ++ Y T VDLWS GCI AE++ KP+ G ++V+QL KI + G P E
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 355 DYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
+ W + LP + + + D L+ L+ +PA R SA SAL
Sbjct: 241 EDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 414 EFFTMKPLPCD--PSSLPKYPPSKEFDA 439
+F + S LP + E +
Sbjct: 298 PYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-133
Identities = 109/291 (37%), Positives = 163/291 (56%), Gaps = 10/291 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+ + L+KIG+GTY VY+A++ + + ALKK+R + E E + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++KL ++ ++ L LVFE+++ DL L K ++ QLL G+ +CH
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
R VLHRD+K NLLI+ G LKIADFGLA +F P + T +VTLWYR P++L+G+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGS 175
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
Y T +D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+ W ++LP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
K + L+ +L +DP R +A AL +F
Sbjct: 236 PNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-132
Identities = 99/312 (31%), Positives = 157/312 (50%), Gaps = 9/312 (2%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+ +EK+ KIG+G+Y V++ R+ D +IVA+KK + ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ L + R L+LVFEY +H + E VK Q L ++ CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
+HRD+K N+LI + ++K+ DFG A P + V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGD 177
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 366
T YG VD+W+ GC+ AEL +G P+ PG+++V+QL+ I K G + + S + +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 367 IFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 425
K P + F + PAL L++ L +DP +R + L +F D
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 426 SSLPKYPPSKEF 437
+ P +
Sbjct: 298 AKEHDKPAENLY 309
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-132
Identities = 93/321 (28%), Positives = 162/321 (50%), Gaps = 9/321 (2%)
Query: 120 AIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-R 178
+ + + +E L +G+G+Y V + R+ D +IVA+KK + + + V+ +A R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMR 73
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
EI +L++L H N++ L + + YLVFE+++H + V+ Y+
Sbjct: 74 EIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 297
Q++ G+ CHS ++HRDIK N+L+ +G++K+ DFG A + P + V T W
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRW 189
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
YR PELL+G YG AVD+W+ GC++ E++ G+P+ PG ++++QL+ I G+ +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 358 RK-SKLPHATIFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+K P + P+ + + + + L + L IDP R A L +F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 416 FTMKPLPCDPSSLPKYPPSKE 436
F M S + K+
Sbjct: 310 FQMDGFAERFSQELQLKVQKD 330
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-132
Identities = 115/342 (33%), Positives = 174/342 (50%), Gaps = 28/342 (8%)
Query: 89 HHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYR 148
HH G G + P+ D + ++ K+G+GTY VY+
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPS--------------ATSIDRYRRITKLGEGTYGEVYK 52
Query: 149 ARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLEGLVTSRMSCSLY 207
A D + VA+K++R ++ E E V A RE+ +L+ L H N+I+L+ ++ L+
Sbjct: 53 AIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR--LH 109
Query: 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-- 265
L+FEY E+DL S +K ++ QL+ G++ CHSR LHRD+K NLL+
Sbjct: 110 LIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168
Query: 266 ---NNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGC 321
+LKI DFGLA +F P + T ++TLWYRPPE+LLG+ +Y T+VD+WS C
Sbjct: 169 DASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226
Query: 322 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAE 380
I AE+ P+ PG +E++QL KIF++ G P + W + LP P+ K
Sbjct: 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286
Query: 381 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
L L+ +L +DP R SA +AL +F+
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 330 bits (848), Expect = e-107
Identities = 118/381 (30%), Positives = 171/381 (44%), Gaps = 32/381 (8%)
Query: 120 AIQGWVPRRA--DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 177
A G P R S+ IG G++ VY+A+ D ++VA+KKV D RF
Sbjct: 42 ATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKN 95
Query: 178 REIHILRRLDHINVIKLEGLVTS----RMSCSLYLVFEYMEHDLAGLASH---PGLKFSE 230
RE+ I+R+LDH N+++L S + L LV +Y+ + +A H
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPL 289
VK YM QL L + HS G+ HRDIK NLL+D + +LK+ DFG A + P
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PN 213
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
S + + +YR PEL+ GAT Y +++D+WS GC+LAEL G+PI PG + V+QL +I K+
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAA 408
G+P+ + R+ P+ T FK Q + F P A+AL LL P R +
Sbjct: 274 GTPTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 409 SALRSEFFTMKPLP-CDPSSLPKYPPSKEFD-----------AKIRDEEARRQGGSKGQR 456
A FF P + P F + AR Q +
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 392
Query: 457 MDLERRGTRESRAIPAPDANA 477
+A +
Sbjct: 393 NATAASDANTGDRGQTNNAAS 413
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 2e-98
Identities = 108/355 (30%), Positives = 172/355 (48%), Gaps = 35/355 (9%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
+R ++ IG G++ V++A+ ++ + VA+KKV D RF RE+ I+R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIV 89
Query: 187 DHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQ 239
H NV+ L+ S L LV EY+ + + H +K YM Q
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
LL L + HS G+ HRDIK NLL+D +G+LK+ DFG A +P S + + +Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSYICSRYY 207
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PEL+ GAT Y T +D+WSTGC++AEL G+P+ PG + ++QL +I K+ G+PS + +
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 359 KSKLPHATIFKPQQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+ P+ K Q ++ F P A+ L+ LL P+ R +A AL FF
Sbjct: 268 -TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF- 325
Query: 418 MKPLPCDPSSLPKYPP--------------SKEFDAKIRDEEARRQGGSKGQRMD 458
L + +P + +++ + A + S+G +
Sbjct: 326 -DELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVH 379
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-91
Identities = 98/342 (28%), Positives = 149/342 (43%), Gaps = 29/342 (8%)
Query: 116 VAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 175
A A + D F+ GQGT+ V ++ VA+KKV D RF
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRF 62
Query: 176 MAREIHILRRL---DHINVIKLEGLVTSRMSCS-----LYLVFEYMEHDLAGLASH---P 224
RE+ I++ L H N+++L+ + L +V EY+ L +
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 225 GLKFSEAQVKCYMQQLLCGLD--HCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFY 281
+ +K ++ QL+ + H S V HRDIK N+L++ +G LK+ DFG A
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 341
P ++P + + + +YR PEL+ G +Y TAVD+WS GCI AE+ G+PI G Q
Sbjct: 183 SP--SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 342 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQ---QPYKRCVAETFKDFPAPALALMETLLS 398
LH+I ++ G PS + RK H + P+ ++ A L+ LL
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 399 IDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP--PSKEFD 438
P +R AL +F L + LP P F
Sbjct: 301 YLPEERMKPYEALCHPYF--DELHDPATKLPNNKDLPEDLFR 340
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-90
Identities = 90/359 (25%), Positives = 152/359 (42%), Gaps = 53/359 (14%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
+ + +G G++ V D++ K ALKKV D R+ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 186 LDHINVIKLEGLVTSRMSCS------------------------------------LYLV 209
LDH+N+IKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 210 FEYMEHDLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID- 265
EY+ L + G + Y+ QL + HS G+ HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 266 NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 325
+ LK+ DFG A P ++P + + + +YR PEL+LGAT Y ++DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 326 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 385
L GKP+ G T ++QL +I ++ G+P+++ + + + P + + +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEG 293
Query: 386 -PAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRD 443
P+ A+ L+E +L +P R + A+ FF L + S ++
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 5e-90
Identities = 89/299 (29%), Positives = 145/299 (48%), Gaps = 23/299 (7%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DH 188
D ++ + K+G+G YS V+ A ++ + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 189 INVIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N+I L +V +S + LVFE+ D L ++ ++ YM ++L LD+C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 146
Query: 248 HSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
HS G++HRD+K N++ID + L++ D+GLA FY P Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVD 204
Query: 307 ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPH 364
Y ++D+WS GC+LA + K P G +QL +I K+ G+ DY K +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 365 ATIFKPQQPYKRCV-------AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
F +E AL ++ LL D R +A A+ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 3e-84
Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 18/322 (5%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHIL 183
V R + L IG+G Y V A D K VA+KK+ F++ + REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKIL 79
Query: 184 RRLDHINVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
R H N+I + ++ + +Y+V + ME DL L L S + ++ Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQI 137
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWY 298
L GL + HS VLHRD+K SNLL++ LKI DFGLA DPD + LT V T WY
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++L + Y ++D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 359 KSKLPHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
A + P+K V F + + AL L++ +L+ +P R AL +
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 417 TMKPLPCDPSSLPKYPPSKEFD 438
+ DPS P +FD
Sbjct: 318 --EQY-YDPSDEPIAEAPFKFD 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-84
Identities = 102/322 (31%), Positives = 157/322 (48%), Gaps = 23/322 (7%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
+P+ + +G G Y +V A D + VA+KK+ F + + RE+ +
Sbjct: 22 LPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLL 76
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
L+ + H NVI L + T S YLV +M+ DL + FSE +++ +
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVY 133
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+L GL + HS GV+HRD+K NL ++ + LKI DFGLA D + +T VVT WY
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 189
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++L +Y VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P ++ +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 359 KSKLPHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
K A + P + F A L+E +L +D R +AA AL FF
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 417 TMKPLPCDPSSLPKYPPSKEFD 438
+P DP + +
Sbjct: 310 --EPF-RDPEEETEAQQPFDDS 328
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-83
Identities = 94/342 (27%), Positives = 143/342 (41%), Gaps = 27/342 (7%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMA------ 177
+ + I G+Y V D + VA+K+V + +V
Sbjct: 20 MQSP---YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 178 --REIHILRRLDHINVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQ 232
REI +L H N++ L + + LYLV E M DLA + + S
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292
++ +M +L GL H GV+HRD+ N+L+ +N + I DF LA D N T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY 193
Query: 293 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352
V WYR PEL++ + VD+WS GC++AE++ K + G T QL+KI ++ G+P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 353 SEDYWRKSKLPHATIF----KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 408
+ P A + P R AL L+ +L +P R S
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 409 SALRSEFFTMKPLPCDPSSLPKYPPSK-EFDAKIRDEEARRQ 449
ALR +F + L DP L + + FD + D +
Sbjct: 313 QALRHPYF--ESL-FDPLDLTEGLSERFHFDESVTDVYDMHK 351
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 8e-83
Identities = 101/334 (30%), Positives = 158/334 (47%), Gaps = 23/334 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
V + L +G G Y V A D VA+KK+ F + + RE+ +
Sbjct: 23 VRAV---YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRL 77
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
L+ + H NVI L + T + YLV +M DL L H L E +++ +
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVY 135
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+L GL + H+ G++HRD+K NL ++ + LKI DFGLA D + +T VVT WY
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 191
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++L Y VD+WS GCI+AE+ GK + G ++QL +I K+ G+P ++ +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 359 KSKLPHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ + A + P A + A+ L+E +L +D R +A AL +F
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 417 TMKPLPCDPSSLPKYPP-SKEFDAKIRDEEARRQ 449
+ L D P+ FD R + ++
Sbjct: 312 --ESL-HDTEDEPQVQKYDDSFDDVDRTLDEWKR 342
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 2e-82
Identities = 106/389 (27%), Positives = 168/389 (43%), Gaps = 71/389 (18%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
+P R +E IG G+Y +V A D +K++VA+KK+ F++ + R + REI I
Sbjct: 51 IPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKR-ILREIAI 105
Query: 183 LRRLDHINVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
L RL+H +V+K+ +V + LY+V E + D L + +E +K +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYN 164
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--------------------- 278
LL G+ + HS G+LHRD+K +N L++ + +K+ DFGLA
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 279 -----SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL------- 326
+ + + LT VVT WYR PEL+L Y A+D+WS GCI AEL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 327 ----YAGKPIMPG--------------------RTEVEQLHKIFKLCGSPSEDYWRKSKL 362
P+ PG R +QL+ IF + G+PSE+ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 363 PHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
A + P + AE F A A+ L++ +L +P R + L FF
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
Query: 421 LPCD-PSSLPKYPPSKEFDAKIRDEEARR 448
+ ++ K + + + R
Sbjct: 405 IAEVETNATEKVRLPFNDWMNMDEPQLRY 433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 2e-82
Identities = 104/313 (33%), Positives = 154/313 (49%), Gaps = 24/313 (7%)
Query: 121 IQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
I G+ + R + L +G G V+ A D D K VA+KK+ + P+SV+ RE
Sbjct: 4 IHGFDLGSR---YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALRE 58
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCS------------LYLVFEYMEHDLAGLASHPGLK 227
I I+RRLDH N++K+ ++ S +Y+V EYME DLA + L
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL- 117
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQN 286
E + +M QLL GL + HS VLHRD+K +NL I+ + +LKI DFGLA DP +
Sbjct: 118 -LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 287 QP--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344
L+ +VT WYR P LLL Y A+D+W+ GCI AE+ GK + G E+EQ+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC-VAETFKDFPAPALALMETLLSIDPAD 403
I + E+ ++ + + + A+ +E +L+ P D
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 404 RGSAASALRSEFF 416
R +A AL +
Sbjct: 297 RLTAEEALSHPYM 309
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-82
Identities = 106/331 (32%), Positives = 156/331 (47%), Gaps = 24/331 (7%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHIL 183
+ F+ +G+G Y V A +IVA+KK+ FD P REI IL
Sbjct: 9 ISSD---FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKIL 63
Query: 184 RRLDHINVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
+ H N+I + + + +Y++ E M+ DL + S L S+ ++ ++ Q
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYFIYQT 121
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA---------SFYDPDQNQPLTS 291
L + H V+HRD+K SNLLI++N LK+ DFGLA + Q +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
V T WYR PE++L + Y A+D+WS GCILAEL+ +PI PGR QL IF + G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 352 P-SEDYWRKSKLPHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAA 408
P S++ R + P A + P + F + L++ +L DPA R +A
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 409 SALRSEFFTMKPLPCD-PSSLPKYPPSKEFD 438
AL + P D P P P EFD
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 1e-81
Identities = 102/334 (30%), Positives = 158/334 (47%), Gaps = 23/334 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
VP R ++ L +G G Y +V A D VA+KK+ F + + RE+ +
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRL 81
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
L+ + H NVI L + T S +YLV M DL + L ++ V+ +
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIY 139
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+L GL + HS ++HRD+K SNL ++ + LKI DFGLA + +T V T WY
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWY 195
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++L +Y VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 359 KSKLPHATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
K A + + A F A+ L+E +L +D R +AA AL +F
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 417 TMKPLPCDPSSLPKYPP-SKEFDAKIRDEEARRQ 449
DP P P + +++ + +
Sbjct: 316 --AQY-HDPDDEPVADPYDQSLESRDLLIDEWKS 346
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 2e-79
Identities = 104/366 (28%), Positives = 166/366 (45%), Gaps = 49/366 (13%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
V R+ +E + K+G+G Y V+++ D ++VA+KK+ F N + REI I
Sbjct: 7 VLRK---YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMI 61
Query: 183 LRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
L L H N++ L ++ + +YLVF+YME DL + L + + QL+
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLI 119
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--------------------SFY 281
+ + HS G+LHRD+K SN+L++ +K+ADFGL+ +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 341
D LT V T WYR PE+LLG+T Y +D+WS GCIL E+ GKPI PG + + Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 342 LHKIFKLCGSPSED------------YWR----KSKLPHATIFKPQQPYKRCVAETFKDF 385
L +I + PS + K ++ + +K + +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 386 PAPALA--LMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PSSLPKYPPSKEFDAKIR 442
A L++ LL +P R SA AL+ F ++ P + P+ + K
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHS 359
Query: 443 DEEARR 448
++ R
Sbjct: 360 IDDYRN 365
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 5e-77
Identities = 95/348 (27%), Positives = 164/348 (47%), Gaps = 38/348 (10%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
V +R ++ L IG G V A D ++ VA+KK+ F N + RE+ +
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVL 77
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
++ ++H N+I L + T + S +Y+V E M+ +L + ++ +
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLY 134
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA +T VVT +Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 192
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++LG Y VD+WS GCI+ E+ G + PG ++Q +K+ + G+P ++ +
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 359 K---------SKLPHATIFKPQQPYKR--------CVAETFKDFPAPALALMETLLSIDP 401
K P +++ +E K + A L+ +L ID
Sbjct: 252 KLQPTVRTYVENRPK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 402 ADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
+ R S AL+ + + P + + P P K+ D + E ++
Sbjct: 308 SKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 355
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 3e-75
Identities = 97/348 (27%), Positives = 163/348 (46%), Gaps = 38/348 (10%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
V +R ++ L IG G V A D + VA+KK+ F N + RE+ +
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVL 114
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
++ ++H N+I L + T + + +YLV E M+ +L + ++ +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 171
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA +T VVT +Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYY 229
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE++LG Y VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +
Sbjct: 230 RAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 359 K---------SKLPHATIFKPQQPYKR--------CVAETFKDFPAPALALMETLLSIDP 401
K P + + +E K + A L+ +L IDP
Sbjct: 289 KLQPTVRNYVENRPK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 402 ADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
A R S AL+ + + P + + P K+ D + E ++
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 392
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-75
Identities = 100/370 (27%), Positives = 161/370 (43%), Gaps = 65/370 (17%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHI 182
VP + IG+G+Y VY A D + +K VA+KKV F++L + R + REI I
Sbjct: 24 VPDN---YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKR-ILREITI 78
Query: 183 LRRLDHINVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
L RL +I+L L+ LY+V E + DL L + +E +K +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYN 137
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--------------------- 278
LL G + H G++HRD+K +N L++ + +K+ DFGLA
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG--------- 329
++ + + LTS VVT WYR PEL+L Y ++D+WSTGCI AEL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 330 --KPIMPG-----------------RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370
P+ PG ++ +QL+ IF + G+P+ED + P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 371 QQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 428
P+++ + + + + L+E++L +P R + AL + K +
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDV-RKKKLE 374
Query: 429 PKYPPSKEFD 438
Sbjct: 375 NFSTKKIILP 384
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-66
Identities = 74/313 (23%), Positives = 128/313 (40%), Gaps = 48/313 (15%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--I 189
+ L +IG G S V++ + ++K+I A+K V + + +++ EI L +L
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 190 NVIKLEG-LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+I+L +T + +Y+V E DL + K Y + +L + H
Sbjct: 89 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH 144
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGA 307
G++H D+K +N LI +G+LK+ DFG+A+ PD + S+V T+ Y PPE +
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 308 TY----------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
+ D+WS GCIL + GK P + + Q+ K+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA---------- 251
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFF 416
I P + F D P +++ L DP R S L +
Sbjct: 252 ---------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
Query: 417 TMKPLPCDPSSLP 429
++ P + +
Sbjct: 297 QIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-64
Identities = 72/332 (21%), Positives = 129/332 (38%), Gaps = 48/332 (14%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--I 189
+ L +IG G S V++ + ++K+I A+K V + + +++ EI L +L
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+I+L + +Y+V E DL + K Y + +L + H
Sbjct: 70 KIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGAT 308
G++H D+K +N LI +G+LK+ DFG+A+ PD + S+V T+ Y PPE + +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 309 Y----------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
D+WS GCIL + GK P + + Q+ K+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 232
Query: 359 KSKLPHATIFKPQQPYK--RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
I P + + +D ++ L DP R S L +
Sbjct: 233 --------IIDPNHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLAHPYV 277
Query: 417 TMKPLPCDPSSLPKYPPSKEFDAKIRDEEARR 448
++ P + + K ++ +
Sbjct: 278 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 7e-64
Identities = 76/318 (23%), Positives = 128/318 (40%), Gaps = 55/318 (17%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
R A FE++ +GQG + V +AR+ + A+KK+R + ++ E+ +L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 187 DHINVIKL-----------EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVK 234
+H V++ + + + +L++ EY E L L L +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD------------ 282
+Q+L L + HS+G++HRD+K N+ ID + +KI DFGLA
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 283 -PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 341
P + LTS + T Y E+L G +Y +D++S G I E+ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 342 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP 401
L K+ + D+ + K ++ L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFDDN------------------KMKVEKK-------IIRLLIDHDP 272
Query: 402 ADRGSAASALRSEFFTMK 419
R A + L S + +K
Sbjct: 273 NKRPGARTLLNSGWLPVK 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-62
Identities = 74/350 (21%), Positives = 132/350 (37%), Gaps = 46/350 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--I 189
+ L +IG G S V++ + ++K+I A+K V + + +++ EI L +L
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
+I+L + +Y+V E DL + K Y + +L + H
Sbjct: 117 KIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGAT 308
G++H D+K +N LI +G+LK+ DFG+A+ PD + S+V + Y PPE + +
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 309 Y----------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
D+WS GCIL + GK P + + Q+ K+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA----------- 279
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFT 417
I P + F D P +++ L DP R S L +
Sbjct: 280 --------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 418 MKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRES 467
++ P + + K ++ + + + G
Sbjct: 326 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 375
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-58
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 39/300 (13%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
P RA+ +E L IG G+Y + R KI+ K++ + ++ + + E+++LR
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLL 241
L H N+++ + R + +LY+V EY E DLA + + E V M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 242 CGLDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
L CH R VLHRD+K +N+ +D +K+ DFGLA + D + + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
+Y PE + + Y D+WS GC+L EL A P ++ E KI + G
Sbjct: 181 YYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF---- 233
Query: 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
++P + ++ +L++ R S L +
Sbjct: 234 ---RRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 58/310 (18%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
R F++++ IG G + V++A+ K +K+V+++N + RE+ L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 186 LDHINVIKL--------------EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFS 229
LDH+N++ + + L++ E+ + L + G K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 230 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289
+ +Q+ G+D+ HS+ +++RD+K SN+ + + +KI DFGL + D
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
T TL Y PE + YG VDL++ G ILAEL + T E L
Sbjct: 179 TRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDL- 231
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409
R + F L++ LLS P DR + +
Sbjct: 232 --------RDGIIS-------------------DIFDKKEKTLLQKLLSKKPEDRPNTSE 264
Query: 410 ALRSEFFTMK 419
LR+ K
Sbjct: 265 ILRTLTVWKK 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 25/296 (8%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ D +GQG +NV+R R + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDH 246
N++KL + + L+ E+ L + P E++ ++ ++ G++H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 247 CHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G++HR+IK N++ D + K+ DFG A + D + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPD 185
Query: 303 LLLGAT-------YYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKLCGS 351
+ A YG VDLWS G G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
+ +K++ + P ++ + P LA + L D
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGF 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-57
Identities = 66/296 (22%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
SF++L ++G G+Y V++ R + ++ A+K+ P+ E+ +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 186 L-DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
+ H ++LE LYL E L G EAQV Y++ L L
Sbjct: 113 VGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
H HS+G++H D+K +N+ + G K+ DFGL + Y PELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELL 228
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
G+ YGTA D++S G + E+ +P E ++ +
Sbjct: 229 QGS--YGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG---------------- 267
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
P+ + +++ +L DP R +A + L +P
Sbjct: 268 --YLPPEFT---------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR-QP 311
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 6e-56
Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 25/296 (8%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ D +GQG +NV+R R + A+K + M RE +L++L+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDH 246
N++KL + + L+ E+ L + P E++ ++ ++ G++H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 247 CHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G++HR+IK N++ D + K+ DFG A + D + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPD 185
Query: 303 LLLGAT-------YYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKLCGS 351
+ A YG VDLWS G G R E ++KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
+ +K++ + P ++ + P LA + L D
Sbjct: 246 GAISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGF 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-56
Identities = 84/327 (25%), Positives = 131/327 (40%), Gaps = 37/327 (11%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILR 184
PR + + +G+G ++ + D D K++ A K V L R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
L H +V+ G +++V E L L +E + + Y++Q++ G
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 153
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
+ H V+HRD+K NL ++ + +KI DFGLA+ + D + T Y PE+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEV 212
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
L + VD+WS GCI+ L GKP E +I K +Y +P
Sbjct: 213 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 261
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
K A +L++ +L DP R + L EFFT +P
Sbjct: 262 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
Query: 424 D-PSSLPKYPPSKEFDAKIRDEEARRQ 449
P + PP D R+
Sbjct: 303 RLPITCLTIPPRFSIAPSSLDPSNRKP 329
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-55
Identities = 77/363 (21%), Positives = 139/363 (38%), Gaps = 40/363 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + +L KIG+G++ + + + +K++ + + RE+ +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 190 NVIK-LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDH 246
N+++ E + SLY+V +Y E DL + + G+ F E Q+ + Q+ L H
Sbjct: 84 NIVQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H R +LHRDIK N+ + +G +++ DFG+A + + + T +Y PE+
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICEN 199
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
Y D+W+ GC+L EL K + + KI P
Sbjct: 200 KP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------------ISGSFP--- 243
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
P + + L+ L +P DR S S L F
Sbjct: 244 ------PVSLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIA----KRIEK 286
Query: 427 SLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKR 486
L ++EF K + + +K ++ I P A + L+ +K
Sbjct: 287 FLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKY 346
Query: 487 QSQ 489
+
Sbjct: 347 GDK 349
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 37/311 (11%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILR 184
PR + + +G+G ++ + D D K++ A K V L R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
L H +V+ G +++V E L L +E + + Y++Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
+ H V+HRD+K NL ++ + +KI DFGLA+ + D + T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 186
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
L + VD+WS GCI+ L GKP E +I K +Y +P
Sbjct: 187 LSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP 235
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
K A +L++ +L DP R + L EFFT +P
Sbjct: 236 -------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
Query: 424 D-PSSLPKYPP 433
P + PP
Sbjct: 277 RLPITCLTIPP 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 69/320 (21%), Positives = 123/320 (38%), Gaps = 56/320 (17%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
R FE + +G+G + V+ A++ A+K++R N E + M RE+ L +L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 187 DHINVIK----------LEGLVTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQV 233
+H +++ E L S LY+ + +L + +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 234 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-----------SFYD 282
Q+ ++ HS+G++HRD+K SN+ + ++K+ DFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 342
T +V T Y PE + G + Y VD++S G IL EL + P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERV 234
Query: 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 402
+ + R K P F +++ +LS P
Sbjct: 235 RTLTDV---------RNLKFPP----------------LFTQKYPCEYVMVQDMLSPSPM 269
Query: 403 DRGSAASALRSEFFTMKPLP 422
+R A + + + F P
Sbjct: 270 ERPEAINIIENAVFEDLDFP 289
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 35/305 (11%)
Query: 120 AIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAR 178
++ + + + F+ + +G+G+++ VYRA + VA+K + + + +
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYM 237
E+ I +L H ++++L +YLV E + ++ + FSE + + +M
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
Q++ G+ + HS G+LHRD+ SNLL+ N +KIADFGLA+ + T T
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPN 177
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
Y PE+ + +G D+WS GC+ L G+P T L+K+ DY
Sbjct: 178 YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY- 229
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
++P A L+ LL +PADR S +S L F +
Sbjct: 230 ---EMP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
Query: 418 MKPLP 422
Sbjct: 268 RNSST 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 3e-53
Identities = 67/311 (21%), Positives = 108/311 (34%), Gaps = 19/311 (6%)
Query: 118 GEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 177
G + +E +++G G + V R D + VA+K+ R + L P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 178 REIHILRRLDHINVIKL----EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSE 230
EI I+++L+H NV+ +GL + L EY E DL + E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYDPDQNQ 287
++ + + L + H ++HRD+K N+++ I KI D G A D +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
T V TL Y PELL Y VD WS G + E G + Q H +
Sbjct: 180 -CTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
+ + P ++ +L RG+
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTD 292
Query: 408 ASALRSEFFTM 418
F
Sbjct: 293 PQNPNVGCFQA 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-53
Identities = 81/288 (28%), Positives = 122/288 (42%), Gaps = 34/288 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
+F KIG+G +S VYRA L VALKKV+ +L R +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLLCGL 244
NVIK L +V E + DL+ + E V Y QL L
Sbjct: 92 PNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
+H HSR V+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
Y D+WS GC+L E+ A + P + L+ + K + + +
Sbjct: 209 HENG-YNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK----------KIEQCDY 255
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+ P Y +E + + ++ DP R
Sbjct: 256 PPL--PSDHY----SEELRQL-------VNMCINPDPEKRPDVTYVYD 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 59/312 (18%), Positives = 112/312 (35%), Gaps = 44/312 (14%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ + K+G+G +S V L ALK++ + RE + R +H N+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNI 88
Query: 192 IKLEG--LVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLLCGLD 245
++L L +L+ + + L G +E Q+ + + GL+
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--------QNQPLTSRVVTLW 297
H++G HRD+K +N+L+ + G + D G + Q ++ T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 298 YRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355
YR PEL ++ D+WS GC+L + G+ P + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDS 255
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+ PQ P + L+ +++++DP R L
Sbjct: 256 VALAV---QNQLSIPQSPR----------HSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
Query: 416 FTMKPLPCDPSS 427
P P ++
Sbjct: 303 ALQPPAPGQHTT 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 4e-50
Identities = 57/312 (18%), Positives = 125/312 (40%), Gaps = 39/312 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARD---------LDQKKIVALKKVRFDNLEPESVRFMA--- 177
+ + + + QG ++ + ++ + + N + S++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 178 -REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME--------HDLAGLASHPGLKF 228
E+ I+ + + + EG++T+ +Y+++EYME L +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 229 SEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287
+KC ++ +L + H+ + + HRD+K SN+L+D NG +K++DFG + + ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDK 205
Query: 288 PLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKI 345
+ T + PPE ++Y G VD+WS G L ++ P + VE + I
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG 405
++ + P + + + ++ L +PA+R
Sbjct: 266 RT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 406 SAASALRSEFFT 417
++ AL+ E+
Sbjct: 316 TSEDALKHEWLA 327
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 48/323 (14%), Positives = 88/323 (27%), Gaps = 56/323 (17%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRR 185
+ + ++ + G S V+ RD+++ + ALK S + + R
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 186 LDHIN------------------------VIKLEGLVTSRMSCSLYLVFEYMEHDLAGL- 220
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 221 -----ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275
+ QL+ + S+G++H NL I +G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMP 334
+ V + Y P E L + A++ W G + ++ P
Sbjct: 239 SALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P 292
Query: 335 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALME 394
F L + W++ L + C P L+
Sbjct: 293 -----------FGLVTPGIKGSWKRPSL--RVPGTDSLAFGSC-----TPLPDFVKTLIG 334
Query: 395 TLLSIDPADRGSAASALRSEFFT 417
L+ D R A+ + F
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFL 357
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 84/290 (28%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDH 188
+ FE +G+G + NVY AR+ K I+ALK + LE + RE+ I L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N+++L G +YL+ EY + KF E + Y+ +L L +C
Sbjct: 69 PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS+ V+HRDIK NLL+ + G LKIADFG + + T TL Y PPE++ G
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 182
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
+ VDLWS G + E GKP T E +I ++ ++ P
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP---- 227
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
A L+ LL +P+ R L + T
Sbjct: 228 ---------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 101/366 (27%), Positives = 156/366 (42%), Gaps = 90/366 (24%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL- 186
+E L IG+G++ V +A D + VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 187 -----DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK------FSEAQVKC 235
+ +NVI + T R + + FE + +L L +K FS V+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYEL-----IKKNKFQGFSLPLVRK 204
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQNQPLTSRV 293
+ +L LD H ++H D+K N+L+ G +K+ DFG + + ++Q + + +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYI 260
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
+ +YR PE++LGA Y G +D+WS GCILAEL G P++PG E +QL + +L G PS
Sbjct: 261 QSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 354 EDYWRKSK-------------------LPHATIFKPQQPYKR------------------ 376
+ SK L ++ +R
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 377 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKE 436
C F DF ++ L DPA R + ALR + + LPK PP+ E
Sbjct: 380 CDDPLFLDF-------LKQCLEWDPAVRMTPGQALRHPWLRRR--------LPK-PPTGE 423
Query: 437 FDAKIR 442
+ R
Sbjct: 424 KTSVKR 429
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 43/297 (14%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++G+G++ V+R +D A+KKVR + E E+ L +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+ L G R + + E +E L L G E + Y+ Q L GL++ H+R
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR 169
Query: 251 GVLHRDIKGSNLLIDNNGIL-KIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLL 305
+LH D+K N+L+ ++G + DFG A PD + + PE+++
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
G VD+WS+ C++ + G P T+ + K+ P
Sbjct: 230 G-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP------------- 272
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
P + A ++ L +P R SA R ++ +
Sbjct: 273 ---PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVGKALQEVG 319
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-49
Identities = 79/297 (26%), Positives = 134/297 (45%), Gaps = 46/297 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++++ K+G G Y V RD A+K +R ++ S + E+ +L+ LDH
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCG 243
N++KL + + YLV E + G + KF+E ++Q+L G
Sbjct: 97 NIMKLYDFFEDKRN--YYLVMECYK----GGELFDEIIHRM--KFNEVDAAVIIKQVLSG 148
Query: 244 LDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ + H ++HRD+K NLL+++ + ++KI DFGL++ ++ + + R+ T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIA 206
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PE+L Y D+WS G IL L AG P G+T+ E L K+ K + W+
Sbjct: 207 PEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN- 263
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
V+E KD ++ +L D R SA AL +
Sbjct: 264 -----------------VSEGAKDL-------IKQMLQFDSQRRISAQQALEHPWIK 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-48
Identities = 64/298 (21%), Positives = 103/298 (34%), Gaps = 45/298 (15%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HI 189
SF D +G G + D + VA+K++ PE F RE+ +LR D H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
NVI+ R Y+ E L + +QQ GL H HS
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 250 RGVLHRDIKGSNLLIDNNG-----ILKIADFGLASFYDPDQN--QPLTSRVVTLWYRPPE 302
++HRD+K N+LI I+DFGL ++ + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 303 LLLGATY--YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
+L VD++S GC+ + + G + + + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
++ L+E ++++DP R SA L+ FF
Sbjct: 257 D-------------------VIARE-------LIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 85/308 (27%), Positives = 125/308 (40%), Gaps = 41/308 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV-RFMAREIHILRRLDH 188
D F+ +G+G + NVY AR+ K I+ALK + LE E V + REI I L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
N++++ R +YL+ E+ +L G +F E + +M++L L +C
Sbjct: 74 PNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYC 130
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H R V+HRDIK NLL+ G LKIADFG + + + TL Y PPE++ G
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRTMCGTLDYLPPEMIEGK 187
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
T + VDLW G + E G P + E +I + D K P
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFP---- 232
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 427
+ L+ LL P R + + P
Sbjct: 233 ---------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP-- 275
Query: 428 LPKYPPSK 435
P Y ++
Sbjct: 276 -PVYQSTQ 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 58/313 (18%), Positives = 108/313 (34%), Gaps = 62/313 (19%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
R F +L+KIG G + +V++ I A+K+ + + RE++ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 187 -DHINVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLL 241
H +V++ + + EY D F EA++K + Q+
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGIL-------------------KIADFGLASFYD 282
GL + HS ++H DIK SN+ I I KI D G +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 342
+ + E+L + D+++ + +P+ +Q
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQW 237
Query: 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 402
H+I R+ +LP + +++ F + L +M + DP
Sbjct: 238 HEI------------RQGRLP---------RIPQVLSQEFTEL----LKVM---IHPDPE 269
Query: 403 DRGSAASALRSEF 415
R SA + ++
Sbjct: 270 RRPSAMALVKHSV 282
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-48
Identities = 69/294 (23%), Positives = 134/294 (45%), Gaps = 50/294 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + + +G+G++ V + +D ++ A+K + + + + + RE+ +L++LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCG 243
N++KL ++ S Y+V E G + +FSE ++Q+ G
Sbjct: 82 NIMKLFEILEDSSS--FYIVGELYT----GGELFDEIIKRK--RFSEHDAARIIKQVFSG 133
Query: 244 LDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ + H ++HRD+K N+L+++ + +KI DFGL++ + + + R+ T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIA 191
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWR 358
PE+L G Y D+WS G IL L +G P G+ E + L ++ G + WR
Sbjct: 192 PEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWR 247
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+++ KD L+ +L+ P+ R +A L
Sbjct: 248 T------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-48
Identities = 80/327 (24%), Positives = 144/327 (44%), Gaps = 55/327 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDH 188
D ++ +G+G++ V +D + A+K + ++ + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLC 242
N++KL + YLV E G + S +FSE ++Q+L
Sbjct: 86 PNIMKLYEFFEDKGY--FYLVGEVYT----GGELFDEIISRK--RFSEVDAARIIRQVLS 137
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
G+ + H ++HRD+K NLL+++ + ++I DFGL++ ++ ++ + ++ T +Y
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYI 195
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYW 357
PE+L G Y D+WSTG IL L +G P G E + L K+ K G + W
Sbjct: 196 APEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQW 251
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+K V+E+ KD + +L+ P+ R SA AL E+
Sbjct: 252 KK------------------VSESAKDL-------IRKMLTYVPSMRISARDALDHEWIQ 286
Query: 418 MKPLPCDPSSLPKYPPS----KEFDAK 440
+P + ++F
Sbjct: 287 TYTKEQISVDVPSLDNAILNIRQFQGT 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-48
Identities = 70/298 (23%), Positives = 133/298 (44%), Gaps = 58/298 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + + +G+G++ V + +D ++ A+K + + + + + RE+ +L++LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQ 239
N++KL ++ S Y+V E G L +FSE ++Q
Sbjct: 82 NIMKLFEILEDSSS--FYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+ G+ + H ++HRD+K N+L+ + + +KI DFGL++ + + + R+ T
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTA 187
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--E 354
+Y PE+L G Y D+WS G IL L +G P G+ E + L ++ G +
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDL 243
Query: 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
WR +++ KD L+ +L+ P+ R +A L
Sbjct: 244 PQWRT------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 86/369 (23%), Positives = 144/369 (39%), Gaps = 67/369 (18%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-------- 186
+ K+G G +S V+ A+D+ VA+K VR D + E+ EI +L+R+
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 187 ---DHINVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLA-SHPGLKFSEAQVKCYMQQL 240
+++KL + +VFE + +L L + VK +QL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 241 LCGLDHCHSR-GVLHRDIKGSNLLID------NNGILKIADFGLASFYDPDQNQPLTSRV 293
L GLD+ H R G++H DIK N+L++ N +KIAD G A + ++ T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSI 196
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFK 347
T YR PE+LLGA + G D+WST C++ EL G + + + + +I +
Sbjct: 197 QTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 348 LCGSPSEDYWRKSKL--------------------PHATIFKPQQPYKRCVAETFKDFPA 387
L G R K P + + + + A+ DF
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF-- 313
Query: 388 PALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEAR 447
+ +L +DP R A + + + P +E D
Sbjct: 314 -----LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR-----VPDRELYGSGSDIPGW 363
Query: 448 RQGGSKGQR 456
+ +R
Sbjct: 364 FEEVRDHKR 372
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-47
Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 38/287 (13%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 195
+IG+G++ VY+ D + VA +++ L + E +L+ L H N+++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 196 G--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG- 251
T + + LV E M L ++ + +Q+L GL H+R
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 252 -VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
++HRD+K N+ I G +KI D GLA+ + + + T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE--MYEEK 205
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
Y +VD+++ G + E+ + P +E + +I++ S K
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV---------------K 247
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
P K + E K+ +E + + +R S L FF
Sbjct: 248 PASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 67/347 (19%), Positives = 124/347 (35%), Gaps = 80/347 (23%)
Query: 132 FEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL 186
+E +D +G+G + V D + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 187 ------DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSE 230
+++ +V + S Y +++ E+ F
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP--------FRL 117
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------------------LK 271
++ Q+ ++ HS + H D+K N+L + +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 272 IADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
+ DFG A++ ++ ++ V T YR PE++L + D+WS GCIL E Y G
Sbjct: 178 VVDFGSATY----DDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232
Query: 332 IMPGRTEVEQLHKIFKLCGSPSEDY----------------WRKSKLPHATIFKPQQPYK 375
+ P E L + ++ G + W + + + +P K
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 376 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
+ + L++ +L DPA R + AL+ FF +
Sbjct: 293 EFMLSQDVEHER-LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 76/357 (21%), Positives = 129/357 (36%), Gaps = 74/357 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV------RFDNLEPESVRFMAREIHIL 183
D + +G G V A + K VA+K + E + + EI IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLKFSEAQVKCY 236
++L+H +IK++ + Y+V E ME +L + EA K Y
Sbjct: 70 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 119
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRV 293
Q+L + + H G++HRD+K N+L+ + + ++KI DFG + + +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC 177
Query: 294 VTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
T Y PE+L+ Y AVD WS G I L+ I L G
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LF----IC--------------LSGY 216
Query: 352 P--SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDP 401
P SE + + + +F AL L++ LL +DP
Sbjct: 217 PPFSEHR------------TQVSLKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 402 ADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMD 458
R + ALR + + + L ++ + + + + +
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAE 320
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-46
Identities = 80/335 (23%), Positives = 140/335 (41%), Gaps = 61/335 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-----------FDNLEPESVRFMAR 178
+S+ K+ K+G G Y V ++ + A+K ++ + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 179 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQ 232
EI +L+ LDH N+IKL + + YLV E+ E G + + KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFYE----GGELFEQIINRH--KFDECD 147
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPL 289
M+Q+L G+ + H ++HRDIK N+L++N +KI DFGL+SF+ D L
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKL 205
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
R+ T +Y PE+L Y D+WS G I+ L G P G+ + + + K+ K
Sbjct: 206 RDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409
+ W+ +++ K+ ++ +L+ D R +A
Sbjct: 264 YYFDFNDWKN------------------ISDEAKEL-------IKLMLTYDYNKRCTAEE 298
Query: 410 ALRSEFFTMKPLPCDPSSLPKYPPS----KEFDAK 440
AL S + + S + ++F+
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGS 333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 61/300 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D+++ +++G+G +S V R A K + L + + RE I R+L H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQ 239
N+++L + YLVF+ + G L +SEA +QQ
Sbjct: 66 NIVRLHDSIQEES--FHYLVFDLVT----------GGELFEDIVAREFYSEADASHCIQQ 113
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+L + +CHS G++HR++K NLL+ +K+ADFGLA + ++ T
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTP 171
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPS- 353
Y PE+L Y VD+W+ G IL L G P P + +I G+
Sbjct: 172 GYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDY 226
Query: 354 -EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
W V K L++++L+++P R +A AL+
Sbjct: 227 PSPEWDT------------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 261
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 76/363 (20%), Positives = 134/363 (36%), Gaps = 81/363 (22%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAR----EIHIL 183
+ +E + +G+GT+ V D + K VALK +R +V EI++L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 184 RRL------DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLK 227
+++ + + + + + + + E++ E++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP-------- 119
Query: 228 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI------------------ 269
+ V+ QL L H + H D+K N+L N+
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 270 -LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
+++ADFG A+F ++ T+ V T YRPPE++L + D+WS GCIL E Y
Sbjct: 180 SIRVADFGSATF----DHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYR 234
Query: 329 GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH----------------ATIFKPQQ 372
G + E L + K+ G +++ + + +
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294
Query: 373 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 432
P K + + + LM +L DPA R + A AL FF P + S
Sbjct: 295 PLKSYMLQDSLEHVQ-LFDLMRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFHTSRN 352
Query: 433 PSK 435
PS+
Sbjct: 353 PSR 355
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 77/351 (21%), Positives = 136/351 (38%), Gaps = 82/351 (23%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILR 184
D +E IG+G++ V +A D +++ VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 185 RL------DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKF 228
+ ++ L+ LV +S +LY + + + G
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY---DLLRNTNFRG--------V 154
Query: 229 SEAQVKCYMQQLLCGLDHCHSR--GVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPD 284
S + + QQ+ L + ++H D+K N+L+ N +KI DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---- 210
Query: 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344
Q + + + +YR PE+LLG Y A+D+WS GCIL E++ G+P+ G EV+Q++K
Sbjct: 211 LGQRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
Query: 345 IFKLCGSPSEDYWRKS---------------------------------KLPHATIFKPQ 371
I ++ G P ++ KL + +
Sbjct: 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329
Query: 372 QPYKRCVAETFKDFPAPA--LALMETLLSIDPADRGSAASALRSEFFTMKP 420
P R E+ L+ +L DP R AL+ FF
Sbjct: 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-46
Identities = 50/347 (14%), Positives = 100/347 (28%), Gaps = 81/347 (23%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRR 185
R + + +GQ A D + + + F P +++ M E+ LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 186 L-------------------------DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 220
L +I++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 221 ------ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 274
S Q++ L H G++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 275 FGLASFYDPDQNQPLTSRVVTLWYRPPELL----------LGATYYGTAVDLWSTGCILA 324
F ++ V+ + PPEL T + D W+ G ++
Sbjct: 250 FEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 325 ELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD 384
++ + + IF+ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 385 FPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 431
P P AL+E L DR A+ + + ++LP Y
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 64/339 (18%), Positives = 121/339 (35%), Gaps = 80/339 (23%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRL 186
+ IGQG+Y V A + + I A+K K + + P+ V + E+ ++++L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYME-------------------------------- 214
H N+ +L + + LV E
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 215 --------HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI-- 264
+ G E + M+Q+ L + H++G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 265 DNNGILKIADFGLASFY---DPDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTG 320
+ + +K+ DFGL+ + + + +T++ T ++ PE+L YG D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 321 CILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLPHATIFKPQQPYKRCV 378
+L L G PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------L 303
Query: 379 AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+ +D L+ LL+ + +R A AL+ + +
Sbjct: 304 SPLARD-------LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 82/300 (27%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D +G+GTY VY RDL + +A+K++ + + + EI + + L H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHK 79
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPG-LKFSEAQVKCYMQQLLCGL 244
N+++ G + + + + E + L L S G LK +E + Y +Q+L GL
Sbjct: 80 NIVQYLG--SFSENGFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 245 DHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
+ H ++HRDIKG N+LI+ +G+LKI+DFG + N + TL Y PE+
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEI 194
Query: 304 LLGATY-YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+ YG A D+WS GC + E+ GKP P + +
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKP--P----------------------FYELGE 230
Query: 363 PHATIFK-------PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
P A +FK P+ P ++ K F +++ DP R A L EF
Sbjct: 231 PQAAMFKVGMFKVHPEIP--ESMSAEAKAF------ILKC-FEPDPDKRACANDLLVDEF 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-45
Identities = 74/369 (20%), Positives = 123/369 (33%), Gaps = 70/369 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-H 188
+ +G G+ V + VA+K+ + + EI +L D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKR-----MLIDFCDIALMEIKLLTESDDH 68
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLA------GLASHPGLKFSEAQVKCYMQQLLC 242
NVI+ T+ LY+ E +L ++ E ++Q+
Sbjct: 69 PNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDN-------------NGILKIADFGLASFYDPDQ---N 286
G+ H HS ++HRD+K N+L+ N + I+DFGL D Q
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 287 QPLTSRVVTLWYRPPELLLGAT------YYGTAVDLWSTGCILAELY-AGKPIMPGRTEV 339
L + T +R PELL + ++D++S GC+ + GK P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244
Query: 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI 399
+ I + G S D + + + R + D L+ ++
Sbjct: 245 SRESNIIR--GIFSLD-------------EMKCLHDRSLIAEATD-------LISQMIDH 282
Query: 400 DPADRGSAASALRSEFFTMK----PLPCDPSSL----PKYPPSKEFDAKIRDEEARRQGG 451
DP R +A LR F K S + PPS + G
Sbjct: 283 DPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
Query: 452 SKGQRMDLE 460
+ D
Sbjct: 343 DWTVKFDKT 351
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 58/309 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVR----FMAREIHI 182
+++E + +G+G S V R K A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 183 LRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKC 235
LR++ H N+I+L+ + +LVF+ M+ L SE + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTF--FFLVFDLMK----KGELFDYLTEKV--TLSEKETRK 128
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 295
M+ LL + H ++HRD+K N+L+D++ +K+ DFG + DP + L T
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGT 186
Query: 296 LWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 350
Y PE++ + YG VD+WSTG I+ L AG P R ++ L I + G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSG 244
Query: 351 SPS--EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 408
+ W ++T KD L+ L + P R +A
Sbjct: 245 NYQFGSPEWDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAE 279
Query: 409 SALRSEFFT 417
AL FF
Sbjct: 280 EALAHPFFQ 288
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 75/326 (23%), Positives = 132/326 (40%), Gaps = 56/326 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D+++ +++G+G +S V R A K + L + + RE I R+L H
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCG 243
N+++L + YLVF+ + G + + +SEA +QQ+L
Sbjct: 89 NIVRLHDSIQEES--FHYLVFDLVT----GGELFEDIVARE--FYSEADASHCIQQILES 140
Query: 244 LDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ +CHS G++HR++K NLL+ +K+ADFGLA + ++ T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLS 198
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWR 358
PE+L Y VD+W+ G IL L G P + +I G+ W
Sbjct: 199 PEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWD 255
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
V K L++++L+++P R +A AL+ +
Sbjct: 256 T------------------VTPEAKS-------LIDSMLTVNPKKRITADQALKVPWICN 290
Query: 419 K----PLPCDPSSLPKYPPSKEFDAK 440
+ ++ K+F+A+
Sbjct: 291 RERVASAIHRQDTVDC---LKKFNAR 313
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 79/373 (21%), Positives = 131/373 (35%), Gaps = 55/373 (14%)
Query: 129 ADSFEKLDKIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
+E L IG+G V AR + V ++++ + E V F+ E+H+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
+H N++ + L++V +M DL + +H +E + +Q +L
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLK 139
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG-LASFYDPDQNQ-----PLTSRVVTL 296
LD+ H G +HR +K S++LI +G + ++ S Q Q V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 297 WYRPPELLL-GATYYGTAVDLWSTGCILAELYAGKP------------------------ 331
+ PE+L Y D++S G EL G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 332 IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALA 391
E + + S D S + P PY R + F F
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF------ 313
Query: 392 LMETLLSIDPADRGSAASALRSEFFTM-KPLPCD--PSSLPKYPPSKEFDAKIRDEEARR 448
+E L +P R SA++ L FF K + P L P F+ +++
Sbjct: 314 -VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGS----QSQD 368
Query: 449 QGGSKGQRMDLER 461
G G +LE
Sbjct: 369 HSGIFGLVTNLEE 381
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALK--------KVRFDNLEPESVRFMA---------- 177
D+IG+G+Y V A + + A+K + P
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 178 ------REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSE 230
+EI IL++LDH NV+KL ++ LY+VFE + + + + SE
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSE 136
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290
Q + Y Q L+ G+++ H + ++HRDIK SNLL+ +G +KIADFG+++ + + L+
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS 195
Query: 291 SRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFK 347
+ V T + PE L + G A+D+W+ G L G+ P M + KI
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCLHSKIKS 254
Query: 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 407
+ + P KD L+ +L +P R
Sbjct: 255 ------QAL----EFPDQPDIAED----------LKD-------LITRMLDKNPESRIVV 287
Query: 408 ASALRSEFFT 417
+ T
Sbjct: 288 PEIKLHPWVT 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-45
Identities = 75/327 (22%), Positives = 122/327 (37%), Gaps = 74/327 (22%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKV------RFDNLEPESVRFMAREIHIL 183
D + +G G V A + K VA++ + E + + EI IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 184 RRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLKFSEAQVKCY 236
++L+H +IK++ + Y+V E ME +L + EA K Y
Sbjct: 195 KKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLY 244
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRV 293
Q+L + + H G++HRD+K N+L+ + + ++KI DFG + + +
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC 302
Query: 294 VTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
T Y PE+L+ Y AVD WS G I L+ I L G
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LF----IC--------------LSGY 341
Query: 352 P--SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDP 401
P SE + + + +F AL L++ LL +DP
Sbjct: 342 PPFSEHR------------TQVSLKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 402 ADRGSAASALRSEFFTMKPLPCDPSSL 428
R + ALR + + + L
Sbjct: 389 KARFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 73/346 (21%), Positives = 135/346 (39%), Gaps = 84/346 (24%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL- 186
F + K+G GT+ V + +D KK A+K VR +++ R E IL+++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 187 ----DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQ 232
++ N++K G L+ + SLY E + ++ G F
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FHIED 138
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI----------------------- 269
+K Y ++L L++ + H D+K N+L+D+
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 270 --LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327
+K+ DFG A+F ++ S + T YR PE++L + + D+WS GC+LAELY
Sbjct: 199 TGIKLIDFGCATF----KSDYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELY 253
Query: 328 AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF--KPQQPYKRCVAETFKDF 385
G + +E L + + ++ ++ + + + K + + +
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 386 PAPA---------------LALMETLLSIDPADRGSAASALRSEFF 416
+ ++L IDP R S A L+ +F
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 42/313 (13%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+G+G+Y V D + A+K K + + + +EI +LRRL H NVI+L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQL 71
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
++ + +Y+V EY + + P +F Q Y QL+ GL++ HS+G++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 254 HRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGA-TYYG 311
H+DIK NLL+ G LKI+ G+A P + + + ++PPE+ G T+ G
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 312 TAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
VD+WS G L + G P G + I K Y +P
Sbjct: 192 FKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----AIP------ 233
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 429
D P L++ +L +PA R S + +F K P +
Sbjct: 234 -------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP--AEAPV 278
Query: 430 KYPPSKEFDAKIR 442
PPS + + R
Sbjct: 279 PIPPSPDTKDRWR 291
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 54/289 (18%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKL 194
+ IG+G++ V A + A KK+ +E + + +EI I++ LDH N+I+L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRL 71
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+YLV E G + F E+ M+ +L + +CH
Sbjct: 72 YETFEDNTD--IYLVMELCT----GGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH 123
Query: 249 SRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
V HRD+K N L + LK+ DFGLA+ + P + + ++V T +Y P++L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLE 181
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLP 363
G YG D WS G ++ L G P T+ E + KI G+ + E W
Sbjct: 182 GL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN---- 233
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+ + L+ LL+ P R ++ AL
Sbjct: 234 --------------VSPQAES-------LIRRLLTKSPKQRITSLQALE 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 70/218 (32%), Positives = 117/218 (53%), Gaps = 11/218 (5%)
Query: 134 KLDK-IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
+L K IG+G ++ V AR + + VA+K + L P S++ + RE+ I++ L+H N++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 193 KL-EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
KL E + T + LYL+ EY ++ L +H +K EA + +Q++ + +CH
Sbjct: 78 KLFEVIETEKT---LYLIMEYASGGEVFDYLVAHGRMKEKEA--RSKFRQIVSAVQYCHQ 132
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+ ++HRD+K NLL+D + +KIADFG ++ + L + Y PEL G Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
G VD+WS G IL L +G G+ E ++ +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-45
Identities = 61/311 (19%), Positives = 116/311 (37%), Gaps = 50/311 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + + +G+G + V+R + KK K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCG 243
N++ L S L ++FE++ G + + + +E ++ Y+ Q+
Sbjct: 62 NILHLHESFESMEE--LVMIFEFIS----GLDIFERINTS-AFELNEREIVSYVHQVCEA 114
Query: 244 LDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
L HS + H DI+ N++ + +KI +FG A P Y P
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAP 172
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRK 359
E+ TA D+WS G ++ L +G P T + + I + E+ +++
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
++ DF ++ LL + R +A+ AL+ + K
Sbjct: 230 ------------------ISIEAMDF-------VDRLLVKERKSRMTASEALQHPWLKQK 264
Query: 420 PLPCDPSSLPK 430
+
Sbjct: 265 IERVSTKVIRT 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-45
Identities = 82/329 (24%), Positives = 134/329 (40%), Gaps = 61/329 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++ +++G+G +S V R + + A + L + + RE I R L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQ 239
N+++L ++ YL+F+ + G L +SEA +QQ
Sbjct: 71 NIVRLHDSISEEG--HHYLIFDLVT----------GGELFEDIVAREYYSEADASHCIQQ 118
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+L + HCH GV+HR++K NLL+ +K+ADFGLA + +Q Q T
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTP 177
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPS- 353
Y PE+L YG VDLW+ G IL L G P P + +I G+
Sbjct: 178 GYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDF 232
Query: 354 -EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
W V KD L+ +L+I+P+ R +AA AL+
Sbjct: 233 PSPEWDT------------------VTPEAKD-------LINKMLTINPSKRITAAEALK 267
Query: 413 SEFFTMKPLPCDPSSLPKYPPS-KEFDAK 440
+ + + + K+F+A+
Sbjct: 268 HPWISHRSTVASCMHRQETVDCLKKFNAR 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+G+G Y V A + ++ VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 195 -EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+ YL EY G + G+ +AQ + QL+ G+ + H
Sbjct: 71 YGHRREGNI---QYLFLEYCSG---GELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLH 122
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGA 307
G+ HRDIK NLL+D LKI+DFGLA+ + ++ + L TL Y PELL
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
++ VD+WS G +L + AG+ +P + ++Y +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKT 226
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
+ +K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 227 YLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLK 270
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 44/292 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D F K+G G + +V+ + +K + D + + + EI +L+ LDH
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHP 80
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
N+IK+ + + +Y+V E E + + SE V M+Q++ L
Sbjct: 81 NIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNAL 137
Query: 245 DHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
+ HS+ V+H+D+K N+L + + +KI DFGLA + D + T+ T Y P
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAP 195
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYWRKS 360
E+ D+WS G ++ L G G + E K P+ R
Sbjct: 196 EVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP- 250
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+ D ++ +L+ DP R SAA L
Sbjct: 251 -----------------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 83/334 (24%), Positives = 139/334 (41%), Gaps = 56/334 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRL 186
D +E + IG+G +S V R + + + A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLL 241
H ++++L +S LY+VFE+M+ ++ A G +SEA YM+Q+L
Sbjct: 84 KHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQIL 140
Query: 242 CGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
L +CH ++HRD+K +L+ +N+ +K+ FG+A RV T +
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHF 199
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--E 354
PE++ YG VD+W G IL L +G G E ++F+ + G
Sbjct: 200 MAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNP 253
Query: 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414
W ++E+ KD L+ +L +DPA+R + AL
Sbjct: 254 RQWSH------------------ISESAKD-------LVRRMLMLDPAERITVYEALNHP 288
Query: 415 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARR 448
+ + E ++R ARR
Sbjct: 289 WL------KERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 77/318 (24%), Positives = 130/318 (40%), Gaps = 49/318 (15%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 194
+G+G Y V A + ++ VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 195 -EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+ YL EY G + G+ +AQ + QL+ G+ + H
Sbjct: 71 YGHRREGNI---QYLFLEYCSG---GELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLH 122
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGA 307
G+ HRDIK NLL+D LKI+DFGLA+ + ++ + L TL Y PELL
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
++ VD+WS G +L + AG+ +P + ++Y +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKT 226
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 427
+ +K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 227 YLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLKKGAKR 275
Query: 428 LPKYPPSKEFDAKIRDEE 445
+
Sbjct: 276 PRVTSGGVSESPSGFSKH 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 74/354 (20%), Positives = 129/354 (36%), Gaps = 76/354 (21%)
Query: 123 GWVPRRADSFEKL----DKIGQGTYSNVYRARDLDQKKIVALK-------KVRFDNLEPE 171
G P + E +++G G ++ V + R+ A K + + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 172 SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG------ 225
+ RE+ ILR++ H NVI L + +R + L+ E + G
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRTD--VVLILELVS----------GGELFDF 105
Query: 226 ----LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGL 277
SE + +++Q+L G+++ H++ + H D+K N+++ +K+ DFGL
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--G 335
A + + T + PE++ G D+WS G I L +G P G
Sbjct: 166 AHEIED--GVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLG 220
Query: 336 RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMET 395
T+ E L I + E+++ +E KDF +
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSH------------------TSELAKDF-------IRK 255
Query: 396 LLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
LL + R + ALR + T D S R + RR+
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPV----DNQQAMVRRESVVNLENFRKQYVRRR 305
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 72/363 (19%), Positives = 134/363 (36%), Gaps = 61/363 (16%)
Query: 114 AAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALK-----KVRFDNL 168
AV E + + + + +G G + V+ A D ++ K V +K KV D
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 169 -EPESVRFMAREIHILRRLDHINVIKL-EGLVTSRMSCSLYLVFEYMEHDLAG------L 220
E + + EI IL R++H N+IK+ + LV ME +G +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLV---MEKHGSGLDLFAFI 121
Query: 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280
HP L A +QL+ + + + ++HRDIK N++I + +K+ DFG A++
Sbjct: 122 DRHPRLDEPLA--SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 340
+ + + T+ Y PE+L+G Y G +++WS G L L
Sbjct: 180 LERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL-------------- 223
Query: 341 QLHKIFKLCGS-PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI 399
+ P + + A I P ++L+ LL
Sbjct: 224 -------VFEENPFCEL---EETVEAAIHPP------------YLVSKELMSLVSGLLQP 261
Query: 400 DPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDL 459
P R + + + T +P+ + + + ++ + + G +
Sbjct: 262 VPERRTTLEKLVTDPWVT-QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQ 320
Query: 460 ERR 462
+
Sbjct: 321 AQE 323
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 66/260 (25%), Positives = 104/260 (40%), Gaps = 25/260 (9%)
Query: 82 MEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKIGQG 141
M HH G +P+ S LA + ++ +G G
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKE------PLESQYQVGPLLGSG 54
Query: 142 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDHI--NVIKL- 194
+ +VY + VA+K V D + E+ +L+++ VI+L
Sbjct: 55 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 195 EGLVTSRMSCSLYLVFEYMEH--DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+ L+ E E DL + L+ A + + Q+L + HCH+ G
Sbjct: 115 DWFERPDS---FVLILERPEPVQDLFDFITERGALQEELA--RSFFWQVLEAVRHCHNCG 169
Query: 252 VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
VLHRDIK N+LID N G LK+ DFG + ++ T T Y PPE + Y+
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 311 GTAVDLWSTGCILAELYAGK 330
G + +WS G +L ++ G
Sbjct: 227 GRSAAVWSLGILLYDMVCGD 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 4e-43
Identities = 77/327 (23%), Positives = 125/327 (38%), Gaps = 62/327 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
+F ++ +G G +S V+ + K+ ALK ++ S+ EI +L+++ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQ 238
N++ LE + S YLV + + G L ++E +Q
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVS----------GGELFDRILERGVYTEKDASLVIQ 113
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVT 295
Q+L + + H G++HRD+K NLL + N + I DFGL+ +++ T
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGT 170
Query: 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-- 353
Y PE+L Y AVD WS G I L G P TE + KI + G
Sbjct: 171 PGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFE 227
Query: 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413
+W ++E+ KDF + LL DP +R + AL
Sbjct: 228 SPFWDD------------------ISESAKDF-------ICHLLEKDPNERYTCEKALSH 262
Query: 414 EFFTMKPLPCDPSSLPKYPPSKEFDAK 440
+ ++ AK
Sbjct: 263 PWIDGNTALHRDIYPSVSLQIQKNFAK 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 74/317 (23%), Positives = 133/317 (41%), Gaps = 40/317 (12%)
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHI 189
+ K + +G G + V++ + +A K ++ ++ E V+ EI ++ +LDH
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHA 146
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+I+L S+ + LV EY++ +L +E +M+Q+ G+ H H
Sbjct: 147 NLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 249 SRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
+LH D+K N+L N +KI DFGLA Y P + L T + PE++
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVVNY 262
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
+ D+WS G I L +G G + E L+ I ++ ++
Sbjct: 263 -DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD------- 314
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
++E K+F + LL + + R SA+ AL+ + + L S
Sbjct: 315 -----------ISEEAKEF-------ISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356
Query: 427 SLPK---YPPSKEFDAK 440
+ K +++F K
Sbjct: 357 AQKKKNRGSDAQDFVTK 373
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-43
Identities = 68/287 (23%), Positives = 120/287 (41%), Gaps = 37/287 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDH 188
D ++ L+++G G + V+R + ++ K + +V+ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+I L + + L+ E++ +L + K SEA+V YM+Q GL H
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 248 HSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
H ++H DIK N++ + +KI DFGLA+ +PD + + T + PE++
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
G D+W+ G + L +G G ++E L + + ED +
Sbjct: 224 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS------ 276
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+ KDF ++ LL +P R + AL
Sbjct: 277 ------------VSPEAKDF-------IKNLLQKEPRKRLTVHDALE 304
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 77/330 (23%), Positives = 121/330 (36%), Gaps = 62/330 (18%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALK-----KVRFDNLEPESVRFMAREI 180
+ +G+G + V+ L + VA+K +V + +SV E+
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEV 85
Query: 181 HILRRLD----HINVIKL-EGLVTSRMSCSLYLVFEYMEH--DL-AGLASHPGLKFSEAQ 232
+L ++ H VI+L + T LV E DL + E
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKG--PLGEGP 140
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTS 291
+C+ Q++ + HCHSRGV+HRDIK N+LID G K+ DFG + ++P T
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD 197
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
T Y PPE + Y+ +WS G + LY M +CG
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGIL---LYD----M--------------VCGD 236
Query: 352 -PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410
P E ++ A + P AL+ L+ P+ R S
Sbjct: 237 IPFERD---QEILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEI 281
Query: 411 LRSEFFTM--KPLPCDPSSLPKYPPSKEFD 438
L + + +P +PS P +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 85/314 (27%), Positives = 126/314 (40%), Gaps = 69/314 (21%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALK-----KVRFDNLEPESVRFM-AREIHIL 183
++ D IG+G S V R A+K R + E VR RE HIL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 184 RRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQ 232
R++ H ++I L S ++LVF+ M L SE +
Sbjct: 154 RQVAGHPHIITLIDSYESSSF--MFLVFDLMR----------KGELFDYLTEKVALSEKE 201
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292
+ M+ LL + H+ ++HRD+K N+L+D+N ++++DFG + +P + L
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLREL 259
Query: 293 VVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKI 345
T Y PE+L + YG VDLW+ G IL L AG P P R ++ L I
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI 317
Query: 346 FKLCGSPS--EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD 403
+ G W + T KD L+ LL +DP
Sbjct: 318 --MEGQYQFSSPEWDD------------------RSSTVKD-------LISRLLQVDPEA 350
Query: 404 RGSAASALRSEFFT 417
R +A AL+ FF
Sbjct: 351 RLTAEQALQHPFFE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 62/303 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRR 185
D +E +++G G ++ V + R K A K ++ L S + RE++ILR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKC 235
+ H N+I L + ++ + L+ E + G L +E +
Sbjct: 65 IRHPNIITLHDIFENKTD--VVLILELVS----------GGELFDFLAEKESLTEDEATQ 112
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLASFYDPDQNQPLTS 291
+++Q+L G+ + HS+ + H D+K N+++ + N +K+ DFG+A + +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKN 170
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLC 349
T + PE++ G D+WS G I L +G P G T+ E L I +
Sbjct: 171 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVN 227
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409
E+Y+ +E KDF + LL DP R + A
Sbjct: 228 YDFDEEYFSN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQ 262
Query: 410 ALR 412
+L
Sbjct: 263 SLE 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 70/354 (19%), Positives = 130/354 (36%), Gaps = 62/354 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRR 185
D ++ +++G G ++ V + R+ A K ++ S + RE+ IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYM----------EHDLAGLASHPGLKFSEAQVKC 235
+ H NVI L + ++ + L+ E + E + +E +
Sbjct: 71 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKE----------SLTEEEATE 118
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTS 291
+++Q+L G+ + HS + H D+K N+++ +KI DFGLA D +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKN 176
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
T + PE++ G D+WS G I L +G G T+ E L + +
Sbjct: 177 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411
++Y+ + KDF + LL DP R + +L
Sbjct: 236 FEDEYFSN------------------TSALAKDF-------IRRLLVKDPKKRMTIQDSL 270
Query: 412 RSEFFTMKPLPCDPSSLPKYPPS---KEFDAKIRDEEARRQGGSK-GQRMDLER 461
+ + K S K+F A+ + G + + +E
Sbjct: 271 QHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIEW 324
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 61/286 (21%), Positives = 106/286 (37%), Gaps = 44/286 (15%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI-NVIKLE 195
++G+G ++ V + + A K ++ + + EI +L VI L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 196 GLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+ + + L+ EY L SE V ++Q+L G+ + H
Sbjct: 96 EVYENTSE--IILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 252 VLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
++H D+K N+L+ + G +KI DFG++ L + T Y PE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPEILNY-D 208
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
TA D+W+ G I L P G E I ++ SE+ +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS------- 259
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V++ DF +++LL +P R +A L
Sbjct: 260 -----------VSQLATDF-------IQSLLVKNPEKRPTAEICLS 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-42
Identities = 83/339 (24%), Positives = 122/339 (35%), Gaps = 86/339 (25%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLD-HINV 191
+G+G++S + + A+K K N + +EI L+ + H N+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAG-------LASHPGLKFSEAQVKCYMQQLLCGL 244
+KL + ++ +LV E + G FSE + M++L+ +
Sbjct: 69 VKLHEVFHDQLH--TFLVMELLN----GGELFERIKKKK---HFSETEASYIMRKLVSAV 119
Query: 245 DHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
H H GV+HRD+K NLL ++N +KI DFG A PD NQPL + TL Y P
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAP 178
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
E LL Y + DLWS G I LY M L G
Sbjct: 179 E-LLNQNGYDESCDLWSLGVI---LY----TM--------------LSGQV--------- 207
Query: 362 LPHATIF--KPQQPYKRCVAETFK-------DFPAP--------ALALMETLLSIDPADR 404
P F + E K F A L++ LL++DP R
Sbjct: 208 -P----FQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKR 262
Query: 405 GSAASALRSEFFTMK-PLPCDPSSLPKYPPSKEFDAKIR 442
+ +E+ L +P P S
Sbjct: 263 LKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 138 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKL-E 195
+G GT+ V VA+K + + V + REI L+ H ++IKL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 196 GLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 250
+ T ++V EY+ G + H + E + + QQ+L +D+CH
Sbjct: 79 VISTPTD---FFMVMEYVSG---GELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH 130
Query: 251 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 310
V+HRD+K N+L+D + KIADFGL++ + L + + Y PE++ G Y
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYA 188
Query: 311 GTAVDLWSTGCILAELYAGK 330
G VD+WS G IL L G
Sbjct: 189 GPEVDIWSCGVILYALLCGT 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+ +D ++ + IG G + RD K++VA+K + E+V+ REI R
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHR 71
Query: 185 RLDHINVIKL-EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLC 242
L H N+++ E ++T L ++ EY +L + G +FSE + + + QQLL
Sbjct: 72 SLRHPNIVRFKEVILTPTH---LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLS 127
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
G+ +CHS + HRD+K N L+D + LKI DFG + S V T Y
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIA 185
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAG 329
PE+LL Y G D+WS G L + G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 84/424 (19%), Positives = 154/424 (36%), Gaps = 64/424 (15%)
Query: 134 KLDK-IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINV 191
L +G GT+ V + VA+K + + V + REI L+ H ++
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 192 IKL-EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLD 245
IKL + + T +++V EY+ G + + L E++ QQ+L G+D
Sbjct: 79 IKLYQVISTPSD---IFMVMEYVSG---GELFDYICKNGRLDEKESRR--LFQQILSGVD 130
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+CH V+HRD+K N+L+D + KIADFGL++ + L + + Y PE++
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVIS 188
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
G Y G VD+WS+G IL L G +P KI + P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF----YTP 236
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
+ ++L++ +L +DP R + E+F
Sbjct: 237 -------------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK- 276
Query: 424 DPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELV--- 480
+P + + + D+EA ++ ++ + + V
Sbjct: 277 -----YLFPEDPSYSSTMIDDEALKE---VCEKFECSEEEVLSCLYNRNHQ-DPLAVAYH 327
Query: 481 LSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGP 540
L + R+ +K +P + P + + P+ + +
Sbjct: 328 LIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQK 387
Query: 541 LAQR 544
+
Sbjct: 388 SKHQ 391
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 71/308 (23%), Positives = 127/308 (41%), Gaps = 42/308 (13%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
D +E + IG G + V A +K+ VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 186 LDHINVIKLEG--LVTSRMSCSLYLVFEYME----HDL----AGLASHPGLKFSEAQVKC 235
H N++ +V L+LV + + D+ H E+ +
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG----LASFYDPDQNQPLTS 291
++++L GL++ H G +HRD+K N+L+ +G ++IADFG LA+ D +N+ +
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
V T + PE++ Y D+WS G EL G P HK
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-------YHKY-----P 231
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVA--ETFKDFPAPALALMETLLSIDPADRGSAAS 409
P + + ++ Q + ++F+ + L DP R +AA
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLC-------LQKDPEKRPTAAE 284
Query: 410 ALRSEFFT 417
LR +FF
Sbjct: 285 LLRHKFFQ 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 70/343 (20%), Positives = 129/343 (37%), Gaps = 72/343 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALK-------KVRFDNLEPESVRFMAREIHI 182
D ++ +++G G ++ V + R+ A K + + E + RE+ I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSI 68
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG----------LKFSEAQ 232
LR++ H N+I L + +R + L+ E + G SE +
Sbjct: 69 LRQVLHPNIITLHDVYENRTD--VVLILELVS----------GGELFDFLAQKESLSEEE 116
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQP 288
+++Q+L G+++ H++ + H D+K N+++ +K+ DFGLA +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVE 174
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIF 346
+ T + PE++ G D+WS G I L +G P G T+ E L I
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANIT 231
Query: 347 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406
+ E+++ + +E KDF + LL + R +
Sbjct: 232 AVSYDFDEEFFSQ------------------TSELAKDF-------IRKLLVKETRKRLT 266
Query: 407 AASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
ALR + T D S + + RR+
Sbjct: 267 IQEALRHPWITPV----DTQQAMVRRESVVNLENFKKQYVRRR 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 77/320 (24%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 194
D +G+G ++ V +L + A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 195 EGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLK--FSEAQVKCYMQQLLCGLDHCHSR 250
YLVFE M G + SH + F+E + +Q + LD H++
Sbjct: 77 IEFFEEEDR--FYLVFEKMR----GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 251 GVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQ------NQPLTSRVVTLWYRPP 301
G+ HRD+K N+L + +KI DF L S + L + + Y P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 302 ELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP---SE 354
E++ A+ Y DLWS G I LY I+ L G P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVI---LY----IL--------------LSGYPPFVGR 229
Query: 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDPADRGS 406
Q + E +FP A L+ LL D R S
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
Query: 407 AASALRSEFFTM----KPLP 422
AA L+ + LP
Sbjct: 290 AAQVLQHPWVQGCAPENTLP 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 81/373 (21%), Positives = 142/373 (38%), Gaps = 59/373 (15%)
Query: 134 KLDK-IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLE-PESVRFMAREIHILRRLDH 188
+ + +G+G++ V A ++ VALK + + V REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 189 INVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++IKL + + T + +V EY +L + +E + + + QQ++C +++C
Sbjct: 69 PHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC 124
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
H ++HRD+K NLL+D+N +KIADFGL++ L + + Y PE++ G
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGK 182
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y G VD+WS G +L + G+ K+ Y +P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY----VMP---- 228
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 427
A +L+ ++ DP R + R +F + +
Sbjct: 229 ---------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--------N 265
Query: 428 LPKY-PPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANA---ELVLSM 483
LP Y P +E D + G+ M E+ + L+
Sbjct: 266 LPDYLRPMEEVQGSYADSRIVSK---LGEAMGFSEDYIVEALRSDENNEVKEAYNLLHEN 322
Query: 484 QKRQSQYNSKSRS 496
Q Q +
Sbjct: 323 QVIQEKLEHHHHH 335
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-41
Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 43/290 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D ++ +++G G + V+R + A K V + + +EI + L H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 214
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
++ L + +++E+M +A + SE + YM+Q+ GL
Sbjct: 215 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGL 268
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
H H +H D+K N++ LK+ DFGL + DP Q + T + PE
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPE 326
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+ G G D+WS G + L +G G + E L + + + +
Sbjct: 327 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG--- 382
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
++E KDF + LL DP R + AL
Sbjct: 383 ---------------ISEDGKDF-------IRKLLLADPNTRMTIHQALE 410
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 75/311 (24%), Positives = 113/311 (36%), Gaps = 73/311 (23%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DH 188
D +E + IG G+YS R A+K + +P EI IL R H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQH 75
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQ 238
N+I L+ + +Y+V E M+ G L FSE + +
Sbjct: 76 PNIITLKDVYDDGKY--VYVVTELMK----------GGELLDKILRQKFFSEREASAVLF 123
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+ +++ H++GV+HRD+K SN+L N ++I DFG A + N L +
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCY 182
Query: 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354
T + PE+L Y A D+WS G + LY M L G
Sbjct: 183 TANFVAPEVLER-QGYDAACDIWSLGVL---LY----TM--------------LTGYTP- 219
Query: 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDPADRGS 406
+ I R + F A L+ +L +DP R +
Sbjct: 220 -FANGPDDTPEEIL------ARIGSGKF-SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 407 AASALRSEFFT 417
AA LR +
Sbjct: 272 AALVLRHPWIV 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-40
Identities = 55/405 (13%), Positives = 108/405 (26%), Gaps = 76/405 (18%)
Query: 87 AQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNV 146
A + A++ + W + R + + +GQ
Sbjct: 39 ANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE----RPRTLVRGTVLGQEDPYAY 94
Query: 147 YRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRL------------------- 186
A D + + + F P + ++ M E+ LR L
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 187 ------DHINVIKLEGLVTSRMSCSLYLVFEYMEHDL----AGLASHPGLK--FSEAQVK 234
+I++ S + ++ M+ +L L SH
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
Q++ L H G++H ++ ++++D G + + F P+
Sbjct: 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 295 TLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 350
+L T A D W+ G + ++ + IF+ C
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC- 333
Query: 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410
K+ P P AL+E L DR A
Sbjct: 334 --------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQA 361
Query: 411 LRSEFFTM---KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS 452
+ + + + P P++E A + G+
Sbjct: 362 METPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGA 406
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 26/224 (11%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 190
+ +G ++ VY A+D+ + ALK++ + E R + +E+ +++L H N
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPN 87
Query: 191 VIKLEG---LVTSRMSCSLYLVFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLC 242
+++ + E L S V Q
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 243 GLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--------- 291
+ H H + ++HRD+K NLL+ N G +K+ DFG A+ + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 292 --RVVTLWYRPPEL--LLGATYYGTAVDLWSTGCILAELYAGKP 331
R T YR PE+ L G D+W+ GCIL L +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 59/293 (20%), Positives = 99/293 (33%), Gaps = 56/293 (19%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 194
+G G V + ALK + + R +E+ + +++ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 195 EGLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ L ++ E ME G + F+E + M+ + +
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 247 CHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
HS + HRD+K NLL + + +LK+ DFG A L + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPE- 199
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRK 359
+LG Y + D+WS G I+ L G P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+E K L+ LL DP +R + +
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 85/347 (24%), Positives = 133/347 (38%), Gaps = 71/347 (20%)
Query: 87 AQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKL----DKIGQGT 142
+ G ++ S A+ P + V I G D+ ++G+G
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG---SNRDALSDFFEVESELGRGA 65
Query: 143 YSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202
S VYR + +K ALK ++ + + VR EI +L RL H N+IKL+ + +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---TEIGVLLRLSHPNIIKLKEIFETPT 121
Query: 203 SCSLYLVFEYMEHDLAGLASHPGL----------KFSEAQVKCYMQQLLCGLDHCHSRGV 252
+ LV E + G +SE ++Q+L + + H G+
Sbjct: 122 E--ISLVLELVT----------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 253 LHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+HRD+K NLL + LKIADFGL+ + + + T Y PE+L G
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRG-CA 226
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRKSKLPHA 365
YG VD+WS G I L G P E +F+ L +W +
Sbjct: 227 YGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWWDE------ 277
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+ KD + L+ +DP R + AL+
Sbjct: 278 ------------VSLNAKDL-------VRKLIVLDPKKRLTTFQALQ 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 78/327 (23%), Positives = 140/327 (42%), Gaps = 45/327 (13%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLD 187
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 188 HINVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
H N I+ G L +LV EY + L E ++ L GL
Sbjct: 113 HPNTIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K N+L+ G++K+ DFG AS P S V T ++ PE++L
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANSFVGTPYWMAPEVIL 223
Query: 306 GAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
Y VD+WS G EL KP P + + ++ + +++ P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKP--P-LFNMNAMSALYHI---------AQNESP 271
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
+ +E F++F +++ L P DR ++ L+ F
Sbjct: 272 A---LQSGH-----WSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ER 313
Query: 424 DPSSL-PKYPPSKEFDAKIRDEEARRQ 449
P+ + +K+ ++ + + R+
Sbjct: 314 PPTVIMDLIQRTKDAVRELDNLQYRKM 340
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 54/304 (17%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+ F KL+KIG+G++ V++ D +K+VA+K + + E E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 189 INVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCG 243
V K G L ++ L+++ EY+ G A PG E Q+ ++++L G
Sbjct: 80 PYVTKYYGSYLKDTK----LWIIMEYLG---GGSALDLLEPG-PLDETQIATILREILKG 131
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
LD+ HS +HRDIK +N+L+ +G +K+ADFG+A Q + T V T ++ PE+
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEV 190
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKLCGSPS-EDYWR 358
+ + Y + D+WS G EL G+P + P + L I K P+ E +
Sbjct: 191 IKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK-NNPPTLEGNYS 244
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418
K K+F +E L+ +P+ R +A L+ +F
Sbjct: 245 KP---------------------LKEF-------VEACLNKEPSFRPTAKELLKHKFILR 276
Query: 419 KPLP 422
Sbjct: 277 NAKK 280
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRL 186
R + F+ +G+G++S V AR+L + A+K + + ++ V ++ RE ++ RL
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
DH +KL T + LY Y ++ +L G F E + Y +++ L+
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALE 144
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELL 304
+ H +G++HRD+K N+L++ + ++I DFG A P+ Q + V T Y PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
+ DLW+ GCI+ +L AG P E KI KL + P
Sbjct: 205 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------EYDFP- 252
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
+ F A L+E LL +D R
Sbjct: 253 ------------------EKFFPKARDLVEKLLVLDATKR 274
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 78/304 (25%), Positives = 133/304 (43%), Gaps = 46/304 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + +KIGQG VY A D+ + VA++++ + + EI ++R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 190 NVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGL 244
N++ LV L++V EY+ G + E Q+ ++ L L
Sbjct: 78 NIVNYLDSYLVGDE----LWVVMEYLA---GGSLTDVVTET-CMDEGQIAAVCRECLQAL 129
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
+ HS V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVV 188
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
YG VD+WS G + E+ G+P + L+ I + P
Sbjct: 189 TRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------ATNGTP- 234
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424
+ Q P K ++ F+DF L L +D RGSA L+ +F +
Sbjct: 235 ----ELQNPEK--LSAIFRDF----LNRC---LEMDVEKRGSAKELLQHQFLKI---AKP 278
Query: 425 PSSL 428
SSL
Sbjct: 279 LSSL 282
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 55/293 (18%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 194
+G G V + + ++ ALK ++ + R RE+ + R +++++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 120
Query: 195 EGLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ L +V E ++ G + F+E + M+ + + +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 247 CHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
HS + HRD+K NLL N ILK+ DFG A + LT+ T +Y PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPE- 233
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRK 359
+LG Y + D+WS G I+ L G P + + G W +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+E K L+ LL +P R + +
Sbjct: 294 ------------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 321
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 61/359 (16%), Positives = 105/359 (29%), Gaps = 99/359 (27%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVA----------------------LKKVR 164
R FE + +G+G + V+ A++ A L K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 165 FDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS------------------- 205
+ ++ + +K E S S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 206 -------------LYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
LY+ + +L Q+ ++ HS
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLA-----------SFYDPDQNQPLTSRVVTLWY 298
+G++HRD+K SN+ + ++K+ DFGL T +V T Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
PE + G Y VD++S G IL EL T++E++ I + R
Sbjct: 243 MSPEQIHGNN-YSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------R 287
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
K P F +++ +LS P +R A + + F
Sbjct: 288 NLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 67/307 (21%), Positives = 132/307 (42%), Gaps = 43/307 (14%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+ +E + ++G G + VY+A++ + + A K + + E + EI IL DH
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75
Query: 189 INVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
++KL G + L+++ E+ + + +E Q++ +Q+L L+
Sbjct: 76 PYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS+ ++HRD+K N+L+ G +++ADFG+++ + + + T ++ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVM 190
Query: 306 GATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
T Y D+WS G L E+ +P P E+ + + K+ S
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSDP------PT 241
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421
L + + + F+DF ++ L +P R SAA L F +
Sbjct: 242 LLTPSKWSVE----------FRDF-------LKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 422 PCDPSSL 428
+L
Sbjct: 282 ITSNKAL 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 49/222 (22%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
R + +G+G + + + +++ +K+ + E+ R +E+ ++R L+
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLE 65
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
H NV+K G++ L + EY++ L G+ ++ +Q + + + G+ +
Sbjct: 66 HPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-------------LTSRV 293
HS ++HRD+ N L+ N + +ADFGLA ++ QP + V
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG 335
++ PE++ G + Y VD++S G +L E+ P
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 76/328 (23%), Positives = 138/328 (42%), Gaps = 49/328 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ F+ L+K+G+G+Y +VY+A + +IVA+K+V ++ + + + +EI I+++ D
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 190 NVIKLEG--LVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
+V+K G + L++V EY D+ L + +E ++ +Q L G
Sbjct: 85 HVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKG 137
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
L++ H +HRDIK N+L++ G K+ADFG+A + T + T ++ PE+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEV 196
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
+ Y D+WS G E+ GKP + + I P
Sbjct: 197 IQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFR 246
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
++ F DF ++ L P R +A L+ F
Sbjct: 247 KPELWSDN----------FTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AK 286
Query: 424 DPSSL-PKYPPSKEFDAKIRDEEARRQG 450
S L + + K ++ + R +G
Sbjct: 287 GVSILRDLINEAMDVKLKRQESQQREEG 314
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 77/302 (25%), Positives = 139/302 (46%), Gaps = 42/302 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ KIG+G+ V AR+ + VA+K + D + + + E+ I+R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 190 NVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
NV+++ LV L+++ E+++ L + S ++ +E Q+ + +L L +
Sbjct: 103 NVVEMYKSYLVGEE----LWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAY 156
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
H++GV+HRDIK ++L+ +G +K++DFG + D + S V T ++ PE++
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISR 215
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
+ Y T VD+WS G ++ E+ G+P + V+ + ++ R S P
Sbjct: 216 SLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPP--- 259
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
K + +K V+ +DF L M L DP +R +A L F P
Sbjct: 260 --KLKNSHK--VSPVLRDF----LERM---LVRDPQERATAQELLDHPFLLQ---TGLPE 305
Query: 427 SL 428
L
Sbjct: 306 CL 307
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 45/309 (14%), Positives = 96/309 (31%), Gaps = 62/309 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILR 184
+G+G ++ VY A D K+ LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH----DLAGLASHPGLK-FSEAQVKCYMQQ 239
+K + LV E + + L + K + V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLI-----------DNNGILKIADFGLASFYDP-DQNQ 287
+L ++ H ++H DIK N ++ D + L + D G + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347
T++ T ++ E+L + +D + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCM--------------------- 278
Query: 348 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCV-AETFKDFPAPALALMETLLSIDPADRGS 406
L G+ + + KP+ ++R + + +F +L+I
Sbjct: 279 LFGTYMKVKNEGGE------CKPEGLFRRLPHLDMWNEF-------FHVMLNIPDCHHLP 325
Query: 407 AASALRSEF 415
+ LR +
Sbjct: 326 SLDLLRQKL 334
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 73/310 (23%), Positives = 130/310 (41%), Gaps = 56/310 (18%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-D 187
A FE ++ +G GTY VY+ R + ++ A+K + ++ + + +EI++L++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 188 HINVIKLEG----LVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQ 239
H N+ G M L+LV E+ DL + + G E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
+L GL H H V+HRDIKG N+L+ N +K+ DFG+++ Q R T
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTVGRRNTFIGT 192
Query: 300 P----PELLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
P PE++ Y DLWS G E+ G P P ++ + +F + +
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--P-LCDMHPMRALFLIPRN 249
Query: 352 PSEDYWRKSKLPHATIFKPQ-QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410
P+ P+ + K + F+ F +E+ L + + R +
Sbjct: 250 PA----------------PRLKSKKWS--KKFQSF-------IESCLVKNHSQRPATEQL 284
Query: 411 LRSEFFTMKP 420
++ F +P
Sbjct: 285 MKHPFIRDQP 294
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 47/205 (22%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+IG G++ VY+ + VA+K + P+ ++ E+ +LR+ H+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ G T+ L +V ++ E L KF ++ +Q G+D+ H
Sbjct: 81 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRVVTLWYRPPELLLGA 307
++ ++HRD+K +N+ + + +KI DFGLA+ + ++ + PE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 308 TY--YGTAVDLWSTGCILAELYAGK 330
Y D+++ G +L EL G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 34/210 (16%), Positives = 77/210 (36%), Gaps = 21/210 (10%)
Query: 132 FEKLD---KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
F++L+ K+ + +++ R Q + +K ++ + R E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
NV+ + G S + L+ +M +++ L ++Q + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 245 DHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
H+ + + +++ID + +I+ + + R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178
Query: 303 LLLGATY--YGTAVDLWSTGCILAELYAGK 330
L + D+WS +L EL +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 54/292 (18%), Positives = 94/292 (32%), Gaps = 76/292 (26%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 195
+G G V + + ++ ALK ++ + R RE+ + R +++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRIV 77
Query: 196 GLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHC 247
+ L +V E ++ G + F+E + M+ + + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 248 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 304
HS + HRD+K NLL N ILK+ DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRKS 360
Y + D+WS G I+ L G P + + G W +
Sbjct: 172 GEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 228
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
V+E K L+ LL +P R + +
Sbjct: 229 -----------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 256
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 49/320 (15%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ D FEK+ ++G G V++ ++A K + + +P + RE+ +L +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
++ G S + + E+M+ L + G + E + ++ GL +
Sbjct: 90 SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 146
Query: 247 CHSRG-VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT-----SRVVTLWYRP 300
+ ++HRD+K SN+L+++ G +K+ DFG++ L S V T Y
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANSFVGTRSYMS 198
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PE L G T+Y D+WS G L E+ G+ +P E + + +
Sbjct: 199 PERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 361 KL-------------PHATIFK---------PQQPYKRCVAETFKDFPAPALALMETLLS 398
+ P IF+ P + + F+DF + L
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLI 310
Query: 399 IDPADRGSAASALRSEFFTM 418
+PA+R + F
Sbjct: 311 KNPAERADLKQLMVHAFIKR 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 132 FEKLD---KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
FE+L+ IG+G + VY R + VA++ + + + ++ RE+ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
NV+ G S L ++ + L + + + + Q+++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF----YDPDQNQPLTSRVVTLWYRPPEL 303
H++G+LH+D+K N+ DN + I DFGL S + L + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 304 LLGATY--------YGTAVDLWSTGCILAELYAGK 330
+ + + D+++ G I EL+A +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-----VRFMAREIHILR 184
+ E +IG+G + V++ R + K +VA+K + + E E+ + RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
L+H N++KL GL+ + +V E++ DL + M + G
Sbjct: 79 NLNHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 244 LDHCHSRG--VLHRDIKGSNLLIDNNG-----ILKIADFGLASFYDPDQNQPLTSRVVTL 296
+++ ++ ++HRD++ N+ + + K+ADFGL+ ++ +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNF 190
Query: 297 WYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGK 330
+ PE + Y D +S IL + G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 22/232 (9%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRL 186
+ D FE L IG+G +S V + ++ A+K + + L+ V E +L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 187 DHINVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
D + +L + LYLV EY DL L S G + + Y+ +
Sbjct: 119 DRRWITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ +D H G +HRDIK N+L+D G +++ADFG D V T Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 300 PPELLLG------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
PE+L YG D W+ G E++ G+ + E KI
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 63/306 (20%), Positives = 112/306 (36%), Gaps = 39/306 (12%)
Query: 121 IQGWV-PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 179
I G + E L ++G GT V++ R ++A+K++R E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 180 IHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 238
+ ++ + D +++ G + + +++ E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 239 QLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
++ L + GV+HRD+K SN+L+D G +K+ DFG++ D+ +
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAA 189
Query: 298 YRPPE----LLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSP 352
Y PE Y D+WS G L EL G+ P +T+ E L K+ +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EE 246
Query: 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
LP F F+ F ++ L+ D R L
Sbjct: 247 PP------LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
Query: 413 SEFFTM 418
F
Sbjct: 284 HSFIKR 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 132 FEKLD---KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+ L+ KIG G++ V+RA VA+K + + E V RE+ I++RL H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLD 245
N++ G VT + L +V EY+ L L S + E + + G++
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 246 HCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
+ H+R ++HR++K NLL+D +K+ DFGL+ S T + PE+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEV 210
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGK 330
L D++S G IL EL +
Sbjct: 211 LRDEP-SNEKSDVYSFGVILWELATLQ 236
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 88/413 (21%), Positives = 156/413 (37%), Gaps = 69/413 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
D FE L IG+G++ V + D KK+ A+K + +E VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 189 INVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
++ L S +++V + + DL F E VK ++ +L+
Sbjct: 75 PFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELV 125
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
LD+ ++ ++HRD+K N+L+D +G + I DF +A+ + +T+ T Y P
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAP 183
Query: 302 ELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
E+ Y AVD WS G EL G+ R+ +I
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVH------------ 230
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-GSAASALRSEFFT- 417
+ P + ++L++ LL +P R + +
Sbjct: 231 -TFETTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
Query: 418 -------MKPLPCDPSSLPKYPPSKE---FDAKIRDEEAR---RQGGSKGQRMDLERRGT 464
K L P + P+K D EE + K +R+ + +
Sbjct: 278 INWDAVFQKRLI------PGFIPNKGRLNCDPTFELEEMILESKPLHKKKKRLAKKEKDM 331
Query: 465 RESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQ 517
R+ E + S+QK +N + + FN +A DP +
Sbjct: 332 RKC-DSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALEQTKDPQGE 383
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
E + +G+G + V +A+ + VA+K++ ++ F+ E+ L R++H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA---FI-VELRQLSRVNHP 61
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDH 246
N++KL G + + LV EY E L + + P ++ A + Q G+ +
Sbjct: 62 NIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 247 CHSR---GVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
HS ++HRD+K NLL+ G +LKI DFG A D +T+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGK 330
+ G+ Y D++S G IL E+ +
Sbjct: 174 VFEGSN-YSEKCDVFSWGIILWEVITRR 200
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 80/368 (21%), Positives = 135/368 (36%), Gaps = 100/368 (27%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN---- 190
+ K+G G +S V+ + D+ KK VA+K V+ E+ EI +L+ + + +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 191 ----VIKL------EGLVTSRMSCSLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQ 239
V++L G+ + + C +VFE + H L VK +QQ
Sbjct: 99 NREMVVQLLDDFKISGVNGTHI-C---MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 240 LLCGLDHCHSR-GVLHRDIKGSNLLI---------------------------------- 264
+L GLD+ H++ ++H DIK N+L+
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 265 ---------------DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+KIAD G A + + + +R YR E+L+G+ Y
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGSGY 270
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLCGSPSEDYWRKSK-- 361
T D+WST C+ EL G + + + + + I +L G K
Sbjct: 271 -NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 362 ---------LPHATIFKPQQPYKRCVAETFKDFP----APALALMETLLSIDPADRGSAA 408
L H T KP ++ V ++ A + +L + P R +AA
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFE--VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 409 SALRSEFF 416
LR +
Sbjct: 388 ECLRHPWL 395
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 20/230 (8%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRL 186
+ FE L IG+G + V + + K+ A+K + ++ L+ E +L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 187 DHINVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
D + L + LYLV +Y DL L S + E + Y+ +
Sbjct: 132 DSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ +D H +HRDIK N+L+D NG +++ADFG D + V T Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 300 PPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
PE+L G YG D WS G + E+ G+ + VE KI
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 9/223 (4%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRL 186
+A+ +E + IG+G + V R +K+ A+K + F+ ++ F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
+ V++L + LY+V EYM DL L S+ E + Y +++ LD
Sbjct: 127 NSPWVVQLFY--AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALD 182
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
HS G +HRD+K N+L+D +G LK+ADFG + + + V T Y PE+L
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 306 ---GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 345
G YYG D WS G L E+ G + V KI
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 62/301 (20%), Positives = 123/301 (40%), Gaps = 39/301 (12%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL- 186
A+ + L +IG+G Y +V + +I+A+K++R ++ + + + ++ ++ R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYM----EHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
D +++ G + ++ E M + + S E + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 243 GLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
L+H ++HRDIK SN+L+D +G +K+ DFG++ + T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 302 ELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYW 357
E + + Y D+WS G L EL G+ P + +QL ++ K G P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
+L + ++ + + +F +F + L+ D + R L+ F
Sbjct: 248 --PQLSN----SEEREF----SPSFINF-------VNLCLTKDESKRPKYKELLKHPFIL 290
Query: 418 M 418
M
Sbjct: 291 M 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 68/307 (22%), Positives = 122/307 (39%), Gaps = 55/307 (17%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI-LRRL 186
+AD E + ++G+G Y V + R + +I+A+K++R + + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYM----EHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
D + G + +++ E M + + E + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQ-TIPEDILGKIAVSIVK 120
Query: 243 GLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV------T 295
L+H HS V+HRD+K SN+LI+ G +K+ DFG++ + L V
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--------LVDDVAKDIDAGC 172
Query: 296 LWYRPPELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGS 351
Y PE + Y D+WS G + EL + P T +QL ++
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV---VEE 229
Query: 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411
PS PQ P + AE F DF L + +R + +
Sbjct: 230 PS----------------PQLPADKFSAE-FVDF-------TSQCLKKNSKERPTYPELM 265
Query: 412 RSEFFTM 418
+ FFT+
Sbjct: 266 QHPFFTL 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 48/287 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
D F +G+G + V+ + K+ A KK+ + + + E IL ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 189 INVIKLEGLVTSRMSC-----SLYLVFEYME------HDLAGLASHPGLKFSEAQVKCYM 237
++ L L LV M H + + F E + Y
Sbjct: 245 RFIVSLA-------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYT 295
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
Q++ GL+H H R +++RD+K N+L+D++G ++I+D GLA T
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPG 354
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
+ PELLLG Y +VD ++ G L E+ A + R E + ++ +
Sbjct: 355 FMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--------- 404
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
+ + Y F + E LL DP R
Sbjct: 405 ---------VLEQAVTYPD-------KFSPASKDFCEALLQKDPEKR 435
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 132 FEKLD---KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM--AREIHILRRL 186
F +L IG G + VYRA + VA+K R D E S +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
H N+I L G+ +L LV E+ + + L+ + + + Q+
Sbjct: 64 KHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRV--LSGK---RIPPDILVNWAVQIAR 116
Query: 243 GLDHCHSRG---VLHRDIKGSNLLIDN--------NGILKIADFGLASFYDPDQNQPLTS 291
G+++ H ++HRD+K SN+LI N ILKI DFGLA + S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMS 173
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 330
+ PE++ + + D+WS G +L EL G+
Sbjct: 174 AAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 57/250 (22%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
++ + L+ +G + V++A+ L++ VA+K F + +S + E++ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 188 HINVIKLEGLVT--SRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
H N+++ G + + L+L+ + E L+ + ++E + GL
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE--TMARGL 134
Query: 245 DHCHSR----------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294
+ H + HRDIK N+L+ NN IADFGLA ++ ++ T V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 295 -TLWYRPPELLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
T Y PE+L GA +D+++ G +L EL + G + L ++
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 350 GSPSEDYWRK 359
PS + ++
Sbjct: 255 QHPSLEDMQE 264
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 56/304 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
++F + +G+G + V + K+ A KK+ + + + E IL +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 189 INVIKLEGLVTSRMSC-----SLYLVFEYME------HDLAGLASHPGLKFSEAQVKCYM 237
V+ L +L LV M H + F EA+ Y
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYA 292
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 297
++ CGL+ H +++RD+K N+L+D++G ++I+D GLA + Q + RV T+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVG 350
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
Y PE++ Y + D W+ GC+L E+ AG+ R + + ++ +L
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------- 400
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR----GSAASALRS 413
+ + + Y F A +L LL DPA+R G +A ++
Sbjct: 401 ---------VKEVPEEYSE-------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 414 -EFF 416
F
Sbjct: 445 HPLF 448
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 60/238 (25%), Positives = 94/238 (39%), Gaps = 32/238 (13%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A + + +IG+G Y V+ + +K VA+K E+ F EI+ + H
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTE---EASWFRETEIYQTVLMRH 90
Query: 189 INVIKLEGLVT--SRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
N++ + LYL+ +Y E +D L S + +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY--LKSTT---LDAKSMLKLAYSSVS 145
Query: 243 GLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTS 291
GL H H+ + HRD+K N+L+ NG IAD GLA + D N+ P +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 292 RVVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344
RV T Y PPE+L + D++S G IL E+ E + +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/223 (24%), Positives = 83/223 (37%), Gaps = 32/223 (14%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A L+ +G+G Y V+R + VA+K + + F E++ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSW---FRETELYNTVMLRH 61
Query: 189 INVIKLEGLVTSRMSCS--LYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
N++ + S L+L+ Y E +D L + +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIAS 116
Query: 243 GLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTS 291
GL H H + HRD+K N+L+ NG IAD GLA + NQ
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 292 RVVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAG 329
RV T Y PE+L VD+W+ G +L E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 32/228 (14%)
Query: 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
+ IG+G + V+R + ++ VA+K F EI+ L H N++
Sbjct: 45 VLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSW---FREAEIYQTVMLRHENIL 99
Query: 193 KLEGLVTSRMSCS--LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
L+LV +Y EH D L + + + GL H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYT---VTVEGMIKLALSTASGLAH 154
Query: 247 CHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVVT 295
H + HRD+K N+L+ NG IAD GLA +D + RV T
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 296 LWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTE 338
Y PE+L + D+++ G + E+ I +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL--RR-L 186
+ F IG+G + VY R D K+ A+K L+ + ++ E L R L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC-----LDKKRIKMKQGETLALNERIML 243
Query: 187 DHINVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
++ +V MS + L + + M DL S G FSEA ++ Y +
Sbjct: 244 SLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAE 300
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
++ GL+H H+R V++RD+K +N+L+D +G ++I+D GLA + + + V T Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWR 358
PE+L Y ++ D +S GC+L +L G P R + H+I ++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTKDKHEIDRM---------- 405
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
F +L+E LL D R
Sbjct: 406 --------TLTMAVELPDS-------FSPELRSLLEGLLQRDVNRR 436
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
+++ +G+G + V R + + VA+K ++ ++ +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
L H N++K +G+ T + L+ E++ L L + K + Q Y Q+ G
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKG 138
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTL 296
+D+ SR +HRD+ N+L+++ +KI DFGL +Y ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF---- 194
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
WY PE L+ + +Y A D+WS G L EL + ++ + K+ G +
Sbjct: 195 WY-APECLMQSKFY-IASDVWSFGVTLHEL-----LTYCDSDSSPMALFLKMIGPT---H 244
Query: 357 W 357
Sbjct: 245 G 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
D F+++ +G G++ V + + A+K + ++ + + E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLC 242
++KLE + + + +LY+V EY+ G + SH L +FSE + Y Q++
Sbjct: 101 PFLVKLEF--SFKDNSNLYMVMEYVA----GGEMFSH--LRRIGRFSEPHARFYAAQIVL 152
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WY 298
++ HS +++RD+K NLLID G +++ DFG A R TL
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------GRTWTLCGTPEA 204
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
PE++L Y AVD W+ G ++ E+ AG P
Sbjct: 205 LAPEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDH 188
D+ + L+ IG+G Y VY+ LD++ VA+K F ++ F+ + I+ + ++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS-LDERP-VAVKV--FSFANRQN--FINEKNIYRVPLMEH 66
Query: 189 INVIKLEG---LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
N+ + VT+ LV EY + L S + + + + GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--SVTRGL 124
Query: 245 DHCHS---------RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-------QNQP 288
+ H+ + HRD+ N+L+ N+G I+DFGL+ + ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 289 LTSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYAGK 330
S V T+ Y PE+L GA VD+++ G I E++
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 3e-27
Identities = 47/340 (13%), Positives = 93/340 (27%), Gaps = 78/340 (22%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE------PESVRFMAREIHIL 183
+ ++ +KIG+G + V++ VA+K + + + ++ + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 184 RRL---------DHINVIKLEGLVTSRMSCS----------------------------L 206
+ L I L + + S L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLID 265
++V E E L S A K + QL L + HRD+ N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 266 NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 325
+ K+ P V++ Y + + +
Sbjct: 197 KTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 326 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH---------ATIFKPQQPYKR 376
+ + + G + + I++L + + W + + K +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 377 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
C K T+L+ SA L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
+ L ++G+G + +V R + ++VA+KK++ + E F REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKS 67
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
L H N++K +G+ S +L L+ EY+ + L L H + ++ Y Q+ G
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 126
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTL 296
+++ ++ +HRD+ N+L++N +KI DFGL F+ +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF---- 182
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
WY PE L + + A D+WS G +L EL Y K P + +
Sbjct: 183 WY-APESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
+ L ++G+G + +V R + ++VA+KK++ + E F REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKS 98
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
L H N++K +G+ S +L L+ EY+ + L L H + ++ Y Q+ G
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 157
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTL 296
+++ ++ +HRD+ N+L++N +KI DFGL +Y +
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF---- 213
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
WY PE L + + A D+WS G +L EL Y K P + +
Sbjct: 214 WY-APESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
F+ L +G G++ V+ R + A+K ++ + + + V E +L + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLC 242
+I++ G T + + ++++ +Y+E G L S L +F K Y ++
Sbjct: 66 PFIIRMWG--TFQDAQQIFMIMDYIE----GGELFSL--LRKSQRFPNPVAKFYAAEVCL 117
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----Y 298
L++ HS+ +++RD+K N+L+D NG +KI DFG A + + TL Y
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA--------KYVPDVTYTLCGTPDY 169
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331
PE++ Y ++D WS G ++ E+ AG
Sbjct: 170 IAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYT 201
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESV-RFMAREIHILRRLDHI 189
++ +DK+G G S VY A D VA+K + + E++ RF RE+H +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQ 71
Query: 190 NVIKL------EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLC 242
N++ + + YLV EY+E L+ G S + Q+L
Sbjct: 72 NIVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILD 122
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPP 301
G+ H H ++HRDIK N+LID+N LKI DFG+A + + T+ V+ T+ Y P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKP 331
E G D++S G +L E+ G+P
Sbjct: 182 EQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIK 193
+G+G +VY A D +++IVALK + + +P M RE RL +V+
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 194 L------EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
+ +G LY+ + DLA + G + + ++Q+ LD
Sbjct: 99 IHDFGEIDGQ--------LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDA 149
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLL 305
H+ G HRD+K N+L+ + + DFG+AS D+ V TL+Y PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208
Query: 306 GATYYGTAVDLWSTGCILAELYAGKP 331
+ D+++ C+L E G P
Sbjct: 209 ESH-ATYRADIYALTCVLYECLTGSP 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR---DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRR 185
+ + ++G+G + +V R D VA+K+++ P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKA 80
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
L ++K G+ SL LV EY+ L L H + +++ Y Q+ G
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKG 139
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRP 300
+++ SR +HRD+ N+L+++ +KIADFGLA D++ + WY
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 198
Query: 301 PELLLGATYYGTAVDLWSTGCILAEL--YAGKP 331
PE L + D+WS G +L EL Y K
Sbjct: 199 PESLSDNIFS-RQSDVWSFGVVLYELFTYCDKS 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 14/236 (5%)
Query: 115 AVAGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV 173
W + R K+G G Y VY VA+K ++ D +E E
Sbjct: 206 YGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE- 262
Query: 174 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEA 231
F+ E +++ + H N+++L G+ T Y++ E+M + +L L + S
Sbjct: 263 -FLK-EAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAV 318
Query: 232 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291
+ Q+ +++ + +HR++ N L+ N ++K+ADFGL+ D
Sbjct: 319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 292 RVVTL-WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
+ W P L + D+W+ G +L E+ G PG + +
Sbjct: 379 AKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESV-RFMAREIHILRRLDHI 189
+E + +G G S V+ ARDL + VA+K +R D +P RF RE L+H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHP 72
Query: 190 NVIKL--EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
++ + G + Y+V EY++ L + G + + + L+
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNF 131
Query: 247 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT--SRVV-TLWYRPPEL 303
H G++HRD+K +N++I +K+ DFG+A D +T + V+ T Y PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKP 331
G + D++S GC+L E+ G+P
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 28/234 (11%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
W + R K+G G Y VY VA+K ++ D +E E F+ +E +
Sbjct: 8 WEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAV 62
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQL 240
++ + H N+++L G+ T Y++ E+M + +L L + S + Q+
Sbjct: 63 MKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---- 296
+++ + +HRD+ N L+ N ++K+ADFGL+ D T+
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIK 177
Query: 297 WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE + Y D+W+ G +L E+ Y P PG + +
Sbjct: 178 WT-APE----SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 30/241 (12%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREI 180
+R +K+ +G+G + V + ++VA+K ++ D + +EI
Sbjct: 28 FHKR--YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEI 84
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQ 238
ILR L H ++IK +G + SL LV EY+ L L H AQ+ + Q
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQ 141
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTS 291
Q+ G+ + H++ +HRD+ N+L+DN+ ++KI DFGLA +Y ++
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 351
WY PE L +Y A D+WS G L EL + + K +L G
Sbjct: 202 F----WY-APECLKEYKFY-YASDVWSFGVTLYEL-----LTHCDSSQSPPTKFLELIGI 250
Query: 352 P 352
Sbjct: 251 A 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 69/289 (23%), Positives = 127/289 (43%), Gaps = 48/289 (16%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILR 184
++FE L +G G Y V+ R + D K+ A+K ++ + + ++ E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 185 RLDHIN-VIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCY 236
+ ++ L + L+L+ +Y+ +L S +F+E +V+ Y
Sbjct: 114 HIRQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIY 164
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
+ +++ L+H H G+++RDIK N+L+D+NG + + DFGL+ + D+ + T+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 297 WYRPPELLLGATY-YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355
Y P+++ G + AVD WS G ++ EL G E +I +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR------- 277
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
I K + PY + + A A L++ LL DP R
Sbjct: 278 -----------ILKSEPPYPQ-------EMSALAKDLIQRLLMKDPKKR 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 52/285 (18%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDH 188
+ F+ L +G+GT+ V R+ + A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 189 INVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLC 242
+ L+ L V EY +L S F+E + + Y +++
Sbjct: 65 PFLTALK-------YAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVS 116
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVV-TLWYR 299
L++ HSR V++RDIK NL++D +G +KI DFGL D T Y
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYL 172
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE+L YG AVD W G ++ E+ G+ + I +
Sbjct: 173 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EE 221
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
+ P + A +L+ LL DP R
Sbjct: 222 IRFP-------------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 62/291 (21%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRR 185
FE L +GQG++ V+ + D +++ A+K ++ L + VR E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 186 LDHINVIKLEGLVTSRMSCS------LYLVFEYMEHDLAG--LASHPGL----KFSEAQV 233
++H ++KL + LYL+ +++ G L + L F+E V
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFL----RGGDLFTR--LSKEVMFTEEDV 128
Query: 234 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293
K Y+ +L LDH HS G+++RD+K N+L+D G +K+ DFGL S D + S
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFC 187
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
T+ Y PE++ + + D WS G ++ E+ G G+ E + I K
Sbjct: 188 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------ 240
Query: 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
K +P + A +L+ L +PA+R
Sbjct: 241 ----AKLGMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 21/235 (8%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREI 180
+ + + IG+G + VY D D KKI A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
I++ H NV+ L G+ R S +V YM+H DL + + + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-- 296
+ G+ + S+ +HRD+ N ++D +K+ADFGLA YD + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 297 -WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W E + T D+WS G +L EL P P + +
Sbjct: 197 KWM-ALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 14/230 (6%)
Query: 122 QGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 180
W + + ++IG+G + V+ R +VA+K R +F+ +E
Sbjct: 107 DKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEA 163
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQ 238
IL++ H N+++L G+ T + +Y+V E ++ D L + + + +
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVG 220
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL- 296
G+++ S+ +HRD+ N L+ +LKI+DFG++ D R V +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
W PE L Y + D+WS G +L E ++ G P + + +
Sbjct: 281 WT-APEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 19/215 (8%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
A +E I G +Y A D + + V LK + M E L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVV 137
Query: 188 HINVIKLEGLV---TSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
H +++++ V Y+V EY+ L A+ Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPE 302
L + HS G+++ D+K N+++ + K+ D G S + + T ++ PE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGYLYGTPGFQAPE 247
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 337
++ A D+++ G LA L P GR
Sbjct: 248 IVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR +S K+GQG + V+ + VA+K ++ + PE F+ +E +++
Sbjct: 181 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMK 234
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +V+ +Y+V EYM L L G Q+ Q+
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPP 301
G+ + +HRD++ +N+L+ N + K+ADFGLA + ++ + W P
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 73/342 (21%), Positives = 130/342 (38%), Gaps = 50/342 (14%)
Query: 74 NFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRA---D 130
+ + E+ E+ A G +A+ +G P+ + + P+ +
Sbjct: 89 HVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN 148
Query: 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHI 189
FE L +G+GT+ V ++ + A+K ++ + + + V E +L+ H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 190 NVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
+ L+ L V EY +L S FSE + + Y +++
Sbjct: 209 FLTALK-------YSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSA 260
Query: 244 LDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
LD+ HS + V++RD+K NL++D +G +KI DFGL + + T Y PE
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE 319
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+L YG AVD W G ++ E+ G+ + + I + +
Sbjct: 320 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------EEIRF 368
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
P + A +L+ LL DP R
Sbjct: 369 P-------------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
IG G V R + VA+K ++ E + F+ E I+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQF 107
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGL 244
DH N+I+LEG+VT +V EYME+ L L +H G +F+ Q+ ++ + G+
Sbjct: 108 DHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGM 164
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPP 301
+ G +HRD+ N+L+D+N + K++DFGL+ + D + T+ + W P
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-AP 223
Query: 302 ELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
E A + +A D+WS G ++ E+ Y +P T + + +
Sbjct: 224 E----AIAFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 60/291 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILR 184
+ FE L +G+G Y V++ R + + KI A+K ++ + + E +IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 185 RLDHINVIKLEGLVTSRMSC-----SLYLVFEYMEHDLAG--LASHPGL----KFSEAQV 233
+ H ++ L + LYL+ EY+ +G L L F E
Sbjct: 77 EVKHPFIVDL-------IYAFQTGGKLYLILEYL----SGGELFMQ--LEREGIFMEDTA 123
Query: 234 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293
Y+ ++ L H H +G+++RD+K N+++++ G +K+ DFGL +
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFC 182
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353
T+ Y PE+L+ + + AVD WS G ++ ++ G P G + + KI K
Sbjct: 183 GTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------ 235
Query: 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
K LP A L++ LL + A R
Sbjct: 236 ----CKLNLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/243 (21%), Positives = 106/243 (43%), Gaps = 25/243 (10%)
Query: 115 AVAGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKI---VALKKVRFDNLEP 170
G + + + + R + E IG+G + +V++ + + VA+K + +
Sbjct: 1 GAMGSSTRDYEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS 58
Query: 171 ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKF 228
+F+ +E +R+ DH +++KL G++T ++++ E +L L
Sbjct: 59 VREKFL-QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKY-SL 113
Query: 229 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQ 287
A + Y QL L + S+ +HRDI N+L+ +N +K+ DFGL+ D +
Sbjct: 114 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 288 PLTSRVVTLWYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQL 342
++ W PE + + +A D+W G + E+ + KP G + +
Sbjct: 174 ASKGKLPIKWM-APE----SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVI 227
Query: 343 HKI 345
+I
Sbjct: 228 GRI 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 26/235 (11%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREI 180
+ + IG G + VY+ ++ VA+K ++ E + V F+ E
Sbjct: 41 IHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEA 97
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQ 238
I+ + H N+I+LEG+++ + ++ EYME+ L L G +FS Q+ ++
Sbjct: 98 GIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLR 154
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-- 296
+ G+ + + +HRD+ N+L+++N + K++DFGL+ + D T+ +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 297 -WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE A Y +A D+WS G ++ E+ Y +P + E + I
Sbjct: 215 RWT-APE----AISYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 23/230 (10%)
Query: 129 ADSFEKLDKIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
A + +G G + V R ++ VA+K ++ E + F+ E I+ +
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQ 102
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
DH N+I+LEG+VT S + +V EYME+ L L H +F+ Q+ ++ + G
Sbjct: 103 FDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASG 159
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRP 300
+ + G +HRD+ N+LI++N + K++DFGL + D T+R + W
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-S 218
Query: 301 PELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
PE A Y +A D+WS G +L E+ Y +P + + + +
Sbjct: 219 PE----AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 30/234 (12%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
W VPR ++ + ++++G G + V+ K VA+K ++ ++ P++ F+A E ++
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANL 61
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQL 240
+++L H +++L +VT +Y++ EYME+ L L + G+K + ++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---- 296
G+ R +HRD++ +N+L+ + KIADFGLA + ++ T+R
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIK 175
Query: 297 WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE A YG D+WS G +L E+ + P PG T E + +
Sbjct: 176 WT-APE----AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 21/235 (8%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREI 180
+ + + IG+G + VY D D KKI A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
I++ H NV+ L G+ R S +V YM+H DL + + + + Q
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-- 296
+ G+ S+ +HRD+ N ++D +K+ADFGLA YD + + L
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 297 -WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W E + T D+WS G +L EL P P + +
Sbjct: 261 KWM-ALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 28/242 (11%)
Query: 113 LAAVAGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE 171
+AA GW + + L IG+G + +V K VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA 60
Query: 172 SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFS 229
F+ E ++ +L H N+++L G++ LY+V EYM L L S
Sbjct: 61 ---FL-AEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 230 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP 288
+ + + +++ +HRD+ N+L+ + + K++DFGL
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 175
Query: 289 LTSRVVTLWYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLH 343
L + W PE A T D+WS G +L E+ + P P + +
Sbjct: 176 LPVK----WT-APE----ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVP 225
Query: 344 KI 345
++
Sbjct: 226 RV 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 24/229 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
F+K+ +G G + VY+ K VA+K++R + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCG 243
+D+ +V +L G+ + ++ L+ + M L + H + + Q+ G
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPP 301
+++ R ++HRD+ N+L+ +KI DFGLA ++ + +V W
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-AL 188
Query: 302 ELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
E + + D+WS G + EL + KP G E +
Sbjct: 189 E----SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 26/231 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVR--FMAREIHILR 184
L+K+G G++ V R K + VA+K ++ D L F+ RE++ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMH 76
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLC 242
LDH N+I+L G+V + + +V E L L H G F + Y Q+
Sbjct: 77 SLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAE 132
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYR 299
G+ + S+ +HRD+ NLL+ ++KI DFGL + + + + W
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC- 191
Query: 300 PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
PE + A D W G L E+ Y +P G + LHKI
Sbjct: 192 APE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR +S K+GQG + V+ + VA+K ++ + PE F+ +E +++
Sbjct: 264 IPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMK 317
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +V+ +Y+V EYM L L G Q+ Q+
Sbjct: 318 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPP 301
G+ + +HRD++ +N+L+ N + K+ADFGLA + ++ + W P
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
L G + D+WS G +L EL G+ PG E L ++
Sbjct: 435 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 51/238 (21%), Positives = 96/238 (40%), Gaps = 33/238 (13%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMARE 179
+ + R + +G+G + VY + +KI VA+K + D +FM E
Sbjct: 7 YGIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SE 63
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYM 237
I++ LDH +++KL G++ +++ E + +L L + + Y
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYS 119
Query: 238 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 296
Q+ + + S +HRDI N+L+ + +K+ DFGL+ D D VT
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTR 175
Query: 297 ----WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE + + TA D+W + E+ + +P + + +
Sbjct: 176 LPIKWM-SPE----SINFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVL 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 21/235 (8%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREI 180
+P IG+G + VY D Q +I A+K + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 181 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
++R L+H NV+ L G++ +++ YM H DL P + + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-- 296
+ G+++ + +HRD+ N ++D + +K+ADFGLA D + R L
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 297 -WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W E + T D+WS G +L EL P + H +
Sbjct: 193 KWT-ALE----SLQTYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFL 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 53/288 (18%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRL 186
+ F L +G+G++ V + ++ A+K ++ D ++ + V E +L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 187 D-HINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
+ +L SC LY V EY+ DL G +F E Y +
Sbjct: 78 GKPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAE 129
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVV-TL 296
+ GL S+G+++RD+K N+++D+ G +KIADFG+ + +D T T
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTP 185
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
Y PE++ YG +VD W+ G +L E+ AG+ G E E I +
Sbjct: 186 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------- 235
Query: 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
P K A+A+ + L++ P R
Sbjct: 236 -HNVAYP-------------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 18/229 (7%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKI---VALKKVRFDNLEPESVRFMAREIH 181
+ R + E IG+G + +V++ + + VA+K + + +F+ +E
Sbjct: 387 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEAL 443
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQ 239
+R+ DH +++KL G++T ++++ E +L L A + Y Q
Sbjct: 444 TMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQ 499
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWY 298
L L + S+ +HRDI N+L+ +N +K+ DFGL+ D + ++ W
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
P + + +A D+W G + E+ + KP G + + +I
Sbjct: 560 APESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 51/232 (21%), Positives = 95/232 (40%), Gaps = 22/232 (9%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
+ R + ++G G + +V + R ++ VA+K ++ + ++ M RE I
Sbjct: 6 LKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQI 63
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
+ +LD+ +++L G+ + +L LV E L + + V + Q+
Sbjct: 64 MHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS---RVVTLWY 298
G+ + + +HRD+ N+L+ N KI+DFGL+ D + + WY
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 299 RPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
PE + + D+WS G + E Y KP E + I
Sbjct: 181 -APE----CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 53/257 (20%), Positives = 96/257 (37%), Gaps = 47/257 (18%)
Query: 119 EAIQGW-VPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVR 174
E ++ +P F +G+G + +V A + D + VA+K ++ D + +
Sbjct: 13 EKLEDVLIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 175 FMAREIHILRRLDHINVIKLEGLVT----SRMSCSLYLVFEYMEH-DL-----AGLASHP 224
RE ++ DH +V KL G+ ++ +M+H DL A
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 225 GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDP 283
+ +M + CG+++ SR +HRD+ N ++ + + +ADFGL+ Y
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 284 DQNQPLTSRVVTLWYR------------PPE-LLLGATYYGTAVDLWSTGCILAEL--YA 328
D +YR E L Y D+W+ G + E+
Sbjct: 191 D------------YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRG 236
Query: 329 GKPIMPGRTEVEQLHKI 345
P G E + +
Sbjct: 237 QTP-YAGIENAEIYNYL 252
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 114 AAVAGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 172
AA GW + + L IG+G + +V K VA+K ++ D
Sbjct: 178 AAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA- 232
Query: 173 VRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSE 230
F+ E ++ +L H N+++L G++ LY+V EYM L L S
Sbjct: 233 --FL-AEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 288
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPL 289
+ + + +++ +HRD+ N+L+ + + K++DFGL L
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 290 TSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345
+ W PE + T D+WS G +L E+Y+ G+ P + + ++
Sbjct: 349 PVK----WT-APE---ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 30/234 (12%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
W + + +IG G + V+ L++ K VA+K +R + E F+ E +
Sbjct: 3 WVIDP--SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEV 56
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQL 240
+ +L H +++L G+ + + LV E+MEH L+ L + G F+ + +
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDV 113
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---- 296
G+ + V+HRD+ N L+ N ++K++DFG+ F DQ TS T
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVK 170
Query: 297 WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE + + D+WS G ++ E+ P R+ E + I
Sbjct: 171 WA-SPE----VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 47/285 (16%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHIL-RR 185
+ F L +G+G++ V + ++ A+K ++ D ++ + V E +L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 186 LDHINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
+ +L SC LY V EY+ DL G +F E Y +
Sbjct: 399 GKPPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAE 450
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
+ GL S+G+++RD+K N+++D+ G +KIADFG+ + + T Y
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 509
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE++ YG +VD W+ G +L E+ AG+ G E E I +
Sbjct: 510 APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------HN 558
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
P K A+A+ + L++ P R
Sbjct: 559 VAYP-------------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 54/243 (22%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 115 AVAGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV 173
+ AG W + L ++G G + V + + VA+K ++ ++ +
Sbjct: 10 STAGLGYGSWEIDP--KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE- 65
Query: 174 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEA 231
F+ E ++ L H +++L G+ T + ++++ EYM + L L +F
Sbjct: 66 -FI-EEAKVMMNLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRH-RFQTQ 120
Query: 232 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 291
Q+ + + +++ S+ LHRD+ N L+++ G++K++DFGL+ + D+ TS
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TS 177
Query: 292 RVVTL----WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQL 342
V + W PPE Y + D+W+ G ++ E+ P T E
Sbjct: 178 SVGSKFPVRWS-PPE----VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETA 231
Query: 343 HKI 345
I
Sbjct: 232 EHI 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 42/285 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LD 187
F+ L IG+G+Y+ V R +I A+K V+ + + E + ++ E H+ + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 188 HINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
H ++ L SC L+ V EY+ DL K E + Y ++
Sbjct: 69 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEIS 120
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLWYR 299
L++ H RG+++RD+K N+L+D+ G +K+ D+G+ P TS T Y
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE+L G YG +VD W+ G ++ E+ AG+ P F + GS
Sbjct: 178 APEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNT 223
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
I + Q R A +++++ L+ DP +R
Sbjct: 224 EDYLFQVILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 70/302 (23%), Positives = 117/302 (38%), Gaps = 56/302 (18%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR- 185
+ + F +G+G++ V+ A + A+K ++ D L + V E +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 186 LDHINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
+H + + +L+ V EY+ DL KF ++ Y +
Sbjct: 75 WEHPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAE 126
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL--- 296
++ GL HS+G+++RD+K N+L+D +G +KIADFG+ +N ++ T
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGT 181
Query: 297 -WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355
Y PE+LLG Y +VD WS G +L E+ G+ G+ E E H I
Sbjct: 182 PDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------- 232
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-GSAASALRSE 414
P + A L+ L +P R G +
Sbjct: 233 --DNPFYP-------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271
Query: 415 FF 416
F
Sbjct: 272 LF 273
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
+ R + L ++G G + V + Q VA+K ++ ++ + F +E
Sbjct: 3 MELKR--EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQT 56
Query: 183 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQL 240
+ +L H ++K G+ + +Y+V EY+ + L L SH +Q+ +
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDV 113
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---- 296
G+ S +HRD+ N L+D + +K++DFG+ + DQ S V T
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVK 170
Query: 297 WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
W PE +Y + D+W+ G ++ E+ P T E + K+
Sbjct: 171 WS-APE----VFHYFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 48/258 (18%), Positives = 94/258 (36%), Gaps = 50/258 (19%)
Query: 119 EAIQGW-VPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVR 174
++ + R + +G+G + +V + D + VA+K ++ DN +
Sbjct: 24 NKLEDVVIDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 175 FMAREIHILRRLDHINVIKLEGLVT---SRMSCSLYLVFEYMEH-DL-----AGLASHPG 225
E ++ H NVI+L G+ S+ ++ +M++ DL
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 226 LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD 284
+ +M + G+++ +R LHRD+ N ++ ++ + +ADFGL+ Y D
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 285 QNQPLTSRVVTLWYR------------PPELLLGATYYG---TAVDLWSTGCILAEL--Y 327
+YR E L + D+W+ G + E+
Sbjct: 202 ------------YYRQGRIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATR 245
Query: 328 AGKPIMPGRTEVEQLHKI 345
P PG E +
Sbjct: 246 GMTP-YPGVQNHEMYDYL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 23/229 (10%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+PR +S + K+G G + V+ A K VA+K ++ ++ E+ F+ E ++++
Sbjct: 185 IPR--ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEANVMK 238
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLC 242
L H ++KL +VT +Y++ E+M L L S G K ++ + Q+
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WY 298
G+ R +HRD++ +N+L+ + + KIADFGLA + ++ T+R W
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWT 352
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
P + G+ + D+WS G +L E+ Y P PG + E + +
Sbjct: 353 APEAINFGS--FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 398
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 51/287 (17%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR- 185
D+FE + +G+G++ V AR + + A+K ++ D L+ + V E IL
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 186 LDHINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQ 239
+H + +L C L+ V E++ DL +F EA+ + Y +
Sbjct: 81 RNHPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAE 132
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLW 297
++ L H +G+++RD+K N+L+D+ G K+ADFG+ T+ T
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPD 189
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
Y PE+L YG AVD W+ G +L E+ G E + I
Sbjct: 190 YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---------- 238
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
+ P A ++++ ++ +P R
Sbjct: 239 DEVVYP-------------------TWLHEDATGILKSFMTKNPTMR 266
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 25/244 (10%)
Query: 116 VAGEAIQ--GWVPRRADSFEKLDKIGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPE 171
+A E I+ R + ++G G + V + + K VA+K ++ + +P
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 172 SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFS 229
+ E +++++LD+ ++++ G+ + S LV E E L L +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNR--HVK 115
Query: 230 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289
+ + + Q+ G+ + +HRD+ N+L+ KI+DFGL+ D+N
Sbjct: 116 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 290 TSRVVTL---WYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQ 341
WY PE Y + D+WS G ++ E Y KP G E
Sbjct: 176 AQTHGKWPVKWY-APE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEV 229
Query: 342 LHKI 345
+
Sbjct: 230 TAML 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 24/229 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
F+K+ +G G + VY+ K VA+K++R + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCG 243
+D+ +V +L G+ + ++ L+ + M L + H + + Q+ G
Sbjct: 74 VDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 129
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPP 301
+++ R ++HRD+ N+L+ +KI DFGLA ++ + +V W
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-AL 188
Query: 302 ELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
E + + D+WS G + EL + KP G E +
Sbjct: 189 E----SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHIL-RRLD 187
F L IG+G++ V AR ++ A+K ++ L+ + + + E ++L + +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 188 HINVIKLEGLVTSRMSC-----SLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCY 236
H ++ L LY V +Y+ G L H L F E + + Y
Sbjct: 98 HPFLVGLH-------FSFQTADKLYFVLDYI----NGGELFYH--LQRERCFLEPRARFY 144
Query: 237 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 296
++ L + HS +++RD+K N+L+D+ G + + DFGL + + N ++ T
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTP 203
Query: 297 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356
Y PE+L Y VD W G +L E+ G P R E I
Sbjct: 204 EYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------- 253
Query: 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
+ +L + A L+E LL D R
Sbjct: 254 -KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 18/226 (7%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
KL +G G + V++ K V +K + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGS 71
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
LDH ++++L GL SL LV +Y+ L + H G + + Q+ G
Sbjct: 72 LDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKG 127
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPP 301
+ + G++HR++ N+L+ + +++ADFG+A PD Q L S + W
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-AL 186
Query: 302 ELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
E + Y D+WS G + EL + +P G E +
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLL 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 42/285 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LD 187
F+ L IG+G+Y+ V R +I A++ V+ + + E + ++ E H+ + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 188 HINVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLL 241
H ++ L SC L+ V EY+ DL K E + Y ++
Sbjct: 112 HPFLVGLH-------SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEIS 163
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLWYR 299
L++ H RG+++RD+K N+L+D+ G +K+ D+G+ P TS T Y
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE+L G YG +VD W+ G ++ E+ AG+ P F + GS
Sbjct: 221 APEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNT 266
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
I + Q R A +++++ L+ DP +R
Sbjct: 267 EDYLFQVILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 304
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-21
Identities = 55/281 (19%), Positives = 109/281 (38%), Gaps = 22/281 (7%)
Query: 77 RKREKMEYVVAQHHPGMGSIP-KASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKL 135
R+ + + P + P K + + + + + +R +
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD 341
Query: 136 DKIGQGTYSNVYRAR-DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 193
++G G + +V + + +K+I VA+K ++ + ++ M RE I+ +LD+ +++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVR 400
Query: 194 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 252
L G+ + +L LV E L + + V + Q+ G+ + +
Sbjct: 401 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 253 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 309
+HR++ N+L+ N KI+DFGL+ D + WY PE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APE----CIN 512
Query: 310 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
+ + D+WS G + E Y KP E + I
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 45/279 (16%), Positives = 78/279 (27%), Gaps = 60/279 (21%)
Query: 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHINVI 192
L G ++A D + VAL V + P+ V + L R+D V
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVA 94
Query: 193 KLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
++ +V +R +V E++ L +A + MQ L D H G
Sbjct: 95 RVLDVVHTRAGG--LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAG 149
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 311
V S + + +G + +A +P
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPDANP---------------------------- 181
Query: 312 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 371
D+ G L L + +P L + P
Sbjct: 182 -QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ-----------------PI 223
Query: 372 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 410
+P A+ +D P A+ + D R ++
Sbjct: 224 EP-----ADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 52/252 (20%), Positives = 101/252 (40%), Gaps = 51/252 (20%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
V R + ++GQG++ VY + + VA+K V E + F+ E
Sbjct: 22 VAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 78
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG--LASHPGLKFSEAQVKCY 236
+++ + +V++L G+V+ ++ E M DL + P + +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 237 MQQLL-------CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP 288
+ +++ G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---- 192
Query: 289 LTSRVVTLWYR------------PPE-LLLGATYYGTAVDLWSTGCILAEL--YAGKPIM 333
+YR PE L G + T D+WS G +L E+ A +P
Sbjct: 193 --------YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPY- 241
Query: 334 PGRTEVEQLHKI 345
G + + L +
Sbjct: 242 QGLSNEQVLRFV 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 46/239 (19%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
+ A F + ++G+ + VY+ +Q + VA+K ++ P F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HE 62
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASH 223
+ RL H NV+ L G+VT L ++F Y H DL
Sbjct: 63 AMLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 224 PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA----- 278
+ Q+ G+++ S V+H+D+ N+L+ + +KI+D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 279 -SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKP 331
+Y N L R W PE A YG D+WS G +L E+ Y +P
Sbjct: 181 ADYYKLLGNSLLPIR----WM-APE----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 40/240 (16%), Positives = 82/240 (34%), Gaps = 32/240 (13%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRFMA 177
+ + + +GQGT++ +++ + V LK + + F
Sbjct: 5 IRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF- 60
Query: 178 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKC 235
++ +L H +++ G+ LV E+++ L L + +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKN-CINILWKLE 117
Query: 236 YMQQLLCGLDHCHSRGVLHRDIKGSNLLID--------NNGILKIADFGLASFYDPDQNQ 287
+QL + ++H ++ N+L+ N +K++D G++ P
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 345
+ W PPE + A D WS G L E+ KP + +L
Sbjct: 176 --ILQERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 24/173 (13%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR--DLDQKKIVALKKVRFDNLEPESVRFMAREIHI 182
+ + + D IG+G + V +AR + A+K+++ + + F E+ +
Sbjct: 22 LDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEV 78
Query: 183 LRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPG 225
L +L H N+I L G R LYL EY H +L +A+
Sbjct: 79 LCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 226 LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
S Q+ + + G+D+ + +HRD+ N+L+ N + KIADFGL+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D+F + +G+G + VY+ R L +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 190 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLC-- 242
N+++L G C LV+ YM + +AS S+ + +Q +
Sbjct: 88 NLLRLRGF------CMTPTERLLVYPYMANG--SVASCLRERPESQPPLDWPKRQRIALG 139
Query: 243 ---GL----DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV- 294
GL DHC + ++HRD+K +N+L+D + DFGLA ++ +T+ V
Sbjct: 140 SARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAVRG 197
Query: 295 TLWYRPPELLLGATYYGTA-VDLWSTGCILAELYAG-KPIMPGRTEVEQ 341
T+ + PE L T + D++ G +L EL G + R +
Sbjct: 198 TIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 48/236 (20%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR----FMAREIHILRR 185
++F+ IG G + VY+ L VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 186 LDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM---Q 238
H +++ L G C + L+++YME+ L H L + M Q
Sbjct: 92 CRHPHLVSLIGF------CDERNEMILIYKYMENG--NLKRH--L-YGSDLPTMSMSWEQ 140
Query: 239 QL-LC-----GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 292
+L +C GL + H+R ++HRD+K N+L+D N + KI DFG++ L++
Sbjct: 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 293 VV-TLWYRPPELLLGATYYGTA-----VDLWSTGCILAELYAGK-PIMPGRTEVEQ 341
V TL Y PE Y+ D++S G +L E+ + I+
Sbjct: 201 VKGTLGYIDPE------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 62/260 (23%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
+ RR ++ ++G+G + V+ A K +VA+K ++ D F RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-RE 67
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLASHPGLKFSE 230
+L L H +++K G+ L +VFEYM+H DL + +
Sbjct: 68 AELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 231 AQVKCYMQQLL-------CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYD 282
A+ + + Q+L G+ + S+ +HRD+ N L+ N ++KI DFG++ Y
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 283 PDQNQPLTSRVVTLWYR------------PPELLLGATYYG---TAVDLWSTGCILAEL- 326
D +YR PPE ++ Y T D+WS G IL E+
Sbjct: 186 TD------------YYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVILWEIF 229
Query: 327 -YAGKPIMPGRTEVEQLHKI 345
Y +P + E + I
Sbjct: 230 TYGKQP-WFQLSNTEVIECI 248
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 59/250 (23%), Positives = 95/250 (38%), Gaps = 42/250 (16%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMA 177
W PR D + +G+G + V A + VA+K ++ E M
Sbjct: 22 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 78
Query: 178 REIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGL 220
E+ IL + H+NV+ L G T + L ++ E+ + +L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-- 278
+ + CY Q+ G++ SR +HRD+ N+L+ ++KI DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 279 ----SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPI 332
Y + L + W PE + Y D+WS G +L E+ P
Sbjct: 198 IYKDPDYVRKGDARLPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP- 250
Query: 333 MPGRTEVEQL 342
PG E+
Sbjct: 251 YPGVKIDEEF 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 61/254 (24%), Positives = 94/254 (37%), Gaps = 45/254 (17%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMA 177
W PR + +G G + V A D VA+K ++ E M
Sbjct: 18 WEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM- 74
Query: 178 REIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL----------AGLASHPG 225
E+ +L L +H+N++ L G T ++ EY + DL +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 226 LKFSEAQVKCYMQQLLC-------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+ ++ ++ LL G+ S+ +HRD+ N+L+ + I KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 279 ------SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGK 330
S Y N L + W PE + Y D+WS G L EL
Sbjct: 193 RDIKNDSNYVVKGNARLPVK----WM-APESIFNCV-YTFESDVWSYGIFLWELFSLGSS 246
Query: 331 PIMPGRTEVEQLHK 344
P PG + +K
Sbjct: 247 P-YPGMPVDSKFYK 259
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 60/243 (24%), Positives = 97/243 (39%), Gaps = 56/243 (23%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
+ RR + ++G+G + V+ A K +VA+K ++ + E F RE
Sbjct: 38 IKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-RE 93
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------------AGLASHP 224
+L L H ++++ G+ T L +VFEYM H DL AG
Sbjct: 94 AELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 225 GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDP 283
Q+ Q+ G+ + +HRD+ N L+ ++KI DFG++ Y
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 284 DQNQPLTSRVVTLWYR------------PPE-LLLGATYYGTAVDLWSTGCILAEL--YA 328
D +YR PPE +L + T D+WS G +L E+ Y
Sbjct: 212 D------------YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYG 257
Query: 329 GKP 331
+P
Sbjct: 258 KQP 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 57/256 (22%), Positives = 93/256 (36%), Gaps = 59/256 (23%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYR--ARDLDQKK---IVALKKVRFDNLEPESVRFMARE 179
VPR + + +G G + VY + VA+K + E + + F+ E
Sbjct: 27 VPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 83
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYM 237
I+ + +H N+++ G+ + +++ E M DL L + + M
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLA--M 139
Query: 238 QQLL-------CGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDPDQN 286
LL CG + +HRDI N L+ G + KI DFG+A Y
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-- 197
Query: 287 QPLTSRVVTLWYR------------PPELLLGATYYG---TAVDLWSTGCILAEL--YAG 329
+YR PPE + G + D WS G +L E+
Sbjct: 198 ----------YYRKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGY 243
Query: 330 KPIMPGRTEVEQLHKI 345
P P ++ E L +
Sbjct: 244 MPY-PSKSNQEVLEFV 258
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 35/185 (18%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMA 177
W PR + +G+G + V +A K VA+K ++ + E +
Sbjct: 18 WEFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL- 74
Query: 178 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL------------------- 217
E ++L++++H +VIKL G + L L+ EY ++ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 218 ----AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273
+ L + + + Q+ G+ + ++HRD+ N+L+ +KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 274 DFGLA 278
DFGL+
Sbjct: 193 DFGLS 197
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR----FMAREIHI 182
+K+G+G + VY+ ++ VA+KK+ ++ + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY-VNNT-TVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 183 LRRLDHINVIKLEGLVTSRMSCS----LYLVFEYM-----EHDLAGLASHPGLKFSE--- 230
+ + H N+++L G S L LV+ YM L+ L P L +
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 231 -----AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285
A G++ H +HRDIK +N+L+D KI+DFGLA +
Sbjct: 138 IAQGAAN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 286 NQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTE 338
+TSR+V T Y PE L G D++S G +L E+ G + R
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 59/262 (22%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRF 175
W PR D +G+G + V A + VA+K ++ D E +
Sbjct: 30 WEFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 176 MAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------A 218
+ E+ +++ + H N+I L G T LY++ EY +L
Sbjct: 88 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 219 GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+ P + + + QL G+++ S+ +HRD+ N+L+ N ++KIADFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 279 -SFYDPDQNQPLTSRVVTLWYR------------PPELLLGATYYGTAVDLWSTGCILAE 325
+ D +Y+ PE L Y D+WS G ++ E
Sbjct: 205 RDINNID------------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWE 251
Query: 326 L--YAGKPIMPGRTEVEQLHKI 345
+ G P PG E +
Sbjct: 252 IFTLGGSP-YPGIPVEELFKLL 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 34/183 (18%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
PR + + IG+G + V++AR + +VA+K ++ + F RE
Sbjct: 44 YPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 100
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------------------- 217
++ D+ N++KL G+ + + L+FEYM + DL
Sbjct: 101 AALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 218 --AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275
A ++S S A+ C +Q+ G+ + R +HRD+ N L+ N ++KIADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 276 GLA 278
GL+
Sbjct: 219 GLS 221
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---------- 186
KIG G + +Y A ++ + A V+ +E + + E+ +R+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 187 -----DHINVIKLEGLVTSRMSCSLY--LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
D++ + G + Y +V E + DL ++ G F ++ V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFY-DPDQNQPLTSRVVTL 296
+L L++ H +H DIK +NLL+ N + +AD+GL+ Y ++
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 297 WYRPPELLLGATYY-------GTAV----DLWSTGCILAELYAGK 330
P + G + G A+ D+ G + GK
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 59/237 (24%), Positives = 88/237 (37%), Gaps = 40/237 (16%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMA 177
W PR F K +G G + V A D VA+K ++ E M
Sbjct: 41 WEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM- 97
Query: 178 REIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH-DL-------------AGLAS 222
E+ I+ L H N++ L G T + ++ EY + DL +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 223 HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA---- 278
S + + Q+ G+ S+ +HRD+ N+L+ N + KI DFGLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 279 --SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKP 331
S Y N L + W PE + Y D+WS G +L E+ P
Sbjct: 216 NDSNYIVKGNARLPVK----WM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 60/263 (22%), Positives = 100/263 (38%), Gaps = 61/263 (23%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRF 175
W PR D +G+G + V A + VA+K ++ D E +
Sbjct: 76 WEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 176 MAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------A 218
+ E+ +++ + H N+I L G T LY++ EY +L
Sbjct: 134 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 219 GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+ P + + + QL G+++ S+ +HRD+ N+L+ N ++KIADFGLA
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 279 SFYDPDQNQPLTSRVV--TLWYR------------PPELLLGATYYGTAVDLWSTGCILA 324
R + +Y+ PE L Y D+WS G ++
Sbjct: 251 -------------RDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMW 296
Query: 325 EL--YAGKPIMPGRTEVEQLHKI 345
E+ G P PG E +
Sbjct: 297 EIFTLGGSP-YPGIPVEELFKLL 318
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 55/254 (21%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYR--ARDLDQKK---IVALKKVRFDNLEPESVRFMARE 179
VPR+ + + +G G + VY + VA+K + E + + F+ E
Sbjct: 68 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 124
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLKFSEAQ 232
I+ + +H N+++ G+ + +++ E M DL +
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 233 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDPDQNQP 288
+ + + CG + +HRDI N L+ G + KI DFG+A Y
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---- 238
Query: 289 LTSRVVTLWYR------------PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKP 331
+YR PPE + G + D WS G +L E+ P
Sbjct: 239 --------YYRKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 332 IMPGRTEVEQLHKI 345
P ++ E L +
Sbjct: 287 Y-PSKSNQEVLEFV 299
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 30/180 (16%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRF 175
W +PR D +G+G + V A ++ VA+K ++ D E +
Sbjct: 64 WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 176 MAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------A 218
+ E+ +++ + H N+I L G T LY++ EY +L
Sbjct: 122 I-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 219 GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+ +P + S + Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/257 (22%), Positives = 95/257 (36%), Gaps = 50/257 (19%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIK 193
+IG+G++ ++ +L + VA+K + P+ + E + L I +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVY 72
Query: 194 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 253
G + LV + + L L G KFS V +Q+L + H + ++
Sbjct: 73 YFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128
Query: 254 HRDIKGSNLLI-----DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGA 307
+RDIK N LI N ++ + DFG+ FY DP Q + YR + L G
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREKKNLSGT 181
Query: 308 TYY-------GTAV----DLWSTGCILAELYAGK---PIMPGRTEVEQLHKIFK------ 347
Y G DL + G + G + T ++ +I +
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241
Query: 348 ---LC-GSPSE--DYWR 358
LC G P E Y
Sbjct: 242 LRELCAGFPEEFYKYMH 258
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 35/185 (18%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMA 177
W PR ++ E +G G + V A VA+K ++ E M
Sbjct: 40 WEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM- 96
Query: 178 REIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGL 220
E+ ++ +L H N++ L G T +YL+FEY + DL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 221 ASHPGLKFSEAQVKCYMQQLLC-------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273
+ L+ E + LLC G++ + +HRD+ N+L+ + ++KI
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 274 DFGLA 278
DFGLA
Sbjct: 215 DFGLA 219
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 61/257 (23%), Positives = 99/257 (38%), Gaps = 46/257 (17%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-- 186
+ + KIG G++ ++Y D+ + VA+K P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 187 -DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
I I+ G +V E + L L + KFS V Q++ ++
Sbjct: 64 GVGIPTIRWCG----AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 246 HCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPP 301
+ HS+ +HRD+K N L+ ++ I DFGLA Y D +Q + YR
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-------YREN 172
Query: 302 ELLLGATYY-------GTAV----DLWSTGCILAELYAGK---PIMPGRTEVEQLHKIFK 347
+ L G Y G DL S G +L G + T+ ++ +I +
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
Query: 348 ---------LC-GSPSE 354
LC G PSE
Sbjct: 233 KKMSTPIEVLCKGYPSE 249
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 53/221 (23%), Positives = 82/221 (37%), Gaps = 39/221 (17%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF--MAREIHILRRL--- 186
F KIG G + + ++L + VA+K LEP R + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
D I + G +V E + L L FS V QL+ +++
Sbjct: 65 DGIPQVYYFG----PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 247 CHSRGVLHRDIKGSNLLI-----DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRP 300
HS+ +++RD+K N LI ++ I DF LA Y DP+ + + YR
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-------YRE 173
Query: 301 PELLLGATYY-------GTAV----DLWSTGCILAELYAGK 330
+ L G Y G DL + G + G
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 44/225 (19%), Positives = 73/225 (32%), Gaps = 39/225 (17%)
Query: 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE- 195
IGQG + +Y A + V +EP + E+ +R I+
Sbjct: 42 PIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 196 ----------------GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
GL +++ + DL + +FS V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFY-DPDQNQPLTSRVVTL 296
+L L++ H +H DIK SNLL++ N + + D+GLA Y ++
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 297 WYRPPELLLGATYY-------GTAV----DLWSTGCILAELYAGK 330
P G + G A DL G + + G
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 15/169 (8%)
Query: 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
PR + F KIG G++ +Y ++ + VA+K P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 186 L---DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC 242
L I ++ G LV + + L L + K S V Q++
Sbjct: 59 LQGGTGIPNVRWFG----VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFY-DPDQNQ 287
++ HS+ LHRDIK N L+ + I DFGLA Y D +Q
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 26/178 (14%), Positives = 52/178 (29%), Gaps = 33/178 (18%)
Query: 137 KIGQGTYSNVYRARDLDQKKI--------VALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+ +Y A +LK L+ + R + E + +R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGR-LFNEQNFFQRAAK 101
Query: 189 INVIKLEG------------LVTSRMSCSLY--LVFEYMEHDLAGL-ASHPGLKFSEAQV 233
+ + + Y LV + L P SE V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 234 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI--DNNGILKIADFGLASFY-DPDQNQP 288
+LL L+ H +H ++ N+ + ++ + +A +G A Y ++
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 52/428 (12%), Positives = 124/428 (28%), Gaps = 131/428 (30%)
Query: 5 CFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLIDKQV 64
+PS + R+RL + + + SR + ++ R L++ +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNV---SRLQPYLKL---------RQALLELRP 149
Query: 65 NGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAA--VAGEAIQ 122
+V + G + G G K W+A +Q
Sbjct: 150 AKNVLIDG---------V--------LGSG---K------------TWVALDVCLSYKVQ 177
Query: 123 G-------WVP-RRADSFEKLDKIGQGTYSNV---YRARDLDQKKIVALKKVRFDNLEPE 171
W+ + +S E + ++ Q + + +R I K+R +++ E
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI----KLRIHSIQAE 233
Query: 172 SVRFMAREIH-----ILRRLDHINVIK-LEG----LVTSRMSC------SLYLVFEYMEH 215
R + + + +L + + L+T+R + ++H
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 216 DLAGLASHPGLKFSEAQVKCYMQQL----------LCGL-------DHCHSRGVLHRDIK 258
L + C Q L + H +
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 259 GSNLLIDNN-GILKIADF-----GLASFYDPDQNQPLTSRV-VTLW----YRPPELLLGA 307
+I+++ +L+ A++ L+ F P + + + + +W +++
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVF--PP-SAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 308 TYYGTAVDLWSTG--CILAELYAGKPIMPGRTEVE---QLHKIF--------KLCGS--- 351
+ + V+ + +Y + + ++E LH+
Sbjct: 411 LHKYSLVEKQPKESTISIPSIY-----LELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 352 -PSED-YW 357
P D Y+
Sbjct: 466 PPYLDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 3e-07
Identities = 35/316 (11%), Positives = 91/316 (28%), Gaps = 65/316 (20%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRF--DSNDGRAM 58
+ C P + + + ++ +S S R + R +
Sbjct: 189 LKN-CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 59 LI-----DKQVNGSVRLHGENFD---------RKREKMEYVVAQH--HPGMGSIPKA--- 99
L+ + + F+ R ++ +++ A H +
Sbjct: 248 LVLLNVQNAKA-------WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 100 SEGEQVAAGWPAWLAAVAGEAIQGWVPRRADS--------FEKLDKIGQGTYSNVYRARD 151
E + + L Q +PR + + + G T+ N +
Sbjct: 301 DEVKSL-------LLKYLDCRPQD-LPREVLTTNPRRLSIIAESIRDGLATWDNW---KH 349
Query: 152 LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL--YLV 209
++ K+ + + + LEP R M + + + + + + + ++
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAH-------IPTILLSLIWFDVI 400
Query: 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD-HCHSRGVLHRDIKGS-NLL--ID 265
+ + L + ++ + + + L + LHR I N+ D
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460
Query: 266 NNGILKIADFGLASFY 281
++ ++ FY
Sbjct: 461 SDDLIPPYLDQY--FY 474
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 15/121 (12%)
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQP 288
CY Q+ G++ SR +HRD+ N+L+ ++KI DFGLA Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIF 346
L + W PE + Y D+WS G +L E+ P PG E+ +
Sbjct: 257 LPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRL 309
Query: 347 K 347
K
Sbjct: 310 K 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 124 W-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMA 177
W PR D + +G+G + V A K VA+K ++ + R +
Sbjct: 17 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 178 REIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH 215
E+ IL + H+NV+ L G T + L ++ E+ +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/159 (15%), Positives = 53/159 (33%), Gaps = 29/159 (18%)
Query: 135 LDKIGQGTYSNVYRARDLDQ----KKIVALKKVRFDNL----EPESVRFM-------ARE 179
+G+G S V+ K + F + + + F E
Sbjct: 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 154
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 239
L++L + V K+ + ++ E ++ ++ +
Sbjct: 155 FRALQKLQGLAVPKVYAWEGN------AVLMELIDAK-----ELYRVRVENPD--EVLDM 201
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278
+L + + RG++H D+ N+L+ GI I DF +
Sbjct: 202 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.6 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.25 | |
| 3p34_A | 232 | Serine/threonine-protein kinase PLK1; phosphoprote | 94.02 | |
| 1q4k_B | 259 | Serine/threonine-protein kinase PLK; six-stranded | 93.57 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.57 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-60 Score=522.32 Aligned_cols=294 Identities=33% Similarity=0.503 Sum_probs=248.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~ 204 (709)
.++|++++.||+|+||.||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ..+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999999999999999987666666677888999999999999999999987642 246
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|||||||+|+|...+... ..|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 89999999999988777654 47999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 ---QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ---~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.....++.+||++|||||++.+...|+.++||||||||||||++|++||.+.+..+++..|++..|.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 23345677999999999999988778999999999999999999999999999999999999999999988775432
Q ss_pred CCCccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 362 LPHATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 362 lp~~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
......+.. .......+...++.+++++++||.+||++||.+|+|++|+|+||||+..+.|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 221111100 01111235566778999999999999999999999999999999999876554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=489.76 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=210.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|++..+|+.||||+++..... ......+.+|+.+|+.|+|||||++++++.+ .+.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 88 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEI 88 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 468899999999999999999999999999999999876543 3345678899999999999999999999987 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||||+|+|+..+... ..|++.+++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus 89 ~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp EEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999999999888877654 47999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
....+.+||+.|||||++.+..+++.++||||||||||||+||++||.+.+..+.+..|... .+
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~-------------- 229 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VY-------------- 229 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CC--------------
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence 23456799999999999998876688999999999999999999999999888888777542 11
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 230 -------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 -------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 012357899999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=498.15 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=225.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|++..+++.||||++.+... .....+.+.+|+.+|+.|+|||||+++++|.+ .+.+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 46789999999999999999999999999999999986432 22345678899999999999999999999987 6789
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||+| +|...+. ....|+|.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 108 yivmEy~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999986 4555544 34579999999999999999999999999999999999999999999999999999875433
Q ss_pred -CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 -NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 -~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+.+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|.+.- +
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~------------ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y------------ 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C------------
T ss_pred CcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C------------
Confidence 23455779999999999998765 8999999999999999999999999999999999887631 1
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHH------HHhcccCCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS------ALRSEFFTMKP 420 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e------~L~hp~f~~~~ 420 (709)
.....+++++++||.+||++||.+|+|++| +++||||+...
T Consensus 252 ---------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 252 ---------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 012357899999999999999999999987 58999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=503.69 Aligned_cols=259 Identities=25% Similarity=0.462 Sum_probs=222.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 689999999999999999999999999999999999887777778889999999999999999999999987 678999
Q ss_pred EEeeccc-ccccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||+| +|...+. ..+..++|.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 9999986 5656554 34456899999999999999999999999999999999999999999999999999876432 1
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
...++.+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|.+....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------- 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------------- 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------------
T ss_pred ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 2234568999999999998765 899999999999999999999999999999999988763111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 244 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 -------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1123588999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=501.18 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=223.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
...|+++++||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ .+.+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 35699999999999999999999999999999999865432 23457799999999999999999999987 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||||+++.+..+... ..|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.... ..
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 9999997655544443 369999999999999999999999999999999999999999999999999998775432 33
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.++.+||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~--------------- 289 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR--------------- 289 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC---------------
T ss_pred ccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC---------------
Confidence 45679999999999987655 89999999999999999999999999999998888865211 11
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
...+..+++++++||.+||++||.+|||++|+|+||||+...
T Consensus 290 ----------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 ----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 012245899999999999999999999999999999998653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=503.16 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=223.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
..|+++++||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ .+.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEE
Confidence 5799999999999999999999999999999999865432 23457899999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||+|+.+..+... ..|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999997655544443 369999999999999999999999999999999999999999999999999998775432 344
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
++.+||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|.... .+.
T Consensus 305 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~---------------- 366 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPR---------------- 366 (423)
T ss_dssp CCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC----------------
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCC----------------
Confidence 6679999999999987755 8999999999999999999999999999999888886521 110
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+..+++++++||.+||++||.+|+|++|+|+||||+..
T Consensus 367 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11234689999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-57 Score=476.80 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=217.0
Q ss_pred CCe-eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--CCCeE
Q 005210 130 DSF-EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSL 206 (709)
Q Consensus 130 ~~y-~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~l 206 (709)
++| ++.++||+|+||.||+|.+..++..||||++..........+.+.+|+.+|+.|+|||||+++++|... ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 677889999999999999999999999999987777777778899999999999999999999998652 24578
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcC-CCcEEEeecccccccCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDN-NGILKIADFGLASFYDP 283 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~-~g~vKL~DFGla~~~~~ 283 (709)
|||||||+++.+..+......+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999997555544444558999999999999999999999998 999999999999984 79999999999986432
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
....+.+||+.|||||++.+ .|+.++||||||||||||+||++||.+.+....+.+++.. +.++.
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~--------- 249 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA--------- 249 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG---------
T ss_pred ---CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC---------
Confidence 33456799999999998865 3899999999999999999999999887766655544321 11111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 250 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1123578899999999999999999999999999999853
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=485.27 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=214.0
Q ss_pred CCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++++.||+|+||.||+|++. .+++.||||+++...........+.+|+.+|+.|+|||||++++++.+ .+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 468999999999999999999984 468899999997654333333356789999999999999999999987 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|||||||+|+.+..++.....|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999965444433444579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
....+.+||+.|||||++.+.. |+.++||||||||||||+||++||.+.+..+.+.+|.+.. +
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------------- 243 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------------- 243 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-------------
T ss_pred -ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C-------------
Confidence 3345679999999999998765 8999999999999999999999999999999999887521 1
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....+|+++.+||.+||++||.+||| ++|+|+||||+..
T Consensus 244 --------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 244 --------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 112358899999999999999999998 5899999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=480.15 Aligned_cols=286 Identities=28% Similarity=0.406 Sum_probs=224.2
Q ss_pred cCCCCCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 125 VPRRADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
+|...+.|++++.||+|+||.||+|++. .+++.||||++.... ....+.+|+.+|+.+ +|||||+++++|..
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3455688999999999999999999875 468899999986543 234567899999998 79999999999987
Q ss_pred cCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeeccccc
Q 005210 201 RMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLAS 279 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~ 279 (709)
.+.+|||||||+++.+..+.. .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus 92 --~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 --NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp --TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 678999999998644433332 59999999999999999999999999999999999999876 899999999997
Q ss_pred ccCCCC---------------------------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC
Q 005210 280 FYDPDQ---------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI 332 (709)
Q Consensus 280 ~~~~~~---------------------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p 332 (709)
...... ....++.+||++|||||++.+...|+.++||||+|||||||++|++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 653221 12234568999999999999887799999999999999999999987
Q ss_pred C-CCCChHHHHHHHHHhhCCCChhhhhhcC---------CCCcc------------ccCC----CCccccchhcccCCCC
Q 005210 333 M-PGRTEVEQLHKIFKLCGSPSEDYWRKSK---------LPHAT------------IFKP----QQPYKRCVAETFKDFP 386 (709)
Q Consensus 333 F-~g~~~~e~l~~I~k~~g~p~~~~w~~~~---------lp~~~------------~~~~----~~~~~~~~~~~~~~~s 386 (709)
| .+.++.+++.+|++.+|++....+.... .|... ...+ .........+.+..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 6778899999999999976554433211 00000 0000 0000011223456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 387 APALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 387 ~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
++++|||.+||++||.+|+|++|+|+||||+..
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=479.49 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=215.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++.++||+|+||.||+|++..+|+.||||+++..... .+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 56799999999999999999999999999999999865432 369999999999999999999987 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~~ 287 (709)
|||||+|+.+..++.....|++.+++.|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999654444444445799999999999999999999999999999999999999988 6999999999877543221
Q ss_pred ----CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 ----PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ----~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|... .+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG----------
T ss_pred cceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC----------
Confidence 123458999999999998865 899999999999999999999999998887777777652 110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------HhcccCCCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA-------------LRSEFFTMKPL 421 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~-------------L~hp~f~~~~~ 421 (709)
+.+..+++++.+.+||.+||++||.+|||+.|+ |+|||+.....
T Consensus 275 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 275 --------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp --------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred --------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 123345789999999999999999999999997 56999976533
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=457.57 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=196.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC-----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----- 203 (709)
.++|++++.||+|+||.||+|++..+|+.||||+++... .....+.+.+|+.+|+.|+|||||+++++|.....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 457999999999999999999999999999999998654 34455678899999999999999999999875322
Q ss_pred -----CeEEEEEeeccccccccccCCCCC---CCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 204 -----CSLYLVFEYMEHDLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 204 -----~~lyLVmEy~~g~L~~~~~~~~~~---lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
..+|||||||.++.+..+...... ..+..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 258999999987544433332222 456678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-----------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH
Q 005210 276 GLASFYDPDQN-----------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344 (709)
Q Consensus 276 Gla~~~~~~~~-----------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~ 344 (709)
|+|+.+..... ...++.+||+.|||||++.+.. |+.++||||||||||||++ ||.+. .+....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 99987653221 1234568999999999998765 8999999999999999996 66543 333333
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+........+. .+...++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 237 LTDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 33222111111 122346678899999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=489.39 Aligned_cols=268 Identities=24% Similarity=0.379 Sum_probs=233.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+ .+.+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997643 3445678899999999999999999999987 788999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC--CcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--GILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~--g~vKL~DFGla~~~~~~~ 285 (709)
|||||+| +|...+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999986 5666666666689999999999999999999999999999999999999854 89999999999987543
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+++..|.+....+...
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 378 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---------- 378 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG----------
T ss_pred -CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc----------
Confidence 3345679999999999998865 8999999999999999999999999999999999887643333222
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 428 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~ 428 (709)
.+..+++++++||.+||++||.+|||+.|+|+||||+....+.....+
T Consensus 379 ---------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~ 426 (573)
T 3uto_A 379 ---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426 (573)
T ss_dssp ---------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence 235689999999999999999999999999999999987666554433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=446.82 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=209.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.++||+|+||.||+|++.. .||||+++......+..+.+.+|+.+|++|+|||||++++++.. +.+|
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEE
Confidence 35789999999999999999998643 49999998766677778889999999999999999999998754 4589
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-C
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-Q 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~ 285 (709)
||||||++ +|...+......+++.++..|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+..... .
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999996 555555555568999999999999999999999999999999999999999999999999999876432 2
Q ss_pred CCCccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
....+..+||+.|||||++.+. ..|+.++||||||||||||+||++||.+.+..+.+..++.....++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---------- 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---------- 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC----------
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC----------
Confidence 2334567899999999999753 3489999999999999999999999999887776666544211110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.....++|+.+.+||.+||+.||.+|||+.+++++
T Consensus 258 -------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 258 -------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0122345689999999999999999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=429.18 Aligned_cols=286 Identities=40% Similarity=0.715 Sum_probs=245.5
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 68999999999999999999999999999999998776666666778899999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccc
Confidence 999999988887776678999999999999999999999999999999999999999999999999999876432 2233
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~~ 367 (709)
...+||+.|+|||++.+...|+.++|||||||++|+|++|. |+|.+.+..+++..+++.++.|..+.|.... ++...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 237 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK- 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC-
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc-
Confidence 45688999999999988777899999999999999999765 5588888999999999999999988876432 11111
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
-.+..+....+....+.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1111222233445566789999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=479.98 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=213.6
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC----ChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIKLEGLVTSR 201 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~----~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~ 201 (709)
+...++|++++.||+|+||.||+|++..+|+.||||++.+... ..........++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 4457899999999999999999999999999999999975432 11222222344566677799999999999987
Q ss_pred CCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 202 MSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
...+|||||||.|+ |..++. ....|+|..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 67899999999964 555544 345799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCChhhh
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~---~~e~l~~I~k~~g~p~~~~w 357 (709)
+.... ..+.+||+.|||||++.+...|+.++||||||||||||++|++||.+.+ ..+....+... .
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~------ 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--A------ 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--C------
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--C------
Confidence 64332 3456999999999999766668999999999999999999999998743 23333333321 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
...+..+|+++++||.+||++||.+|++ ++|+++||||+..
T Consensus 411 ---------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 411 ---------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 0122468999999999999999999998 7999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=456.59 Aligned_cols=294 Identities=35% Similarity=0.556 Sum_probs=231.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ 205 (709)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 57899999999999999999999999999999999766556667788899999999999999999999885422 357
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||++++|..++... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 9999999999888877654 479999999999999999999999999999999999999999999999999998764221
Q ss_pred C--------------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-----------
Q 005210 286 N--------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA----------- 328 (709)
Q Consensus 286 ~--------------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt----------- 328 (709)
. ...+..+||++|+|||++.....|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 134567899999999988766679999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCC--CccccchhcccCCCC
Q 005210 329 GKPIMPGRT--------------------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ--QPYKRCVAETFKDFP 386 (709)
Q Consensus 329 G~~pF~g~~--------------------~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~--~~~~~~~~~~~~~~s 386 (709)
|+++|+|.+ ..+++..|+..+|.|..+.|.......+..+... ......+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 889998865 3688999999999999988765332222111111 111223556677889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 387 APALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 387 ~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
+++.+||.+||.+||.+|||++|+|+||||+....+.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 9999999999999999999999999999999765543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=431.22 Aligned_cols=287 Identities=39% Similarity=0.692 Sum_probs=239.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 688999999999999999999985 58999999997665444455678899999999999999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999999888887777779999999999999999999999999999999999999999999999999998764322 23
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc-cc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~-~~ 367 (709)
....++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+.+..++..++.+....|........ ..
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 34568899999999998866789999999999999999999999999999999999999999998877754321110 00
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..........+....+.+++++.+||.+||++||.+|||++++|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0111111223455567789999999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=437.40 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=210.3
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
-++|.+.+.||+|+||.||+|++. .++..||||+++.. .....+.+.+|+.+|++|+|||||++++++.+ .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 367999999999999999999875 36889999999743 35556778999999999999999999999977 6
Q ss_pred CeEEEEEeecccc-ccccccC------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcE
Q 005210 204 CSLYLVFEYMEHD-LAGLASH------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 270 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~v 270 (709)
+.+|||||||+++ |...+.. ....|++.++..|+.||+.||.|||+++||||||||+||||+.++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 7899999999864 4444432 23469999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 005210 271 KIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 271 KL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~ 348 (709)
||+|||+|+........ .....+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..|.+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876433222 223457899999999998765 8999999999999999998 99999999988888877652
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
. . ......+|+++.+||.+||+.||.+|||+.+++ +||+
T Consensus 247 ~--~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 247 R--V--------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp C--C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred C--C--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 1 1 011245889999999999999999999999984 4554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=447.27 Aligned_cols=290 Identities=33% Similarity=0.548 Sum_probs=232.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 57899999999999999999999999999999999766556666777889999999997 99999999999865556899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC---
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--- 284 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~--- 284 (709)
||||||+++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999988776654 36899999999999999999999999999999999999999999999999999865321
Q ss_pred -----------------CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 005210 285 -----------------QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 347 (709)
Q Consensus 285 -----------------~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k 347 (709)
.....+..+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 122345568999999999998867789999999999999999999999999999999999999
Q ss_pred hhCCCChhhhhhcCCCCccccCC---------CCcccc-------ch--hcccCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 005210 348 LCGSPSEDYWRKSKLPHATIFKP---------QQPYKR-------CV--AETFKDFPAPALALMETLLSIDPADRGSAAS 409 (709)
Q Consensus 348 ~~g~p~~~~w~~~~lp~~~~~~~---------~~~~~~-------~~--~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e 409 (709)
.++.|..+.+.....+....+.. ...... .. ......+++.+.+||.+||++||.+|||+++
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 99999988775543332211100 000000 00 0112368999999999999999999999999
Q ss_pred HHhcccCCCCC
Q 005210 410 ALRSEFFTMKP 420 (709)
Q Consensus 410 ~L~hp~f~~~~ 420 (709)
+|+||||+...
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=438.88 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=203.9
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|.+.++||+|+||.||+|++. .++..||||+++.. .....+.+.+|+.+|++|+|||||++++++.+ .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 357999999999999999999865 46889999999743 45566778999999999999999999999976 6
Q ss_pred CeEEEEEeecccc-ccccccC--------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC
Q 005210 204 CSLYLVFEYMEHD-LAGLASH--------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~--------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g 268 (709)
..+|||||||+++ |..++.. ...+|++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 7899999999965 4443322 124699999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005210 269 ILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 346 (709)
Q Consensus 269 ~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~ 346 (709)
++||+|||+|+.+..... ...+..+||+.|||||++.+.. |+.++||||||||||||+| |++||.+.+..+.+..|.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987643322 2334568999999999998765 8999999999999999999 999999999888888775
Q ss_pred HhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 347 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 347 k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+.. . ......+|+++.+||.+||+.||.+|||+.|++++
T Consensus 275 ~g~--~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGR--E--------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTC--C--------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCC--C--------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 421 1 01124578999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=446.40 Aligned_cols=294 Identities=32% Similarity=0.549 Sum_probs=242.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC---Ce
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~~ 205 (709)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.|+||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 678999999999999999999999999999999998665566667788999999999999999999999865321 57
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||++++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 9999999999888777653 479999999999999999999999999999999999999999999999999998764332
Q ss_pred C---------------------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-----------CCCCC
Q 005210 286 N---------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-----------GKPIM 333 (709)
Q Consensus 286 ~---------------------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-----------G~~pF 333 (709)
. ...+..+||++|+|||++.....|+.++||||||||||||++ |+++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 134677999999999998776779999999999999999997 67888
Q ss_pred CCCC-----------------hHHHHHHHHHhhCCCChhhhhhcCCCCccccCC--CCccccchhcccCCCCHHHHHHHH
Q 005210 334 PGRT-----------------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP--QQPYKRCVAETFKDFPAPALALME 394 (709)
Q Consensus 334 ~g~~-----------------~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~ 394 (709)
+|.+ ..+++..|+..+|.|+.+.+.....+....+.. .......+...++.+++.+.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 8765 478899999999999998876533222211110 111112344566789999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 395 TLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 395 ~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
+||++||.+|||++|+|+||||+....+.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999999999999999999765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=421.64 Aligned_cols=283 Identities=37% Similarity=0.683 Sum_probs=235.1
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 6799999999999999999998 678999999997654333334567799999999999999999999976 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998888777666689999999999999999999999999999999999999999999999999998764322 223
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCcc-c
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHAT-I 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~~-~ 367 (709)
...++|+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+.+..+++.++.+....|.... ++... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 455889999999999876668999999999999999999999999999999999999999998887775321 11110 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+... ....+......+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVY--EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCC--CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccc--cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000 011234455678999999999999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=434.05 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=210.0
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
..+++++++||+|+||.||+|... .+++.||||+++... .....+.+.+|+.+|++|+|||||++++++.. .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--C
Confidence 457889999999999999999864 467899999997543 33345678899999999999999999999976 5
Q ss_pred CeEEEEEeeccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
..+|||||||++ +|...+... ...|++.++..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 679999999986 454544321 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCC-CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005210 268 GILKIADFGLASFYDPD-QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 345 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I 345 (709)
+++||+|||+|+.+... .....+..+||+.|||||++.+.. |+.++||||||||||||+| |++||.+.+..+.+..|
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999876432 223345568999999999998765 8999999999999999998 89999999988887777
Q ss_pred HHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 346 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 346 ~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
...... ....++|+.+.+||..||+.||.+|||+.+++++
T Consensus 261 ~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 532100 1124688999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=453.82 Aligned_cols=287 Identities=31% Similarity=0.527 Sum_probs=232.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++|||||++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999999999999999999876555666778889999999999999999999986532 25
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|||||||++++...+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999988877654 4899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
...+..+||++|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|++.+|.|..++|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 3345679999999999998864 8999999999999999999999999999999999999999999998875432000
Q ss_pred ccccCCCCccc-cchhcccCC------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIFKPQQPYK-RCVAETFKD------------FPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~~~~~~~~-~~~~~~~~~------------~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...+.....+. ..+...++. .++.+++||.+||++||.+|||++|+|+||||+....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 00000000000 001111111 2567999999999999999999999999999986433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=434.67 Aligned_cols=290 Identities=32% Similarity=0.536 Sum_probs=237.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999999999999999997655555666778899999999999999999999875321 4
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+||||||++++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 5799999997777666554 36999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.+..++|++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|++.+|.|+.+.+.......
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 3456899999999999886668999999999999999999999999999999999999999999988876432211
Q ss_pred ccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 365 ATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 365 ~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
...+.. .......+...+..+++.+.+||.+||.+||.+|||++++|+||||+....+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 111100 001122345566788999999999999999999999999999999997655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=423.71 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=226.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 3678999999999999999999999999999999998777677777888999999999999999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--G 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--C
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--C
Confidence 99999986444333333347999999999999999999999999999999999999999999999999999876433 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||++|+|||++.+...++.++|||||||+||+|++|++||.+.+..+....+.... +
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~--------------- 231 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--Y--------------- 231 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C---------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------
Confidence 34567899999999999987766789999999999999999999999999888887776421 1
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.....+++.+.+||.+||..||.+|||++++|+||||+...
T Consensus 232 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 232 ------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 01124788999999999999999999999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=425.60 Aligned_cols=296 Identities=44% Similarity=0.700 Sum_probs=242.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC-----
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----- 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----- 202 (709)
..++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 468899999999999999999999999999999998766544444455678999999999999999999987643
Q ss_pred -CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 -SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 -~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+||||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3578999999999988888777678999999999999999999999999999999999999999999999999999876
Q ss_pred CCC---CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 282 DPD---QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~~---~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
... ........+||+.|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|.+.++.+..+.|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 422 22233556889999999999887778999999999999999999999999999999999999999999888775
Q ss_pred hcCCCCc-cccCCCCccccchhcccC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 359 KSKLPHA-TIFKPQQPYKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 359 ~~~lp~~-~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
....... ..+.........+...+. ..++.+.+||.+||++||.+|||++|+|+||||+..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 4221100 000000000011111111 1478899999999999999999999999999999876554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=423.97 Aligned_cols=288 Identities=36% Similarity=0.666 Sum_probs=224.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++.... ......+.+|+.+|+.++||||+++++++.. .+.+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 5689999999999999999999999999999999976542 2233457789999999999999999999876 678999
Q ss_pred EEeeccccccccccC-----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 209 VFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 209 VmEy~~g~L~~~~~~-----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
||||++++|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999999887665532 123589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-C
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-L 362 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-l 362 (709)
.. ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..|++.+|.+....|.... +
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 22 223456889999999999876668999999999999999999999999999999999999999999988876422 2
Q ss_pred CCccccC---CCCccccc-hhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 363 PHATIFK---PQQPYKRC-VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 363 p~~~~~~---~~~~~~~~-~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+...... +....... .......++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 2111100 01111111 1122346889999999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=431.85 Aligned_cols=290 Identities=33% Similarity=0.529 Sum_probs=228.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~ 204 (709)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 5789999999999999999999999999999999976555556677788999999999999999999998652 125
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||++++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999998877776654 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
..+..+||++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|++.+|.|..+.|.......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23456899999999999886678999999999999999999999999999999999999999999988876432211
Q ss_pred ccccCC--CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 365 ATIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 365 ~~~~~~--~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
...+.. .......+...+..+++.+.+||.+||++||.+|||++++|+||||+....+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 111100 001112344556788999999999999999999999999999999997655543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=423.69 Aligned_cols=297 Identities=39% Similarity=0.691 Sum_probs=241.3
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP---ESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
...++|++++.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--K 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--T
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--C
Confidence 34678999999999999999999999999999999987543221 122457789999999999999999999876 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..+|+||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 77999999999988887777666899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-C
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-L 362 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-l 362 (709)
.. ......++|+.|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|+..++.+..+.|.... +
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Cc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 32 234556899999999999876668999999999999999999999999999999999999999999988885432 2
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 428 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~ 428 (709)
+....+... ....+...+..+++.+.+||.+||..||.+|||++|+|+||||+..+.+.....+
T Consensus 244 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~ 307 (346)
T 1ua2_A 244 PDYVTFKSF--PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307 (346)
T ss_dssp TTCCCCCCC--CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred ccccccccc--CCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccC
Confidence 211111110 1112344557789999999999999999999999999999999987666544333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=425.27 Aligned_cols=287 Identities=37% Similarity=0.663 Sum_probs=232.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 6899999999999999999999999999999999754321 111234579999999999999999999976 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+++++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccc
Confidence 999999988887776667999999999999999999999999999999999999999999999999999865432 2233
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc-ccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~-~~~ 368 (709)
...+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..+++.++.|..+.|........ ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4558899999999998867789999999999999999999999999999999999999999999888754211100 000
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.........+......+++.+.+||.+||++||.+|||++|+|+||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 1111111223445567899999999999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=421.73 Aligned_cols=288 Identities=36% Similarity=0.662 Sum_probs=228.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 3678999999999999999999999999999999998665555555667799999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-----CCCcEEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-----NNGILKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-----~~g~vKL~DFGla~~~~ 282 (709)
|||||++++|...+.... .+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999999998877765543 699999999999999999999999999999999999994 45569999999998765
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK- 361 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~- 361 (709)
... ......++|+.|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+.+.+++..++.|....|....
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 332 233456789999999999887778999999999999999999999999999999999999999999887775422
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
++......+..............+++.+.+||.+||++||.+|||++++|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 1111111111111111111223478999999999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=430.94 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=208.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-----CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+..+ ++.||||++.... .....+.+.+|+.+|.+|.| ||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 47899999999999999999997654 4689999997543 34456678899999999965 8999999988653
Q ss_pred CCeEEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 203 SCSLYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
...+|||||||+++ |...+.. ....|++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 45789999999964 4444321 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHH
Q 005210 267 NGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 344 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~ 344 (709)
++++||+|||+|+.+...... ..+..+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+.+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876443322 234567899999999998765 8999999999999999998 9999998775555555
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
++.....+ .....+++++.+||..||+.||.+|||+.++++|
T Consensus 300 ~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44321111 1123578999999999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=413.45 Aligned_cols=286 Identities=38% Similarity=0.637 Sum_probs=233.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC---hHHHHHHHHHHHHHHhc---CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRL---DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999999999999999999754321 11123455777777766 4999999999987633
Q ss_pred C---CeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 203 S---CSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 203 ~---~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
. ..+|+||||++++|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2589999999998877766543 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+++.+|+..++.+....|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876432 2345668999999999998765 7999999999999999999999999999999999999999999988885
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.........+.+. ....+....+.+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 4322222222221 1223455667899999999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=407.32 Aligned_cols=289 Identities=32% Similarity=0.554 Sum_probs=235.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 468999999999999999999999999999999997766666667778899999999999999999999987 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 99999988777666556679999999999999999999999999999999999999999999999999998764322 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc-cc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TI 367 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~-~~ 367 (709)
....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++......+........ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 34568899999999998866789999999999999999999999999999999999998888877654332111100 00
Q ss_pred c-CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 368 F-KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 368 ~-~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
. .+.......+...++.++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0 0111111223344567999999999999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=422.07 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=224.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.+.|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 577999999999999999999999999999999998654321 134568899999999999999999999976 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~ 280 (709)
.+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 8999999997654444444455899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..|.........+.|
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 242 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF--- 242 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred cCCC--CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc---
Confidence 6542 2345568999999999987654 899999999999999999999999999999988888765444443333
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 243 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 ----------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ----------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468899999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=428.93 Aligned_cols=284 Identities=37% Similarity=0.574 Sum_probs=233.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
..+|++++.||+|+||.||+|.+..+++.||||++..... ...+|+.+|+.|+|||||++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999999999999999875431 2237999999999999999999885421 23
Q ss_pred eEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-CcEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~-g~vKL~DFGla~~ 280 (709)
.++|||||+++++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 578999999987665543 345579999999999999999999999999999999999999955 6789999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+.... .....+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.+|++.+|.|..+.|...
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64332 2345689999999999988767899999999999999999999999999999999999999999999888653
Q ss_pred CCCCccccCCCCccccchhcc-cCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAET-FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~-~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
. +....+.........+... ...+++++.+||.+||.+||.+|||+.++|+||||.....
T Consensus 285 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 285 N-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp C-SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred C-hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 2 2222221111111223222 2468899999999999999999999999999999976533
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=421.09 Aligned_cols=282 Identities=31% Similarity=0.530 Sum_probs=232.3
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec------
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR------ 201 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~------ 201 (709)
..++|++++.||+|+||.||+|.+..+|+.||||++...... ..+|+.+|+.|+|||||++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 367899999999999999999999999999999998754321 23799999999999999999988542
Q ss_pred ------------------------------CCCeEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhh
Q 005210 202 ------------------------------MSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCH 248 (709)
Q Consensus 202 ------------------------------~~~~lyLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH 248 (709)
....+|+||||++++|...+. ..+..+++..++.++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 234589999999987655443 34567999999999999999999999
Q ss_pred hCCeeeccCCCccEEEc-CCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHH
Q 005210 249 SRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 327 (709)
Q Consensus 249 ~~gIvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELl 327 (709)
++||+||||||+||||+ .++.+||+|||++..+.... .....++|+.|+|||++.+...|+.++||||||||+|||+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 99999999999999998 68999999999998764432 3345688999999999988777899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhc-ccCCCCHHHHHHHHHhcccCCCCCCC
Q 005210 328 AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE-TFKDFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 328 tG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
+|++||.+.+..+++..|++.+|.|+.+.|....-.......+.... ..+.. ....+++.+.+||.+||++||.+|||
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA-KDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCc-ccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 99999999999999999999999999988765322111111111111 12222 33458999999999999999999999
Q ss_pred HHHHHhcccCCC
Q 005210 407 AASALRSEFFTM 418 (709)
Q Consensus 407 a~e~L~hp~f~~ 418 (709)
+.|+|+||||+.
T Consensus 316 ~~e~l~hp~f~~ 327 (383)
T 3eb0_A 316 PYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHTSGGGHH
T ss_pred HHHHhcCHHHHH
Confidence 999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=416.98 Aligned_cols=292 Identities=34% Similarity=0.525 Sum_probs=242.9
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---C
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---S 203 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~ 203 (709)
...++|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 34578999999999999999999999999999999997533 3445577889999999999999999999886532 2
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 204 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..+|+||||++++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 103 KDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 46899999999988776654 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... ......+||++|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..|...+|.|..+.|....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 221 223456899999999998877778999999999999999999999999999999999999999999988765321
Q ss_pred CCCcccc--CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 362 LPHATIF--KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 362 lp~~~~~--~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
......+ .........+...+..+++.+.+||.+||++||.+|||++++|+||||+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 1110000 00111122345566788999999999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=409.60 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=226.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 57899999999999999999999999999999998743 2344567899999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC--CCcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~--~g~vKL~DFGla~~~~~~~ 285 (709)
|||||++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999986 566666555567999999999999999999999999999999999999987 789999999999876543
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 226 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH---------
T ss_pred -CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh---------
Confidence 2345568999999999998754 79999999999999999999999999999888888876544433333
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+..++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 227 ----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 ----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ----------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 346899999999999999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=423.90 Aligned_cols=287 Identities=29% Similarity=0.520 Sum_probs=225.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 57899999999999999999999999999999999876556666777889999999999999999999987532 23
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+||||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 7899999999988777653 5899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+||+.|+|||++.+.. |+.++||||||||+|+|++|++||.+.+..+++.+|++.++.|..+.|.......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2234568999999999998754 8999999999999999999999999999999999999999999888775321000
Q ss_pred cccc--CCC---Cccccchhcc--------cCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIF--KPQ---QPYKRCVAET--------FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~--~~~---~~~~~~~~~~--------~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...+ .+. .......... ....++.+++||.+||++||.+|||++++|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 0000 000 0000000000 0112567999999999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=420.71 Aligned_cols=283 Identities=34% Similarity=0.541 Sum_probs=230.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
..+|++++.||+|+||.||+|.+..++. ||+|++...... ..+|+.+|+.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 5679999999999999999999988776 888887644211 237999999999999999999986532 23
Q ss_pred eEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGla~~ 280 (709)
.+||||||++++++..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 488999999987665433 2345799999999999999999999999999999999999999 799999999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+.... .....++|++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|++.+|.|..+.+...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64332 2345688999999999988777899999999999999999999999999999999999999999998877543
Q ss_pred CCCCccccCCCCccccchhc-ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAE-TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
.........+... ...+.. ....+++++.+||.+||++||.+|||+.++|+||||+....
T Consensus 270 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 NPNYMEHKFPQIR-PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CGGGSSSCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred Chhhhhhcccccc-CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 2111111111111 111222 23458999999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=416.21 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=224.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.|+||||+++++++.. ...+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 467999999999999999999999999999999998877777777888999999999999999999999977 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEeecccccccCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGla~~~~~~~ 285 (709)
||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 999998754433333445799999999999999999999999999999999999998654 5999999999876532
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. |+.++||||||||+|+|++|++||.+.+..+.+..|..........
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 252 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 252 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred -cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 2334568999999999987754 8999999999999999999999999999888888776543222211
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+..+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 253 ---------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ---------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ---------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 22457899999999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=415.16 Aligned_cols=286 Identities=34% Similarity=0.544 Sum_probs=237.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---- 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~---- 204 (709)
.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 5789999999999999999999999999999999987665666677888999999999999999999998763221
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++|...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 2499999999887776533 5999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+++..+.|..+.+.......
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3456889999999999886668999999999999999999999999999999999999999999888765432111
Q ss_pred ccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...+. ........+...+..+++.+.+||.+||++||.+|||++++|+||||+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 11000 0111122344556778999999999999999999999999999999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=409.24 Aligned_cols=289 Identities=30% Similarity=0.577 Sum_probs=237.6
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
...++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEE
Confidence 34789999999999999999999999999999999998776666666778899999999999999999999987 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999999998777665555579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC-CCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~-lp~~ 365 (709)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.+..+.... .+..
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 223456789999999999887668999999999999999999999999999999999999888887765432110 0000
Q ss_pred c-ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 366 T-IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 366 ~-~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
. ...+...........++.+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0 0011111122244455678999999999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=406.02 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=222.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.+.|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|+.|+||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 457999999999999999999999999999999998654321 135668899999999999999999999976 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~ 280 (709)
.+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 8999999998654444444455799999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+.... .....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..+..........
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 239 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 239 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH-----
T ss_pred CCCCC--ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc-----
Confidence 64332 234568999999999987654 7999999999999999999999999999888888876643333222
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 --------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 240 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp --------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred --------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 23467899999999999999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=420.43 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=216.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
.++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.+ +||||+++++++.. ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 6889999999999999999999999999999999975422 223456678899999998 79999999999977 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||||.++.+.........+++.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence 999999987544444333457999999999999999999999999999999999999999999999999999864322 2
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.....
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 241 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------------- 241 (353)
T ss_dssp -------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2345668999999999987654 89999999999999999999999999999998888865211
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa------~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||++||.+|+++ +++++||||+..
T Consensus 242 -------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 242 -------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 0113478899999999999999999999 999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=413.71 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=219.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEE
Confidence 5789999999999999999999999999999999975421 12334567899999999999999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 99999987544444333457999999999999999999999999999999999999999999999999999864322 22
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+....|.... +
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~--------------- 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--I--------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C---------------
T ss_pred cccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C---------------
Confidence 345668999999999987755 7999999999999999999999999998888777775421 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||+.||.+|| +++++++||||...
T Consensus 223 ------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 01235789999999999999999999 99999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=399.30 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=214.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh------------------------HHHHHHHHHHHHHH
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------------------------ESVRFMAREIHILR 184 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~------------------------~~~~~~~rEi~iL~ 184 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 678999999999999999999999999999999997653211 12356789999999
Q ss_pred hcCCCceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 185 ~L~HpnIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
.|+||||+++++++.......+||||||++++.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999998755678999999998765554443 3479999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCcc--CCccccccchhHHHHHHHhCCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~--y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.......
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998764332 22345689999999999876542 478899999999999999999999988777666
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
..+....... .....+++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 250 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6554311000 01246889999999999999999999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=426.68 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=223.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+|+.|+|||||++++++.. ...+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 568999999999999999999999999999999998777666667788999999999999999999999976 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc---CCCcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGla~~~~~~ 284 (709)
|||||.++ |...+.. ...+++.++..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 88 v~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999875 4444443 45799999999999999999999999999999999999998 4678999999999876543
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
. ......+||+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+..|..........
T Consensus 167 ~-~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------- 235 (444)
T 3soa_A 167 Q-QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--------- 235 (444)
T ss_dssp C-CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred C-ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc---------
Confidence 2 2334568999999999987754 8999999999999999999999999999988888886643222222
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 236 ----------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 ----------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ----------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 23468899999999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=419.74 Aligned_cols=292 Identities=36% Similarity=0.637 Sum_probs=220.5
Q ss_pred CCCeeE-EeeecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEK-LDKIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~-~~~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.+.|++ .++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.|+|||||++++++.......
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345776 448999999999999966 57889999998755433 24668999999999999999999997766788
Q ss_pred EEEEEeeccccccccccC--------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----cCCCcEEEe
Q 005210 206 LYLVFEYMEHDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIA 273 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~--------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~ 273 (709)
+||||||++++|...+.. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999999988776542 22359999999999999999999999999999999999999 677899999
Q ss_pred ecccccccCCCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---------HHHH
Q 005210 274 DFGLASFYDPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQL 342 (709)
Q Consensus 274 DFGla~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---------~e~l 342 (709)
|||++..+..... ......+||++|+|||++.+...|+.++||||||||||||++|++||.+... .+++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987643211 2334568999999999998877789999999999999999999999987765 5889
Q ss_pred HHHHHhhCCCChhhhhhcC-CCCcccc----C----CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSK-LPHATIF----K----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~-lp~~~~~----~----~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..|+..+|.|....|.... ++....+ . ........+.......++.+.+||.+||++||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 9999999999988886432 1111100 0 00000011112223457889999999999999999999999999
Q ss_pred ccCCCCCCCCC
Q 005210 414 EFFTMKPLPCD 424 (709)
Q Consensus 414 p~f~~~~~~~~ 424 (709)
|||+..+.+..
T Consensus 335 p~f~~~~~~~~ 345 (405)
T 3rgf_A 335 PYFLEDPLPTS 345 (405)
T ss_dssp GGGTSSSCCCS
T ss_pred hhhccCCCCcc
Confidence 99998877654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=430.55 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=224.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|+++++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|..++||||+++++++.+ ...+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 149 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNL 149 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEE
Confidence 36789999999999999999999999999999999975321 11112236789999999999999999999977 6789
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||.+ +|...+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999975 5656655545689999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCccccccccCCCCchhhc----CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 286 NQPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~----~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
....+..+||+.|+|||++. +...|+.++|||||||+||||++|++||.+.+..+.+.+|+...... .
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~ 301 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------Q 301 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------C
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc--------c
Confidence 43344568999999999987 24458999999999999999999999999999999988886521100 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMKPL 421 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~~~ 421 (709)
+......+++.+++||.+||+.+|.+ |++++++++||||+...+
T Consensus 302 ----------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 302 ----------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp ----------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred ----------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 11123468999999999999999888 999999999999986543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=399.10 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=219.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV--GDELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEE
Confidence 3678999999999999999999999999999999997654322 3557899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999765444433322 689999999999999999999999999999999999999999999999999987654332
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+....+..+.... .+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~-------------- 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE-------------- 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC--------------
T ss_pred ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC--------------
Confidence 334568999999999998765 7999999999999999999999999998888777665431 110
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 236 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 -----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 01123578899999999999999999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.56 Aligned_cols=286 Identities=34% Similarity=0.546 Sum_probs=235.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----~ 204 (709)
.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999998765556666778899999999999999999999876322 2
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++|...+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 4699999999877766533 5999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+....-..
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 3455889999999999876668999999999999999999999999999999999999999999887765422110
Q ss_pred ccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 365 ATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 365 ~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
...+. ........+...+..+++.+.+||.+||+.||.+|||++++|+||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 00000 0000112233445678999999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=424.63 Aligned_cols=279 Identities=27% Similarity=0.387 Sum_probs=226.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|..++||||+++++++.+ ...+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 46889999999999999999999999999999999975321 12233457789999999999999999999977 6789
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||.+ +|..++...+..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999975 5655555444579999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCccccccccCCCCchhhcC------CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 286 NQPLTSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~------~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
.......+||+.|+|||++.+ ...|+.++||||||||+|||++|++||.+.+..+.+.+|.......
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------- 289 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL------- 289 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc-------
Confidence 333345689999999999973 3458999999999999999999999999999998888886421000
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccCCCCCCCCCCCCCCCCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GSAASALRSEFFTMKPLPCDPSSLPKYPP 433 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kR---pTa~e~L~hp~f~~~~~~~~p~~~p~~pp 433 (709)
. +......+++++++||.+||+ +|.+| ++++++++||||+...+.......|.+.|
T Consensus 290 -~----------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 290 -S----------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp -C----------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred -C----------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 0 001124689999999999999 99998 59999999999987654433333344433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=405.78 Aligned_cols=279 Identities=26% Similarity=0.415 Sum_probs=228.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----CCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----HINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HpnIv~l~~~~~~~~~ 203 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+. ||||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 67899999999999999999999999999999998642 344556778999999996 9999999999987 6
Q ss_pred CeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC----------------
Q 005210 204 CSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---------------- 266 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---------------- 266 (709)
..+||||||++++|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 7899999999777777665433 35999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC
Q 005210 267 ---------NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 337 (709)
Q Consensus 267 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~ 337 (709)
++.+||+|||++...... ....+||+.|+|||++.+.. |+.++|||||||+||+|++|++||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999865332 24568899999999998765 8999999999999999999999999999
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccc-----------------cchhcccCCCCHHHHHHHHHhcccC
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK-----------------RCVAETFKDFPAPALALMETLLSID 400 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~-----------------~~~~~~~~~~s~~~~dLI~~lL~~D 400 (709)
..+.+..+....+.++...+..........+....... .+........++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 99999999998888877665432211111110000000 0111111234577889999999999
Q ss_pred CCCCCCHHHHHhcccCC
Q 005210 401 PADRGSAASALRSEFFT 417 (709)
Q Consensus 401 P~kRpTa~e~L~hp~f~ 417 (709)
|.+|||++++|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.19 Aligned_cols=290 Identities=30% Similarity=0.483 Sum_probs=227.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC-----C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM-----S 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~-----~ 203 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 678999999999999999999999999999999986543221 23457888889999999999999986522 2
Q ss_pred CeEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhh--hCCeeeccCCCccEEEcC-CCcEEEeeccc
Q 005210 204 CSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCH--SRGVLHRDIKGSNLLIDN-NGILKIADFGL 277 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH--~~gIvHrDLKP~NILld~-~g~vKL~DFGl 277 (709)
..+|+||||+++++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 2489999999988665433 35567999999999999999999999 999999999999999996 89999999999
Q ss_pred ccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
+..+.... .....+||+.|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..+.+.++.|..+.|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98765432 2345678999999999987777899999999999999999999999999999999999999999999887
Q ss_pred hhcCCCCccc--c-CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 358 RKSKLPHATI--F-KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 358 ~~~~lp~~~~--~-~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.......... + ....++...+.......++.+.+||.+||+.||.+|||+.++|+||||+....+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 6543221111 0 1112222233333344778999999999999999999999999999998765544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=424.99 Aligned_cols=265 Identities=28% Similarity=0.398 Sum_probs=221.5
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++++.+ ...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 143 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRY 143 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 347899999999999999999999999999999999975311 11112346789999999999999999999977 678
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|||||||+++ |..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|..+...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999764 5444432 36999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCccccccccCCCCchhhcCCc---cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~---~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
........+||+.|+|||++.+.. .|+.++|||||||+||||++|++||.+.+..+.+.+|........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 293 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------- 293 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc--------
Confidence 333344678999999999998643 278999999999999999999999999999999888875311000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCC--CCCHHHHHhcccCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMKP 420 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~k--RpTa~e~L~hp~f~~~~ 420 (709)
......+++.+++||.+||+.+|.+ |++++++++||||+...
T Consensus 294 -----------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 294 -----------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp -----------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred -----------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 0012358999999999999999988 99999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=401.91 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=215.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 468999999999999999999999999999999999755332 223557799999999999999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-CC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~ 286 (709)
|||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... ..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999987555545555567999999999999999999999999999999999999999999999999999865322 22
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+||+.|+|||++.+...++.++|||||||+||+|++|+.||.+................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------- 226 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------- 226 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------------
Confidence 23345689999999999988776688999999999999999999999876654332222211100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
....+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 011124578999999999999999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=406.36 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=189.0
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--CeEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSLY 207 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~ly 207 (709)
.+|.+.++||+|+||.||+|++ +|+.||||+++... ........|+.++..|+|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999987 58899999986432 222223456666778999999999999876432 3689
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC--------CeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
||||||+++.+..++.. ..+++.++..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999996544444433 3689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCCC---CccccccccCCCCchhhcCCc-----cCCccccccchhHHHHHHHhCCCCCCCCCh-------------
Q 005210 280 FYDPDQNQ---PLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTE------------- 338 (709)
Q Consensus 280 ~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~-----~y~~~~DIWSLG~iL~ELltG~~pF~g~~~------------- 338 (709)
........ .....+||++|||||++.+.. .|+.++||||||||||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443221 223468999999999997642 367899999999999999999887754322
Q ss_pred -HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 339 -VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 339 -~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.+.+.... ..++|..+.. ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~-----------------~~~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVCE-----------------QKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTT-----------------SCCCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhc-----------------ccCCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122111100 0001111100 0001233568899999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=405.51 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=219.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEE
Confidence 5789999999999999999999999999999999975421 11234567789999999999999999999976 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999987444433333457999999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------- 220 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------------- 220 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------------
T ss_pred -cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 23568999999999988755 89999999999999999999999999998888888865210
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||..||.+|+ +++++++||||+..
T Consensus 221 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 221 ------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 01135788999999999999999999 99999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=416.68 Aligned_cols=281 Identities=32% Similarity=0.508 Sum_probs=230.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc------CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL------DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L------~HpnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 56899999999999999999999999999999999743 34455677899998887 57799999999987
Q ss_pred CCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc--EEEeeccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLAS 279 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGla~ 279 (709)
...+||||||+.++|...+.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 67899999999998887765533 35999999999999999999999999999999999999999887 9999999997
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
.... .....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++..|+..+|.|....+..
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCC----cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 6432 234568999999999998765 79999999999999999999999999999999999999999999887654
Q ss_pred cCCCCccccCC-----------------------------CCccccchhccc-CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 005210 360 SKLPHATIFKP-----------------------------QQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAAS 409 (709)
Q Consensus 360 ~~lp~~~~~~~-----------------------------~~~~~~~~~~~~-~~~s~~~~dLI~~lL~~DP~kRpTa~e 409 (709)
........... ..+..+.+...+ ...++.+.+||.+||++||.+|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 32110000000 000011111112 235788999999999999999999999
Q ss_pred HHhcccCCCC
Q 005210 410 ALRSEFFTMK 419 (709)
Q Consensus 410 ~L~hp~f~~~ 419 (709)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=407.36 Aligned_cols=289 Identities=29% Similarity=0.446 Sum_probs=232.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---------ChHHHHHHHHHHHHHHhcCCCceeeeeceEe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---------EPESVRFMAREIHILRRLDHINVIKLEGLVT 199 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---------~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~ 199 (709)
.++|++.+.||+|+||.||+|.+.. +..||||++..... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 6789999999999999999999865 89999999865432 2233467889999999999999999999885
Q ss_pred ec---CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 200 SR---MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 200 ~~---~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
.. ....+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 42 235789999999999998888777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
++...... ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99754332 2234568899999999998766689999999999999999999999999999999999999999998776
Q ss_pred hhhcCCCCccccC---CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 357 WRKSKLPHATIFK---PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 357 w~~~~lp~~~~~~---~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
+.....+....+. ........+......+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 5432211111110 001112234555677899999999999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=406.07 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=215.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.+ +||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 36789999999999999999999999999999999986643 445667788999999988 89999999999977 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999986544433333447999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhhCCCChhh
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR---------TEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~---------~~~e~l~~I~k~~g~p~~~~ 356 (709)
.......+||+.|+|||++.+.. |+.++||||||||+|||++|++||.+. ........|... .
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~----- 235 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q----- 235 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--C-----
T ss_pred CCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--C-----
Confidence 22345668999999999998755 799999999999999999999999752 122222333221 0
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa------~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.||.+||++ +++++||||+..
T Consensus 236 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 236 ----------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 01123578999999999999999999995 899999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=398.38 Aligned_cols=294 Identities=33% Similarity=0.522 Sum_probs=234.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec---CCC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR---MSC 204 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~---~~~ 204 (709)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3678999999999999999999999999999999996432 344556678999999999999999999887542 136
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7899999999887776654 36999999999999999999999999999999999999999999999999999876432
Q ss_pred CCC---------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 285 QNQ---------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 285 ~~~---------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..++..+|.|...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111 12345789999999998776668999999999999999999999999999999999999998887633
Q ss_pred hhhhcC-CCCcccc-CC-CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 356 YWRKSK-LPHATIF-KP-QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 356 ~w~~~~-lp~~~~~-~~-~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
...... .+....+ .. .......+...+..+++.+.+||.+||..||.+|||++++|+||||+....+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 211100 0000000 00 000011233445678999999999999999999999999999999997655543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=411.58 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=218.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++.+.||+|+||.||+|++..+++.||||+++.... .......+..|+.+|..+ +||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 47899999999999999999999999999999999975421 112345577899999877 99999999999977 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999865444333333479999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|... .+
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~------------- 235 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------------- 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------------
T ss_pred -CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 2345668999999999998765 799999999999999999999999999988888877542 11
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH-HHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~-e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||+.||.+||++. ++++||||+..
T Consensus 236 --------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 236 --------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp --------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 01134789999999999999999999998 99999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=415.90 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=212.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
.++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|..+ +|||||++++++.. ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 6789999999999999999999999999999999986543 233445677899999887 89999999999977 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||||.++.+.........+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999987544444333457999999999999999999999999999999999999999999999999999863322 2
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhhCCCChhhh
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---------~e~l~~I~k~~g~p~~~~w 357 (709)
......+||+.|+|||++.+.. |+.++||||||||||||++|++||.+... ......|... .
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~------ 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--Q------ 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--C------
T ss_pred CccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--c------
Confidence 3345678999999999998765 79999999999999999999999975321 1122333221 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccCCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 419 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa------~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||++||.+|+++ +++++||||+..
T Consensus 279 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 01224588999999999999999999985 899999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=408.05 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=220.1
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCE
Confidence 346889999999999999999999999999999999975422 12234567899999999999999999999876 678
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||+.++ |...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 116 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999864 4444433 347999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.... +
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~------------ 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--V------------ 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------------
T ss_pred ----cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--C------------
Confidence 23568999999999998765 7999999999999999999999999999888888876521 1
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||+.||.+||+ ++++++||||...
T Consensus 256 ---------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 ---------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 012357899999999999999999998 9999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=387.81 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=223.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEE
Confidence 3688999999999999999999999999999999998777677777888999999999999999999999876 67899
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc---EEEeecccccccCC
Q 005210 208 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGla~~~~~ 283 (709)
+||||+.++ +...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999875 4344433 347999999999999999999999999999999999999986655 99999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 228 (284)
T 3kk8_A 161 S--EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS--------- 228 (284)
T ss_dssp S--CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------
T ss_pred C--ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc---------
Confidence 2 2234568999999999988765 799999999999999999999999999888887777553222111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+..+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 229 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 ----------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ----------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ----------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 1224678999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=408.86 Aligned_cols=292 Identities=21% Similarity=0.285 Sum_probs=219.0
Q ss_pred CCCCCeeEEeeeccc--CceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 127 RRADSFEKLDKIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G--~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
...++|++++.||+| +||.||+|++..+++.||||++............+.+|+.+|+.++|||||++++++.. ..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 99 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DN 99 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TT
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CC
Confidence 347889999999999 99999999999999999999998876667777888999999999999999999999987 67
Q ss_pred eEEEEEeecccccc-ccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 205 SLYLVFEYMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 205 ~lyLVmEy~~g~L~-~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
.+|||||||.++.+ .++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 89999999986544 43332 23569999999999999999999999999999999999999999999999999886542
Q ss_pred CC------CCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-----
Q 005210 283 PD------QNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG----- 350 (709)
Q Consensus 283 ~~------~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g----- 350 (709)
.. ........+||+.|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+.+..++....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 11122334789999999999874 4589999999999999999999999998877666555432111
Q ss_pred ---CCChhhhhhcC-------CCCccccCCCCc--cccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 351 ---SPSEDYWRKSK-------LPHATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 351 ---~p~~~~w~~~~-------lp~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+....+.... +..........+ ...........+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 00000000000 000000000000 000112234568899999999999999999999999999999986
Q ss_pred CC
Q 005210 419 KP 420 (709)
Q Consensus 419 ~~ 420 (709)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=394.37 Aligned_cols=291 Identities=35% Similarity=0.581 Sum_probs=229.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec-------
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR------- 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~------- 201 (709)
.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 57899999999999999999999999999999998754 355667788999999999999999999887431
Q ss_pred -----CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeec
Q 005210 202 -----MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADF 275 (709)
Q Consensus 202 -----~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DF 275 (709)
....+|+||||++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 2467899999999887776643 4699999999999999999999999999999999999997 5679999999
Q ss_pred ccccccCCCC--CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 276 GLASFYDPDQ--NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 276 Gla~~~~~~~--~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
|++....... ........+|++|+|||++.+...++.++|||||||++|||++|++||.+.+..+.+..+....+.+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9998764321 12234457799999999988766689999999999999999999999999999999999998887777
Q ss_pred hhhhhhcCCCCccccC-CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 354 EDYWRKSKLPHATIFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.+.+............ ........+......++..+.+||.+||+.||.+|||++++|+||||+....|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 6655431110000000 000001123344567899999999999999999999999999999999765554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=394.93 Aligned_cols=289 Identities=39% Similarity=0.630 Sum_probs=235.0
Q ss_pred CCCCCeeEEeeecccCceEEEEEEEC-CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEee--
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTS-- 200 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~-- 200 (709)
...++|++++.||+|+||.||+|.+. .+++.||||+++...........+.+|+.+++.+ .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34678999999999999999999995 6789999999975443322223355777777766 89999999998862
Q ss_pred -cCCCeEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 201 -RMSCSLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 201 -~~~~~lyLVmEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
.....+|+||||++++|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 135678999999998877766543 335999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+... .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..++..++.+....|.
T Consensus 168 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 168 RIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccCC--CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 865422 2234567899999999998765 7999999999999999999999999999999999999999999888875
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.........+... ....+......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 245 RDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TTCSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhccc--CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 4221111111111 11123445577999999999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=406.32 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=215.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.+.|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.|+||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 4679999999999999999999999999999999974321 11134567899999999999999999999987 678
Q ss_pred EEEEEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc---EEEeecccc
Q 005210 206 LYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLA 278 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGla 278 (709)
+|||||||++ +|...+.. .+..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999986 44443322 3346899999999999999999999999999999999999986654 999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+.... ......+||+.|+|||++.+.. |+.++||||||||||+|++|++||.+.. .+.+..+.+.........
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~-- 255 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ-- 255 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH--
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc--
Confidence 8765432 2234568999999999998755 7999999999999999999999998853 445555544322222222
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 256 -----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 -----------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -----------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -----------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 24688999999999999999999999999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=415.15 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=216.2
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...++|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence 3478999999999999999999999999999999999753211 1123467899999999999999999999987 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||++++++..+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999999988888776553 37999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+...++
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------------- 220 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------------- 220 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------------
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------------
Confidence 23345689999999999988775688999999999999999999999765322111100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..........+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 221 ---------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ---------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ---------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ---------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 001112234578999999999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.88 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=218.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++++.||+|+||.||+|++..+++.||||+++.... .....+.+.+|+.+|..+ .||||+++++++.. ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 36899999999999999999999999999999999975422 122345677899999988 89999999999876 678
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||+.++ |...+. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 96 ~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999864 444443 3347999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|.... +
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~------------ 238 (353)
T 2i0e_A 175 -GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--V------------ 238 (353)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------------
T ss_pred -CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--C------------
Confidence 22345668999999999998755 7999999999999999999999999999888888886521 0
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||+.||.+|| +++++++||||+..
T Consensus 239 ---------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 239 ---------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred ---------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 01235889999999999999999999 47999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=399.04 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=210.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|+++++||+|+||.||+|.+..+++.||||++...............|+..+..+ .||||+++++++.. ...+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEE
Confidence 3679999999999999999999999999999999876655555555555666666655 99999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||++++|...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 134 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-- 211 (311)
T 3p1a_A 134 LQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-- 211 (311)
T ss_dssp EEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence 999999998888777666679999999999999999999999999999999999999999999999999998764332
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......||+.|+|||++.+ .++.++|||||||++|||++|..+|.+...... +.. +...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~-------------- 270 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLP-------------- 270 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCC--------------
T ss_pred CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCC--------------
Confidence 2345579999999999876 379999999999999999999877766433222 211 1111
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 271 -----------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 -----------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223468899999999999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=406.22 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=222.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.|+||||+++++++.. ...+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 578999999999999999999999999999999997543 3344567899999999999999999999976 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC--CCcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~--~g~vKL~DFGla~~~~~~~ 285 (709)
|||||.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999986 555555555567999999999999999999999999999999999999974 578999999999876543
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. ++.++||||||||||||++|.+||.+.+..+.+..+........
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 270 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------ 270 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 2334568999999999987754 79999999999999999999999999998888887765321111
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 271 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 271 -------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 12234689999999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=419.14 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=222.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 468899999999999999999999999999999999754221 1234568899999999999999999999977 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 999999976544444444557999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+||+.|+|||++.+...++.++||||||||+|+|++|++||.+.+..+.+.+|.....
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 233 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------------- 233 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC----------------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence 2345568999999999998877568899999999999999999999999888888777754211
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 234 -------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0113478899999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=399.00 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=209.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
..++|++++.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3678999999999999999999985 6899999999986543 22334567789999999999999999999876
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
...+||||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 67899999999865444333334479999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+.+|.+...
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------ 238 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------------ 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------------
T ss_pred cCC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 222 2234568999999999997755 79999999999999999999999999998888888765211
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||..||.+|| ++.++|+||||+..
T Consensus 239 -----------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 239 -----------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -----------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 11235789999999999999999999 89999999999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=409.03 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=215.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++|||||++++++.. ...+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 6789999999999999999999999999999999975421 22335667899999999999999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+... .
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999987655544445567999999999999999999999999999999999999999999999999999876432 3
Q ss_pred CccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCChhhhhhcCC
Q 005210 288 PLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.....+||+.|+|||++.+. ..|+.++||||||||||||++|++||.+... .+.+..+...
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------- 235 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-------------- 235 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------------
Confidence 34567899999999998742 3489999999999999999999999985432 2233333221
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-HHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-a~e~L~hp~f~~~ 419 (709)
.......+++.+.+||.+||+.||.+||+ ++++++||||...
T Consensus 236 ---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 236 ---------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ---------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 01112357899999999999999999998 9999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.10 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=221.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.+.|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|+.+.||||+++++++.. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 467999999999999999999999999999999998654321 135668899999999999999999999876 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~ 280 (709)
.+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 8999999997644443333455799999999999999999999999999999999999999888 799999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 240 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE----- 240 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCccc--cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh-----
Confidence 65432 234557999999999987654 7999999999999999999999999999888888776543222222
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 241 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 241 --------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp --------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred --------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 23468899999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=404.52 Aligned_cols=282 Identities=27% Similarity=0.419 Sum_probs=227.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC--------CCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--------HINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIv~l~~~~~~ 200 (709)
.++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 57899999999999999999999999999999998643 445567889999999995 7889999998863
Q ss_pred c--CCCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCC--------
Q 005210 201 R--MSCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNG-------- 268 (709)
Q Consensus 201 ~--~~~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g-------- 268 (709)
. ....+||||||++++++..+.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 256899999999988887766543 5699999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeecccccccCCCCCCCccccccccCCCCchhhcCC
Q 005210 269 -----------------------------------------ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307 (709)
Q Consensus 269 -----------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~ 307 (709)
.+||+|||++...... .+..+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 3455899999999999876
Q ss_pred ccCCccccccchhHHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCChhhhhhcCCCCccccC--------CCCc
Q 005210 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK--------PQQP 373 (709)
Q Consensus 308 ~~y~~~~DIWSLG~iL~ELltG~~pF~g~~------~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~--------~~~~ 373 (709)
. |+.++||||||||||||++|++||.+.+ ..+.+..+.+.+|.++...+............ ...+
T Consensus 269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 5 7999999999999999999999998765 67788889999999888776543322110000 0000
Q ss_pred cc--cchhc---ccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 374 YK--RCVAE---TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 374 ~~--~~~~~---~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.. ..+.+ .....+..+.+||.+||++||.+|||++++|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 00001 11224567889999999999999999999999999973
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=409.62 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=211.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHH-HHhcCCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHI-LRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~i-L~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|..+ ++.++||||+++++++.. ...
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 46789999999999999999999999999999999986643 23344556677777 567899999999999877 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999987544433333447999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|....
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------- 255 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------------- 255 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC----------------
T ss_pred CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------------
Confidence 22345668999999999998755 8999999999999999999999999999888888886521
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa----~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.||.+|+++ .++++||||+..
T Consensus 256 -------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred -------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01124588999999999999999999986 699999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=422.07 Aligned_cols=258 Identities=30% Similarity=0.497 Sum_probs=215.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|++..++..||||++............+.+|+.+|+.|+|||||++++++.. ...+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 457999999999999999999999999999999998765444445668899999999999999999999977 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---CcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGla~~~~~~ 284 (709)
|||||.++ |...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999875 4444433 3479999999999999999999999999999999999999764 45999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.+....+....
T Consensus 193 --~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 260 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-------- 260 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG--------
T ss_pred --ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh--------
Confidence 23455689999999998864 389999999999999999999999999999988888876433332222
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+..+++.+.+||.+||++||.+|||+.++|+||||+.
T Consensus 261 -----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 -----------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 3468999999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=402.03 Aligned_cols=255 Identities=28% Similarity=0.381 Sum_probs=210.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+|+.+|.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 56799999999999999999999999999999999865432 24688888888 79999999999976 67899
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC----CcEEEeecccccccC
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN----GILKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~----g~vKL~DFGla~~~~ 282 (709)
||||||.+ +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||..+ +.+||+|||++..+.
T Consensus 93 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 93 VVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999986 45555444 4579999999999999999999999999999999999998543 359999999998764
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC---CChHHHHHHHHHhhCCCChhhhhh
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG---RTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g---~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+ .+..+.+..|........
T Consensus 172 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------ 243 (342)
T 2qr7_A 172 AEN-GLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS------ 243 (342)
T ss_dssp CTT-CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC------
T ss_pred CCC-CceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC------
Confidence 432 2334568999999999987654 78999999999999999999999986 344555555543211111
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 244 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 244 -------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 11234689999999999999999999999999999999653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=421.33 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=223.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.|+||||+++++++.. ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 56799999999999999999999999999999999766442 3345678899999999999999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~ 284 (709)
+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999865443333334579999999999999999999999999999999999999 46789999999999876543
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..|.+....+...
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 249 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP--------- 249 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG---------
T ss_pred --cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc---------
Confidence 33456689999999999976 38999999999999999999999999999999888887643222222
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 250 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 250 ----------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ----------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 224588999999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=404.67 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=213.8
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmE 211 (709)
|...+.||+|+||.||+|.+..+|+.||||+++... ....+.+.+|+.+|+.|+||||+++++++.. ...+|||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 344678999999999999999999999999998643 3445678899999999999999999999977 678999999
Q ss_pred eccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE--cCCCcEEEeecccccccCCCCCCC
Q 005210 212 YMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI--DNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 212 y~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl--d~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|+++ +|...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.... .
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 9986 5555555555579999999999999999999999999999999999999 567899999999998775432 2
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. ++.++||||||||||||++|++||.+.+..+.+..|+.....+.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------- 308 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------------- 308 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---------------
T ss_pred cccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---------------
Confidence 34557999999999987654 79999999999999999999999999999999888876432221
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 309 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 309 ----------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1223568999999999999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=421.89 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=218.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.|+||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 568999999999999999999999999999999997543222334667899999999999999999999977 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc---CCCcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGla~~~~~~ 284 (709)
|||||.++ |...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999865 4444433 34799999999999999999999999999999999999995 4568999999999876433
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+||+.|+|||++.+. |+.++||||||||+|+|++|++||.+.+..+.+..+......+...
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 244 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP--------- 244 (486)
T ss_dssp ------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG---------
T ss_pred --CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---------
Confidence 234556899999999998763 8999999999999999999999999999999888886543222222
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 245 ----------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 ----------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ----------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ----------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 224588999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.49 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=220.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999999765332 24567899999999999999999999976 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~~ 285 (709)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999874443333334469999999999999999999999999999999999999 788999999999998765432
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......+....|
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred --chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 33456899999999998764 799999999999999999999999999988888887664433333322
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 -----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 357899999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=396.97 Aligned_cols=258 Identities=29% Similarity=0.384 Sum_probs=200.3
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..+.|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+|+.|+||||+++++++.. ...+|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEE
Confidence 3577999999999999999999999999999999997542 23456789999999999999999999976 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccccccCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPD 284 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~~~~~~ 284 (709)
|||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999986444333344457999999999999999999999999999999999999975 889999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e-~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+....+ .+..+........
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~---------- 271 (349)
T 2w4o_A 205 --VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI---------- 271 (349)
T ss_dssp ----------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC----------
T ss_pred --cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC----------
Confidence 2234568999999999998765 7999999999999999999999998776555 4444443211111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 272 ---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 272 ---------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ---------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ---------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 11234688999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=398.86 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=221.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
...|++++.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence 35699999999999999999999999999999999866433 3455678899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 99999999888777655567999999999999999999999999999999999999999999999999999865432
Q ss_pred CccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 PLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
...+||+.|+|||++.+ ...|+.++||||||||+|||++|++||.+.+..+.+..+.... .+.
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~~~------------ 272 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA------------ 272 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC------------
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC------------
Confidence 34589999999999863 3458999999999999999999999999988887777665421 100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||+.||.+|||++++|+||||...
T Consensus 273 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 --------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113578889999999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=389.78 Aligned_cols=281 Identities=30% Similarity=0.528 Sum_probs=224.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+|+.|. ||||+++++++.......+|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 578999999999999999999999999999999987432 355789999999997 99999999999876667899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~ 286 (709)
+||||+.++.+..+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999765544443 489999999999999999999999999999999999999777 89999999998765432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCC-CCCChHHHHHHHHHhhCCCChhhh-hhcCCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM-PGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPH 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF-~g~~~~e~l~~I~k~~g~p~~~~w-~~~~lp~ 364 (709)
.....++|+.|+|||++.+...++.++|||||||+||+|++|+.|| .+.+..+++..+.+.++.+....+ .......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2345689999999999988666899999999999999999999887 566777888888877775433222 1111110
Q ss_pred cccc------CCCCccccc-hhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIF------KPQQPYKRC-VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~------~~~~~~~~~-~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+ .....+... .......+++.+.+||.+||++||.+|||++++|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000 000111111 111223479999999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=417.35 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEE
Confidence 35789999999999999999999999999999999975422 23344567789999999999999999999987 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||+++.+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999875554444444579999999999999999999998 99999999999999999999999999999864322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|.....
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------- 366 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------------- 366 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------
T ss_pred CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence 22345678999999999998765 79999999999999999999999999988888777754210
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||++||.+|| |++++|+||||+..
T Consensus 367 --------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 367 --------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 11235789999999999999999999 99999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=417.28 Aligned_cols=260 Identities=31% Similarity=0.485 Sum_probs=219.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-----------HHHHHHHHHHHHHHhcCCCceeeeec
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----------ESVRFMAREIHILRRLDHINVIKLEG 196 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-----------~~~~~~~rEi~iL~~L~HpnIv~l~~ 196 (709)
..++|++++.||+|+||.||+|.+..++..||||++....... ...+.+.+|+.+|+.|+||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3678999999999999999999999999999999998654321 23456889999999999999999999
Q ss_pred eEeecCCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEE
Q 005210 197 LVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKI 272 (709)
Q Consensus 197 ~~~~~~~~~lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL 272 (709)
++.. ...+|||||||.++ |...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFED--KKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEc--CCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9976 67899999999874 4444433 34799999999999999999999999999999999999999776 6999
Q ss_pred eecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 005210 273 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352 (709)
Q Consensus 273 ~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p 352 (709)
+|||++..+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..|.+....+
T Consensus 191 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 191 VDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EECCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999876543 23455689999999999864 38999999999999999999999999999999888887643333
Q ss_pred ChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 353 ~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
....| ..+++.+.+||.+||++||.+|||++++|+||||+..
T Consensus 267 ~~~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 267 DFNDW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred Ccccc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 33333 4689999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=391.56 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=219.1
Q ss_pred CCCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
.+.|.+. +.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ .||||+++++++.. ...+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 4568887 899999999999999999999999999986655444556788999999999 56999999999976 6789
Q ss_pred EEEEeecccc-ccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeeccccccc
Q 005210 207 YLVFEYMEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFY 281 (709)
Q Consensus 207 yLVmEy~~g~-L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~~~ 281 (709)
|+||||+.++ |...+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999875 4444432 2357999999999999999999999999999999999999997 789999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......+..
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 254 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------- 254 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------
T ss_pred CCcc--ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------
Confidence 4322 234568999999999987655 799999999999999999999999999988888877664333221
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~ 421 (709)
..+..+++.+.+||.+||+.||.+|||++++|+||||+...+
T Consensus 255 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 ------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 223468899999999999999999999999999999987544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=404.11 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=201.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|++..+++.||||++....... +.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEE
Confidence 4688999999999999999999999999999999998654322 346789999999999999999999976 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc--EEEeecccccccCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~--vKL~DFGla~~~~~~~ 285 (709)
|||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999986444333333447999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..++....... ..
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------~~---- 240 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK------YS---- 240 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC------CC----
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC------CC----
Confidence 2234568999999999998877555669999999999999999999988654333333222110000 00
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 241 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 -------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00112478999999999999999999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=390.16 Aligned_cols=266 Identities=26% Similarity=0.349 Sum_probs=207.3
Q ss_pred ccCCCCCCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 005210 124 WVPRRADSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR 201 (709)
Q Consensus 124 ~~~~~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~ 201 (709)
+..+..+.|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++..
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~- 82 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE- 82 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 334557889995 789999999999999999999999999976532 2345678999999985 79999999999987
Q ss_pred CCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc---EEEeeccc
Q 005210 202 MSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGL 277 (709)
Q Consensus 202 ~~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGl 277 (709)
...+||||||+.+ +|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 83 -EDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred -CCEEEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 6789999999985 44444433 347999999999999999999999999999999999999998775 99999999
Q ss_pred ccccCCCC------CCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCCh---------
Q 005210 278 ASFYDPDQ------NQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--------- 338 (709)
Q Consensus 278 a~~~~~~~------~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--------- 338 (709)
+..+.... .......+||+.|+|||++.+ ...|+.++|||||||++|+|++|++||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 97653211 112234579999999999874 13478999999999999999999999987642
Q ss_pred ------HHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 339 ------VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 339 ------~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+.......+ ...+..+++.+.+||.+||+.||.+|||++++|+
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFP-------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCcccC-------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 122333322111111 1123468899999999999999999999999999
Q ss_pred cccCCCC
Q 005210 413 SEFFTMK 419 (709)
Q Consensus 413 hp~f~~~ 419 (709)
||||+..
T Consensus 296 hp~~~~~ 302 (316)
T 2ac3_A 296 HPWVQGC 302 (316)
T ss_dssp STTCC--
T ss_pred ChhhcCC
Confidence 9999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=388.89 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=217.0
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.. ...+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 488889999999999999999999999999999765432 34567799999999999999999999987 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcc
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 290 (709)
||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99987655554443 369999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 291 ~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+.... .+.
T Consensus 200 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~----------------- 260 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK----------------- 260 (321)
T ss_dssp CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCC-----------------
T ss_pred cccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC-----------------
Confidence 568999999999987654 7999999999999999999999999988887777665421 000
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 261 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 --------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00123478899999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.27 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=203.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||+++.........+.+.++..+++.++||||+++++++.. ...+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 3678999999999999999999999999999999997654444445555566666888899999999999976 67899
Q ss_pred EEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 208 LVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
+||||+++++...+. ..+..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999999987755443 3456799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhh---cCCccCCccccccchhHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChhhhhh
Q 005210 284 DQNQPLTSRVVTLWYRPPELL---LGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l---~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
.. ......||+.|+|||++ .....++.++|||||||++|+|++|+.||.. ......+..+.... .+
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------- 232 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SP------- 232 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CC-------
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CC-------
Confidence 32 22344789999999997 3445589999999999999999999999987 44444555444321 00
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 233 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 233 -------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0011357889999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=396.30 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=191.2
Q ss_pred CCeeEE---eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCe
Q 005210 130 DSFEKL---DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 130 ~~y~~~---~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ 205 (709)
++|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCE
Confidence 456665 7899999999999999999999999999743 2345678999999996 9999999999976 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEeecccccccC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYD 282 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGla~~~~ 282 (709)
+||||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999998744433333345799999999999999999999999999999999999998766 89999999998664
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhhCCCChh
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-------VEQLHKIFKLCGSPSED 355 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~-------~e~l~~I~k~~g~p~~~ 355 (709)
.. .......+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+. .+.+..|......+..+
T Consensus 161 ~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PD-NQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C-----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CC-CCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 33 23345568899999999987655 89999999999999999999999987543 34444443322122111
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 -------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 -------------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -------------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -------------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 224689999999999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=396.19 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=214.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC---CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..++..||||++.... ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 567999999999999999999999999999999997542 234456778899999999999999999999976 678
Q ss_pred EEEEEeecccc-ccccccC---------------------------------------CCCCCCHHHHHHHHHHHHHHHh
Q 005210 206 LYLVFEYMEHD-LAGLASH---------------------------------------PGLKFSEAQVKCYMQQLLCGLD 245 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~---------------------------------------~~~~lse~~i~~i~~QIl~aL~ 245 (709)
+|||||||+++ |...+.. ....+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999764 4333320 0123478889999999999999
Q ss_pred hhhhCCeeeccCCCccEEEcCCC--cEEEeecccccccCCC---CCCCccccccccCCCCchhhcCC-ccCCccccccch
Q 005210 246 HCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPD---QNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWST 319 (709)
Q Consensus 246 yLH~~gIvHrDLKP~NILld~~g--~vKL~DFGla~~~~~~---~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSL 319 (709)
|||++||+||||||+||||+.++ .+||+|||++..+... .........||+.|+|||++.+. ..|+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 8999999999865321 11223466899999999998752 458999999999
Q ss_pred hHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhccc
Q 005210 320 GCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI 399 (709)
Q Consensus 320 G~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~ 399 (709)
||+||||++|+.||.+.+..+.+..+......... ..+..+++.+.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHHHcCC
Confidence 99999999999999999998888887653221111 12235789999999999999
Q ss_pred CCCCCCCHHHHHhcccCCCCC
Q 005210 400 DPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 400 DP~kRpTa~e~L~hp~f~~~~ 420 (709)
||.+|||+.++|+||||+...
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTS
T ss_pred ChhHCCCHHHHhcChhhccCh
Confidence 999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=398.35 Aligned_cols=279 Identities=28% Similarity=0.465 Sum_probs=224.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CC-----ceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HI-----NVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hp-----nIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 68899999999999999999999999999999999743 344566778999998884 55 48999998877
Q ss_pred CCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhh--hCCeeeccCCCccEEEc--CCCcEEEeeccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCH--SRGVLHRDIKGSNLLID--NNGILKIADFGL 277 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH--~~gIvHrDLKP~NILld--~~g~vKL~DFGl 277 (709)
...+||||||++++|...+.... ..+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 67899999999998887766543 46999999999999999999999 47999999999999995 477899999999
Q ss_pred ccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 278 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 278 a~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
+...... ....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++..|.+.++.|+...+
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876432 34568999999999998765 899999999999999999999999999999999999999999988766
Q ss_pred hhcC--------CCCcc-----------ccCCCCccccchhcccC--------------C----CCHHHHHHHHHhcccC
Q 005210 358 RKSK--------LPHAT-----------IFKPQQPYKRCVAETFK--------------D----FPAPALALMETLLSID 400 (709)
Q Consensus 358 ~~~~--------lp~~~-----------~~~~~~~~~~~~~~~~~--------------~----~s~~~~dLI~~lL~~D 400 (709)
.... ++... .+.+ +..+.+...+. . .++.+.+||.+||++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKP--PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCC--TTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HhhHHHHHHHHhccccccccccccccccccCC--cchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 4321 01000 0000 00000110000 0 0136899999999999
Q ss_pred CCCCCCHHHHHhcccCCCC
Q 005210 401 PADRGSAASALRSEFFTMK 419 (709)
Q Consensus 401 P~kRpTa~e~L~hp~f~~~ 419 (709)
|.+|||++++|+||||+..
T Consensus 361 P~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC-
T ss_pred hhhCCCHHHHhcCcccccC
Confidence 9999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=394.22 Aligned_cols=260 Identities=30% Similarity=0.440 Sum_probs=219.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC--Ch----HHHHHHHHHHHHHHhc-CCCceeeeeceEeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EP----ESVRFMAREIHILRRL-DHINVIKLEGLVTSR 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~--~~----~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~ 201 (709)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.... .. ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 4679999999999999999999999999999999986532 22 2245677999999999 89999999999876
Q ss_pred CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+||||||++++.+..+......+++..++.++.||+.||.|||+.||+|+||||+||||+.+|.+||+|||++..+
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 6789999999987544433333457999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCC-----ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGA-----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~-----~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
.... .....+||+.|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+.+..+......+....
T Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 5432 23456899999999998632 3478999999999999999999999999888888777765332222222
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
+..++..+.+||.+||+.||.+|||++++|+||||+
T Consensus 329 -------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 -------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 245788999999999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=392.67 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=223.9
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 114 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--ND 114 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CC
Confidence 3446789999999999999999999999999999999986533 45566778899999999999999999999976 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 89999999996544444433457999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------- 258 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred c-ccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--------------
Confidence 2 2234567999999999998765 79999999999999999999999999887777666643210
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.....+++.+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 259 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 259 ---------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 0123578889999999999999999999999999999876443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=383.36 Aligned_cols=260 Identities=28% Similarity=0.392 Sum_probs=211.3
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
....+.|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 94 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHN 94 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCe
Confidence 3446789999999999999999999999999999999986542 2234667899999999999999999999976 678
Q ss_pred EEEEEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccc
Q 005210 206 LYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLA 278 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla 278 (709)
+|+||||+++ +|...+.. .+..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999986 45544422 23579999999999999999999999999999999999999 45678999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 175 ~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------- 243 (285)
T 3is5_A 175 ELFKSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN------- 243 (285)
T ss_dssp CC------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred eecCCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc-------
Confidence 876432 22345678999999998864 3789999999999999999999999998877766555431110
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 244 -------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 01112347889999999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=382.90 Aligned_cols=257 Identities=32% Similarity=0.460 Sum_probs=214.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence 368899999999999999999999999999999998654221 1224567899999999999999999999976 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999996544433333347999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 225 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------- 225 (279)
T ss_dssp ------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------
T ss_pred -cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC---------------
Confidence 224557899999999987754 789999999999999999999999999888877776542111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
....+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 226 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 226 --------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp --------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 123478889999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=391.88 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=209.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~ 205 (709)
..+.|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.|.| |||+++++++.. ...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCE
Confidence 356799999999999999999997 568899999998777777777888999999999976 999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||..++|...+... ..+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+....
T Consensus 84 ~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999998888877776653 4799999999999999999999999999999999999996 6889999999998765432
Q ss_pred CC-CccccccccCCCCchhhcC----------CccCCccccccchhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCC
Q 005210 286 NQ-PLTSRVVTLWYRPPELLLG----------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPS 353 (709)
Q Consensus 286 ~~-~~~~~~gT~~Y~APE~l~~----------~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~-~e~l~~I~k~~g~p~ 353 (709)
.. .....+||+.|+|||++.+ ...|+.++||||||||||||++|++||.+... ...+..+.....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--- 238 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH--- 238 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS---
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc---
Confidence 22 2345689999999999864 24578999999999999999999999987543 333333322100
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
........+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 ------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 239 ------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 001122356789999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=404.41 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=203.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE------PESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~------~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.|+||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 57899999999999999999999999999999999764321 1222347789999999999999999998753
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEeeccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLAS 279 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~DFGla~ 279 (709)
..+|||||||.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45899999998755444444455899999999999999999999999999999999999997544 59999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH-HHHhhCCCChhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK-IFKLCGSPSEDY 356 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~-I~k~~g~p~~~~ 356 (709)
.+... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+......+.. +.......
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 76432 23345689999999999864 34578899999999999999999999987654333332 22211111
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....+..+++.+.+||.+||++||.+|||++++|+||||+.
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12234568999999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=384.14 Aligned_cols=265 Identities=29% Similarity=0.443 Sum_probs=219.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 5789999999999999999999999999999999975421 12345678899999999999999999999865556789
Q ss_pred EEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
||||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999886655443 34579999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCCccccccccCCCCchhhcCCc-cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 -NQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 -~~~~~~~~gT~~Y~APE~l~~~~-~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.. .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~----------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--Y----------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--C-----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--C-----------
Confidence 22234557899999999987643 34789999999999999999999999988877776664421 0
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.....+++.+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 1123578899999999999999999999999999999875443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=389.84 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=214.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--Ce
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~ 205 (709)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 6789999999999999999999999999999999986543 34556678899999999999999999998865332 24
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 69999999865444443334479999999999999999999999999999999999999999999999999998764322
Q ss_pred C--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 N--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 ~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 239 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 239 (311)
T ss_dssp -----------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH----------
T ss_pred cccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc----------
Confidence 2 2233457899999999998765 79999999999999999999999999988887777655322221
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......+++.+.+||.+||+.||.+||++.++|.|+|+..
T Consensus 240 ---------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1223468999999999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=379.03 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=209.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++.. ...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 35789999999999999999999999999999999987655555667788999999999 99999999999977 6789
Q ss_pred EEEEeeccc-cccccccCC---CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---------------
Q 005210 207 YLVFEYMEH-DLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--------------- 267 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~--------------- 267 (709)
|+||||+++ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999986 555544332 2469999999999999999999999999999999999999844
Q ss_pred ----CcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHH
Q 005210 268 ----GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 343 (709)
Q Consensus 268 ----g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~ 343 (709)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---H 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---H
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---H
Confidence 47999999999876432 23468999999999987766778999999999999999999887655332 2
Q ss_pred HHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 344 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 344 ~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+... . .......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQG--R--------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTT--C--------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcC--C--------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 22210 0 011224688999999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=378.63 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=215.7
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 57999999999999999999999999999999998654322 135668899999999999999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeeccccccc
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFY 281 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~~ 281 (709)
+|+||||+.+..+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999997544433333344799999999999999999999999999999999999999877 8999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 232 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------- 232 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCCC--cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-------
Confidence 4322 234557899999999987655 799999999999999999999999999888877776543222211
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 233 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 ------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 223568899999999999999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.60 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=215.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 46799999999999999999999999999999999755432 344668899999999999999999999877 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-CC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~~ 287 (709)
||||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999875444444445579999999999999999999999999999999999999999999999999997653221 12
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+................
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----------------
Confidence 2345678999999999987665678999999999999999999999876543222221111000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
....+..+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001124578999999999999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=399.83 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=211.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~~~~~l 206 (709)
...|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|. ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 4569999999999999999999865 889999999887767777788999999999996 5999999998876 6679
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||+.+++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 132 ~lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999998777777766554 3789999999999999999999999999999999999995 68999999999987654322
Q ss_pred C-CccccccccCCCCchhhcCC----------ccCCccccccchhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCCh
Q 005210 287 Q-PLTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSE 354 (709)
Q Consensus 287 ~-~~~~~~gT~~Y~APE~l~~~----------~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~-~e~l~~I~k~~g~p~~ 354 (709)
. .....+||+.|+|||++.+. ..|+.++||||||||||||++|++||.+... ...+..++.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~--- 286 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 286 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC---
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc---
Confidence 2 23456899999999998752 3488999999999999999999999987543 3444444321000
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.......+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 287 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 001123467899999999999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=377.34 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=215.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--CCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~l 206 (709)
...|.+.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4458999999999999999999999999999999987777777778889999999999999999999988653 24668
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEc-CCCcEEEeecccccccCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDP 283 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGla~~~~~ 283 (709)
|+||||++++.+..+......+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999987544444443457999999999999999999999999 99999999999998 789999999999976433
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+.........+
T Consensus 185 ---~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 248 (290)
T 1t4h_A 185 ---SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 248 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred ---cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----------
Confidence 233456799999999988653 7999999999999999999999998866655554433211111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 11223467889999999999999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.70 Aligned_cols=264 Identities=28% Similarity=0.404 Sum_probs=223.6
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+.||||+++++++.. ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence 346789999999999999999999999999999999976543 45566778899999999999999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999965444444434579999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------- 232 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------------
T ss_pred -cccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------------
Confidence 2234567899999999987755 78999999999999999999999999887776665543100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
.....+++.+.+||.+||+.||.+|||++++|+||||+..+.+.
T Consensus 233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 233 --------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred --------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 11235788999999999999999999999999999998765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=384.48 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=202.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC-----
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~----- 203 (709)
.++|++++.||+|+||.||+|++..+++.||||+++... .....+.+.+|+.+|+.|+||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 568999999999999999999999999999999998654 23345678899999999999999999998865321
Q ss_pred --------------------------------------------------CeEEEEEeecccccc-ccccCCC--CCCCH
Q 005210 204 --------------------------------------------------CSLYLVFEYMEHDLA-GLASHPG--LKFSE 230 (709)
Q Consensus 204 --------------------------------------------------~~lyLVmEy~~g~L~-~~~~~~~--~~lse 230 (709)
..+|+|||||+++.+ ..+.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 248999999987544 4433322 23566
Q ss_pred HHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-----------CCccccccccCCC
Q 005210 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-----------QPLTSRVVTLWYR 299 (709)
Q Consensus 231 ~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-----------~~~~~~~gT~~Y~ 299 (709)
..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77999999999999999999999999999999999999999999999987654321 2234567999999
Q ss_pred CchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchh
Q 005210 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVA 379 (709)
Q Consensus 300 APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~ 379 (709)
|||++.+.. |+.++|||||||++|||++|..++.. ....+..+.. ... .
T Consensus 244 aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~---~~~-------------------------~ 292 (332)
T 3qd2_B 244 SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN---LKF-------------------------P 292 (332)
T ss_dssp CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT---TCC-------------------------C
T ss_pred ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc---cCC-------------------------C
Confidence 999998765 79999999999999999998765421 1111111111 110 1
Q ss_pred cccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 380 ETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 380 ~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+...++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 112235677899999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=382.45 Aligned_cols=263 Identities=27% Similarity=0.395 Sum_probs=214.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 5789999999999999999999999999999999876543 45566788999999999999999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999987544444333447999999999999999999999999999999999999999999999999999876544433
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+...+++... .+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~--------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP--------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC---------------
T ss_pred ccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC---------------
Confidence 444567999999999998765 7999999999999999999999999998877765554321 11
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
........++|+.+.+||.+||..||.+||+..+.|.+.|...
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0112334578999999999999999999998778888777653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=376.12 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=220.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC---C----hHHHHHHHHHHHHHHhcC-CCceeeeeceEe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---E----PESVRFMAREIHILRRLD-HINVIKLEGLVT 199 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~---~----~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~ 199 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++..... . ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 36899999999999999999999999999999999986542 1 123456779999999995 999999999987
Q ss_pred ecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 200 SRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 200 ~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
. ...+|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 6 67899999999864443333334579999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhc-----CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~-----~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
.+.... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 765432 234567899999999986 2344789999999999999999999999998888877777653211111
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 -------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1224578899999999999999999999999999999854
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=379.32 Aligned_cols=264 Identities=29% Similarity=0.469 Sum_probs=222.3
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
|...++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.......
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 45678999999999999999999999999999999999887777777788999999999999999999999887655778
Q ss_pred EEEEEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCC-----eeeccCCCccEEEcCCCcEEEeecc
Q 005210 206 LYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~g-----IvHrDLKP~NILld~~g~vKL~DFG 276 (709)
+|+||||+++ +|...+.. ....+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999986 55554432 2345999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------ 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------
T ss_pred hheeecccc-ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc------
Confidence 998764321 1123457899999999998765 79999999999999999999999999887777666654210
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||+.||.+|||+.++|+|+|++..
T Consensus 234 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 ----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ----------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01123578899999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=380.03 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=216.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence 67899999999999999999999999999999998753221 1123567899999999999999999999876 67899
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
+||||+++ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 99999986 45444433 346999999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 229 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---------------- 229 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred -ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----------------
Confidence 223457899999999988755 79999999999999999999999999888777766653210
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~ 420 (709)
.....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 230 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 230 -------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 11235788999999999999999999999999999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=429.33 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=220.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++++.||+|+||.||+|++..+++.||||+++.... .....+.+..|+.+|..+ +||||+++++++.. ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 46889999999999999999999999999999999975421 122345677899999987 79999999998876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||||+.++.+..++.....|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999875444444334579999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|.....
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------------- 559 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------------- 559 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------------
T ss_pred -cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence 2345678999999999997765 89999999999999999999999999999998888865210
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa-----~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||++||.+|+++ +++++||||+..
T Consensus 560 --------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 --------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp --------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred --------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1123588999999999999999999997 999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=399.76 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=200.9
Q ss_pred CCCCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHh-cCCCceeeeeceEee--cCC
Q 005210 128 RADSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR-LDHINVIKLEGLVTS--RMS 203 (709)
Q Consensus 128 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~~~~~--~~~ 203 (709)
..++|.+. +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++.+ ++||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 36778887 6899999999999999999999999999632 245688988754 589999999998864 224
Q ss_pred CeEEEEEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccc
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLA 278 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla 278 (709)
..+|||||||.+ +|...+... ...+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 578999999986 555555443 246999999999999999999999999999999999999997 789999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHH----HHHHHHHhhCCCCh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE----QLHKIFKLCGSPSE 354 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e----~l~~I~k~~g~p~~ 354 (709)
...... ...+..+||+.|+|||++.+.. |+.++||||||||||||++|++||.+..... ....|.......
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~-- 286 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF-- 286 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC--
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC--
Confidence 875432 2335668999999999987654 8999999999999999999999998765432 222222110000
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
....+..++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus 287 -----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 -----------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -----------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 011234689999999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=381.81 Aligned_cols=280 Identities=25% Similarity=0.412 Sum_probs=225.9
Q ss_pred CCCeeEEeeecccCceEEEEEEE-CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSR 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------Iv~l~~~~~~~ 201 (709)
.++|++++.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.+.|++ |+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 57899999999999999999998 568899999998643 344566789999999987654 9999999877
Q ss_pred CCCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC--------------
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-------------- 266 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-------------- 266 (709)
...+||||||+++++...+...+ ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 67899999999888887765443 46899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH
Q 005210 267 -----NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 341 (709)
Q Consensus 267 -----~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~ 341 (709)
++.+||+|||++...... ....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 23458899999999998755 79999999999999999999999999999999
Q ss_pred HHHHHHhhCCCChhhhhhcCCCCccc-----cCCCCccccch----------hcccCCCCHHHHHHHHHhcccCCCCCCC
Q 005210 342 LHKIFKLCGSPSEDYWRKSKLPHATI-----FKPQQPYKRCV----------AETFKDFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 342 l~~I~k~~g~p~~~~w~~~~lp~~~~-----~~~~~~~~~~~----------~~~~~~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
+..+.+..+.++...+.......... +.......+.. .......++.+.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 99999999888877765432111000 00000000000 0011123567899999999999999999
Q ss_pred HHHHHhcccCCC
Q 005210 407 AASALRSEFFTM 418 (709)
Q Consensus 407 a~e~L~hp~f~~ 418 (709)
+.++|+||||+.
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.91 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=215.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 4679999999999999999999999999999999985432 223457799999999999999999999876 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~ 284 (709)
||||+++ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999986 45444433 3479999999999999999999999999999999999999 7788999999999976432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+........
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 227 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE----------- 227 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-----------
T ss_pred --CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 2234557899999999987654 79999999999999999999999999988888777765321111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 228 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 --------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp --------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred --------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11234688999999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=392.41 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=209.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE------SVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~------~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 5689999999999999999999999999999999986543211 23346689999999999999999999976
Q ss_pred CCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
...+|+||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 67899999998653 33333344457999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||..... +.. .
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~-----------~-- 239 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE-----------A-- 239 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT-----------T--
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh-----------h--
Confidence 543 2334568999999999998877568999999999999999999999965221 000 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.......+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus 240 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 240 ----------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00112347899999999999999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=420.90 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=214.6
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.. ...
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCE
Confidence 446789999999999999999999999999999999975422 11234557789999999999999999999876 678
Q ss_pred EEEEEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 206 LYLVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
+|||||||++ +|...+... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999986 454444432 23599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh----HHHHHHHHHhhCCCChhhhhh
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE----VEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~----~e~l~~I~k~~g~p~~~~w~~ 359 (709)
. ......+||+.|+|||++.+.. |+.++||||||||||||++|++||.+... .+....+... +
T Consensus 339 ~--~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---~------- 405 (576)
T 2acx_A 339 G--QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---P------- 405 (576)
T ss_dssp T--CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---C-------
T ss_pred C--ccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---c-------
Confidence 2 2334568999999999998755 89999999999999999999999988643 2222222211 0
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+|| +++++++||||+..
T Consensus 406 -------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 -------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred -------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 011245889999999999999999999 89999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=379.15 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=193.3
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
....++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 84 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SN 84 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SS
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CC
Confidence 3456789999999999999999999999999999999974321 11224567899999999999999999999876 67
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 89999999976 45555555556799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+.+..+...
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 227 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--------------- 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS---------------
T ss_pred CCC-cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc---------------
Confidence 222 223457899999999887654 789999999999999999999999876544333222100
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......++..+.+||.+||..||.+|||++++|+||||...
T Consensus 228 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 --------------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred --------------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 001123478899999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=382.82 Aligned_cols=281 Identities=25% Similarity=0.395 Sum_probs=226.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc------eeeeeceEeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-KIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSR 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------Iv~l~~~~~~~ 201 (709)
.++|++++.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.+.|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 578999999999999999999998877 78999998643 344566788999999997766 8888888876
Q ss_pred CCCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----------------
Q 005210 202 MSCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---------------- 264 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---------------- 264 (709)
...+||||||++++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 67899999999988887665543 469999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH
Q 005210 265 ---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 341 (709)
Q Consensus 265 ---d~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~ 341 (709)
+.++.+||+|||++...... ....+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999864332 24458999999999998765 79999999999999999999999999999999
Q ss_pred HHHHHHhhCCCChhhhhhcCCCCcc-----ccCCCCccccchhc----------ccCCCCHHHHHHHHHhcccCCCCCCC
Q 005210 342 LHKIFKLCGSPSEDYWRKSKLPHAT-----IFKPQQPYKRCVAE----------TFKDFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 342 l~~I~k~~g~p~~~~w~~~~lp~~~-----~~~~~~~~~~~~~~----------~~~~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
+..+.+.++.++...+......... .+.......+.... .....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 9999999998887766543211100 00000000000000 01112457899999999999999999
Q ss_pred HHHHHhcccCCCC
Q 005210 407 AASALRSEFFTMK 419 (709)
Q Consensus 407 a~e~L~hp~f~~~ 419 (709)
++++|+||||+..
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=382.41 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=206.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC------hHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE------PESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~------~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 46799999999999999999999999999999999754321 1223457789999999999999999999865
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc---EEEeeccccc
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLAS 279 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGla~ 279 (709)
..+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 87 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 238999999986444333344557999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhc--CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHH-HHHHHhhCCCChhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL-HKIFKLCGSPSEDY 356 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~--~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l-~~I~k~~g~p~~~~ 356 (709)
.+... ......+||+.|+|||++. +...|+.++|||||||++|+|++|.+||.+......+ ..+.......
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 239 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 239 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC----
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc----
Confidence 76432 1223457899999999984 3445789999999999999999999999875543222 2232211111
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
....+..++..+.+||.+||..||.+|||++++|+||||+.
T Consensus 240 ---------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 12233568899999999999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=412.42 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=216.0
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
+...++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KT 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CC
Confidence 34568899999999999999999999999999999999754321 1234567889999999999999999999876 67
Q ss_pred eEEEEEeecccc-ccccccCC---CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 205 SLYLVFEYMEHD-LAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~-L~~~~~~~---~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.+|||||||+++ |...+... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 899999999864 44443322 34699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC----hHHHHHHHHHhhCCCChhh
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT----EVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~----~~e~l~~I~k~~g~p~~~~ 356 (709)
+..... .....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+ ..+....|....
T Consensus 339 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 339 LKAGQT-KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA------- 409 (543)
T ss_dssp CCTTCC-CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-------
T ss_pred ccCCCc-ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-------
Confidence 654322 234458999999999998754 8999999999999999999999998764 234444443310
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||++||.+||+ ++++++||||+..
T Consensus 410 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 410 ----------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ----------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 0112457899999999999999999995 5899999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.75 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=208.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence 6789999999999999999999999999999999975321 11234567899999999999999999999876 67899
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 99999986 44444433 347999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 228 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------------- 228 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------------
Confidence 2234557899999999998766557899999999999999999999998877776666543110
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 -------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0113468889999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=394.79 Aligned_cols=266 Identities=17% Similarity=0.188 Sum_probs=196.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhc--CCCceeeee-------ceE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL--DHINVIKLE-------GLV 198 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L--~HpnIv~l~-------~~~ 198 (709)
...|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999987654 334566777886655555 699988754 333
Q ss_pred eecCC---------------CeEEEEEeeccccccccccCCCCCCCHHHH------HHHHHHHHHHHhhhhhCCeeeccC
Q 005210 199 TSRMS---------------CSLYLVFEYMEHDLAGLASHPGLKFSEAQV------KCYMQQLLCGLDHCHSRGVLHRDI 257 (709)
Q Consensus 199 ~~~~~---------------~~lyLVmEy~~g~L~~~~~~~~~~lse~~i------~~i~~QIl~aL~yLH~~gIvHrDL 257 (709)
..... ..+|||||||+++|...+...+..+++..+ ..++.||+.||.|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 32211 458999999998888777654334555555 577799999999999999999999
Q ss_pred CCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcC-CccCCccccccchhHHHHHHHhCCCCCCCC
Q 005210 258 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGR 336 (709)
Q Consensus 258 KP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~y~~~~DIWSLG~iL~ELltG~~pF~g~ 336 (709)
||+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ...|+.++|||||||+||||++|++||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999875321 224567899999999975 235899999999999999999999999876
Q ss_pred ChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 337 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 337 ~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
.... ...|....... .............+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 297 ~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 297 TPGI-------------KGSWKRPSLRV-------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CTTC-------------TTCCCBCCTTS-------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred Cccc-------------ccchhhhhhhh-------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 4210 00111000000 000011112235789999999999999999999999999999999
Q ss_pred CC
Q 005210 417 TM 418 (709)
Q Consensus 417 ~~ 418 (709)
+.
T Consensus 357 ~~ 358 (371)
T 3q60_A 357 LQ 358 (371)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=378.47 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=207.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+ ++..||||++..........+.+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEE
Confidence 57899999999999999999986 57889999998777777777888999999999999999999999876 567999
Q ss_pred EEeeccc-cccccccCCCC--CCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 209 VFEYMEH-DLAGLASHPGL--KFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~--~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
||||+.+ +|...+...+. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999987 45444443321 3999999999999999999999999 99999999999999999999999999976533
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------ 257 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------------ 257 (309)
T ss_dssp -----------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------------
T ss_pred cc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence 22 2234568999999999998765 799999999999999999999999998887776665322111
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh--cccCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTM 418 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~--hp~f~~ 418 (709)
......+++.+.+||.+||+.||.+|||++++++ .++++.
T Consensus 258 ---------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 ---------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1122468899999999999999999999999987 677764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=386.53 Aligned_cols=283 Identities=29% Similarity=0.470 Sum_probs=222.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeece
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----------HINVIKLEGL 197 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIv~l~~~ 197 (709)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 57899999999999999999999999999999998743 344566778999999886 8999999999
Q ss_pred EeecC--CCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEc------CC
Q 005210 198 VTSRM--SCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLID------NN 267 (709)
Q Consensus 198 ~~~~~--~~~lyLVmEy~~g~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld------~~ 267 (709)
+.... ...+|+||||++++|...+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87532 237899999998777776654 334699999999999999999999998 999999999999994 44
Q ss_pred CcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC------hHHH
Q 005210 268 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQ 341 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~------~~e~ 341 (709)
+.+||+|||++..+... ....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 48999999999876432 23458899999999998765 7999999999999999999999998765 5677
Q ss_pred HHHHHHhhCCCChhhhhhcCCCCc-----cccC---C--CCccccchh---cccCCCCHHHHHHHHHhcccCCCCCCCHH
Q 005210 342 LHKIFKLCGSPSEDYWRKSKLPHA-----TIFK---P--QQPYKRCVA---ETFKDFPAPALALMETLLSIDPADRGSAA 408 (709)
Q Consensus 342 l~~I~k~~g~p~~~~w~~~~lp~~-----~~~~---~--~~~~~~~~~---~~~~~~s~~~~dLI~~lL~~DP~kRpTa~ 408 (709)
+..++..+|.++...|...+.... ..+. . ..+....+. .....++..+.+||.+||+.||.+|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 888999999988776654321100 0000 0 000001111 11123456789999999999999999999
Q ss_pred HHHhcccCCCC
Q 005210 409 SALRSEFFTMK 419 (709)
Q Consensus 409 e~L~hp~f~~~ 419 (709)
++|+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=402.73 Aligned_cols=253 Identities=18% Similarity=0.249 Sum_probs=199.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHH---HHHhcCCCceeeee-------c
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH---ILRRLDHINVIKLE-------G 196 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~---iL~~L~HpnIv~l~-------~ 196 (709)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+. +|+.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 35789999999999999999999999999999999986532 3445677889994 55555899999998 5
Q ss_pred eEeecCC----------C-----eEEEEEeeccccccccccCCC------CCCCHHHHHHHHHHHHHHHhhhhhCCeeec
Q 005210 197 LVTSRMS----------C-----SLYLVFEYMEHDLAGLASHPG------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255 (709)
Q Consensus 197 ~~~~~~~----------~-----~lyLVmEy~~g~L~~~~~~~~------~~lse~~i~~i~~QIl~aL~yLH~~gIvHr 255 (709)
++..... . ..||||||++++|...+...+ ..+++..++.|+.||+.||.|||++||+||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5443211 1 379999999888777665322 123348888899999999999999999999
Q ss_pred cCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCC----------ccCCccccccchhHHHHH
Q 005210 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAE 325 (709)
Q Consensus 256 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----------~~y~~~~DIWSLG~iL~E 325 (709)
||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. ..|+.++|||||||+|||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 3345577 999999999876 258999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC
Q 005210 326 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG 405 (709)
Q Consensus 326 LltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp 405 (709)
|++|++||.+.+..+.+..+ ......+++.+.+||.+||+.||.+||
T Consensus 306 lltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999765432221111 112256899999999999999999999
Q ss_pred CHHHHHhcccCCC
Q 005210 406 SAASALRSEFFTM 418 (709)
Q Consensus 406 Ta~e~L~hp~f~~ 418 (709)
|+.++|+||||+.
T Consensus 353 t~~e~l~hp~f~~ 365 (377)
T 3byv_A 353 LPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHTSHHHHH
T ss_pred CHHHHhhChHHHH
Confidence 9999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=396.29 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=208.9
Q ss_pred CCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 578999999999999999999985 5899999999864321 111223456799999999 79999999999877
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
...+||||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 67899999999874444333334479999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCCh----HHHHHHHHHhhCCCChhhh
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTE----VEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~----~e~l~~I~k~~g~p~~~~w 357 (709)
..........+||+.|+|||++.+. ..++.++||||||||||||++|+.||..... .+....+... .
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~------ 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--E------ 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--C------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--C------
Confidence 4333334456899999999999863 3478999999999999999999999976432 2222223221 0
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|| |++++|+||||+..
T Consensus 283 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 283 ---------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 011245788999999999999999999 99999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=375.05 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=217.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 568999999999999999999999999999999998655444455678899999999999999999999876 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC---CcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~---g~vKL~DFGla~~~~~~ 284 (709)
||||+.++ |...+.. ...+++.+++.++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999864 4444433 3479999999999999999999999999999999999999754 47999999999876433
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
. ......+|+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 242 (287)
T 2wei_A 178 T--KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----------- 242 (287)
T ss_dssp S--SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred C--ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 2 23445789999999998764 78999999999999999999999999988877777654211111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 243 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 243 --------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp --------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred --------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 1123467899999999999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=385.82 Aligned_cols=278 Identities=22% Similarity=0.334 Sum_probs=211.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.......+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 5789999999999999999999999999999999975432 122456679999999999999999999988765668999
Q ss_pred EEeeccc-cccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----cCCCcEEEeeccccccc
Q 005210 209 VFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFY 281 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~ 281 (709)
||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999985 4544444322 239999999999999999999999999999999999999 77888999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcC-------CccCCccccccchhHHHHHHHhCCCCCCCCC----hHHHHHHHHHhhC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLG-------ATYYGTAVDLWSTGCILAELYAGKPIMPGRT----EVEQLHKIFKLCG 350 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~----~~e~l~~I~k~~g 350 (709)
.... .....+||+.|+|||++.. ...|+.++||||||||+|||++|+.||.... ..+.+.++...
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 242 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-- 242 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--
Confidence 5432 2345679999999999862 3458999999999999999999999997533 34555555443
Q ss_pred CCChhhhhhcCCCCccc--cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 351 SPSEDYWRKSKLPHATI--FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~--~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
.|. ..|.......... +....+. .......++..+.+||.+||+.||.+|||++|+|+||=
T Consensus 243 ~p~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPS-GAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCT-TCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCc-ccchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 221 1111100000000 0000000 00112235567899999999999999999999999973
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=370.21 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=217.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999999865432 345678899999999999999999999887 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999987554444443 479999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|++||......+.+..+.+.. +
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 236 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P---------------- 236 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------------
T ss_pred cCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------------
Confidence 34557899999999987754 7899999999999999999999999888776665553311 0
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 237 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 ----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01123578899999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=380.54 Aligned_cols=275 Identities=21% Similarity=0.376 Sum_probs=215.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh---------------HHHHHHHHHHHHHHhcCCCcee
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP---------------ESVRFMAREIHILRRLDHINVI 192 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~---------------~~~~~~~rEi~iL~~L~HpnIv 192 (709)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.|+||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 367899999999999999999998 89999999997542111 1126678999999999999999
Q ss_pred eeeceEeecCCCeEEEEEeeccc-ccccc------ccC-CCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEE
Q 005210 193 KLEGLVTSRMSCSLYLVFEYMEH-DLAGL------ASH-PGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLL 263 (709)
Q Consensus 193 ~l~~~~~~~~~~~lyLVmEy~~g-~L~~~------~~~-~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NIL 263 (709)
++++++.. ...+|+||||+++ +|... +.. ....+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999877 6789999999997 55544 322 15679999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCc-cccccchhHHHHHHHhCCCCCCCCCh-HHH
Q 005210 264 IDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT-AVDLWSTGCILAELYAGKPIMPGRTE-VEQ 341 (709)
Q Consensus 264 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~-~~DIWSLG~iL~ELltG~~pF~g~~~-~e~ 341 (709)
|+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|++||.+.+. .+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999875432 3345678999999999987745666 99999999999999999999998877 555
Q ss_pred HHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 342 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 342 l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+..+.......+. .+ .....+.. ..........+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 262 ~~~i~~~~~~~~~-~~-------~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPL-DR-------NHFLYPLT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCC-SS-------SSSTTTTC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCcc-ch-------hhhhcccc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 5555332111100 00 00000000 001122235689999999999999999999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=386.55 Aligned_cols=284 Identities=22% Similarity=0.308 Sum_probs=213.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEE
Confidence 3678999999999999999999999999999999998653 45566778899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||++++.+..+......+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+...
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999998744443333344799999999999999999999996 9999999999999999999999999999755321
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHH-hhCCCChhhhhhcCCC-C
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK-LCGSPSEDYWRKSKLP-H 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k-~~g~p~~~~w~~~~lp-~ 364 (709)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+....+.. ..+.+....+...... .
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 123458899999999998754 79999999999999999999999998776654333211 1111111111000000 0
Q ss_pred cccc----CCCCcccc----ch-----hcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIF----KPQQPYKR----CV-----AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~----~~~~~~~~----~~-----~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+ .+...... .. ......++..+.+||.+||+.||.+|||++++|+||||+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000 00000000 00 0011247889999999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=378.21 Aligned_cols=269 Identities=25% Similarity=0.374 Sum_probs=194.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 6789999999999999999999999999999999865432 2334567789999999999999999999876 567999
Q ss_pred EEeeccc-cccccccC-------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 209 VFEYMEH-DLAGLASH-------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999976 44444321 345699999999999999999999999999999999999999999999999999976
Q ss_pred cCCCC----CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 281 YDPDQ----NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 281 ~~~~~----~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
+.... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+......+............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 248 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE-- 248 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT--
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc--
Confidence 54321 112234578999999999876455799999999999999999999999988776655444321110000
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...........++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 -----------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -----------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0001122345688999999999999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=371.44 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=203.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec-------
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR------- 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~------- 201 (709)
.++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 46799999999999999999999999999999998643 44567788999999999999999999987642
Q ss_pred ----CCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 202 ----MSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 202 ----~~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
....+|+||||+++ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 24678999999986 6666655455578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC-CChHHHH
Q 005210 277 LASFYDPDQ-------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQL 342 (709)
Q Consensus 277 la~~~~~~~-------------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l 342 (709)
++..+.... .......+||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998654211 1223456789999999999876668999999999999999998 4433 2333333
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
..+....... ........+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRSVSIEF-------------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHSTTCCC-------------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhcccccccc-------------------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 3332211000 01122356788999999999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.42 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=210.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 578999999999999999999999999999999987543 2335667899999999999999999999876 568999
Q ss_pred EEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 999998765543 3333457999999999999999999999999999999999999999999999999987543111 01
Q ss_pred CccccccccCCCCchhhc----CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 288 PLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~----~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+..+.+..+.+.....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence 123457899999999984 34457899999999999999999999999988877776665421100
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||..||..||.+|||+.++|+||||+..
T Consensus 242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 00123468889999999999999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=373.04 Aligned_cols=262 Identities=25% Similarity=0.432 Sum_probs=210.0
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC---
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM--- 202 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~--- 202 (709)
...+.|++++.||+|+||.||+|.+..+++.||||++...... ...+.+|+.+++.+ .||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3478899999999999999999999999999999999755332 34577899999999 8999999999987643
Q ss_pred -CCeEEEEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 203 -SCSLYLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 203 -~~~lyLVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
...+||||||+++ +|...+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 4679999999987 55554433 23479999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~ 355 (709)
.+.... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+..+.... .+
T Consensus 178 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--- 252 (326)
T 2x7f_A 178 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-AP--- 252 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC---
T ss_pred ecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cc---
Confidence 764322 12334578999999999873 3447899999999999999999999999888777666554311 00
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 253 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 -----------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -----------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -----------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123578899999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.54 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=210.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 5789999999999999999999999999999999976432 3457789999999999999999999877 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++ |...+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 99999874 444444345579999999999999999999999999999999999999999999999999997764322 2
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.... .+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-------------- 244 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPT-------------- 244 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC--------------
T ss_pred ccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Ccc--------------
Confidence 234457899999999987765 7999999999999999999999999888766655443311 000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 245 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 245 -----------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp -----------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred -----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00123468899999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.79 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=199.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||++..........+.+..+..+++.++||||+++++++.. ...+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEE
Confidence 4678999999999999999999999999999999998765444444555566667888899999999999877 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||+++.+..+.......+++..++.++.||+.||.|||+. ||+|+||||+||||+.++.+||+|||++..+....
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 9999996555444444355799999999999999999999995 99999999999999999999999999997654322
Q ss_pred CCccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 287 QPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.. ....+.+..+..... +
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~--------- 248 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P--------- 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C---------
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C---------
Confidence 2334578999999999852 34478999999999999999999999987 445555555544210 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.......+++.+.+||..||..||.+|||++++|+||||+.
T Consensus 249 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 ----------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ----------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00112357899999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=362.77 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=210.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEE
Confidence 578999999999999999999986 46779999998654433 457799999999999999999999876 667999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||++++ |...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999864 55555555567999999999999999999999999999999999999999999999999999876443322
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------
Confidence 334456788999999987655 7999999999999999999 99999999888877776542110
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||..||+.||.+|||+.+++++
T Consensus 227 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0113468889999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.39 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=205.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.. ......+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEE
Confidence 6789999999999999999999999999999999853 345667788999999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999987 555555554567999999999999999999999999999999999999999999999999999876432221
Q ss_pred C-------------ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 288 P-------------LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 288 ~-------------~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
. ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------- 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------- 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence 1 12457999999999998754 7999999999999999999999886532110000
Q ss_pred hhhhhcCCCCccccCCCCcccc-chhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 355 DYWRKSKLPHATIFKPQQPYKR-CVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~-~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
...... ........+++.+.+||.+||+.||.+|||+.++++
T Consensus 233 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 ----------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ----------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000 001123467889999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.30 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=193.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS-- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~-- 203 (709)
.++|++.+.||+|+||.||+|.+..++. .||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 5789999999999999999999887775 89999998765555667788999999999999999999999876322
Q ss_pred --CeEEEEEeecccc-ccccccC-----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 204 --CSLYLVFEYMEHD-LAGLASH-----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 204 --~~lyLVmEy~~g~-L~~~~~~-----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
..+|+||||+.++ |...+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 1249999999874 4443321 2236999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 005210 276 GLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 276 Gla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~ 353 (709)
|++..+..... .......+|+.|+|||++.+.. |+.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 257 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--- 257 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC---
Confidence 99987643222 2223445688999999987765 7999999999999999999 9999999888777776653210
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHhcccCCCC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-------AASALRSEFFTMK 419 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-------a~e~L~hp~f~~~ 419 (709)
......+++.+.+||.+||+.||.+||| +++++.|+|+...
T Consensus 258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0112457889999999999999999999 7888899999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=380.25 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=208.6
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-------CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 578999999999999999999875 35668999998754 3445567788999999999 89999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+||||||+.+ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 6679999999986 454444322 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+..... .......+|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+....+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987643322 2233456789999999998765 8999999999999999999 99999988776665
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+.... . ......++..+.+||..||+.||.+|||+.+++++
T Consensus 316 ~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGH--R--------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTC--C--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCC--C--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5543210 0 01123578899999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.77 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=209.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..++. .||||+++... .....+.+.+|+.+|+.|+||||+++++++.. ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCc
Confidence 5789999999999999999999986554 59999997543 45556778899999999999999999999876 667
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999986 555555555568999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC--ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQP--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~--~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... .....+|+.|+|||++.+.. |+.++|||||||++|||++ |..||.+.+..+.+..+......+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--------- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred ccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---------
Confidence 2221 22345578899999997655 7999999999999999999 999999998888777765421111
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+++.+.+||..||..||.+|||+.++++
T Consensus 275 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 -------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12357899999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.42 Aligned_cols=252 Identities=20% Similarity=0.223 Sum_probs=206.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.| +||||+++++++.. ...+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 46899999999999999999999999999999998755322 2367899999999 99999999999877 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc-----EEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-----LKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~-----vKL~DFGla~~~~ 282 (709)
|||||+.++|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999977777776655568999999999999999999999999999999999999998887 9999999998764
Q ss_pred CCCCC------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCC
Q 005210 283 PDQNQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPS 353 (709)
Q Consensus 283 ~~~~~------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~---~~e~l~~I~k~~g~p~ 353 (709)
..... .....+||+.|+|||++.+.. ++.++||||||||||||++|+.||.+.+ ..+.+..|........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 32221 124568999999999998755 7999999999999999999999998843 3444444433211111
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+| .+.+||..||..||.+||+++++++
T Consensus 241 ------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 011122345 8999999999999999999988876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.70 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=210.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+ .|+||+++++++.. ...+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 57899999999999999999999999999999998754322 2366899999999 89999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc-----EEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-----LKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~-----vKL~DFGla~~~~ 282 (709)
+||||+.++|...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999977777777665667999999999999999999999999999999999999987776 9999999998764
Q ss_pred CCCC------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC---ChHHHHHHHHHhhCCCC
Q 005210 283 PDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR---TEVEQLHKIFKLCGSPS 353 (709)
Q Consensus 283 ~~~~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~---~~~e~l~~I~k~~g~p~ 353 (709)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+. +..+.+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 1234567999999999987755 799999999999999999999999884 34444444433211111
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+++.+.+||..||+.||.+|||+.++++
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22334568999999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=377.01 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=207.8
Q ss_pred CCCeeEEeeecccCceEEEEEE-----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|. +..+++.||||+++... .....+.+.+|+.+|..+ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 6789999999999999999999 56678999999997543 344556788999999999 899999999998763
Q ss_pred CCeEEEEEeeccc-cccccccCCC--------------------------------------------------------
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG-------------------------------------------------------- 225 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~-------------------------------------------------------- 225 (709)
...+|+||||+.+ +|...+....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4568999999986 4444443221
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC-CCccccccc
Q 005210 226 ---------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVT 295 (709)
Q Consensus 226 ---------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT 295 (709)
..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 1289999999999999999999999999999999999999999999999999986643222 223455789
Q ss_pred cCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCcc
Q 005210 296 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 374 (709)
Q Consensus 296 ~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~ 374 (709)
+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+....+.+...+.....+
T Consensus 259 ~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 315 (359)
T 3vhe_A 259 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 315 (359)
T ss_dssp GGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred ceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------
Confidence 9999999988755 7999999999999999998 999999887655555544321111
Q ss_pred ccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 375 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 375 ~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||..||+.||.+|||+.++++|
T Consensus 316 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123478899999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.33 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=210.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+. ++..||||++....... ..+.+|+.+++.++||||+++++++.. ...+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceE
Confidence 4678999999999999999999875 56779999997654433 457789999999999999999999866 67799
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
+||||++++ |...+...+..+++.+++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999865 5555544444699999999999999999999999999999999999999999999999999987654433
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 224 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------------- 224 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------------
T ss_pred hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------------
Confidence 3333445678899999987755 7999999999999999999 99999998888777766432110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||..||+.||.+|||+.++|++
T Consensus 225 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 --------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112367889999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.32 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=204.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|.....||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 96 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKI 96 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEE
Confidence 344555669999999999999999999999999997653 2344667899999999999999999999977 678999
Q ss_pred EEeecccc-ccccccCC--CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccccCCC
Q 005210 209 VFEYMEHD-LAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~--~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~~~~~ 284 (709)
||||+.++ |...+... ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++..+...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999764 44444332 235679999999999999999999999999999999999987 899999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCC-ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~-~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
. .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+................
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 243 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------ 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence 2 223345789999999998754 23789999999999999999999999765433321111111000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 011224578999999999999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.99 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=208.2
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.+. ||||+++++++.. ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence 3567999999999999999999985 5889999999877667777788899999999997 5999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|||||+..++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+....
T Consensus 103 ~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 103 IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 9999998877777766543 4789999999999999999999999999999999999996 5899999999998764332
Q ss_pred CC-CccccccccCCCCchhhcCC----------ccCCccccccchhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCC
Q 005210 286 NQ-PLTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPS 353 (709)
Q Consensus 286 ~~-~~~~~~gT~~Y~APE~l~~~----------~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~-~e~l~~I~k~~g~p~ 353 (709)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ...+..+......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 258 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 258 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc--
Confidence 21 22345789999999998752 3478899999999999999999999987543 3333333211000
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.......+..+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 259 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 259 -------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp -------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred -------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 01112357889999999999999999999999999999875433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=381.19 Aligned_cols=258 Identities=21% Similarity=0.343 Sum_probs=210.9
Q ss_pred CCCeeEEeeecccCceEEEEEE-----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++++.||+|+||.||+|. +..++..||||+++... .......+.+|+.+++.++|||||++++++.. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 5789999999999999999999 45678899999986433 34455567899999999999999999999876 5
Q ss_pred CeEEEEEeeccc-cccccccCC------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC---cEEEe
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g---~vKL~ 273 (709)
..+|||||||.+ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 678999999976 555544322 24599999999999999999999999999999999999999555 59999
Q ss_pred ecccccccCC-CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||+++.+.. .........++|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999975422 1122234557899999999987755 8999999999999999998 99999999888877776542100
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....++..+.+||..||+.||.+|||+.++|++.++..
T Consensus 306 ----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 306 ----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112457889999999999999999999999999987753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.33 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=207.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeE
Confidence 3678999999999999999999876 67789999998654433 457789999999999999999999876 67799
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
+||||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999975 55555554455799999999999999999999999999999999999999999999999999987644322
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 241 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------- 241 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC-------------
Confidence 2233446688899999998655 7999999999999999998 999999998888777775421111
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....+++.+.+||..||+.||.+|||+.++|+|
T Consensus 242 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 ---------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 113467889999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=380.11 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=208.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.. ...+||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence 57899999999999999999999999999999998744 344555667899999999999999999999876 567999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||++ +|...+...+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999985 555555544556999999999999999999999999999999999999999999999999999864322111
Q ss_pred C-ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 288 P-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 288 ~-~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
. .....+|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+....+.+....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC--------------
T ss_pred ecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1 11224577899999987655 7999999999999999998 99999998877666555331100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+|+.+.+||..||+.||.+|||+.++++
T Consensus 335 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 --------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012347889999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.77 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cC
Confidence 367899999999999999999998754 4579999986432 3455677889999999999999999999874 35
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 68999999986 55555554555799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
..........+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------ 235 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------ 235 (281)
T ss_dssp ----------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred ccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------------
Confidence 3333334446688999999987654 7999999999999999996 9999999887777666643110
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01124678999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=353.80 Aligned_cols=250 Identities=16% Similarity=0.200 Sum_probs=211.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+. +..||||++..........+.+.+|+.+++.++||||+++++++.......+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3678999999999999999999984 88899999988776777778899999999999999999999999875457899
Q ss_pred EEEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 208 LVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
+||||+++ +|...+.... ..+++.+++.++.||+.||.|||++| |+||||||+||||+.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999986 5655554433 25899999999999999999999999 99999999999999999999999998764322
Q ss_pred CCCCCccccccccCCCCchhhcCCcc--CCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~--y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
...++|+.|+|||++.+... ++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 33478999999999987542 2337999999999999999999999988887776665421111
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122458899999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.60 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=190.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHH-HHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+. +++.++||||+++++++.. ...+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCce
Confidence 36889999999999999999999999999999999986543 333344555665 6777899999999999977 6789
Q ss_pred EEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHHhhhhhC-CeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 207 YLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~-gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
||||||+.+++...+.. ....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999999876665432 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhc---CCccCCccccccchhHHHHHHHhCCCCCCCCChH-HHHHHHHHhhCCCChhhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLL---GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~---~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~-e~l~~I~k~~g~p~~~~w 357 (709)
.... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.... +.+..+.. +.+
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~----- 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCC-----
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCC-----
Confidence 4322 223447899999999984 2334789999999999999999999999875432 11111100 000
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
+ .........+++.+.+||..||..||.+|||+.++|+||||..
T Consensus 248 ------------~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 248 ------------P-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ------------C-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------C-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0 0011122468899999999999999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.10 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=197.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 47889999999999999999999999999999999875532 34455778899999999999999999999977 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|+||||+++..+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999998744433333344799999999999999999999999999999999999999999999999999987654443
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.... ...+......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-------------- 253 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPR-------------- 253 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCC--------------
T ss_pred ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCC--------------
Confidence 4445668999999999987754 79999999999999999999999988765433 3322211000
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-CHHHHHh
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-SAASALR 412 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-Ta~e~L~ 412 (709)
.......+|+.+.+||.+||..||.+|| |++++++
T Consensus 254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122356889999999999999999999 6776664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.34 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=199.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+.. .||||+++.........+.+.+|+.+|+.++||||++++++.. ...+|+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEE
Confidence 6789999999999999999998643 4999999877767777788999999999999999999998653 456899
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-CC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-~~ 286 (709)
||||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999986 455555555667999999999999999999999999999999999999999999999999999765431 22
Q ss_pred CCccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+....+.+..+......+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 245 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----------- 245 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------
Confidence 23345678999999999862 34478899999999999999999999998877776666554211110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+......+++.+.+||..||+.||.+|||+.++|+
T Consensus 246 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 ------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012223468899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.55 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=208.1
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|.+.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|+.|+||||+++++++.. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 578999999999999999999983 45689999998754 345566778899999999999999999999876 6
Q ss_pred CeEEEEEeeccc-cccccccCCC-----------------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCC
Q 005210 204 CSLYLVFEYMEH-DLAGLASHPG-----------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~~-----------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP 259 (709)
..+|+||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 679999999985 4444443221 2489999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCC
Q 005210 260 SNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRT 337 (709)
Q Consensus 260 ~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~ 337 (709)
+||||+.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987643222 1223446788999999998755 7999999999999999999 999999887
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+....+.... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766555443210 001124578999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=369.59 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=209.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
..++|++++.||+|+||.||+|.+. .+++.||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3678999999999999999999987 456899999987543 44556778899999999999999999999876
Q ss_pred CCeEEEEEeeccc-cccccccCC-----------------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHP-----------------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIK 258 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~-----------------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLK 258 (709)
...+||||||+++ +|...+... ...+++.+++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6779999999986 454443321 1579999999999999999999999999999999
Q ss_pred CccEEEcCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCC
Q 005210 259 GSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGR 336 (709)
Q Consensus 259 P~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~ 336 (709)
|+||||+.++.+||+|||++..+..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999999999976543221 2233457799999999988655 7999999999999999999 99999998
Q ss_pred ChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 337 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 337 ~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+..+.+..+.... . ......+++.+.+||..||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGN--I--------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTC--C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCC--c--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8877776664310 0 01123578899999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=374.98 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=208.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeceEeec
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLD--HINVIKLEGLVTSR 201 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~ 201 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+. |+||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 3678999999999999999999999999999999998654321 11234567999999996 5999999999976
Q ss_pred CCCeEEEEEeecc--ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeecccc
Q 005210 202 MSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLA 278 (709)
Q Consensus 202 ~~~~lyLVmEy~~--g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFGla 278 (709)
...+|+||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 120 -~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 -PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred -CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 678999999997 455555443 34799999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+... ......||+.|+|||++.+...++.++|||||||++|||++|+.||..... +... ..
T Consensus 198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~~------ 260 (320)
T 3a99_A 198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QV------ 260 (320)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CC------
T ss_pred cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--cc------
Confidence 876432 234557999999999998776568899999999999999999999965421 1110 00
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 261 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 261 ---------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 0123578999999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.80 Aligned_cols=269 Identities=23% Similarity=0.364 Sum_probs=202.3
Q ss_pred CCCeeEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 5789999999999999999998 5678999999998743 355567788999999999999999999998765456
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+||||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 78999999976 56665555555699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... .......+|..|+|||++.+.. ++.++|||||||++|+|++|..||...... ... ..+......+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~---~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR---MIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---HHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---hhcCccccchhHHH
Confidence 322 1223445788899999998765 799999999999999999999988653211 111 11111100000000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+. ..... .........+++.+.+||..||+.||.+|||+.++++
T Consensus 241 ~~--~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LI--ELLKN-----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH--HHHHT-----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH--HHHhc-----cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 00000 0001123468899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.47 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=210.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|.+.+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++.+ +|||||++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 5789999999999999999999754 3467999999755 3455567788999999999 99999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+||||||+.+ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 6679999999986 555444322 2359999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++..+..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987643222 2234456789999999998755 7999999999999999999 99999998877766
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+..... ......+++.+.+||..||+.||.+|||+.+++++
T Consensus 304 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65543210 01124578999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.20 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=202.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC--CCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--SCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~--~~~l 206 (709)
.++|++++.||+|+||.||+|++. ++.||||++.... .......+|+.+|+.++|||||++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 678999999999999999999875 7899999986542 23344567999999999999999999987643 3458
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC----------CeeeccCCCccEEEcCCCcEEEeec
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR----------GVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~----------gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
||||||+++ +|...+.. ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999987 55554433 2599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC-CCccccccccCCCCchhhcCC----ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 005210 276 GLASFYDPDQN-QPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 350 (709)
Q Consensus 276 Gla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~----~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g 350 (709)
|++..+..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+......+........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654322 223446899999999999863 3467789999999999999999999987654322222222223
Q ss_pred CCChhhhhhcCCCCccccCCCCccccchhccc--CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+....+........ ..+. +...+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 256 HPSLEDMQEVVVHKK--KRPV------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SCCHHHHHHHHTTSC--CCCC------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhhhhhccc--CCCC------ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 333322221100000 0000 00111 113456999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.72 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=200.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhc----CCCceeeeeceEe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRL----DHINVIKLEGLVT 199 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L----~HpnIv~l~~~~~ 199 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3678999999999999999999999999999999997654322 1223355799999999 8999999999987
Q ss_pred ecCCCeEEEEEee-ccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc-CCCcEEEeecc
Q 005210 200 SRMSCSLYLVFEY-MEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFG 276 (709)
Q Consensus 200 ~~~~~~lyLVmEy-~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld-~~g~vKL~DFG 276 (709)
. ....|+|||| +.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 6 5678999999 554 45444443 44799999999999999999999999999999999999999 88999999999
Q ss_pred cccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 277 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 277 la~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
++..+... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+... +....
T Consensus 186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~------- 249 (312)
T 2iwi_A 186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE------- 249 (312)
T ss_dssp SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC-------
T ss_pred hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc-------
Confidence 99876532 234567899999999998766556689999999999999999999975421 21100
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......++..+.+||.+||..||.+|||++++|+||||+..
T Consensus 250 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 ----------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ----------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 01123578899999999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.79 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=204.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHH-----HHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-----VRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~-----~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 67899999999999999999999999999999998765432211 15688999999999999999999988652
Q ss_pred CeEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCc-----EEEeec
Q 005210 204 CSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGI-----LKIADF 275 (709)
Q Consensus 204 ~~lyLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~-----vKL~DF 275 (709)
.++||||+. ++|...+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+||
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 279999998 4666666666668999999999999999999999999 999999999999988776 999999
Q ss_pred ccccccCCCCCCCccccccccCCCCchhhcC-CccCCccccccchhHHHHHHHhCCCCCCCCChHHH--HHHHHHhhCCC
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ--LHKIFKLCGSP 352 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~--l~~I~k~~g~p 352 (709)
|++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+...... ...+... +..
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GLR 248 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CCC
Confidence 99975432 2345689999999998843 34478999999999999999999999987654332 3333221 110
Q ss_pred ChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 353 ~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||..||+.||.+|||+.++++
T Consensus 249 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 --------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122467899999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.25 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=196.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC--hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~--~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..++|++.+.||+|+||.||+|.+. +..||||+++..... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCc
Confidence 3678999999999999999999974 789999998754322 2335678899999999999999999999876 567
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC---eeeccCCCccEEEcC--------CCcEEEee
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG---VLHRDIKGSNLLIDN--------NGILKIAD 274 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g---IvHrDLKP~NILld~--------~g~vKL~D 274 (709)
+|+||||++++.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 899999998765555444 347999999999999999999999999 999999999999986 77899999
Q ss_pred cccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 275 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 275 FGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
||++..+.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--- 232 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC---
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC---
Confidence 99998654322 23457899999999987755 799999999999999999999999998877766655321100
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 233 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01124578899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=358.85 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=211.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEE
Confidence 4678999999999999999999999999999999997543 345667899999999999999999999876 67799
Q ss_pred EEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||+.+ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999985 55555433 33469999999999999999999999999999999999999999999999999998775444
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------------- 230 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------- 230 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred cccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------------
Confidence 33344556788999999997665 7999999999999999999 9999998876665555433110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||..||..||.+|||+.++++
T Consensus 231 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 --------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112457899999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.47 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=206.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++.. ....+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccC-CCCceEE
Confidence 67899999999999999999999999999999998765432 236789999999999887777665544 2678899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~~ 285 (709)
||||++++|...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999777777776555679999999999999999999999999999999999999 478899999999998764432
Q ss_pred C------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCChhh
Q 005210 286 N------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 286 ~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---~e~l~~I~k~~g~p~~~~ 356 (709)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+... .+.+..+......+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 2 1234568999999999998765 79999999999999999999999987432 233333332110000
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+|+.+.+||..||+.||.+|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223568899999999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=368.40 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=180.4
Q ss_pred CCCeeEEe-eecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC--CCe
Q 005210 129 ADSFEKLD-KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--SCS 205 (709)
Q Consensus 129 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~--~~~ 205 (709)
.++|.+++ .||+|+||.||+|.+..+++.||||++... .. ...+....++.+.||||+++++++.... ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 67899966 699999999999999999999999998643 11 1222334456779999999999886522 345
Q ss_pred EEEEEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccccc
Q 005210 206 LYLVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASF 280 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~~ 280 (709)
+||||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 8999999987 5555554432 46999999999999999999999999999999999999986 45699999999986
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
.... .....++|+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.........+....... ..
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------~~ 250 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------QY 250 (336)
T ss_dssp C-------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc------cc
Confidence 5432 234557899999999986654 7899999999999999999999998766544322211100000 00
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
......+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 ---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 ---------------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---------------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00111234689999999999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.64 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=201.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECC---CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS-- 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~-- 203 (709)
.++|.+.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 5789999999999999999998765 56689999998776667777888999999999999999999999876332
Q ss_pred -CeEEEEEeecccc-cccccc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecc
Q 005210 204 -CSLYLVFEYMEHD-LAGLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 276 (709)
Q Consensus 204 -~~lyLVmEy~~g~-L~~~~~-----~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFG 276 (709)
..+|+||||+.++ |...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 2569999999864 444331 334579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 277 LASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 277 la~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
++..+..... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 267 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR---- 267 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----
T ss_pred cceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC----
Confidence 9986643221 1223446688999999998755 7999999999999999999 9999998887776666543210
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124678899999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=372.21 Aligned_cols=265 Identities=20% Similarity=0.192 Sum_probs=201.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-----CeEEEEEEEecCCCCh-HHH--------HHHHHHHHHHHhcCCCceeee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEP-ESV--------RFMAREIHILRRLDHINVIKL 194 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~-~~~--------~~~~rEi~iL~~L~HpnIv~l 194 (709)
.++|++.+.||+|+||.||+|.+..+ ++.||||++....... ... ..+..|+.++..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 56899999999999999999998765 5889999987653110 000 123346666777889999999
Q ss_pred eceEeecCC--CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc--CCCcE
Q 005210 195 EGLVTSRMS--CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGIL 270 (709)
Q Consensus 195 ~~~~~~~~~--~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld--~~g~v 270 (709)
++++..... ..+||||||++++|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998876322 56899999997677777666656899999999999999999999999999999999999999 88999
Q ss_pred EEeecccccccCCCCC------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH
Q 005210 271 KIADFGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344 (709)
Q Consensus 271 KL~DFGla~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~ 344 (709)
||+|||+++.+..... ......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999987643211 1223456999999999998765 79999999999999999999999986443333222
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+....+. ..|+ ....+|+.+.+||..||..||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~----------------~~~~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLM----------------DKCF--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHH----------------HHHS--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHH----------------HHhc--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22111000000000 0001 01468999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.42 Aligned_cols=254 Identities=21% Similarity=0.241 Sum_probs=203.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+..+.. .....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEE
Confidence 57899999999999999999999999999999997654332 236689999999999888877766644 2678899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~~ 285 (709)
||||++++|...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999777777776555679999999999999999999999999999999999999 788999999999998764432
Q ss_pred C------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChH---HHHHHHHHhhCCCChhh
Q 005210 286 N------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV---EQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 286 ~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~---e~l~~I~k~~g~p~~~~ 356 (709)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. ..+..+.......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS----
T ss_pred cCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc----
Confidence 2 1233568899999999998765 799999999999999999999999875432 2222222211000
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
........+|+.+.+||..||+.||.+|||+.++++
T Consensus 238 --------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 --------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 012223568899999999999999999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=358.89 Aligned_cols=247 Identities=17% Similarity=0.229 Sum_probs=201.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCC-------eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQK-------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS 200 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~ 200 (709)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3678999999999999999999998877 469999986542 3445678899999999999999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc--------EE
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--------LK 271 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~--------vK 271 (709)
....||||||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 5678999999985 565555554445999999999999999999999999999999999999998887 99
Q ss_pred EeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCChHHHHHHHHHhhC
Q 005210 272 IADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCG 350 (709)
Q Consensus 272 L~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~~~e~l~~I~k~~g 350 (709)
|+|||++..... .....+|+.|+|||++.+...++.++|||||||++|||++|. +||...+..... .+.....
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~ 235 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRH 235 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccC
Confidence 999999875432 234468999999999987566899999999999999999954 555555444333 3322100
Q ss_pred CCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 -----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112356778999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.67 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=210.1
Q ss_pred CCCeeEEe-eecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLD-KIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCC
Confidence 46788877 9999999999999864 468889999997653 4556677889999999999999999999984 356
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 8999999987 455555555567999999999999999999999999999999999999999999999999999876433
Q ss_pred CC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.. .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+.... .
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~--------- 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R--------- 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--C---------
T ss_pred cceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--c---------
Confidence 22 1223345689999999987654 7999999999999999998 999999988877766654310 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
......+++.+.+||..||..||.+|||+.+++++.+
T Consensus 232 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0122468899999999999999999999999998643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.79 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=206.5
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|+.| .||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 57899999999999999999997 3467789999997543 233446788999999999 99999999999876
Q ss_pred CCeEEEEEeeccc-cccccccCCC----------------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG----------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~----------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP 259 (709)
...+||||||+++ +|...+.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 6679999999976 5655554432 2389999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCC
Q 005210 260 SNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRT 337 (709)
Q Consensus 260 ~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~ 337 (709)
+||||+.++.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++|||||||+||+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999866433222 223446788999999987755 7999999999999999998 999999887
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
..+.+..++.....+ .....+++.+.+||..||..||.+|||+.+++++-.
T Consensus 280 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 280 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 666555554321000 112357889999999999999999999999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.59 Aligned_cols=269 Identities=23% Similarity=0.359 Sum_probs=202.6
Q ss_pred CCCeeEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
...|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3569999999999999999999 57789999999997543 223446688999999999999999999999875557
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 79999999986 55555545555799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... .......+|..|+|||++.+.. ++.++|||||||++|+|++|..|+.... .. +....+..........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~~~~~~~- 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHGQMTVTR- 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCGGGHHHH-
T ss_pred CCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCcccccCHHH-
Confidence 332 2233457888999999998765 7899999999999999999998764321 11 1111111111100000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+. ..... .........+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~--~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LV--NTLKE-----GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HH--HHHHT-----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HH--HHHhc-----cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00 00000 0001123468899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=351.33 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=209.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+. ++..||||++....... +.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 578999999999999999999986 67789999998654433 457899999999999999999999876 567999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+++ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999986 555555555557999999999999999999999999999999999999999999999999999876432222
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+.+..+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred ccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence 233446788999999987654 7999999999999999999 89999998887777766432100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||..||+.||.+|||+.+++++
T Consensus 225 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113468889999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.49 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=204.2
Q ss_pred CCCeeEEe-eecccCceEEEEEE--ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLD-KIGQGTYSNVYRAR--DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~-~LG~G~fG~Vy~a~--~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
..+|.+.+ .||+|+||.||+|. ...+++.||||+++.........+.+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence 46799998 99999999999995 4567889999999866555555677889999999999999999999883 456
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999865444433334579999999999999999999999999999999999999999999999999998764432
Q ss_pred CC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 286 NQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 286 ~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+... ..
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~~---------- 238 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER---------- 238 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC----------
T ss_pred CcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC----------
Confidence 21 122335678899999997655 7899999999999999999 99999998877766555331 00
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||..||+.||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112457899999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.84 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=209.3
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+|+.| +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 57899999999999999999985 4678899999997543 344567788999999999 99999999999876
Q ss_pred CCeEEEEEeeccc-cccccccCCC-----------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG-----------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~-----------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 5678999999986 5555443322 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+......+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999876543322 123445788999999987755 7999999999999999998 99999988766655
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..++.....+ .....++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5554421110 1123578899999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.19 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=188.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEee------c
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTS------R 201 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~------~ 201 (709)
..+|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.+. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 45899999999999999999999999999999998654 3455667889999999995 9999999998842 2
Q ss_pred CCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEcCCCcEEEeeccc
Q 005210 202 MSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGL 277 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld~~g~vKL~DFGl 277 (709)
....+|+||||++++|...+.. ....+++.+++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 2456899999999988776643 3447999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CccccccccCCCCchhhc--CCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHH
Q 005210 278 ASFYDPDQNQ-----------PLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 344 (709)
Q Consensus 278 a~~~~~~~~~-----------~~~~~~gT~~Y~APE~l~--~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~ 344 (709)
+..+...... .....+||+.|+|||++. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876432211 112456899999999884 234478999999999999999999999976544332221
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~ 415 (709)
... .......+..+.+||.+||+.||.+|||+.++|++-.
T Consensus 265 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 KYS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 100 0011345677899999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.22 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=205.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECC---CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---C
Confidence 36789999999999999999998654 34569999987543 34556778899999999999999999998764 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 56999999986 45555544455699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 284 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 284 ~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----------- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----------- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred ccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----------
Confidence 4333334456788999999987654 7999999999999999998 99999887776666555432110
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0123478899999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=366.45 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=203.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeE----EEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~----vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|.+..++.. ||+|++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 57899999999999999999999988876 67776643321 2222345689999999999999999998853 5
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 68999999985 56666655556799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......+|+.|+|||++.+.. |+.++|||||||++|+|++ |+.||.+....+....+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---------- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC----------
T ss_pred ccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC----------
Confidence 4332 234556788999999998655 7999999999999999999 99999988766665555331100
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 237 ------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356678899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.40 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=207.2
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 57899999999999999999985 4578899999997543 344556788999999999 799999999988653
Q ss_pred CCeEEEEEeeccc-cccccccCCCC---------------CCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPGL---------------KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~~---------------~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
...+|+||||+++ +|...+..... .+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4568999999986 55554443322 2899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHH
Q 005210 267 NGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 344 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~ 344 (709)
++.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999876433221 223456789999999997755 7999999999999999998 9999988765554444
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.....+ .....+++.+.+||..||+.||.+|||+.++++|
T Consensus 263 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33321110 1123478899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=362.98 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=208.3
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 578999999999999999999876 467889999987543 34445668899999999999999999999876 5
Q ss_pred CeEEEEEeeccc-cccccccCC---------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEe
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP---------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~---------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 273 (709)
..+|+||||+.+ +|...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 678999999986 554443321 1357999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 257 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 257 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC--
Confidence 9999976532221 1223346689999999987655 7999999999999999999 899999988777766654310
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.......++..+.+||.+||..||.+|||+.+++++
T Consensus 258 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 --------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011124678999999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.39 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=207.5
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-------CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 578999999999999999999986 467789999987543 445567788999999999 99999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccCCC---------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHPG---------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~~---------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|+||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 6689999999986 5555443322 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987643221 1223346688999999987755 7999999999999999999 99999998877766
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+..... ......++..+.+||..||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65543210 01123578899999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.98 Aligned_cols=253 Identities=27% Similarity=0.339 Sum_probs=204.8
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEE--EEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCC
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIV--ALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 203 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v--AIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~ 203 (709)
...++|++.+.||+|+||.||+|++..++..+ |||.+.... .....+.+.+|+.+|+++ +||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 98 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--R 98 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--C
Confidence 34578999999999999999999999998865 999987432 233455688999999999 99999999999977 6
Q ss_pred CeEEEEEeeccc-cccccccCCC---------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC
Q 005210 204 CSLYLVFEYMEH-DLAGLASHPG---------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 267 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~~---------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~ 267 (709)
..+||||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 789999999976 5555544332 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005210 268 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 346 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~ 346 (709)
+.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+....+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CeEEEcccCcCcccccc--ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999999754321 1223346688999999987654 7999999999999999998 999999988777665553
Q ss_pred HhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 347 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 347 k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
... .......+++.+.+||.+||..||.+|||++++|++
T Consensus 256 ~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 210 001123578899999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=379.10 Aligned_cols=275 Identities=23% Similarity=0.364 Sum_probs=208.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.......+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 5689999999999999999999999999999999975432 122455678999999999999999999988765568899
Q ss_pred EEeeccc-cccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE----cCCCcEEEeeccccccc
Q 005210 209 VFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFY 281 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl----d~~g~vKL~DFGla~~~ 281 (709)
|||||.+ +|...+.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999986 4544444322 239999999999999999999999999999999999999 77888999999999876
Q ss_pred CCCCCCCccccccccCCCCchhhcCC-------ccCCccccccchhHHHHHHHhCCCCCCC----CChHHHHHHHHHhhC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGA-------TYYGTAVDLWSTGCILAELYAGKPIMPG----RTEVEQLHKIFKLCG 350 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~-------~~y~~~~DIWSLG~iL~ELltG~~pF~g----~~~~e~l~~I~k~~g 350 (709)
.... .....+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+ ....+.+.++.. +
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~ 242 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--G 242 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--S
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--C
Confidence 4332 23456799999999998652 3478899999999999999999999975 334555555544 3
Q ss_pred CCChhhhhhcCCCCcc--ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 351 SPSEDYWRKSKLPHAT--IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~--~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.|.. .|......... .+....+. .......++..+.+||.+||+.||.+|+|+.++++
T Consensus 243 ~p~~-~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSG-AISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTT-CCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcc-cchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 3322 11110000000 00000000 00111235567889999999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.83 Aligned_cols=261 Identities=17% Similarity=0.176 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECC---CCeEEEEEEEecCCCChH---------HHHHHHHHHHHHHhcCCCceeeeec
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPE---------SVRFMAREIHILRRLDHINVIKLEG 196 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~---tg~~vAIK~i~~~~~~~~---------~~~~~~rEi~iL~~L~HpnIv~l~~ 196 (709)
.++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 5789999999999999999999987 888999999876532110 1123567889999999999999999
Q ss_pred eEeec--CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC--cEEE
Q 005210 197 LVTSR--MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--ILKI 272 (709)
Q Consensus 197 ~~~~~--~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g--~vKL 272 (709)
++... ....+||||||+.++|...+...+ .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 88762 256899999999666666555443 799999999999999999999999999999999999999887 9999
Q ss_pred eecccccccCCCC------CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC--ChHHHHHH
Q 005210 273 ADFGLASFYDPDQ------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR--TEVEQLHK 344 (709)
Q Consensus 273 ~DFGla~~~~~~~------~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~--~~~e~l~~ 344 (709)
+|||+++.+.... ........||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999998764321 11224568999999999998764 799999999999999999999999653 22222222
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhccc--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
........... +.... ..+++.+.+||..||..||.+|||+.++++.
T Consensus 274 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22221111111 11111 2688999999999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.75 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=198.3
Q ss_pred CCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence 568999999999999999999887 567789999987543 44556778899999999999999999999876 677
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||+++ +|...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999975 565565555567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCc--cccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQPL--TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~~--~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
..... ....+|+.|+|||++.+.. |+.++|||||||+||||++ |+.||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---------- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---------- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----------
T ss_pred CccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22211 2234578899999988655 7999999999999999998 99999998877776665432110
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||..||+.||.+|||+.++++
T Consensus 270 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 112357888999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=365.01 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=204.8
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
...++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeE
Confidence 3478899999999999999999996 468899999976543 3345678899999999999999999999876 6789
Q ss_pred EEEEeeccc-cccccccCCC---CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 207 YLVFEYMEH-DLAGLASHPG---LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~---~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
|+||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999986 4544443322 358999999999999999999999999999999999999999999999999998654
Q ss_pred CC-CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 283 PD-QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 283 ~~-~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.. .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+....+... ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 264 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQ 264 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTTC
T ss_pred cccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcccccc
Confidence 32 222234456899999999987755 799999999999999999999999875432211111000 00000000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
+. ....+. .........+..+.+||.+||+.||.+|||+.++|++-
T Consensus 265 ~~--~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LE--QIVDPN-----LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CC--SSSSSS-----CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH--HhcChh-----hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00 000000 00111223456789999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.09 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=205.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 578999999999999999999975 5678999999765433 3457899999999999999999998754 45899
Q ss_pred EEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+.+ +|...+... +..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999976 444444332 12689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------- 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------------
Confidence 3333456788999999987654 7999999999999999999 9999999888777666543110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......++..+.+||..||..||.+|||+.++++
T Consensus 229 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112357889999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.26 Aligned_cols=259 Identities=20% Similarity=0.336 Sum_probs=206.3
Q ss_pred CCCCeeEEeeecccCceEEEEEE-----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
..++|++++.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 35789999999999999999999 55678899999986443 34455678899999999999999999999876
Q ss_pred CCeEEEEEeeccc-cccccccCCC------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEE
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKI 272 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL 272 (709)
...+||||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. +..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 5678999999965 5555443322 35899999999999999999999999999999999999984 446999
Q ss_pred eecccccccCCCC-CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC
Q 005210 273 ADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 350 (709)
Q Consensus 273 ~DFGla~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g 350 (709)
+|||++....... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 9999997553222 22233457799999999987655 7999999999999999998 9999999887777666643210
Q ss_pred CCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......++..+.+||..||+.||.+|||+.+++++.|+..
T Consensus 264 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 ----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0112357889999999999999999999999999988753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.55 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=206.5
Q ss_pred CCCeeEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 5789999999999999999999 5778999999998754 345566788999999999999999999998765577
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+||||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 89999999975 45555444344699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh-hhhhhc
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE-DYWRKS 360 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~-~~w~~~ 360 (709)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.............. ...+.. ......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cccccHHHHHHHh
Confidence 3221 223456788999999987765 79999999999999999999999876433211100000 000000 000000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.. .........+++.+.+||..||+.||.+|||+.++++
T Consensus 258 --------~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 258 --------EE-----GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp --------HT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------hc-----ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0001123468899999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=380.96 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=196.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
..+|.+.+.||+|+||.||. ....+++.||||++...... .+.+|+.+|+.+ +|||||++++++.. ...+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKD--RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEec--CCEEE
Confidence 45699999999999999764 34567899999999754322 245799999999 89999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---C--CcEEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---N--GILKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~--g~vKL~DFGla~~~~ 282 (709)
||||||+++|...+......+++.+++.++.||+.||.|||++||+||||||+||||+. + ..+||+|||++..+.
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999999888888776666777788899999999999999999999999999999953 2 358899999998764
Q ss_pred CCCC--CCccccccccCCCCchhhcC--CccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 283 PDQN--QPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 283 ~~~~--~~~~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
.... ......+||+.|+|||++.+ ...++.++||||||||+|||++ |.+||........ ..+. +......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~~~~ 250 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSLDCL 250 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCCTTS
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCcccc
Confidence 3221 23345689999999999875 3346789999999999999999 8999965543322 2221 11110000
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
......+..+.+||.+||+.||.+|||++++|+||||..
T Consensus 251 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 ----------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 001123456889999999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=352.10 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=206.4
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
+.....|++.+.||+|+||.||+|.+..+ ...||+|++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS- 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-
Confidence 33456799999999999999999997644 346899998643 3455667788999999999999999999986542
Q ss_pred CCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
....|+||||+++ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 5678999999987 566666555667999999999999999999999999999999999999999999999999999865
Q ss_pred CCCC---CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 282 DPDQ---NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 282 ~~~~---~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
.... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------
T ss_pred cccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------
Confidence 4322 11233456788999999997755 7999999999999999999 77888887776666655432110
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 252 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012347889999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.12 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=198.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEE----EEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIV----ALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v----AIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.| |+|.++... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~ 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---S 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---C
Confidence 578999999999999999999998887765 667665332 23345678899999999999999999999875 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++||||+.+ +|...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 47899999985 55555555556799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......+|+.|+|||++.+.. |+.++|||||||++|||++ |+.||.+.+..+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred CcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC----------
Confidence 3322 223446688999999998755 7999999999999999999 99999988776655444321100
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||.+||+.||.+|||+.++|++
T Consensus 239 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123467889999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.93 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=207.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe-----EEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.+|+.| +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 5789999999999999999999987664 79999987543 345567788999999999 89999999999876
Q ss_pred CCeEEEEEeeccc-cccccccC-------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASH-------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 268 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~-------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g 268 (709)
...+|+||||+++ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 5679999999986 55444332 134689999999999999999999999999999999999999999
Q ss_pred cEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005210 269 ILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 346 (709)
Q Consensus 269 ~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~ 346 (709)
.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+......+..+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999865433221 123345688999999988755 7999999999999999998 999999877666655554
Q ss_pred HhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 347 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 347 k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+ ......++.+.+||..||+.||.+|||+.+++++
T Consensus 281 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 421111 0123467889999999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=376.26 Aligned_cols=259 Identities=26% Similarity=0.336 Sum_probs=193.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~l 206 (709)
..+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|+.+ +|||||++++++.. ...+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~ 84 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFL 84 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeE
Confidence 35567778999999999998754 567999999998753 234567899999886 89999999998876 6789
Q ss_pred EEEEeeccccccccccCCCCC------CCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC-------------
Q 005210 207 YLVFEYMEHDLAGLASHPGLK------FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN------------- 267 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~------lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~------------- 267 (709)
|||||||+++|...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 999999998877766543311 1334567899999999999999999999999999999754
Q ss_pred CcEEEeecccccccCCCCCC---CccccccccCCCCchhhcC------CccCCccccccchhHHHHHHHh-CCCCCCCCC
Q 005210 268 GILKIADFGLASFYDPDQNQ---PLTSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYA-GKPIMPGRT 337 (709)
Q Consensus 268 g~vKL~DFGla~~~~~~~~~---~~~~~~gT~~Y~APE~l~~------~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~ 337 (709)
+.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++||||||||+|||++ |+.||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877543221 2234689999999999975 2458999999999999999999 999997765
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
..+ ..+....... +.. . ......+++.+.+||.+||+.||.+|||+.++|+||||.
T Consensus 245 ~~~--~~i~~~~~~~----------~~~------~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 245 SRE--SNIIRGIFSL----------DEM------K------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp THH--HHHHHTCCCC----------CCC------T------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhH--HHHhcCCCCc----------ccc------c------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 443 2332211100 000 0 000123567899999999999999999999999999997
Q ss_pred C
Q 005210 418 M 418 (709)
Q Consensus 418 ~ 418 (709)
.
T Consensus 301 ~ 301 (434)
T 2rio_A 301 P 301 (434)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.57 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=203.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCC----eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
...+|.+.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--Y 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--C
Confidence 3578999999999999999999987653 459999997543 44455678899999999999999999999876 6
Q ss_pred CeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 204 CSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
..+||||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 789999999987 5555555555679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 283 PDQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 283 ~~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
..... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------- 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------- 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--------
Confidence 33221 122335678999999987655 7999999999999999998 99999998887777666432110
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 270 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 --------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123578899999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.45 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=195.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC-CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcE
Confidence 3678999999999999999999999999999999998643 345666778899999999999999999999987 6789
Q ss_pred EEEEeeccc-ccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 207 YLVFEYMEH-DLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
|+||||+.+ +|...+. .....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999987 4444332 234579999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCChhhhhhc
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT--EVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~--~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ..+....+.. ...+.
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~------- 257 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP------- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSCC-------
T ss_pred CCC-ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCCC-------
Confidence 322 2233457899999999987754 7999999999999999999999997653 2222232221 11110
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||..||..||.+|||+.+++++
T Consensus 258 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 258 -------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0113578899999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=382.90 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=209.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
..+|++.+.||+|+||.||+|.+..++..||||+++..... .+.+.+|+.+|+.|+|||||++++++.. ...+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 56799999999999999999999999999999998765433 4567899999999999999999999876 567999
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||.+ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999985 55555543 334699999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+.+..+.+...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 3333445678999999987655 7999999999999999999 9999999877666555432110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+++.+.+||..||+.||.+|||+.++++
T Consensus 438 -------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112457899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.94 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=206.9
Q ss_pred CCCCCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC
Q 005210 126 PRRADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM 202 (709)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~ 202 (709)
+.....|.+.+.||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 94 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP- 94 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-
Confidence 4445568888999999999999999766554 7999998643 3445667788999999999999999999998763
Q ss_pred CCeEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 SCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 ~~~lyLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
....|+||||+. ++|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 344589999996 4666666665668999999999999999999999999999999999999999999999999999765
Q ss_pred CCC---CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 005210 282 DPD---QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357 (709)
Q Consensus 282 ~~~---~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w 357 (709)
... .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.++|.+.+..+....+......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------ 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------
T ss_pred cCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------
Confidence 332 112233457789999999997755 7999999999999999999 56677776666655555432111
Q ss_pred hhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 358 ~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 248 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ----------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112357889999999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=350.63 Aligned_cols=254 Identities=26% Similarity=0.327 Sum_probs=194.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeec--CCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSR--MSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~~~~~~--~~~ 204 (709)
.++|++++.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 67899999999999999999987 6889999998643 23445567777777 7999999999986542 235
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhh--------hCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH--------SRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH--------~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
.+|+||||+++ +|...+ .. ..+++..++.++.||+.||.||| +.||+||||||+||||+.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l-~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYL-QL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHH-TT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHH-hh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 68999999987 444444 32 37999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCC---CccccccccCCCCchhhcCCc-----cCCccccccchhHHHHHHHhC----------CCCCCCCC
Q 005210 276 GLASFYDPDQNQ---PLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAG----------KPIMPGRT 337 (709)
Q Consensus 276 Gla~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~-----~y~~~~DIWSLG~iL~ELltG----------~~pF~g~~ 337 (709)
|++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765432221 123458999999999998753 245799999999999999999 88886532
Q ss_pred ----hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 338 ----EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 338 ----~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+..+....+.. +..+. ......+++.+.+||..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQR-----------------PNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCC-----------------CCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccCCC-----------------CCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 233333332211100 00000 0011235577999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.10 Aligned_cols=273 Identities=19% Similarity=0.260 Sum_probs=201.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+ .+++.||||++....... ....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 67899999999999999999985 468899999987543221 12247789999999999999999999876 667899
Q ss_pred EEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhC---CeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 209 VFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR---GVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~---gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
||||+.+ +|...+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999987 44444433 233599999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
............||+.|+|||++.+.. ++.++|||||||++|+|++|++||........ .......|....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~ 255 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGL 255 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT--------SCSBHHHHHTTT
T ss_pred CcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccc--------cchhHHHHHHHH
Confidence 654444455567999999999987765 79999999999999999999999952110000 000000111100
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
........ ..............+..+.+||..||+.||.+|||+.++|+|-.-
T Consensus 256 ~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEA--LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTT--SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhh--hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000000 000000011112234679999999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=362.67 Aligned_cols=255 Identities=15% Similarity=0.161 Sum_probs=200.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC--------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceee-------
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ--------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK------- 193 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t--------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~------- 193 (709)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 47899999999999999999999884 889999998754 24678999999999999998
Q ss_pred --------eeceEeecCCCeEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 194 --------LEGLVTSRMSCSLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 194 --------l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
+++++.. ....+||||||+.++|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 4445443 25789999999966776666543 3579999999999999999999999999999999999999
Q ss_pred cCCC--cEEEeecccccccCCCCC------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC
Q 005210 265 DNNG--ILKIADFGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 336 (709)
Q Consensus 265 d~~g--~vKL~DFGla~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~ 336 (709)
+.++ .+||+|||++..+..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999987643211 1224458999999999988754 799999999999999999999999876
Q ss_pred C-hHHHHHHHHH-hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 337 T-EVEQLHKIFK-LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 337 ~-~~e~l~~I~k-~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. ..+.+..... ....+.. . . . .......+++.+.+||..||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~-~------------~-----~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGP-F------------V-----G--PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCC-E------------E-----C--TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhh-h------------h-----h--hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 3333333222 1111100 0 0 0 00112457899999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=375.30 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=206.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|+.|+|||||++++++. ...+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccE
Confidence 3578999999999999999999985 467899999976543 3456889999999999999999999875 35689
Q ss_pred EEEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
||||||.+ +|...+... +..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999986 555554432 2368999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........+|+.|+|||++.+.. |+.++|||||||+||||++ |+.||.+.+..+.+..+......+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------ 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------ 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------
T ss_pred eeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 22223345678899999997655 7999999999999999999 999999998888877765421111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....+++.+.+||.+||..||.+|||++++++
T Consensus 406 ----------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ----------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12357899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=355.28 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=201.4
Q ss_pred CCCe-eEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSF-EKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y-~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++| ++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|+.++||||+++++++.....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4455 999999999999998875 3458899999999755 345556778899999999999999999999987656
Q ss_pred CeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 204 CSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
..+|+||||+++ +|...+... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 789999999986 454444332 48999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 283 PDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 283 ~~~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
.... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+......-..
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~- 258 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMTVL- 258 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHHHH-
T ss_pred ccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchhHH-
Confidence 4322 1223456788999999998765 78999999999999999999999865432110 0001110000000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.+ ...... .........+++.+.+||..||+.||.+|||+.++++
T Consensus 259 ~~--~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RL--TELLER-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HH--HHHHHT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--HHHHhc-----ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 000000 0001123468899999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.29 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=202.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee--------
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS-------- 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~-------- 200 (709)
..+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 457999999999999999999999999999999997643 235689999999999999999998754
Q ss_pred ------cCCCeEEEEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEE
Q 005210 201 ------RMSCSLYLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 272 (709)
Q Consensus 201 ------~~~~~lyLVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 272 (709)
.....+|+||||+++ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 123568999999997 55554432 2357999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 005210 273 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 352 (709)
Q Consensus 273 ~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p 352 (709)
+|||++..+.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..+|.... .....+..
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~----- 233 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD----- 233 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT-----
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc-----
Confidence 9999998765432 234457899999999998755 7999999999999999999998874211 11111110
Q ss_pred ChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 353 ~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
. .....++..+.+||.+||..||.+|||+.+++++.+.-.
T Consensus 234 -------~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -------G-------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -------T-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -------c-------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0 011347888999999999999999999999999988653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=358.85 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=199.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEE----EEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIV----ALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~v----AIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---S 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---C
Confidence 678999999999999999999999888766 566554332 23345667899999999999999999999875 2
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++||||+.+ +|...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 47899999885 56665555556799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
... .......+|+.|+|||++.+.. |+.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred ccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 222 2223445688999999998755 7999999999999999999 99999988776665555331100
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||..||..||.+|||+.++|+
T Consensus 239 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 ------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112347888999999999999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=371.35 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=203.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.|+||||+++++++.. ..+||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 5789999999999999999999875 456999999765433 3457899999999999999999998854 56899
Q ss_pred EEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||.+ +|...+.. .+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999986 55554432 234689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+|+.|+|||++.+.. |+.++|||||||+||||++ |+.||.+.+..+.+..+.+....
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 400 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 3333446688999999988654 7999999999999999999 99999999888877766432110
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh--cccCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTM 418 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~--hp~f~~ 418 (709)
.....+++.+.+||..||+.||.+|||++++++ ..+|..
T Consensus 401 --------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 112357889999999999999999999999986 466654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.76 Aligned_cols=241 Identities=27% Similarity=0.412 Sum_probs=189.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.+|++++||||+++++++.+ .+|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence 568999999999999999999874 688999998632 234667899999999999999999998753 4799
Q ss_pred EEeeccc-cccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhh---CCeeeccCCCccEEEcCCCc-EEEeeccccccc
Q 005210 209 VFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHS---RGVLHRDIKGSNLLIDNNGI-LKIADFGLASFY 281 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~---~gIvHrDLKP~NILld~~g~-vKL~DFGla~~~ 281 (709)
||||+++ +|...+.... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999986 4544444322 247899999999999999999999 89999999999999998886 799999999765
Q ss_pred CCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChhhhhh
Q 005210 282 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 282 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~--~e~l~~I~k~~g~p~~~~w~~ 359 (709)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+..+.. +.
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC--------
T ss_pred ccc----cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC--------
Confidence 322 23457899999999998754 79999999999999999999999975432 222222211 10
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......++..+.+||.+||+.||.+|||++++++
T Consensus 222 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01123468899999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=354.36 Aligned_cols=257 Identities=20% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--CCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~l 206 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 56899999999999999999999999999999998754 345567788999999999999999999988632 24578
Q ss_pred EEEEeeccc-cccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 207 YLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
|+||||+.+ +|...+.. .+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999987 45444432 45679999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC--------CccccccccCCCCchhhcCCc--cCCccccccchhHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCC
Q 005210 283 PDQNQ--------PLTSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGS 351 (709)
Q Consensus 283 ~~~~~--------~~~~~~gT~~Y~APE~l~~~~--~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e-~l~~I~k~~g~ 351 (709)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||....... .+.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-- 263 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-- 263 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc--
Confidence 21110 012345799999999987543 36889999999999999999999995311000 011111000
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
. .......++..+.+||.+||+.||.+|||+.+++++-
T Consensus 264 --------~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 264 --------L-----------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------C-----------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0 0011245788999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=365.45 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=199.5
Q ss_pred cCCCCCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec
Q 005210 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR 201 (709)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~ 201 (709)
++.....|++.+.||+|+||.||+|.+..+ +..||||.++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 444456799999999999999999987543 346899998643 2345567788999999999999999999987542
Q ss_pred CCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 202 MSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 202 ~~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
...+|+||||+.+ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 163 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 163 -EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 4578999999986 66666666666799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCC---CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 005210 281 YDPDQN---QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 356 (709)
Q Consensus 281 ~~~~~~---~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~ 356 (709)
+..... ...+...+|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+....+.... .
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--~---- 314 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R---- 314 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--C----
T ss_pred ccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--C----
Confidence 533221 1223446788999999988655 7999999999999999999 789998877666555543310 0
Q ss_pred hhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 357 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 357 w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 315 ----------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123578899999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=348.72 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-CC--eEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-QK--KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg--~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|.+.. ++ ..||||+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 5689999999999999999998643 33 3689999876543 345567788999999999999999999998752
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++||||+.+ +|...+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+..
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 38999999985 55555554445699999999999999999999999999999999999999999999999999987644
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3221 123446788999999987655 7899999999999999999 999999998887777665321110
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....++..+.+||..||..||.+|||+.+++++
T Consensus 245 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1124578999999999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=374.84 Aligned_cols=253 Identities=17% Similarity=0.215 Sum_probs=197.6
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCC-Cceeeee----------
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH-INVIKLE---------- 195 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~H-pnIv~l~---------- 195 (709)
....|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.|.| .|+..+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 35569999999999999999999999999999999874432 22345678899999999977 3221111
Q ss_pred -----------ceEeec---CCCeEEEEEeeccccccccc------cCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeec
Q 005210 196 -----------GLVTSR---MSCSLYLVFEYMEHDLAGLA------SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 255 (709)
Q Consensus 196 -----------~~~~~~---~~~~lyLVmEy~~g~L~~~~------~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHr 255 (709)
.++... ....++++|+++.++|..++ ...+..+++..+..++.||+.||.|||++||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111111 12357899999998887766 2334468889999999999999999999999999
Q ss_pred cCCCccEEEcCCCcEEEeecccccccCCCCCCCccccccccCCCCchhhc---------CCccCCccccccchhHHHHHH
Q 005210 256 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL---------GATYYGTAVDLWSTGCILAEL 326 (709)
Q Consensus 256 DLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~---------~~~~y~~~~DIWSLG~iL~EL 326 (709)
||||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++||||||||||||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999865432 345577 9999999983 334578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC
Q 005210 327 YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 406 (709)
Q Consensus 327 ltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT 406 (709)
++|+.||.+.+..+....+ ......+|+.+.+||.+||+.||.+|||
T Consensus 311 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHCCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999776532211111 1122468899999999999999999999
Q ss_pred HHHHHhcccCCC
Q 005210 407 AASALRSEFFTM 418 (709)
Q Consensus 407 a~e~L~hp~f~~ 418 (709)
+.++|+||||+.
T Consensus 358 ~~~~l~~~~~~~ 369 (413)
T 3dzo_A 358 PLQAMETPEYEQ 369 (413)
T ss_dssp HHHHTTSHHHHH
T ss_pred HHHHHhCHHHHH
Confidence 999999999963
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=369.77 Aligned_cols=245 Identities=21% Similarity=0.372 Sum_probs=202.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++|||||++++++... ...+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 3678999999999999999999874 7799999997543 235678999999999999999999987653 34799
Q ss_pred EEEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
||||||.+ +|...+...+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999986 5555554333 24799999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+|+.|+|||++.+.. |+.++|||||||+||||++ |+.||.+.+..+.+..+.+...
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------------
T ss_pred ---ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 12336788999999998765 7999999999999999998 9999998877666665543110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+|+.+.+||..||..||.+|||+.++++
T Consensus 405 --------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 --------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112457899999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=385.55 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=200.8
Q ss_pred eeecccCceEEEEEEE--CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~--~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
+.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|+.|+|||||++++++.. ..+|||||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 4899999999999954 4667899999998765555566788999999999999999999998854 4589999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--CCccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTS 291 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~ 291 (709)
.++.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... ...+.
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 8755544444455799999999999999999999999999999999999999999999999999987654322 22334
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..+|+.|+|||++.+.. |+.++||||||||||||++ |+.||.+.+..+....+.+....
T Consensus 532 ~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------- 591 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 591 (635)
T ss_dssp ---CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred CCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 45688999999997655 7999999999999999998 99999999888877766542100
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||..||..||.+|||++++++
T Consensus 592 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112357899999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.24 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=191.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC------ChHHHHHHHHHHHHHHhcC---------CCceee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRLD---------HINVIK 193 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~------~~~~~~~~~rEi~iL~~L~---------HpnIv~ 193 (709)
.++|++++.||+|+||.||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 789999999986642 2233466789999999986 555555
Q ss_pred eec-----------------eEeec-----------CCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHH
Q 005210 194 LEG-----------------LVTSR-----------MSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGL 244 (709)
Q Consensus 194 l~~-----------------~~~~~-----------~~~~lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL 244 (709)
+++ ++... ....+|||||||.++ ++..+.. ..+++.+++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 544 44321 156899999999764 6666544 4689999999999999999
Q ss_pred hhhh-hCCeeeccCCCccEEEcCCC--------------------cEEEeecccccccCCCCCCCccccccccCCCCchh
Q 005210 245 DHCH-SRGVLHRDIKGSNLLIDNNG--------------------ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303 (709)
Q Consensus 245 ~yLH-~~gIvHrDLKP~NILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~ 303 (709)
.||| ++||+||||||+||||+.++ .+||+|||+|+.+.. ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 899999999987643 23489999999999
Q ss_pred hcCCccCCccccccchhHH-HHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcc
Q 005210 304 LLGATYYGTAVDLWSTGCI-LAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 381 (709)
Q Consensus 304 l~~~~~y~~~~DIWSLG~i-L~ELltG~~pF~g~~~~e-~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~ 381 (709)
+.+.. +.++|||||+++ .+++++|..||.+..... ....+........ ......
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~ 304 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------KCNTPA 304 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------CCCSHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------ccchhh
Confidence 98754 789999998777 778899999985432111 2223322110000 001112
Q ss_pred cCCCCHHHHHHHHHhcccCCCCCCCHHHHH-hcccCC
Q 005210 382 FKDFPAPALALMETLLSIDPADRGSAASAL-RSEFFT 417 (709)
Q Consensus 382 ~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L-~hp~f~ 417 (709)
+..+++++.+||.+||++| |++|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 3457889999999999987 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=370.14 Aligned_cols=255 Identities=22% Similarity=0.254 Sum_probs=205.2
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|.+..+++.||||++....... .+.+|+.+++.|.|++++..+.++.. .....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGV-EGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEE
Confidence 3678999999999999999999999999999999987654322 35689999999987555444433332 267889
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE---cCCCcEEEeecccccccCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl---d~~g~vKL~DFGla~~~~~~ 284 (709)
|||||+.++|..++......|++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999878887776556689999999999999999999999999999999999999 58899999999999876543
Q ss_pred CCC------CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCChh
Q 005210 285 QNQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSED 355 (709)
Q Consensus 285 ~~~------~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---~e~l~~I~k~~g~p~~~ 355 (709)
... .....+||+.|+|||++.+.. |+.++||||||||||||++|+.||.+... .+.+.++....-.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---- 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----
Confidence 221 123568999999999998765 79999999999999999999999987543 3334443321100
Q ss_pred hhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 356 ~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+......++.++.+||..||..||.+||++.++++
T Consensus 235 --------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 --------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1122334578999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.22 Aligned_cols=245 Identities=17% Similarity=0.217 Sum_probs=192.6
Q ss_pred CCCeeEEeeecccCceEEEEE-----EECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a-----~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~ 200 (709)
.++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.|. |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 578999999999999999999 467889999999987542 334667888888886 8999999999876
Q ss_pred cCCCeEEEEEeeccc-cccccccC----CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---------
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--------- 266 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~----~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~--------- 266 (709)
.+..|||||||++ +|...+.. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 6778999999985 45554432 3457999999999999999999999999999999999999998
Q ss_pred --CCcEEEeecccccccCC-CCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHH
Q 005210 267 --NGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 343 (709)
Q Consensus 267 --~g~vKL~DFGla~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~ 343 (709)
++.+||+|||+|+.+.. ......+..+||+.|+|||++.+.. |+.++||||||||||||++|+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~---- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG---- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC----
Confidence 89999999999976431 2223345678999999999998866 899999999999999999999998543220
Q ss_pred HHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q 005210 344 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414 (709)
Q Consensus 344 ~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp 414 (709)
.|. ......+ ...++.+.+||..||+.+|.+|++..+.|.+.
T Consensus 292 ------------~~~-----------~~~~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 ------------ECK-----------PEGLFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ------------EEE-----------ECSCCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ------------cee-----------echhccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 010 0000000 02356788999999999999997766655543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.34 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=194.1
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.+++.++||||+++++++... ...+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceE
Confidence 367899999999999999999987 48899999987542 345678999999999999999999987542 45789
Q ss_pred EEEeeccc-cccccccCCC-CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~-~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||+++ +|...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999986 5555443322 13899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |++||.+.+..+....+.+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------- 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred ---ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 12336788999999987654 7999999999999999998 999998877665555443210
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+++.+.+||..||..||.+|||+.++++
T Consensus 232 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00112457899999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.76 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=200.1
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCC--CChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN--LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
|...+.||+|+||.||+|.+ +++.||||++.... ......+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEE
Confidence 45568999999999999986 67899999987542 233456678899999999999999999999876 5679999
Q ss_pred Eeeccc-cccccccC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 210 FEYMEH-DLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 210 mEy~~g-~L~~~~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||+++ +|...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 999975 44444432 234699999999999999999999999999999999999999999999999999987643322
Q ss_pred C-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CChhhhhhcCCC
Q 005210 287 Q-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS--PSEDYWRKSKLP 363 (709)
Q Consensus 287 ~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~--p~~~~w~~~~lp 363 (709)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......+..+...... +.-..|...
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 263 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK--- 263 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS---
T ss_pred cccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc---
Confidence 2 12345789999999988753 789999999999999999999999876554433333222111 111111000
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.......+..+.+||..||..||.+|||+.+++++
T Consensus 264 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 -------------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -------------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011112345678999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=349.65 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=203.3
Q ss_pred CCCeeEEeeecccCceEEEEEE----ECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~----~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 5679999999999999999998 4678999999998754 345566788999999999999999999988765455
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 78999999986 56665555555799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......+|..|+|||++.+.. ++.++|||||||++|+|++|..||..... . +....+......+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhccccchhhhHHH
Confidence 3221 123345688899999988765 78999999999999999999988864311 1 11111111110000000
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
+. ..+... ........+++.+.+||..||..||.+|||+.++++
T Consensus 272 ~~--~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LI--ELLKNN-----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH--HHHHTT-----CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH--HHhhcC-----CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 000000 000112467899999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.65 Aligned_cols=240 Identities=20% Similarity=0.298 Sum_probs=187.8
Q ss_pred CCCCeeEE-eeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHH-HhcCCCceeeeeceEee--cCC
Q 005210 128 RADSFEKL-DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL-RRLDHINVIKLEGLVTS--RMS 203 (709)
Q Consensus 128 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL-~~L~HpnIv~l~~~~~~--~~~ 203 (709)
..++|.++ +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.+.||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 36778888 7899999999999999999999999998642 3456889888 55699999999998864 224
Q ss_pred CeEEEEEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccc
Q 005210 204 CSLYLVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLA 278 (709)
Q Consensus 204 ~~lyLVmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla 278 (709)
..+||||||+++ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 678999999986 565555433 346999999999999999999999999999999999999998 789999999998
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..... ..|+.++|||||||++|||++|++||.+....+....+...
T Consensus 168 ~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---------- 213 (299)
T 3m2w_A 168 KETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---------- 213 (299)
T ss_dssp EECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS----------
T ss_pred ccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH----------
Confidence 65321 23788999999999999999999999876543321111000
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+. ..........+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 214 ---------~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 ---------IR--MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---------SC--TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ---------Hh--hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 000001112235689999999999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=375.63 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=208.4
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.|+|||||++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccce
Confidence 35789999999999999999999865 456999999865433 3457899999999999999999998854 5689
Q ss_pred EEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 208 LVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
||||||.+ +|...+.. .+..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999986 55555442 23468999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
........+|..|+|||++.+.. |+.++||||||||||||++ |+.||.+....+.+..+.+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 11223345678999999988654 7999999999999999999 99999999888877766432100
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc--ccCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS--EFFT 417 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h--p~f~ 417 (709)
.....++..+.+||..||..||.+|||++++++. .+|.
T Consensus 484 ---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ---------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1123578899999999999999999999999863 5554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=378.68 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=205.1
Q ss_pred CCCeeEEe-eecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLD-KIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~-~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.|+|||||++++++.. ..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CC
Confidence 34556666 8999999999999876 456779999997653 23345678899999999999999999999865 45
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|||||||.++ |...+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999875 55555555567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC--ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QNQP--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~~~--~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... .....+|+.|+|||++.+.. |+.++||||||||||||++ |+.||.+.+..+.+..|.+.. .
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--~--------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R--------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--C---------
T ss_pred CceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence 2211 12234568999999997654 8999999999999999998 999999998888777665321 0
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH---HhcccCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFTM 418 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~---L~hp~f~~ 418 (709)
......+++.+.+||..||..||.+|||+.++ |++.|+..
T Consensus 558 -----------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 558 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01124588999999999999999999999997 45666543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.12 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=202.0
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceE
Confidence 36789999999999999999998854 49999987654433334456789999999999999999999876 56799
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC--
Q 005210 208 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-- 284 (709)
Q Consensus 208 LVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~-- 284 (709)
+||||+.+ +|...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++......
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999985 55555555555799999999999999999999999999999999999998 789999999998764321
Q ss_pred --CCCCccccccccCCCCchhhcC--------CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 285 --QNQPLTSRVVTLWYRPPELLLG--------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 285 --~~~~~~~~~gT~~Y~APE~l~~--------~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
.........||+.|+|||++.+ ...|+.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-- 262 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN-- 262 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--
Confidence 1222344568999999999875 2347889999999999999999999999988777766654321000
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....++..+.+||..||..||.+|||+.++++
T Consensus 263 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 -------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011247788999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.69 Aligned_cols=278 Identities=23% Similarity=0.280 Sum_probs=191.2
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHH--HHhcCCCceeeeeceEee---cC
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI--LRRLDHINVIKLEGLVTS---RM 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~i--L~~L~HpnIv~l~~~~~~---~~ 202 (709)
..++|++++.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 478999999999999999999976 68999999997542 2223334444 556899999999875532 22
Q ss_pred CCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC---------CeeeccCCCccEEEcCCCcEEE
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---------GVLHRDIKGSNLLIDNNGILKI 272 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~---------gIvHrDLKP~NILld~~g~vKL 272 (709)
...+||||||+++ +|...+... .+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 3468999999976 555554332 458999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC-------CCCccccccccCCCCchhhcCC------ccCCccccccchhHHHHHHHhCCCC-CCCCCh
Q 005210 273 ADFGLASFYDPDQ-------NQPLTSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYAGKPI-MPGRTE 338 (709)
Q Consensus 273 ~DFGla~~~~~~~-------~~~~~~~~gT~~Y~APE~l~~~------~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~~ 338 (709)
+|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||+||||++|..| |.+...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764321 1223355799999999999763 3467899999999999999999644 444332
Q ss_pred HHHHHHHHH-hhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH------H
Q 005210 339 VEQLHKIFK-LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA------L 411 (709)
Q Consensus 339 ~e~l~~I~k-~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~------L 411 (709)
.+....+.. ....|..+.+....... ...+..+ ..+ .....+++.+.+||.+||+.||.+|||+.++ |
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFP--EAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTS--CCCCCCC--TTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhccc--ccCCCCC--ccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111111111 11112211111000000 0000000 000 0011245579999999999999999999999 4
Q ss_pred hcccCCCC
Q 005210 412 RSEFFTMK 419 (709)
Q Consensus 412 ~hp~f~~~ 419 (709)
.++|-+..
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 47777654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.23 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=189.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeecCC--C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSRMS--C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~~~~~~~~--~ 204 (709)
.++|++++.||+|+||.||+|.+. ++.||||++.... .....+|..++.. ++||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 468999999999999999999874 8899999986432 2233455666555 499999999999876422 6
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC--------CeeeccCCCccEEEcCCCcEEEeec
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~--------gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
.+||||||+.+ +|...+.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 89999999987 55555433 2699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC---CccccccccCCCCchhhcCCccCCc------cccccchhHHHHHHHhC----------CCCCCCC
Q 005210 276 GLASFYDPDQNQ---PLTSRVVTLWYRPPELLLGATYYGT------AVDLWSTGCILAELYAG----------KPIMPGR 336 (709)
Q Consensus 276 Gla~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~~y~~------~~DIWSLG~iL~ELltG----------~~pF~g~ 336 (709)
|++..+...... .....+||+.|+|||++.+.. +.. ++|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999776433222 123558999999999998754 334 38999999999999999 5666442
Q ss_pred C----hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 337 T----EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 337 ~----~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
. ....+..+...... .+..+. ......+++.+.+||..||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKL-----------------RPSFPN----RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCC-----------------CCCCCG----GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHhhhcc-----------------Cccccc----cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 1 22222222211000 000000 0011235677999999999999999999999997
Q ss_pred c
Q 005210 413 S 413 (709)
Q Consensus 413 h 413 (709)
+
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=375.11 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=205.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC---CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t---g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 56799999999999999999998654 4679999886432 34555778899999999999999999998843 46
Q ss_pred EEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+||||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 8999999985 555555545557999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.........+|+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------ 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------ 611 (656)
T ss_dssp ---------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------------
T ss_pred cceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 333334456788999999987654 7999999999999999997 99999999888887777542110
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 612 ----------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112457899999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=386.18 Aligned_cols=281 Identities=23% Similarity=0.303 Sum_probs=207.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee----cCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS----RMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~----~~~~ 204 (709)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. ......+.+.+|+.+|+.++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 57899999999999999999999999999999998754 345566778899999999999999999988644 1256
Q ss_pred eEEEEEeeccc-cccccccCCC--CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc---EEEeecccc
Q 005210 205 SLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLA 278 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~--~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~---vKL~DFGla 278 (709)
.+|||||||.+ +|...+.... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999976 5555444322 36999999999999999999999999999999999999997764 999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
..+.... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+......+...+...+.. ....
T Consensus 172 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~--~~~~ 246 (676)
T 3qa8_A 172 KELDQGE--LCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE--HIVV 246 (676)
T ss_dssp CBTTSCC--CCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCS
T ss_pred ccccccc--ccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch--hhhh
Confidence 8765432 234568999999999987655 7999999999999999999999998765543322111100000 0000
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.........+....+. .......+++.+.+||..||.+||.+|||+.++|+||||+.
T Consensus 247 ~~~l~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000111111010 11222346788999999999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.50 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=195.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHh--cCCCceeeeeceEeecCC--C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSRMS--C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~~~~~~~~--~ 204 (709)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.++.. ++||||+++++++..... .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 45799999999999999999987 5899999998643 23456789999988 799999999999876432 2
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhh--------hCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH--------SRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH--------~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
.+|+||||+.+ +|...+.. ..+++.+++.++.||+.||.||| +.||+||||||+||||+.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999997 55555433 36899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCC---CccccccccCCCCchhhcCCcc-----CCccccccchhHHHHHHHhC----------CCCCCCCC
Q 005210 276 GLASFYDPDQNQ---PLTSRVVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAG----------KPIMPGRT 337 (709)
Q Consensus 276 Gla~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~~-----y~~~~DIWSLG~iL~ELltG----------~~pF~g~~ 337 (709)
|++......... .....+||+.|+|||++.+... ++.++|||||||+||||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876443221 2345579999999999976532 33689999999999999999 67776542
Q ss_pred ----hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 338 ----EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 338 ----~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+.+...+..... .+..+. . + ....++..+.+||..||+.||.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~-~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKL-----------------RPNIPN-R-W--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCC-----------------CCCCCG-G-G--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHh-----------------CCCCcc-c-c--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22222222210000 000000 0 0 011344678999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.47 Aligned_cols=229 Identities=18% Similarity=0.107 Sum_probs=184.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.++..++||||+++++++.. .+.+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEE
Confidence 4789999999999999999999999999999999986644 35566778899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||++++.+..+...+ ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999865444444433 4667899999999999999999999999999999999999999998543
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
|++| ++.++|||||||+||||++|+.||.+.+..+.+....+.
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~------------------- 217 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD------------------- 217 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-------------------
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-------------------
Confidence 3332 688999999999999999999999886542211000000
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.............++++.+.+||.+||+.||.+| |+.++++.
T Consensus 218 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 218 ---TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ---TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ---hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0000011233446789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=376.23 Aligned_cols=243 Identities=22% Similarity=0.287 Sum_probs=198.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC---C
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---C 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~---~ 204 (709)
.++|++.+.||+|+||.||+|.+.. +++.||||++... ........+.+|+.+|+.++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 7899999998653 244556678899999999999999999999876322 1
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|||||||+++.+..+... .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 27999999997665554433 79999999999999999999999999999999999999875 8999999999876432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
...+||+.|+|||++.+. ++.++||||||||||+|++|.++|.+.... +.+.
T Consensus 235 -----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~----------- 286 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE----------- 286 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT-----------
T ss_pred -----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc-----------
Confidence 445799999999998764 488999999999999999999988652110 0000
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
. .....+++.+.+||.+||++||.+||+..++|.|+|+.
T Consensus 287 ------~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ------D--------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------T--------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------c--------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00112457799999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=315.91 Aligned_cols=187 Identities=17% Similarity=0.075 Sum_probs=133.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEEecCCC----C----hHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCeEE
Q 005210 137 KIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----E----PESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 137 ~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~----~----~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++.|++|.+..++..-+|+.||+|++..... . ....+.+.+|+.+|+++ .|+||+++++++++ ...+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 35677777788777777899999999986532 1 12345688999999999 79999999999987 78899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||||+|+.+..++..+.++++. .|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999987666666666678775 478999999999999999999999999999999999999999998765433 3
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCC
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 331 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~ 331 (709)
..++.+||+.|||||++.+. +..++|+||+|+++++|+++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 44567999999999999875 5678999999999998877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=263.82 Aligned_cols=186 Identities=17% Similarity=0.136 Sum_probs=137.9
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChH------HHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE------SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~------~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
...+.||+|+||.||+|. ..+..+|+|++........ ..+.+.+|+.+|++++||||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 345689999999999994 4577899998765433211 23457899999999999999955444444 4557
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 207 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 207 yLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||||++ +|...+.. +..++.||+.||.|||++||+||||||+||||+. .+||+|||+++.+....
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999985 45444433 5689999999999999999999999999999998 99999999999865422
Q ss_pred CC------CccccccccCCCCchhhcC-CccCCccccccchhHHHHHHHhCCCCC
Q 005210 286 NQ------PLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIM 333 (709)
Q Consensus 286 ~~------~~~~~~gT~~Y~APE~l~~-~~~y~~~~DIWSLG~iL~ELltG~~pF 333 (709)
.. .....+||+.|||||++.+ ...|+..+|+|+..+-..+.+.++..|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1235689999999999875 133788899999998888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=223.54 Aligned_cols=148 Identities=15% Similarity=0.123 Sum_probs=117.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----------------HHHHHHHHHHHHHHhcCCCcee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----------------ESVRFMAREIHILRRLDHINVI 192 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----------------~~~~~~~rEi~iL~~L~HpnIv 192 (709)
...|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 44577789999999999999999 889999999997532211 13456789999999998 5 7
Q ss_pred eeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEE
Q 005210 193 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 272 (709)
Q Consensus 193 ~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL 272 (709)
++.+++.. +.+|+|||||+++.+..+.. .++..++.||+.||.|||++||+||||||+||||+ ++.+||
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYRVRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGGCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHHcch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 77776643 45699999998744433321 23557999999999999999999999999999999 999999
Q ss_pred eecccccccCCCCCCCccccccccCCCCchhhc
Q 005210 273 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305 (709)
Q Consensus 273 ~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~ 305 (709)
+|||+|+. +..|+|||++.
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHH
Confidence 99999964 34579999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.5e-21 Score=196.10 Aligned_cols=139 Identities=19% Similarity=0.223 Sum_probs=106.7
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeE--EEEEEEecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEP----------------------ESVRFMAREIHILRRL 186 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAIK~i~~~~~~~----------------------~~~~~~~rEi~iL~~L 186 (709)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998788989 9999976432110 1123577899999999
Q ss_pred CCCce--eeeeceEeecCCCeEEEEEeeccc------cccccccCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCeeeccC
Q 005210 187 DHINV--IKLEGLVTSRMSCSLYLVFEYMEH------DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDI 257 (709)
Q Consensus 187 ~HpnI--v~l~~~~~~~~~~~lyLVmEy~~g------~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDL 257 (709)
.|++| +.++.+ ...||||||+++ .|..... .+++..+..++.||+.||.||| ++||+||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 88764 333321 245899999953 2222211 1345678899999999999999 999999999
Q ss_pred CCccEEEcCCCcEEEeeccccccc
Q 005210 258 KGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 258 KP~NILld~~g~vKL~DFGla~~~ 281 (709)
||+||||+. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-17 Score=179.38 Aligned_cols=140 Identities=17% Similarity=0.181 Sum_probs=98.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-----C----------hHHHH-----HHHHHHHHHHhcCCC
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-----E----------PESVR-----FMAREIHILRRLDHI 189 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-----~----------~~~~~-----~~~rEi~iL~~L~Hp 189 (709)
.-|++...||+|+||.||+|.+. +|+.||||+++.... . ..... ...+|...|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999974 689999999864210 0 00111 113466677777443
Q ss_pred ceeeeeceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-
Q 005210 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG- 268 (709)
Q Consensus 190 nIv~l~~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g- 268 (709)
++. +...+.. ...+|||||++|..+..+.. .+.+..++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 174 gv~-vp~p~~~---~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFP-VPEPIAQ---SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCS-CCCEEEE---ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCC-CCeeeec---cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 332 2111211 12379999999865544322 224567889999999999999999999999999998776
Q ss_pred ---------cEEEeecccccc
Q 005210 269 ---------ILKIADFGLASF 280 (709)
Q Consensus 269 ---------~vKL~DFGla~~ 280 (709)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=126.33 Aligned_cols=140 Identities=14% Similarity=0.142 Sum_probs=106.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
.+.|.+...++.|+++.||++.. .+..++||+....... ....+.+|+.+|+.|. +.++.++++++.. .+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceE
Confidence 34688899999999999999974 3678999998642111 1124778999999984 6778888887765 57889
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh--------------------------------------
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-------------------------------------- 249 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-------------------------------------- 249 (709)
+||||++|..+..... +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999865443211 122345678899999999998
Q ss_pred ---------------------CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 ---------------------RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ---------------------~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876666799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=1e-10 Score=118.58 Aligned_cols=135 Identities=13% Similarity=0.111 Sum_probs=97.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~~~~~~~~l 206 (709)
...|.+....+.|..+.||++.. .+|..|+||+..... ...+.+|+.+|+.|.+.+ +.+++.+... .+..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCC
Confidence 44566554445666799999964 567789999976431 134668999999985444 4567776654 4568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC-----------------------------------
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG----------------------------------- 251 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g----------------------------------- 251 (709)
|+||||++|..+. .. ... ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999986554 21 112 2356677888888888753
Q ss_pred -----------------------eeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 252 -----------------------VLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 252 -----------------------IvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=7.7e-10 Score=119.02 Aligned_cols=143 Identities=15% Similarity=0.223 Sum_probs=104.1
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEe--cCCCChHHHHHHHHHHHHHHhcC--CCceeeeeceEeecC-CCeEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRM-SCSLY 207 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~--~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~~-~~~ly 207 (709)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+.. .+..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34778999999999998753 4578888765 32211 12345778999999996 455778877765421 14579
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh--------------------------------------
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-------------------------------------- 249 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-------------------------------------- 249 (709)
+||||++|..+.... -..+++.+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999986553211 1247888999999999999999997
Q ss_pred --------------------CCeeeccCCCccEEEcCCCc--EEEeecccccc
Q 005210 250 --------------------RGVLHRDIKGSNLLIDNNGI--LKIADFGLASF 280 (709)
Q Consensus 250 --------------------~gIvHrDLKP~NILld~~g~--vKL~DFGla~~ 280 (709)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.5e-09 Score=114.21 Aligned_cols=183 Identities=18% Similarity=0.191 Sum_probs=118.3
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCc--eeeeeceEeecC-CCeEEEEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN--VIKLEGLVTSRM-SCSLYLVF 210 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~Hpn--Iv~l~~~~~~~~-~~~lyLVm 210 (709)
++.|+.|.+..||++. ..++||+... ......+.+|+.+|+.| .+.. +.+++....... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4569999999999863 3588888542 23456788999999988 3333 333433322211 12358999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-----------------------------------------
Q 005210 211 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS----------------------------------------- 249 (709)
Q Consensus 211 Ey~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~----------------------------------------- 249 (709)
|+++|..+..... ..++..+...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999865432111 246778888888888888888885
Q ss_pred -----------------CCeeeccCCCccEEEcC--CCcEEEeecccccccCCCCCCCccccccccCC---CCchhhcC-
Q 005210 250 -----------------RGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWY---RPPELLLG- 306 (709)
Q Consensus 250 -----------------~gIvHrDLKP~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y---~APE~l~~- 306 (709)
..++|+|++|.|||++. .+.+.|+||+.+..-++... . .....+ ..|+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l---~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--F---ISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--H---HTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--H---HHHHhhccccCHHHHHHH
Confidence 13799999999999998 45689999999875432100 0 001111 23332111
Q ss_pred CccCC------------ccccccchhHHHHHHHhCCCCC
Q 005210 307 ATYYG------------TAVDLWSTGCILAELYAGKPIM 333 (709)
Q Consensus 307 ~~~y~------------~~~DIWSLG~iL~ELltG~~pF 333 (709)
...|+ .-.+.|+++.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00011 1258999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2e-06 Score=90.64 Aligned_cols=134 Identities=13% Similarity=0.167 Sum_probs=91.7
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEeecCCCeEEEEEe
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI---NVIKLEGLVTSRMSCSLYLVFE 211 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIv~l~~~~~~~~~~~lyLVmE 211 (709)
++.|+.|....||+. +..++||+-. .......+.+|+.+|+.|.+. .|.+++.+... ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 557889999999988 4568888742 234456788999999999652 24455555432 2456789999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhC-----------------------------------------
Q 005210 212 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR----------------------------------------- 250 (709)
Q Consensus 212 y~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~----------------------------------------- 250 (709)
|++|..+....- ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999865433111 1245555555556665555555532
Q ss_pred -------------------CeeeccCCCccEEEcC---CCc-EEEeecccccc
Q 005210 251 -------------------GVLHRDIKGSNLLIDN---NGI-LKIADFGLASF 280 (709)
Q Consensus 251 -------------------gIvHrDLKP~NILld~---~g~-vKL~DFGla~~ 280 (709)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 58999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.1e-06 Score=87.90 Aligned_cols=132 Identities=17% Similarity=0.154 Sum_probs=87.5
Q ss_pred eecccCce-EEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEEEEEeecc
Q 005210 137 KIGQGTYS-NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYME 214 (709)
Q Consensus 137 ~LG~G~fG-~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~lyLVmEy~~ 214 (709)
.+..|..+ .||+......+..++||+-.. .....+.+|+.+|+.|. +-.|.+++.++.+ .+..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeC
Confidence 44445444 699988777778899998653 23456788999999883 3335677777766 567899999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh---------------------------------------------
Q 005210 215 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS--------------------------------------------- 249 (709)
Q Consensus 215 g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~--------------------------------------------- 249 (709)
|..+...... .......++.++...|..||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7533221100 111122333444444444442
Q ss_pred -------------CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 -------------RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 -------------~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127999999999999987777899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=9.4e-06 Score=88.23 Aligned_cols=78 Identities=17% Similarity=0.149 Sum_probs=48.8
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCC--Ch---HHHHHHHHHHHHHHhcCC--Cc-eeeeeceEeecCCCe
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EP---ESVRFMAREIHILRRLDH--IN-VIKLEGLVTSRMSCS 205 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~--~~---~~~~~~~rEi~iL~~L~H--pn-Iv~l~~~~~~~~~~~ 205 (709)
.++.||.|.++.||++....+++.|+||....... .. .....+.+|+.+|+.+.. +. +.+++.+ + ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEM 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCc
Confidence 36789999999999997666678899998653211 00 112345679999988732 33 4455533 2 233
Q ss_pred EEEEEeeccc
Q 005210 206 LYLVFEYMEH 215 (709)
Q Consensus 206 lyLVmEy~~g 215 (709)
.+|||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5899999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.1e-05 Score=83.86 Aligned_cols=86 Identities=9% Similarity=0.099 Sum_probs=53.3
Q ss_pred eeEEeee-cccCceEEEEEEEC---C---CCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcC-C--CceeeeeceEee
Q 005210 132 FEKLDKI-GQGTYSNVYRARDL---D---QKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-H--INVIKLEGLVTS 200 (709)
Q Consensus 132 y~~~~~L-G~G~fG~Vy~a~~~---~---tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~-H--pnIv~l~~~~~~ 200 (709)
...++.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446788 88999999988653 1 256788887543210 0000123567888888883 2 346667666543
Q ss_pred cC-CCeEEEEEeeccccc
Q 005210 201 RM-SCSLYLVFEYMEHDL 217 (709)
Q Consensus 201 ~~-~~~lyLVmEy~~g~L 217 (709)
.. .+..|+||||++|..
T Consensus 102 ~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp STTTSSCEEEEECCCCBC
T ss_pred CCccCCceEEEEecCCCC
Confidence 21 135689999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=9.5e-05 Score=77.65 Aligned_cols=30 Identities=23% Similarity=0.338 Sum_probs=27.4
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00099 Score=70.46 Aligned_cols=74 Identities=20% Similarity=0.247 Sum_probs=56.1
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC---CCceeeeeceEeecCCCeEEEEE
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYLVF 210 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~~~~~~~~~~lyLVm 210 (709)
..+.|+.|.+..+|+... ++..++||+.... ....+.+|+..|+.|. ...+.+++.+... ....|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence 467899999999999874 4667889987532 2456788999998883 3567777776654 46789999
Q ss_pred eecccc
Q 005210 211 EYMEHD 216 (709)
Q Consensus 211 Ey~~g~ 216 (709)
||+++.
T Consensus 111 e~l~G~ 116 (312)
T 3jr1_A 111 EALNKS 116 (312)
T ss_dssp ECCCCC
T ss_pred EeccCC
Confidence 999864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00027 Score=77.43 Aligned_cols=32 Identities=9% Similarity=0.424 Sum_probs=28.0
Q ss_pred hhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 248 H~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998776 99999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00082 Score=70.30 Aligned_cols=142 Identities=14% Similarity=0.134 Sum_probs=76.4
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc--eeeeeceE----eecCCCe
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLV----TSRMSCS 205 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~~~----~~~~~~~ 205 (709)
...++.|+.|....||++... +| .+++|+..... . ...+..|+.+++.|.... +.+++... .....+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 345678888999999998753 33 68899876421 1 123456777777763212 33333210 0011356
Q ss_pred EEEEEeecccccccc---------------c--cCCC--CC----CCHHHHHHHH---------------HHHHHHHhhh
Q 005210 206 LYLVFEYMEHDLAGL---------------A--SHPG--LK----FSEAQVKCYM---------------QQLLCGLDHC 247 (709)
Q Consensus 206 lyLVmEy~~g~L~~~---------------~--~~~~--~~----lse~~i~~i~---------------~QIl~aL~yL 247 (709)
.++||+|++|..... + .... .. .....-...+ ..+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999998743210 0 0000 00 1111000000 0122334444
Q ss_pred h-------hCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 248 H-------SRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 248 H-------~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
. ..+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 2369999999999999877666899999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0019 Score=67.26 Aligned_cols=69 Identities=16% Similarity=0.023 Sum_probs=41.9
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCeEEEEEeec
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~lyLVmEy~ 213 (709)
++.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+....+ .+++.+. ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~----~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD----PATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC----TTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE----CCCCEEEEeec
Confidence 678999999999998 4588888653211 01112468888877732222 3554432 22236899999
Q ss_pred -ccc
Q 005210 214 -EHD 216 (709)
Q Consensus 214 -~g~ 216 (709)
++.
T Consensus 90 ~~g~ 93 (301)
T 3dxq_A 90 AGAQ 93 (301)
T ss_dssp TTCE
T ss_pred CCCc
Confidence 653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.004 Score=68.60 Aligned_cols=72 Identities=18% Similarity=0.218 Sum_probs=48.5
Q ss_pred EEeeecccCceEEEEEEECC-------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCe
Q 005210 134 KLDKIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCS 205 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~ 205 (709)
.++.|+.|....||++.... .+..|+||+..... . ...+.+|+.+++.|...++ .++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 46788999999999998653 25678899874321 1 1334579999988843333 566654422
Q ss_pred EEEEEeeccc
Q 005210 206 LYLVFEYMEH 215 (709)
Q Consensus 206 lyLVmEy~~g 215 (709)
.+||||++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 289999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.002 Score=69.13 Aligned_cols=74 Identities=9% Similarity=0.119 Sum_probs=42.7
Q ss_pred EEeeecccCceEEEEEEECC--------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCc-eeeeeceEeecCCC
Q 005210 134 KLDKIGQGTYSNVYRARDLD--------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSC 204 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~--------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~~~~~~~~~ 204 (709)
.+..|+.|....||++.... .+..|++|+.... .........|..+++.|...+ +.++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF----NG 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec----CC
Confidence 35678888889999997643 1257888875432 111112357888888874333 34565433 12
Q ss_pred eEEEEEeecccc
Q 005210 205 SLYLVFEYMEHD 216 (709)
Q Consensus 205 ~lyLVmEy~~g~ 216 (709)
++||||++|.
T Consensus 110 --~~v~e~i~G~ 119 (369)
T 3c5i_A 110 --GRIEEWLYGD 119 (369)
T ss_dssp --EEEEECCCSE
T ss_pred --cEEEEEecCC
Confidence 6899999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0023 Score=69.55 Aligned_cols=141 Identities=17% Similarity=0.168 Sum_probs=82.6
Q ss_pred CCeeEEeeecccCceEEEEEEECC-------CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeec
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSR 201 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~ 201 (709)
+.++ ++.|..|-...+|++.... ++..|+||+.-. .. .....+.+|..+++.|. +.-..++++++.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-IL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-cc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 3444 4678778888999998642 346788887422 11 12344568999998883 2223556655432
Q ss_pred CCCeEEEEEeeccccccccc--c----------------C----CCCCC--CHHHHHHHHHHHHHH--------------
Q 005210 202 MSCSLYLVFEYMEHDLAGLA--S----------------H----PGLKF--SEAQVKCYMQQLLCG-------------- 243 (709)
Q Consensus 202 ~~~~lyLVmEy~~g~L~~~~--~----------------~----~~~~l--se~~i~~i~~QIl~a-------------- 243 (709)
.+||||++|..+... . . -+... -..++..|+.++...
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 299999987432210 0 0 01111 245677776655321
Q ss_pred -----Hhhhh----h----CCeeeccCCCccEEEcCC----CcEEEeecccccc
Q 005210 244 -----LDHCH----S----RGVLHRDIKGSNLLIDNN----GILKIADFGLASF 280 (709)
Q Consensus 244 -----L~yLH----~----~gIvHrDLKP~NILld~~----g~vKL~DFGla~~ 280 (709)
+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22222 2 259999999999999876 7899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0061 Score=62.88 Aligned_cols=76 Identities=16% Similarity=0.162 Sum_probs=51.8
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCC---ceeeeeceEeecCCCeEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI---NVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIv~l~~~~~~~~~~~ly 207 (709)
...-+..+|.|..+.||+... .+|+.|.||+....... ....+.+|+..|+.|.-- .+.+++.+ . .-+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~----~~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D----DRT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E----TTE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c----Cce
Confidence 345688999999999999974 67889999986543221 123467899999988422 23444433 2 137
Q ss_pred EEEeeccc
Q 005210 208 LVFEYMEH 215 (709)
Q Consensus 208 LVmEy~~g 215 (709)
+||||+.+
T Consensus 87 lv~e~l~~ 94 (288)
T 3f7w_A 87 LAMEWVDE 94 (288)
T ss_dssp EEEECCCC
T ss_pred EEEEeecc
Confidence 89999864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.014 Score=61.00 Aligned_cols=139 Identities=14% Similarity=0.086 Sum_probs=78.3
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCC--ceeeeece---EeecCCCeEEEE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI--NVIKLEGL---VTSRMSCSLYLV 209 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp--nIv~l~~~---~~~~~~~~lyLV 209 (709)
+..|+ |....||++.. .+|+.+++|+.+...... ..+..|..+++.|... .+++++.. ......+..|+|
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 34667 88889998753 346679999986443222 3456788888877321 24444432 000113566899
Q ss_pred Eeecccccccc-------------------ccC-C---CCCCCHHHH----------------------HHHHHHHHHHH
Q 005210 210 FEYMEHDLAGL-------------------ASH-P---GLKFSEAQV----------------------KCYMQQLLCGL 244 (709)
Q Consensus 210 mEy~~g~L~~~-------------------~~~-~---~~~lse~~i----------------------~~i~~QIl~aL 244 (709)
|+|++|..... ... . ...+..... ...+..++..|
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998742210 000 0 001111110 11112222222
Q ss_pred hhh----hhCCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 245 DHC----HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 245 ~yL----H~~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 221 234689999999999998 4 899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.014 Score=64.85 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=47.6
Q ss_pred EEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEeecCCCeEEEEEee
Q 005210 134 KLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEY 212 (709)
Q Consensus 134 ~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~~~~~~lyLVmEy 212 (709)
.++.|+.|-...+|++.....+..|+||+....... .. ...+|..+|+.|...++ .++++++. . .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--II-NREREKKISCILYNKNIAKKIYVFFT---N---GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CS-CHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEe
Confidence 467899999999999987554578889986432110 00 12479999999965444 46666552 2 259999
Q ss_pred cccc
Q 005210 213 MEHD 216 (709)
Q Consensus 213 ~~g~ 216 (709)
++|.
T Consensus 183 I~G~ 186 (458)
T 2qg7_A 183 MDGY 186 (458)
T ss_dssp CCSE
T ss_pred eCCc
Confidence 9863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.015 Score=61.74 Aligned_cols=31 Identities=26% Similarity=0.394 Sum_probs=27.6
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeecccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASF 280 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~~ 280 (709)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999998888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0074 Score=60.34 Aligned_cols=97 Identities=14% Similarity=0.020 Sum_probs=63.1
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHHHhhhh-hCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCcccccc
Q 005210 216 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 294 (709)
Q Consensus 216 ~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH-~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~g 294 (709)
+|..++...+.+|+|+++|.++.|.+.+|.-+- ...-..+=+.|..|+|..+|.|-+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 355566666779999999999999999987762 11112344567999999999988763 1110 11
Q ss_pred ccCCCCchhhcCCccCCccccccchhHHHHHHHh
Q 005210 295 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328 (709)
Q Consensus 295 T~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt 328 (709)
...+.|||.+. ...+.+.=|||||++||..+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 22466888653 224677889999999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0033 Score=66.19 Aligned_cols=32 Identities=28% Similarity=0.349 Sum_probs=27.6
Q ss_pred hCCeeeccCCCccEEEcCC----CcEEEeecccccc
Q 005210 249 SRGVLHRDIKGSNLLIDNN----GILKIADFGLASF 280 (709)
Q Consensus 249 ~~gIvHrDLKP~NILld~~----g~vKL~DFGla~~ 280 (709)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6899999998864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.069 Score=58.74 Aligned_cols=93 Identities=12% Similarity=0.174 Sum_probs=54.0
Q ss_pred HhhhhhcccCccCCCCCCeeEEeeecccCceEEEEEEECCC-------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhc
Q 005210 114 AAVAGEAIQGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQ-------KKIVALKKVRFDNLEPESVRFMAREIHILRRL 186 (709)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L 186 (709)
.......+++|.....+. ..++.|..|-...+|++..... +..|+|++..... +..-...+|..+++.|
T Consensus 55 ~~l~~~~~p~w~~~~~~~-~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L 130 (424)
T 3mes_A 55 IGICRKNIPGWKEINESY-IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYL 130 (424)
T ss_dssp HHHHHHHSTTCTTCCGGG-EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHH
T ss_pred HHHHHHHcCccccCCCCc-eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHH
Confidence 333444555664322222 3456787888889999986531 5678888853221 1111234788888888
Q ss_pred CCCc-eeeeeceEeecCCCeEEEEEeecccc
Q 005210 187 DHIN-VIKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 187 ~Hpn-Iv~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
.-.+ ..++++.+. + ++||||++|.
T Consensus 131 ~~~gi~P~l~~~~~----~--~~I~efI~G~ 155 (424)
T 3mes_A 131 SNINIAPNIIADFP----E--GRIEEFIDGE 155 (424)
T ss_dssp HHTTSSCCEEEEET----T--EEEEECCCSE
T ss_pred HhcCCCCCEEEEcC----C--CEEEEEeCCc
Confidence 4222 345554331 2 6899999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.25 E-value=0.22 Score=53.98 Aligned_cols=29 Identities=28% Similarity=0.529 Sum_probs=24.8
Q ss_pred eeeccCCCccEEE------cCCCcEEEeecccccc
Q 005210 252 VLHRDIKGSNLLI------DNNGILKIADFGLASF 280 (709)
Q Consensus 252 IvHrDLKP~NILl------d~~g~vKL~DFGla~~ 280 (709)
++|+|+.+.|||+ +.++.+.|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4467899999998753
|
| >3p34_A Serine/threonine-protein kinase PLK1; phosphoprotein binding domain, PLK1, kinase, transferase; HET: TPO; 1.40A {Homo sapiens} PDB: 3p2z_A* 3p2w_A* 3p35_A* 3p36_A* 3p37_A* 3q1i_A* 4e67_A* 4e9c_A* 4e9d_A* 2ogq_A 2ojs_A* 2ojx_A 3bzi_A* 3mhn_A* 3mhq_A 3mq8_B* 4h5x_B 4h70_B* 4h71_B* 4hco_B* ... | Back alignment and structure |
|---|
Probab=94.02 E-value=0.0057 Score=61.57 Aligned_cols=31 Identities=19% Similarity=-0.005 Sum_probs=26.2
Q ss_pred hhcCCCCCCCCCccccccCCCcccccccccc
Q 005210 548 AKAGKNTDDAPKISTGADLSTGLVAARRSLL 578 (709)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (709)
.|++||+|||+|||+||+||++.+++-=++.
T Consensus 47 ~wVskWVDYS~KYG~GYqLsdgsvGVlFND~ 77 (232)
T 3p34_A 47 FWVSKWVDYSDKYGLGYQLCDNSVGVLFNDS 77 (232)
T ss_dssp CCEEEEEEETTTTEEEEEETTSCEEEEETTS
T ss_pred eeeeeeecccCccceEEEecCCcEEEEEcCC
Confidence 4567999999999999999999988765543
|
| >1q4k_B Serine/threonine-protein kinase PLK; six-stranded anti-parallel beta sheet with one alpha helix, transferase; HET: TPO; 2.30A {Homo sapiens} SCOP: d.223.1.2 d.223.1.2 | Back alignment and structure |
|---|
Probab=93.57 E-value=0.0083 Score=61.54 Aligned_cols=30 Identities=20% Similarity=0.018 Sum_probs=25.4
Q ss_pred hhcCCCCCCCCCccccccCCCccccccccc
Q 005210 548 AKAGKNTDDAPKISTGADLSTGLVAARRSL 577 (709)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (709)
.|+.||+||++|||+||+||||.+++-=++
T Consensus 65 ~wVsKWVDYSnKYG~GYqLsdgsvGvlFND 94 (259)
T 1q4k_B 65 FWVSKWVDYSDKYGLGYQLCDNSVGVLFND 94 (259)
T ss_dssp CCEEEEEEETTTTEEEEEETTSCEEEEETT
T ss_pred cceeeccccccccceeEEecCCcEEEEEeC
Confidence 356799999999999999999998875443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.57 E-value=0.063 Score=59.70 Aligned_cols=65 Identities=11% Similarity=0.165 Sum_probs=18.7
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEE------EEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEee
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVAL------KKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS 200 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAI------K~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~ 200 (709)
.+.+.|| ||.||++....+...||+ |.++......+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3455676 999999998766668898 7766544445555667889999999999999999887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 709 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-83 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-80 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-74 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-72 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-72 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-71 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-64 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-63 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-62 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-56 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-26 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (675), Expect = 3e-83
Identities = 130/311 (41%), Positives = 179/311 (57%), Gaps = 12/311 (3%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
+EKL KIGQGT+ V++AR + VALKKV +N + REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 187 DHINVIKLEGLVTSRMS------CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 240
H NV+ L + ++ S S+YLVF++ EHDLAGL S+ +KF+ +++K MQ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---QPLTSRVVTLW 297
L GL + H +LHRD+K +N+LI +G+LK+ADFGLA + +N T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
YRPPELLLG YG +DLW GCI+AE++ PIM G TE QL I +LCGS + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 358 RK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALA--LMETLLSIDPADRGSAASALRSE 414
+ + KR V + K + A L++ LL +DPA R + AL +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 415 FFTMKPLPCDP 425
FF P+P D
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (655), Expect = 2e-80
Identities = 111/301 (36%), Positives = 169/301 (56%), Gaps = 7/301 (2%)
Query: 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHI 189
EKLD +G+G ++ VY+ARD + +IVA+KK++ + + R REI +L+ L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N+I L + ++ LVF++ME DL + L + + +K YM L GL++ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+LHRD+K +NLL+D NG+LK+ADFGLA + T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARM 177
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
YG VD+W+ GCILAEL P +PG ++++QL +IF+ G+P+E+ W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 429
P + F L L++ L +P R +A AL+ ++F+ +P P LP
Sbjct: 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
Query: 430 K 430
+
Sbjct: 297 R 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (617), Expect = 2e-74
Identities = 110/327 (33%), Positives = 160/327 (48%), Gaps = 13/327 (3%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
+ L IG+G Y V A D K VA+KK+ + R + REI IL R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 189 INVIKLEGLV---TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
N+I + ++ T +YLV M DL L S + ++ Q+L GL
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPEL 303
+ HS VLHRD+K SNLL++ LKI DFGLA DPD + LT V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
+L + Y ++D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 364 HATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421
A + P+K V F + + AL L++ +L+ +P R AL +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 422 PCDPSSLPKYPPSKEFDAKIRDEEARR 448
DPS P +FD ++ D +
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 6e-73
Identities = 107/328 (32%), Positives = 156/328 (47%), Gaps = 18/328 (5%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
S+ IG G++ VY+A+ D ++VA+KKV D RF RE+ I+R+LDH
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHC 73
Query: 190 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLC 242
N+++L S L LV +Y+ + +A H VK YM QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 243 GLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
L + HS G+ HRDIK NLL+D + +LK+ DFG A + +P S + + +YR P
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAP 191
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
EL+ GAT Y +++D+WS GC+LAEL G+PI PG + V+QL +I K+ G+P+ + R+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421
+ PQ P A+AL LL P R + A FF L
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DEL 309
Query: 422 PCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
LP + E +
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 2e-72
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 31/294 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++ + +G+G Y V A + ++ VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
NV+K G R YL EY P + E + + QL+ G+ + H
Sbjct: 64 NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGAT 308
G+ HRDIK NLL+D LKI+DFGLA+ + + + L +++ TL Y PELL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
++ VD+WS G +L + AG+ ++ Q + +K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------- 228
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
+K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 229 -------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLK 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 5e-72
Identities = 100/321 (31%), Positives = 154/321 (47%), Gaps = 12/321 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ L +G G Y V A D VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 190 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
NVI L + T + YLV +M DL L H K E +++ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ H+ G++HRD+K NL ++ + LKI DFGLA D +T VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y VD+WS GCI+AE+ GK + G ++QL +I K+ G+P ++ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 366 TIFKPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
+ P K+ A + A+ L+E +L +D R +A AL +F
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 424 DPSSLPKYPPSKEFDAKIRDE 444
D + KY S + + DE
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDE 332
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 6e-72
Identities = 115/296 (38%), Positives = 166/296 (56%), Gaps = 6/296 (2%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
++F+K++KIG+GTY VY+AR+ ++VALKK+R D REI +L+ L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++KL ++ + LYLVFE++ DL + + +K Y+ QLL GL CH
Sbjct: 62 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S VLHRD+K NLLI+ G +K+ADFGLA + T VVTLWYR PE+LLG
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCK 178
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
YY TAVD+WS GCI AE+ + + PG +E++QL +IF+ G+P E W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT--MKPLP 422
+ ++ ++ +L+ +L DP R SA +AL FF KP+P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (596), Expect = 3e-71
Identities = 105/321 (32%), Positives = 154/321 (47%), Gaps = 12/321 (3%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ ++ L +G G Y +V A D VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 190 NVIKLEGLVTSRMSC----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
NVI L + T S +YLV M DL + K ++ V+ + Q+L GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+ HS ++HRD+K SNL ++ + LKI DFGLA D + T V T WYR PE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK--SKLP 363
+Y VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +K S+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423
I Q K A F A+ L+E +L +D R +AA AL +F P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 424 DPSSLPKYPPSKEFDAKIRDE 444
D Y S E + DE
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 230 bits (588), Expect = 6e-71
Identities = 102/287 (35%), Positives = 154/287 (53%), Gaps = 4/287 (1%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + L+KIG+GTY VY+A++ + + ALKK+R + + REI IL+ L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N++KL ++ ++ L LVFE+++ DL L K ++ QLL G+ +CH
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
R VLHRD+K NLLI+ G LKIADFGLA + + +VTLWYR P++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKK 177
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
Y T +D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+ W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
K + L+ +L +DP R +A AL +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 7e-69
Identities = 112/289 (38%), Positives = 162/289 (56%), Gaps = 4/289 (1%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+EKL+KIG+GTY V++A++ + +IVALK+VR D+ + REI +L+ L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N+++L ++ S LVFE+ + DL VK ++ QLL GL CHS
Sbjct: 62 NIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
R VLHRD+K NLLI+ NG LK+A+FGLA + + ++ VVTLWYRPP++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 310 YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
Y T++D+WS GCI AEL P+ PG +QL +IF+L G+P+E+ W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
P P + A L++ LL +P R SA AL+ +F+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-68
Identities = 62/306 (20%), Positives = 118/306 (38%), Gaps = 23/306 (7%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
+ D FEK+ ++G G V++ ++A K + + + + RE+ +L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-RELQVLHECN 62
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
++ G S + + E+M+ + E + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 248 HSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
+ ++HRD+K SN+L+++ G +K+ DFG++ S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 307 ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWR-----KS 360
T+Y D+WS G L E+ G+ PI P + +L ++ G +E R +
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAP---------ALALMETLLSIDPADRGSAASAL 411
+ +P + + P + L +PA+R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 412 RSEFFT 417
F
Sbjct: 297 VHAFIK 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 223 bits (569), Expect = 2e-67
Identities = 68/331 (20%), Positives = 119/331 (35%), Gaps = 35/331 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D ++ +++G G + V+R + A K V + + +EI + L H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
++ L + +++E+M +L + K SE + YM+Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 249 SRGVLHRDIKGSNLLI--DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
+H D+K N++ + LK+ DFGL + DP Q + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG 199
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
G D+WS G + L +G G + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
+ LL DP R + AL + T P S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 427 SLPKYPPSKEFDAKIRDEEARRQGGSKGQRM 457
+P +K D+ +A + R+
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 8e-67
Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 39/297 (13%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD 187
RA+ +E L IG G+Y + R KI+ K++ + ++ + + E+++LR L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQVKCYMQQLLCG 243
H N+++ + R + +LY+V EY E DLA + + + E V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 244 LDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
L CH R VLHRD+K +N+ +D +K+ DFGLA + D + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYY 180
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
PE + Y D+WS GC+L EL A P ++ E KI + +
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
++P+ + ++ +L++ R S L +
Sbjct: 231 FRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (561), Expect = 9e-67
Identities = 77/323 (23%), Positives = 132/323 (40%), Gaps = 39/323 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDH 188
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N I+ G + +LV EY + L E ++ L GL + H
Sbjct: 75 PNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S ++HRD+K N+L+ G++K+ DFG AS P S V T ++ PE++L
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMD 187
Query: 309 Y--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
Y VD+WS G EL KP + + L+ I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------- 228
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
+ +E F++ +++ L P DR ++ L+ F + P
Sbjct: 229 -NESPALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280
Query: 427 SLPKYPPS--KEFDAKIRDEEAR 447
L + +E D + +
Sbjct: 281 DLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-66
Identities = 65/301 (21%), Positives = 125/301 (41%), Gaps = 39/301 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D +E + ++G G + VY+A++ + + A K + + E + EI IL DH
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++KL + L+++ E+ + + +E+Q++ +Q L L++ H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
++HRD+K N+L +G +K+ADFG+++ Q S + T ++ PE+++ T
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCET 186
Query: 309 Y----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
Y D+WS G L E+ +P + L KI K P+
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQP------- 238
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM---KPL 421
+ + ++ L + R + + L+ F T+ KP+
Sbjct: 239 ------------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
Query: 422 P 422
Sbjct: 281 R 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 4e-66
Identities = 83/289 (28%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRRLDH 188
+ FE +G+G + NVY AR+ K I+ALK + LE V + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+++L G + +YL+ EY KF E + Y+ +L L +CH
Sbjct: 66 PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S+ V+HRDIK NLL+ + G LKIADFG + + + TL Y PPE++ G
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG-R 179
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
+ VDLWS G + E GKP T E +I ++ + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-------------- 225
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
A L+ LL +P+ R L + T
Sbjct: 226 ---------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 219 bits (560), Expect = 5e-66
Identities = 72/347 (20%), Positives = 129/347 (37%), Gaps = 37/347 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D ++ L+++G G + V+R + ++ K + P + EI I+ +L H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHP 86
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+I L + + L+ E++ +L + K SEA+V YM+Q GL H H
Sbjct: 87 KLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 249 SRGVLHRDIKGSNLLID--NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
++H DIK N++ + +KI DFGLA+ +PD + + T + PE++
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR 202
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
G D+W+ G + L +G G ++E L + + ED +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT--MKPLPCD 424
A ++ LL +P R + AL + L
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 425 PSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIP 471
S ++ K D A + + R+ + I
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 343
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-65
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 37/308 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + +KIGQG VY A D+ + VA++++ + EI ++R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNP 77
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N++ L++V EY+ E Q+ ++ L L+ HS
Sbjct: 78 NIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS 134
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
V+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KA 192
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
YG VD+WS G + E+ G+P + L+ I G+P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP------------ 239
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPLPCDPSSL 428
+ A + L +D RGSA L+ +F + KPL S
Sbjct: 240 -------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---SSLT 283
Query: 429 PKYPPSKE 436
P +KE
Sbjct: 284 PLIAAAKE 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-64
Identities = 112/298 (37%), Positives = 158/298 (53%), Gaps = 13/298 (4%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
R +E + +IG+G Y V++ARDL + + VALK+VR E RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 186 L---DHINVIKLEGLVT---SRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQ 238
L +H NV++L + T + L LVFE+++ D L P +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 239 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 298
QLL GLD HS V+HRD+K N+L+ ++G +K+ADFGLA Y TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 181
Query: 299 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
R PE+LL + Y T VDLWS GCI AE++ KP+ G ++V+QL KI + G P E+ W
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ F + + + D L+ L+ +PA R SA SAL +F
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-64
Identities = 93/335 (27%), Positives = 160/335 (47%), Gaps = 23/335 (6%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++ L IG G V A D + VA+KK+ + RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 192 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
I L + T + + +YLV E M+ L ++ ++ + Q+LCG+ H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS G++HRD+K SN+++ ++ LKI DFGLA + +T VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG- 192
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 368 FKPQQPYKR-------------CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 414
+ + Y +E K + A L+ +L IDPA R S AL+
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 415 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
+ + P + + P K+ D + E ++
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-63
Identities = 62/318 (19%), Positives = 119/318 (37%), Gaps = 36/318 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ + + +G+G + V+R + KK K V+ + V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ L S L ++FE++ D+ + + +E ++ Y+ Q+ L H
Sbjct: 62 NILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 249 SRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 306
S + H DI+ N++ + +KI +FG A P N Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 307 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366
TA D+WS G ++ L +G T + + I + E+ +
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 426
K+ A+ ++ LL + R +A+ AL+ + K
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 427 SLPKYPPSKEFDAKIRDE 444
+ + + I+ +
Sbjct: 272 VIRTLKHRRYYHTLIKKD 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 209 bits (532), Expect = 2e-62
Identities = 87/299 (29%), Positives = 147/299 (49%), Gaps = 21/299 (7%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DH 188
D ++ + K+G+G YS V+ A ++ + V +K ++ P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N+I L +V +S + LVFE++ + ++ ++ YM ++L LD+CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTD--FKQLYQ-TLTDYDIRFYMYEILKALDYCH 146
Query: 249 SRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
S G++HRD+K N++ID+ + L++ D+GLA FY P Q RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204
Query: 308 TYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHA 365
Y ++D+WS GC+LA + K P G +QL +I K+ G+ DY K +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 366 TIFKPQQPY-------KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417
F + +E AL ++ LL D R +A A+ +F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 207 bits (527), Expect = 3e-62
Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 44/301 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-------VRFMAREIHI 182
+++E + +G+G S V R K A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 183 LRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQL 240
LR++ H N+I+L+ + +LVF+ M+ +L + SE + + M+ L
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRAL 119
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L + H ++HRD+K N+L+D++ +K+ DFG + DP + L T Y
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177
Query: 301 PELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 355
PE++ + YG VD+WSTG I+ L AG P R ++ L I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 356 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
W D+ L+ L + P R +A AL F
Sbjct: 238 EW-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 416 F 416
F
Sbjct: 273 F 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (529), Expect = 4e-62
Identities = 79/321 (24%), Positives = 127/321 (39%), Gaps = 36/321 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
D ++ D +G G +S V A D +K+VA+K + LE + EI +L ++ H
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ L+ + S LYL+ + + +L G ++E + Q+L + + H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 249 SRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
G++HRD+K NLL D + + I+DFGL+ DP L++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLA 182
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y AVD WS G I L G P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 425
D A + L+ DP R + AL+ +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 426 SSLPKYPPSKEFDAKIRDEEA 446
K+ AK + ++A
Sbjct: 277 IHQSVSEQIKKNFAKSKWKQA 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 34/292 (11%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRR 185
+R + F+ +G+G++S V AR+L + A+K + ++ + V ++ RE ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
LDH +KL LY Y ++ F E + Y +++ L+
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELL 304
+ H +G++HRD+K N+L++ + ++I DFG A P+ Q + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 305 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364
+ DLW+ GCI+ +L AG P E KI KL E ++
Sbjct: 183 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF------- 234
Query: 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+D L+E LL +D R
Sbjct: 235 ---------------PKARD-------LVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-60
Identities = 57/297 (19%), Positives = 115/297 (38%), Gaps = 33/297 (11%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+IG G++ VY+ + VA+K + P+ ++ E+ +LR+ H+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
N++ G T+ L +V ++ E L KF ++ +Q G+D+ H
Sbjct: 65 NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLG- 306
++ ++HRD+K +N+ + + +KI DFGLA+ ++ ++ + PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 307 -ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y D+++ G +L EL G+ +Q+ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------ 223
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
+ +++ + P LM L +R L S + LP
Sbjct: 224 -----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 9e-58
Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 37/291 (12%)
Query: 132 FEKLD-KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 190
F K D +IG+G++ VY+ D + VA +++ L + E +L+ L H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 191 VIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+++ T + + LV E M ++ + +Q+L GL H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 249 SRG--VLHRDIKGSNLLI-DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
+R ++HRD+K N+ I G +KI D GLA+ + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y +VD+++ G + E+ + Q+++ P+
Sbjct: 187 EK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------ 232
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416
+ + K+ ++E + + +R S L FF
Sbjct: 233 -------SFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 63/312 (20%), Positives = 121/312 (38%), Gaps = 40/312 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE----SVRFMAREIHILRR 185
D ++ +++G G ++ V + R+ A K ++ + S + RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
+ H NVI L + ++ + L+ E + +E + +++Q+L G+
Sbjct: 70 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGI----LKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 301
+ HS + H D+K N+++ + + +KI DFGLA D + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAP 185
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
E++ G D+WS G I L +G G T+ E L + + ++Y+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 421
+ A A + LL DP R + +L+ + KP
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--KPK 277
Query: 422 PCDPSSLPKYPP 433
+ +
Sbjct: 278 DTQQALSSAWSH 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 190 bits (484), Expect = 4e-56
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 31/292 (10%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD 187
+D +E + +G G S V+ ARDL + VA+K +R D +P RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 188 HINVIKLEGLVTSR--MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
H ++ + + Y+V EY++ H + + + L+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPEL 303
H G++HRD+K +N++I +K+ DFG+A N + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 304 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363
G + D++S GC+L E+ G+P G + V ++ + P
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 415
+ A A++ L+ +P +R A+ +R++
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 57/330 (17%), Positives = 113/330 (34%), Gaps = 41/330 (12%)
Query: 130 DSFEKLDK-IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-D 187
D ++ + +G G V + + ++ ALK ++ RE+ + R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQ 63
Query: 188 HINVIKLEGLVTSRMSC--SLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCG 243
+++++ + + + L +V E ++ +L + F+E + M+ +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 244 LDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
+ + HS + HRD+K NLL N ILK+ DFG A + + T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
PE+L Y + D+WS G I+ L G P + + ++
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT-MK 419
+ + L+ LL +P R + + +
Sbjct: 241 ---------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
Query: 420 PLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 449
+P P + + + EE
Sbjct: 280 KVPQTPLHTSRVLKEDKERWEDVKEEMTSA 309
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 188 bits (477), Expect = 5e-54
Identities = 71/313 (22%), Positives = 127/313 (40%), Gaps = 42/313 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRR 185
+ F IG+G + VY R D K+ A+K + ++ + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
D ++ + + L + + M FSEA ++ Y +++ GL+
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 305
H H+R V++RD+K +N+L+D +G ++I+D GLA + + + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 306 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365
Y ++ D +S GC+L +L G ++ H+I ++ + + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFFTMKP 420
F +L+E LL D R A S FF +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF--RS 270
Query: 421 LPCDPSSLPKYPP 433
L L KYPP
Sbjct: 271 LDWQMVFLQKYPP 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 50/309 (16%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILR 184
++ +G G + +VY + VA+K V D + E + + E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 185 RLD--HINVIKLEGLVTSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQL 240
++ VI+L S L+ E E DL + G E + + Q+
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQV 119
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
L + HCH+ GVLHRDIK N+LID N G LK+ DFG + + T T Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYS 176
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PPE + Y+G + +WS G +L ++ G E+ + F+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------ 224
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419
+ + L+ L++ P+DR + +
Sbjct: 225 -----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 420 PLPCDPSSL 428
LP + + +
Sbjct: 262 LLPQETAEI 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 64/298 (21%), Positives = 127/298 (42%), Gaps = 43/298 (14%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
VPR ++ + ++++G G + V+ K VA+K ++ ++ P++ E ++++
Sbjct: 10 VPR--ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL---AEANLMK 63
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLC 242
+L H +++L +VT +Y++ EYME+ L + G+K + ++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 243 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 302
G+ R +HRD++ +N+L+ + KIADFGLA + ++ + + PE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 303 LLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
+ + D+WS G +L E+ G+ PG T E + + +
Sbjct: 181 AINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------------- 225
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFT 417
++ +P + P LM P DR + +FFT
Sbjct: 226 -----GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 70/326 (21%), Positives = 128/326 (39%), Gaps = 52/326 (15%)
Query: 117 AGEAIQGW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 175
G A W +PR +S K+GQG + V+ + VA+K ++ + PE+
Sbjct: 5 QGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL- 60
Query: 176 MAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQV 233
+E ++++L H +++L +V+ +Y+V EYM G Q+
Sbjct: 61 --QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 115
Query: 234 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 293
Q+ G+ + +HRD++ +N+L+ N + K+ADFGLA + ++
Sbjct: 116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAEL-YAGKPIMPGRTEVEQLHKIFKLCGSP 352
+ + PE L + D+WS G +L EL G+ PG E L ++ +
Sbjct: 176 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----- 229
Query: 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
++ P + P LM +P +R +
Sbjct: 230 --------------GYRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQA 266
Query: 413 --SEFFTMKPLPCDPSSLPKYPPSKE 436
++FT S+ P+Y P +
Sbjct: 267 FLEDYFT--------STEPQYQPGEN 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 36/290 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LD 187
+ F +G+G++ V+ A + A+K ++ D L + V E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 247
H + + ++ + L+ V EY+ KF ++ Y +++ GL
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 248 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 307
HS+G+++RD+K N+L+D +G +KIADFG+ + + T Y PE+LLG
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ 178
Query: 308 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y +VD WS G +L E+ G+ G+ E E H I
Sbjct: 179 -KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------------- 217
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS-EFF 416
P P + A L+ L +P R +R F
Sbjct: 218 DNPFYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 37/289 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRR 185
L+K+G G++ V R + VA+K ++ D L +PE++ RE++ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGL 244
LDH N+I+L G+V + + +V E L F + Y Q+ G+
Sbjct: 68 LDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPEL 303
+ S+ +HRD+ NLL+ ++KI DFGL + + + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 304 LLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
L + A D W G L E++ G+ G + LHKI K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------------- 229
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 411
+ +P +D P +M + P DR + +
Sbjct: 230 ---EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (447), Expect = 2e-50
Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 42/293 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
F+ L +G G++ V+ R + A+K ++ + + + V E +L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+I++ G ++++ +Y+E +F K Y ++ L++ H
Sbjct: 64 PFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S+ +++RD+K N+L+D NG +KI DFG A + + T Y PE++
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
Y ++D WS G ++ E+ AG ++ KI + + P
Sbjct: 178 -YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------AELRFP----- 221
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFF 416
F L+ L++ D + R +F
Sbjct: 222 --------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
+ +IG G + V+ L++ K VA+K +R + E E ++ +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+++L G+ + LVFE+MEH L+ F+ + + G+ +
Sbjct: 61 KLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
V+HRD+ N L+ N ++K++DFG+ F DQ T + + PE+ +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 309 YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
Y + D+WS G ++ E+++ GK R+ E + I +T
Sbjct: 179 -YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STG 218
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
F+ +P + +M P DR + + LR
Sbjct: 219 FRLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-50
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 39/293 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH 188
+ F+ L +G+GT+ V R+ + A+K +R + + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 189 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+ L+ + L V EY F+E + + Y +++ L++ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
SR V++RDIK NL++D +G +KI DFGL D + + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-N 180
Query: 309 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368
YG AVD W G ++ E+ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFF 416
+ + P + A +L+ LL DP R A + FF
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-50
Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 46/294 (15%)
Query: 123 GW-VPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH 181
GW + + L IG+G + +V K VA+K ++ + + E
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIK----NDATAQAFLAEAS 52
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQ 239
++ +L H N+++L G++ LY+V EYM L L S + +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 240 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 299
+ +++ +HRD+ N+L+ + + K++DFGL Q + + + +
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 300 PPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
PE L + T D+WS G +L E+Y+ G+ P + + ++ K
Sbjct: 168 APEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+K P P +M+ +D A R S
Sbjct: 216 --------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 1e-49
Identities = 58/323 (17%), Positives = 107/323 (33%), Gaps = 41/323 (12%)
Query: 127 RRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
R + + KIG G++ ++Y D+ + VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 246
I + +V E + L L + KFS V Q++ +++
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 247 CHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQN------QPLTSRVVTLW 297
HS+ +HRD+K N L+ ++ I DFGLA Y + + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 298 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 357
Y LG DL S G +L G G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 358 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSE 414
++ + K +P+ + S+ D+ + R+
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 415 FFTMKPLPCDPS--SLPKYPPSK 435
F ++ K+ S+
Sbjct: 277 FHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (435), Expect = 5e-49
Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 38/284 (13%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
++ +IG+G++ ++ +L + VA+K + P+ R +L I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE-YRTYKLLAGCTGIPN 65
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
+ G + LV + + L L G KFS V +Q+L + H +
Sbjct: 66 VYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 252 VLHRDIKGSNLLIDN-----NGILKIADFGLASFYDPD------QNQPLTSRVVTLWYRP 300
+++RDIK N LI ++ + DFG+ FY + + T Y
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
LG DL + G + G G K ++
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----------- 229
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 404
++ + E FP M ++
Sbjct: 230 ----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-49
Identities = 53/285 (18%), Positives = 113/285 (39%), Gaps = 37/285 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
L ++G G + V + Q VA+K ++ ++ + E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFI---EEAKVMMNLSHE 59
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 248
+++L G+ T + ++++ EYM + L +F Q+ + + +++
Sbjct: 60 KLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 249 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 308
S+ LHRD+ N L+++ G++K++DFGL+ + D+ + + PPE+L+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S 176
Query: 309 YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
+ + D+W+ G ++ E+Y+ GK T E I A
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------------AQG 217
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+ +P +M + +R + L
Sbjct: 218 LRLYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 1e-48
Identities = 54/283 (19%), Positives = 106/283 (37%), Gaps = 31/283 (10%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 189
K+G G Y VY VA+K ++ D +E E +E +++ + H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 190 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 249
N+++L G+ T + F + L L + S + Q+ +++
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 250 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 309
+ +HRD+ N L+ N ++K+ADFGL+ D + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 310 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369
+ D+W+ G +L E+ ++ Q++++ + ++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------------KDYR 234
Query: 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
++P + P LM +P+DR S A +
Sbjct: 235 MERP---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 74/328 (22%), Positives = 134/328 (40%), Gaps = 43/328 (13%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNL--EPESVRFMAREIHILR 184
++FE L +G G Y V+ R + K+ A+K ++ + + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 185 RLDHI-NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCG 243
+ ++ L + L+L+ +Y+ +F+E +V+ Y+ +++
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 303
L+H H G+++RDIK N+L+D+NG + + DFGL+ + D+ + T+ Y P++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 304 LLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+ G + + AVD WS G ++ EL G E +I + Y
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----- 256
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFFT 417
++ A A L++ LL DP R A FF
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF- 295
Query: 418 MKPLPCDPSSLPKYPPSKEFDAKIRDEE 445
+ + D + K P F IRDE
Sbjct: 296 -QKINWDDLAAKKVPAP--FKPVIRDEL 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 55/303 (18%), Positives = 113/303 (37%), Gaps = 41/303 (13%)
Query: 124 WVPRRADSFEKLDKIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIH 181
++ R+ + E ++G G + V + +K K VA+K ++ + +P + E +
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 241
++++LD+ ++++ G+ + S LV E E + + + Q+
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 242 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYR 299
G+ + +HRD+ N+L+ KI+DFGL+ D+N + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 300 PPELLLGATYYGTAVDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358
PE + + + D+WS G ++ E G+ G E + K
Sbjct: 178 APECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------- 225
Query: 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS---ALRSEF 415
+ P P LM + D +R A+ LR+ +
Sbjct: 226 --------GERMGCP---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 416 FTM 418
+ +
Sbjct: 269 YDV 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 2e-48
Identities = 66/308 (21%), Positives = 126/308 (40%), Gaps = 45/308 (14%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRL 186
+ IG G + V K VA+K ++ E + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
DH NVI LEG+VT S + ++ E+ME+ L +F+ Q+ ++ + G+
Sbjct: 85 DHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV----TLWYRPP 301
+ +HRD+ N+L+++N + K++DFGL+ F + D + P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 302 ELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360
E + + +A D+WS G ++ E+ + G+ T + ++ I +
Sbjct: 203 EAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------- 248
Query: 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 420
++ P D P+ LM D R + T+
Sbjct: 249 ------DYRLPPP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVN----TLDK 289
Query: 421 LPCDPSSL 428
+ +P+SL
Sbjct: 290 MIRNPNSL 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 57/299 (19%), Positives = 114/299 (38%), Gaps = 43/299 (14%)
Query: 130 DSFEKLD-KIGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 186
D+ D ++G G + +V + R ++ VA+K ++ + ++ M RE I+ +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQL 66
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
D+ +++L G+ + +L LV E L + + V + Q+ G+
Sbjct: 67 DNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPEL 303
+ + +HRD+ N+L+ N KI+DFGL+ D + L + PE
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 304 LLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+ + + D+WS G + E + G+ E + I +
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------------- 227
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS---ALRSEFFTM 418
+ + P + P ALM DR + +R+ ++++
Sbjct: 228 ----GKRMECP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 5e-48
Identities = 65/333 (19%), Positives = 121/333 (36%), Gaps = 51/333 (15%)
Query: 95 SIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRA-----DSFEKLDKIGQGTYSNVYRA 149
+ K SE E V +LA + ++ W D F+++ +G G++ V
Sbjct: 5 AAKKGSEQESVKE----FLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 150 RDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208
+ + A+K + + + + + E IL+ ++ ++KLE + + +
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 268
+ + L +FSE + Y Q++ ++ HS +++RD+K NLLID G
Sbjct: 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 269 ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 328
+++ DFG A + T PE++L Y AVD W+ G ++ E+ A
Sbjct: 179 YIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAA 233
Query: 329 GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP 388
G P ++ KI F +
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPS-----------------------------HFSSD 264
Query: 389 ALALMETLLSIDPADR-----GSAASALRSEFF 416
L+ LL +D R ++F
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 55/293 (18%), Positives = 112/293 (38%), Gaps = 40/293 (13%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIH 181
+ R + E IG+G + +V++ + + VA+K + + +F+ +E
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 60
Query: 182 ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQL 240
+R+ DH +++KL G++T ++++ E +L A + Y QL
Sbjct: 61 TMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 241 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 300
L + S+ +HRDI N+L+ +N +K+ DFGL+ + + + + + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 301 PELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359
PE + + A D+W G + E+ G G + + +I +
Sbjct: 178 PESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GER 227
Query: 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+P + P +LM + DP+ R
Sbjct: 228 LPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 2e-46
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 65/319 (20%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMARE 179
PR ++ E + IG+G + V++AR + +VA+K ++ + F RE
Sbjct: 10 YPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 66
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL------------------ 220
++ D+ N++KL G + + L+FEYM + DL
Sbjct: 67 AALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 221 -----ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275
+S S A+ C +Q+ G+ + R +HRD+ N L+ N ++KIADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 276 GLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIM 333
GL+ + Y D + + + + + PPE + Y T D+W+ G +L E+++ G
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALM 393
G E ++ + R + ++ P LM
Sbjct: 244 YGMAHEEVIYYV------------RDGNIL----------------ACPENCPLELYNLM 275
Query: 394 ETLLSIDPADRGSAASALR 412
S PADR S S R
Sbjct: 276 RLCWSKLPADRPSFCSIHR 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-46
Identities = 69/314 (21%), Positives = 116/314 (36%), Gaps = 62/314 (19%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLDQKKI-----VALKKVRFDNLEPESVRFMAREIHILR 184
++ E +G G + V A K VA+K ++ E M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMT 95
Query: 185 RL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSE------------ 230
+L H N++ L G T S +YL+FEY + DL KFSE
Sbjct: 96 QLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 231 ----------AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280
+ C+ Q+ G++ + +HRD+ N+L+ + ++KI DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 281 YDPDQNQPL-TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTE 338
D N + + + + + PE L Y D+WS G +L E+++ G PG
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 339 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLS 398
+K+ + FK QP +M++ +
Sbjct: 273 DANFYKLIQ------------------NGFKMDQP---------FYATEEIYIIMQSCWA 305
Query: 399 IDPADRGSAASALR 412
D R S +
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 68/303 (22%), Positives = 109/303 (35%), Gaps = 33/303 (10%)
Query: 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 188
A + + IG+G + V+R + ++ VA+K + E F EI+ L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 189 INVIKLEGLVTSRMSC--SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
N++ L+LV +Y EH L + + + + GL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLA 114
Query: 246 HCHS--------RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVV 294
H H + HRD+K N+L+ NG IAD GLA +D + RV
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 295 TLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
T Y PE+L + D+++ G + E+ I G E QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVP 233
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409
PS + RK +P P + E + +M + A R +A
Sbjct: 234 SDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALR 287
Query: 410 ALR 412
+
Sbjct: 288 IKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 4e-45
Identities = 80/342 (23%), Positives = 134/342 (39%), Gaps = 51/342 (14%)
Query: 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 191
+ + K+G G +S V+ A+D+ VA+K VR D + E+ EI +L+R++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 192 IKLEGLVTSRMSCSLYLVFEYMEHD---------------LAGLASHPGLKFSEAQVKCY 236
K + + + + L F + + LA + + VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 237 MQQLLCGLDHC-HSRGVLHRDIKGSNLLIDNNGI------LKIADFGLASFYDPDQNQPL 289
+QLL GLD+ G++H DIK N+L++ +KIAD G A +YD +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLH 343
+R YR PE+LLGA +G D+WST C++ EL G + + + +
Sbjct: 191 QTR----EYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 344 KIFKLCGSPSEDYWRKSKLPHATI-------------FKPQQPYKRCVAETFKDFPAPAL 390
+I +L G R K F P + + KD
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 391 ALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 432
+ +L +DP R A + + L + +P
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 346
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 60/331 (18%), Positives = 115/331 (34%), Gaps = 46/331 (13%)
Query: 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILR 184
+ F+K+ +G G + VY+ + + + V + K + P++ + + E +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 243
+D+ +V +L G+ + ++ L+ + M L + + Q+ G
Sbjct: 67 SVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 244 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPE 302
+++ R ++HRD+ N+L+ +KI DFGLA ++ + + + E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 303 LLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361
+L Y D+WS G + EL G G E + K
Sbjct: 184 SILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM--- 418
+ QP +M ID R + EF M
Sbjct: 229 -----GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII-EFSKMARD 273
Query: 419 --KPLPCDPSSLPKYPPSKE--FDAKIRDEE 445
+ L P + F + DEE
Sbjct: 274 PQRYLVIQGDERMHLPSPTDSNFYRALMDEE 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 63/285 (22%), Positives = 106/285 (37%), Gaps = 39/285 (13%)
Query: 136 DKIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 192
+ IG+G + VY LD +K A+K + E +F+ E I++ H NV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 193 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 251
L G + R S +V YM+H DL + + + + Q+ G+ S+
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 252 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL---TSRVVTLWYRPPELLLGAT 308
+HRD+ N ++D +K+ADFGLA + + T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 309 YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367
+ T D+WS G +L EL G P P + + + R+ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP---- 256
Query: 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+ P P +M R S + +
Sbjct: 257 ---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-43
Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 59/314 (18%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMARE 179
PR + +G G + V A D VA+K ++ E M E
Sbjct: 20 FPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SE 76
Query: 180 IHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH------------------DLAGL 220
+ +L L +H+N++ L G T ++ EY + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280
L + + Q+ G+ S+ +HRD+ N+L+ + I KI DFGLA
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 281 YDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTE 338
D N + + + PE + Y D+WS G L EL++ G PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 339 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLS 398
+ +K+ K F+ P + PA +M+T
Sbjct: 254 DSKFYKMIK------------------EGFRMLSP---------EHAPAEMYDIMKTCWD 286
Query: 399 IDPADRGSAASALR 412
DP R + ++
Sbjct: 287 ADPLKRPTFKQIVQ 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-42
Identities = 60/309 (19%), Positives = 120/309 (38%), Gaps = 39/309 (12%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRR 185
+ IG G + VY+ ++ VA+K ++ E + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 186 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGL 244
H N+I+LEG+++ + ++ EYME+ +FS Q+ ++ + G+
Sbjct: 66 FSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 245 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPE 302
+ + +HRD+ N+L+++N + K++DFGL+ + D T+ + + + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 303 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362
+ + +A D+WS G ++ E+ ++ K
Sbjct: 184 AISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227
Query: 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422
F+ P D P+ LM + A R A + + P
Sbjct: 228 ---DGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKLIRAP 274
Query: 423 CDPSSLPKY 431
+L +
Sbjct: 275 DSLKTLADF 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 67/324 (20%), Positives = 119/324 (36%), Gaps = 56/324 (17%)
Query: 130 DSFEKLDKIGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRL- 186
+ + D IG+G + V +AR + A+K+++ + + F E+ +L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 187 DHINVIKLEGLVTSRMSCSLYLVFEYMEH----------------DLAGLASHPGLKFSE 230
H N+I L G LYL EY H +A+ S
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 231 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 290
Q+ + + G+D+ + +HRD+ N+L+ N + KIADFGL+ + + T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 291 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKIFKLC 349
+ + + E L + Y T D+WS G +L E + G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 350 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 409
++ ++P + LM P +R S A
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 410 ALR--SEFFTMKPLPCDPSSLPKY 431
L + + + + K+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 54/311 (17%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMARE 179
PR D + +G+G + V A + VA+K ++ E M+
Sbjct: 10 FPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67
Query: 180 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL----------------AGLASH 223
++ H+NV+ L G T L ++ E+ +
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 224 PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283
+ + CY Q+ G++ SR +HRD+ N+L+ ++KI DFGLA
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 284 DQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQ 341
D + L + PE + Y D+WS G +L E+++ PG E+
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 342 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP 401
+ K + + P M +P
Sbjct: 246 FCRRLK------------------EGTRMRAP---------DYTTPEMYQTMLDCWHGEP 278
Query: 402 ADRGSAASALR 412
+ R + + +
Sbjct: 279 SQRPTFSELVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 55/315 (17%), Positives = 114/315 (36%), Gaps = 49/315 (15%)
Query: 130 DSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILR 184
+ ++GQG++ VY + + VA+K V E + F+ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMK 78
Query: 185 RLDHINVIKLEGLVTSRMSCSLYLVFEYME----------HDLAGLASHPGLKFSEAQVK 234
+ +V++L G+V+ ++ E M A + S +++
Sbjct: 79 EFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 235 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS-FYDPDQNQPLTSRV 293
++ G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 294 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSP 352
+ + + PE L + T D+WS G +L E+ + G + + L +
Sbjct: 197 LPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248
Query: 353 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412
+ L + + P LM +P R S +
Sbjct: 249 -----MEGGLL----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
Query: 413 SEFFTMKPLPCDPSS 427
S M+P + S
Sbjct: 288 SIKEEMEPGFREVSF 302
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 62/313 (19%), Positives = 113/313 (36%), Gaps = 58/313 (18%)
Query: 125 VPRRADSFEKLDKIGQGTYSNVYRARDLDQKK-------IVALKKVRFDNLEPESVRFMA 177
+PR D +G+G + V A + K VA+K ++ D E + +
Sbjct: 10 LPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI- 66
Query: 178 REIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH----------------DLAGL 220
E+ +++ + H N+I L G T LY++ EY
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 221 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 280
+ +P + S + Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 281 YDPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV 339
T + + + + PE L Y D+WS G +L E++ V
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 340 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI 399
E+L K+ K + +P + +M
Sbjct: 244 EELFKLLK------------------EGHRMDKP---------SNCTNELYMMMRDCWHA 276
Query: 400 DPADRGSAASALR 412
P+ R + +
Sbjct: 277 VPSQRPTFKQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (260), Expect = 3e-26
Identities = 28/203 (13%), Positives = 66/203 (32%), Gaps = 30/203 (14%)
Query: 136 DKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM--------AREIHILRRLD 187
+G+G S V+ + +K + + + V+ + R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 188 HINVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 245
+ KL+G + ++ E ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 246 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPE 302
+ RG++H D+ N+L+ GI I DF + + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFSRT- 175
Query: 303 LLLGATYYGTAVDLWSTGCILAE 325
Y T D+ S + +
Sbjct: 176 -------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.8 | |
| d2ogqa1 | 124 | Serine/threonine-protein kinase plk C-terminal dom | 94.66 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-59 Score=489.82 Aligned_cols=293 Identities=38% Similarity=0.680 Sum_probs=246.7
Q ss_pred eEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh---HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP---ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.++.||+|+||+||+|++..+|+.||||+++...... ...+.+.+|+.+|+.++|||||++++++.. .+.+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeeh
Confidence 46889999999999999999999999999997654321 223467899999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||.++++..+......+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 9999998888777777789999999999999999999999999999999999999999999999999998765433 233
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC-Ccccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp-~~~~~ 368 (709)
...+||++|+|||++.+...|+.++||||||||||||++|.+||.+.+..+++.+|++.+|.|..+.|...... ....+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45689999999999987777899999999999999999999999999999999999999999998887543222 11111
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 430 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~ 430 (709)
... ....+...+..+++++++||.+||++||.+||||+|+|+||||+..|.|+.+..+|.
T Consensus 238 ~~~--~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 KSF--PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CCC--CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred ccC--CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 111 112244556788999999999999999999999999999999999998887777764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-57 Score=470.91 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=217.8
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+.++|++++.||+|+||.||+|++..+|+.||||+++..... +..+.+.+|+.+|++|+|||||++++++.+ .+.+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeE
Confidence 378899999999999999999999999999999999865432 234567899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-C
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-N 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~ 286 (709)
||||||+++.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999864444444455589999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
...+..+||+.|||||++.+...++.++||||||||||||++|++||.+.........+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 334567899999999999887766889999999999999999999998776554444333221110
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
...+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 226 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1123458899999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=469.14 Aligned_cols=291 Identities=39% Similarity=0.666 Sum_probs=242.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+|+.||||+++...........+.+|+.+|++++|||||++++++.+ .+.+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeE
Confidence 368999999999999999999999999999999997665444445678899999999999999999999987 778999
Q ss_pred EEeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHDLAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~L~~~~-~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.+++...+ ......+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 9999998766654 3445579999999999999999999999999999999999999999999999999998765332 3
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+++.++++..+.|.+..|..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34556899999999999888778999999999999999999999999999999999999999999888775422111111
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
.................++.++.+||.+||++||.+|||+.|+|+||||+..+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1111111223445567889999999999999999999999999999999876444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=466.38 Aligned_cols=255 Identities=33% Similarity=0.465 Sum_probs=220.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++|||||++++++.+ .+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 67899999999999999999999999999999999754321 2234567899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||||+++.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999997555444444457999999999999999999999999999999999999999999999999999865432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+..+.+.+|.+.- +
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~--------------- 221 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--F--------------- 221 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--C---------------
T ss_pred cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C---------------
Confidence 235668999999999998765 7999999999999999999999999999888888775421 0
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 222 ------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 ------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 012357899999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=464.12 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=212.5
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
+.++|++++.||+|+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+...+.+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 46899999999999999999999999999999999988877777778899999999999999999999998776567899
Q ss_pred EEEeecccc-ccccccC---CCCCCCHHHHHHHHHHHHHHHhhhhhCC-----eeeccCCCccEEEcCCCcEEEeecccc
Q 005210 208 LVFEYMEHD-LAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 208 LVmEy~~g~-L~~~~~~---~~~~lse~~i~~i~~QIl~aL~yLH~~g-----IvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
||||||+++ |..++.. .+..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999864 4444322 3457999999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
+.+.... ......+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|... .+
T Consensus 162 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~------ 231 (269)
T d2java1 162 RILNHDT-SFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF------ 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC------
T ss_pred eecccCC-CccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC------
Confidence 8875432 2345678999999999997755 899999999999999999999999999988888877542 10
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 416 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f 416 (709)
......+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 232 --------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01123578999999999999999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=464.22 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=222.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.. .+.+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEE
Confidence 35799999999999999999999999999999999865432 23568899999999999999999999987 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 209 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 209 VmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
|||||+++.+..+... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 9999997655544443 369999999999999999999999999999999999999999999999999998775433 33
Q ss_pred ccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+||+.|+|||++.+.. |+.++|||||||+||+|++|++||.+.+..+.+..+... +.+..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~-------------- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL-------------- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSCCC--------------
T ss_pred ccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCC--------------
Confidence 45668999999999998755 799999999999999999999999999988888777653 11111
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....+++.+++||.+||++||.+|||++|+|+||||+.
T Consensus 237 -----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 -----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112457899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-55 Score=471.46 Aligned_cols=269 Identities=24% Similarity=0.386 Sum_probs=231.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ .+.+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997543 3445678899999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC--CCcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~--~g~vKL~DFGla~~~~~~~ 285 (709)
|||||++ +|...+......+++.+++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999986 555666555667999999999999999999999999999999999999964 678999999999877543
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|||||++.+.. |+.++||||||||+|||++|++||.+.+..+.+..|......+..
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred -cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 3345678999999999998765 799999999999999999999999999999999888764322221
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 429 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p 429 (709)
..+..+++++++||.+||++||.+|||++|+|+||||+....+..+..+|
T Consensus 247 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp --------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 22346899999999999999999999999999999999876665554443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-55 Score=459.39 Aligned_cols=285 Identities=36% Similarity=0.632 Sum_probs=240.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|+++++||+|+||.||+|++. +|+.||||+++.........+.+.+|+.+|++++|||||++++++.. .+.+|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 68999999999999999999985 78999999997765444445678899999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++++..+......+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 9999999888887777789999999999999999999999999999999999999999999999999998765432 223
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccC
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 369 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~ 369 (709)
...++|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++..|.|....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 45578999999999988887899999999999999999999999999999999999999999988887542211111111
Q ss_pred CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 370 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 370 ~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
........+...+..+++.+.|||.+||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111122344556788999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=466.06 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=219.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~l 206 (709)
+.++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|++|+|||||++++++.+ .+.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEE
Confidence 35789999999999999999999999999999999975432 22345678899999999999999999999987 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ- 285 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~- 285 (709)
|||||||+++.+..+......+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999975444333344579999999999999999999999999999999999999999999999999998875432
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.......+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+..+.+.+|.+.- +
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~------------- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y------------- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--C-------------
T ss_pred ccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--C-------------
Confidence 23345678999999999998765 8999999999999999999999999999998888886421 1
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHH------HHhcccCCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS------ALRSEFFTMKP 420 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e------~L~hp~f~~~~ 420 (709)
.....+++++++||.+||++||.+|||++| +++||||+...
T Consensus 228 --------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 228 --------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp --------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred --------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 011357899999999999999999999987 58899998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-55 Score=463.73 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=223.1
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC-hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
.|++++.||+|+||.||+|++..+++.||||+++..... ....+.+.+|+.+|+.|+|||||++++++.+ ...+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence 499999999999999999999999999999999876543 4456678899999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
||||.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence 99999887776655556899999999999999999999999999999999999999999999999999986543 2
Q ss_pred cccccccCCCCchhhcC--CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 290 TSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~--~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
...+||+.|||||++.+ ...|+.++|||||||+||||++|++||.+.+..+.+.++......+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 233 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------- 233 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 34689999999999975 2458999999999999999999999999999888888876521100
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+|+.+.+||.+||+.||.+|||++++|+||||...
T Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0113578999999999999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=459.84 Aligned_cols=296 Identities=43% Similarity=0.693 Sum_probs=239.7
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC-----
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----- 202 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----- 202 (709)
..++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.|+||||+++++++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 378999999999999999999999999999999998766555555566789999999999999999999875422
Q ss_pred -CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccccc
Q 005210 203 -SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 281 (709)
Q Consensus 203 -~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~ 281 (709)
.+.+|+|||||.++++.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3568999999999888877777778999999999999999999999999999999999999999999999999999776
Q ss_pred CCCC---CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 282 DPDQ---NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 282 ~~~~---~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
.... .......+||++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+.+..|.+.++.+..+.|.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4322 2233456899999999999887779999999999999999999999999999999999999999999887764
Q ss_pred hcCCCCc-cccCCCCccccchhccc--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCC
Q 005210 359 KSKLPHA-TIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 423 (709)
Q Consensus 359 ~~~lp~~-~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~ 423 (709)
....... ..+.............+ ...++.++|||.+||++||++|||++|+|+||||+..|.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 4221111 11111111111111111 12477899999999999999999999999999999876654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-55 Score=463.79 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=206.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++.+.||+|+||.||+|++..+++.||||++....... ....+.+|+.+|+.|+|||||++++++.+ .+.+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 466999999999999999999999999999999998665432 23457799999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc---CCCcEEEeecccccccCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPD 284 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld---~~g~vKL~DFGla~~~~~~ 284 (709)
|||||++ +|...+.. ...|++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999985 55555544 45799999999999999999999999999999999999995 5789999999999876433
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+.+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+..+....|.+....+.
T Consensus 164 --~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------- 229 (307)
T d1a06a_ 164 --SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----------- 229 (307)
T ss_dssp -----------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred --CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-----------
Confidence 2345568999999999998765 89999999999999999999999999999888888865322211
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....++|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 230 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 --------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11235689999999999999999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=470.77 Aligned_cols=284 Identities=23% Similarity=0.317 Sum_probs=213.9
Q ss_pred CCCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 128 RADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 128 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
..++|++++.||+|+||.||+|++..+|+.||||+++... .......+.+|+.+|+.|+|||||+++++|.+ ...+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 4688999999999999999999999999999999998653 33445678899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||||.++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999975555444444579999999999999999999997 59999999999999999999999999999876432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChhhhh----hcC
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWR----KSK 361 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~-l~~I~k~~g~p~~~~w~----~~~ 361 (709)
..++.+||++|||||++.+.. |+.++||||||||||||++|+.||.+.+..+. +..+....|.+....+. ...
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234569999999999999865 89999999999999999999999988764432 22233333332221100 000
Q ss_pred CC-CccccCCCCccccc----hhcc-----cCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 362 LP-HATIFKPQQPYKRC----VAET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 362 lp-~~~~~~~~~~~~~~----~~~~-----~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.. ......+....... .... ...++.++.+||.+||++||.+|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00 00000000000000 0000 1236789999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=455.74 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=223.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.+.|++++.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|++|+|||||++++++.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence 457999999999999999999999999999999998654322 235678899999999999999999999987 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC----cEEEeecccccc
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASF 280 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g----~vKL~DFGla~~ 280 (709)
.+|||||||+++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 8999999999654443333345799999999999999999999999999999999999999776 599999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
+... ......+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.+..+.+..|.+....+..
T Consensus 167 ~~~~--~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------ 237 (293)
T d1jksa_ 167 IDFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237 (293)
T ss_dssp CTTS--CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH------
T ss_pred cCCC--ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc------
Confidence 6533 2335568999999999998754 899999999999999999999999999999998888764333222
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+.++|+.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 238 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 238 -------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 2235689999999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-54 Score=467.52 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=226.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.+.|++++.||+|+||.||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 467999999999999999999999999999999997643 3345567899999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEc--CCCcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld--~~g~vKL~DFGla~~~~~~~ 285 (709)
|||||++ +|...+...+.+|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999996 45566666666899999999999999999999999999999999999998 5789999999999987543
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......+||+.|+|||++.+.. |+.++|||||||+||||+||++||.+.+..+++.+|.+....+..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 249 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 249 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred -CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 3345678999999999998765 899999999999999999999999999999999988764333221
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
..+..+|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 250 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2235689999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=456.22 Aligned_cols=288 Identities=39% Similarity=0.641 Sum_probs=236.5
Q ss_pred CCCCCeeEEeeecccCceEEEEEEECCC-CeEEEEEEEecCCCChHHHHHHHHHHHHHHhc---CCCceeeeeceEeec-
Q 005210 127 RRADSFEKLDKIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSR- 201 (709)
Q Consensus 127 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~~~~~~- 201 (709)
+..++|++++.||+|+||.||+|++..+ ++.||||+++...........+.+|+.+|+.| +|||||++++++...
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3467899999999999999999999765 67899999976544333333455788887766 799999999988542
Q ss_pred --CCCeEEEEEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 202 --MSCSLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 202 --~~~~lyLVmEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
....+|+|||||.++++.. .......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 2457899999999876543 3344557999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 005210 279 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 358 (709)
Q Consensus 279 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~ 358 (709)
...... ......+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|++.++.|....|.
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 765332 3345678999999999998765 8999999999999999999999999999999999999999999988886
Q ss_pred hcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 359 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 359 ~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.........+... ...........+++.+.+||.+||++||.+|||++|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 241 RDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TTCSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 5332222222111 1122344556789999999999999999999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=461.11 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=219.4
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
+.|++++.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+|+.|+|||||++++++.+ .+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 56999999999999999999999999999999997653 3345567899999999999999999999987 6789999
Q ss_pred Eeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCC
Q 005210 210 FEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 288 (709)
Q Consensus 210 mEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 288 (709)
||||+++.+.. +......|++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+... ...
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 99999765544 3444557999999999999999999999999999999999999999999999999999764321 112
Q ss_pred ccccccccCCCCchhhcC----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 289 LTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 289 ~~~~~gT~~Y~APE~l~~----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+||+.|||||++.+ ...|+.++|||||||+||||++|++||.+.+..+.+.+|.+.- +.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~----------- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP----------- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC-----------
Confidence 235689999999999853 3458999999999999999999999999999888888876521 10
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.......+|+++.+||.+||++||.+|||++|+|+||||+.
T Consensus 234 -------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 -------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00112357899999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=450.55 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=214.4
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec--CCCeEEEE
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLV 209 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~--~~~~lyLV 209 (709)
|++.++||+|+||.||+|++..++..||||++..........+.+.+|+.+|++|+|||||++++++... ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677799999999999999999999999999987766677777889999999999999999999998653 24578999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCC--eeeccCCCccEEEc-CCCcEEEeecccccccCCCCC
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~g--IvHrDLKP~NILld-~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||+++.+..+......+++.+++.|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 999997655544444457999999999999999999999998 99999999999997 578999999999986433
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+||+.|||||++.+. |+.++||||||||||||++|++||.+......+.+.+.. +.+..
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~------------ 232 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA------------ 232 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG------------
T ss_pred CccCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc------------
Confidence 233567899999999988753 899999999999999999999999887665554443321 11111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
.....+++++.+||.+||++||++|||++|+|+||||+
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11235788999999999999999999999999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=463.23 Aligned_cols=299 Identities=32% Similarity=0.522 Sum_probs=241.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC----CC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~----~~ 204 (709)
.++|++++.||+|+||+||+|.+..+|+.||||+++.........+.+.+|+.+|+.|+|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999999999999999999876666677788899999999999999999999987532 23
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|||||||+.++...... ..|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 6899999997666655433 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
..+..+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+++..+....+.++.++|.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 23566899999999999887778999999999999999999999999999999999999999999988876533221
Q ss_pred ccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCCCCCCCCCCC
Q 005210 365 ATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 433 (709)
Q Consensus 365 ~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~pp 433 (709)
...+. ........+...+..+++.+++||.+||.+||.+|||++|+|+||||+....+...+..+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~~ 321 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDD 321 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCCC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCCC
Confidence 11110 0011122344556788999999999999999999999999999999997655554444444433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=467.33 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=224.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccc
Confidence 5789999999999999999999999999999999985432 22345667899999999999999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||||+++.+..+......++|..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Cc
Confidence 99999997665555555568999999999999999999999999999999999999999999999999999876432 23
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
.....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|.... +
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~--------------- 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--I--------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C---------------
T ss_pred ccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--C---------------
Confidence 445679999999999998765 7999999999999999999999999999988888776521 1
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 418 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~ 418 (709)
..+..+|+++++||.+||++||.+|+ +++++|+||||+.
T Consensus 223 ------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 11245899999999999999999999 4999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=459.87 Aligned_cols=281 Identities=36% Similarity=0.554 Sum_probs=234.1
Q ss_pred CeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCCeE
Q 005210 131 SFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSCSL 206 (709)
Q Consensus 131 ~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~~l 206 (709)
+|..+++||+|+||+||+|++..+|+.||||++...... ..+|+.+|++|+|||||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765321 23799999999999999999988542 24568
Q ss_pred EEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccC
Q 005210 207 YLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYD 282 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~---~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~ 282 (709)
|||||||++++...+. .....+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655442 3455799999999999999999999999999999999999999775 89999999998764
Q ss_pred CCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCC
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 362 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~l 362 (709)
.. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.+|++.+|.+..+.|.....
T Consensus 175 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 43 2345568999999999998877799999999999999999999999999999999999999999999988875432
Q ss_pred CCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 363 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 363 p~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.......+..............+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222111111111111223345689999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-54 Score=458.87 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=224.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 5689999999999999999999999999999999975432 12335678899999999999999999999987 77899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+|||||.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999998777666666668999999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
..+.+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+.+|.+.- +
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~--------------- 218 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--L--------------- 218 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--C---------------
T ss_pred -cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--C---------------
Confidence 34568999999999998765 8999999999999999999999999999999988886521 1
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.....+++++.+||.+||.+||.+|+ |++++|+||||+..
T Consensus 219 ------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 ------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 11235789999999999999999996 99999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=441.33 Aligned_cols=287 Identities=39% Similarity=0.674 Sum_probs=244.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++|||||++++++.. ...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 68999999999999999999999999999999998776666677888999999999999999999999987 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCCCc
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 289 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 289 (709)
|||+.++++..+......+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999988777776677789999999999999999999999999999999999999999999999999998765432 233
Q ss_pred cccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcccc
Q 005210 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 368 (709)
Q Consensus 290 ~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~ 368 (709)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4457789999999998877789999999999999999998865 678888999999999999998877754221111111
Q ss_pred CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 369 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 369 ~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.+..............+++.+.+||.+||++||.+||||+|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 112222233445567789999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=452.52 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=225.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999997643 233457799999999999999999999987 678999
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCC--CcEEEeecccccccCCCC
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--GILKIADFGLASFYDPDQ 285 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~--g~vKL~DFGla~~~~~~~ 285 (709)
|||||+| +|...+...+..+++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999996 5666665556689999999999999999999999999999999999999854 48999999999876432
Q ss_pred CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 286 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 286 ~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
......++|+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+.+|.+....++...|
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred -CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------
Confidence 2345568999999999987765 899999999999999999999999999999999999875444443333
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+.+|+++++||.+||.+||.+|||++|+|+||||+..
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 4689999999999999999999999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-53 Score=442.01 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=223.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh-------HHHHHHHHHHHHHHhcC-CCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-------ESVRFMAREIHILRRLD-HINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-------~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~ 200 (709)
.++|++.+.||+|+||+||+|++..+++.||||+++...... ...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 578999999999999999999999999999999998764321 22345779999999996 9999999999987
Q ss_pred cCCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 201 RMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.+.+|||||||++ +|...+.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 7889999999986 55555543 4579999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcC-----CccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLG-----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 354 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~ 354 (709)
.+.... ..+..+||+.|+|||++.+ ...|+.++||||+|||||||++|+.||.+.+..+.+..|......+.
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~- 235 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG- 235 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence 875432 3455789999999999863 34478899999999999999999999999999888888875321111
Q ss_pred hhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCC
Q 005210 355 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 418 (709)
Q Consensus 355 ~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~ 418 (709)
.....++|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 236 ------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 ------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1123468999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=460.97 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=222.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++.. ...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 5789999999999999999999999999999999975432 22335667899999999999999999999977 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
+||||+.++.+.........|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999997655544444457999999999999999999999999999999999999999999999999999876432
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 367 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~ 367 (709)
....+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|......
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 256 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---------------- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred -cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC----------------
Confidence 34568999999999998765 799999999999999999999999999998888888653111
Q ss_pred cCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 368 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
....+++++.+||.+||.+||.+|+ |++++|+||||+..
T Consensus 257 -------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 257 -------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 1235889999999999999999995 99999999999853
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-52 Score=455.57 Aligned_cols=260 Identities=24% Similarity=0.332 Sum_probs=211.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC----hHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|++..+|+.||||++...... .........|+.+++.++|||||++++++.. .+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence 67899999999999999999999999999999999754321 1112222345667777789999999999987 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|||||||.++.+..++.....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 89999999996554444444557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.....+||+.|+|||++.+...|+.++||||||||||||++|++||.+.+..+....+......+
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------------ 225 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------------ 225 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------------
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------------
Confidence 23456899999999999876678999999999999999999999998765433322221111110
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccCCCC
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpT-----a~e~L~hp~f~~~ 419 (709)
......+|+++.+||.+||++||.+||| |+++|+||||+..
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 1122468999999999999999999999 8999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=447.87 Aligned_cols=290 Identities=34% Similarity=0.534 Sum_probs=236.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~ 204 (709)
.++|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999987766666777888999999999999999999988642 123
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+++++++++|..++.. .+|++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 4566665555666665533 369999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......|++..+.+..+.+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 233456899999999999888778999999999999999999999999999999999999999998887764322111
Q ss_pred ccccC--CCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCCCC
Q 005210 365 ATIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 424 (709)
Q Consensus 365 ~~~~~--~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 424 (709)
...+. ........+...+..+++.+++||.+||++||.+|||++|+|+||||+....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 11110 1111122344556789999999999999999999999999999999997655443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=448.63 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=219.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHH-hcCCCceeeeeceEeecCCCeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILR-RLDHINVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~-~L~HpnIv~l~~~~~~~~~~~l 206 (709)
.++|++++.||+|+||.||+|.+..+++.||||+++.... .....+.+.+|+.++. .++|||||++++++.+ .+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCce
Confidence 3689999999999999999999999999999999975422 1223445567777765 6899999999999987 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||||+++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~ 157 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-D 157 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-c
Confidence 999999997655555555568999999999999999999999999999999999999999999999999999866433 2
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
...+..+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+..+++.+|... .|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------------- 220 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------------- 220 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--------------
T ss_pred ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------------
Confidence 3345568999999999998765 899999999999999999999999999998888888542 11
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH-HHHhcccCCCC
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 419 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~-e~L~hp~f~~~ 419 (709)
.....+|+++.+||.+||++||.+|||+. ++++||||+..
T Consensus 221 -------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11235899999999999999999999995 89999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=450.98 Aligned_cols=288 Identities=31% Similarity=0.512 Sum_probs=229.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeec----CCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~----~~~ 204 (709)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++|||||+++++|... ..+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3689999999999999999999999999999999988777777777889999999999999999999998653 247
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 205 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
.+|+|||||.++++..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 8999999999998877643 6899999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
...+..++|+.|+|||++.+.. |+.++||||+||++|+|++|++||.+.+...++.+|+...+.+..++|.......
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 3345668999999999998864 8999999999999999999999999999999999999999999988885421100
Q ss_pred cccc-----CCCCccccc--------hhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 365 ATIF-----KPQQPYKRC--------VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 365 ~~~~-----~~~~~~~~~--------~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
...+ ......... .......+++++++||.+||.+||++||||+|+|+||||+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 0000 000000000 011112356789999999999999999999999999999875443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=441.18 Aligned_cols=291 Identities=34% Similarity=0.532 Sum_probs=236.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecC---CCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~---~~~ 205 (709)
.++|++++.||+|+||+||+|.+..+|+.||||+++... .....+.+.+|+.+|+.|+|||||++++++.... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 467999999999999999999999999999999997654 3455667889999999999999999999886532 235
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 285 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 285 (709)
+||||++++++|...+... .+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 7788877777887776543 69999999999999999999999999999999999999999999999999998764322
Q ss_pred --CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 286 --NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 286 --~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.......+||+.|+|||++.....|+.++||||+||++|||++|++||.+.+..++...+...++.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 223455689999999999977777899999999999999999999999999999999999999888887654332111
Q ss_pred Ccccc--CCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCCCCC
Q 005210 364 HATIF--KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 422 (709)
Q Consensus 364 ~~~~~--~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~~~~ 422 (709)
....+ .........+...++++++.+++||.+||++||.+|||++|+|+||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 11100 111111222445667899999999999999999999999999999999866443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-51 Score=435.92 Aligned_cols=281 Identities=29% Similarity=0.507 Sum_probs=228.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
.++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|+.+. ||||+++++++.......+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 578999999999999999999999999999999987432 355779999999995 99999999999876667899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCC-cEEEeecccccccCCCCC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQN 286 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g-~vKL~DFGla~~~~~~~~ 286 (709)
+|||||.++.+..+. ..|++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|..+....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999976655443 3699999999999999999999999999999999999998655 69999999998765432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChhhhhh-cCCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRK-SKLPH 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g-~~~~e~l~~I~k~~g~p~~~~w~~-~~lp~ 364 (709)
.....++|+.|+|||++.+...|+.++|||||||++|||++|+.||.. .+..++...+.+.+|.+....|.. .....
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 345668999999999999887789999999999999999999988864 567778888888888765544422 11111
Q ss_pred ccccC------CCCcccc-chhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 365 ATIFK------PQQPYKR-CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 365 ~~~~~------~~~~~~~-~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
...+. ....... ........++++++|||.+||++||.+|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11110 0111111 1122334588999999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=435.18 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=209.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCCh----HHHHHHHHHHHHHHhcC--CCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLD--HINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|++..+|+.||||+++...... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 468999999999999999999999999999999998653321 11223568999999996 8999999999987
Q ss_pred CCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-CCcEEEeecccccc
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASF 280 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-~g~vKL~DFGla~~ 280 (709)
.+.+|+||||+.+ +++..+......+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+|..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 6789999999975 344333334457999999999999999999999999999999999999985 57999999999987
Q ss_pred cCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 281 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 281 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
... ...+..+||+.|+|||++.+...++.++|||||||+||||++|+.||.+.+ .+.+. ..
T Consensus 161 ~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~-------- 221 (273)
T d1xwsa_ 161 LKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QV-------- 221 (273)
T ss_dssp CCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CC--------
T ss_pred ccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--cc--------
Confidence 543 234567899999999999887767888999999999999999999997642 22221 00
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
.....+|+++.+||.+||++||.+|||++|+|+||||+..
T Consensus 222 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 222 -------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1123589999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-51 Score=428.77 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=214.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--Ce
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~ 205 (709)
.++|++.+.||+|+||.||+|++..+|+.||||+++.... +......+.+|+.+|+.++|||||++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999987654 45566778999999999999999999999876432 45
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC-
Q 005210 206 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD- 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~- 284 (709)
+|||||||+++.+.........+++.+++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 8999999997665545545558999999999999999999999999999999999999999999999999998765332
Q ss_pred -CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 -QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 -~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
........+||+.|||||++.+.. |+.++||||||||||||+||++||.+.+..+.+.++.+....+.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 234 (277)
T ss_dssp -------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----------
T ss_pred ccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----------
Confidence 222345668999999999998765 89999999999999999999999999999988888865322221
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCC
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 417 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~ 417 (709)
.....++|+.+.+||.+||++||.+||+..+.|.|+|++
T Consensus 235 ---------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 122356899999999999999999999666666777753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=442.51 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=208.0
Q ss_pred CCCeeEEe-eecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeec--CCC
Q 005210 129 ADSFEKLD-KIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR--MSC 204 (709)
Q Consensus 129 ~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~--~~~ 204 (709)
.++|+++. .||+|+||.||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 67899886 599999999999999999999999999742 3466899987655 899999999998652 346
Q ss_pred eEEEEEeeccc-cccccccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeeccccc
Q 005210 205 SLYLVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLAS 279 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~ 279 (709)
.+|||||||+| +|...+... ...|++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 79999999985 666665543 347999999999999999999999999999999999999985 5679999999998
Q ss_pred ccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 280 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 280 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
...... .....+||+.|||||++.+.. |+.++||||||||||+|+||++||.+.+..+....+........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 765432 335668999999999887654 89999999999999999999999998876655554433211000
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccCCCC
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 419 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~hp~f~~~ 419 (709)
+. .....+..+|+++.+||.+||++||.+|||+.|+|+||||...
T Consensus 234 --------~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 --------YE-------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --------SS-------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred --------CC-------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00 0011223588999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=425.57 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=210.1
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 578999999999999999999753 359999998776666777889999999999999999999998643 46899
Q ss_pred EEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCC-C
Q 005210 209 VFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-N 286 (709)
Q Consensus 209 VmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~-~ 286 (709)
|||||++ +|...+......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...... .
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999985 5555555555679999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCccccccccCCCCchhhcCC--ccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 QPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~--~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
...+...||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+...++..+......++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------- 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 334566899999999998753 3479999999999999999999999999887777666554321111
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+.....++|+.+.+||.+||..||.+|||+.+++++
T Consensus 230 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0123345689999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-50 Score=422.82 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=207.3
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+..+++.||||+++.+... .+.+.+|+.+|++|+|||||++++++.. .+.+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEE
Confidence 56899999999999999999999999999999998765433 3567899999999999999999999976 678999
Q ss_pred EEeecccc-cccccc-CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHD-LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~-L~~~~~-~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||+++ +...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999965 444443 3445799999999999999999999999999999999999999999999999999987755444
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~p-F~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
...+...||+.|+|||++.+.. |+.++|||||||+||||++|..| |.+.+..+ +.+++.....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~-------------- 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYR-------------- 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCC--------------
T ss_pred eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCC--------------
Confidence 4444556899999999988765 89999999999999999996655 55554444 4433321100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
......+|+.+.+||.+||+.||.+|||++++++
T Consensus 235 -------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0122458899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=414.70 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=200.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++++.||+|+||.||+|.+. ++..||||+++...... +.+.+|+.++++++|||||++++++.. ...+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceecc--CCceEE
Confidence 468999999999999999999986 56789999997654433 457899999999999999999999976 567999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
|||||+++ |...+......+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999865 44555555667999999999999999999999999999999999999999999999999999877554444
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+..|......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------------- 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 221 (263)
T ss_dssp -------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------------
T ss_pred eecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 445568899999999998765 8999999999999999999 67888888887777776542100
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++++.+||..||+.||.+|||++++|+|
T Consensus 222 -------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0113468899999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=417.88 Aligned_cols=253 Identities=23% Similarity=0.413 Sum_probs=211.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+. ++..||||+++...... +.+.+|+.+|++++|||||++++++.. +.+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 468999999999999999999975 57889999997654433 457899999999999999999998754 45799
Q ss_pred EEeecccccccc-ccC-CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHDLAGL-ASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~L~~~-~~~-~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||+++.+.. +.. ....+++.++..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999765543 322 223599999999999999999999999999999999999999999999999999998765444
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
...+...||+.|||||++.+.. |+.++|||||||+||||+| |.++|...+..+.+..+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 4445668899999999998655 7999999999999999999 56777777777777666431100
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh--cccCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFT 417 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~--hp~f~ 417 (709)
.....+++++.+||.+||+.||.+|||++++++ ++||+
T Consensus 230 --------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112357899999999999999999999999998 88886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=418.05 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=203.6
Q ss_pred eeecccCceEEEEEEEC--CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEEEeec
Q 005210 136 DKIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 136 ~~LG~G~fG~Vy~a~~~--~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
++||+|+||.||+|.+. .+++.||||+++....+....+.+.+|+.+|++|+|||||++++++.. ..+|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 47999999999999864 456789999997665556666788999999999999999999999854 3579999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC--Cccc
Q 005210 214 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTS 291 (709)
Q Consensus 214 ~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~ 291 (709)
+++.+..+......+++.++..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...... ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 97655544445557999999999999999999999999999999999999999999999999999876543322 2234
Q ss_pred cccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCccccCC
Q 005210 292 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 370 (709)
Q Consensus 292 ~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~ 370 (709)
..||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+..+....|.+. ..
T Consensus 170 ~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~------------------ 228 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER------------------ 228 (277)
T ss_dssp -CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC------------------
T ss_pred cCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC------------------
Confidence 57899999999998765 7999999999999999998 89999999887776666431 10
Q ss_pred CCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH---HhcccCC
Q 005210 371 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFT 417 (709)
Q Consensus 371 ~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~---L~hp~f~ 417 (709)
......+|+++.+||..||+.||.+|||++++ |+|+|+.
T Consensus 229 --------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 01124578999999999999999999999998 5676653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=415.11 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=213.1
Q ss_pred CCCeeEEee-ecccCceEEEEEEECC--CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDK-IGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~-LG~G~fG~Vy~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|.+.+. ||+|+||.||+|.+.. ++..||||+++... .....+.+.+|+.+|++|+|||||++++++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---Ce
Confidence 467888884 9999999999998764 45579999997543 45566778899999999999999999998864 35
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|||||||+++ |...+......+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 89999999965 54545555668999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 285 QN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 285 ~~--~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.. .......||+.|+|||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..|.+. ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~~--------- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--KR--------- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--CC---------
T ss_pred ccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CC---------
Confidence 22 2233457899999999998765 8999999999999999998 99999998888777766431 10
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHH---HhcccCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFT 417 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~---L~hp~f~ 417 (709)
.+...++|+++.+||..||+.||.+|||+.++ |+|+|++
T Consensus 231 -----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01224688999999999999999999999888 6788875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-49 Score=418.34 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=200.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe---EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+|++|+|||||++++++.. ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 4679999999999999999999987765 58888876443 44556678899999999999999999999976 577
Q ss_pred EEEEEeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|||||||+++.+. .+......+++.++..|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999976544 45555567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC----CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhh
Q 005210 285 QNQ----PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 359 (709)
Q Consensus 285 ~~~----~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~ 359 (709)
... ......||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..|.+....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-------- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-------- 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred CCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 221 122346799999999988755 8999999999999999998 89999999988887777542111
Q ss_pred cCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 360 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 360 ~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....++++.+.+||..||+.||.+|||+.+++++
T Consensus 253 --------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 --------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123578999999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=409.36 Aligned_cols=250 Identities=20% Similarity=0.341 Sum_probs=215.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.++||+|+||.||+|++. +++.||||+++...... +.+.+|+.++++++|||||++++++.+ .+.+|+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEE
Confidence 468999999999999999999984 78899999998765543 457899999999999999999999976 678999
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCCC
Q 005210 209 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 287 (709)
Q Consensus 209 VmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 287 (709)
||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999855 55555555567999999999999999999999999999999999999999999999999999877555444
Q ss_pred CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCcc
Q 005210 288 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 366 (709)
Q Consensus 288 ~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~~ 366 (709)
......+|+.|+|||++.+.. |+.++|||||||++|||+| |+.||.+.+..+...+|.+....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred eecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 555678999999999998765 7999999999999999998 899999999888887775421111
Q ss_pred ccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 367 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....+++.+.+||.+||+.||.+|||++++|+|
T Consensus 222 --------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113577899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=423.14 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=206.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe-----EEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 4689999999999999999999876543 69999986543 233445678999999998 89999999999977
Q ss_pred CCeEEEEEeeccc-cccccccCCC----------------------CCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCC
Q 005210 203 SCSLYLVFEYMEH-DLAGLASHPG----------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259 (709)
Q Consensus 203 ~~~lyLVmEy~~g-~L~~~~~~~~----------------------~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP 259 (709)
.+.+|||||||++ +|...+.... ..+++.+++.|+.||+.||.|||++|||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 6789999999986 4544443321 3589999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEeecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCC
Q 005210 260 SNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRT 337 (709)
Q Consensus 260 ~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~ 337 (709)
+|||++.++++||+|||+|+........ .....+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876443322 234567899999999988765 8999999999999999997 899999988
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
..+.+.++++....+ .....+|+++.+||.+||+.||.+|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777777766521111 1123578999999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=409.45 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=199.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC---eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+.+|+.+|++++|||||++++++.. +.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 368999999999999999999987653 56888887543 345556778899999999999999999998853 56
Q ss_pred EEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCC
Q 005210 206 LYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 284 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 284 (709)
+|||||||.++ +...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 89999999865 44444455567999999999999999999999999999999999999999999999999999877554
Q ss_pred CCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCC
Q 005210 285 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 363 (709)
Q Consensus 285 ~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp 363 (709)
.....+...||+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+.+.+|... ..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--~~----------- 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ER----------- 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--CC-----------
T ss_pred cceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CC-----------
Confidence 444445667899999999998655 8999999999999999998 89999999888887777532 10
Q ss_pred CccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 364 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
....+++|+.+.+||.+||..||.+|||+.+++++
T Consensus 228 ---------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234689999999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=425.77 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=216.6
Q ss_pred CCCeeEEeeecccCceEEEEEEEC---CCCeEEEEEEEecCCC--ChHHHHHHHHHHHHHHhcCC-CceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDH-INVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~ 202 (709)
.++|++++.||+|+||.||+|++. .+|+.||||+++.... +....+.+.+|+.+|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 578999999999999999999974 4789999999865432 12233456789999999976 899999999987
Q ss_pred CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccC
Q 005210 203 SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 282 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~ 282 (709)
...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 67899999999975555444445578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCccccccccCCCCchhhcCCc-cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 283 PDQNQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 283 ~~~~~~~~~~~gT~~Y~APE~l~~~~-~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
...........||+.|+|||.+.+.. .|+.++|||||||+||||++|+.||.+.+..+....+.+....+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--------- 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------- 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC---------
Confidence 54444455678999999999997643 46889999999999999999999999877666555554421110
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccCCCC
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 419 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRp-----Ta~e~L~hp~f~~~ 419 (709)
.......+++.+.+||.+||.+||.+|| |++|+|+||||+..
T Consensus 252 ----------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 252 ----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ----------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 0012246899999999999999999999 58999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=408.00 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=205.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|++..+ ..||||+++...... +.+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec---CCeEE
Confidence 57899999999999999999998765 569999997654433 457899999999999999999998853 45899
Q ss_pred EEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~L~~~~~~--~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
|||||.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+.....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999764443322 234699999999999999999999999999999999999999999999999999987755444
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
...+...||+.|+|||++.+.. |+.++|||||||+||||++ |.++|.+....+.+..+.+....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 4455678999999999998765 7999999999999999999 56777777777777776542211
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh--cccCCCC
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTMK 419 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~--hp~f~~~ 419 (709)
.....+++++.+||.+||+.||++|||+++++. ++||+..
T Consensus 234 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 122457899999999999999999999999987 8899753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=400.38 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC----eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
...|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+|++|+|||||++++++.. ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CC
Confidence 467999999999999999999987655 479999997543 34455668899999999999999999999876 67
Q ss_pred eEEEEEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g~L~~~-~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|+|||||.++++.. +......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 7999999999765543 444556799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG-~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
.... ......||+.|||||++.+.. |+.++|||||||+||||++| .++|.+.+..+.+..+.... .
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~--------- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-R--------- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-C---------
T ss_pred CCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-C---------
Confidence 3221 223456899999999998765 89999999999999999995 56666666666655553211 0
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.....+++..+.+||..||+.||.+|||+.++++
T Consensus 232 ------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0112357889999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=409.77 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=203.2
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCe----EEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
..+|++++.||+|+||.||+|.+..+|+ .||+|+++... .....+.+.+|+.+|++|+|||||++++++.. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~ 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---S 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 4679999999999999999999988876 57888876432 23345678899999999999999999999875 3
Q ss_pred eEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~-g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
..++||||+. ++|...+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+..
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 4677777776 566666666667899999999999999999999999999999999999999999999999999988754
Q ss_pred CCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcC
Q 005210 284 DQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 361 (709)
Q Consensus 284 ~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~ 361 (709)
.... ......||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+....+.+.. .+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~--------- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL--------- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC---------
T ss_pred ccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC---------
Confidence 3332 233457899999999998765 8999999999999999998 899999887776665554311 00
Q ss_pred CCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 362 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 362 lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.....+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=402.44 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=196.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 3689999999999999999999754 45789999987543 334455677788888776 789999999887653
Q ss_pred CCeEEEEEeecccccc-ccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC
Q 005210 203 SCSLYLVFEYMEHDLA-GLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 266 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~-~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~ 266 (709)
...+|+|||||+++.+ ..+.. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 5678999999986544 33321 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhC-CCCCCCCChHHHHHH
Q 005210 267 NGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHK 344 (709)
Q Consensus 267 ~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG-~~pF~g~~~~e~l~~ 344 (709)
++++||+|||+|+....... ...+..+||+.|||||++.+.. |+.++|||||||++|||++| .+||.+....+.+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987643322 2334568999999999998755 89999999999999999986 578988776666655
Q ss_pred HHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 345 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 345 I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
++.....+ .....+++++.+||.+||+.||.+|||++++|+|
T Consensus 249 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54421111 1123578899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=398.60 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=199.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-CC--eEEEEEEEecCCC-ChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-QK--KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 204 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-tg--~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~ 204 (709)
.++|++++.||+|+||.||+|++.. ++ ..||||++..... ..+..+.+.+|+.+|++|+|||||++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 3679999999999999999998643 33 4689999876544 34556778899999999999999999999864 3
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCC
Q 005210 205 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 283 (709)
Q Consensus 205 ~lyLVmEy~~g-~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~ 283 (709)
.+|||||||++ ++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 57999999985 44444444455799999999999999999999999999999999999999999999999999998744
Q ss_pred CCCC--CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 284 DQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 284 ~~~~--~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
.... ......||..|+|||++.+.. |+.++|||||||++|||+| |++||.+.+..+.+.+|.+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred CCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--------
Confidence 3221 223446788999999998755 8999999999999999998 899999999999888886521111
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
....++|+.+.+||.+||..||.+|||+.++++
T Consensus 235 -------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123468899999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-47 Score=399.08 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=208.0
Q ss_pred CCCeeEEeeecccCceEEEEEEEC-----CCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 468999999999999999999975 356889999987543 45556778999999999999999999999976 6
Q ss_pred CeEEEEEeecccc-ccccccC-----------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCC
Q 005210 204 CSLYLVFEYMEHD-LAGLASH-----------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 259 (709)
Q Consensus 204 ~~lyLVmEy~~g~-L~~~~~~-----------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP 259 (709)
..+++||||+.++ |...+.. ....|++.++..|+.||+.||.|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 7799999999864 4333321 123489999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEeecccccccCCCC-CCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCC
Q 005210 260 SNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRT 337 (709)
Q Consensus 260 ~NILld~~g~vKL~DFGla~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~ 337 (709)
+||||+.++++||+|||+|+.+.... ....++..||+.|+|||++.+.. |+.++||||||||||||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999998664332 22334567899999999998765 899999999999999999985 7899999
Q ss_pred hHHHHHHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 338 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 338 ~~e~l~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+.+..+.+.. . .....++|+++.+||..||+.||.+|||+.++++
T Consensus 248 ~~e~~~~v~~~~--~--------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGN--I--------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTC--C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC--C--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888887765321 0 1123468899999999999999999999999965
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-46 Score=392.23 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=206.8
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+|+.+++.++|+|+|.++..+... ....|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 57999999999999999999999999999999987654322 356899999999888766655444332 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC---CCcEEEeecccccccCCCCC
Q 005210 210 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 210 mEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~---~g~vKL~DFGla~~~~~~~~ 286 (709)
|||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999888877777778999999999999999999999999999999999999864 45799999999987643221
Q ss_pred ------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChhhhhhc
Q 005210 287 ------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 360 (709)
Q Consensus 287 ------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~ 360 (709)
......+||+.|||||++.+.. |+.++|||||||++|||++|++||.+....+....+.+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------- 232 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------- 232 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--------
T ss_pred ccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--------
Confidence 1234568999999999998765 8999999999999999999999998876655544433211000
Q ss_pred CCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhcccCCC
Q 005210 361 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA---SALRSEFFTM 418 (709)
Q Consensus 361 ~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~---e~L~hp~f~~ 418 (709)
..........++|+++.+||..||+.||.+||+++ ++|+|+|.+.
T Consensus 233 -------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00012233457899999999999999999999987 5578887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=388.24 Aligned_cols=245 Identities=21% Similarity=0.354 Sum_probs=196.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 208 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyL 208 (709)
.++|++.+.||+|+||.||+|.+ +|..||||+++.+. ..+.+.+|+.+|++++|||||++++++... .+.+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEE
Confidence 57899999999999999999997 47789999997543 235578999999999999999999988653 356899
Q ss_pred EEeeccccccc-cccCC-CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC
Q 005210 209 VFEYMEHDLAG-LASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 286 (709)
Q Consensus 209 VmEy~~g~L~~-~~~~~-~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 286 (709)
||||++++.+. .+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999865444 43322 234899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChhhhhhcCCCCc
Q 005210 287 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 365 (709)
Q Consensus 287 ~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l~~I~k~~g~p~~~~w~~~~lp~~ 365 (709)
.....+|+.|+|||++.+.. |+.++|||||||++|||+| |++||.+.+..+.+..|.+..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------------- 217 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 217 (262)
T ss_dssp -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred --CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 23346799999999998765 7999999999999999998 799998887777766663210
Q ss_pred cccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 366 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. .+....+++.+.+||..||..||.+|||+.+++++
T Consensus 218 ---~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ---K---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---C---------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 11234578999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=394.83 Aligned_cols=251 Identities=27% Similarity=0.331 Sum_probs=203.9
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeE--EEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecCCCe
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 205 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~~~~ 205 (709)
.++|++.+.||+|+||.||+|++..++.. ||||+++... ..+..+.+.+|+.+|.++ +|||||++++++.. .+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 47899999999999999999999988875 6777775433 233456688999999999 79999999999987 678
Q ss_pred EEEEEeecccc-ccccccC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCc
Q 005210 206 LYLVFEYMEHD-LAGLASH---------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 269 (709)
Q Consensus 206 lyLVmEy~~g~-L~~~~~~---------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~ 269 (709)
+||||||++++ |...+.. ....|++.++..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999964 4444322 2357999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q 005210 270 LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKL 348 (709)
Q Consensus 270 vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~-~pF~g~~~~e~l~~I~k~ 348 (709)
+||+|||+++....... .....||..|+|||.+.+.. |+.++||||||||+|||++|. +||.+.+..+.+..|.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999986543222 23446899999999998765 799999999999999999965 789888887777666431
Q ss_pred hCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 349 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 349 ~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
. . ......+++++.+||.+||+.||++|||+.++|++
T Consensus 243 ~--~--------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y--R--------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C--C--------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C--C--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 0 01224578999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=389.20 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=202.4
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCC-------eEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQK-------KIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~ 200 (709)
.++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|+.++.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 478999999999999999999976654 479999997654 344556678899999888 89999999999976
Q ss_pred cCCCeEEEEEeeccccccc-cccCC---------------CCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 201 RMSCSLYLVFEYMEHDLAG-LASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~L~~-~~~~~---------------~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
.+.+|+|||||+++.+. .+... ...+++.+++.|+.||+.||.|||+++||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 67899999999865444 33221 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||+++....... ......++|+.|+|||++.+.. |+.++||||||||||||++ |.+||.+.+..+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987643322 2344567899999999998754 8999999999999999998 79999888877665
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
..+... ..+ .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 554321 111 112458899999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=390.83 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=209.6
Q ss_pred CCCeeEEeeecccCceEEEEEEE-----CCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhc-CCCceeeeeceEeecC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM 202 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~~~~~~~ 202 (709)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+++++ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 47899999999999999999986 3577899999997654 345566788999999999 79999999999976
Q ss_pred CCeEEEEEeeccccccccccC------------------CCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEE
Q 005210 203 SCSLYLVFEYMEHDLAGLASH------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 264 (709)
Q Consensus 203 ~~~lyLVmEy~~g~L~~~~~~------------------~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILl 264 (709)
...+|||||||+++.+..+.. ....+++.++..|+.||+.||.|||++|||||||||+||||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 567999999998654433221 22368999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecccccccCCCCC-CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHh-CCCCCCCCChHHHH
Q 005210 265 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 342 (709)
Q Consensus 265 d~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELlt-G~~pF~g~~~~e~l 342 (709)
+.++.+||+|||+++....... ...+..+||+.|+|||++.+.. |+.++|||||||+||||+| |.++|.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 2334568899999999998654 7999999999999999998 78888888877777
Q ss_pred HHHHHhhCCCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.++++....+ .....+|+.+.+||.+||+.||.+|||++++|+
T Consensus 258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7766431111 112357899999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-44 Score=389.47 Aligned_cols=282 Identities=28% Similarity=0.424 Sum_probs=216.9
Q ss_pred CCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeceE
Q 005210 130 DSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----------HINVIKLEGLV 198 (709)
Q Consensus 130 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIv~l~~~~ 198 (709)
++|+++++||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.+|+.+. |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999999999999999999754 233455678999998875 47899999988
Q ss_pred eecCCCeEEEEEeecccc---ccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh-CCeeeccCCCccEEEcCCC------
Q 005210 199 TSRMSCSLYLVFEYMEHD---LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNG------ 268 (709)
Q Consensus 199 ~~~~~~~lyLVmEy~~g~---L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-~gIvHrDLKP~NILld~~g------ 268 (709)
........++||+++... ...........+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 766566777888776532 222333445579999999999999999999998 8999999999999998665
Q ss_pred cEEEeecccccccCCCCCCCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCC------hHHHH
Q 005210 269 ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQL 342 (709)
Q Consensus 269 ~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~------~~e~l 342 (709)
.+||+|||.+..... .....+||+.|+|||++.+.. |+.++|||||||++++|++|+.||.+.. ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986532 234568999999999998765 7999999999999999999999997543 45677
Q ss_pred HHHHHhhCCCChhhhhhcCCCCcc--------ccC--CCCccccchhc---ccCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 005210 343 HKIFKLCGSPSEDYWRKSKLPHAT--------IFK--PQQPYKRCVAE---TFKDFPAPALALMETLLSIDPADRGSAAS 409 (709)
Q Consensus 343 ~~I~k~~g~p~~~~w~~~~lp~~~--------~~~--~~~~~~~~~~~---~~~~~s~~~~dLI~~lL~~DP~kRpTa~e 409 (709)
..++..+|.++.+.+......... .+. ...+....... .....++.+.|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 888889999887766543211100 000 01111111111 12235678999999999999999999999
Q ss_pred HHhcccCCCC
Q 005210 410 ALRSEFFTMK 419 (709)
Q Consensus 410 ~L~hp~f~~~ 419 (709)
+|+||||+..
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=390.09 Aligned_cols=252 Identities=18% Similarity=0.246 Sum_probs=208.7
Q ss_pred CCCeeEEeeecccCceEEEEEEECC-----CCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 203 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~ 203 (709)
.++|++.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.++++++|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 4799999999999999999998753 45789999987543 44455678899999999999999999999876 5
Q ss_pred CeEEEEEeecccccc-cccc---------CCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEe
Q 005210 204 CSLYLVFEYMEHDLA-GLAS---------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273 (709)
Q Consensus 204 ~~lyLVmEy~~g~L~-~~~~---------~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~ 273 (709)
..+|||||||.++.+ ..+. .....+++.++..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 679999999986543 3322 112357999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCC-CccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCC
Q 005210 274 DFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGS 351 (709)
Q Consensus 274 DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG-~~pF~g~~~~e~l~~I~k~~g~ 351 (709)
|||+|+.+...... ..+..+||+.|+|||.+.+.. |+.++|||||||+||||+|| .+||.+.+..+.+..+.+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-- 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC--
Confidence 99999876433222 233457899999999998765 78999999999999999998 58899988888877775421
Q ss_pred CChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 352 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 352 p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
.......+++.+.+||.+||+.||.+|||+.++|+
T Consensus 253 --------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 --------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01122457899999999999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=382.42 Aligned_cols=250 Identities=21% Similarity=0.235 Sum_probs=198.4
Q ss_pred eEEeeecccCceEEEEEEECCCC---eEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCCCeEEEE
Q 005210 133 EKLDKIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 209 (709)
Q Consensus 133 ~~~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~~~lyLV 209 (709)
...++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+.+|++|+|||||++++++... ...+|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEE
Confidence 33678999999999999987653 36899998743 3456677899999999999999999999987653 4679999
Q ss_pred Eeeccccccc-cccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeecccccccCCCCC--
Q 005210 210 FEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 286 (709)
Q Consensus 210 mEy~~g~L~~-~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DFGla~~~~~~~~-- 286 (709)
||||+++.+. ++......+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999975554 4555566788999999999999999999999999999999999999999999999999987643322
Q ss_pred -CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCC-ChHHHHHHHHHhhCCCChhhhhhcCCCC
Q 005210 287 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-TEVEQLHKIFKLCGSPSEDYWRKSKLPH 364 (709)
Q Consensus 287 -~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~-~~~e~l~~I~k~~g~p~~~~w~~~~lp~ 364 (709)
.......||+.|+|||++.+.. |+.++|||||||+||||+||..||... +..+....+... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~------------ 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR------------ 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC------------
T ss_pred ceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC------------
Confidence 2233457899999999988755 799999999999999999976666543 333333433321 10
Q ss_pred ccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 365 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
+ .....+++.+.+||..||..||.+|||+.|+++|
T Consensus 253 -----~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -----L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----C---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 1123578899999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.7e-44 Score=373.77 Aligned_cols=253 Identities=19% Similarity=0.222 Sum_probs=207.0
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC-CceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~~~~~~~~~~ly 207 (709)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.|.| +||+.+++++.. ....|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccE
Confidence 36899999999999999999999999999999998754322 235679999999965 899999988876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcC-----CCcEEEeecccccccC
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-----NGILKIADFGLASFYD 282 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~-----~g~vKL~DFGla~~~~ 282 (709)
+||||++++|...+...+..+++..+..++.|++.||.|||++||+||||||+||||+. ++.+||+|||+|+.+.
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999998888887777778999999999999999999999999999999999999974 5789999999998764
Q ss_pred CCCC------CCccccccccCCCCchhhcCCccCCccccccchhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCC
Q 005210 283 PDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPS 353 (709)
Q Consensus 283 ~~~~------~~~~~~~gT~~Y~APE~l~~~~~y~~~~DIWSLG~iL~ELltG~~pF~g~~~---~e~l~~I~k~~g~p~ 353 (709)
.... ......+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+... .+.+.++....-.+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence 3211 1234568999999999998765 89999999999999999999999986543 33333333211000
Q ss_pred hhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q 005210 354 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 412 (709)
Q Consensus 354 ~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~ 412 (709)
...+..+++|+++.+|+..|+..+|.+||+.+.+.+
T Consensus 236 -----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 -----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 122344678999999999999999999998766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=373.46 Aligned_cols=272 Identities=23% Similarity=0.229 Sum_probs=188.6
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCceeeeeceEeecCC--CeE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSL 206 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~~~~~~~~--~~l 206 (709)
+.+|.+.+.||+|+||.||+|++ +|+.||||+++... ........|+..+..++|||||++++++..... ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 45789999999999999999986 68899999986432 111222345555667899999999999876432 468
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh--------CCeeeccCCCccEEEcCCCcEEEeecccc
Q 005210 207 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS--------RGVLHRDIKGSNLLIDNNGILKIADFGLA 278 (709)
Q Consensus 207 yLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~--------~gIvHrDLKP~NILld~~g~vKL~DFGla 278 (709)
|||||||.++.+..+.... .+++.++..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999875554444333 68999999999999999999996 59999999999999999999999999999
Q ss_pred cccCCCCC---CCccccccccCCCCchhhcCCc-----cCCccccccchhHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 005210 279 SFYDPDQN---QPLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 350 (709)
Q Consensus 279 ~~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~-----~y~~~~DIWSLG~iL~ELltG~~pF~g~~~~e~l~~I~k~~g 350 (709)
..+..... ......+||+.|+|||++.+.. .|+.++|||||||+||||+||.+||......+...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~ 234 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPS 234 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-ccc
Confidence 87643322 1234568999999999987642 25778999999999999999998875432111000000 000
Q ss_pred CCChhhhhhcCCCCccccCCCCccccchhcccCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q 005210 351 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 413 (709)
Q Consensus 351 ~p~~~~w~~~~lp~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~lL~~DP~kRpTa~e~L~h 413 (709)
.+......... ....++|..+.. ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~--~~~~~~p~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVV--CEQKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHH--TTSCCCCCCCGG----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHH--hccccCCCCCcc----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000000000 000001110000 0011233458899999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.1e-24 Score=211.13 Aligned_cols=165 Identities=16% Similarity=0.120 Sum_probs=120.6
Q ss_pred eeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCC----------------hHHHHHHHHHHHHHHhcCCCceeeee
Q 005210 132 FEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----------------PESVRFMAREIHILRRLDHINVIKLE 195 (709)
Q Consensus 132 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----------------~~~~~~~~rEi~iL~~L~HpnIv~l~ 195 (709)
+.+.++||+|+||.||+|.+. +|+.||||+++..... ........+|..+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999984 6899999987642110 01123345789999999999999887
Q ss_pred ceEeecCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhhCCeeeccCCCccEEEcCCCcEEEeec
Q 005210 196 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 275 (709)
Q Consensus 196 ~~~~~~~~~~lyLVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~~gIvHrDLKP~NILld~~g~vKL~DF 275 (709)
++.. .+|||||+++..... +++..+..++.||+.+|.|||++||+||||||+||||+.+ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 5431 279999999865433 3455567899999999999999999999999999999865 5899999
Q ss_pred ccccccCCCCCCCccccccccCCCC------chhhcCCccCCccccccchhHH
Q 005210 276 GLASFYDPDQNQPLTSRVVTLWYRP------PELLLGATYYGTAVDLWSTGCI 322 (709)
Q Consensus 276 Gla~~~~~~~~~~~~~~~gT~~Y~A------PE~l~~~~~y~~~~DIWSLG~i 322 (709)
|+|......... .|.. .+.+ ...|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence 999765322111 1111 1222 1347899999998543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.13 E-value=2.7e-06 Score=84.06 Aligned_cols=140 Identities=14% Similarity=0.127 Sum_probs=85.5
Q ss_pred CCCeeEEeeecccCceEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcC-CCceeeeeceEeecCCCeEE
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLY 207 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~~~~~~~~~~ly 207 (709)
...|+..+..+.++.+.||+.. .++..+.||+....... ....+.+|..+|..|. +--+.+++.+... .+..|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceE
Confidence 3456766665555567899885 45556788887543211 1223567888888773 3335666666555 56789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHHhhhhh--------------------------------------
Q 005210 208 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-------------------------------------- 249 (709)
Q Consensus 208 LVmEy~~g~L~~~~~~~~~~lse~~i~~i~~QIl~aL~yLH~-------------------------------------- 249 (709)
+||++++|..+....... .. ...++.++...|..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999875443211110 01 11122223333333331
Q ss_pred ---------------------CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 ---------------------RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ---------------------~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999877667799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=7.4e-05 Score=73.00 Aligned_cols=73 Identities=15% Similarity=0.141 Sum_probs=48.1
Q ss_pred eecccCc-eEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCC--CceeeeeceEeecCCCeEEEEEeec
Q 005210 137 KIGQGTY-SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFEYM 213 (709)
Q Consensus 137 ~LG~G~f-G~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~~~~~~~~~~lyLVmEy~ 213 (709)
.+..|.. +.||+... .++..+.+|....... ..+.+|+.+|+.|.. -.+.+++.+..+ .+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 4455553 67999874 5566788897654322 235678888887733 235566666554 56789999999
Q ss_pred cccc
Q 005210 214 EHDL 217 (709)
Q Consensus 214 ~g~L 217 (709)
+|..
T Consensus 89 ~G~~ 92 (255)
T d1nd4a_ 89 PGQD 92 (255)
T ss_dssp SSEE
T ss_pred eccc
Confidence 8743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=3.4e-05 Score=81.64 Aligned_cols=77 Identities=19% Similarity=0.211 Sum_probs=48.0
Q ss_pred EeeecccCceEEEEEEECCCCeEEEEEEEecC-CC----ChHHHHHHHHHHHHHHhc-CC--CceeeeeceEeecCCCeE
Q 005210 135 LDKIGQGTYSNVYRARDLDQKKIVALKKVRFD-NL----EPESVRFMAREIHILRRL-DH--INVIKLEGLVTSRMSCSL 206 (709)
Q Consensus 135 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~-~~----~~~~~~~~~rEi~iL~~L-~H--pnIv~l~~~~~~~~~~~l 206 (709)
.+.||.|....||++.+..+++.|+||.-... .. .+....+..+|+.+|+.+ .+ ..+.+++.+ + ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d--~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c--CCCC
Confidence 66899999999999998888888999975421 00 111233455788888877 22 345556543 2 2334
Q ss_pred EEEEeeccc
Q 005210 207 YLVFEYMEH 215 (709)
Q Consensus 207 yLVmEy~~g 215 (709)
++|||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.85 E-value=0.0019 Score=65.81 Aligned_cols=69 Identities=16% Similarity=0.216 Sum_probs=42.6
Q ss_pred eEEEEEEECCCCeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-----eeeeceEeecCCCeEEEEEeecccc
Q 005210 144 SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-----IKLEGLVTSRMSCSLYLVFEYMEHD 216 (709)
Q Consensus 144 G~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-----v~l~~~~~~~~~~~lyLVmEy~~g~ 216 (709)
-.||++.. ++|..|++|+.+..... .+.+..|...|..|....| +..-+-.........+.|++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 58999975 67888999998765433 3446678888888742222 1221111111246678899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.60 E-value=0.0049 Score=64.24 Aligned_cols=77 Identities=17% Similarity=0.200 Sum_probs=49.8
Q ss_pred CCCeeEEeeecccCceEEEEEEECCC-------CeEEEEEEEecCCCChHHHHHHHHHHHHHHhcCCCce-eeeeceEee
Q 005210 129 ADSFEKLDKIGQGTYSNVYRARDLDQ-------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTS 200 (709)
Q Consensus 129 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~~~~~ 200 (709)
.++++ ++.|+.|-.-.+|++..... .+.|.+++.- .... .-...+|..+++.+.-.++ .++++++.+
T Consensus 42 ~~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 42 LEHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred ccceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 46888899999999986532 3456666653 2211 2235589999998843344 467666532
Q ss_pred cCCCeEEEEEeecccc
Q 005210 201 RMSCSLYLVFEYMEHD 216 (709)
Q Consensus 201 ~~~~~lyLVmEy~~g~ 216 (709)
.+||||++|.
T Consensus 117 ------g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ------GRLEEYIPSR 126 (395)
T ss_dssp ------EEEECCCCEE
T ss_pred ------ceEEEEeccc
Confidence 5899999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.80 E-value=0.018 Score=57.47 Aligned_cols=30 Identities=27% Similarity=0.462 Sum_probs=27.1
Q ss_pred CCeeeccCCCccEEEcCCCcEEEeeccccc
Q 005210 250 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 279 (709)
Q Consensus 250 ~gIvHrDLKP~NILld~~g~vKL~DFGla~ 279 (709)
.||||+|+.++|||++.+..+-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988878899999875
|
| >d2ogqa1 d.223.1.2 (A:371-494) Serine/threonine-protein kinase plk C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Polo-box domain superfamily: Polo-box domain family: Polo-box duplicated region domain: Serine/threonine-protein kinase plk C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.66 E-value=0.0016 Score=57.04 Aligned_cols=36 Identities=22% Similarity=0.209 Sum_probs=28.2
Q ss_pred CccchhhhhhcCCCCCCCCCccccccCCCccccccccc
Q 005210 540 PLAQRAAWAKAGKNTDDAPKISTGADLSTGLVAARRSL 577 (709)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (709)
|...|..| +.||+||++|||+||+||++.+++-=+.
T Consensus 33 P~~~P~~~--V~KWvDYS~KyGlgY~LSdgtvGV~FND 68 (124)
T d2ogqa1 33 PACIPIFW--VSKWVDYSDKYGLGYQLCDNSVGVLFND 68 (124)
T ss_dssp GGGCCSCC--EEEEEEETTTTEEEEEETTSCEEEEETT
T ss_pred CccCCCEE--eEeeeecCCCceEEEEEcCCcEEEEEeC
Confidence 44444444 5699999999999999999999985444
|